"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,DE,T2,DE 69130710 T2,191-474-804-124-430,1999-09-02,1999,DE 69130710 T,1991-10-16,US 60050190 A;;US 9107696 W,1990-10-19,VORRICHTUNG ZUR STEREOTAKTISCHEN CHIRURGIE UND VERFAHREN ZUR STEUERUNG DER VORRICHTUNG,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INC,ADLER JOHN,,https://lens.org/191-474-804-124-430,Granted Patent,no,0,0,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,G01R33/48;;A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,,0,0,,,,EXPIRED
2,DE,D1,DE 69130710 D1,100-368-377-959-942,1999-02-11,1999,DE 69130710 T,1991-10-16,US 60050190 A;;US 9107696 W,1990-10-19,VORRICHTUNG ZUR STEREOTAKTISCHEN CHIRURGIE UND VERFAHREN ZUR STEUERUNG DER VORRICHTUNG,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INC,ADLER JOHN,,https://lens.org/100-368-377-959-942,Granted Patent,no,0,0,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,G01R33/48;;A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,,0,0,,,,EXPIRED
3,US,A,US 2952306 A,064-542-420-731-669,1960-09-13,1960,US 62649656 A,1956-12-05,US 62649656 A,1956-12-05,Chair brace,,JOHN ADLER,JOHN ADLER,,https://lens.org/064-542-420-731-669,Granted Patent,no,11,6,1,1,0,F16B12/40;;Y10T403/46;;Y10T403/46;;F16B12/40,F16B12/40,,0,0,,,,EXPIRED
4,US,A,US 2699817 A,187-714-586-497-727,1955-01-18,1955,US 38099153 A,1953-09-18,US 38099153 A,1953-09-18,Folding high chair,,JOHN ADLER;;ADLER DALE O,JOHN ADLER;;ADLER DALE O,,https://lens.org/187-714-586-497-727,Granted Patent,no,7,15,1,1,0,A47D1/023;;A47D1/023;;A47D1/008;;A47D1/008,A47D1/02,,0,0,,,,EXPIRED
5,CA,A,CA 522470 A,026-429-816-952-510,1956-03-06,1956,CA 522470D A,,CA 522470T A,,AUTOMATIC-TAPERED SOCKET LEG LOCKING DEVICE FOR CARD TABLES,,SHWAYDER BROTHERS INC,ADLER JOHN B,,https://lens.org/026-429-816-952-510,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
6,US,A,US 2498229 A,158-223-310-870-019,1950-02-21,1950,US 3773848 A,1948-07-09,US 3773848 A,1948-07-09,Portable service station mounted on a vehicle,,JAX INC,ADLER JOHN H,,https://lens.org/158-223-310-870-019,Granted Patent,no,17,173,1,1,0,B60P3/14;;B60P3/14;;Y10S119/01;;Y10S119/01;;Y10T137/3802;;Y10T137/3802;;Y10T137/4874;;Y10T137/4874;;Y10T137/6633;;Y10T137/6633,B60P3/14,,0,0,,,,EXPIRED
7,EP,A1,EP 0011690 A1,155-563-077-586-514,1980-06-11,1980,EP 79103532 A,1979-09-19,US 96419878 A,1978-11-28,Improved amusement device.,"An amusement device for use by children both for enter- tainmentas well as a coordination aid. The device comprises a plurality of thin essentially similar segments (10), each segment pivotally engaging adjacent segments in snap-in relation (12). The pivotal engagement enables rotation of one segment (10) with respect to an adjacently engaged segment (10) through a predetermined angle. Locking means are formed into the segments (10), preventing translation of one segment (10) with respect to another when such segments (10) are engaged. When connected in the form of an open belt, the device may be manipulated in various entertaining manners, and upon articulation, the impact of adjacent segments (10) produces a slapping sound for additional amusement. When the free ends of the belt arrangement are engaged to form a closed loop, two segment stacks (16, 18) are created. Back-and-forth manipulation of each segment stack causes individual segments (10) to move from one stack (16,. 18) to the other. Additionally, by providing indicia such as pictures, performations, and patterns on each segment face, a changing visual display is obtained as the segments (10) are articulated from one stack (16, 18) to the other.",ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/155-563-077-586-514,Patent Application,yes,5,0,4,4,0,A63H33/22;;A63H33/22;;A63H33/00;;A63H33/00,A63H33/00;;A63H33/22,,0,0,,,,DISCONTINUED
8,CA,A,CA 525136 A,197-201-889-276-955,1956-05-15,1956,CA 525136D A,,CA 525136T A,,CHAIR SEAT FASTENER,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/197-201-889-276-955,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
9,US,A,US 2567417 A,067-032-471-946-028,1951-09-11,1951,US 6893149 A,1949-01-03,US 6893149 A,1949-01-03,Locking brace for folding table legs,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/067-032-471-946-028,Granted Patent,no,10,5,1,1,0,A47B3/0915;;A47B3/0915,,,0,0,,,,EXPIRED
10,US,B1,US 7068663 B1,107-999-414-883-090,2006-06-27,2006,US 76811701 A,2001-01-23,US 76811701 A,2001-01-23,Path routing and provisioning method and apparatus,"An apparatus, method and computer program product for a data communications system includes transmitting data in a transport overhead field to at least one network element, the data providing a source identifier and a destination identifier, and using the data in the transport overhead field to provide end-to-end service. One embodiment includes applying a routing protocol to read the source identifier and the destination identifier to provide routing, provisioning and restoration of functions. The transport overhead field is a J1 field in a SONET communication packet according to an embodiment. The J1 field includes the source identifier and the destination identifier and provides data for the end-to-end, or path-level services. Further, the J1 field, according to an embodiment, includes additional data such as one or more of transport identification data (TID), Internet Protocol (IP) addresses, Common Language Location Information (CLLI) data, and requests for bandwidth. By including the source identifier and the destination identifier, the method avoids manual point-by-point routing of STS-Ns. Another embodiment is directed applying a wavelength routing protocol to the data in the transport overhead field to provide end-to-end services, the wavelength protocol locating new paths for communication. According to this embodiment, an intelligent routing software system in combination with the wavelength routing protocol determines end-to-end routing automatically. Alternatively, the wavelength protocol locates new paths for communication via a user interface.",CISCO TECH INC,ADLER JOHN C,CISCO TECHNOLOGY INC (2001-01-19),https://lens.org/107-999-414-883-090,Granted Patent,yes,12,20,1,1,0,H04J3/1611;;H04J2203/0053;;H04L45/10;;H04L45/62;;H04L45/10;;H04J2203/0053;;H04L45/62;;H04J3/1611,H04L12/28,370/395.51;;370/392,1,0,,,"Jay Hosler and Peter Lothberg, Reflector Communications Channel for Automatic Protection Switching, filed Mar. 27, 2000, US App. No. 09/537,439.",EXPIRED
11,US,A,US 2708146 A,130-991-692-712-408,1955-05-10,1955,US 40628054 A,1954-01-26,US 40628054 A,1954-01-26,Table leg mounting bracket and latch structure therefor,,SHWAYDER BROTHERS INC,ADLER JOHN B,,https://lens.org/130-991-692-712-408,Granted Patent,no,8,8,1,1,0,A47B3/0815;;A47B2003/0821;;A47B3/0815;;A47B2003/0821,,,0,0,,,,EXPIRED
12,CA,A,CA 394615 A,154-452-206-116-247,1941-02-18,1941,CA 394615D A,,CA 394615T A,,FOLDING ARM CHAIR,,ADLER JOHN B,ADLER JOHN B,,https://lens.org/154-452-206-116-247,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
13,US,A,US 1510026 A,041-383-990-036-334,1924-09-30,1924,US 60175522 A,1922-11-18,US 60175522 A,1922-11-18,"Rear light, license plate, and holder therefor",,ADLER JOHN A,ADLER JOHN A,,https://lens.org/041-383-990-036-334,Granted Patent,no,0,1,1,1,0,B60Q1/56;;B60Q1/56,B60Q1/56,,0,0,,,,EXPIRED
14,EP,A1,EP 0482122 A1,068-235-199-338-272,1992-04-29,1992,EP 90917895 A,1990-06-27,US 37710889 A;;US 53200390 A,1989-07-06,RETURNING FLYING RING TOY AND IMPROVED AIRFOIL.,"Un jouet (10) en forme d'anneau volant, retournant au lanceur, présente une forme plane annulaire-triangulaire modifiée et constitue un plan aérodynamique amélioré présentant une transition abrupte (49) sur la surface supérieure (15 - 46, 48), à proximité du bord de fuite (33).",ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/068-235-199-338-272,Patent Application,yes,0,1,5,9,0,A63H33/18;;A63B65/08,A63B65/08;;A63H33/18,,0,0,,,,DISCONTINUED
15,US,A,US 2255870 A,060-551-710-726-031,1941-09-16,1941,US 30575939 D,1939-11-24,US 30575939 D,1939-11-24,Chair construction,,SHWAYDER BROS INC,ADLER JOHN B,,https://lens.org/060-551-710-726-031,Granted Patent,no,0,4,1,1,0,A47C4/24;;A47C4/24,A47C4/24,,0,0,,,,EXPIRED
16,US,A,US 2853348 A,134-072-270-042-553,1958-09-23,1958,US 64194257 A,1957-02-25,US 64194257 A,1957-02-25,Table leg locking mechanism,,ADLER JOHN B,ADLER JOHN B,,https://lens.org/134-072-270-042-553,Granted Patent,no,6,5,1,1,0,A47B3/0911;;A47B3/0911,,,0,0,,,,EXPIRED
17,EP,A4,EP 0482122 A4,137-932-066-632-616,1992-10-07,1992,EP 90917895 A,1990-06-27,US 37710889 A;;US 53200390 A,1989-07-06,RETURNING FLYING RING TOY AND IMPROVED AIRFOIL,,"ADLER, ALAN JOHN","ADLER, ALAN JOHN",,https://lens.org/137-932-066-632-616,Search Report,no,1,0,5,9,0,A63H33/18;;A63B65/08,A63B65/08;;A63H33/18,,1,0,,,See also references of WO 9100757A1,DISCONTINUED
18,CA,A,CA 517224 A,099-055-499-592-754,1955-10-04,1955,CA 517224D A,,CA 517224T A,,TABLE LEG MOUNTING BRACKET AND LATCH STRUCTURE THEREFOR,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/099-055-499-592-754,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
19,GB,A,GB 983171 A,109-229-390-600-480,1965-02-10,1965,GB 3505462 A,1962-09-14,GB 3505462 A,1962-09-14,Improvements in or relating to tobacco pipes,"983,171. Tobacco pipes. ADOLPH FRANKAU & CO. Ltd. Sept. 13, 1963 [Sept. 14, 1962], No. 35054/62, Heading A2M. A tobacco pipe in which the stem of the pipe comprises a fixed part 11 and a mouthpiece 12 detachably connected to the fixed part is characterized in that the adjoining and contacting surfaces of the fixed part 11 and mouthpiece 12 are inclined at similar angles to the axis of the stem. A short tube 13 projects from the bore of the fixed part 11 and provides a mounting for the mouthpiece 12. Alternatively (Fig. 4, not shown) the tube 13 may be provided on the mouthpiece 12. The contacting end surfaces are inclined at an angle between 50-65 degrees to the axis of the stem.",ADOLPH FRANKAU & CO LTD,ADLER JOHN JAMES,,https://lens.org/109-229-390-600-480,Granted Patent,no,0,1,3,3,0,A24F7/02,A24F7/02,,0,0,,,,EXPIRED
20,US,B2,US 7280865 B2,132-414-077-415-068,2007-10-09,2007,US 2779201 A,2001-12-20,US 2779201 A,2001-12-20,Anchored fiducial apparatus and method,An anchored fiducial apparatus is described. The fiducial apparatus anchors itself in the target region once inserted so that the fiducial apparatus does not move relative to the target region.,ACCURAY INC,ADLER JOHN R,ACCURAY INCORPORATED (2001-12-19),https://lens.org/132-414-077-415-068,Granted Patent,yes,34,48,2,2,0,A61B90/39;;A61B90/39;;A61B2090/3925;;A61B2090/3925;;A61B2090/3987;;A61B2090/3987,A61B5/05;;A61B19/00,600/429;;600/425;;600/562;;600/414;;600/420;;600/424;;604/116;;606/130;;606/167;;606/185,0,0,,,,EXPIRED
21,CA,A,CA 523523 A,161-999-114-378-648,1956-04-03,1956,CA 523523D A,,CA 523523T A,,TABLET ARM CHAIR,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/161-999-114-378-648,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
22,CA,A,CA 534712 A,074-687-000-114-074,1956-12-18,1956,CA 534712D A,,CA 534712T A,,FOLDING TRAY TABLE,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/074-687-000-114-074,Granted Patent,no,0,1,1,1,0,,,,0,0,,,,EXPIRED
23,AT,T1,AT E175092 T1,029-645-767-105-723,1999-01-15,1999,AT 91920552 T,1991-10-16,US 60050190 A,1990-10-19,VORRICHTUNG ZUR STEREOTAKTISCHEN CHIRURGIE UND VERFAHREN ZUR STEUERUNG DER VORRICHTUNG,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INC,ADLER JOHN R,,https://lens.org/029-645-767-105-723,Granted Patent,no,0,0,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,G01R33/48;;A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,,0,0,,,,EXPIRED
24,US,A,US 2666681 A,170-684-260-640-27X,1954-01-19,1954,US 21336351 A,1951-03-01,US 21336351 A,1951-03-01,Convertible folding tray table and coffee table,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/170-684-260-640-27X,Granted Patent,no,13,23,1,1,0,A47B3/02;;A47B3/02,A47B3/02,,0,0,,,,EXPIRED
25,DE,A1,DE 1961361 A1,081-674-275-942-232,1971-07-15,1971,DE 1961361 A,1969-12-06,DE 1961361 A;;GB 4745969 A;;US 5612670 A,1969-09-26,Verfahren und Vorrichtung zur gegenseitigen Ausrichtung von Gegenstaenden,,TEXAS INSTRUMENTS INC,JOHN ADLER ALAN,,https://lens.org/081-674-275-942-232,Patent Application,no,0,1,4,6,0,G05D3/20;;H01L21/681,G05D3/20;;H01L21/68,,0,0,,,,EXPIRED
26,US,A,US 2757717 A,089-869-038-758-168,1956-08-07,1956,US 44643654 A,1954-07-29,US 44643654 A,1954-07-29,Reinforced chair seats,,SHWAYDER BROS INC,ADLER JOHN B,,https://lens.org/089-869-038-758-168,Granted Patent,no,4,4,1,1,0,A47C7/16;;A47C7/16,A47C7/16,,0,0,,,,EXPIRED
27,EP,A1,EP 0181394 A1,111-285-972-567-965,1986-05-21,1986,EP 85902787 A,1985-05-08,US 60879184 A,1984-05-10,GLIDING RING.,"Anneau planeur jouet consistant en un profilé aérodynamique formant une figure fermée (1) et pourvu d'une étroite lèvre de séparation (8) sur le périmètre externe (6) de la surface supérieure (2), de manière à équilibrer la portance aérodynamique, à l'avant et à l'arrière, dans une plage étendue de vitesses en vol plané.",ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/111-285-972-567-965,Patent Application,yes,0,0,13,14,0,A63H33/18;;A63H33/18,A63B65/10;;A63H27/127;;A63H33/18,,1,0,,,See references of WO 8505283A1,EXPIRED
28,WO,A3,WO 2007/139607 A3,151-947-845-927-148,2008-10-02,2008,US 2007/0006331 W,2007-03-12,US 44014306 A,2006-05-23,BREAST RESTRAINT,A method and apparatus to immobilize a breast of a patient and position a fiducial about the exterior of the breast. The apparatus includes a cup forming a cavity to accept the breast of the patient within the cup. The apparatus also includes a fiducial marker coupled to the cup. The fiducial marker has a spatial relationship with a target region of the breast.,ACCURAY INC;;ADLER JOHN R,ADLER JOHN R,,https://lens.org/151-947-845-927-148,Search Report,yes,2,0,3,3,0,A61B6/0414;;A61B6/502;;A61N2005/1061;;A61N2005/1097;;A61B90/17;;A61B90/39;;A61B2090/3908;;A61B2090/395;;A61B6/502;;A61N2005/1061;;A61B6/0414;;A61N2005/1097;;A61B90/17;;A61B90/39;;A61B2090/3908;;A61B2090/395,A61B6/00,,0,0,,,,PENDING
29,EP,B1,EP 0181394 B1,198-000-208-040-644,1989-08-16,1989,EP 85902787 A,1985-05-08,US 60879184 A,1984-05-10,GLIDING RING,,"ADLER, ALAN JOHN","ADLER, ALAN JOHN",,https://lens.org/198-000-208-040-644,Granted Patent,yes,16,0,13,14,0,A63H33/18;;A63H33/18,A63B65/10;;A63H27/127;;A63H33/18,,0,0,,,,EXPIRED
30,US,A,US 2155522 A,046-541-032-094-664,1939-04-25,1939,US 14646937 A,1937-06-04,US 14646937 A,1937-06-04,Folding armchair,,ADLER JOHN B,ADLER JOHN B,,https://lens.org/046-541-032-094-664,Granted Patent,no,0,10,1,1,0,A47C4/24;;A47C4/24,A47C4/24,,0,0,,,,EXPIRED
31,US,B2,US 7660238 B2,078-932-826-540-506,2010-02-09,2010,US 59057606 A,2006-10-31,US 59057606 A;;US 67674300 A,2000-09-29,Mesh with protection channel access (MPCA),"A method for a communications network with a protect channel transmitting protect channel data and working channel transmitting working channel data includes transmitting the working channel data via the protect channel upon a disruption in the working channel, and restoring the transmitting of protect channel data, wherein the restoring includes applying a mesh restoration protocol to the communications network to restore the transmittal of the protect channel data. The restoring includes finding one or more alternate channels to transmit the protect channel data, the one or more alternate channels including connected working and protect channels. An apparatus disposed in a communication network having a protect channel and a working channel includes a node controller, a route processor coupled to the node controller, the route processor implementing a mesh restoration protocol, and a circuit coupled to the node controller and the route processor, the circuit including a logic gate for receiving signals identifying disruptions in transmissions in the protect channel and the working channel and a switch responsive to the signals identifying disruptions in transmissions in the protect channel and the working channel, the switch communicating with the route processor to implement mesh restoration of protect channel data. In one embodiment, the circuit is coupled to at least one line card, the line card transmitting the signals identifying disruptions in transmissions in the protect channel and the working channel. The circuit further includes an input/output circuit for receiving instructions identifying criteria for applying mesh restoration to protect channel data.",CISCO TECH INC,ADLER JOHN C,,https://lens.org/078-932-826-540-506,Granted Patent,yes,30,3,3,3,0,H04J3/14;;Y10S370/907;;H04J3/14;;Y10S370/907,H04L12/28;;H04J3/14,370/223;;370/218;;370/907,1,1,029-069-151-425-574,10.1109/35.783131,"Doverspike et al, Future Transport Network Architectures, IEEEE Aug. 1999, pp. 96-101.",EXPIRED
32,US,A1,US 2014/0138457 A1,132-505-990-453-770,2014-05-22,2014,US 201313925045 A,2013-06-24,US 201313925045 A;;US 201261728285 P,2012-11-20,Thermoelectric Pumping Apparatus,"A thermoelectric pumping apparatus for use with a heating device includes a water receptacle. A thermoelectric device includes a “cool” side coupled to the receptacle and an opposed “hot” side, the thermoelectric device generating current upon a temperature differential between the cool and hot sides. A conduction member is proximate the hot side and in selective communication with the heating device. A spring is positioned between a top side of the conduction member and receptacle, the spring being movable between a compressed configuration at which the conduction member is in thermal communication with the hot side of the thermoelectric device and an extended configuration at which the top side of the conduction member is not in thermal communication with the hot side of the thermoelectric device. A water pump is in fluid communication with the water in the receptacle and selectively energized by the thermoelectric device to output the water.",ADLER KENNETH JOHN,ADLER KENNETH JOHN,EAGLE DESIGN LLC (2021-04-07),https://lens.org/132-505-990-453-770,Patent Application,yes,13,1,4,4,0,B05B17/08;;B05B17/08;;F04B17/03;;F04B17/03;;F04B19/20;;F04B19/20;;F04B23/02;;F04B23/02;;F04B23/021,B05B17/08;;F04B23/02,239/23,0,0,,,,ACTIVE
33,US,A,US 3525810 A,163-541-470-174-666,1970-08-25,1970,US 3525810D A,1966-12-05,US 59914166 A,1966-12-05,MICROPHONE ASSEMBLY FOR USE IN A STETHOSCOPE,,ITEK CORP,ADLER ALAN JOHN,,https://lens.org/163-541-470-174-666,Granted Patent,no,6,18,1,1,0,A61B7/04;;A61B7/04,A61B7/04,179/1,0,0,,,,EXPIRED
34,CA,A,CA 388153 A,041-013-168-206-812,1940-04-23,1940,CA 388153D A,,CA 388153T A,,FUEL ATOMIZER,,ADLER JOHN J,ADLER JOHN J,,https://lens.org/041-013-168-206-812,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
35,US,A,US 961061 A,045-696-549-317-111,1910-06-07,1910,US 1909/0494524 A,1909-05-07,US 1909/0494524 A,1909-05-07,ROTARY BRUSH.,,ADLER JOHN WILLIAM,ADLER JOHN WILLIAM,,https://lens.org/045-696-549-317-111,Granted Patent,no,0,0,1,1,0,A46B13/08;;A46B13/08,,,0,0,,,,EXPIRED
36,US,A,US 1830523 A,151-712-969-396-135,1931-11-03,1931,US 19420427 A,1927-05-25,US 19420427 A,1927-05-25,Folding chair,,LYON METAL PRODUCTS INC,ADLER JOHN B,,https://lens.org/151-712-969-396-135,Granted Patent,no,0,2,1,1,0,A47C4/20;;A47C4/20,A47C4/20,,0,0,,,,EXPIRED
37,US,A,US 2719574 A,005-548-034-192-510,1955-10-04,1955,US 33830953 A,1953-02-24,US 33830953 A,1953-02-24,Tablet arm chair,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/005-548-034-192-510,Granted Patent,no,10,4,1,1,0,A47C7/70;;A47B3/14;;A47C7/68;;A47C7/70;;A47B3/14,A47C7/68;;A47C7/70,,0,0,,,,EXPIRED
38,US,B1,US 7170852 B1,011-704-917-198-43X,2007-01-30,2007,US 67674300 A,2000-09-29,US 67674300 A,2000-09-29,Mesh with projection channel access (MPCA),"A method for a communications network with a protect channel transmitting protect channel data and working channel transmitting working channel data includes transmitting the working channel data via the protect channel upon a disruption in the working channel, and restoring the transmitting of protect channel data, wherein the restoring includes applying a mesh restoration protocol to the communications network to restore the transmittal of the protect channel data. The restoring includes finding one or more alternate channels to transmit the protect channel data, the one or more alternate channels including connected working and protect channels. An apparatus disposed in a communication network having a protect channel and a working channel includes a node controller, a route processor coupled to the node controller, the route processor implementing a mesh restoration protocol, and a circuit coupled to the node controller and the route processor, the circuit including a logic gate for receiving signals identifying disruptions in transmissions in the protect channel and the working channel and a switch responsive to the signals identifying disruptions in transmissions in the protect channel and the working channel, the switch communicating with the route processor to implement mesh restoration of protect channel data. In one embodiment, the circuit is coupled to at least one line card, the line card transmitting the signals identifying disruptions in transmissions in the protect channel and the working channel. The circuit further includes an input/output circuit for receiving instructions identifying criteria for applying mesh restoration to protect channel data.",CISCO TECH INC,ADLER JOHN C,CISCO TECHNOLOGY INC (2000-12-08),https://lens.org/011-704-917-198-43X,Granted Patent,yes,20,31,3,3,0,H04J3/14;;Y10S370/907;;H04J3/14;;Y10S370/907,H04J3/14;;H04L12/28,370/223;;370/218;;370/907,0,0,,,,EXPIRED
39,WO,A1,WO 1992/006644 A1,032-754-805-182-457,1992-04-30,1992,US 9107696 W,1991-10-16,US 60050190 A,1990-10-19,APPARATUS FOR AND METHOD OF STEREOTOXIC SURGERY,"A method and an apparatus are set forth for selectively irradiating a target (18) within a patient (14). A 3-dimensional mapping is provided of a mapping region (16) surrounding the target. A beaming apparatus (20) emits a collimated beam. Diagnostic beams (26, 28) at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target (18). The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused onto the target region (16).",ACCURAY INC,ADLER JOHN R,,https://lens.org/032-754-805-182-457,Patent Application,yes,6,14,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G01R33/48;;G21K5/00;;G21K5/04,,1,0,,,"M. COHEN and J. MITCHELL, ""Cobalt-60 TELETHERAPY: A Compendium of International Practice"", published 1984, by International Atomic Energey Agency (Vienna), see page 3.",PATENTED
40,DE,A1,DE 2256240 A1,053-733-997-614-902,1973-05-17,1973,DE 2256240 A,1972-11-16,GB 5321071 A,1971-11-16,STAHLRAHMEN,,A T A IND CO LTD,ADLER JOHN OLDRECH,,https://lens.org/053-733-997-614-902,Patent Application,no,0,0,11,11,0,E04B1/24;;E04B2001/2415;;E04B2001/2424;;E04B2001/2448;;E04B2001/2463;;E04B2001/2487;;E04C3/40,E04B1/24;;E04C3/40,,0,0,,,,DISCONTINUED
41,US,A1,US 2008/0285440 A1,051-961-952-761-628,2008-11-20,2008,US 59057606 A,2006-10-31,US 59057606 A;;US 67674300 A,2000-09-29,Mesh with protection channel access (MPCA),"A method for a communications network with a protect channel transmitting protect channel data and working channel transmitting working channel data includes transmitting the working channel data via the protect channel upon a disruption in the working channel, and restoring the transmitting of protect channel data, wherein the restoring includes applying a mesh restoration protocol to the communications network to restore the transmittal of the protect channel data. The restoring includes finding one or more alternate channels to transmit the protect channel data, the one or more alternate channels including connected working and protect channels. An apparatus disposed in a communication network having a protect channel and a working channel includes a node controller, a route processor coupled to the node controller, the route processor implementing a mesh restoration protocol, and a circuit coupled to the node controller and the route processor, the circuit including a logic gate for receiving signals identifying disruptions in transmissions in the protect channel and the working channel and a switch responsive to the signals identifying disruptions in transmissions in the protect channel and the working channel, the switch communicating with the route processor to implement mesh restoration of protect channel data. In one embodiment, the circuit is coupled to at least one line card, the line card transmitting the signals identifying disruptions in transmissions in the protect channel and the working channel. The circuit further includes an input/output circuit for receiving instructions identifying criteria for applying mesh restoration to protect channel data.",CISCO SYSTEMS INC,ADLER JOHN C,,https://lens.org/051-961-952-761-628,Patent Application,yes,30,16,3,3,0,H04J3/14;;Y10S370/907;;H04J3/14;;Y10S370/907,H04J3/14,370/223,0,0,,,,EXPIRED
42,US,A1,US 2003/0120141 A1,050-171-596-145-868,2003-06-26,2003,US 2779201 A,2001-12-20,US 2779201 A,2001-12-20,Anchored fiducial apparatus and method,"
   An anchored fiducial apparatus is described. The fiducial apparatus anchors itself in the target region once inserted so that the fiducial apparatus does not move relative to the target region. 
",ADLER JOHN R.,ADLER JOHN R,ACCURAY INCORPORATED (2001-12-19),https://lens.org/050-171-596-145-868,Patent Application,yes,34,38,2,2,0,A61B90/39;;A61B90/39;;A61B2090/3925;;A61B2090/3925;;A61B2090/3987;;A61B2090/3987,A61B19/00,600/407,0,0,,,,EXPIRED
43,US,A,US 2767780 A,060-716-815-325-210,1956-10-23,1956,US 40628254 A,1954-01-26,US 40628254 A,1954-01-26,Backplate for folding chair,,SHWAYDER BROTHERS INC,ADLER JOHN B,,https://lens.org/060-716-815-325-210,Granted Patent,no,6,4,1,1,0,A47C7/40;;A47C7/40,A47C7/40,,0,0,,,,EXPIRED
44,US,A,US 2729280 A,101-641-628-176-653,1956-01-03,1956,US 41728054 A,1954-03-19,US 41728054 A,1954-03-19,Chair seat fastener,,SHWAYDER BROTHERS INC,ADLER JOHN B,,https://lens.org/101-641-628-176-653,Granted Patent,no,7,4,1,1,0,A47C7/16;;A47C7/16,A47C7/16,,0,0,,,,EXPIRED
45,GB,A,GB 189512392 A,117-180-356-178-090,1896-05-02,1896,GB 189512392D A,1895-06-26,GB 189512392T A,1895-06-26,Improvements in Catches for Railway Carriage and other Doors or Gates.,,ADLER JOHN JULIUS,ADLER JOHN JULIUS,,https://lens.org/117-180-356-178-090,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
46,AT,T1,AT E45507 T1,164-820-781-495-182,1989-09-15,1989,AT 85902787 T,1985-05-08,EP 85902787 A;;US 60879184 A;;US 8500869 W,1984-05-10,GLEITENDER RING.,,ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/164-820-781-495-182,Granted Patent,no,0,0,1,14,0,,A63B65/00;;A63H27/00,,0,0,,,,DISCONTINUED
47,CA,A1,CA 2829978 A1,180-208-819-337-024,2014-05-20,2014,CA 2829978 A,2013-10-11,US 201261728285 P;;US 201313925045 A,2012-11-20,THERMOELECTRIC PUMPING APPARATUS,"A thermoelectric pumping apparatus for use with a heating device includes a water receptacle. A thermoelectric device includes a ""cool"" side coupled to the receptacle and an opposed ""hot"" side, the thermoelectric device generating current upon a temperature differential between the cool and hot sides. A conduction member is proximate the hot side and in selective communication with the heating device. A spring is positioned between a top side of the conduction member and receptacle, the spring being movable between a compressed configuration at which the conduction member is in thermal communication with the hot side of the thermoelectric device and an extended configuration at which the top side of the conduction member is not in thermal communication with the hot side of the thermoelectric device. A water pump is in fluid communication with the water in the receptacle and selectively energized by the thermoelectric device to output the water.",ADLER KENNETH JOHN,ADLER KENNETH JOHN,,https://lens.org/180-208-819-337-024,Patent Application,no,0,0,4,4,0,B05B17/08;;B05B17/08;;F04B17/03;;F04B17/03;;F04B19/20;;F04B19/20;;F04B23/02;;F04B23/02;;F04B23/021,F04D13/08;;F04B17/03;;H01L35/28,,0,0,,,,DISCONTINUED
48,CA,A,CA 505028 A,188-975-824-938-981,1954-08-10,1954,CA 505028D A,,CA 505028T A,,CONVERTIBLE FOLDING TRAY TABLE AND COFFEE TABLE,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/188-975-824-938-981,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
49,DE,D1,DE 3572309 D1,053-261-615-063-939,1989-09-21,1989,DE 3572309 T,1985-05-08,US 60879184 A;;US 8500869 W,1984-05-10,GLIDING RING,,ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/053-261-615-063-939,Granted Patent,no,0,0,13,14,0,A63H33/18;;A63H33/18,A63B65/10;;A63H27/127;;A63H33/18,,0,0,,,,EXPIRED
50,CN,U,CN 202981628 U,082-135-531-056-680,2013-06-12,2013,CN 201220655692 U,2012-12-04,CN 201220655692 U,2012-12-04,Coffee filter pressing device,"The utility model discloses a coffee filter pressing device which comprises a filter drum, a compression bar and a detachable filter paper cover, wherein the filter drum is in an equant hollow shape, the upper portion and the bottom portion of the filter drum are respectively in an large-caliber opening shape, the filter paper cover is fixedly arranged at the bottom of the filter drum, and a detachable sealing plug is arranged on the compression bar. Coffee extracted through the coffee filter pressing device tastes good, and the coffee filter pressing device is simple in structure and convenient to carry.",ADLER ALAN JOHN,ALLEN JOHN ADLER,,https://lens.org/082-135-531-056-680,Limited Patent,no,0,2,1,1,0,,A47J31/08,,0,0,,,,EXPIRED
51,GB,A,GB 189511607 A,106-391-372-923-848,1896-04-25,1896,GB 189511607D A,1895-06-14,GB 189511607T A,1895-06-14,Improvements in Railway Carriage and other Door Locks and Staples.,,ADLER JOHN JULIUS,ADLER JOHN JULIUS,,https://lens.org/106-391-372-923-848,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
52,US,A,US 2757998 A,152-126-152-536-767,1956-08-07,1956,US 41920854 A,1954-03-29,US 41920854 A,1954-03-29,Convertible folding tray table and coffee table,,SHWAYDER BROTHERS INC,ADLER JOHN B,,https://lens.org/152-126-152-536-767,Granted Patent,no,10,9,1,1,0,A47B3/02;;A47B3/02;;A47B2003/0806;;A47B2003/0806,A47B3/02,,0,0,,,,EXPIRED
53,WO,A2,WO 2007/139607 A2,193-991-315-385-937,2007-12-06,2007,US 2007/0006331 W,2007-03-12,US 44014306 A,2006-05-23,BREAST RESTRAINT,A method and apparatus to immobilize a breast of a patient and position a fiducial about the exterior of the breast. The apparatus includes a cup forming a cavity to accept the breast of the patient within the cup. The apparatus also includes a fiducial marker coupled to the cup. The fiducial marker has a spatial relationship with a target region of the breast.,ACCURAY INC;;ADLER JOHN R,ADLER JOHN R,,https://lens.org/193-991-315-385-937,Patent Application,yes,0,1,3,3,0,A61B6/0414;;A61B6/502;;A61N2005/1061;;A61N2005/1097;;A61B90/17;;A61B90/39;;A61B2090/3908;;A61B2090/395;;A61B6/502;;A61N2005/1061;;A61B6/0414;;A61N2005/1097;;A61B90/17;;A61B90/39;;A61B2090/3908;;A61B2090/395,G21K5/08;;A61B6/00,,0,0,,,,PENDING
54,US,E,US RE048650 E,009-773-706-660-265,2021-07-20,2021,US 201816165929 A,2018-10-19,US 201816165929 A;;US 201313925045 A;;US 201261728285 P,2012-11-20,Thermoelectric pumping apparatus,"A thermoelectric pumping apparatus for use with a heating device includes a water receptacle. A thermoelectric device includes a “cool” side coupled to the receptacle and an opposed “hot” side, the thermoelectric device generating current upon a temperature differential between the cool and hot sides. A conduction member is proximate the hot side and in selective communication with the heating device. A spring is positioned between a top side of the conduction member and receptacle, the spring being movable between a compressed configuration at which the conduction member is in thermal communication with the hot side of the thermoelectric device and an extended configuration at which the top side of the conduction member is not in thermal communication with the hot side of the thermoelectric device. A water pump is in fluid communication with the water in the receptacle and selectively energized by the thermoelectric device to output the water.",ADLER KENNETH JOHN,ADLER KENNETH JOHN,,https://lens.org/009-773-706-660-265,Amended Patent,yes,25,0,4,4,0,B05B17/08;;B05B17/08;;F04B17/03;;F04B17/03;;F04B19/20;;F04B19/20;;F04B23/02;;F04B23/02;;F04B23/021,B05B17/08;;F04B17/03;;F04B19/20;;F04B23/02;;H01L35/00,,0,0,,,,PENDING
55,EP,B1,EP 0553282 B1,058-317-269-365-927,1998-12-30,1998,EP 91920552 A,1991-10-16,US 9107696 W;;US 60050190 A,1990-10-19,APPARATUS FOR STEREOTOXIC SURGERY AND METHOD OF CONTROL OF THE APPARATUS,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INC,ADLER JOHN R,,https://lens.org/058-317-269-365-927,Granted Patent,yes,8,0,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,G01R33/48;;A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,,4,0,,,"14TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE 10 March 1988 , UNIVERSITY OF NEW HAMPSHIRE DURHAM NH pages 47 - 49 XP13803 FRIETS ET AL. 'improved accuracy for the frameless stereotaxic operating microscope';;IMAGES OF THE TWENTY-FIRST CENTURY CONFERENCE OF IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY vol. 11 , 9 November 1989 , SEATTLE WASHINGTON , XP91939 LAVALLEE 'A new system for computer assisted neurosurgery';;IEEE COMPUTER GRAPHICS AND APPLICATIONS vol. 10, no. 3 , May 1990 , LOS ALAMITOS, CA. USA pages 43 - 51 XP161263 ADAMS ET AL. 'Computer assisted surgery';;M. COHEN and J. MITCHELL, ""Cobalt-60 TELETHERAPY: A Compendium of International Practice"", published 1984, by International Atomic Energey Agency (Vienna), see page 3.",EXPIRED
56,CA,A,CA 273753 A,056-593-642-980-652,1927-09-13,1927,CA 273753D A,,CA 273753T A,,LARDING NEEDLE,,ADLER FREDERICK JOHN,ADLER FREDERICK JOHN,,https://lens.org/056-593-642-980-652,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
57,JP,A,JP 2002191708 A,011-497-253-575-191,2002-07-10,2002,JP 2001320444 A,2001-10-18,US 60050190 A,1990-10-19,METHOD FOR DIRECTING RADIATION BEAM TO TARGET REGION,"PROBLEM TO BE SOLVED: To provide a method to direct a surgical means, for which an X-ray linear accelerator is used, to the target region of a patient. SOLUTION: A stated device selectively irradiates the target (18) in the patient (14). The three-dimensional image of an imaging region (16) around the target is provided. A beam device (20) emits a collimating beam. Beams (26 and 28) for the diagnosis pass the imaging region at angles which are already known to each other and not zero. Thus, the image of a projected shadow in the imaging region is obtained. The electronic display of the image is compared to reference data in which the target (18) is arranged. The focal point of the collimating beam is adjusted onto the target region, and relative locations of the beam device and the physiological body are regulated. The comparison is repeated with a short period of time interval, and the regulation is repeated with the focal point of the collimating beam adjusted to the target region (16) when required.",ACCURAY INC,ADLER JOHN R,,https://lens.org/011-497-253-575-191,Patent Application,no,0,3,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04;;G01R33/48,,0,0,,,,PENDING
58,CA,A,CA 536565 A,033-364-440-972-642,1957-01-29,1957,CA 536565D A,,CA 536565T A,,REINFORCED CHAIR SEATS,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/033-364-440-972-642,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
59,US,A,US 2719068 A,060-126-907-831-380,1955-09-27,1955,US 40628154 A,1954-01-26,US 40628154 A,1954-01-26,Table leg mounting bracket with locking structure,,SHWAYDER BROTHERS INC,ADLER JOHN B,,https://lens.org/060-126-907-831-380,Granted Patent,no,7,4,1,1,0,A47B3/0812;;F16B12/52;;A47B3/0812;;F16B12/52,F16B12/52,,0,0,,,,EXPIRED
60,AU,A,AU 1972/048651 A,078-457-066-986-707,1974-05-09,1974,AU 1972/048651 A,1972-11-09,GB 5321071 A,1971-11-16,STEEL FRAME CONSTRUCTION,,A T A IND CO LTD,ADLER JOHN OLDRECH,,https://lens.org/078-457-066-986-707,Patent Application,no,0,0,11,11,0,E04B1/24;;E04B2001/2415;;E04B2001/2424;;E04B2001/2448;;E04B2001/2463;;E04B2001/2487;;E04C3/40,E04B1/24;;E04C3/40,,0,0,,,,DISCONTINUED
61,US,A,US 2680662 A,166-284-044-979-693,1954-06-08,1954,US 33974153 A,1953-03-02,US 33974153 A,1953-03-02,Banquet table frame and leg mounting,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/166-284-044-979-693,Granted Patent,no,9,7,1,1,0,A47B3/0912;;A47B3/0912,,,0,0,,,,EXPIRED
62,EP,A1,EP 0553282 A1,179-804-838-902-24X,1993-08-04,1993,EP 91920552 A,1991-10-16,US 9107696 W;;US 60050190 A,1990-10-19,APPARATUS FOR AND METHOD OF STEREOTOXIC SURGERY.,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INC,ADLER JOHN R,,https://lens.org/179-804-838-902-24X,Patent Application,yes,0,1,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,G01R33/48;;A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,,0,0,,,,EXPIRED
63,US,B2,US 9795979 B2,176-013-537-620-812,2017-10-24,2017,US 201313925045 A,2013-06-24,US 201313925045 A;;US 201261728285 P,2012-11-20,Thermoelectric pumping apparatus,"A thermoelectric pumping apparatus for use with a heating device includes a water receptacle. A thermoelectric device includes a “cool” side coupled to the receptacle and an opposed “hot” side, the thermoelectric device generating current upon a temperature differential between the cool and hot sides. A conduction member is proximate the hot side and in selective communication with the heating device. A spring is positioned between a top side of the conduction member and receptacle, the spring being movable between a compressed configuration at which the conduction member is in thermal communication with the hot side of the thermoelectric device and an extended configuration at which the top side of the conduction member is not in thermal communication with the hot side of the thermoelectric device. A water pump is in fluid communication with the water in the receptacle and selectively energized by the thermoelectric device to output the water.",ADLER KENNETH JOHN,ADLER KENNETH JOHN,EAGLE DESIGN LLC (2021-04-07),https://lens.org/176-013-537-620-812,Granted Patent,yes,23,11,4,4,0,B05B17/08;;B05B17/08;;F04B17/03;;F04B17/03;;F04B19/20;;F04B19/20;;F04B23/02;;F04B23/02;;F04B23/021,H01L35/00;;B05B17/08;;F04B17/03;;F04B19/20;;F04B23/02,,0,0,,,,ACTIVE
64,EP,A4,EP 0553282 A4,190-123-945-788-328,1994-04-13,1994,EP 91920552 A,1991-10-16,US 9107696 W;;US 60050190 A,1990-10-19,EP 0553282 A4,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INCORPORATED,"ADLER, JOHN, R.",,https://lens.org/190-123-945-788-328,Search Report,no,4,0,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,G01R33/48;;A61B5/055;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,,3,2,044-831-173-814-488;;127-457-616-189-784,10.1109/nebc.1988.19340;;10.1109/38.55152,"FRIETS ET AL.: ""improved accuracy for the frameless stereotaxic operating microscope"", 14TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 10 March 1988 (1988-03-10), UNIVERSITY OF NEW HAMPSHIRE DURHAM NH, pages 47 - 49, XP000013803;;LAVALLEE: ""A new system for computer assisted neurosurgery"", IMAGES OF THE TWENTY-FIRST CENTURY CONFERENCE OF IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, vol. 11, 9 November 1989 (1989-11-09), SEATTLE WASHINGTON, XP000091939;;ADAMS ET AL.: ""Computer assisted surgery"", IEEE COMPUTER GRAPHICS AND APPLICATIONS, vol. 10, no. 3, May 1990 (1990-05-01), LOS ALAMITOS, CA. USA, pages 43 - 51, XP000161263",EXPIRED
65,US,A1,US 2007/0276229 A1,022-699-682-056-298,2007-11-29,2007,US 44014306 A,2006-05-23,US 44014306 A,2006-05-23,Breast restraint,A method and apparatus to immobilize a breast of a patient and position a fiducial about the exterior of the breast. The apparatus includes a cup forming a cavity to accept the breast of the patient within the cup. The apparatus also includes a fiducial marker coupled to the cup. The fiducial marker has a spatial relationship with a target region of the breast.,ACCURAY INC,ADLER JOHN R,ACCURAY INCORPORATED (2006-05-22),https://lens.org/022-699-682-056-298,Patent Application,yes,4,19,3,3,0,A61B6/0414;;A61B6/502;;A61N2005/1061;;A61N2005/1097;;A61B90/17;;A61B90/39;;A61B2090/3908;;A61B2090/395;;A61B6/502;;A61N2005/1061;;A61B6/0414;;A61N2005/1097;;A61B90/17;;A61B90/39;;A61B2090/3908;;A61B2090/395,A61B6/00;;G21K5/08,600/426;;378/68,0,0,,,,DISCONTINUED
66,US,A,US 2303189 A,030-968-958-468-123,1942-11-24,1942,US 30591139 A,1939-11-24,US 30591139 A,1939-11-24,Folding chair construction,,SHWAYDER BROS INC,ADLER JOHN B,,https://lens.org/030-968-958-468-123,Granted Patent,no,0,15,1,1,0,A47C4/24;;A47C4/24,A47C4/24,,0,0,,,,EXPIRED
67,US,A,US 2684111 A,089-542-858-574-933,1954-07-20,1954,US 10466949 A,1949-07-14,US 10466949 A,1949-07-14,Folding chair,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/089-542-858-574-933,Granted Patent,no,5,2,1,1,0,A47C4/20;;A47C4/20,A47C4/20,,0,0,,,,EXPIRED
68,CA,A,CA 240680 A,114-081-251-301-459,1924-06-10,1924,CA 240680D A,,CA 240680T A,,ROENTGENOGRAMASCOPE,,ADLER JOHN A,ADLER JOHN A,,https://lens.org/114-081-251-301-459,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
69,EP,A4,EP 0181394 A4,070-774-041-473-698,1986-08-21,1986,EP 85902787 A,1985-05-08,US 60879184 A,1984-05-10,GLIDING RING.,,ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/070-774-041-473-698,Search Report,no,0,0,13,14,0,A63H33/18;;A63H33/18,A63B65/10;;A63H27/127;;A63H33/18,,0,0,,,,EXPIRED
70,US,A,US 2680473 A,144-913-799-662-337,1954-06-08,1954,US 26373351 A,1951-12-28,US 26373351 A,1951-12-28,Folding chair,,SHWAYDER BROTHERS,ADLER JOHN B,,https://lens.org/144-913-799-662-337,Granted Patent,no,6,1,1,1,0,A47C4/20;;A47C4/20,A47C4/20,,0,0,,,,EXPIRED
71,GB,A,GB 1282468 A,177-824-301-630-374,1972-07-19,1972,GB 4745969 A,1969-09-26,DE 1961361 A;;GB 4745969 A;;US 5612670 A,1969-09-26,ALIGNMENT SYSTEM,"1282468 Template-followers TEXAS INSTRUMENTS Inc 26 Sep 1969 47459/69 Heading G3N A predetermined alignment between a particular area of an object scene and a work implement employs an arrangement whereby the area of a raster scan is reduced until a comparison determines that the predetermined condition of alignment has been achieved. As shown, a semi-conductor 21 is mounted on a jig, (not shown), and is scanned by a flying spot scanner 31, mounted in an inspection module supported by an arm of a lead-wire cutting and attaching mechanism, (not shown), through a lens 33. Part of the light reflected from the semiconductor 21 is fed through an objective lens 34 and a fibre-optic tube 35 to a multiplier photo-tube 32. Part of the view of the scanner 31 is fed via a mirror 38 and lens 39 through a reference standard, comprising a photographic transparency, to a multiplier photo-tube 41. The output signals from the photo-tubes 32, 41 are compared in an analyzer unit 44 producing quadrature and rotational error signals x, y which are fed to a servo unit 45 producing a mechanical movement aligning the lead-mechanism with the semi-conductor device. The signals from the multiplier photo-tubes 32, 41 are alternatively fed, through a switch 50, to a viewing monitor tube 49. The size of the raster on scanner 31 is adjusted by a zoom control 165 whereby the scanned area of the semi-conductor device is reduced as the misalignment decreases.",TEXAS INSTRUMENTS INC,ADLER ALAN JOHN,,https://lens.org/177-824-301-630-374,Granted Patent,no,0,0,4,6,0,G05D3/20;;H01L21/681,G05D3/20;;H01L21/68,B3R R10           -;;B3R R17X          R17;;G3N NE3X          RX;;G3N NGE3A         GE3A;;G3N N252          BJ;;G3N N252          RX;;G3N N275          GE3A;;G3N N275          RX,0,0,,,,EXPIRED
72,US,A,US 1526732 A,035-158-540-593-901,1925-02-17,1925,US 71811024 A,1924-06-05,US 71811024 A,1924-06-05,Tail or signal light construction,,ADLER JOHN A,ADLER JOHN A,,https://lens.org/035-158-540-593-901,Granted Patent,no,0,1,1,1,0,B60Q1/56;;B60Q1/56,B60Q1/56,,0,0,,,,EXPIRED
73,AU,A,AU 1979/051005 A,186-119-721-573-428,1980-05-29,1980,AU 1979/051005 A,1979-09-20,US 96419878 A,1978-11-28,AMUSEMENT DEVICE USING ARTICULATED INTERCONNECTED SEGMENTS,,ADLER ALAN JOHN,ADLER ALAN JOHN,,https://lens.org/186-119-721-573-428,Patent Application,no,0,0,4,4,0,A63H33/22;;A63H33/22;;A63H33/00;;A63H33/00,A63H33/00;;A63H33/22,,0,0,,,,DISCONTINUED
74,US,A,US 3575465 A,186-616-466-214-459,1971-04-20,1971,US 3575465D A,1969-06-25,US 83630469 A,1969-06-25,MODULAR CONSTRUCTION,,EVOLUTIONS IV CORP,DOLBY JOHN;;ADLER JAMES,,https://lens.org/186-616-466-214-459,Granted Patent,no,6,45,1,1,0,A47B83/00;;A47B87/0253;;A47B2220/02;;A47C13/005;;A47D1/006;;A47D11/00;;A47D11/002;;Y10S206/821;;A47C13/005;;A47B87/0253;;A47D11/00;;A47B2220/02;;A47D11/002;;A47D1/006;;A47B83/00;;Y10S206/821,A47B83/00;;A47B87/02;;A47D11/00,297/118,0,0,,,,EXPIRED
75,US,A,US 1809564 A,187-892-677-082-879,1931-06-09,1931,US 12936726 A,1926-08-16,US 12936726 A,1926-08-16,Folding table,,LYON METAL PRODUCTS INC,O'CONNOR JOHN B;;ADLER JOHN B,,https://lens.org/187-892-677-082-879,Granted Patent,no,0,15,1,1,0,A47B3/0815;;A47B2003/0821;;A47B3/0815;;A47B2003/0821,,,0,0,,,,EXPIRED
76,CA,A,CA 315476 A,171-968-578-090-627,1931-09-22,1931,CA 315476D A,,CA 315476T A,,FOLDING TABLE,,LYON METAL PRODUCTS,ADLER JOHN B;;O'CONNOR JOHN B,,https://lens.org/171-968-578-090-627,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
77,US,A,US 1851055 A,165-249-336-641-168,1932-03-29,1932,US 12936626 A,1926-08-16,US 12936626 A,1926-08-16,Table construction,,LYON METAL PRODUCTS INC,O'CONNOR JOHN B;;ADLER JOHN B,,https://lens.org/165-249-336-641-168,Granted Patent,no,0,9,1,1,0,A47B13/086;;A47B13/086,A47B13/08,,0,0,,,,EXPIRED
78,AU,A1,AU 2003/290696 A1,050-732-183-141-065,2004-06-03,2004,AU 2003/290696 A,2003-11-12,US 29321602 A;;US 0335801 W,2002-11-12,A METHOD AND APPARATUS FOR TRACKING AN INTERNAL TARGET REGION WITHOUT AN IMPLANTED FIDUCIAL,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/050-732-183-141-065,Patent Application,no,0,0,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B6/12;;A61B19/00;;A61N5/10,,0,0,,,,DISCONTINUED
79,US,A1,US 2017/0180991 A1,126-028-735-377-890,2017-06-22,2017,US 201514974993 A,2015-12-18,US 201514974993 A,2015-12-18,SECURE COMMUNICATION CONNECTION FORMATION,"In some examples, method includes positioning a first electronic device in a target orientation with respect to a second electronic device and moving the first and second electronic devices in at least two degrees of freedom of motion while the first electronic device is maintained in the target orientation with respect to the second electronic device. The method may also include operating the first electronic device while the first and second electronic devices share a secure communication connection that is based on a first numerical value and a second numerical value. The first numerical value may be based on data that describes the movement of the first electronic device while maintained in the target orientation, and the second numerical value may be based on data that describes the movement of the second electronic device while the first electronic device is maintained in the target orientation.",EMPIRE TECHNOLOGY DEV LLC,NICHOLLS MICHAEL JOHN;;ADLER NATHAN,EMPIRE TECHNOLOGY DEVELOPMENT LLC (2015-11-02),https://lens.org/126-028-735-377-890,Patent Application,yes,6,1,2,2,0,H04L63/107;;H04W84/18;;G01S13/74;;G01S1/00;;H04W76/10;;H04L63/107;;H04W84/18;;G01S13/74;;G01S1/00,H04W12/08;;H04W12/06;;H04W76/02,,0,0,,,,INACTIVE
80,US,B2,US 9572997 B2,122-022-419-089-077,2017-02-21,2017,US 201314133111 A,2013-12-18,US 201314133111 A;;US 201113306951 A;;US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,Frameless radiosurgery treatment system and method,A method of compensating for breathing and other motions of a patient during treatment includes periodically generating internal positional data about an internal target region. The method further includes generating external positional data about external motion of the patient's body using an external sensor and generating a correlation between one or more positions of the internal target region and one or more positions of an external region using the external positional data of the external sensor and the internal positional data of the internal target region. The method further includes predicting the position of the internal target region at some later time based on the correlation model.,ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/122-022-419-089-077,Granted Patent,yes,8,0,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/05;;A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,EXPIRED
81,US,B2,US 9775042 B2,198-617-228-042-700,2017-09-26,2017,US 201514974993 A,2015-12-18,US 201514974993 A,2015-12-18,Secure communication connection formation,"In some examples, method includes positioning a first electronic device in a target orientation with respect to a second electronic device and moving the first and second electronic devices in at least two degrees of freedom of motion while the first electronic device is maintained in the target orientation with respect to the second electronic device. The method may also include operating the first electronic device while the first and second electronic devices share a secure communication connection that is based on a first numerical value and a second numerical value. The first numerical value may be based on data that describes the movement of the first electronic device while maintained in the target orientation, and the second numerical value may be based on data that describes the movement of the second electronic device while the first electronic device is maintained in the target orientation.",EMPIRE TECHNOLOGY DEV LLC,NICHOLLS MICHAEL JOHN;;ADLER NATHAN,EMPIRE TECHNOLOGY DEVELOPMENT LLC (2015-11-02),https://lens.org/198-617-228-042-700,Granted Patent,yes,16,0,2,2,0,H04L63/107;;H04W84/18;;G01S13/74;;G01S1/00;;H04W76/10;;H04L63/107;;H04W84/18;;G01S13/74;;G01S1/00,H04W12/08;;H04W12/06;;H04W76/02,,3,0,,,"“http://en.wikipedia.org/wiki/Alice—and—Bob”, accessed Dec. 18, 2015.;;“https://lacklustre.net/projects/crackle/”, accessed Dec. 18, 2015.;;“Bluetooth: With Low Energy Comes Low Security” Mick Ryan iSEC Partners, 2013.",INACTIVE
82,US,B2,US 8277143 B2,018-662-887-808-349,2012-10-02,2012,US 77901110 A,2010-05-12,US 77901110 A;;US 21609909 P;;US 28045209 P;;US 28347109 P;;US 28450409 P;;US 34156310 P,2009-05-12,Surface mount vehicle anti-ram security systems,"Anti-ram systems according to embodiments of the invention comprise at least one bollard section comprising a base of limited height and a plurality of spaced bollards extending upwardly from the base. An anti-ram system according to embodiments of the invention may be erected or installed on a paved surface such as asphalt, concrete, paver stones, etc., or on an unpaved surface such as soil, and need not be partially of fully buried, and yet can qualify for Department of State crash ratings previously assigned to buried bollard systems. Disclosed anti-ram system also comprise a plurality of bollard sections and one or more connectors for interconnecting two or more of the bollard sections, and may also include an anchor or anchor system engaging at least each end of a bollard section not connected to another bollard section. The bollard sections may be filled with ballast and high friction structure may be attached to the bottom of the bollard sections to resist sliding after impact.",ADLER RICHARD S;;CRAWFORD JOHN;;RSA PROTECTIVE TECHNOLOGY LLC,ADLER RICHARD S;;CRAWFORD JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2010-09-24),https://lens.org/018-662-887-808-349,Granted Patent,yes,97,21,5,5,0,E01F13/12;;E01F9/685;;E01F13/12;;E01F9/685,E01F15/00,404/6;;404/9;;256/13.1,2,0,,,"http://web.archive.org/web/20020525043057/http://globalsecurity.org/military/library...dated Feb. 12, 2007, 9 pgs.;;Department of Defense Handbook, ""Selection and Application of Vehicle Barriers"" MIL-DDBK-1013/4, Feb. 1, 1999.",ACTIVE
83,US,A,US 2915583 A,091-311-999-168-481,1959-12-01,1959,US 56804956 A,1956-02-27,US 56804956 A,1956-02-27,Television receiver,,ZENITH RADIO CORP,ROBERT ADLER;;SPRACKLEN JOHN G,,https://lens.org/091-311-999-168-481,Granted Patent,no,4,1,1,1,0,H04N5/52;;H04N5/52;;H04N5/08;;H04N5/08,H04N5/08;;H04N5/52,,0,0,,,,EXPIRED
84,US,A,US 2779818 A,094-769-175-449-874,1957-01-29,1957,US 50547655 A,1955-05-02,US 50547655 A,1955-05-02,Demodulating systems for color television,,ZENITH RADIO CORP,ROBERT ADLER;;RENNICK JOHN L,,https://lens.org/094-769-175-449-874,Granted Patent,no,2,20,2,2,0,H04N9/66;;H04N9/66,H04N9/66,,0,0,,,,EXPIRED
85,CA,A,CA 841563 A,192-548-075-722-46X,1970-05-12,1970,CA 841563D A,,CA 841563T A,,SAMPLING DEVICE AND METHODS OF PREPARING AND USING SAME,,LITTLE INC A,ADLER NORMAN;;MOGAYZEL JOHN W,,https://lens.org/192-548-075-722-46X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
86,US,B2,US 7699558 B2,003-270-518-585-277,2010-04-20,2010,US 19125105 A,2005-07-26,US 19125105 A;;US 59101804 P;;US 60095504 P;;US 60595904 P;;US 62238504 P;;US 67496505 P;;US 67954705 P,2004-07-26,Anti-ram system and method of installation,"An anti-ram system and method of construction having a shallow mounted base pad from which extend a plurality of bollards. Very little or only a shallow excavation is required for the base of the bollard system, which can be partially or fully assembled prior to bringing it to the installation site. The shallow mounting pad or base of the bollard system of this invention may be formed or constructed in various ways and of various materials, and in various configurations. The shallow mounting pad or base is constructed so as to have considerable mass.",RSA PROTECTIVE TECHNOLOGIES LL,ADLER RICHARD S;;CRAWFORD JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2009-11-09),https://lens.org/003-270-518-585-277,Granted Patent,yes,41,27,7,7,0,E01F13/00;;E01F13/12;;E01F9/623;;E01F9/685;;E01F13/12;;E01F13/00;;E01F9/623;;E01F9/685,E01F13/00,404/6,4,0,,,"http://web.archive.org/web/20020525043057/http://globalsecurity.org/military/library . . . dated Feb. 12, 2007, 9 pgs.;;Department of Defence Handbook, ""Selection and Application of Vehicle Barriers"" MIL-DDBK-1013/14, Feb. 1, 1999.;;PCT International Preliminary Report on Patentability, Apr. 3, 2007, 5 pgs.;;International Search Report, Mar. 20, 2007, 1 pg.",ACTIVE
87,US,B2,US 8086299 B2,108-816-363-651-274,2011-12-27,2011,US 35644209 A,2009-01-20,US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,Frameless radiosurgery treatment system and method,A method and apparatus for selectively and accurately localizing and treating a target within a patient are provided. A three dimensional mapping of a region surrounding the target is coupled to a surgical intervention. Two or more diagnostic beams at a known non-zero angle to one another may pass through the mapping region to produce images of projections within the mapping region in order to accurately localize and treat the target wherein the images are captured using one or more image recorders.,ADLER JOHN R;;SCHWEIKARD ACHIM;;ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/108-816-363-651-274,Granted Patent,yes,65,202,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;A61B5/00;;A61B5/06;;G01B11/00;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427,13,2,052-877-376-782-790;;000-676-958-439-67X,10863083;;10.1016/s0360-3016(00)00524-1;;17518376;;10.1581/mrcas.2005.010211;;10.1002/rcs.39,"Minohara, S. et al., ""Respiratory Gated Irradiation System for Heavy-Ion Radiotherapy"", International Journal of Radiation: Oncology Biology Physics, Pergamon Press, US, vol. 47, No. 4, Jul. 1, 2000, ISSN: 0360-3016.;;Coste-Manière, È., ""Robotic whole body stereotactic radiosurgery: clinical advantages of the CyberKnife® integrated system"", The International Journal of Medical Robotics +Computer Assisted Surgery, 2005, www.roboticpublications.com, pp. 28-39.;;Supplementary Partial European search report, Application No. EP01970945, mailed Jun. 28, 2006.;;Supplementary European Search Report for European Patent Application No. 01 970 945.0, Oct. 16, 2006, 5 pages.;;Supplementary European Search Report for European Patent Application No. 01 970 945.0 dated Apr. 5, 2006, 5 pages.;;Examination Report for European Patent Application No. 01 970 945.0, dated Jan. 16, 2007, 7 pages.;;Examination Report for European Patent Application No. 01 970 945.0, dated Feb. 23, 2010, 6 pages.;;Examination Report for Japanese Patent Application No. 2007-212216, mailed Mar. 2, 2010, 1 page.;;Examination Report for Japanese Patent Application No. 2007-212216, 2 pages.;;Examination Report for Japanese Patent Application 2002-526277, Apr. 19, 2007, 4 pages.;;Examination Report for Japanese Patent Application 2002-526277, May 18, 2006, 4 pages.;;Examination Report for Japanese Patent Application 2002-526277, Sep. 22, 2006, 3 pages.;;English Abstract, J P8112272 published May 7, 1996, 1 page.",EXPIRED
88,US,B2,US 7260426 B2,111-038-556-312-738,2007-08-21,2007,US 29321602 A,2002-11-12,US 29321602 A,2002-11-12,Method and apparatus for tracking an internal target region without an implanted fiducial,"A method and apparatus for locating an internal target region during treatment without implanted fiducials is presented. The method comprises producing a plurality of first images that show an internal volume including the internal target region, then producing a live image of the internal volume during treatment and matching this live image to one of the plurality of first images. Since the first images show the internal target region, matching the live image to one of the first images identifies the position of the target region regardless of whether the second image itself shows the position of the target region. The first images may be any three-dimensional images such as CT scans, magnetic resonance imaging, and ultrasound. The live image may be, for example, an x-ray image. The invention may be used in conjunction with a real-time sensor to track the position of the target region on a real-time basis.",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (2002-11-06),https://lens.org/111-038-556-312-738,Granted Patent,yes,7,137,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B5/00;;A61B6/12;;A61B19/00;;A61N5/10,600/407;;600/410;;600/411;;600/425;;600/427;;600/428;;600/437;;600/534;;600/595,1,0,,,"PCT Written Opinion, mailed Feb. 1, 2006, International Application No. PCT/US03/35801, International Filing Date Nov. 12, 2003, 5 pages.",EXPIRED
89,US,A1,US 2004/0092815 A1,118-959-388-864-146,2004-05-13,2004,US 29321602 A,2002-11-12,US 29321602 A,2002-11-12,Method and apparatus for tracking an internal target region without an implanted fiducial,"
   A method and apparatus for locating an internal target region during treatment without implanted fiducials is presented. The method comprises producing a plurality of first images that show an internal volume including the internal target region, then producing a live image of the internal volume during treatment and matching this live image to one of the plurality of first images. Since the first images show the internal target region, matching the live image to one of the first images identifies the position of the target region regardless of whether the second image itself shows the position of the target region. The first images may be any three-dimensional images such as CT scans, magnetic resonance imaging, and ultrasound. The live image may be, for example, an x-ray image. The invention may be used in conjunction with a real-time sensor to track the position of the target region on a real-time basis. 
",SCHWEIKARD ACHIM;;ADLER JOHN R.,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (2002-11-06),https://lens.org/118-959-388-864-146,Patent Application,yes,7,203,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B6/12;;A61B19/00;;A61N5/10,600/425,0,0,,,,EXPIRED
90,US,A,US 2533750 A,135-328-593-801-625,1950-12-12,1950,US 59171245 A,1945-05-03,US 59171245 A;;US 53770444 A,1944-05-27,High-gain amplifier tube,,ZENITH RADIO CORP,ROBERT ADLER;;PRENTISS JOHN G,,https://lens.org/135-328-593-801-625,Granted Patent,no,11,2,1,2,0,H01J21/02;;H01J21/02,H01J21/02,,0,0,,,,EXPIRED
91,US,B2,US 7680337 B2,077-633-675-279-809,2010-03-16,2010,US 35968106 A,2006-02-22,US 35968106 A;;US 65518505 P,2005-02-22,Process for finding endmembers in a data set,"The invention provides a method for identifying one or more materials in a scene by determining a set of spectral vectors, called endmembers, from a data set comprised of spectra from the image data, and matching the set of endmembers to predefined library materials. The image data of the scene is captured with a sensor, and comprises a plurality of spectra. The method applies an iterative mathematical criterion, termed residual minimization, to find the endmembers. The first endmember may be selected based on the largest mean square value or the largest mean magnitude value. Subsequent endmembers are determined by calculating weighting factors, such that the weighting factors are non-negative and the calculated vector differences, or residuals, generate the smallest error metric. The error metric is dependent upon the vector difference between two spectra in the image data set, and may be the mean squared vector difference between two spectra.",SPECTRAL SCIENCES INC,GRUNINGER JOHN;;ADLER-GOLDEN STEVEN,SPECTRAL SCIENCES INC (2006-02-21),https://lens.org/077-633-675-279-809,Granted Patent,yes,15,20,2,2,0,G06V20/13;;G06V20/13,G01J5/02;;G06V20/13,382/191;;250/339.07;;382/224,11,3,082-442-337-199-442;;079-196-387-126-680;;024-950-661-076-775,10.1117/12.328097;;10.1109/tgrs.2003.820314;;10.1109/igarss.2001.977104,"Bowles et al. (Jul. 1998) ""Comparison of output from ORASIS and pixel purity calculations."" Proc. SPIE vol. 3438 pp. 148-156.;;Cipar et al. (Apr. 2002) ""Comparison of endmember extraction techniques."" Proc. SPIE vol. 4725 pp. 1-9.;;Friedman, J.H. (Dec. 2001) ""Greedy function approximation: a gradient boosting machine."" Annals of Statistics, vol. 29 No. 5, pp. 1189-1232.;;Gruninger et al. (Jun. 2000) ""Hyperspectral mixture analysis using constrained projections onto material subspaces."" Proc. Int'l Symposium on Spectral Sensing Research, pp. 162-170.;;Gruninger et al. (Apr. 2001) ""Automated optimal channel selection for spectral imaging sensors."" Proc. SPIE vol. 4381, pp. 68-75.;;Plaza et al. (Mar. 2004) A quantitative and comparative analysis of endmember extraction algorithms from hyperspectral data. IEEE Trans. on Geoscience and Remote Sensing, vol. 42 No. 3, pp. 650-663.;;Zhu et al. (Jul. 2001) ""Probability guided and minimum residual exhaustive searching approaches for subpixel classification."" IEEE Int'l Geoscience and Remote Sensing Symposium, vol. 4 pp. 1883-1885.;;Research Systems Inc. (Oct. 2004) ""RSI extends the power of remote sensing and image analysis with ENVI 4.1."" Press Release. http://www.rsinc.com/pr/detail.asp?PRID=112, as archived by The Internet Archive, http://www.archive.org/.;;Winter ME. N-Finder: an algorithm for fast autonomous spectral end-member determination in hyperspectral data, Dept of Earth Sciences, University of Queensland and TRA, Inc. Jul. 1999.;;Research Systems, Inc. ENVI 4.2 User's Guide, vol. 1 & 2, ITT Industries. Aug. 2005.;;Boardman, JW, et al. Mapping target signatures via partial unmixing of AVIRIS data: in Summaries, 5th JPL Airborne Earth Science Wksp,1995,JPL Publication 95-1, v. 1, p. 23-26.",ACTIVE
92,CA,A,CA 608818 A,146-162-662-058-903,1960-11-15,1960,CA 608818D A,,CA 608818T A,,FREQUENCY DISCRIMINATION SYSTEM,,ZENITH RADIO CORP,ADLER ROBERT;;SPRACKLEN JOHN G,,https://lens.org/146-162-662-058-903,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
93,US,A,US 4673918 A,139-348-794-105-494,1987-06-16,1987,US 67603984 A,1984-11-29,US 67603984 A,1984-11-29,Light guide having focusing element and internal reflector on same face,"An improved light collector for use in a touch panel device which has a plurality of substantially parallel light beams directed across a display surface thereof, which collector collects the light in the light beams and redirects it in a direction substantially perpendicular to the light beams for detection by a light detector positioned adjacent one end of the light collector. The collector comprises a multi-sided elongated strip of light transmissive material having a longitudinal axis, and being terminated by a light collection station. A plurality of longitudinally spaced light focusing elements are disposed along a first side of the strip. A like plurality of longitudinally spaced light redirecting elements, likewise disposed along the first side of the strip, are individually paired with an assigned one of the light focusing elements and each such redirecting element has a light intercepting surface having transverse dimensions small in comparison to the cross-sectional dimensions of the strip. The light intercepting surface of each redirecting element is tilted with respect to the longitudinal axis of the strip. A like plurality of longitudinally spaced light reflectors are disposed along that side of the strip which is opposite the first side and each reflector is located at a point on the strip which is intermediate an assigned one of the light focusing elements and that element's paired light redirecting element.",ZENITH ELECTRONICS CORP,ADLER ROBERT;;JAROSZ JOHN M,ZENITH ELECTRONICS CORPORATION (1984-11-09),https://lens.org/139-348-794-105-494,Granted Patent,yes,4,105,1,1,0,G06F3/0421;;G06F3/0421,G06F3/033;;G06F3/042,340365P;;340/712;;455/612;;350/96.1;;350/96.18;;250/227,0,0,,,,EXPIRED
94,US,A1,US 2012/0308302 A1,165-274-043-832-096,2012-12-06,2012,US 201213491878 A,2012-06-08,US 201213491878 A;;US 69473010 A;;US 19125105 A;;US 59101804 P;;US 60095504 P;;US 60595904 P;;US 62238504 P;;US 67496505 P;;US 67954705 P,2004-07-26,ANTI-RAM SYSTEM AND METHOD OF INSTALLATION,"An anti-ram system and method of construction having a shallow mounted base pad from which extend a plurality of bollards. Very little or only a shallow excavation is required for the base of the bollard system, which can be partially or fully assembled prior to bringing it to the installation site. The shallow mounting pad or base of the bollard system of this invention may be formed or constructed in various ways and of various materials, and in various configurations. The shallow mounting pad or base is constructed so as to have considerable mass.",ADLER RICHARD S;;CRAWFORD JOHN;;RSA PROTECTIVE TECHNOLOGIES LLC,ADLER RICHARD S;;CRAWFORD JOHN,,https://lens.org/165-274-043-832-096,Patent Application,yes,2,19,7,7,0,E01F13/00;;E01F13/12;;E01F9/623;;E01F9/685;;E01F13/12;;E01F13/00;;E01F9/623;;E01F9/685,E01F15/00,404/6,0,0,,,,DISCONTINUED
95,US,A1,US 2006/0188161 A1,171-022-717-289-912,2006-08-24,2006,US 35968106 A,2006-02-22,US 35968106 A;;US 65518505 P,2005-02-22,Process for finding endmembers in a data set,"A method of representing spectral data, such as hyperspectral imaging data (HSI) and multispectral imaging data (MSI), as a set of simplex models. The method finds end-images or end-spectra in the data (termed “endmembers”) as extreme points, and simultaneously determines the abundance of the endmembers.",GRUNINGER JOHN;;ADLER-GOLDEN STEVEN,GRUNINGER JOHN;;ADLER-GOLDEN STEVEN,SPECTRAL SCIENCES INC (2006-02-21),https://lens.org/171-022-717-289-912,Patent Application,yes,15,16,2,2,0,G06V20/13;;G06V20/13,G06V20/13,382/191,0,0,,,,ACTIVE
96,US,A1,US 2010/0166498 A1,196-511-067-714-976,2010-07-01,2010,US 69473010 A,2010-01-27,US 69473010 A;;US 19125105 A;;US 59101804 P;;US 60095504 P;;US 60595904 P;;US 62238504 P;;US 67496505 P;;US 67954705 P,2004-07-26,ANTI-RAM SYSTEM AND METHOD OF INSTALLATION,"An anti-ram system and method of construction having a shallow mounted base pad from which extend a plurality of bollards. Very little or only a shallow excavation is required for the base of the bollard system, which can be partially or fully assembled prior to bringing it to the installation site. The shallow mounting pad or base of the bollard system of this invention may be formed or constructed in various ways and of various materials, and in various configurations. The shallow mounting pad or base is constructed so as to have considerable mass.",RSA PROTECTIVE TECHNOLOGIES LL,ADLER RICHARD S;;CRAWFORD JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2009-11-09),https://lens.org/196-511-067-714-976,Patent Application,yes,20,14,7,7,0,E01F13/00;;E01F13/12;;E01F9/623;;E01F9/685;;E01F13/12;;E01F13/00;;E01F9/623;;E01F9/685,E01F15/00,404/6,0,0,,,,ACTIVE
97,US,B2,US 7318805 B2,060-704-672-871-303,2008-01-15,2008,US 27359802 A,2002-10-18,US 27359802 A;;US 65777100 A;;US 27040499 A,1999-03-16,Apparatus and method for compensating for respiratory and patient motion during treatment,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/060-704-672-871-303,Granted Patent,yes,36,272,5,5,0,A61N5/1049;;A61N5/1049;;A61B6/08;;A61B6/08;;A61B6/12;;A61B6/12;;A61B6/527;;A61B6/527;;A61B10/0233;;A61B10/0233;;A61B18/20;;A61B18/20;;A61B34/20;;A61B34/20;;A61B34/25;;A61B34/25;;A61B90/10;;A61B90/10;;A61B90/39;;A61B90/39;;A61B2017/00694;;A61B2017/00694;;A61B2017/00699;;A61B2017/00699;;A61B2034/105;;A61B2034/105;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/378;;A61B2090/378;;A61N5/1037;;A61N5/1037;;A61N5/1067;;A61N5/1067;;A61N5/107;;A61N5/107;;A61N7/02;;A61N7/02;;A61N2005/1058;;A61N2005/1058;;A61N2005/1061;;A61N2005/1061,A61B6/00;;G01B11/00;;A61B5/055;;A61B5/06;;A61B6/03;;A61B6/08;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/439;;600/427,1,1,052-877-376-782-790,10863083;;10.1016/s0360-3016(00)00524-1,"Minohara, S. et al., ""Respiratory Gated Irradiation System for Heavy-Ion Radiotherapy"", International Journal of Radiation: Oncology Biology Physics, Pergamon Press, US, vol. 47, No. 4, Jul. 1, 2000, ISSN: 0360-3016.",EXPIRED
98,US,A1,US 2011/0033232 A1,094-636-125-659-225,2011-02-10,2011,US 77901110 A,2010-05-12,US 77901110 A;;US 21609909 P;;US 28045209 P;;US 28347109 P;;US 28450409 P;;US 34156310 P,2009-05-12,SURFACE MOUNT VEHICLE ANTI-RAM SECURITY SYSTEMS,"Anti-ram systems according to embodiments of the invention comprise at least one bollard section comprising a base of limited height and a plurality of spaced bollards extending upwardly from the base. An anti-ram system according to embodiments of the invention may be erected or installed on a paved surface such as asphalt, concrete, paver stones, etc., or on an unpaved surface such as soil, and need not be partially of fully buried, and yet can qualify for Department of State crash ratings previously assigned to buried bollard systems. Disclosed anti-ram system also comprise a plurality of bollard sections and one or more connectors for interconnecting two or more of the bollard sections, and may also include an anchor or anchor system engaging at least each end of a bollard section not connected to another bollard section. The bollard sections may be filled with ballast and high friction structure may be attached to the bottom of the bollard sections to resist sliding after impact.",RSA PROTECTIVE TECHNOLOGY LLC,ADLER RICHARD S;;CRAWFORD JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2010-09-24),https://lens.org/094-636-125-659-225,Patent Application,yes,43,28,5,5,0,E01F13/12;;E01F9/685;;E01F13/12;;E01F9/685,E01F15/00,404/6,0,0,,,,ACTIVE
99,CA,A,CA 582165 A,158-620-351-078-588,1959-08-25,1959,CA 582165D A,,CA 582165T A,,COLOR TELEVISION,,ZENITH RADIO CORP,ADLER ROBERT;;SPRACKLEN JOHN G,,https://lens.org/158-620-351-078-588,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
100,US,B2,US 8523479 B2,165-773-882-258-538,2013-09-03,2013,US 201213607935 A,2012-09-10,US 201213607935 A;;US 77901110 A;;US 21609909 P;;US 28045209 P;;US 28347109 P;;US 28450409 P;;US 34156310 P,2009-05-12,Surface mount vehicle anti-ram security systems,"Disclosed anti-ram systems comprise at least one bollard section comprising a base of limited height and a plurality of spaced bollards extending upwardly from the base, which may be erected or installed on a paved surface such as asphalt, concrete, paver stones, etc., or on an unpaved surface such as soil, and need not be partially of fully buried, and yet can qualify for Department of State crash ratings previously assigned to buried bollard systems. Disclosed anti-ram systems also comprise a plurality of bollard sections and one or more connectors for interconnecting two or more of the bollard sections, and may also include an anchor or anchor system engaging at least each end of a bollard section not connected to another bollard section. The bollard sections may be filled with ballast and high friction structure may be attached to the bottom of the bollard sections to resist sliding after impact.",ADLER RICHARD STEVEN;;CRAWFORD JOHN;;RSA PROTECTIVE TECHNOLOGY LLC,ADLER RICHARD STEVEN;;CRAWFORD JOHN,RSA TECHNOLOGIES INC (2012-08-25);;RSA PROTECTIVE TECHNOLOGIES INC (2010-09-24),https://lens.org/165-773-882-258-538,Granted Patent,yes,34,15,5,5,0,E01F13/12;;E01F9/685;;E01F13/12;;E01F9/685,E01F15/00,404/6;;256/13.1,2,0,,,"http://web.archive.org/web/20020525043057/http://globalsecurity.org/military/library...dated Feb. 12, 2007, 9 pgs.;;Department of Defense Handbook, ""Selection and Application of Vehicle Barriers"" MIL-DDBK-1013/14, Feb. 1, 1999.",ACTIVE
101,WO,A1,WO 2002/022019 A1,173-898-530-705-428,2002-03-21,2002,US 0128686 W,2001-09-14,US 66310400 A,2000-09-15,FRAMELESS RADIOSURGERY TREATMENT SYSTEM AND METHOD,"The radiation treatment device (10) may include a data processor (12), a disk or tape and a storage unit (13) which may store a three dimensional image of the patient (14). A beaming apparatus (20) emits a collimated surgical ionizing beam directed at a target region (18). The beaming apparatus may be activated by an operator throwing as switch (23) at a control console (24) connected to the beaming apparatus (20) by a cable (22).",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/173-898-530-705-428,Patent Application,yes,2,11,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,1,0,,,See also references of EP 1328195A4,PENDING
102,JP,A,JP 2008023347 A,195-068-699-965-845,2008-02-07,2008,JP 2007212216 A,2007-08-16,US 66310400 A,2000-09-15,FRAMELESS RADIATION SURGICAL THERAPY SYSTEM AND METHOD THEREOF,"<P>PROBLEM TO BE SOLVED: To provide an improved frameless radiation therapy system and method for using the same. <P>SOLUTION: The radiation therapy apparatus 10 comprises a data processor 12, a disc or a tape, and a housing unit for housing the three-dimensional image of a patient 14. A beam generator 20, irradiates surgical ionizing beams directed to a target area, and is activated by an operator by switching a switch 23 disposed on a control table 24 connected to the beam generator 20 via a cable 22. <P>COPYRIGHT: (C)2008,JPO&INPIT",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/195-068-699-965-845,Patent Application,no,2,7,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;A61N5/10;;A61B5/06;;G01B11/00;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,ACTIVE
103,US,A1,US 2014/0107477 A1,087-862-751-876-640,2014-04-17,2014,US 201314133111 A,2013-12-18,US 201314133111 A;;US 201113306951 A;;US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,FRAMELESS RADIOSURGERY TREATMENT SYSTEM AND METHOD,A method of compensating for breathing and other motions of a patient during treatment includes periodically generating internal positional data about an internal target region. The method further includes generating external positional data about external motion of the patient's body using an external sensor and generating a correlation between one or more positions of the internal target region and one or more positions of an external region using the external positional data of the external sensor and the internal positional data of the internal target region. The method further includes predicting the position of the internal target region at some later time based on the correlation model.,ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/087-862-751-876-640,Patent Application,yes,8,4,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61N5/10;;A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/426;;600/427,0,0,,,,EXPIRED
104,DE,A1,DE 2548848 A1,197-603-562-397-685,1976-05-13,1976,DE 2548848 A,1975-10-31,US 51989774 A,1974-11-01,OPTISCHES LESESYSTEM,,THOMSON BRANDT,ADLER ROBERT DR;;RENNICK JOHN,,https://lens.org/197-603-562-397-685,Patent Application,no,0,0,10,10,0,G11B7/004;;G11B7/005;;G11B7/08;;G11B7/0901;;G11B7/0901;;G11B7/08;;G11B7/005;;G11B7/004,H04N5/85;;G11B7/004;;G11B7/005;;G11B7/08;;G11B7/09;;G11B7/135,,0,0,,,,DISCONTINUED
105,US,A,US 3511570 A,009-822-163-450-613,1970-05-12,1970,US 3511570D A,1969-04-07,US 55320866 A;;US 81389769 A,1966-05-26,METHOD OF PREPARING SAMPLES FROM SOLUTION,,LITTLE INC A,MOGAYZEL JOHN W;;ADLER NORMAN,,https://lens.org/009-822-163-450-613,Granted Patent,no,1,1,1,2,0,G01N1/28;;G01N1/28;;Y10T436/255;;Y10T436/255,G01N1/28,356/36,0,0,,,,EXPIRED
106,US,A1,US 2003/0125622 A1,014-551-637-576-787,2003-07-03,2003,US 27359802 A,2002-10-18,US 27359802 A;;US 65777100 A;;US 27040499 A,1999-03-16,Apparatus and method for compensating for respiratory and patient motion during treatment,"
   An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers. 
",SCHWEIKARD ACHIM;;ADLER JOHN R.,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/014-551-637-576-787,Patent Application,yes,28,205,5,5,0,A61N5/1049;;A61N5/1049;;A61B6/08;;A61B6/08;;A61B6/12;;A61B6/12;;A61B6/527;;A61B6/527;;A61B10/0233;;A61B10/0233;;A61B18/20;;A61B18/20;;A61B34/20;;A61B34/20;;A61B34/25;;A61B34/25;;A61B90/10;;A61B90/10;;A61B90/39;;A61B90/39;;A61B2017/00694;;A61B2017/00694;;A61B2017/00699;;A61B2017/00699;;A61B2034/105;;A61B2034/105;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/378;;A61B2090/378;;A61N5/1037;;A61N5/1037;;A61N5/1067;;A61N5/1067;;A61N5/107;;A61N5/107;;A61N7/02;;A61N7/02;;A61N2005/1058;;A61N2005/1058;;A61N2005/1061;;A61N2005/1061,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/08;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/437,0,0,,,,EXPIRED
107,US,A1,US 2005/0027194 A1,042-566-963-897-372,2005-02-03,2005,US 91976504 A,2004-08-17,US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,Frameless radiosurgery treatment system and method,A method and apparatus for selectively and accurately localizing and treating a target within a patient are provided. A three dimensional mapping of a region surrounding the target is coupled to a surgical intervention. Two or more diagnostic beams at a known non-zero angle to one another may pass through the mapping region to produce images of projections within the mapping region in order to accurately localize and treat the target wherein the images are captured using one or more image recorders.,ADLER JOHN R.;;SCHWEIKARD ACHIM,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/042-566-963-897-372,Patent Application,yes,30,48,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427,0,0,,,,DISCONTINUED
108,JP,A,JP 2009297554 A,101-776-421-631-063,2009-12-24,2009,JP 2009225262 A,2009-09-29,US 27040499 A,1999-03-16,APPARATUS FOR COMPENSATING FOR RESPIRATION AND PATIENT MOTION DURING TREATMENT,"<P>PROBLEM TO BE SOLVED: To provide an apparatus for improving positional accuracy and medical effectiveness of surgical treatment when a first detecting device, for periodically generating positional data about an internal target region in the body of a patient, does not operate. <P>SOLUTION: The apparatus for compensating for breathing and other motion of the patient during treatment includes: the first detecting device for periodically generating positional data about the internal target region in the body of a patient; a second detecting device for continuously generating positional data about one or more external sensors indicating external motion of the body of the patient when the first detecting device does not operate; and a processor that generates the correspondence between the position of the internal target region and the position of the external sensor and determines the position of the internal target region to be treated when the first detecting device does not operates for compensation of movement of the patient. The position is determined based on the generating position of an external marker corresponding to a predetermined position of the internal target region. <P>COPYRIGHT: (C)2010,JPO&INPIT",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/101-776-421-631-063,Patent Application,no,15,3,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,A61N5/10;;A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,INACTIVE
109,AT,T1,AT E269035 T1,006-058-297-179-726,2004-07-15,2004,AT 00917928 T,2000-03-14,US 27040499 A;;US 0006660 W,1999-03-16,VORRICHTUNG UND VERFAHREN ZUM KOMPENSIEREN DER ATMUNGS- UND PATIENTENBEWEGUNG WÄHREND DER BEHANDLUNG,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers adapted to be attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/006-058-297-179-726,Granted Patent,no,0,0,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,DISCONTINUED
110,WO,A1,WO 2010/132616 A1,002-840-378-795-365,2010-11-18,2010,US 2010/0034619 W,2010-05-12,US 21609909 P;;US 28045209 P;;US 28347109 P;;US 28450409 P;;US 34156310 P,2009-05-12,SURFACE MOUNT VEHICLE ANTI-RAM SECURITY SYSTEMS,"Anti-ram systems according to embodiments of the invention comprise at least one bollard section comprising a base of limited height and a plurality of spaced bollards extending upwardly from the base. An anti-ram system according to embodiments of the invention may be erected or installed on a paved surface such as asphalt, concrete, paver stones, etc., or on an unpaved surface such as soil, and need not be partially of fully buried, and yet can qualify for Department of State crash ratings previously assigned to buried bollard systems. Disclosed anti-ram system also comprise a plurality of bollard sections and one or more connectors for interconnecting two or more of the bollard sections, and may also include an anchor or anchor system engaging at least each end of a bollard section not connected to another bollard section. The bollard sections may be filled with ballast and high friction structure may be attached to the bottom of the bollard sections to resist sliding after impact.",RSA PROTECTIVE TECHNOLOGIES LL;;ADLER RICHARD S;;CRAWFORD JOHN,ADLER RICHARD S;;CRAWFORD JOHN,,https://lens.org/002-840-378-795-365,Patent Application,yes,3,25,5,5,0,E01F13/12;;E01F9/685;;E01F13/12;;E01F9/685,E01F13/12,,0,0,,,,PENDING
111,EP,A4,EP 1176919 A4,012-940-351-702-924,2003-04-02,2003,EP 00917928 A,2000-03-14,US 0006660 W;;US 27040499 A,1999-03-16,APPARATUS AND METHOD FOR COMPENSATING FOR RESPIRATORY AND PATIENT MOTION DURING TREATMENT,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers adapted to be attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,"ACCURAY, INC. (2004-11-03)",https://lens.org/012-940-351-702-924,Search Report,no,3,0,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,EXPIRED
112,US,B1,US 6501981 B1,031-022-939-945-114,2002-12-31,2002,US 65777100 A,2000-09-08,US 65777100 A;;US 27040499 A,1999-03-16,Apparatus and method for compensating for respiratory and patient motions during treatment,"
    An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers. 
",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (2000-09-07),https://lens.org/031-022-939-945-114,Granted Patent,yes,14,651,5,5,0,A61N5/1049;;A61N5/1049;;A61B6/08;;A61B6/08;;A61B6/12;;A61B6/12;;A61B6/527;;A61B6/527;;A61B10/0233;;A61B10/0233;;A61B18/20;;A61B18/20;;A61B34/20;;A61B34/20;;A61B34/25;;A61B34/25;;A61B90/10;;A61B90/10;;A61B90/39;;A61B90/39;;A61B2017/00694;;A61B2017/00694;;A61B2017/00699;;A61B2017/00699;;A61B2034/105;;A61B2034/105;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/378;;A61B2090/378;;A61N5/1037;;A61N5/1037;;A61N5/1067;;A61N5/1067;;A61N5/107;;A61N5/107;;A61N7/02;;A61N7/02;;A61N2005/1058;;A61N2005/1058;;A61N2005/1061;;A61N2005/1061,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/08;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427;;606/130;;600/429;;600/439;;378/69,0,0,,,,EXPIRED
113,WO,A3,WO 2004/044612 A3,081-763-081-681-606,2004-09-23,2004,US 0335801 W,2003-11-12,US 29321602 A,2002-11-12,A METHOD AND APPARATUS FOR TRACKING AN INTERNAL TARGET REGION WITHOUT AN IMPLANTED FIDUCIAL,"A method and apparatus for locating an internal target region during treatment without implanted fiducials is presented. The method comprises producing a plurality of first images that show an internal volume including the internal target region, then producing a live image of the internal volume during treatment and matching this live image to one of the plurality of first images. Since the first images show the internal target region, matching the live image to one of the first images identifies the position of the target region regardless of whether the second image itself shows the position of the target region. The first images may be any three­dimensional images such as CT scans, magnetic resonance imaging, and ultrasound. The live image may be, for example, an x-ray image. The invention may be used in conjunction with a real-time sensor to track the position of the target region on a real-time basis.",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/081-763-081-681-606,Search Report,yes,2,0,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B6/12;;A61B19/00;;A61N5/10,,1,0,,,See also references of EP 1565106A4,PENDING
114,US,B2,US 8634898 B2,105-052-338-963-464,2014-01-21,2014,US 201113306951 A,2011-11-29,US 201113306951 A;;US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,Frameless radiosurgery treatment system and method,A method of compensating for breathing and other motions of a patient during treatment includes periodically generating internal positional data about an internal target region. The method further includes continuously generating external positional data about external motion of the patient's body using an external sensor and generating a correlation model between the position of the internal target region and the external sensor using the external positional data of the external sensor and the internal positional data of the internal target region. The method further includes predicting the position of the internal target region at some later time based on the correlation model.,ADLER JOHN R;;SCHWEIKARD ACHIM;;ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/105-052-338-963-464,Granted Patent,yes,69,9,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;G01B11/00;;A61B5/06;;G03B42/02;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427;;600/426;;600/428,13,2,000-676-958-439-67X;;052-877-376-782-790,17518376;;10.1581/mrcas.2005.010211;;10.1002/rcs.39;;10863083;;10.1016/s0360-3016(00)00524-1,"Coste-Maniere, E., (2005). ""Robotic Whole Body Stereotactic Radiosurgery: Clinical Advantages of the CyberKnife® Integrated System,"" The International Journal of Medical Robotics + Computer Assisted Surgery, www.roboticpublications.com, pp. 28-39.;;Supplementary Partial European Search Report, Application No. EP01970945, mailed Jun. 28, 2006.;;Minohara, S. et al. (Jul. 2000). ""Respiratory Gated Irridation System for Heavy-Ion Radiotherapy,"" International Journal of Radiation: Oncology Biology Physics, Pergamon Press, US vol. 47, No. 4, ISSN:0360-3016.;;Supplementary European Search Report for European Patent Application No. 01 970 945.0, Oct. 16, 2006, 5 pages.;;Supplementary European Search Report for European Patent Application No. 01 970 945.0 dated Apr. 5, 2006, 5 pages.;;Examination Report for European Patent Application No. 01 970 945.0, dated Jan. 16, 2007, 7 pages.;;Examination Report for European Patent Application No. 01 970 945.0, dated Feb. 23, 2010, 6 pages.;;Examination Report for Japanese Patent Application No. 2007-212216, mailed Mar. 2, 2010, 1 page.;;Examination Report for Japanese Patent Application No. 2007-212216, 2 pages.;;Examination Report for Japanese Patent Application 2002-526277, Apr. 19, 2007, 4 pages.;;Examination Report for Japanese Patent Application 2002-526277, May, 18, 2006, 4 pages.;;Examination Report for Japanese Patent Application 2002-526277, Sep. 22, 2006, 3 pages.;;English Abstract, JP8112272 published May 7, 1996, 1 page.",EXPIRED
115,WO,A1,WO 2000/054689 A1,136-271-363-017-247,2000-09-21,2000,US 0006660 W,2000-03-14,US 27040499 A,1999-03-16,APPARATUS AND METHOD FOR COMPENSATING FOR RESPIRATORY AND PATIENT MOTION DURING TREATMENT,"This invention relates to internal markers (152) attached to the target organ (151) being imaged by a stereotaxic x-ray device. The internal markers (152) on the target organ (151) may be imaged by a first x-ray source (160), and a second x-ray source (162) which are positioned at some predetermined angle with respect to each other similar to the diagnostic x-ray beams. The x-ray sources may generate a first, a second diagnostic x-ray beam (164, 166) that pass through a target organ (151) near the internal markers (152) that are received by a first, a second x-ray receiver (168, 170), respectively, which receive the x-ray beams, and generate an electrical signal corresponding to the received x-rays. The stereotaxic x-ray device permits the precise location of the internal markers (152) to be determined by analyzing the images generated.",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/136-271-363-017-247,Patent Application,yes,2,48,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,A61B5/055;;A61B5/06;;G01B11/00;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,PATENTED
116,US,A1,US 2009/0129545 A1,175-390-796-351-685,2009-05-21,2009,US 35644209 A,2009-01-20,US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,FRAMELESS RADIOSURGERY TREATMENT SYSTEM AND METHOD,A method and apparatus for selectively and accurately localizing and treating a target within a patient are provided. A three dimensional mapping of a region surrounding the target is coupled to a surgical intervention. Two or more diagnostic beams at a known non-zero angle to one another may pass through the mapping region to produce images of projections within the mapping region in order to accurately localize and treat the target wherein the images are captured using one or more image recorders.,ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/175-390-796-351-685,Patent Application,yes,52,42,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61N5/10;;A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,378/65;;600/427,0,0,,,,EXPIRED
117,EP,A1,EP 1328195 A1,023-274-006-008-349,2003-07-23,2003,EP 01970945 A,2001-09-14,US 0128686 W;;US 66310400 A,2000-09-15,FRAMELESS RADIOSURGERY TREATMENT SYSTEM,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (2017-07-12),https://lens.org/023-274-006-008-349,Patent Application,yes,0,0,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;A61B5/06;;A61N5/10;;A61B6/00;;G01B11/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,EXPIRED
118,US,B2,US 11850022 B2,100-313-123-463-519,2023-12-26,2023,US 201615011108 A,2016-01-29,US 201615011108 A;;US 201314040604 A;;US 201261719301 P;;US 201361798066 P;;US 201314040609 A,2012-10-26,NIR image-guided targeting,"A method includes determining skin characteristics in a region of a patient. An in-treatment optical scan is performed on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. A plurality of detected signals is detected from the optical scan. The skin characteristics are filtered out from the plurality of detected signals. Skeletal anatomy positioning associated with the region is determined from the plurality of signals that is filtered.",VARIAN MED SYS INC,ADLER JR JOHN;;SHARDA AGAM,VARIAN MEDICAL SYSTEMS INC (2013-10-01),https://lens.org/100-313-123-463-519,Granted Patent,yes,13,0,4,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B6/032;;A61B5/0036;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B5/00;;A61B5/055;;A61B6/00;;A61B6/03;;A61N5/06;;A61N5/10,,6,0,,,"Leblond et al., “Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications” Journal of Photochemistry and Photobiology B: Biology 98 (2010) 77-94 (Year: 2010).;;Snoeks, et al. “Optical Advances in Skeletal Imaging Applied to Bone Metastases”, Bone, Pergaman Press., Oxford, GB, vol. 48 No. 1, Jan. 1, 2011 pp. 106-114, XP027568405.;;Mansfield, et al. “Autofluorescence Removal, Multiplexing, and Automated Analysis Methods for In-Vivo Fluorescence Imaging”, Journal of Biomedical Optics, vol. 10 No. 4 Jan. 1, 2005 p. 041207, XP055269855.;;Zaheer, et al. “In Vivo Near-Infrared Fluorescence Imaging of Osteoblastic Activity” Nature Biotechnology, vol. 19, No. 12 Dec. 1, 2011 pp. 1148-1154, XP055269648.;;Brouwer, et al. “Image Navigation as a Means to Expand the Boundaries of Fluorescence-Guided Surgery” Physics in Medicine and Biology, Institute of Physics Publishing, Bristol GB vol. 57, No. 10 May 1, 2012 pp. 3123-3136 XP020221940.;;Kaijzel, et al. “Multimodal Imaging and Treatment of Bone Metastasis” Clinical & Experimental Metastasis Official Journal of Themetastasis Research Society, Kluwer Academic Publishers, Do, vol. 26, No. 4, Oct. 22, 2008 pp. 371-379 XP019672682.",ACTIVE
119,US,A1,US 2013/0112007 A1,124-588-303-512-318,2013-05-09,2013,US 201213671176 A,2012-11-07,US 201213671176 A;;US 201161628830 P,2011-11-07,Fouling Resistant Flow Metering System,"Appurtenances added to a pipe mitigate the effects of upstream valves, sluice gates or pipe elbows to condition the pipe flow for accurate flow rate detection by a reverse propeller meter. Further appurtenances allow the reverse propeller meter to be used in extreme debris situations such as weeds, vines and moss present in many canal systems. The system provides an electronic signal that indicates flow rate and accumulated flow volume, or the signal can be transmit to a central headquarters for remote gate control or canal automation.",RSA ENVIRONMENTAL;;RSA ENVIRONMENTAL,ADLER RICHARD STEVEN;;REPLOGLE JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2015-12-23),https://lens.org/124-588-303-512-318,Patent Application,yes,14,6,5,5,0,G01F15/00;;G01F1/10;;E03F7/00;;E03F2201/20;;Y10T137/0441;;G01F1/00;;G01F1/66;;E02B1/00;;Y10T137/0441;;E03F7/00;;E03F2201/20;;G01F15/00;;G01F1/10;;G01F1/42;;G01F1/46;;G01F1/56,E02B1/00;;G01F1/00;;G01F1/66,73/861.08;;73/861.18;;73/195;;73/198;;137/15.08,2,1,008-037-681-588-807,10.3733/ca.v052n01p25,"McCrometer brochure, 2008.;;Blaine R. Hanson and Larry J. Schwankl, ""Water Turbulence Disrupts Accuracy of Some Flow Meters"", California Agriculture, v. 52, no. 1, 1998, pages 25-30.",ACTIVE
120,US,A1,US 2013/0034387 A1,156-623-730-625-757,2013-02-07,2013,US 201213607935 A,2012-09-10,US 201213607935 A;;US 77901110 A;;US 21609909 P;;US 28045209 P;;US 28347109 P;;US 28450409 P;;US 34156310 P,2009-05-12,SURFACE MOUNT VEHICLE ANTI-RAM SECURITY SYSTEMS,"Disclosed anti-ram systems comprise at least one bollard section comprising a base of limited height and a plurality of spaced bollards extending upwardly from the base, which may be erected or installed on a paved surface such as asphalt, concrete, paver stones, etc., or on an unpaved surface such as soil, and need not be partially of fully buried, and yet can qualify for Department of State crash ratings previously assigned to buried bollard systems. Disclosed anti-ram systems also comprise a plurality of bollard sections and one or more connectors for interconnecting two or more of the bollard sections, and may also include an anchor or anchor system engaging at least each end of a bollard section not connected to another bollard section. The bollard sections may be filled with ballast and high friction structure may be attached to the bottom of the bollard sections to resist sliding after impact.",RSA PROTECTIVE TECHNOLOGY LLC;;ADLER RICHARD S;;CRAWFORD JOHN,ADLER RICHARD S;;CRAWFORD JOHN,RSA TECHNOLOGIES INC (2012-08-25);;RSA PROTECTIVE TECHNOLOGIES INC (2010-09-24),https://lens.org/156-623-730-625-757,Patent Application,yes,0,12,5,5,0,E01F13/12;;E01F9/685;;E01F13/12;;E01F9/685,E01F15/00,404/6,0,0,,,,ACTIVE
121,CA,A,CA 1068403 A,009-291-408-274-647,1979-12-18,1979,CA 238810 A,1975-10-31,US 51989774 A,1974-11-01,OPTICAL READ-OUT SYSTEM FOR VIDEO DISC,OPTICAL READ-OUT SYSTEM FOR VIDEO DISC An optical read-out system comprising a matrix of four photoreceptors arranged to develop output signals representing information stored in a video disc as well as error signals for maintaining proper tracking registration of the reading beam with the storage track of the disc. The matrix enables all four photoreceptors to contribute to the development of the output signals and permits separate treatment of high frequency and low frequency signal information for improved results with respect to response and signal-to-noise ratio.,THOMSON BRANDT,ADLER ROBERT;;RENNICK JOHN L,,https://lens.org/009-291-408-274-647,Granted Patent,no,0,0,10,10,0,G11B7/004;;G11B7/005;;G11B7/08;;G11B7/0901;;G11B7/0901;;G11B7/08;;G11B7/005;;G11B7/004,H04N5/85;;G11B7/004;;G11B7/005;;G11B7/08;;G11B7/09;;G11B7/135,352-55,0,0,,,,EXPIRED
122,US,A1,US 2016/0143581 A1,044-220-117-285-777,2016-05-26,2016,US 201615011108 A,2016-01-29,US 201615011108 A;;US 201314040604 A;;US 201261719301 P;;US 201361798066 P;;US 201314040609 A,2012-10-26,NIR IMAGE-GUIDED TARGETING,"A method includes determining skin characteristics in a region of a patient. An in-treatment optical scan is performed on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. A plurality of detected signals is detected from the optical scan. The skin characteristics are filtered out from the plurality of detected signals. Skeletal anatomy positioning associated with the region is determined from the plurality of signals that is filtered.",VARIAN MED SYS INC,ADLER JR JOHN;;SHARDA AGAM,VARIAN MEDICAL SYSTEMS INC (2013-10-01),https://lens.org/044-220-117-285-777,Patent Application,yes,0,0,4,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B6/032;;A61B5/0036;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B5/00;;A61B5/055;;A61B6/00;;A61B6/03;;A61N5/10,,0,0,,,,ACTIVE
123,WO,A1,WO 2019/232227 A1,086-754-125-694-036,2019-12-05,2019,US 2019/0034680 W,2019-05-30,US 201862678098 P,2018-05-30,RADIOSURGICAL NEUROMODLATION CLOSE TO CRITICAL STRUCTURES,"Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.",ZAP SURGICAL SYSTEMS INC,ADLER JOHN;;SCHNEIDER M BRET,,https://lens.org/086-754-125-694-036,Patent Application,yes,10,0,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61B5/00;;A61B5/05;;A61B18/00;;A61K9/00;;A61K41/00;;A61N1/36;;A61N5/10,,1,0,,,See also references of EP 3801217A4,PENDING
124,EP,A1,EP 1176919 A1,102-288-906-877-903,2002-02-06,2002,EP 00917928 A,2000-03-14,US 0006660 W;;US 27040499 A,1999-03-16,APPARATUS AND METHOD FOR COMPENSATING FOR RESPIRATORY AND PATIENT MOTION DURING TREATMENT,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers adapted to be attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,"ACCURAY, INC. (2004-11-03)",https://lens.org/102-288-906-877-903,Patent Application,yes,0,0,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,EXPIRED
125,EP,A4,EP 1565106 A4,117-205-496-353-485,2010-09-08,2010,EP 03783278 A,2003-11-12,US 0335801 W;;US 29321602 A,2002-11-12,A METHOD AND APPARATUS FOR TRACKING AN INTERNAL TARGET REGION WITHOUT AN IMPLANTED FIDUCIAL,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/117-205-496-353-485,Search Report,no,3,0,9,9,0,A61B5/7285;;A61B6/12;;A61B6/469;;A61B6/541;;A61B8/543;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61N2005/1062;;A61B2034/2055;;A61B2034/2072;;A61B34/20;;A61B2090/364;;A61B90/361;;A61B2090/376;;A61B2090/3762;;A61N5/1049;;A61B6/12;;A61N2005/1062;;A61B6/541;;A61B5/7285;;A61N2005/1061;;A61B6/469;;A61N5/1064;;A61N5/1067;;A61B8/543;;A61B2034/2072;;A61B2034/2055;;A61B2090/364;;A61B34/20;;A61B2090/376;;A61B90/361;;A61B2090/3762,A61B6/12;;A61B19/00;;A61N5/10,,0,0,,,,DISCONTINUED
126,US,A1,US 2016/0216139 A1,155-638-406-638-447,2016-07-28,2016,US 201615010561 A,2016-01-29,US 201615010561 A;;US 201213671176 A;;US 201161628830 P,2011-11-07,FOULING RESISTANT FLOW METERING SYSTEM,"Appurtenances added to a pipe mitigate the effects of upstream valves, sluice gates or pipe elbows to condition the pipe flow for accurate flow rate detection by a reverse propeller meter. Further appurtenances allow the reverse propeller meter to be used in extreme debris situations such as weeds, vines and moss present in many canal systems. The system provides an electronic signal that indicates flow rate and accumulated flow volume, or the signal can be transmit to a central headquarters for remote gate control or canal automation.",RSA PROTECTIVE TECH LLC,ADLER RICHARD STEVEN;;REPLOGLE JOHN,,https://lens.org/155-638-406-638-447,Patent Application,yes,3,1,5,5,0,G01F15/00;;G01F1/10;;E03F7/00;;E03F2201/20;;Y10T137/0441;;G01F1/00;;G01F1/66;;E02B1/00;;Y10T137/0441;;E03F7/00;;E03F2201/20;;G01F15/00;;G01F1/10;;G01F1/42;;G01F1/46;;G01F1/56,G01F1/42;;G01F1/46;;G01F1/56;;G01F1/66,,0,0,,,,ACTIVE
127,EP,B1,EP 1328195 B1,177-589-244-805-547,2017-07-12,2017,EP 01970945 A,2001-09-14,US 0128686 W;;US 66310400 A,2000-09-15,FRAMELESS RADIOSURGERY TREATMENT SYSTEM,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (2017-07-12),https://lens.org/177-589-244-805-547,Granted Patent,yes,6,2,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61N5/10;;A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,1,0,,,"MINOHARA S ET AL: ""RESPIRATORY GATED IRRADIATION SYSTEM FOR HEAVY-ION RADIOTHERAPY"" INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, US, vol. 47, no. 4, 1 July 2000 (2000-07-01), pages 1097-1103, XP001051093 ISSN: 0360-3016",EXPIRED
128,US,A,US 3452601 A,183-010-645-250-767,1969-07-01,1969,US 3452601D A,1966-05-26,US 55320866 A,1966-05-26,SAMPLING DEVICE AND METHODS OF PREPARING AND USING SAME,,LITTLE INC A,MOGAYZEL JOHN W;;ADLER NORMAN,,https://lens.org/183-010-645-250-767,Granted Patent,no,2,2,1,2,0,G01N1/28;;G01N1/28,G01N1/28,73/425.4,0,0,,,,EXPIRED
129,US,A1,US 2017/0128744 A1,031-294-329-699-584,2017-05-11,2017,US 201715412958 A,2017-01-23,US 201715412958 A;;US 201314133111 A;;US 201113306951 A;;US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,FRAMELESS RADIOSURGERY TREATMENT SYSTEM AND METHOD,A method of compensating for breathing and other motions of a patient during treatment includes periodically generating internal positional data about an internal target region. The method further includes generating external positional data about external motion of the patient's body using an external sensor and generating a correlation between one or more positions of the internal target region and one or more positions of an external region using the external positional data of the external sensor and the internal positional data of the internal target region. The method further includes predicting the position of the internal target region at some later time based on the correlation model.,ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,ACCURAY INCORPORATED (2000-09-14),https://lens.org/031-294-329-699-584,Patent Application,yes,1,2,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61N5/10;;A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61B34/20;;A61B90/10;;A61N5/01;;A61N5/06;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,DISCONTINUED
130,US,A,US 4001494 A,045-254-498-064-194,1977-01-04,1977,US 51989774 A,1974-11-01,US 51989774 A,1974-11-01,PHOTORECEPTOR MATRIX FOR OPTICAL VIDEO PLAYBACK SYSTEM,A matrix of four photoreceptors is arranged to develop output signals representing information stored in a video disc as well as error signals for maintaining proper tracking registration of the reading beam with the storage track of the disc. The matrix enables all four photoreceptors to contribute to the development of the output signals and permits separate treatment of high frequency and low frequency signal information for improved results with respect to response and signal-to-noise ratio.,ZENITH RADIO CORP,ADLER ROBERT;;RENNICK JOHN L,,https://lens.org/045-254-498-064-194,Granted Patent,yes,5,11,10,10,0,G11B7/004;;G11B7/005;;G11B7/08;;G11B7/0901;;G11B7/0901;;G11B7/08;;G11B7/005;;G11B7/004,G11B7/004;;G11B7/005;;H04N5/85;;G11B7/08;;G11B7/09;;G11B7/135,358/127,1,1,143-223-526-358-028,10.5594/j10637,"""An Experimental Optical Videodisc Playback System"" by G. Hrbek; July 1974, Journal of the SMPTE vol. 83.",EXPIRED
131,WO,A1,WO 2013/070709 A1,087-234-310-360-916,2013-05-16,2013,US 2012/0063879 W,2012-11-07,US 201161628830 P,2011-11-07,FOULING RESISTANT FLOW METERING SYSTEM,"Appurtenances added to a pipe mitigate the effects of upstream valves, sluice gates or pipe elbows to condition the pipe flow for accurate flow rate detection by a reverse propeller meter. Further appurtenances allow the reverse propeller meter to be used in extreme debris situations such as weeds, vines and moss present in many canal systems. The system provides an electronic signal that indicates flow rate and accumulated flow volume, or the signal can be transmit to a central headquarters for remote gate control or canal automation.",RSA ENVIRONMENTAL,ADLER RICHARD S;;REPLOGLE JOHN,,https://lens.org/087-234-310-360-916,Patent Application,yes,5,0,5,5,0,G01F15/00;;G01F1/10;;E03F7/00;;E03F2201/20;;Y10T137/0441;;G01F1/00;;G01F1/66;;E02B1/00;;Y10T137/0441;;E03F7/00;;E03F2201/20;;G01F15/00;;G01F1/10;;G01F1/42;;G01F1/46;;G01F1/56,G01F17/00,,1,0,,,"ITRC: ""SBx7 Flow Rate Measurement Compliance for Agricultural Irrigation Districts"", REPORT, October 2012 (2012-10-01), pages 1, 19 - 20, Retrieved from the Internet <URL:http://www.itrc.org/reports/sbx7/sbx7.pdf> [retrieved on 20121226]",PENDING
132,AU,A,AU 2001/090891 A,106-125-276-807-925,2002-03-26,2002,AU 2001/090891 A,2001-09-14,US 66310400 A;;US 0128686 W,2000-09-15,Frameless radiosurgery treatment system and method,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/106-125-276-807-925,Patent Application,no,0,0,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,PENDING
133,US,B2,US 8215865 B2,139-646-372-197-523,2012-07-10,2012,US 69473010 A,2010-01-27,US 69473010 A;;US 19125105 A;;US 59101804 P;;US 60095504 P;;US 60595904 P;;US 62238504 P;;US 67496505 P;;US 67954705 P,2004-07-26,Anti-ram system and method of installation,"An anti-ram system and method of construction having a shallow mounted base pad from which extend a plurality of bollards. Very little or only a shallow excavation is required for the base of the bollard system, which can be partially or fully assembled prior to bringing it to the installation site. The shallow mounting pad or base of the bollard system of this invention may be formed or constructed in various ways and of various materials, and in various configurations. The shallow mounting pad or base is constructed so as to have considerable mass.",ADLER RICHARD S;;CRAWFORD JOHN;;RSA PROTECTIVE TECHNOLOGIES LLC,ADLER RICHARD S;;CRAWFORD JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2009-11-09),https://lens.org/139-646-372-197-523,Granted Patent,yes,50,18,7,7,0,E01F13/00;;E01F13/12;;E01F9/623;;E01F9/685;;E01F13/12;;E01F13/00;;E01F9/623;;E01F9/685,E01F13/00,404/6;;256/13.1,4,0,,,"PCT International Preliminary Report on Patentability, Apr. 3, 2007, 5 pgs.;;International Search Report, Mar. 20, 2007, 1 pg.;;http://web.archive.org/web/20020525043057/http://globalsecurity.org/military/library... dated Feb. 12, 2007, 9 pgs.;;Department of Defence Handbook, ""Selection and Application of Vehicle Barriers"" MIL-DDBK-1013/14, Feb. 1, 1999.",ACTIVE
134,US,A,US 2616035 A,172-885-155-188-449,1952-10-28,1952,US 6828648 A,1948-12-30,US 6828648 A,1948-12-30,Radio receiver employing a single tube amplifier-converter,,ZENITH RADIO CORP,ROBERT ADLER;;SPRACKLEN JOHN G,,https://lens.org/172-885-155-188-449,Granted Patent,no,6,5,1,1,0,H03D7/10;;H03D7/10,H03D7/10,,0,0,,,,EXPIRED
135,WO,A1,WO 2002/019908 A1,027-339-457-309-271,2002-03-14,2002,US 0128164 W,2001-09-06,US 65777100 A,2000-09-08,APPARATUS AND METHOD FOR COMPENSATING FOR RESPIRATORY AND PATIENT MOTION DURING TREATMENT,The radiation treatment device (10) may include a data processor (12) and a disc storage unit (13). Beaming apparatus may be activated by the operator throwing a switch (23) at a control console (24).,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/027-339-457-309-271,Patent Application,yes,1,29,5,5,0,A61N5/1049;;A61N5/1049;;A61B6/08;;A61B6/08;;A61B6/12;;A61B6/12;;A61B6/527;;A61B6/527;;A61B10/0233;;A61B10/0233;;A61B18/20;;A61B18/20;;A61B34/20;;A61B34/20;;A61B34/25;;A61B34/25;;A61B90/10;;A61B90/10;;A61B90/39;;A61B90/39;;A61B2017/00694;;A61B2017/00694;;A61B2017/00699;;A61B2017/00699;;A61B2034/105;;A61B2034/105;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/378;;A61B2090/378;;A61N5/1037;;A61N5/1037;;A61N5/1067;;A61N5/1067;;A61N5/107;;A61N5/107;;A61N7/02;;A61N7/02;;A61N2005/1058;;A61N2005/1058;;A61N2005/1061;;A61N2005/1061,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/08;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,PENDING
136,US,B2,US 9261387 B2,114-447-378-174-710,2016-02-16,2016,US 201213671176 A,2012-11-07,US 201213671176 A;;US 201161628830 P,2011-11-07,Fouling resistant flow metering system,"Appurtenances added to a pipe mitigate the effects of upstream valves, sluice gates or pipe elbows to condition the pipe flow for accurate flow rate detection by a reverse propeller meter. Further appurtenances allow the reverse propeller meter to be used in extreme debris situations such as weeds, vines and moss present in many canal systems. The system provides an electronic signal that indicates flow rate and accumulated flow volume, or the signal can be transmit to a central headquarters for remote gate control or canal automation.",RSA PROTECTIVE TECHNOLOGIES LLC,ADLER RICHARD STEVEN;;REPLOGLE JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2015-12-23),https://lens.org/114-447-378-174-710,Granted Patent,yes,14,0,5,5,0,G01F15/00;;G01F1/10;;E03F7/00;;E03F2201/20;;Y10T137/0441;;G01F1/00;;G01F1/66;;E02B1/00;;Y10T137/0441;;E03F7/00;;E03F2201/20;;G01F15/00;;G01F1/10;;G01F1/42;;G01F1/46;;G01F1/56,G01F1/00;;E02B1/00;;E03F7/00;;G01F1/10;;G01F1/66;;G01F15/00,,2,1,008-037-681-588-807,10.3733/ca.v052n01p25,"McCrometer brochure, 2008.;;Blaine R. Hanson and Larry J. Schwankl, ""Water Turbulence Disrupts Accuracy of Some Flow Meters"", California Agriculture, v. 52, No. 1, 1998, pp. 25-30.",ACTIVE
137,US,A,US 2838668 A,179-394-528-856-381,1958-06-10,1958,US 63212457 A,1957-01-02,US 63212457 A,1957-01-02,Frequency discrimination system,,ZENITH RADIO CORP,ROBERT ADLER;;SPRACKLEN JOHN G,,https://lens.org/179-394-528-856-381,Granted Patent,no,5,2,1,3,0,G08C23/02;;G08C23/02,G08C23/02,,0,0,,,,EXPIRED
138,EP,B1,EP 1176919 B1,185-797-131-033-671,2004-06-16,2004,EP 00917928 A,2000-03-14,US 0006660 W;;US 27040499 A,1999-03-16,APPARATUS AND METHOD FOR COMPENSATING FOR RESPIRATORY AND PATIENT MOTION DURING TREATMENT,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers adapted to be attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,"ACCURAY, INC. (2004-11-03)",https://lens.org/185-797-131-033-671,Granted Patent,yes,4,0,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,EXPIRED
139,WO,A2,WO 2004/044612 A2,095-550-897-757-123,2004-05-27,2004,US 0335801 W,2003-11-12,US 29321602 A,2002-11-12,A METHOD AND APPARATUS FOR TRACKING AN INTERNAL TARGET REGION WITHOUT AN IMPLANTED FIDUCIAL,"A method and apparatus for locating an internal target region during treatment without implanted fiducials is presented. The method comprises producing a plurality of first images that show an internal volume including the internal target region, then producing a live image of the internal volume during treatment and matching this live image to one of the plurality of first images. Since the first images show the internal target region, matching the live image to one of the first images identifies the position of the target region regardless of whether the second image itself shows the position of the target region. The first images may be any three­dimensional images such as CT scans, magnetic resonance imaging, and ultrasound. The live image may be, for example, an x-ray image. The invention may be used in conjunction with a real-time sensor to track the position of the target region on a real-time basis.",ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/095-550-897-757-123,Patent Application,yes,0,13,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B6/12;;A61B19/00;;A61N5/10,,0,0,,,,PENDING
140,US,A1,US 2009/0208285 A1,127-635-071-891-598,2009-08-20,2009,US 19125105 A,2005-07-26,US 19125105 A;;US 59101804 P;;US 60095504 P;;US 60595904 P;;US 62238504 P;;US 67496505 P;;US 67954705 P,2004-07-26,Anti-ram system and method of installation,"An anti-ram system and method of construction having a shallow mounted base pad from which extend a plurality of bollards. Very little or only a shallow excavation is required for the base of the bollard system, which can be partially or fully assembled prior to bringing it to the installation site. The shallow mounting pad or base of the bollard system of this invention may be formed or constructed in various ways and of various materials, and in various configurations. The shallow mounting pad or base is constructed so as to have considerable mass.",ADLER RICHARD S;;CRAWFORD JOHN,ADLER RICHARD S;;CRAWFORD JOHN,RSA PROTECTIVE TECHNOLOGIES LLC (2009-11-09),https://lens.org/127-635-071-891-598,Patent Application,yes,29,28,7,7,0,E01F13/00;;E01F13/12;;E01F9/623;;E01F9/685;;E01F13/12;;E01F13/00;;E01F9/623;;E01F9/685,E01F13/00,404/6,0,0,,,,ACTIVE
141,US,A,US 2426681 A,003-503-448-655-907,1947-09-02,1947,US 53770444 A,1944-05-27,US 53770444 A,1944-05-27,High gain amplifier,,ZENITH RADIO CORP,ROBERT ADLER;;PRENTISS JOHN G,,https://lens.org/003-503-448-655-907,Granted Patent,no,10,1,1,2,0,H03F3/02;;H03F3/02,H03F3/02,,0,0,,,,EXPIRED
142,US,A,US 2852599 A,039-678-198-741-60X,1958-09-16,1958,US 59866756 A,1956-07-18,US 59866756 A,1956-07-18,Color television,,ZENITH RADIO CORP,ROBERT ADLER;;SPRACKLEN JOHN G,,https://lens.org/039-678-198-741-60X,Granted Patent,no,3,0,1,1,0,H04N9/455;;H04N9/455,H04N9/455,,0,0,,,,EXPIRED
143,US,A1,US 2012/0078090 A1,124-169-633-098-600,2012-03-29,2012,US 201113306951 A,2011-11-29,US 201113306951 A;;US 35644209 A;;US 91976504 A;;US 66310400 A;;US 27040499 A,1999-03-16,FRAMELESS RADIOSURGERY TREATMENT SYSTEM AND METHOD,A method of compensating for breathing and other motions of a patient during treatment includes periodically generating internal positional data about an internal target region. The method further includes continuously generating external positional data about external motion of the patient's body using an external sensor and generating a correlation model between the position of the internal target region and the external sensor using the external positional data of the external sensor and the internal positional data of the internal target region. The method further includes predicting the position of the internal target region at some later time based on the correlation model.,ADLER JOHN R;;SCHWEIKARD ACHIM,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/124-169-633-098-600,Patent Application,yes,4,2,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;A61B5/05;;A61B5/06;;G01B11/00;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427,0,0,,,,EXPIRED
144,CA,A,CA 560849 A,097-480-487-647-089,1958-07-22,1958,CA 560849D A,,CA 560849T A,,DEMODULATING SYSTEMS,,ZENITH RADIO CORP,ADLER ROBERT;;RENNICK JOHN L,,https://lens.org/097-480-487-647-089,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
145,EP,A2,EP 1565106 A2,157-893-276-000-429,2005-08-24,2005,EP 03783278 A,2003-11-12,US 0335801 W;;US 29321602 A,2002-11-12,A METHOD AND APPARATUS FOR TRACKING AN INTERNAL TARGET REGION WITHOUT AN IMPLANTED FIDUCIAL,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/157-893-276-000-429,Patent Application,yes,0,0,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B6/12;;A61B19/00;;A61N5/10,,0,0,,,,DISCONTINUED
146,AU,A,AU 2001/090688 A,010-547-299-141-133,2002-03-22,2002,AU 2001/090688 A,2001-09-06,US 65777100 A;;US 0128164 W,2000-09-08,Apparatus and method for compensating for respiratory and patient motion during treatment,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/010-547-299-141-133,Patent Application,no,0,0,5,5,0,A61N5/1049;;A61N5/1049;;A61B6/08;;A61B6/08;;A61B6/12;;A61B6/12;;A61B6/527;;A61B6/527;;A61B10/0233;;A61B10/0233;;A61B18/20;;A61B18/20;;A61B34/20;;A61B34/20;;A61B34/25;;A61B34/25;;A61B90/10;;A61B90/10;;A61B90/39;;A61B90/39;;A61B2017/00694;;A61B2017/00694;;A61B2017/00699;;A61B2017/00699;;A61B2034/105;;A61B2034/105;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/378;;A61B2090/378;;A61N5/1037;;A61N5/1037;;A61N5/1067;;A61N5/1067;;A61N5/107;;A61N5/107;;A61N7/02;;A61N7/02;;A61N2005/1058;;A61N2005/1058;;A61N2005/1061;;A61N2005/1061,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/08;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,PENDING
147,EP,A4,EP 1328195 A4,035-360-596-987-140,2006-11-15,2006,EP 01970945 A,2001-09-14,US 0128686 W;;US 66310400 A,2000-09-15,FRAMELESS RADIOSURGERY TREATMENT SYSTEM AND METHOD,,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (2017-07-12),https://lens.org/035-360-596-987-140,Search Report,no,4,0,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,2,1,052-877-376-782-790,10863083;;10.1016/s0360-3016(00)00524-1,"MINOHARA S ET AL: ""RESPIRATORY GATED IRRADIATION SYSTEM FOR HEAVY-ION RADIOTHERAPY"", INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, US, vol. 47, no. 4, 1 July 2000 (2000-07-01), pages 1097 - 1103, XP001051093, ISSN: 0360-3016;;See also references of WO 0222019A1",EXPIRED
148,CA,A,CA 605469 A,030-453-069-549-860,1960-09-20,1960,CA 605469D A,,CA 605469T A,,TELEVISION RECEIVER,,ZENITH RADIO CORP,SPRACKLEN JOHN G;;ADLER ROBERT,,https://lens.org/030-453-069-549-860,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
149,US,A1,US 2024/0057867 A1,047-645-442-609-651,2024-02-22,2024,US 202318496351 A,2023-10-27,US 202318496351 A;;US 201615011108 A;;US 201314040604 A;;US 201361798066 P;;US 201261719301 P,2012-10-26,NIR IMAGE-GUIDED TARGETING,"A method includes determining skin characteristics in a region of a patient. An in-treatment optical scan is performed on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. A plurality of detected signals is detected from the optical scan. The skin characteristics are filtered out from the plurality of detected signals. Skeletal anatomy positioning associated with the region is determined from the plurality of signals that is filtered.",VARIAN MED SYS INC,ADLER JR JOHN;;SHARDA AGAM,,https://lens.org/047-645-442-609-651,Patent Application,yes,0,0,7,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4836;;A61B6/032;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4836;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B5/00;;A61B5/055;;A61B6/00;;A61B6/03;;A61N5/10,,0,0,,,,PENDING
150,CA,A,CA 454684 A,062-643-672-812-983,1949-02-15,1949,CA 454684D A,,CA 454684T A,,HIGH GAIN AMPLIFIER,,ZENITH RADIO CORP,ADLER ROBERT;;PRENTISS JOHN G,,https://lens.org/062-643-672-812-983,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
151,AU,A8,AU 2003/290696 A8,095-461-269-809-40X,2004-06-03,2004,AU 2003/290696 A,2003-11-12,US 29321602 A;;US 0335801 W,2002-11-12,A method and apparatus for tracking an internal target region without an implanted fiducial,,ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,,https://lens.org/095-461-269-809-40X,Patent Application,no,0,0,9,9,0,A61N5/1049;;A61N5/1049;;A61B5/7285;;A61B5/7285;;A61B6/12;;A61B6/12;;A61B6/469;;A61B6/469;;A61B6/541;;A61B6/541;;A61B8/543;;A61B8/543;;A61B34/20;;A61B34/20;;A61B90/361;;A61B90/361;;A61B2034/2055;;A61B2034/2055;;A61B2034/2072;;A61B2034/2072;;A61B2090/364;;A61B2090/364;;A61B2090/376;;A61B2090/376;;A61B2090/3762;;A61B2090/3762;;A61N5/1064;;A61N5/1064;;A61N5/1067;;A61N5/1067;;A61N2005/1061;;A61N2005/1061;;A61N2005/1062;;A61N2005/1062,A61B6/12;;A61B19/00;;A61N5/10,,0,0,,,,DISCONTINUED
152,US,A,US 6144875 A,181-305-727-604-413,2000-11-07,2000,US 27040499 A,1999-03-16,US 27040499 A,1999-03-16,Apparatus and method for compensating for respiratory and patient motion during treatment,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers adapted to be attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,ACCURAY INCORPORATED (1999-03-15),https://lens.org/181-305-727-604-413,Granted Patent,yes,7,662,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427;;606/130;;600/429;;600/439;;378/69,0,0,,,,EXPIRED
153,US,B2,US 9983033 B2,189-649-453-956-71X,2018-05-29,2018,US 201615010561 A,2016-01-29,US 201615010561 A;;US 201213671176 A;;US 201161628830 P,2011-11-07,Fouling resistant flow metering system,"Appurtenances added to a pipe mitigate the effects of upstream valves, sluice gates or pipe elbows to condition the pipe flow for accurate flow rate detection by a reverse propeller meter. Further appurtenances allow the reverse propeller meter to be used in extreme debris situations such as weeds, vines and moss present in many canal systems. The system provides an electronic signal that indicates flow rate and accumulated flow volume, or the signal can be transmit to a central headquarters for remote gate control or canal automation.",RSA PROTECTIVE TECH LLC,ADLER RICHARD STEVEN;;REPLOGLE JOHN,,https://lens.org/189-649-453-956-71X,Granted Patent,yes,17,1,5,5,0,G01F15/00;;G01F1/10;;E03F7/00;;E03F2201/20;;Y10T137/0441;;G01F1/00;;G01F1/66;;E02B1/00;;Y10T137/0441;;E03F7/00;;E03F2201/20;;G01F15/00;;G01F1/10;;G01F1/42;;G01F1/46;;G01F1/56,G01F1/42;;E02B1/00;;E03F7/00;;G01F1/00;;G01F1/10;;G01F1/46;;G01F1/56;;G01F1/66;;G01F15/00,,2,1,008-037-681-588-807,10.3733/ca.v052n01p25,"McCrometer brochure, 2008.;;Blaine R. Hanson and Larry J. Schwanki, “Water Turbulance Disrupts Accuracy of Some Flow Meters”, California Agriculture, v. 52, No. 1, 1998, pp. 25-30.",ACTIVE
154,AU,A,AU 2000/038827 A,185-155-611-179-114,2000-10-04,2000,AU 2000/038827 A,2000-03-14,US 27040499 A;;US 0006660 W,1999-03-16,Apparatus and method for compensating for respiratory and patient motion during treatment,An apparatus and method for performing treatment on an internal target region while compensating for breathing and other motion of the patient is provided in which the apparatus comprises a first imaging device for periodically generating positional data about the internal target region and a second imaging device for continuously generating positional data about one or more external markers adapted to be attached to the patient's body or any external sensor such as a device for measuring air flow. The apparatus further comprises a processor that receives the positional data about the internal target region and the external markers in order to generate a correspondence between the position of the internal target region and the external markers and a treatment device that directs the treatment towards the position of the target region of the patient based on the positional data of the external markers.,ACCURAY INC,SCHWEIKARD ACHIM;;ADLER JOHN R,,https://lens.org/185-155-611-179-114,Patent Application,no,0,0,15,15,0,A61B6/12;;A61B10/0233;;A61B18/20;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N7/02;;A61N2005/1061;;A61B90/10;;A61B2034/2072;;A61B34/20;;A61B2034/2065;;A61B90/39;;A61B6/12;;A61B90/10;;A61N5/1049;;A61B10/0233;;A61B18/20;;A61B34/20;;A61B2017/00694;;A61B2017/00699;;A61B2034/2065;;A61B2034/2072;;A61N5/1049;;A61B2017/00694;;A61B10/0233;;A61B18/20;;A61N5/107;;A61B2017/00699;;A61N5/1067;;A61N2005/1061;;A61N7/02;;A61B6/12;;A61B90/10;;A61B2034/2072;;A61B2034/2065;;A61B34/20;;A61B90/39,G01B11/00;;A61B5/055;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,,0,0,,,,DISCONTINUED
155,US,B1,US 6778850 B1,189-130-873-513-949,2004-08-17,2004,US 66310400 A,2000-09-15,US 66310400 A;;US 27040499 A,1999-03-16,Frameless radiosurgery treatment system and method,"
    A method and apparatus for selectively and accurately localizing and treating a target within a patient are provided. A three dimensional mapping of a region surrounding the target is coupled to a surgical intervention. Two or more diagnostic beams at a known non-zero angle to one another may pass through the mapping region to produce images of projections within the mapping region in order to accurately localize and treat the target wherein the images are captured using one or more image recorders. 
",ACCURAY INC,ADLER JOHN R;;SCHWEIKARD ACHIM,ACCURAY INC (2000-09-14),https://lens.org/189-130-873-513-949,Granted Patent,yes,18,245,17,17,0,A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B6/4458;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B6/4458;;A61B6/12;;A61B10/0233;;A61B2017/00694;;A61B2017/00699;;A61N5/1049;;A61N5/1064;;A61N5/1067;;A61N2005/1061;;A61B90/10;;A61B34/20;;A61B2090/376;;A61B2090/101;;A61B90/39;;A61B18/20;;A61N7/02;;A61B6/527;;A61N5/103;;A61B2034/2055;;A61B2034/2072;;A61B2090/3983;;A61N5/1048,A61B5/055;;G01B11/00;;A61B5/06;;A61B6/00;;A61B6/03;;A61B6/12;;A61B8/00;;A61B10/00;;A61B10/02;;A61B17/00;;A61B17/34;;A61B18/00;;A61B18/20;;A61B19/00;;A61N5/01;;A61N5/06;;A61N5/10;;A61N7/02;;G01B15/00;;G01B21/00;;G01R33/48,600/427;;600/429;;378/4;;606/130,0,0,,,,EXPIRED
156,CN,B,CN 102811920 B,128-079-161-830-416,2015-04-01,2015,CN 201180015013 A,2011-03-11,IB 2011051033 W;;US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/128-079-161-830-416,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
157,BR,B1,BR 112012023543 B1,033-150-905-817-48X,2020-02-27,2020,BR 112012023543 A,2011-03-11,IB 2011051033 W;;US 72848210 A,2010-03-22,unidade de embalagem de dispensamento de dose,"unidade de dispensamento de dose de volume resistente a criança. unidade de embalagem de dispensamento de dose em volume resistente a criança, e um processo para abertura de unidade de embalagem, incluindo um recipiente (101) e uma tampa (102) acoplada com o recipiente. o recipiente inclui um reservatório, uma abertura (103) e uma extremidade superior do reservatório, e uma protuberância (704) estendendo-se ma partir de uma superfície do recipiente. a tampa acopla com o recipiente e deslizaentre uma posição fechada e uma posição aberta. a tampa inclui umaz parede superior (401), uma parede lateral (402a,402b) estendendo-se para baixo a partir de uma borda externa da parede superior, e uma coluna (804a) configurada para acoplar a protuberância em uma primeira posição quando a tampa é fechada de modo a manter a tampa fechada. pelo menos uma porção da coluna estende-se substancialmente paralela à parede lateral em uma distância da parede lateral. pressão de parede lateral para dentro colocada a coluna em uma segunda posição, onde na segunda posição a coluna é desacoplada da protuberância.",WYETH LLC,ARI TAO ADLER;;ROBERT JOHN MCCAFFREY,PF CONSUMER HEALTHCARE 1 LLC (US) (2022-06-07);;WYETH LLC (US) (2022-05-24),https://lens.org/033-150-905-817-48X,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65B69/00;;B65D43/20;;B65D50/04,,0,0,,,,ACTIVE
158,KR,A,KR 20140025594 A,096-456-009-112-50X,2014-03-04,2014,KR 20147001807 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/096-456-009-112-50X,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,,,0,0,,,,DISCONTINUED
159,MX,A,MX 2012010838 A,117-724-060-577-861,2012-10-10,2012,MX 2012010838 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT.,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/117-724-060-577-861,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
160,CN,A,CN 104960754 A,116-301-997-586-432,2015-10-07,2015,CN 201510171316 A,2011-03-11,US 72848210 A;;CN 201180015013 A,2010-03-22,Child resistant bulk dose dispensing unit,"The present invention relates to a child-resistant bulk dose dispensing packaging unit, more specifically to a packaging unit, which including a container and a lid. The container is applied to maintain content to be distributed and has an aperture at a top end of the container, wherein the size of the aperture is designed to distribute content through the aperture; and a lid, which is configured to slidingly engage the container along the end portion thereof, and is capable of sliding between a closed position and an open position in a first direction and covering the aperture in the closed position, wherein the aperture in the open position is at least partially exposed. At least one of the container and the lid comprises at least one elasticity portion which may be deflected in the direction substantially perpendicular to the first direction so that the lid is broken away from the container and is capable of sliding to the opening position in the first direction.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/116-301-997-586-432,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
161,BR,A2,BR 112012023543 A2,055-732-605-090-002,2016-07-26,2016,BR 112012023543 A,2011-03-11,IB 2011051033 W;;US 72848210 A,2010-03-22,unidade de dispensamento de dose de volume resistente a criança,"unidade de dispensamento de dose de volume resistente a criança. unidade de embalagem de dispensamento de dose em volume resistente a criança, e um processo para abertura de unidade de embalagem, incluindo um recipiente (101) e uma tampa (102) acoplada com o recipiente. o recipiente inclui um reservatório, uma abertura (103) e uma extremidade superior do reservatório, e uma protuberância (704) estendendo-se ma partir de uma superfície do recipiente. a tampa acopla com o recipiente e deslizaentre uma posição fechada e uma posição aberta. a tampa inclui umaz parede superior (401), uma parede lateral (402a,402b) estendendo-se para baixo a partir de uma borda externa da parede superior, e uma coluna (804a) configurada para acoplar a protuberância em uma primeira posição quando a tampa é fechada de modo a manter a tampa fechada. pelo menos uma porção da coluna estende-se substancialmente paralela à parede lateral em uma distância da parede lateral. pressão de parede lateral para dentro colocada a coluna em uma segunda posição, onde na segunda posição a coluna é desacoplada da protuberância.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (US) (2022-06-07);;WYETH LLC (US) (2022-05-24),https://lens.org/055-732-605-090-002,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
162,PH,B1,PH 12014501281 B1,079-422-194-972-832,2016-09-14,2016,PH 12014501281 A,2014-06-06,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/079-422-194-972-832,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
163,US,A,US 3511596 A,126-437-307-783-144,1970-05-12,1970,US 3511596D A,1965-09-17,US 48804465 A,1965-09-17,METHOD OF REMOVING AMMONIA AND METHANOL FROM GASES,,AMERICAN CYANAMID CO,ADLER STEPHEN FRED;;KEGGI JANIS JOHN,,https://lens.org/126-437-307-783-144,Granted Patent,no,10,10,1,1,0,B01D53/34;;B01D53/34,B01D53/34,23/2,0,0,,,,EXPIRED
164,SG,A,SG 10201403782Y A,037-439-441-875-819,2014-09-26,2014,SG 10201403782Y A,2011-03-11,US 72848210 A,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/037-439-441-875-819,Unknown,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,,,0,0,,,,PENDING
165,NZ,A,NZ 602273 A,037-495-773-853-09X,2014-08-29,2014,NZ 60227311 A,2011-03-11,IB 2011051033 W;;US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,"602273 Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,"PF CONSUMER HEALTHCARE 1 LLC, US (2021-02-02)",https://lens.org/037-495-773-853-09X,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,PENDING
166,US,A,US 1413371 A,053-639-539-800-483,1922-04-18,1922,US 48874321 A,1921-07-30,US 48874321 A,1921-07-30,Automatic air-supply control for internal-combustion engines,,ADLER JOHN B;;GEHLE THEODORE F,ADLER JOHN B;;GEHLE THEODORE F,,https://lens.org/053-639-539-800-483,Granted Patent,no,0,21,1,1,0,F02M1/14;;Y10T137/7898;;Y10T137/7839;;F02M1/14;;F16K15/038;;F16K15/035;;F16K15/033,F02M1/14,,0,0,,,,EXPIRED
167,EP,A1,EP 2767485 A1,099-529-925-984-999,2014-08-20,2014,EP 14168311 A,2011-03-11,US 72848210 A;;EP 11713363 A,2010-03-22,Child resistant bulk dose dispensing unit,"A packaging unit (1300) comprising a container (1301) adapted to hold contents to be dispensed and having an aperture (1303) at an end thereof, the aperture (1303) being sized to dispense the contents therethrough; and a lid (1302) configured to slideably engage the container (1301) about the end thereof, the lid (1302) being slideable in a first direction between a closed position in which the lid (1302) covers the aperture (1303) and an open position in which the aperture (1303) is at least partially uncovered, wherein at least one of the container (1301) and the lid (1302) includes at least one resilient portion (1304, 1307) capable of being deflected in a direction substantially perpendicular to the first direction so as to disengage the lid (1302) from the container (1301) when in the closed position such that the lid (1302) is capable of sliding in the first direction to the open position.
",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,"PF CONSUMER HEALTHCARE 1 LLC, WILMINGTON, US (2020-09-22)",https://lens.org/099-529-925-984-999,Patent Application,yes,5,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
168,CA,A,CA 1060710 A,020-946-652-471-40X,1979-08-21,1979,CA 269515 A,1977-01-12,US 70572376 A,1976-07-15,PRESSURE PROBE UNLOADING DEVICE FOR PNEUMATIC OPERATED DISCHARGE GATES,"A vacuum operated discharge gate for unloading a hopper includes a tubular discharge member which has opposite ends adapted to be attached to a suction system for discharging a hopper. A probe adapted to be positioned in the tubular discharge member adapts the vacuum system to be connected to a positive pressure source, the probe including openings and baffles associated therewith which provides a restriction within the probe thereby providing a negative pressure differential in an area adjacent the openings.",PULLMAN INC,ADLER FRANKLIN P;;PAVOLKA JOHN D,,https://lens.org/020-946-652-471-40X,Granted Patent,no,0,0,2,2,0,B65G53/40;;B65G53/40,B65G53/40,105-123.5,0,0,,,,EXPIRED
169,AU,B2,AU 2014/240317 B2,124-372-094-343-390,2016-05-12,2016,AU 2014/240317 A,2014-10-07,AU 2011/231179 A;;AU 2014/240317 A,2011-03-11,Child resistant bulk dose dispensing unit,"Abstract Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",PF CONSUMER HEALTHCARE 1 LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2020-05-14),https://lens.org/124-372-094-343-390,Granted Patent,no,1,0,2,2,0,,B65D50/04,,0,0,,,,ACTIVE
170,US,A1,US 2013/0281758 A1,175-999-144-866-077,2013-10-24,2013,US 201313865903 A,2013-04-18,US 201313865903 A;;US 201261635033 P,2012-04-18,Treatment of refractory neuropsychiatric disorders using targeted radiation,"Provided herein are methods for treating neuropsychiatric disorders by delivering radiation to an area in the subgenual anterior cingulate cortex, particularly to the cingulate area 25. Those methods are also beneficial to treat refractory neuropsychiatric disorders.",SOLVASON HUGH BRENT;;ADLER JOHN R;;UNIV LELAND STANFORD JUNIOR,SOLVASON HUGH BRENT;;ADLER JOHN R,THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (2013-09-18),https://lens.org/175-999-144-866-077,Patent Application,yes,2,7,1,1,0,A61N5/1084;;A61N5/10;;A61N5/1084,A61N5/10,600/1,2,0,,,"Adler et al., ""Radiosurgical Neuromodulation for Treatment Resistant Depression in a Setting of Bipolar Disease"", SRS/SBRT Scientific Meeting 2012, (2012).;;Bipolar Network News, ""Deep Brain Stimulation"", (January 18, 2011), Retreived from the Internet: .",DISCONTINUED
171,EP,B1,EP 2550209 B1,081-125-866-659-365,2014-07-09,2014,EP 11713363 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,"PF CONSUMER HEALTHCARE 1 LLC; US (2022-02-01);;PF CONSUMER HEALTHCARE 1 LLC, WILMINGTON, DELA, US (2021-09-27);;PF CONSUMER HEALTHCARE 1 LLC, WILMINGTON, US (2020-09-22);;WYETH LLC (2014-03-05);;PF CONSUMER HEALTHCARE 1 LLC, US (2021-02-25)",https://lens.org/081-125-866-659-365,Granted Patent,yes,4,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
172,US,A,US 2500481 A,097-733-576-583-956,1950-03-14,1950,US 60569445 A,1945-07-18,US 60569445 A,1945-07-18,Hinge structure,,ADLER JOHN B;;ROSA LEONARD J,ADLER JOHN B;;ROSA LEONARD J,,https://lens.org/097-733-576-583-956,Granted Patent,no,8,3,1,1,0,E05D3/02;;E05D2700/04;;E05D3/02;;E05D2700/04,E05D3/02,,0,0,,,,EXPIRED
173,US,B2,US 8657136 B2,188-416-921-502-898,2014-02-25,2014,US 72848210 A,2010-03-22,US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,"Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed.",ADLER ARI TAO;;MCCAFFREY ROBERT JOHN;;WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2019-07-29);;GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC (2021-12-31);;WYETH LLC (2010-03-16),https://lens.org/188-416-921-502-898,Granted Patent,yes,20,11,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/02,215/201;;220/348,0,0,,,,ACTIVE
174,US,A1,US 2014/0121494 A1,049-607-759-478-472,2014-05-01,2014,US 201314040604 A,2013-10-02,US 201314040604 A;;US 201261719301 P;;US 201361798066 P;;US 201314040609 A,2012-10-26,NIR IMAGE-GUIDED TARGETING,"A method for targeting. The method includes determining skin characteristics in a region of a patient. An in-treatment optical scan is performed on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. A plurality of detected signals is detected from the optical scan. The skin characteristics are filtered out from the plurality of detected signals. Skeletal anatomy positioning associated with the region is determined from the plurality of signals that is filtered.",VARIAN MED SYS INC,ADLER JR JOHN R;;SHARDA AGAM,VARIAN MEDICAL SYSTEMS INC (2013-10-01),https://lens.org/049-607-759-478-472,Patent Application,yes,5,3,4,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B6/032;;A61B5/0036;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B5/00;;A61B5/055;;A61B6/03,600/411;;600/473;;600/427,0,0,,,,ACTIVE
175,KR,A,KR 20120135266 A,059-559-610-841-826,2012-12-12,2012,KR 20127024670 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/059-559-610-841-826,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D43/20;;B65D45/00,,0,0,,,,ACTIVE
176,US,A1,US 2011/0226772 A1,069-296-330-491-607,2011-09-22,2011,US 72848210 A,2010-03-22,US 72848210 A,2010-03-22,Child Resistant Bulk Dose Dispensing Unit,"Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2019-07-29);;GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC (2021-12-31);;WYETH LLC (2010-03-16),https://lens.org/069-296-330-491-607,Patent Application,yes,17,15,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D45/00,220/315,0,0,,,,ACTIVE
177,US,A1,US 2013/0281999 A1,079-344-877-591-202,2013-10-24,2013,US 201213453338 A,2012-04-23,US 201213453338 A,2012-04-23,METHOD OF PERFORMING MICROBEAM RADIOSURGERY,A method of performing microbeam radiosurgery on a patient whereby target tissue within a patient is irradiated with high energy electromagnetic radiation from an inverse Compton scattering radiation source via microbeam envelopes.,ADLER JOHN R;;WRIGHT MICHAEL DEAN;;VARIAN MED SYS INC,ADLER JOHN R;;WRIGHT MICHAEL DEAN,VARIAN MEDICAL SYSTEMS INC (2012-04-20),https://lens.org/079-344-877-591-202,Patent Application,yes,2,2,1,1,0,A61N5/1077;;H05G2/00;;H05H7/06;;A61N2005/1085;;H01S4/00;;A61N5/1077;;H05G2/00;;A61N2005/1085;;H05H7/06;;H01S4/00,A61B18/18,606/33,1,0,,,"C.Bruni, R. Chiche, R.Cizeron, Y. Fedala, J. Haissinski, et al.. ThomX - Conceptual Design Report. 2009, pp.1-136.",DISCONTINUED
178,US,S,US D0349573 S,100-701-770-002-844,1994-08-09,1994,US 93090492 F,1992-08-17,US 93090492 F,1992-08-17,Quick-lock holder for laparoscopic instrument,,FLEXBAR MACHINE CORP,BOOKWALTER JOHN R;;ADLER DAVID T,FLEXBAR MACHINE CORP (1992-06-18),https://lens.org/100-701-770-002-844,Design Right,yes,6,4,1,1,0,,,D24/128,0,0,,,,EXPIRED
179,ES,T3,ES 2501043 T3,183-103-345-753-445,2014-10-01,2014,ES 11713363 T,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,Unidad para dispensado de dosis a granel a prueba de niños,"Una unidad de embalaje (100) que comprende: un recipiente (101) adaptado para mantener el contenido a ser dispensado y que tiene una abertura (103) en un extremo del mismo, estando dimensionada la abertura (103) para dispensar el contenido a su través; y una tapa (102) configurada para acoplarse de modo deslizante al recipiente (101) sobre un extremo del mismo, siendo la tapa (102) deslizante en una primera dirección entre una posición cerrada, en la que la tapa (102) cubre la abertura (103) y una posición abierta en la que la abertura (103) está al menos parcialmente descubierta, en la que al menos uno de entre el recipiente (101) y la tapa (102) incluye al menos una parte resiliente capaz de ser flexionada en una dirección sustancialmente perpendicular a la primera dirección de modo que desacople la tapa (102) del recipiente cuando está en su posición cerrada de modo que la tapa (102) sea capaz de deslizarse en la primera dirección hasta la posición abierta, caracterizada porque que el recipiente (101) comprende una tapa que tiene un saliente (704) que se extiende desde la misma y la tapa (102) comprende una pared superior (401), una pared lateral (402a) que se extiende desde la pared superior (401) y que incluye al menos una parte resiliente y un puntal (804) que se extiende desde la pared superior (401) y que está separado de la pared lateral (402a) en una disposición sustancialmente paralela, estando configurado el puntal (804) para acoplar el saliente (704) en una primera posición cuando la tapa (102) está en la posición cerrada, de modo que limite la apertura de la tapa (102) a lo largo de la primera dirección, y estando configurado además el puntal (804) de modo que la deflexión de la al menos una parte resiliente desplaza el puntal (804) a una segunda posición en la que el puntal (804) se desacopla del saliente (704).",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/183-103-345-753-445,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
180,WO,A9,WO 2008/086430 A9,071-708-547-306-134,2008-09-25,2008,US 2008/0050652 W,2008-01-09,US 87972407 P;;US 87965407 P,2007-01-09,METHOD FOR DEPOSITING RADIATION IN HEART MUSCLE,"Radiosurgical treatment of tissues of the heart to mitigate arrhythmias such as atrial fibrillation or the like. Radiosurgical targeting of the relatively rapid movement of heart tissues may be enhanced by generating a moving model volume using a time-sequence of three dimensional acquired tissue volumes. A digitally reconstructed radiograph (DRR) may be generated from the model at a desired cardiac and/or respiration motion phase and compared to an X-ray or the like taken immediately before or during treatment. When a series of radiation beams will be directed to a heart tissue to alleviate an arrhythmia, the treatment system may alter the radiation beam series in response to the type of the arrhythmia.",CYBERHEART INC;;ADLER JOHN;;SUMANAWEERA THILAKA;;MAGUIRE PATRICK,ADLER JOHN;;SUMANAWEERA THILAKA;;MAGUIRE PATRICK,,https://lens.org/071-708-547-306-134,Patent Application,no,0,0,3,26,0,A61B5/1135;;A61B2017/00243;;A61B2017/00703;;A61N5/1037;;A61N5/1049;;A61N5/1067;;A61N5/1068;;A61N2005/1062;;A61B90/10;;A61B90/36;;A61B2090/363;;A61B2034/301;;A61B2090/364;;A61B34/30;;A61B2090/101;;A61B34/10;;A61N5/1049;;A61B2017/00243;;A61N5/1037;;A61B2017/00703;;A61N2005/1062;;A61N5/1067;;A61B5/1135;;A61N5/1068;;A61B2090/101;;A61B2090/363;;A61B90/36;;A61B34/10;;A61B90/10;;A61B34/30;;A61B2090/364;;A61B2034/301,A61N5/10;;A61B17/00;;A61B19/00,,0,0,,,,PENDING
181,TW,B,TW I443052 B,083-559-430-058-607,2014-07-01,2014,TW 100109549 A,2011-03-21,US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/083-559-430-058-607,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,,,0,0,,,,ACTIVE
182,PT,E,PT 2550209 E,194-653-313-844-970,2014-09-16,2014,PT 11713363 T,2011-03-11,US 72848210 A,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/194-653-313-844-970,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
183,CN,A,CN 102811920 A,045-084-274-051-475,2012-12-05,2012,CN 201180015013 A,2011-03-11,IB 2011051033 W;;US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/045-084-274-051-475,Patent Application,no,6,5,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
184,TW,A,TW 201434717 A,040-370-268-360-998,2014-09-16,2014,TW 103118068 A,2011-03-21,US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,"A packaging unit (1300) comprising a container (1301) adapted to hold contents to be dispensed and having an aperture (1303) at an end thereof, the aperture (1303) being sized to dispense the contents therethrough; and a lid (1302) configured to slideably engage the container (1301) about the end thereof, the lid (1302) being slideable in a first direction between a closed position in which the lid (1302) covers the aperture (1303) and an open position in which the aperture (1303) is at least partially uncovered, wherein at least one of the container (1301) and the lid (1302) includes at least one resilient portion (1304, 1307) capable of being deflected in a direction substantially perpendicular to the first direction so as to disengage the lid (1302) from the container (1301) when in the closed position such that the lid (1302) is capable of sliding in the first direction to the open position.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/040-370-268-360-998,Patent of Addition,no,0,1,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04;;B65D83/04;;B65D83/06,,0,0,,,,ACTIVE
185,US,S,US D0389242 S,063-463-814-856-219,1998-01-13,1998,US 5505096 F,1996-05-30,US 5505096 F,1996-05-30,Combined laphroscopic tool holder and positioner,,FLEXBAR MACHINE CORP,BOOKWALTER JOHN R;;ADLER DAVID T,,https://lens.org/063-463-814-856-219,Design Right,yes,6,13,1,1,0,,,D24/138;;2401,1,0,,,"The Codman Catalog ""Surgical Products Catalog Retractor"", pp. G-75 G-74 .COPYRGT.1992.",EXPIRED
186,WO,A1,WO 2008/086430 A1,098-582-912-724-406,2008-07-17,2008,US 2008/0050652 W,2008-01-09,US 87972407 P;;US 87965407 P,2007-01-09,METHOD FOR DEPOSITING RADIATION IN HEART MUSCLE,"Radiosurgical treatment of tissues of the heart to mitigate arrhythmias such as atrial fibrillation or the like. Radiosurgical targeting of the relatively rapid movement of heart tissues may be enhanced by generating a moving model volume using a time-sequence of three dimensional acquired tissue volumes. A digitally reconstructed radiograph (DRR) may be generated from the model at a desired cardiac and/or respiration motion phase and compared to an X-ray or the like taken immediately before or during treatment. When a series of radiation beams will be directed to a heart tissue to alleviate an arrhythmia, the treatment system may alter the radiation beam series in response to the type of the arrhythmia.",CYBERHEART INC;;ADLER JOHN;;SUMANAWEERA THILAKA;;MAGUIRE PATRICK,ADLER JOHN;;SUMANAWEERA THILAKA;;MAGUIRE PATRICK,,https://lens.org/098-582-912-724-406,Patent Application,yes,4,6,3,26,0,A61B5/1135;;A61B2017/00243;;A61B2017/00703;;A61N5/1037;;A61N5/1049;;A61N5/1067;;A61N5/1068;;A61N2005/1062;;A61B90/10;;A61B90/36;;A61B2090/363;;A61B2034/301;;A61B2090/364;;A61B34/30;;A61B2090/101;;A61B34/10;;A61N5/1049;;A61B2017/00243;;A61N5/1037;;A61B2017/00703;;A61N2005/1062;;A61N5/1067;;A61B5/1135;;A61N5/1068;;A61B2090/101;;A61B2090/363;;A61B90/36;;A61B34/10;;A61B90/10;;A61B34/30;;A61B2090/364;;A61B2034/301,A61N5/10;;A61B17/00;;A61B19/00,,0,0,,,,PENDING
187,NZ,A,NZ 626033 A,142-829-328-918-418,2015-10-30,2015,NZ 62603311 A,2011-03-11,US 72848210 A;;NZ 60227311 A,2010-03-22,Child resistant bulk dose dispensing unit,"A packaging unit comprising: a container adapted to hold contents to be dispensed and having an aperture at an end thereof, the aperture being sized to dispense the contents therethrough; and a lid configured to slideably engage the container about the end thereof, the lid being slideable in a first direction between a closed position in which the lid covers the aperture and an open position in which the aperture is at least partially uncovered, wherein at least one of the container and the lid includes at least one resilient portion capable of being deflected in a direction substantially perpendicular to the first direction so as to disengage the lid from the container when in the closed position such that the lid is capable of sliding in the first direction to the open position; wherein the lid comprises a top wall and a side wall extending from the top wall, the side wall defining a lid aperture, and the container further comprising a flexible arm having the at least one resilient portion, the flexible arm further having an enlarged portion configured to be received within the lid aperture when the lid is in the closed position, the at least one resilient portion of the arm being configured such that the enlarged portion is capable of being deflected out of the lid aperture to permit movement of the lid in the first direction.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,"PF CONSUMER HEALTHCARE 1 LLC, US (2021-02-02)",https://lens.org/142-829-328-918-418,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,PENDING
188,US,A1,US 2008/0177280 A1,171-379-960-000-770,2008-07-24,2008,US 97172508 A,2008-01-09,US 97172508 A;;US 87972407 P;;US 87965407 P,2007-01-09,Method for Depositing Radiation in Heart Muscle,"Radiosurgical treatment of tissues of the heart to mitigate arrhythmias such as atrial fibrillation or the like. Radiosurgical targeting of the relatively rapid movement of heart tissues may be enhanced by generating a moving model volume using a time-sequence of three dimensional acquired tissue volumes. A digitally reconstructed radiograph (DRR) may be generated from the model at a desired cardiac and/or respiration motion phase and compared to an X-ray or the like taken immediately before or during treatment. When a series of radiation beams will be directed to a heart tissue to alleviate an arrhythmia, the treatment system may alter the radiation beam series in response to the type of the arrhythmia.",CYBERHEART INC,ADLER JOHN;;SUMANAWEERA THILAKA;;MAGUIRE PATRICK,,https://lens.org/171-379-960-000-770,Patent Application,yes,46,54,3,26,0,A61B5/1135;;A61B2017/00243;;A61B2017/00703;;A61N5/1037;;A61N5/1049;;A61N5/1067;;A61N5/1068;;A61N2005/1062;;A61B90/10;;A61B90/36;;A61B2090/363;;A61B2034/301;;A61B2090/364;;A61B34/30;;A61B2090/101;;A61B34/10;;A61N5/1049;;A61B2017/00243;;A61N5/1037;;A61B2017/00703;;A61N2005/1062;;A61N5/1067;;A61B5/1135;;A61N5/1068;;A61B2090/101;;A61B2090/363;;A61B90/36;;A61B34/10;;A61B90/10;;A61B34/30;;A61B2090/364;;A61B2034/301,A61B19/00,606/130;;901/41,0,0,,,,DISCONTINUED
189,CN,A,CN 112218683 A,044-856-125-117-224,2021-01-12,2021,CN 201980036174 A,2019-05-30,US 201862678098 P;;US 2019/0034680 W,2018-05-30,RADIOSURGICAL NEUROMODLATION CLOSE TO CRITICAL STRUCTURES,"Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.",ZAP SURGICAL SYSTEMS INC,ADLER JOHN JR;;SCHNEIDER M BRET,,https://lens.org/044-856-125-117-224,Patent Application,no,11,0,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61N7/02;;A61B34/10;;A61B34/20;;A61K9/00;;A61K41/00;;A61N5/10,,3,0,,,"潘晓婧等: ""纳米壳聚糖对重离子的放射增敏和防护作用"", 《中国组织工程研究》;;耿聆: ""辐射防护剂和辐射敏增剂的研究进展"", 《国际放射医学核医学杂志》;;J.DENEKAMP: ""放射防护剂与肿瘤治疗的关系"", 《国外医学(临床放射学分册)》",PENDING
190,TW,B,TW I601672 B,046-947-783-845-668,2017-10-11,2017,TW 103118068 A,2011-03-21,US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/046-947-783-845-668,Granted Patent,no,1,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,,,0,0,,,,ACTIVE
191,AU,C1,AU 2011/231179 C1,079-148-461-182-749,2015-07-02,2015,AU 2011/231179 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,Child resistant bulk dose dispensing unit,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",PF CONSUMER HEALTHCARE 1 LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2020-05-14),https://lens.org/079-148-461-182-749,Amended Patent,no,5,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
192,US,S,US D0388515 S,046-059-772-748-373,1997-12-30,1997,US 5505196 F,1996-05-30,US 5505196 F,1996-05-30,Combined laparoscopic tool holder and positioner,,FLEXBAR MACHINE CORP,BOOKWALTER JOHN R;;ADLER DAVID T,,https://lens.org/046-059-772-748-373,Design Right,yes,6,12,1,1,0,,,D24/138;;2401,0,0,,,,EXPIRED
193,EP,B1,EP 2767485 B1,071-538-617-735-198,2016-01-13,2016,EP 14168311 A,2011-03-11,US 72848210 A;;EP 11713363 A,2010-03-22,Child resistant bulk dose dispensing unit,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,"PF CONSUMER HEALTHCARE 1 LLC, WILMINGTON, US (2020-09-22)",https://lens.org/071-538-617-735-198,Granted Patent,yes,2,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
194,EP,A1,EP 2550209 A1,080-540-728-457-062,2013-01-30,2013,EP 11713363 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,"PF CONSUMER HEALTHCARE 1 LLC; US (2022-02-01);;PF CONSUMER HEALTHCARE 1 LLC, WILMINGTON, DELA, US (2021-09-27);;PF CONSUMER HEALTHCARE 1 LLC, WILMINGTON, US (2020-09-22);;WYETH LLC (2014-03-05);;PF CONSUMER HEALTHCARE 1 LLC, US (2021-02-25)",https://lens.org/080-540-728-457-062,Patent Application,yes,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
195,AU,A1,AU 2011/231179 A1,087-986-578-792-922,2012-10-04,2012,AU 2011/231179 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,Child resistant bulk dose dispensing unit,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2020-05-14),https://lens.org/087-986-578-792-922,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
196,US,A,US 4027921 A,144-382-564-363-463,1977-06-07,1977,US 70572376 A,1976-07-15,US 70572376 A,1976-07-15,Pressure probe unloading device for pneumatic operated discharge gates,"A vacuum operated discharge gate for unloading a hopper includes a tubular discharge member which has opposite ends adapted to be attached to a suction system for discharging a hopper. A probe adapted to be positioned in the tubular discharge member adapts the vacuum system to be connnected to a positive pressure source, the probe including openings and baffles associated therewith which provides a restriction within the probe thereby providing a negative pressure differential in an area adjacent the openings.",PULLMAN INC,ADLER FRANKLIN P;;PAVOLKA JOHN D,GENERAL ELECTRIC RAILCAR LEASING SERVICES CORPORATION (1992-09-01);;GENERAL ELECTRIC CAPITAL CORPORATION (1992-06-01);;PULLMAN LEASING COMPANY A DE CORP (1984-02-24),https://lens.org/144-382-564-363-463,Granted Patent,yes,10,5,2,2,0,B65G53/40;;B65G53/40,B65G53/40,302/52,0,0,,,,EXPIRED
197,US,B2,US 9271673 B2,172-912-108-517-562,2016-03-01,2016,US 201314040604 A,2013-10-02,US 201314040604 A;;US 201261719301 P;;US 201361798066 P;;US 201314040609 A,2012-10-26,NIR image-guided targeting,"A method for targeting. The method includes determining skin characteristics in a region of a patient. An in-treatment optical scan is performed on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. A plurality of detected signals is detected from the optical scan. The skin characteristics are filtered out from the plurality of detected signals. Skeletal anatomy positioning associated with the region is determined from the plurality of signals that is filtered.",VARIAN MED SYS INC,ADLER JR JOHN R;;SHARDA AGAM,VARIAN MEDICAL SYSTEMS INC (2013-10-01),https://lens.org/172-912-108-517-562,Granted Patent,yes,5,0,4,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B6/032;;A61B5/0036;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B5/00;;A61B5/055;;A61B6/03;;A61N5/06;;A61N5/10,,0,0,,,,ACTIVE
198,AU,A1,AU 2014/240317 A1,177-144-895-352-797,2014-10-23,2014,AU 2014/240317 A,2014-10-07,AU 2011/231179 A;;AU 2014/240317 A,2011-03-11,Child resistant bulk dose dispensing unit,"Abstract Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2020-05-14),https://lens.org/177-144-895-352-797,Patent Application,no,0,0,2,2,0,,B65D50/04,,0,0,,,,ACTIVE
199,AU,B2,AU 2011/231179 B2,018-978-742-394-094,2015-01-22,2015,AU 2011/231179 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,Child resistant bulk dose dispensing unit,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,PF CONSUMER HEALTHCARE 1 LLC (2020-05-14),https://lens.org/018-978-742-394-094,Granted Patent,no,5,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
200,US,A1,US 2014/0190129 A1,074-752-234-486-522,2014-07-10,2014,US 201414155137 A,2014-01-14,US 201414155137 A;;US 72848210 A,2010-03-22,Child Resistant Bulk Dose Dispensing Unit,"Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/074-752-234-486-522,Patent Application,yes,4,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65B69/00;;B65D50/04;;B65D43/20,53/492;;220/351,0,0,,,,DISCONTINUED
201,TW,A,TW 201139227 A,122-362-674-963-308,2011-11-16,2011,TW 100109549 A,2011-03-21,US 72848210 A,2010-03-22,Child resistant bulk dose dispensing unit,"Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/122-362-674-963-308,Patent of Addition,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D83/06;;A61J1/00,,0,0,,,,ACTIVE
202,CA,C,CA 2793036 C,159-433-682-824-197,2017-03-28,2017,CA 2793036 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,"Child-resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/159-433-682-824-197,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
203,PL,T3,PL 2550209 T3,192-134-607-742-163,2014-11-28,2014,PL 11713363 T,2011-03-11,US 72848210 A;;EP 11713363 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/192-134-607-742-163,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,PENDING
204,SG,A1,SG 183876 A1,051-280-052-652-692,2012-10-30,2012,SG 2012065116 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/051-280-052-652-692,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,,,0,0,,,,PENDING
205,WO,A1,WO 2011/117769 A1,141-178-756-328-876,2011-09-29,2011,IB 2011051033 W,2011-03-11,US 72848210 A,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC;;ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/141-178-756-328-876,Patent Application,yes,7,2,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,PENDING
206,US,S,US D0389913 S,001-532-674-540-008,1998-01-27,1998,US 5505296 F,1996-05-30,US 5505296 F,1996-05-30,Combined lap aroscopic tool holder and positioner,,FLEXBAR MACHINE CORP,BOOKWALTER JOHN R;;ADLER DAVID T,,https://lens.org/001-532-674-540-008,Design Right,yes,6,13,1,1,0,,,D24/138;;2401,1,0,,,"The Codman Catalog Surgical Product Catalog. ""Retractor"" p. G-75, G-74 .COPYRGT.1992.",EXPIRED
207,RU,C1,RU 2518804 C1,003-350-497-802-614,2014-06-10,2014,RU 2012140701 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,METERING PACKAGE SAFE FOR CHILDREN,"FIELD: packaging industry.SUBSTANCE: package comprises a container (101) and a cap (102) connected to the container. The container comprises a vessel, an opening (103) at the upper end of the vessel and a ledge (704) protruding from its surface. The cap is connected to the container and slides between a closed position and an open position. The cap has an upper wall (401), a side wall (402a, 402b) extending downwards from the outer edge of the upper wall, and a leg made for connection with the ledge in the first position when the cap is closed, to hold the cap closed. At least a part of the leg extends essentially parallel to the side wall at a distance from it. Pushing the side wall inwards transmits the leg into the second position, at that in the second position the leg is disconnected from the ledge.EFFECT: increased safety.8 cl, 37 dwg",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/003-350-497-802-614,Granted Patent,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
208,US,A,US 3455294 A,040-902-091-364-866,1969-07-15,1969,US 3455294D A,1966-02-25,US 53009266 A,1966-02-25,RESPIRATORY DEVICE,,RICHARD H ADLER;;WHITNEY JOHN K,ADLER RICHARD H;;WHITNEY JOHN K,,https://lens.org/040-902-091-364-866,Granted Patent,no,5,29,1,1,0,A61M16/0045;;A61M16/0045;;A61M16/0833;;A61M16/0833,A61M16/00,128/25,0,0,,,,EXPIRED
209,PH,A1,PH 12014501281 A1,053-094-752-912-831,2016-09-14,2016,PH 12014501281 A,2014-06-06,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container and a lid engaged with the container. The container includes a reservoir, an aperture at a top end of the reservoir, and a protrusion extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall, a side wall extending down from an outer edge of the top wall, and a post configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,TAO ADLER ARI;;JOHN MCCAFFREY ROBERT,,https://lens.org/053-094-752-912-831,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
210,CA,A1,CA 2793036 A1,015-366-328-749-551,2011-09-29,2011,CA 2793036 A,2011-03-11,US 72848210 A;;IB 2011051033 W,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,"Child- resistant bulk dose dispensing packaging unit, and a method for opening the packaging unit, including a container (101) and a lid (102) engaged with the container. The container includes a reservoir, an aperture (103) at a top end of the reservoir, and a protrusion (704) extending from a surface of the container. The lid engages with the container and slides between a closed position and an open position. The lid includes a top wall (401), a side wall (402a, 402b) extending down from an outer edge of the top wall, and a post (804a) configured to engage the protrusion at a first position when the lid is closed so as to keep the lid closed. At least a portion of the post extends substantially parallel to the side wall at a distance from the side wall. Pressing the side wall inward places the post at a second position, wherein at the second position the post is disengaged from the protrusion.",WYETH LLC,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/015-366-328-749-551,Patent Application,no,0,1,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
211,CO,A2,CO 6630097 A2,028-544-773-061-30X,2013-03-01,2013,CO 12165832 A,2012-09-24,US 72848210 A,2010-03-22,Unidad para dispensado de dosis volumericas a prueba de niños,"Unidad de envase para dispensado de dosis voluméricas a prueba de niños y un procedimiento para la apertura de la unidad de envase, que incluye un contenedor y una tapa acoplada con el contenedor. El contenedor incluye un depósito, una abertura en un extremo superior del depósito y un saliente que se extiende desde una superficie del contenedor. La tapa se acopla con el contenedor y se desliza entre una posición cerrada y una posición abierta. La tapa incluye una pared superior, una pared lateral que se extiende hacia abajo desde un borde exterior de la pared superior y un poste configurado para acoplarse a un saliente en una primera posición cuando la tapa está cerrada de modo que mantenga la tapa cerrada. Al menos una parte del poste se extiende sustancialmente en paralelo a la pared lateral y a una distancia de la pared lateral. La presión en la pared lateral hacia el interior coloca el poste en una segunda posición, desacoplándose en la segunda posición el poste del saliente.",WYETH CORP,ADLER ARI TAO;;MCCAFFREY ROBERT JOHN,,https://lens.org/028-544-773-061-30X,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D50/04,,0,0,,,,ACTIVE
212,US,A,US 1813653 A,187-545-736-131-84X,1931-07-07,1931,US 30172628 A,1928-08-24,US 30172628 A,1928-08-24,Folding chair,,LYON METAL PRODUCTS INC,ADLER JOHN B;;O'CONNOR JOHN B;;VANCE WALTER N,,https://lens.org/187-545-736-131-84X,Granted Patent,no,0,4,1,1,0,A47C4/24;;A47C4/24,A47C4/24,,0,0,,,,EXPIRED
213,US,A1,US 2018/0260809 A1,172-347-698-965-699,2018-09-13,2018,US 201715454042 A,2017-03-09,US 201715454042 A,2017-03-09,ADAPTIVE DIGITIZED CARDS,"A digitized card data structure is stored in association with a digital card environment. The digitized card data structure corresponds to a card issued to a card holder. The digitized card data structure has a component for providing output to the card holder. Under a first condition the component provides a first output and under a second condition, the component provides a second output different from the first output.",MASTERCARD INTERNATIONAL INC,TRYON KERRY;;BAKER JOHN;;ADLER GARY;;RAYNOR NIGEL JOHN,MASTERCARD INTERNATIONAL INCORPORATED (2017-02-28),https://lens.org/172-347-698-965-699,Patent Application,yes,10,0,3,3,0,G06Q20/3224;;G06Q20/405;;G06Q20/351;;G06Q20/36;;G06Q30/0226;;G06Q20/351;;G06Q20/36;;G06Q20/10;;G06Q20/24;;G06Q30/0226;;G06Q20/3224;;G06Q20/405,G06Q20/34;;G06Q20/10;;G06Q20/24;;G06Q20/36,,0,0,,,,DISCONTINUED
214,US,A,US 1966272 A,128-971-665-204-547,1934-07-10,1934,US 36207729 A,1929-05-10,US 36207729 A,1929-05-10,Lock,,LYON METAL PRODUCTS INC,VANCE WALTER N;;O'CONNOR JOHN B;;ADLER JOHN B,,https://lens.org/128-971-665-204-547,Granted Patent,no,0,6,1,1,0,E05C9/045;;E05C9/045;;E05C9/041;;E05C9/041;;E05C9/047;;E05C9/047;;Y10S292/68;;Y10S292/68;;Y10T70/5115;;Y10T70/5115;;Y10T70/527;;Y10T70/527;;Y10T70/5796;;Y10T70/5796;;Y10T292/08;;Y10T292/08,E05C9/04,,0,0,,,,EXPIRED
215,US,A,US 1798182 A,045-126-316-190-768,1931-03-31,1931,US 37230629 A,1929-06-20,US 37230629 A,1929-06-20,Boltless structure,,LYON METAL PRODUCTS INC,VANCE WALTER N;;O'CONNOR JOHN B;;ADLER JOHN B,,https://lens.org/045-126-316-190-768,Granted Patent,no,0,13,1,1,0,A47B47/03;;A47B47/03,A47B47/03,,0,0,,,,EXPIRED
216,EP,A1,EP 3801217 A1,008-605-154-761-56X,2021-04-14,2021,EP 19810531 A,2019-05-30,US 201862678098 P;;US 2019/0034680 W,2018-05-30,RADIOSURGICAL NEUROMODLATION CLOSE TO CRITICAL STRUCTURES,,ZAP SURGICAL SYSTEMS INC,ADLER JOHN R JR;;SCHNEIDER M BRET,,https://lens.org/008-605-154-761-56X,Patent Application,yes,0,0,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61B5/00;;A61B5/05;;A61B18/00;;A61K9/00;;A61K41/00;;A61N1/36;;A61N5/10,,0,0,,,,PENDING
217,US,A1,US 2024/0042237 A1,138-770-029-724-682,2024-02-08,2024,US 202318222281 A,2023-07-14,US 202318222281 A;;US 201916426977 A;;US 201862678098 P,2018-05-30,Radiosurgical Neuromodulation Close to Critical Structures,"Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.",ZAP SURGICAL SYSTEMS INC,ADLER JR JOHN R;;SCHNEIDER M BRET,ZAP SURGICAL SYSTEMS INC (2019-09-17),https://lens.org/138-770-029-724-682,Patent Application,yes,0,0,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61K51/04;;A61N5/10;;A61M37/00,,0,0,,,,PENDING
218,EP,A4,EP 3801217 A4,030-084-106-562-431,2022-07-20,2022,EP 19810531 A,2019-05-30,US 201862678098 P;;US 2019/0034680 W,2018-05-30,RADIOSURGICAL NEUROMODLATION CLOSE TO CRITICAL STRUCTURES,,ZAP SURGICAL SYSTEMS INC,ADLER JOHN R JR;;SCHNEIDER M BRET,,https://lens.org/030-084-106-562-431,Search Report,no,4,0,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61K41/00;;A61M37/00;;A61N1/36;;A61N5/10,,1,0,,,See also references of WO 2019232227A1,PENDING
219,US,B2,US 9808651 B2,073-189-245-969-080,2017-11-07,2017,US 201313900131 A,2013-05-22,US 201313900131 A;;US 201261651470 P,2012-05-24,Treatment of anxiety disorders by external application of ionizing radiation,"Medical systems, devices, and methods provide improved radiosurgical techniques for treatment of anxiety disorders (such as Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder (GAD), Panic Disorder, Social Phobia, Specific Phobia, and the like). Radiation can be directed from a radiation source outside the patient toward a target tissue deep within the patient's brain using a stereotactic radiosurgical platform, typically without having to impose the surgical trauma associated with accessing deep brain tissues. The target will often include at least a portion of the amygdala, with exemplary treatments being directed to targets that are limited to a sub-region of the amygdala. Rather than applying sufficient radiation to kill the neural tissue within the target, a cellularly sub-lethal dose of the radiation may be applied. Without imposing frank cell death throughout the target, the radiation can mitigate the anxiety disorder, obesity, or the like, often by modulating the level of neural activity within the target and in associated tissues.",SCHNEIDER M BRET;;ADLER JR JOHN R,SCHNEIDER M BRET;;ADLER JR JOHN R,ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/073-189-245-969-080,Granted Patent,yes,20,1,3,3,0,A61N5/0618;;A61N5/1042;;A61N5/1084;;A61N5/1039;;A61N5/0618;;A61N5/1042;;A61N5/1084;;A61N5/1039;;A61N5/1031;;A61N5/1049,A61N5/10;;A61N5/06,,15,7,004-229-238-641-491;;016-423-074-261-904;;030-019-655-024-002;;088-605-253-045-077;;025-580-865-305-112;;105-163-612-129-619;;028-225-259-495-123,11584307;;10.1038/35094560;;7632622;;10.1016/0920-9964(94)00055-d;;15627591;;10.1016/j.neuroimage.2004.08.041;;2336467;;10.2307/3577608;;11229981;;10.1176/appi.ajp.158.3.405;;10.1016/s0166-4328(01)00364-3;;11718882;;10.1007/978-3-7091-6117-3_4;;12379003,"Hyman et al., “Addiction and the Brain: The Neurobiology of Compulsion and Its Persistence”, Nature Reviews: Neuroscience 2001; 2: 695-703.;;Kandel et al., “Principles of Neural Science 4th Edition”, New York: McGraw-Hill Companies Inc, 2000. 1002-1006.;;Lewine et al., “Differences in Qualitative Brain Morphology Findings in Schizophrenia, Major Depression, Bipolar Disorder, and Normal Volunteers”, Schizophrenia Research 1995; 15: 253-259.;;Maltby et al., “Dysfunctional Action Monitoring Hyperactivates Frontal-striatal Circuits in Obsessive-Compulsive Disorder: an Event-related fMRI study”, Neuroimage 2005; 24:495-503.;;Pellmar et al., “Time-and Dose-Dependent Changes in Neuronal Activity Produced by X Radiation in Brain Slices”, Radiation Research 1990; 122: 209-214.;;Pizzagali et al., “Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis”, American Journal of Psychiatry 2001; 158: 405-415.;;Tracy et al., “The Hippocampus and Motivation Revisited: Appetite and Activity”, Behavioral Brain Research 2001; 127: 13-23.;;Regis et al., “Gamma Knife Surgery, a Neuromodulation Therapy in Epilepsy Surgery!”, Acta Neorochirurgica Supplements, vol. 84, 2002, pp. 37-47.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration; International Search Report and Written Opinion of the International Searching Authority for corresponding International Application No. PCT/US2013/041626 dated Oct. 21, 2013, 10 pages.;;Non-Final Office Action for U.S. Appl. No. 12/261,347 dated Dec. 22, 2011, 22 pages.;;Final Office Action for U.S. Appl. No. 12/261,347 dated Jun. 21, 2012, 17 pages.;;Notice of Allowance for U.S. Appl. No. 12/261,347 dated Oct. 12, 2012, 7 pages.;;Non-Final Office Action for U.S. Appl. No. 13/708,076 dated Sep. 10, 2013, 16 pages.;;Notice of Allowance for U.S. Appl. No. 13/708,076 dated Jan. 30, 2014, 11 pages.;;Non-Final Office Action for U.S. Appl. No. 14/266,090 dated Aug. 13, 2014, 11 pages.",ACTIVE
220,DE,C2,DE 3000758 C2,139-283-436-490-914,1988-09-01,1988,DE 3000758 A,1980-01-10,US 399279 A,1979-01-16,DE 3000758 C2,,"ADLER, ALAN JOHN, PALO ALTO, CALIF., US","ADLER, ALAN JOHN, PALO ALTO, CALIF., US",,https://lens.org/139-283-436-490-914,Granted Patent,no,0,1,20,21,0,B64C39/06;;B64C39/06,A63B65/10;;B64C39/06,,0,0,,,,EXPIRED
221,DE,B2,DE 1961361 B2,154-745-079-667-511,1974-10-10,1974,DE 1961361 A,1969-12-06,DE 1961361 A;;GB 4745969 A;;US 5612670 A,1969-09-26,DE 1961361 B2,,"TEXAS INSTRUMENTS INC., DALLAS, TEX. (V.ST.A.)","ADLER, ALAN JOHN, PALO ALTO, CALIF. (V.ST.A.)",,https://lens.org/154-745-079-667-511,Patent Application,no,0,0,4,6,0,G05D3/20;;H01L21/681,G05D3/20;;H01L21/68,,0,0,,,,EXPIRED
222,WO,A1,WO 2013/176991 A1,029-515-420-471-403,2013-11-28,2013,US 2013/0041626 W,2013-05-17,US 201261651470 P,2012-05-24,TREATMENT OF ANXIETY DISORDERS BY EXTERNAL APPLICATION OF IONIZING RADIATION,"Medical systems, devices, and methods provide improved radiosurgical techniques for treatment of anxiety disorders (such as Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder (GAD), Panic Disorder, Social Phobia, Specific Phobia, and the like). Radiation can be directed from a radiation source outside the patient toward a target tissue deep within the patient's brain using a stereotactic radiosurgical platform, typically without having to impose the surgical trauma associated with accessing deep brain tissues. The target will often include at least a portion of the amygdala, with exemplary treatments being directed to targets that are limited to a sub-region of the amygdala. Rather than applying sufficient radiation to kill the neural tissue within the target, a cellularly sub-lethal dose of the radiation may be applied. Without imposing frank cell death throughout the target, the radiation can mitigate the anxiety disorder, obesity, or the like, often by modulating the level of neural activity within the target and in associated tissues",SCHNEIDER M BRET;;ADLER JOHN R JR,SCHNEIDER M BRET;;ADLER JOHN R JR,,https://lens.org/029-515-420-471-403,Patent Application,yes,7,2,3,3,0,A61N5/0618;;A61N5/1042;;A61N5/1084;;A61N5/1039;;A61N5/0618;;A61N5/1042;;A61N5/1084;;A61N5/1039;;A61N5/1031;;A61N5/1049,A61N1/30;;A61N5/10,,0,0,,,,PENDING
223,US,B2,US 11745029 B2,070-755-725-326-572,2023-09-05,2023,US 201916426977 A,2019-05-30,US 201916426977 A;;US 201862678098 P,2018-05-30,Radiosurgical neuromodulation close to critical structures,"Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.",ZAP SURGICAL SYSTEMS INC,ADLER JR JOHN R;;SCHNEIDER M BRET,ZAP SURGICAL SYSTEMS (2019-09-17),https://lens.org/070-755-725-326-572,Granted Patent,yes,30,0,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61N5/10;;A61K51/04;;A61M37/00,,8,3,113-225-996-162-282;;024-187-011-755-526;;015-783-392-538-393,10.1007/s00702-014-1193-3;;25081016;;9210244;;10.1007/bf01628134;;29385922;;10.3171/2017.11.focus17620,"Glutamate receptor antibodies in neurological diseases...and can be removed or silenced in some patients by immunotherapy. Levite M. J Neural Transm (Vienna). Aug. 2014;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub Aug. 1, 2014. PMID: 25081016.(see attached) (Year: 2014).;;Luo SX, Huang EJ. Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. Am J Pathol. Mar. 2016;186(3):478-88. doi: 10.1016/j.ajpath.2015.09.023. Epub Dec. 24, 2015. PMID: 26724386; PMCID: PMC4816693.(see attached) (Year: 2016).;;Supprian T, Hofmann E. The fornix of the human brain: evidence of left/right asymmetry on axial MRI scans. Surg Radiol Anat. 1997;19(2):105-9. doi: 10.1007/BF01628134. PMID: 9210244(see attached) (Year: 1997).;;Protein Data Bankin Europe (PDBe). http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/CPT. Defined at Jul. 8, 1999 (see attached). (Year: 1999).;;Denekamp, “Relationship Between Radioprotective Agents and Tumor Therapy”, Foreign Medicine (Clinical Radiology Section), Issue 1, Mar. 2, 1982.;;Ling, “Research Progress of Radiation Protective Agents and Radiation Sensitizers”, International Journal of Radiation Medicine and Nuclear Medicine, Issue 1, Feb. 28, 1992.;;Pan et al., “Nano-Chitosan Effect on Ion-Heavy Radiation Protection and Sensitization”, Chinese Journal of Tissue Engineering Research, vol. 3, 2012, pp. 409-412.;;Lamsam, et al., “A Review of Potential Applications of Mr-Guided Focused Ultrasound for Targeting Brain Tumor Therapy”, Departments of Neurosurgery and Radiology, vol. 44, No. 2, pp. 1-7, Feb. 2018.",ACTIVE
224,US,A1,US 2014/0155677 A1,117-332-692-458-059,2014-06-05,2014,US 201313900131 A,2013-05-22,US 201313900131 A;;US 201261651470 P,2012-05-24,Treatment of Anxiety Disorders by External Application of Ionizing Radiation,"Medical systems, devices, and methods provide improved radiosurgical techniques for treatment of anxiety disorders (such as Post-Traumatic Stress Disorder (PTSD), Generalized Anxiety Disorder (GAD), Panic Disorder, Social Phobia, Specific Phobia, and the like). Radiation can be directed from a radiation source outside the patient toward a target tissue deep within the patient's brain using a stereotactic radiosurgical platform, typically without having to impose the surgical trauma associated with accessing deep brain tissues. The target will often include at least a portion of the amygdala, with exemplary treatments being directed to targets that are limited to a sub-region of the amygdala. Rather than applying sufficient radiation to kill the neural tissue within the target, a cellularly sub-lethal dose of the radiation may be applied. Without imposing frank cell death throughout the target, the radiation can mitigate the anxiety disorder, obesity, or the like, often by modulating the level of neural activity within the target and in associated tissues.",SCHNEIDER M BRET;;ADLER JR JOHN R,SCHNEIDER M BRET;;ADLER JR JOHN R,ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/117-332-692-458-059,Patent Application,yes,3,0,3,3,0,A61N5/0618;;A61N5/1042;;A61N5/1084;;A61N5/1039;;A61N5/0618;;A61N5/1042;;A61N5/1084;;A61N5/1039;;A61N5/1031;;A61N5/1049,A61N5/10,600/1,0,0,,,,ACTIVE
225,US,A,US 3982218 A,002-899-084-871-728,1976-09-21,1976,US 50728474 A,1974-09-19,US 50728474 A,1974-09-19,Temperature sensing device and method,"A temperature sensing device and a method of forming it is disclosed. A first film or coating of an adherent electro-conductive metallic oxide is applied over the exterior surface of a dielectric substrate. The metal oxide coating is thereafter thoroughly cleansed and a second coating or layer of a metal having a relatively high temperature coefficient of resistance is applied over the metallic oxide film so as to form a strong physical bond as well as a chemical bond therebetween. The composite so formed is fired at a temperature up to about 750.degree.C. If desired, the metal layer is thereafter suitably spiralled to provide the desired resistance and terminal leads are attached to the element. Also, if desired, the element is then coated with a dielectric protective coating.",CORNING GLASS WORKS,ADLER MERYLE D W;;BROWN JOHN T,,https://lens.org/002-899-084-871-728,Granted Patent,yes,4,13,10,10,0,H01C1/1406;;H01C7/021;;H01C7/22;;H01C17/075;;Y10S205/917;;H01C17/075;;H01C7/22;;H01C7/021;;H01C1/1406;;Y10S205/917,G01K7/18;;H01C1/14;;H01C7/02;;H01C7/22;;H01C17/075,H1K KFDX          FDX,0,0,,,,EXPIRED
226,CH,A,CH 528077 A,008-114-222-964-718,1972-09-15,1972,CH 1378070 A,1970-09-17,US 86426369 A,1969-09-22,"Verfahren und Einrichtung zum automatischen, fortlaufenden Behandeln von Strömungsmediumproben mit verschiedenen Reagenzien",,TECHNIKON INSTR CORP,JOHN C A PEOPLES;;STANFORD L ADLER,,https://lens.org/008-114-222-964-718,Granted Patent,no,0,1,17,17,0,G01N35/08;;G01N2035/00435;;Y10S436/808;;G01N35/08;;G01N2035/00435;;Y10S436/808,G01N33/48;;G01N33/80;;G01N35/00;;G01N35/08,,0,0,,,,EXPIRED
227,US,A,US 5207223 A,032-066-233-538-761,1993-05-04,1993,US 60050190 A,1990-10-19,US 60050190 A,1990-10-19,APPARATUS FOR AND METHOD OF PERFORMING STEREOTAXIC SURGERY,"A method and an apparatus are set forth for selectively irradiating a target within a patient. A 3-dimensional mapping is provided of a mapping region surrounding the target. A beaming apparatus emits a collimated beam. Diagnostic beams at a known non-zero angle to one another pass through the mapping region. They produce images of projections within the mapping region. Electronic representations of the images are compared with the reference data thereby locating the target. The relative positions of the beaming apparatus and the living organism are adjusted in such a manner that the collimated beam is focused on the target region. The comparison is repeated at small time intervals and, when the comparison so indicates, the adjusting step is repeated, as needed, and in such a manner that the collimated beam remains focused on to the target region.",ACCURAY INC,ADLER JOHN R;;SCHONBERG RUSSELL;;SCHONBERG PETER,ACCURAY INCORPORATED (2005-10-11);;LODATO FRANK J. (1990-12-04);;PACIFIC REPUBLIC CAPITAL CORP (1998-03-30);;ADLER JOHN R (1991-10-10),https://lens.org/032-066-233-538-761,Granted Patent,yes,8,480,11,11,0,A61B6/08;;A61N5/1049;;A61N5/1067;;A61N5/107;;A61N5/1083;;A61N2005/1061;;A61B6/4458;;A61B6/4464;;A61B2090/101;;A61N5/1049;;A61N2005/1061;;A61N5/107;;A61N5/1083;;A61N5/1067;;A61B6/08;;A61B6/4464;;A61B6/4458;;A61B2090/101,A61B5/055;;G01R33/48;;A61B6/03;;A61B6/08;;A61B19/00;;A61N5/10;;G21K5/00;;G21K5/04,128/653.1;;606/130,1,0,,,"Cobalt 60 Teletherapy: A Compendium of International Practice, International Atomic Agency, Vienna, 1984; Montague Cohen & Joseph S. Mitchell.",EXPIRED
228,US,A,US 4942332 A,181-179-506-351-382,1990-07-17,1990,US 27918088 A,1988-12-02,US 27918088 A,1988-12-02,Tied slit mask for color cathode ray tubes,"A slit-type foil tension mask and associated front assembly for a color cathode ray tube comprise a series of parallel strips separated by slits. The strips are loosely coupled by widely spaced ties, the wide tie spacing being such as to produce a strip coupling which promotes handleability of the mask during mask and tube fabrication and facilitates damping of strip vibration when mounted in a tube, but which is insufficient to induce unacceptable Poisson contraction of the mask when uniaxially tensed along the direction of the strips in the plane of the mask, or to permit an unacceptable thermal expansion perpendicular to said strips.",ZENITH ELECTRONICS CORP,ADLER ROBERT;;COULT JOHN H;;STRAUSS PAUL,ZENITH ELECTRONICS CORPORATION (1988-11-30),https://lens.org/181-179-506-351-382,Granted Patent,yes,12,42,1,2,0,H01J29/07;;H01J29/07;;H01J2229/0744;;H01J2229/0744;;H01J2229/0761;;H01J2229/0761,H01J29/07,313/402;;313/403;;313/269,1,1,040-206-731-843-218,10.1109/jrproc.1954.274643,"Improvements in the RCA Three Beam Shadow Mask Color Kinescope by M. J. Grimes et al, Proceeding of the I R E, Jan. 1954, pp. 315 325.",EXPIRED
229,US,A1,US 2020/0268475 A1,024-662-292-910-085,2020-08-27,2020,US 202016787234 A,2020-02-11,US 202016787234 A;;US 201962811402 P,2019-02-27,Device and Method for Radiosurgical Treatment of Uterine Fibroids,Removable marker implants having fiducial markers disposed on multiple elongate members extend and splay laterally outward when deployed thereby providing improved 3D localization and tracking of a portion of the patient's body for stereotactic radiosurgery. Such an approach is particularly useful for tracking of the uterus during radiosurgery treatment of uterine fibroids. Such implants can include an outer sheath that contains the multiple elongate members during delivery into the portion of the body. The elongate members can be slidably disposed within the shaft and advanced into an expanded deployed position by advancement of an applicator shaft or rod within the sheath. Marker implant can also be integrally formed implants with flexible arms having fiducial markers thereon that can be constrained in a sheath for delivery and resiliently splay laterally outward when released from the shaft. Methods of delivery and deployment are also provided.,ZAP SURGICAL SYSTEMS INC,ADLER JR JOHN R;;SCHNEIDER M BRET,ZAP SURGICAL SYSTEMS INC (2020-02-13),https://lens.org/024-662-292-910-085,Patent Application,yes,1,1,3,3,0,A61F6/14;;A61N5/1084;;A61N5/1049;;A61N2005/1055;;A61N2005/1061;;A61N2005/1058;;A61N2005/1051;;A61B90/39;;A61B2090/3912;;A61B2090/3991;;A61B2090/3966;;A61B17/42;;A61B2090/3987;;A61B2017/00867;;A61B2090/376;;A61B2090/374;;A61B2090/3762;;A61B2090/3954;;A61B2090/3925;;A61B2090/363;;A61B90/37;;A61B2017/4216;;A61B90/39;;A61B2090/3983;;A61B2090/3987;;A61B2090/3912,A61B90/00;;A61B34/20;;A61F6/14;;A61N5/10,,0,0,,,,ACTIVE
230,US,A,US 4973283 A,143-523-800-740-938,1990-11-27,1990,US 48360490 A,1990-02-21,US 48360490 A;;US 27918088 A,1988-12-02,Method of manufacturing a tied slit mask CRT,"A slit-type foil tension mask and associated front assembly for a color cathode ray tube comprise a series of parallel strips separated by slits. The strips are loosely coupled by widely spaced ties, the wide tie spacing being such as to produce a strip coupling which promotes handleability of the mask during mask and tube fabrication and facilitates damping of strip vibration when mounted in a tube, but which is insufficient to induce unacceptable Poisson contraction of the mask when uniaxially tensed along the direction of the strips in the plane of the mask, or to permit an unacceptable thermal expansion perpendicular to said strips.",ZENITH ELECTRONICS CORP,ADLER ROBERT;;COULT JOHN H;;STRAUSS PAUL,,https://lens.org/143-523-800-740-938,Granted Patent,yes,12,25,1,2,0,H01J29/07;;H01J2229/0744;;H01J2229/0761;;H01J29/07;;H01J2229/0761;;H01J2229/0744,H01J29/07,445/30;;445/47,1,0,,,"Grimes et al., Proceedings of the I R E, Jan., 1954, pp. 315 325.",EXPIRED
231,AU,A,AU 1970/020211 A,067-587-397-971-303,1972-03-23,1972,AU 1970/020211 A,1970-09-22,US 86426369 A,1969-09-22,New and improved automatic method and apparatus for the sequential typing of fluids,,TECHNICON INSTR CORPORATION,PEOPLES JOHN C A;;ADLER STANFORD L,,https://lens.org/067-587-397-971-303,Patent Application,no,0,0,17,17,0,G01N35/08;;G01N2035/00435;;Y10S436/808;;G01N35/08;;G01N2035/00435;;Y10S436/808,G01N33/48;;G01N33/80;;G01N35/00;;G01N35/08,,0,0,,,,EXPIRED
232,US,A,US 3991613 A,101-615-096-001-633,1976-11-16,1976,US 55681175 A,1975-03-10,US 55681175 A,1975-03-10,Sensing element for flow meter,"A sensing element for measuring fluid flow comprising an elongated cylindrically-shaped support on which is disposed two resistive films having high TCR values. The support is symmetrical about a plane parallel with the direction of flow, and one of the resistive films is disposed on each side of that plane. The films are less than 10,000 A thick, thereby possessing a high ratio of surface area to thermal mass. These films are quickly cooled by pressure variations accompanying the generation of vortices in the fluid stream, and they are therefore capable of operating at high frequencies.",CORNING GLASS WORKS,ADLER MERYLE D W;;BROWN JOHN T,,https://lens.org/101-615-096-001-633,Granted Patent,yes,9,21,1,1,0,G01F1/684;;G01F1/692;;G01F1/3266;;G01F1/692;;G01F1/684;;G01F1/3266,G01F1/32;;G01F1/684;;G01F1/692,73194VS,1,0,,,"Sharpsteen ""Fluid Amplifier Measures Flow Velocity "" in Control Engineering 1/66.",EXPIRED
233,US,A,US 3635680 A,165-992-892-652-854,1972-01-18,1972,US 3635680D A,1969-09-22,US 86426369 A,1969-09-22,AUTOMATIC METHOD AND APPARATUS FOR THE SEQUENTIAL TYPING OF BLOOD SAMPLES,"Method and apparatus for the automatic, sequential typing of blood samples are provided and comprise the supply from blood sample supply means of said blood samples in the form of a stream of successive blood sample plasmas and a concomitant stream of successive blood sample cells, the supply from reagent dispensing means of a successive stream of different antisera, as spaced by a separating fluid, and a successive stream of different reagent cells, as spaced by a separating fluid, the division of said blood sample cells stream into quotients by the introduction of a separating fluid at spaced points therein, the merger of a different one of said antisera with each of the blood sample cells quotients from each of said blood samples, the merger of said different reagent cells with the blood sample plasma from each of said blood samples, the incubation of said antisera-blood sample cells stream and of said reagent cells-blood sample plasma stream to promote reaction therebetween, and the provision of readily readable and reproducible results of the blood-typing procedure.",TECHNICON CORP,PEOPLES JOHN C A;;ADLER STANFORD L,TECHNICON INSTRUMENTS CORPORATION (1987-12-31),https://lens.org/165-992-892-652-854,Granted Patent,no,6,14,17,17,0,G01N35/08;;G01N2035/00435;;Y10S436/808;;G01N35/08;;G01N2035/00435;;Y10S436/808,G01N33/80;;G01N35/00;;G01N33/48;;G01N35/08,23230   B;;23253   R;;23/259;;195/103.5;;424/11,0,0,,,,EXPIRED
234,US,A1,US 2023/0270523 A1,155-031-388-154-682,2023-08-31,2023,US 202318144563 A,2023-05-08,US 202318144563 A;;US 202016787234 A;;US 201962811402 P,2019-02-27,Device and Method for Radiosurgical Treatment of Uterine Fibroids,Removable marker implants having fiducial markers disposed on multiple elongate members extend and splay laterally outward when deployed thereby providing improved 3D localization and tracking of a portion of the patient's body for stereotactic radiosurgery. Such an approach is particularly useful for tracking of the uterus during radiosurgery treatment of uterine fibroids. Such implants can include an outer sheath that contains the multiple elongate members during delivery into the portion of the body. The elongate members can be slidably disposed within the shaft and advanced into an expanded deployed position by advancement of an applicator shaft or rod within the sheath. Marker implant can also be integrally formed implants with flexible arms having fiducial markers thereon that can be constrained in a sheath for delivery and resiliently splay laterally outward when released from the shaft. Methods of delivery and deployment are also provided.,ZAP SURGICAL SYSTEMS INC,ADLER JR JOHN R;;SCHNEIDER M BRET,ZAP SURGICAL SYSTEMS INC (2020-02-13),https://lens.org/155-031-388-154-682,Patent Application,yes,0,0,3,3,0,A61F6/14;;A61N5/1084;;A61N5/1049;;A61N2005/1055;;A61N2005/1061;;A61N2005/1058;;A61N2005/1051;;A61B90/39;;A61B2090/3912;;A61B2090/3991;;A61B2090/3966;;A61B17/42;;A61B2090/3987;;A61B2017/00867;;A61B2090/376;;A61B2090/374;;A61B2090/3762;;A61B2090/3954;;A61B2090/3925;;A61B2090/363;;A61B90/37;;A61B2017/4216;;A61B90/39;;A61B2090/3983;;A61B2090/3987;;A61B2090/3912,A61B90/00,,0,0,,,,PENDING
235,DE,C3,DE 1961361 C3,015-990-384-179-847,1975-05-28,1975,DE 1961361 A,1969-12-06,DE 1961361 A;;GB 4745969 A;;US 5612670 A,1969-09-26,DE 1961361 C3,,"TEXAS INSTRUMENTS INC., DALLAS, TEX. (V.ST.A.)","ADLER, ALAN JOHN, PALO ALTO, CALIF. (V.ST.A.)",,https://lens.org/015-990-384-179-847,Granted Patent,no,0,0,4,6,0,G05D3/20;;H01L21/681,G05D3/20;;H01L21/68,,0,0,,,,EXPIRED
236,US,A1,US 2019/0366123 A1,016-148-866-328-448,2019-12-05,2019,US 201916426977 A,2019-05-30,US 201916426977 A;;US 201862678098 P,2018-05-30,Radiosurgical Neuromodulation Close to Critical Structures,"Methods of treatment and treatment systems for performing radiomodulatory stereotactic radiosurgery to treat brain disorders in which target neural tissues associated with the brain disorder are sensitized to radiation by administration of a molecular substance and/or non-targeted critical structures are protected from radiation by a molecular substance, in order to treat disorders of brain circuitry. Specific embodiments disclose means for treating pain, obesity and drug addiction.",ZAP SURGICAL SYSTEMS INC,ADLER JR JOHN R;;SCHNEIDER M BRET,ZAP SURGICAL SYSTEMS (2019-09-17),https://lens.org/016-148-866-328-448,Patent Application,yes,2,1,8,8,0,A61M37/0092;;A61N2005/1098;;A61N5/1084;;A61K41/0038;;A61N5/1031;;A61N2005/1098;;A61M37/0092;;A61K51/0497,A61N5/10;;A61K51/04;;A61M37/00,,4,3,113-225-996-162-282;;042-076-182-064-51X;;024-187-011-755-526,10.1007/s00702-014-1193-3;;25081016;;10.1016/j.ajpath.2015.09.023;;pmc4816693;;26724386;;9210244;;10.1007/bf01628134,"Glutamate receptor antibodies in neurological diseases...and can be removed or silenced in some patients by immunotherapy. Levite M. J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. PMID: 25081016.(see attached) (Year: 2014);;Luo SX, Huang EJ. Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. Am J Pathol. 2016 Mar;186(3):478-88. doi: 10.1016/j.ajpath.2015.09.023. Epub 2015 Dec 24. PMID: 26724386; PMCID: PMC4816693.(see attached) (Year: 2016);;Supprian T, Hofmann E. The fornix of the human brain: evidence of left/right asymmetry on axial MRI scans. Surg Radiol Anat. 1997;19(2):105-9. doi: 10.1007/BF01628134. PMID: 9210244(see attached) (Year: 1997);;Protein Data Bank in Europe (PDBe). http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/CPT. Defined at 1999-07-08 (see attached). (Year: 1999)",ACTIVE
237,DE,A1,DE 2538966 A1,136-679-287-287-470,1976-04-01,1976,DE 2538966 A,1975-09-02,US 50728474 A,1974-09-19,VERFAHREN ZUR HERSTELLUNG ELEKTRISCHER TEMPERATURFUEHLER,,CORNING GLASS WORKS,BROWN JOHN THOMAS;;ADLER MERYLE DANIEL WALTER,,https://lens.org/136-679-287-287-470,Patent Application,no,0,3,10,10,0,H01C1/1406;;H01C7/021;;H01C7/22;;H01C17/075;;Y10S205/917;;H01C17/075;;H01C7/22;;H01C7/021;;H01C1/1406;;Y10S205/917,G01K7/18;;H01C1/14;;H01C7/02;;H01C7/22;;H01C17/075,,0,0,,,,DISCONTINUED
238,US,B2,US 11684446 B2,178-299-684-973-676,2023-06-27,2023,US 202016787234 A,2020-02-11,US 202016787234 A;;US 201962811402 P,2019-02-27,Device for radiosurgical treatment of uterine fibroids,Removable marker implants having fiducial markers disposed on multiple elongate members extend and splay laterally outward when deployed thereby providing improved 3D localization and tracking of a portion of the patient's body for stereotactic radiosurgery. Such an approach is particularly useful for tracking of the uterus during radiosurgery treatment of uterine fibroids. Such implants can include an outer sheath that contains the multiple elongate members during delivery into the portion of the body. The elongate members can be slidably disposed within the shaft and advanced into an expanded deployed position by advancement of an applicator shaft or rod within the sheath. Marker implant can also be integrally formed implants with flexible arms having fiducial markers thereon that can be constrained in a sheath for delivery and resiliently splay laterally outward when released from the shaft. Methods of delivery and deployment are also provided.,ZAP SURGICAL SYSTEMS INC,ADLER JR JOHN R;;SCHNEIDER M BRET,ZAP SURGICAL SYSTEMS INC (2020-02-13),https://lens.org/178-299-684-973-676,Granted Patent,yes,133,0,3,3,0,A61F6/14;;A61N5/1084;;A61N5/1049;;A61N2005/1055;;A61N2005/1061;;A61N2005/1058;;A61N2005/1051;;A61B90/39;;A61B2090/3912;;A61B2090/3991;;A61B2090/3966;;A61B17/42;;A61B2090/3987;;A61B2017/00867;;A61B2090/376;;A61B2090/374;;A61B2090/3762;;A61B2090/3954;;A61B2090/3925;;A61B2090/363;;A61B90/37;;A61B2017/4216;;A61B90/39;;A61B2090/3983;;A61B2090/3987;;A61B2090/3912,A61B90/00,,18,15,036-671-788-803-785;;062-298-666-510-335;;014-443-487-631-104;;005-027-932-751-595;;012-667-555-559-504;;057-352-776-989-66X;;026-594-496-075-588;;105-470-141-413-823;;102-688-669-369-800;;034-891-604-485-05X;;023-034-676-931-826;;014-120-520-883-13X;;055-694-801-470-702;;097-194-108-082-165;;001-579-699-735-942,10.1108/01439910210425504;;10.1016/0360-3016(95)02082-9;;7493831;;10.1016/j.ijrobp.2011.01.054;;21640508;;25151538;;10.1016/j.ijrobp.2014.06.046;;21452713;;10.1118/1.3539725;;10.1016/j.ijrobp.2011.01.046;;21477942;;10.1016/s0360-3016(02)02953-x;;12243838;;10.1007/s13566-013-0113-8;;10.1016/j.ijrobp.2006.12.024;;17331669;;10.1117/1.3080134;;19256707;;8309444;;10.1118/1.596958;;10.21236/ada497867;;10.1088/0031-9155/45/12/303;;11131183;;10.7759/cureus.2146;;29632755;;pmc5880589;;pmc4638225;;10.2967/jnumed.114.153239;;25858046,"Bodduluri et al., “X-ray guided robotic radiosurgery for solid tumors”, Industrial Robot: An International Journal, vol. 29, No. 3, 2002, pp. 221-227.;;Dong et al., “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, 1995, pp. 1053-1060.;;Eifel et al., “Gynecologic Radiation Oncology: A Practical Guide”, 2016, 1 pg.;;Harris et al., “Assessment of Organ Motion in Postoperative Endometrial and Cervical Cancer Patients Treated With Intensity-Modulated Radation Therapy”, Int J Radiat Oncol Biol Phys. vol. 81, No. 4, 2011, pp. e645-e650.;;Heijkoop et al., “Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT”, International Journal of Radiation Oncology Biology Physics vol. 90, No. 3, 2014, pp. 673-679.;;Hissoiny et al., “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, physics.med-ph, Jan. 2011, 28 pp.;;Jonsson et al., “Internal Fiducial Markers and Susceptibility Effects in MRI-Simulation and Measurement of Spatial Accuracy”, Int J Radiat Oncol Biol Phys. vol. 82, No. 5, 2012, pp. 1612-1618.;;Jung et al., “Flexible Gd2O2S:Tb scintillators pixelated with polyethylene microstructures for digital x-ray image sensors”, J. Micromech. Microeng. 19, 2009, 10pp.;;Kaatee et al., “Detection of Organ Movement in Cervix Cancer Patients Using a Fluoroscopic Electronic Portal Imaging Device and Radiopaque Markers”, Int. J. Radiat. Oncol. Biol. Phys. vol. 54, No. 2, 2002, pp. 576-583.;;Latifi et al., “Assessment of intact cervix motion using implanted fiducials in patients treated with helical tomotherapy with daily MVCT positioning”, J Radiat Oncol 2, 2013, pp. 323-329.;;Li et al., “Interfractional Variations in Patient Setup and Anatomic”, Int. J. Radiat. Oncol. Biol. Phys. vol. 68, No. 2, 2007, pp. 581-591.;;Lo et al., “Hardware acceleration of a Monte Carlo simulation for photodynamic treatment planning”, Journal of Biomedical Optics, vol. 14(1), Jan./Feb. 2009, pp. 014019-1 thru 014019-11.;;MacKie et al., “Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy ”, Medical Physics 20, 1709 (1993); doi: 10.1118/1.596958, Jun. 4, 1998, 1709-1719.;;Osher et al., “Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising”, 2008, pp. 1-19.;;Ruchala et al., “Megavoltage CT image reconstruction during tomotherapy treatments”, Phys. Med. Biol. vol. 45, 2000, pp. 3545-3562.;;Schonberg , “The History of the Portable Linear Accelerator”, American Association for Physicists in Medicine, downloaded from the internet: https://www.aapm.org/meetings/2001AM/pdf/7221-68900.pdf, 2001, pp. 1-14.;;Weidlich et al., “Characterization of a Novel Revolving Radiation Collimator”, Cureus, vol. 10, No. 2, Feb. 2018, pp. 1-9.;;Zaman et al., “Scintillating Balloon-Enabled Fiber-Optic System for Radionuclide Imaging of Atherosclerotic Plaques”, J Nucl Med 56(5), 2015, 771-777.",ACTIVE
239,CA,A,CA 1033467 A,184-664-088-315-466,1978-06-20,1978,CA 230157 A,1975-06-25,US 50728474 A,1974-09-19,TEMPERATURE SENSING DEVICE AND METHOD,,CORNING GLASS WORKS,ADLER MERYLE D W;;BROWN JOHN T,,https://lens.org/184-664-088-315-466,Granted Patent,no,0,0,10,10,0,H01C1/1406;;H01C7/021;;H01C7/22;;H01C17/075;;Y10S205/917;;H01C17/075;;H01C7/22;;H01C7/021;;H01C1/1406;;Y10S205/917,G01K7/18;;H01C1/14;;H01C7/02;;H01C7/22;;H01C17/075,356-108,0,0,,,,EXPIRED
240,AU,B2,AU 453981 B2,141-609-469-028-100,1974-09-20,1974,AU 1970/020211 A,1970-09-22,US 86426369 A,1969-09-22,New and improved automatic method and apparatus for the sequential typing of fluids,,TECHNICON INSTR,PEOPLES JOHN C A;;ADLER STANFORD L,,https://lens.org/141-609-469-028-100,Granted Patent,no,0,1,17,17,0,G01N35/08;;G01N2035/00435;;Y10S436/808;;G01N35/08;;G01N2035/00435;;Y10S436/808,G01N33/48;;G01N33/80;;G01N35/00;;G01N35/08,,0,0,,,,EXPIRED
241,US,A1,US 2017/0043188 A1,130-368-138-193-79X,2017-02-16,2017,US 201615238472 A,2016-08-16,US 201615238472 A;;US 201414266090 A;;US 201213708076 A;;US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical Neuromodulation Devices, Systems, and Methods for Treatment of Behavioral Disorders by External Application of Ionizing Radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;BORCHERS III DOYLE JOHN;;ADLER JOHN R,SCHNEIDER M BRET;;BORCHERS III DOYLE JOHN;;ADLER JOHN R,SCHNEIDER M. BRET (2009-06-02);;ADLER JOHN R (2009-06-02),https://lens.org/130-368-138-193-79X,Patent Application,yes,1,2,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,,1,1,045-190-827-782-753,10.1016/j.brainres.2006.03.096;;16762327,"Jenrow KA, Ratkewicz AE, Zalinski DN, Roszka KM, Lemke NW, Elisevich KV. Influence of ionizing radiation on the course of kindled epileptogenesis. Brain Res. 2006 Jun 13;1094(1):207-16. Epub 2006 Jun 8.",DISCONTINUED
242,US,B2,US 8038961 B2,076-869-514-845-333,2011-10-18,2011,US 57522605 A,2005-07-21,DE 102004045245 A;;EP 2005053544 W,2004-09-17,Apparatus and process for preparing silanes,"Provided is an apparatus for preparing silanes of the general formula HnSiCU n where n=1, 2, 3 and/or 4 by dismutation of a chlorinated silane in the presence of a catalyst, wherein the apparatus includes: a distillation column having a column bottom, a column top, at least one feed inlet, a plurality of product offtakes, and a chimney tray; and a side reactor containing a catalyst bed having an upper edge, the side reactor being connected to the distillation column via at least three pipes including a first pipe, a second pipe, and a third pipe.",EVONIK DEGUSSA GMBH,SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,EVONIK DEGUSSA GMBH (2007-02-06),https://lens.org/076-869-514-845-333,Granted Patent,yes,22,19,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,B01J8/02;;C01B33/107,422/211;;422/610;;422/630;;422/631;;423/342;;203/29;;X203DIG 6,8,0,,,"U.S. Appl. No. 12/088,286, filed Mar. 27, 2008, Adler, et al.;;U.S. Appl. No. 10/581,458, filed Jun. 1, 2006, Adler, et al.;;U.S. Appl. No. 10/587,399, filed Jul. 27, 2006, Poepken, et al.;;U.S. Appl. No. 11/575,226, filed Mar. 14, 2007, Sonnenschein, et al.;;U.S. Appl. No. 11/569,774, filed May 10, 2005, Sonnenschein, et al.;;U.S. Appl. No. 11/569,783, filed May 10, 2005, Sonnenschein, et al.;;U.S. Appl. No. 12/744,204, filed May 21, 2010, Rauleder, et al.;;U.S. Appl. No. 13/062,431, filed Mar. 4, 2011, Troll, et al.",INACTIVE
243,DE,D1,DE 68909568 D1,101-232-592-115-981,1993-11-04,1993,DE 68909568 T,1989-12-11,US 28265788 A,1988-12-12,ANALYTISCHES TESTGERAET.,,MILES INC,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/101-232-592-115-981,Granted Patent,no,0,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
244,SG,A,SG 11201907970R A,101-859-613-066-402,2019-09-27,2019,SG 11201907970R A,2018-02-27,US 201715454042 A;;US 2018/0019863 W,2017-03-09,ADAPTIVE DIGITIZED CARDS,"Digital Component Management Digital Delivery Services Digital Card Environments 1-1 cc 00 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 13 September 2018 (13.09.2018) WIP0 I PCT iiimmoimiolollmonolomomioomuomommotm# (10) International Publication Number WO 2018/164877 Al (51) International Patent Classification: G06Q 20/32 (2012.01) G06Q 20/36 (2012.01) G06Q 20/34 (2012.01) G06Q 20/40 (2012.01) (21) International Application Number: PCT/US2018/019863 (22) International Filing Date: 27 February 2018 (27.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 15/454,042 09 March 2017 (09.03.2017) US (71) Applicant: MASTERCARD INTERNATIONAL IN- CORPORATED [US/US]; 2000 Purchase Street, Pur- (84) Designated States chase, NY 10577 (US). (72) Inventors: TRYON, Kerry; 486 Mitchell Drive, Valley Cottage, NY 10989 (US). BAKER, John; 110 Livingston Street, Apt 3A, Brooklyn, NY 11201 (US). ADLER, Gary; 1116 Magnolia Road, Teaneck, NJ 07666 (US). RAYNOR, Nigel, John; Orchard Cottage Petworth Road, Haslemere GU27 3AU (GB). (74) Agent: DOBBYN, Colm, J.; Mastercard International In- corporated, 2000 Purchase Street, Purchase, NY 10577 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (54) Title: ADAPTIVE DIGITIZED CARDS 100 102 104 106 Mobile Device 01-108 FIG. 1 (57) : A digitized card data structure is stored in association with a digital card environment. The digitized card data structure corresponds to a card issued to a card holder. The digitized card data structure has a component for providing output to the card holder. Under a first condition the component provides a first output and under a second condition, the component provides a second output different from the first output. [Continued on next page] WO 2018/164877 Al D ill Published: — with international search report (Art. 21(3))",MASTERCARD INTERNATIONAL INC,TRYON KERRY;;BAKER JOHN;;ADLER GARY;;RAYNOR NIGEL,,https://lens.org/101-859-613-066-402,Unknown,no,0,0,3,3,0,G06Q20/3224;;G06Q20/405;;G06Q20/351;;G06Q20/36;;G06Q30/0226;;G06Q20/351;;G06Q20/36;;G06Q20/10;;G06Q20/24;;G06Q30/0226;;G06Q20/3224;;G06Q20/405,G06Q20/32;;G06Q20/34;;G06Q20/36;;G06Q20/40,,0,0,,,,PENDING
245,KR,A,KR 20070053269 A,107-510-939-233-545,2007-05-23,2007,KR 20077006137 A,2005-07-21,DE 102004045245 A;;EP 2005053544 W,2004-09-17,APPARATUS AND PROCESS FOR PREPARING SILANES,,DEGUSSA,SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,,https://lens.org/107-510-939-233-545,Patent Application,no,0,3,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,C01B33/107;;B01D3/00;;B01J8/02;;C01B33/04,,0,0,,,,INACTIVE
246,NO,L,NO 20071960 L,097-860-239-292-076,2007-04-17,2007,NO 20071960 A,2007-04-17,DE 102004045245 A;;EP 2005053544 W,2004-09-17,Apparat og prosess for a fremstille silaner,"Oppfinnelsen gjelder et apparat for fremstilling av silaner av den generelle formelen HnSiCl4-n, der n= 1,2,3 og/eller 4 ved dismutasjon av minst en relativ høyklorinert silan i nærvær av en katalysator som er basert på minst en destillasjonskolonne (1) som har en kolonnebunn (1.1) og et kolonnetak (1.2), minst en sidereaktor (2) med katalysatorseng (3), minst et fødeinntak (1.3), et produktutløp (1.4) og minst et videre produktutløp (1.5 eller 1.8). Destilleringskolonnen (1) er utstyrt med minst en pipeplate (4), og minst en sidereaktor (2) er forbundet med destilleringskolonnen (1) gjennom minst tre rør (5,6,7) på den måten at forbindelsespunktet av linjen (5) til destillasjonskolonnen (1) for avlasting av kondensatet fra pipeplaten er ved et høyere nivå enn den øvre kanten av katalysatorsengen (3, 3.1 eller 3.2). Linjen (6) for avlasting av væskefasen fra sidereaktoren (2) åpner opp (6. 1) inn i destillasjonskolonnen (1) under pipeplaten (4) og denne åpningen (6, 6. 1) er ved et lavere nivå enn den øvre kanten av katalysatorsengen (3, 3.1 eller 3.2) og linjen (7) for avlasting av gassfasen fra den assosierte sidereaktoren (2) åpner (7.1) inn i destilleringskolonnen (1) over nivået (4.1) av pipeplaten (4). Videre tilveiebringer den foreliggende oppfinnelsen en fremgangsmåte for å fremstille de gitte silanene i apparatet ifølge oppfinnelsen.",DEGUSSA,ADLER PETER;;SONNENSCHEIN RAYMUND;;POPKEN TIM;;KAHSNITZ JOHN,,https://lens.org/097-860-239-292-076,Abstract,no,0,0,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,B01J8/02;;B01D3/00;;C01B33/107,,0,0,,,,DISCONTINUED
247,DE,B4,DE 102004045245 B4,019-247-953-543-560,2007-11-15,2007,DE 102004045245 A,2004-09-17,DE 102004045245 A,2004-09-17,Vorrichtung und Verfahren zur Herstellung von Silanen,,DEGUSSA,SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,"EVONIK DEGUSSA GMBH, 40474 DUESSELDORF, DE (2007-12-27);;DEGUSSA GMBH, 40474 DUESSELDORF, DE (2007-04-19)",https://lens.org/019-247-953-543-560,Granted Patent,no,3,0,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,C01B33/04;;C01B33/107,,0,0,,,,INACTIVE
248,US,A1,US 2020/0368714 A1,070-192-965-153-758,2020-11-26,2020,US 201816636883 A,2018-08-07,US 201816636883 A;;US 201762546212 P;;US 2018/0045573 W,2017-08-16,SORBENTS COMPRISING ACTIVATED CARBON AND AMMONIUM PHOSPHATES,"Disclosed herein are particulate sorbents, such as sorbents that can be used for mercury removal applications. The absorbent can comprise at least one ammonium phosphate and at least one activated carbon selected from unhalogenated activated carbon and halogenated activated carbon, wherein the halogenated activated carbon contains at least one halogen impregnant on its surface. Also disclosed are methods of making sorbents, and methods of mercury removal, e.g., from flue gas generated by coal combustion.",CABOT CORP,ADLER GERALD D;;SATTERFIELD JOHN M;;KOEHLERT KENNETH,CABOT CORPORATION (2017-09-08),https://lens.org/070-192-965-153-758,Patent Application,yes,0,0,4,4,0,B01J20/0259;;B01J20/20;;B01D53/02;;B01D53/02;;B01D53/508;;B01D53/64;;B01D53/64;;B01D53/81;;B01D2251/108;;B01D2251/206;;B01D2251/206;;B01D2251/61;;B01D2251/61;;B01D2253/102;;B01D2253/102;;B01D2253/25;;B01D2253/25;;B01D2257/302;;B01D2257/602;;B01D2257/602;;B01D2258/0283;;B01J20/0292;;B01J20/0292;;B01J20/046;;B01J20/20;;B01J20/28004;;B01J20/28016;;B01J20/3021;;B01J20/3204;;B01J20/3234;;F23J15/003;;F23J15/003;;F23J2215/60;;F23J2215/60,B01J20/02;;B01D53/02;;B01D53/50;;B01D53/64;;B01D53/81;;B01J20/20;;B01J20/28;;F23J15/00,,0,0,,,,DISCONTINUED
249,WO,A1,WO 2007/006101 A1,153-868-406-401-731,2007-01-18,2007,AU 2006/000990 W,2006-07-13,AU 2005/903721 A,2005-07-13,SURFACE PROTEINS OF PASTEURELLA MULTOCIDA,"This invention relates to bacterial proteins, and in particular to the identification of surface proteins of the bacterial pathogen Pasteurella multocida which are useful as antigens for vaccines. Immunogenic proteins which are able to elicit protective immunity are disclosed and claimed.",UNIV MONASH;;AL-HASANI KEITH;;ADLER BEN;;BOYCE JOHN DALLAS,AL-HASANI KEITH;;ADLER BEN;;BOYCE JOHN DALLAS,,https://lens.org/153-868-406-401-731,Patent Application,yes,1,5,1,1,0,A61K38/16;;A61K39/00;;A61K39/102;;A61K2039/53;;C07K14/285;;C07K16/1242;;A61P31/04,C07K14/285;;A61K38/16;;A61K39/102;;A61K39/40;;A61K48/00;;A61P31/04;;C07H21/02;;C07H21/04;;C07K16/12,,2,1,007-584-835-500-924,10.1073/pnas.051634598;;pmc30675;;11248100,"MAY B.J. ET AL.: ""Complete genomic sequence of Pasteurella multocida, Pm70"", PROC. NATL. ACAD. SCI. USA, vol. 98, no. 6, 2001, pages 3460 - 3465, XP002202785;;DATABASE PROTEIN [online] XP003006250, accession no. NCBI Database accession no. (Q9CKB7)",PENDING
250,US,A1,US 2021/0261587 A1,168-094-573-445-094,2021-08-26,2021,US 202117161275 A,2021-01-28,US 202117161275 A;;US 202062967811 P;;US 202063028242 P,2020-01-30,STRAD-binding agents and Uses Thereof,"Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.",UNIV CALIFORNIA;;SHANGPHARMA INNOVATION INC,GORDAN JOHN;;MITCHELL DOMINIQUE;;BERESIS RICHARD;;ADLER MARC,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (2021-01-27);;SHANGPHARMA INNOVATION INC (2021-01-21),https://lens.org/168-094-573-445-094,Patent Application,yes,0,0,8,8,7,C07D241/26;;C07D241/28;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D417/12;;C07D401/04;;C07D487/04;;C07D519/00;;C07D413/12;;C07F9/650952;;C07F9/6561;;C07F9/58;;C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P3/10;;C07F9/58;;C07F9/650952;;C07F9/6561;;C07D401/12;;C07D403/12;;C07D403/10;;C07D409/04;;C07D403/04;;C07D401/04;;C07D405/12;;C07D417/04;;C07F9/650952;;C07D241/26;;C07D417/12;;C07D401/12;;C07D403/10;;C07D403/04;;C07D409/04;;C07D413/12;;C07D405/12;;C07D403/12,C07F9/6509;;C07D241/26;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D413/12;;C07D417/12,,3,0,,,"Database Registry Chemical Abstracts Service, Columbus, Ohio, Accession No. RN 1232410-60-4. Entered STN: 16 Jul 2010.;;Database Registry Chemical Abstracts Service, Columbus, Ohio, Accession No. RN 1232423-21-0. Entered STN: 16 Jul 2010.;;Database Registry Chemical Abstracts Service, Columbus, Ohio, Accession No. RN 1903809-63-1. Entered STN: 04 May 2016.",PENDING
251,DE,T2,DE 68909568 T2,006-971-404-312-36X,1994-01-27,1994,DE 68909568 T,1989-12-11,US 28265788 A,1988-12-12,Analytisches Testgerät.,,MILES INC,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/006-971-404-312-36X,Granted Patent,no,0,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
252,EP,A1,EP 4097223 A1,034-289-213-792-560,2022-12-07,2022,EP 21747178 A,2021-01-28,US 202062967811 P;;US 202063028242 P;;US 2021/0015503 W,2020-01-30,STRAD-BINDING AGENTS AND USES THEREOF,,UNIV CALIFORNIA;;SHANGPHARMA INNOVATION INC,GORDAN JOHN;;MITCHELL DOMINIQUE;;BERESIS RICHARD;;ADLER MARC,,https://lens.org/034-289-213-792-560,Patent Application,yes,0,0,8,8,7,C07D241/26;;C07D241/28;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D417/12;;C07D401/04;;C07D487/04;;C07D519/00;;C07D413/12;;C07F9/650952;;C07F9/6561;;C07F9/58;;C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P3/10;;C07F9/58;;C07F9/650952;;C07F9/6561;;C07D401/12;;C07D403/12;;C07D403/10;;C07D409/04;;C07D403/04;;C07D401/04;;C07D405/12;;C07D417/04;;C07F9/650952;;C07D241/26;;C07D417/12;;C07D401/12;;C07D403/10;;C07D403/04;;C07D409/04;;C07D413/12;;C07D405/12;;C07D403/12,C12N9/12;;A61K31/4965;;A61K31/497;;A61K31/519;;A61P7/12;;C07D413/14;;C07D417/12,,0,0,,,,PENDING
253,UA,C2,UA 91346 C2,041-805-066-019-51X,2010-07-26,2010,UA A200704230 A,2005-07-21,DE 102004045245 A,2004-09-17,APPARATUS AND PROCESS FOR PREPARING SILANES,"The invention relates to an apparatus, for preparing silanes of the general formula HSiClwhere n=1, 2, 3 and/or 4 by dismutation of at least one relatively highly chlorinated silane in the presence of a catalyst, which is based on at least one distillation column (1) having a column bottom (1.1) and a column top (1.2), at least one side reactor (2) with catalyst bed (3), at least one feed inlet (1.3), a product offtake (1.4) and at least one further product offtake (1.5 or 1.8), where the distillation column (1) is provided with at least one chimney tray (4) and at least one side reactor (2) is connected to the distillation column (1) via at least three pipes (5, 6, 7) in such a way that the connection point of the line (5) to the distillation column (1) for the discharge of the condensate from the chimney tray (4, 4.1) is at a higher level than the upper edge of the catalyst bed (3, 3.1 or 3.2), the line (6) for the discharge of the liquid phase from the side reactor (2) opens (6.1) into the distillation column (1) below the chimney tray (4) and this opening (6, 6.1) is at a lower level than the upper edge of the catalyst bed (3, 3.1 or 3.2) and the line (7) for the discharge of the gas phase from the associated side reactor (2) opens (7.1) into the distillation column (1) above the level (4.1) of the chimney tray (4). Furthermore, the present invention provides a process for preparing said silanes in the apparatus of the invention.",DEGUSSA,ADLER PETER;;SONNENSCHEIN RAYMUND;;POPKEN TIM;;KAHSNITZ JOHN,,https://lens.org/041-805-066-019-51X,Limited Patent,no,0,0,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,C01B33/107;;B01D3/00;;B01J8/02,,0,0,,,,EXPIRED
254,EP,B1,EP 0373863 B1,091-253-860-104-771,1993-09-29,1993,EP 89312931 A,1989-12-11,US 28265788 A,1988-12-12,ANALYTICAL TEST DEVICE,,MILES INC.(AN INDIANA CORP.),"ADLER, STANFORD L.;;CAMPISI, JOHN;;LEONG, KOON-WAH",MILES INC.(AN INDIANA CORP.) (1992-05-06),https://lens.org/091-253-860-104-771,Granted Patent,yes,3,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
255,EP,A3,EP 0373863 A3,133-432-496-677-279,1990-10-03,1990,EP 89312931 A,1989-12-11,US 28265788 A,1988-12-12,ANALYTICAL TEST DEVICE,"An analytical device (10) for the qualitative and/or quantitative determination of an analyte in a liquid test sample, comprises a base (12) supporting a porous member (16) which has an analyte-responsive substance therein, the substance being capable of undergoing a detectable response to the presence and/or concentration of analyte in the test sample. A cover (18) integral with the base (12) is provided with a reaction well (28) formed therein for storing a dried reaction component (34) and for receiving the liquid test sample to form (with the reaction component) a liquid reaction mixture therein. The reaction well has a passage (30) which is normally spaced from the porous member (16) and effectively closed to transfer therethrough of the reaction mixture, but which is movable towards the porous member effectively to open the passage to allow flow therethrough of the reaction mixture into the porous member (16). The analyte responsive substance in the porous member will undergo a detectable response to any analyte present in the liquid reaction mixture. The base can be provided with a suitable viewing port (54) to permit monitoring of the detectable response generated in the porous member.  ",TECHNICON INSTRUMENTS CORPORATION(A DELAWARE CORPORATION),"ADLER, STANFORD L.;;CAMPISI, JOHN;;LEONG, KOON-WAH",MILES INC.(AN INDIANA CORP.) (1992-05-06),https://lens.org/133-432-496-677-279,Search Report,yes,3,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
256,DE,D1,DE 3277248 D1,199-015-062-031-881,1987-10-15,1987,DE 3277248 T,1982-06-08,US 28375881 A,1981-07-16,"METHOD AND APPARATUS FOR GENERATING A NOISELESS SLIDING BLOCK CODE FOR A (1,7) CHANNEL WITH RATE 2/3",,IBM,ADLER ROY LEE;;HASSNER MARTIN;;MOUSSOURIS JOHN PETER,,https://lens.org/199-015-062-031-881,Granted Patent,no,0,0,7,7,0,G06T9/005;;G11B20/1426;;G06T9/005;;G11B20/1426,H03M7/14;;G06T9/00;;G11B20/14;;H04L25/49,,0,0,,,,EXPIRED
257,DK,D0,DK 622689 D0,197-557-118-107-122,1989-12-11,1989,DK 622689 A,1989-12-11,US 28265788 A,1988-12-12,ANALYTISK TESTINDRETNING,,TECHNICON INSTR,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/197-557-118-107-122,Patent Application,no,0,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,DISCONTINUED
258,US,A,US 4150670 A,004-250-318-906-716,1979-04-24,1979,US 85114177 A,1977-11-14,US 85114177 A,1977-11-14,Anesthesia detector and display apparatus,"An electromechanical monitor for rapid quantitative detection of an anesthetic gas in the gaseous flow of an anesthesia administration system wherein deformation due to directly proportional reversible swelling of an elastic membrane in contact with the gas is mechanically detected and translated into an electrical signal. The membrane is preferably disc-shaped, constructed of silicone rubber, and horizontally mounted within the device. The electrical signal developed may be employed to generate an information display and/or provide automatic control of anesthetic and other gas content within the system.",UNIVERSITY PATENTS INC,ADLER LAWRENCE;;JEWETT WARREN R;;THEISS JOHN B,,https://lens.org/004-250-318-906-716,Granted Patent,yes,4,88,1,1,0,A61M16/104;;A61M2230/435;;G01N33/0027;;A61M16/1055;;A61M16/106;;Y10T137/2509;;Y10T137/2509;;A61M16/104;;A61M2230/435;;G01N33/0027;;A61M16/1055;;A61M16/106,A61M16/10;;G01N33/00,128/188,0,0,,,,EXPIRED
259,US,A1,US 2008/0095691 A1,058-552-438-493-461,2008-04-24,2008,US 57522605 A,2005-07-21,DE 102004045245 A;;EP 2005053544 W,2004-09-17,Apparatus and Process for Preparing Silanes,"The invention relates to an apparatus, for preparing silanes of the general formula H n SiCl 4-n where n=1, 2, 3 and/or 4 by dismutation of at least one relatively highly chlorinated silane in the presence of a catalyst, which is based on at least one distillation column ( 1 ) having a column bottom ( 1.1 ) and a column top ( 1.2 ), at least one side reactor ( 2 ) with catalyst bed ( 3 ), at least one feed inlet ( 1.3 ), a product offtake ( 1.4 ) and at least one further product offtake ( 1.5 or 1.8 ), where the distillation column ( 1 ) is provided with at least one chimney tray ( 4 ) and at least one side reactor ( 2 ) is connected to the distillation column ( 1 ) via at least three pipes ( 5, 6, 7 ) in such a way that the connection point of the line ( 5 ) to the distillation column ( 1 ) for the discharge of the condensate from the chimney tray ( 4, 4.1 ) is at a higher level than the upper edge of the catalyst bed ( 3, 3.1 or 3.2 ), the line ( 6 ) for the discharge of the liquid phase from the side reactor ( 2 ) opens ( 6.1 ) into the distillation column ( 1 ) below the chimney tray ( 4 ) and this opening ( 6, 6.1 ) is at a lower level than the upper edge of the catalyst bed ( 3, 3.1 or 3.2 ) and the line ( 7 ) for the discharge of the gas phase from the associated side reactor ( 2 ) opens ( 7.1 ) into the distillation column ( 1 ) above the level ( 4.1 ) of the chimney tray ( 4 ). Furthermore, the present invention provides a process for preparing said silanes in the apparatus of the invention.",DEGUSSA,SONNENSCHEIN RAYMUND;;ADLER PETER;;POPKEN TIM;;KAHSNITZ JOHN,EVONIK DEGUSSA GMBH (2007-02-06),https://lens.org/058-552-438-493-461,Patent Application,yes,12,21,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,B01D3/00;;B01J8/02;;C01B33/107,423/342;;422/188;;422/196;;422/211,0,0,,,,INACTIVE
260,DE,C3,DE 2046120 C3,145-032-356-500-941,1975-12-11,1975,DE 2046120 A,1970-09-18,US 86426369 A,1969-09-22,DE 2046120 C3,,"TECHNICON INSTRUMENTS CORP., TARRYTOWN, N.Y. (V.ST.A.)","PEOPLES, JOHN C.A., NANUET;;ADLER, STANFORD L., MONSEY",,https://lens.org/145-032-356-500-941,Granted Patent,no,0,0,17,17,0,G01N35/08;;G01N2035/00435;;Y10S436/808;;G01N35/08;;G01N2035/00435;;Y10S436/808,G01N33/48;;G01N33/80;;G01N35/00;;G01N35/08,,0,0,,,,EXPIRED
261,WO,A1,WO 2006/029930 A1,037-512-885-386-416,2006-03-23,2006,EP 2005053544 W,2005-07-21,DE 102004045245 A,2004-09-17,APPARATUS AND PROCESS FOR PREPARING SILANES,"The invention relates to an apparatus, for preparing silanes of the general formula HnSiCl4-n where n = 1, 2, 3 and/or 4 by dismutation of at least one relatively highly chlorinated silane in the presence of a catalyst, which is based on at least one distillation column (1) having a column bottom (1.1) and a column top (1.2), at least one side reactor (2) with catalyst bed (3), at least one feed inlet (1.3), a product offtake (1.4) and at least one further product offtake (1.5 or 1.8), where the distillation column (1) is provided with at least one chimney tray (4) and at least one side reactor (2) is connected to the distillation column (1) via at least three pipes (5, 6, 7) in such a way that the connection point of the line (5) to the distillation column (1) for the discharge of the condensate from the chimney tray (4, 4.1) is at a higher level than the upper edge of the catalyst bed (3, 3.1 or 3.2), the line (6) for the discharge of the liquid phase from the side reactor (2) opens (6.1) into the distillation column (1) below the chimney tray (4) and this opening (6, 6.1) is at a lower level than the upper edge of the catalyst bed (3, 3.1 or 3.2) and the line (7) for the discharge of the gas phase from the associated side reactor (2) opens (7.1) into the distillation column (1) above the level (4.1) of the chimney tray (4). Furthermore, the present invention provides a process for preparing said silanes in the apparatus of the invention.",DEGUSSA;;SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,,https://lens.org/037-512-885-386-416,Patent Application,yes,5,14,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,B01D3/00;;B01J8/02;;C01B33/107,,0,0,,,,PENDING
262,WO,A1,WO 2021/155004 A1,051-716-436-554-164,2021-08-05,2021,US 2021/0015503 W,2021-01-28,US 202062967811 P;;US 202063028242 P,2020-01-30,STRAD-BINDING AGENTS AND USES THEREOF,"Disclosed herein, inter alia , are compounds for binding STRAD pseudokinase and uses thereof.",UNIV CALIFORNIA;;SHANGPHARMA INNOVATION INC,GORDAN JOHN;;MITCHELL DOMINIQUE;;BERESIS RICHARD;;ADLER MARC,,https://lens.org/051-716-436-554-164,Patent Application,yes,9,0,8,8,7,C07D241/26;;C07D241/28;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D417/12;;C07D401/04;;C07D487/04;;C07D519/00;;C07D413/12;;C07F9/650952;;C07F9/6561;;C07F9/58;;C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P3/10;;C07F9/58;;C07F9/650952;;C07F9/6561;;C07D401/12;;C07D403/12;;C07D403/10;;C07D409/04;;C07D403/04;;C07D401/04;;C07D405/12;;C07D417/04;;C07F9/650952;;C07D241/26;;C07D417/12;;C07D401/12;;C07D403/10;;C07D403/04;;C07D409/04;;C07D413/12;;C07D405/12;;C07D403/12,C12N9/12;;A61K31/4965;;A61K31/497;;A61K31/519;;A61P7/12;;C07D413/14;;C07D417/12,,2,2,090-913-975-694-868;;026-174-428-214-848,10.1042/bsr20150226;;26589967;;pmc4718504;;10.1371/journal.pbio.1000126;;pmc2686265;;19513107,"HAMMARÉN HENRIK M., VIRTANEN ANNIINA T., SILVENNOINEN OLLI: ""Nucleotide-binding mechanisms in pseudokinases"", BIOSCIENCE REPORTS, vol. 36, e00282, 20 November 2016 (2016-11-20), pages 1 - 20, XP055846185, DOI: 10.1042/BSR20150226;;ZEQIRAJ ELTON, FILIPPI BEATRICE MARIA, GOLDIE SIMON, NAVRATILOVA IVA, BOUDEAU JÉRÔME, DEAK MARIA, ALESSI DARIO R., VAN AALTEN DAAN: ""ATP and M025a Regulate the Conformational State of the STRADalpha Pseudokinase and Activation of the LKB1 Tumour Suppressor"", PLOS BIOLOGY, vol. 7, no. 6, 9 June 2009 (2009-06-09), pages e1000126-1 - e1000126-20, XP055846187, DOI: 10.1371/journal.pbio.1000126",PENDING
263,ES,T3,ES 2045473 T3,076-144-296-878-584,1994-01-16,1994,ES 89312931 T,1989-12-11,US 28265788 A,1988-12-12,DISPOSITIVO DE ENSAYO ANALITICO.,"UN DISPOSITIVO ANALITICO (10) PARA LA DETERMINACION CUALITATIVA Y/O CUANTITATIVA DE UN ANALITICO EN UNA MUESTRA DE ENSAYO LIQUIDO COMPRENDE UNA BASE (12) PORTADORA DE UN ELEMENTO POROSO (16) QUE TIENE UN SUSTANCIA REACTIVA AL ANALITICO EN EL MISMO, LA SUSTANCIA PUEDE EXPERIMENTAR UN RESPUESTA DETECTABLE ANTE LA PRESENCIA Y/O CONCENTRACION DEL ANALITICO EN LA MUESTRA DE ENSAYO. UNA TAPA (18) INTEGRAL CON LA BASE (12) SE PROPORCIONA CON UNA DEPOSITO DE REACCION (28) FORMADA EN LA MISMA PARA ALMACENAR UNA COMPONENTE DE REACCION DESHIDRATADO (34) Y PARA RECIBIR LA MUESTRA DE ENSAYO LIQUIDO PARA FORMAR (CON EL COMPONENTE DE REACCION) UNA MEZCLA DE REACCION LIQUIDA EN LA MISMA. EL DEPOSITO DE LA REACCION TIENE UN PASO INTERMEDIO (30) QUE GENERALMENTE ESTA SEPARADO DEL ELEMENTO POROSO (16) Y CERRADO EFICAZMENTE PARA TRANSFERIR A TRAVES DE LA MEZCLA DE REACCION, PERO QUE SE DESPLAZA HACIA EL ELEMENTO POROSO EFICAZMENTE PARA ABRIR EL PASO INTERMEDIO PARA PERMITIR EL FLUJO A TRAVES DE LA MEZCLA DEREACCION AL ELEMENTO POROSO (16). LA SUSTANCIA REACTIVA DEL ANALITICO EN EL ELEMENTO POROSO EXPERIMENTARA UNA REACCION DETECTABLE PARA CUALQUIER ANALITICO PRESENTE EN LA MEZCLA DE REACCION LIQUIDA. LA BASE SE PUEDE PROPORCIONAR CON UN PUERTO DE VISUALIZACION ADECUADO (54) PARA PERMITIR LA MONITOREO DE LA REACCION DETECTABLE GENERADA EN EL ELEMENTO POROSO.",MILES INC,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/076-144-296-878-584,Granted Patent,no,0,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
264,DK,A,DK 622689 A,101-629-553-377-845,1990-06-13,1990,DK 622689 A,1989-12-11,US 28265788 A,1988-12-12,ANALYTISK TESTINDRETNING,,TECHNICON INSTR,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/101-629-553-377-845,Patent Application,no,0,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,DISCONTINUED
265,EP,A1,EP 1791613 A1,096-696-506-888-803,2007-06-06,2007,EP 05763051 A,2005-07-21,EP 2005053544 W;;DE 102004045245 A,2004-09-17,APPARATUS AND PROCESS FOR PREPARING SILANES,,DEGUSSA,SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,EVONIK DEGUSSA GMBH (2008-08-06),https://lens.org/096-696-506-888-803,Patent Application,yes,0,0,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,B01D3/00;;B01J8/02;;C01B33/107,,1,0,,,See references of WO 2006029930A1,DISCONTINUED
266,US,A1,US 2020/0386281 A1,143-824-870-137-48X,2020-12-10,2020,US 202016743658 A,2020-01-15,US 202016743658 A;;US 201962859392 P,2019-06-10,ROTOR CARRIER CONNECTION,"A rotor for a hybrid drivetrain includes a rotor carrier, at least one rotor segment, and a torque converter. The rotor carrier has a first tubular portion with an outer surface, and an annular portion with a first through hole. The at least one rotor segment is installed on the outer surface. The torque converter has an impeller with a first shell and a plurality of first blades fixed to the first shell, a cover with a second shell fixed to the first shell to form a hydraulic chamber and a fastener fixed to the second shell and extending through the first through hole, and a turbine disposed in the hydraulic chamber and including a third shell and a plurality of second blades fixed to the second shell.",SCHAEFFLER TECHNOLOGIES AG,MOASHER MOHAMMAD;;RAMSEY JOHN;;HECK THOMAS;;ADLER CARL,SCHAEFFLER TECHNOLOGIES AG & CO. KG (2019-09-23),https://lens.org/143-824-870-137-48X,Patent Application,yes,0,0,5,6,0,F16H41/04;;F16H41/24;;B60K17/02;;H02K7/006;;H02K5/203;;B60K2006/4825;;B60K6/387;;B60K6/405;;B60K6/48;;F16H45/02;;Y02T10/62;;B60K17/02;;B60K6/26;;B60K6/405;;B60K2006/4825;;B60Y2200/92;;B60Y2400/426;;H02K1/28;;H02K7/006,F16D33/18;;B60K17/02;;F16H41/28,,0,0,,,,ACTIVE
267,US,A,US 4413251 A,138-601-132-340-073,1983-11-01,1983,US 28375881 A,1981-07-16,US 28375881 A,1981-07-16,"Method and apparatus for generating a noiseless sliding block code for a (1,7) channel with rate 2/3",An algorithm and the hardware embodiment for producing a run length limited code useful in magnetic recording channels are described. The system described produces sequences which have a minimum of 1 zero and a maximum of 7 zeros between adjacent 1's. The code is generated by a sequential scheme that map 2 bits of unconstrained into 3 bits of constrained data. The encoder is a finite state machine whose internal state description requires 3 bits. It possesses the attractive feature of reset data blocks which reset it to a fixed state. The decoder requires a lookahead of two future channel symbols (6 bits) and its operation is channel state independent. The error propagation due to a random error is 5 bits. The hardware implementation is extremely simple and can operate at very high data speeds.,IBM,ADLER ROY L;;HASSNER MARTIN;;MOUSSOURIS JOHN P,INTERNATIONAL BUSINESS MACHINES CORPORATION (1981-07-07),https://lens.org/138-601-132-340-073,Granted Patent,yes,3,91,7,7,0,G06T9/005;;G11B20/1426;;G06T9/005;;G11B20/1426,G06T9/00;;G11B20/14;;H03M7/14;;H04L25/49,340347DD,1,0,,,"Adlr ""Memoirs of the American Mathematical Society"" Jul. 1979 vol. 20 No. 219.",EXPIRED
268,CH,A,CH 360522 A,146-442-761-644-373,1962-02-28,1962,CH 360522D A,1957-04-15,US 57833356 A;;US 20157X A;;US 110357X A;;US 67625957 A,1957-01-02,"Ubertragungseinrichtung für Ultraschallsignale zu Steuerungszwecken, insbesondere zur Betätigung eines Fernsehempfängers",,ZENITH RADIO CORP,ROBERT ADLER;;JOHN G SPRACKLEN;;ROBERT C EHLERS,,https://lens.org/146-442-761-644-373,Granted Patent,no,0,0,4,4,0,B06B3/02;;B06B3/04;;H04N5/58;;H04Q9/00;;Y10S116/30;;H04N5/58;;B06B3/04;;H04Q9/00;;B06B3/02;;Y10S116/30,B06B3/02;;B06B3/04;;H04N5/58;;H04Q9/00,42S,0,0,,,,EXPIRED
269,KR,A,KR 20220150442 A,145-752-320-828-684,2022-11-10,2022,KR 20227029995 A,2021-01-28,US 202062967811 P;;US 202063028242 P;;US 2021/0015503 W,2020-01-30,STRAD-결합제 및 이의 용도,"특히 , STRAD 유사 키나아제에 결합하기 위한 화합물 및 그 용도가 본원에서 개시된다.",UNIV CALIFORNIA;;SHANGPHARMA INNOVATION INC,GORDAN JOHN;;MITCHELL DOMINIQUE;;BERESIS RICHARD;;ADLER MARC,,https://lens.org/145-752-320-828-684,Patent Application,no,0,0,8,8,0,C07D241/26;;C07D241/28;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D417/12;;C07D401/04;;C07D487/04;;C07D519/00;;C07D413/12;;C07F9/650952;;C07F9/6561;;C07F9/58;;C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P3/10;;C07F9/58;;C07F9/650952;;C07F9/6561;;C07D401/12;;C07D403/12;;C07D403/10;;C07D409/04;;C07D403/04;;C07D401/04;;C07D405/12;;C07D417/04;;C07F9/650952;;C07D241/26;;C07D417/12;;C07D401/12;;C07D403/10;;C07D403/04;;C07D409/04;;C07D413/12;;C07D405/12;;C07D403/12,C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P3/10;;A61P35/00;;C07D401/12;;C07D403/12;;C07F9/58;;C07F9/6509;;C07F9/6561,,0,0,,,,PENDING
270,AU,A,AU 1989/042697 A,198-195-615-635-525,1990-06-14,1990,AU 1989/042697 A,1989-10-09,US 28265788 A,1988-12-12,ANALYTICAL TEST DEVICE AND THE USE THEREOF,,TECHNICON INSTR,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/198-195-615-635-525,Patent Application,no,0,1,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
271,AU,B2,AU 616058 B2,037-059-856-633-868,1991-10-17,1991,AU 1989/042697 A,1989-10-09,US 28265788 A,1988-12-12,ANALYTICAL TEST DEVICE AND THE USE THEREOF,,TECHNICON INSTR,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,,https://lens.org/037-059-856-633-868,Granted Patent,no,0,0,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
272,CN,A,CN 101099157 A,064-916-973-363-986,2008-01-02,2008,CN 200580046121 A,2005-12-13,US 2005/0045040 W;;US 64234005 P;;US 5149905 A,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,JAKE RUBINSTEIN JONATHAN;;MITCHELL ADLER;;WESLEY ARCHIBALD JOHN,,https://lens.org/064-916-973-363-986,Patent Application,no,0,14,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,ACTIVE
273,CN,A,CN 102538758 A,167-618-579-598-743,2012-07-04,2012,CN 201110428489 A,2011-12-19,US 97367110 A,2010-12-20,Plural detector time-of-flight depth mapping,"The inventin relates to plural detector time-of-flight depth mapping. The depth-mapping method (38) comprises exposing first and second detectors (18, 18') oriented along different optical axes to (40) light dispersed from a scene, and furnishing an output responsive to a depth coordinate of a locus of the scene. The output increases with an increasing first amount of light received by the first detector during a first period, and decreases with an increasing second amount of light received by the second detector during a second period different than the first.",MICROSOFT CORP,SAGI KATZ;;AVISHAI ADLER;;GIORA YAHAV;;JOHN TARDIF,MICROSOFT TECHNOLOGY LICENSING LLC (2015-07-24),https://lens.org/167-618-579-598-743,Patent Application,no,6,3,4,4,0,A63F2300/1087;;G01S17/87;;G01S17/894;;A63F13/213;;A63F2300/66;;A63F13/52;;A63F2300/1031;;A63F13/235;;A63F13/213;;A63F2300/1087;;G01S17/87;;G01S17/894,G01C11/00;;G01S17/894;;G01S17/87,,0,0,,,,ACTIVE
274,CA,A1,CA 3169649 A1,181-287-392-680-337,2021-08-05,2021,CA 3169649 A,2021-01-28,US 202062967811 P;;US 202063028242 P;;US 2021/0015503 W,2020-01-30,STRAD-BINDING AGENTS AND USES THEREOF,"Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.",UNIV CALIFORNIA;;SHANGPHARMA INNOVATION INC,GORDAN JOHN;;MITCHELL DOMINIQUE;;BERESIS RICHARD;;ADLER MARC,,https://lens.org/181-287-392-680-337,Patent Application,no,0,0,8,8,7,C07D241/26;;C07D241/28;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D417/12;;C07D401/04;;C07D487/04;;C07D519/00;;C07D413/12;;C07F9/650952;;C07F9/6561;;C07F9/58;;C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P3/10;;C07F9/58;;C07F9/650952;;C07F9/6561;;C07D401/12;;C07D403/12;;C07D403/10;;C07D409/04;;C07D403/04;;C07D401/04;;C07D405/12;;C07D417/04;;C07F9/650952;;C07D241/26;;C07D417/12;;C07D401/12;;C07D403/10;;C07D403/04;;C07D409/04;;C07D413/12;;C07D405/12;;C07D403/12,C12N9/12;;A61K31/4965;;A61K31/497;;A61K31/519;;A61P7/12;;C07D413/14;;C07D417/12,,0,0,,,,PENDING
275,DE,B2,DE 2046120 B2,194-753-140-333-838,1975-04-24,1975,DE 2046120 A,1970-09-18,US 86426369 A,1969-09-22,DE 2046120 B2,,"TECHNICON INSTRUMENTS CORP., TARRYTOWN, N.Y. (V.ST.A.)","PEOPLES, JOHN C.A., NANUET;;ADLER, STANFORD L., MONSEY",,https://lens.org/194-753-140-333-838,Patent Application,no,0,1,17,17,0,G01N35/08;;G01N2035/00435;;Y10S436/808;;G01N35/08;;G01N2035/00435;;Y10S436/808,G01N33/48;;G01N33/80;;G01N35/00;;G01N35/08,,0,0,,,,EXPIRED
276,EP,A3,EP 0070387 A3,199-297-386-685-345,1985-07-03,1985,EP 82105020 A,1982-06-08,US 28375881 A,1981-07-16,"METHOD AND APPARATUS FOR GENERATING A NOISELESS SLIDING BLOCK CODE FOR A (1,7) CHANNEL WITH RATE 2/3",An encoder for producing a run length limited code useful in magnetic recording channels producing sequences which have a minimum of 1 zero and a maximum of 7 zeros between adjacent 1's. The code is generated by a sequential scheme that maps 2 bits of unconstrained data (s) into 3 bits of constrained date (y). The encoder comprises a fairly simple logic network (20) and is a finite state machine whose internal state description requires 3 bits (x). It possesses the attractive feature of certain reset data blocks which reset it to a fixed state. The error propagation due to a random error is 5 bits. The hardware implementation is extremely simple and can operate at very high data speeds.,INTERNATIONAL BUSINESS MACHINES CORPORATION,"ADLER, ROY LEE;;HASSNER, MARTIN;;MOUSSOURIS, JOHN PETER",,https://lens.org/199-297-386-685-345,Search Report,yes,3,0,7,7,0,G06T9/005;;G11B20/1426;;G06T9/005;;G11B20/1426,H03M7/14;;G06T9/00;;G11B20/14;;H04L25/49,,2,1,063-669-471-657-122,10.1109/tmag.1976.1059222,"IBM TECHNICAL DISCLOSURE BULLETIN, vol. 23, no. 9, February 1981, pages 4375-4378, NEW YORK, (US). P.A. FRANASZEK: ""Efficient code for digital magnetic recording"".;;IEEE TRANSACTIONS ON MAGNETICS, vol. MAG 12, no. 6, November 1976, pages 740-742, NEW YORK, (US). T. HORIGUCHI et al.: ""An optimization of modulation codes in digital recording"".",EXPIRED
277,US,A,US 5106758 A,172-324-574-756-965,1992-04-21,1992,US 28265788 A,1988-12-12,US 28265788 A,1988-12-12,ANALYTICAL TEST DEVICE AND THE USE THEREOF,"The analytical device includes a base adapted to support a porous member having dispersed throughout at least one analyte responsive substance which undergoes a detectable response to the presence and concentration of the analyte in the test sample. A cover integral with the base is provided with a reaction well adapted for storing a dried reaction component and for receiving the liquid test sample deposited on the analytical device whereby the liquid test sample and the reaction component form a liquid reaction mixture therein. A passage is included in the reaction well for selectively transferring the reaction mixture therethrough. This passage is normally spaced from the porous member and effectively closed to transfer therethrough of the reaction mixture, and is selectively movable toward the porous member to effectively open to passage therethrough of the reaction mixture whereby the analyte responsive substance will undergo a detectable response to the analyte present in the liquid reaction mixture. The base is provided with a suitable viewing port to permit monitoring of the detectable response generated as a result of the at least one analyte responsive substance interacting with the analyte in the test sample. Such a detectable response may be detected by appropriate photometric or colorimetric apparatus.",TECHNICON INSTR,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,TECHNICON INSTRUMENTS CORPORATION A CORP. OF DE (1988-11-17),https://lens.org/172-324-574-756-965,Granted Patent,yes,5,17,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N21/78;;G01N31/22;;G01N33/52,436/165;;436/178;;422/56;;422/57;;422/58;;435/7.1,0,0,,,,EXPIRED
278,US,A1,US 2012/0154542 A1,199-812-535-803-397,2012-06-21,2012,US 97367110 A,2010-12-20,US 97367110 A,2010-12-20,PLURAL DETECTOR TIME-OF-FLIGHT DEPTH MAPPING,"A depth-mapping method comprises exposing first and second detectors oriented along different optical axes to light dispersed from a scene, and furnishing an output responsive to a depth coordinate of a locus of the scene. The output increases with an increasing first amount of light received by the first detector during a first period, and decreases with an increasing second amount of light received by the second detector during a second period different than the first.",KATZ SAGI;;ADLER AVISHAI;;YAHAV GIORA;;TARDIF JOHN;;MICROSOFT CORP,KATZ SAGI;;ADLER AVISHAI;;YAHAV GIORA;;TARDIF JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-12-13),https://lens.org/199-812-535-803-397,Patent Application,yes,11,32,4,4,0,A63F2300/1087;;G01S17/87;;G01S17/894;;A63F13/213;;A63F2300/66;;A63F13/52;;A63F2300/1031;;A63F13/235;;A63F13/213;;A63F2300/1087;;G01S17/87;;G01S17/894,G01S17/894;;H04N13/02;;G01S17/87;;G06K9/00,348/47;;382/154;;X348E13074,0,0,,,,ACTIVE
279,AU,A1,AU 2021/212770 A1,011-258-511-798-753,2022-08-18,2022,AU 2021/212770 A,2021-01-28,US 202062967811 P;;US 202063028242 P;;US 2021/0015503 W,2020-01-30,Strad-binding agents and uses thereof,"Disclosed herein,",SHANGPHARMA INNOVATION INC;;UNIV CALIFORNIA,GORDAN JOHN;;MITCHELL DOMINIQUE;;BERESIS RICHARD;;ADLER MARC,,https://lens.org/011-258-511-798-753,Patent Application,no,0,0,8,8,0,C07D241/26;;C07D241/28;;C07D401/12;;C07D403/04;;C07D403/10;;C07D403/12;;C07D405/12;;C07D409/04;;C07D417/12;;C07D401/04;;C07D487/04;;C07D519/00;;C07D413/12;;C07F9/650952;;C07F9/6561;;C07F9/58;;C07D241/24;;A61K31/4965;;A61K31/506;;A61K31/5377;;A61P35/00;;A61P3/10;;C07F9/58;;C07F9/650952;;C07F9/6561;;C07D401/12;;C07D403/12;;C07D403/10;;C07D409/04;;C07D403/04;;C07D401/04;;C07D405/12;;C07D417/04;;C07F9/650952;;C07D241/26;;C07D417/12;;C07D401/12;;C07D403/10;;C07D403/04;;C07D409/04;;C07D413/12;;C07D405/12;;C07D403/12,C12N9/12;;A61K31/4965;;A61K31/497;;A61K31/519;;A61P7/12;;C07D413/14;;C07D417/12,,0,0,,,,PENDING
280,US,B2,US 8803952 B2,054-026-201-589-558,2014-08-12,2014,US 97367110 A,2010-12-20,US 97367110 A,2010-12-20,Plural detector time-of-flight depth mapping,"A depth-mapping method comprises exposing first and second detectors oriented along different optical axes to light dispersed from a scene, and furnishing an output responsive to a depth coordinate of a locus of the scene. The output increases with an increasing first amount of light received by the first detector during a first period, and decreases with an increasing second amount of light received by the second detector during a second period different than the first.",KATZ SAGI;;ADLER AVISHAI;;YAHAV GIORA;;TARDIF JOHN;;MICROSOFT CORP,KATZ SAGI;;ADLER AVISHAI;;YAHAV GIORA;;TARDIF JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-12-13),https://lens.org/054-026-201-589-558,Granted Patent,yes,110,10,4,4,0,A63F2300/1087;;G01S17/87;;G01S17/894;;A63F13/213;;A63F2300/66;;A63F13/52;;A63F2300/1031;;A63F13/235;;A63F13/213;;A63F2300/1087;;G01S17/87;;G01S17/894,G01S17/894;;H04N13/02;;G01S17/87,348/47,37,12,101-303-238-353-237;;006-459-361-273-408;;000-234-203-548-618;;123-142-523-178-152;;058-694-806-455-404;;077-335-876-952-865;;029-078-551-513-551;;000-036-793-543-51X;;080-341-345-902-534;;103-170-105-553-522;;011-377-277-382-283;;050-768-644-354-392,10.1109/iccvw.2009.5457430;;10.1109/tpami.2010.172;;20820074;;10.1109/cvpr.2008.4587761;;10.1109/icsens.2004.1426205;;10.1109/cvpr.1996.517074;;10.1109/16.628817;;10.1109/namw.1997.609859;;10.1007/bfb0053007;;10.1109/34.598236;;10.1109/afgr.2000.840627;;10.1109/34.598226;;10.1109/34.216730;;10.1145/319120.319127,"Whyte et al., ""Multiple range imaging camera operation with minimal performance impact"", Retrieved at << http://researchcommons.waikato.ac.nz/bitstream/10289/3826/1/Multiple%20range%20imaging%20camera.pdf >>, 2010, pp. 10.;;Gokturk et al., ""A Time-Of-Flight Depth Sensor-System Description, Issues and Solutions"", Retrieved at >,Jan. 24, 2005, pp. 9.;;Kim et al., ""Multi-view Image and ToF Sensor Fusion for Dense 3D Reconstruction"", Retrieved at >, 2009, pp. 8.;;Zhu et al., ""Fusion of Time-of-Flight Depth and Stereo for High Accuracy Depth Maps"", Retrieved at >, Aug. 5, 2008, pp. 8.;;Blais et al., ""Range Error Analysis of an Integrated Time-of-Flight, Triangulation, and Photogrammetric 3D Laser Scanning System"", Retrieved at >,Apr. 2000, pp. 14.;;Stoppa et al., ""A New Architecture for TOF-based Range-finding Sensor"", Retrieved at >,2004, pp. 4.;;Katz, Sagi et al., ""Time-Of-Flight Depth Mapping,"" U.S. Appl. No. 12/897,145, filed Oct. 4, 2010, 49 pages.;;""Integrated Low Power Depth Camera and Projection Device,"" U.S. Appl. No. 12/892,589, filed Sep. 28, 2010, 36 pages.;;Lucas, Bruce D. et al., ""An Iterative Image Registration Technique with an Application to Stereo Vision,"" Proceedings of Imaging Understanding Workshop, pp. 121-130 (1981), 10 pages.;;Kanade et al., ""A Stereo Machine for Video-rate Dense Depth Mapping and Its New Applications"", IEEE Computer Society Conference on Computer Vision and Pattern Recognition, 1996, pp. 196-202,The Robotics Institute, Carnegie Mellon University, Pittsburgh, PA.;;Miyagawa et al., ""CCD-Based Range Finding Sensor"", Oct. 1997, pp. 1648-1652, vol. 44 No. 10, IEEE Transactions on Electron Devices.;;Rosenhahn et al., ""Automatic Human Model Generation"", 2005, pp. 41-48, University of Auckland (CITR), New Zealand.;;Aggarwal et al., ""Human Motion Analysis: A Review"", IEEE Nonrigid and Articulated Motion Workshop, 1997, University of Texas at Austin, Austin, TX.;;Shag et al., ""An Open System Architecture for a Multimedia and Multimodal User Interface"", Aug. 24, 1998, Japanese Society for Rehabilitation of Persons with Disabilities (JSRPD), Japan.;;Kohler, ""Special Topics of Gesture Recognition Applied in Intelligent Home Environments"", In Proceedings of the Gesture Workshop, 1998, pp. 285-296, Germany.;;Kohler, ""Vision Based Remote Control in Intelligent Home Environments"", University of Erlangen-Nuremberg/Germany, 1996, pp. 147-154, Germany.;;Kohler, ""Technical Details and Ergonomical Aspects of Gesture Recognition applied in Intelligent Home Environments"", 1997, Germany.;;Hasegawa et al., ""Human-Scale Haptic Interaction with a Reactive Virtual Human in a Real-Time Physics Simulator"", Jul. 2006, vol. 4, No. 3, Article 6C, ACM Computers in Entertainment, New York, NY.;;Qian et al., ""A Gesture-Driven Multimodal Interactive Dance System"", Jun. 2004, pp. 1579-1582, IEEE International Conference on Multimedia and Expo (ICME), Taipei, Taiwan.;;Zhao, ""Dressed Human Modeling, Detection, and Parts Localization"", 2001, The Robotics Institute, Carnegie Mellon University, Pittsburgh, PA.;;He, ""Generation of Human Body Models"", Apr. 2005, University of Auckland, New Zealand.;;Isard et al., ""Condensation-Conditional Density Propagation for Visual Tracking"", 1998, pp. 5-28, International Journal of Computer Vision 29(1), Netherlands.;;Livingston, ""Vision-based Tracking with Dynamic Structured Light for Video See-through Augmented Reality"", 1998, University of North Carolina at Chapel Hill, North Carolina, USA.;;Wren et al., ""Pfinder: Real-Time Tracking of the Human Body"", MIT Media Laboratory Perceptual Computing Section Technical Report No. 353, Jul. 1997, vol. 19, No. 7, pp. 780-785, IEEE Transactions on Pattern Analysis and Machine Intelligence, Caimbridge, MA.;;Breen et al., ""Interactive Occlusion and Collusion of Real and Virtual Objects in Augmented Reality"", Technical Report ECRC-95-02, 1995, European Computer-Industry Research Center GmbH, Munich, Germany.;;Freeman et al., ""Television Control by Hand Gestures"", Dec. 1994, Mitsubishi Electric Research Laboratories, TR94-24, Caimbridge, MA.;;Hongo et al., ""Focus of Attention for Face and Hand Gesture Recognition Using Multiple Cameras"", Mar. 2000, pp. 156-161, 4th IEEE International Conference on Automatic Face and Gesture Recognition, Grenoble, France.;;Pavlovic et al., ""Visual Interpretation of Hand Gestures for Human-Computer Interaction: A Review"", Jul. 1997, pp. 677-695, vol. 19, No. 7, IEEE Transactions on Pattern Analysis and Machine Intelligence.;;Azarbayejani et al., ""Visually Controlled Graphics"", Jun. 1993, vol. 15, No. 6, IEEE Transactions on Pattern Analysis and Machine Intelligence.;;Granieri et al., ""Simulating Humans in VR"", The British Computer Society, Oct. 1994, Academic Press.;;Brogan et al., ""Dynamically Simulated Characters in Virtual Environments"", Sep./Oct. 1998, pp. 2-13, vol. 18, Issue 5, IEEE Computer Graphics and Applications.;;Fisher et al., ""Virtual Environment Display System"", ACM Workshop on Interactive 3D Graphics, Oct. 1986, Chapel Hill, NC.;;""Virtual High Anxiety"", Tech Update, Aug. 1995, pp. 22.;;Sheridan et al., ""Virtual Reality Check"", Technology Review, Oct. 1993, pp. 22-28, vol. 96, No. 7.;;Stevens, ""Flights into Virtual Reality Treating Real World Disorders"", The Washington Post, Mar. 27, 1995, Science Psychology, 2 pages.;;""Simulation and Training"", 1994, Division Incorporated.;;State Intellectual Property Office of China, Office Action of Chinese Patent Application No. 201110428489.9, Nov. 20, 2013, 12 pages.",ACTIVE
281,DE,A1,DE 102020114597 A1,187-986-187-969-60X,2020-12-10,2020,DE 102020114597 A,2020-06-02,US 201962859392 P;;US 202016743658 A,2019-06-10,Verbindung für Rotorträger,"Ein Rotor für den Antriebsstrang eines Hybridfahrzeugs enthält einen Rotorträger, mindestens ein Rotorsegment und einen Drehmomentwandler. Der Rotorträger hat einen ersten rohrförmigen Abschnitt mit einer Außenfläche und einen ringförmigen Abschnitt mit einem ersten Durchgangsloch. Das mindestens eine Rotorsegment ist an der Außenfläche angebracht. Der Drehmomentwandler hat ein Laufrad mit einem ersten Gehäuse und einer Vielzahl an dem ersten Gehäuse befestigter erster Schaufeln, einen Deckel mit einem an dem ersten Gehäuse befestigten zweiten Gehäuse zum Bilden einer Hydraulikkammer und ein an dem zweiten Gehäuse befestigten Befestigungselement, das sich durch das erste Durchgangsloch erstreckt, und eine in der Hydraulikkammer angeordnete Turbine, die ein drittes Gehäuse und eine Vielzahl an dem zweiten Gehäuse befestigter zweiter Schaufeln enthält.",SCHAEFFLER TECHNOLOGIES AG,MOASHER MOHAMMAD;;RAMSEY JOHN;;HECK THOMAS;;ADLER CARL,,https://lens.org/187-986-187-969-60X,Patent Application,no,0,0,1,6,0,B60K6/48;;B60K6/26;;B60K6/387;;B60K6/40;;B60K6/405;;B60K6/50;;B60K2006/4825;;Y02T10/62,B60K6/40;;B60K6/26;;B60K6/387;;B60K6/405;;B60K6/50,,0,0,,,,PENDING
282,US,A1,US 2011/0234756 A1,044-798-850-632-971,2011-09-29,2011,US 73291810 A,2010-03-26,US 73291810 A,2010-03-26,DE-ALIASING DEPTH IMAGES,Techniques are provided for de-aliasing depth images. The depth image may have been generated based on phase differences between a transmitted and received modulated light beam. A method may include accessing a depth image that has a depth value for a plurality of locations in the depth image. Each location has one or more neighbor locations. Potential depth values are determined for each of the plurality of locations based on the depth value in the depth image for the location and potential aliasing in the depth image. A cost function is determined based on differences between the potential depth values of each location and its neighboring locations. Determining the cost function includes assigning a higher cost for greater differences in potential depth values between neighboring locations. The cost function is substantially minimized to select one of the potential depth values for each of the locations.,MICROSOFT CORP,ADLER AVISHAI;;KATZ SAGI;;GILBOA GUY;;TARDIF JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-03-25),https://lens.org/044-798-850-632-971,Patent Application,yes,99,40,4,4,0,G06T2207/10028;;G06T5/70;;G06T2207/10028;;G06T5/70,G06K9/00;;H04N13/02,348/46;;382/154;;382/275;;X348E13074,0,0,,,,INACTIVE
283,EP,A1,EP 0604621 A1,097-413-807-488-938,1994-07-06,1994,EP 93915214 A,1993-06-04,US 9305356 W;;US 90062292 A,1992-06-18,FOOTBALL WITH FINS THAT PROMOTE ROTATION IN FLIGHT.,"L'invention concerne un ballon ovale de football américain (10) présentant des ailerons externes (15a, 15b) montés sur les côtés opposés du ballon (10) et conçus pour favoriser la rotation de ce dernier sur son axe longitudinal (13). Chaque aileron (15a, 15b) est configuré comme un profil de voilure présentant une surface supérieure (20) et une surface inférieure (22), la surface supérieure (20) représentant la direction de la poussée. Chaque aileron (15a, 15b) est orienté de manière à former un angle d'inclinaison hélicoïdale d'au moins 15 degrés. Les bords d'attaque (17) et de fuite (18) des ailerons (15a, 15b) sont positionnés longitudinalement de façon que le centre net de la poussée aérodynamique de ces derniers (15a, 15b) soit situé à l'arrière du point central dudit ballon de football (10) afin de favoriser la stabilité en vol de celui-ci.",ADLER ALAN JOHN;;BOYLE BRENDAN J;;MANDELBAUM FERN,ADLER ALAN JOHN;;BOYLE BRENDAN J;;MANDELBAUM FERN,,https://lens.org/097-413-807-488-938,Patent Application,yes,0,0,6,6,0,A63B43/002;;A63B43/002;;A63B2243/007;;A63B2243/007;;Y10S273/20;;Y10S273/20,A63B43/00;;A63B43/02,,0,0,,,,DISCONTINUED
284,EP,A2,EP 0070387 A2,160-806-506-124-380,1983-01-26,1983,EP 82105020 A,1982-06-08,US 28375881 A,1981-07-16,"Method and apparatus for generating a noiseless sliding block code for a (1,7) channel with rate 2/3.",An encoder for producing a run length limited code useful in magnetic recording channels producing sequences which have a minimum of 1 zero and a maximum of 7 zeros between adjacent 1's. The code is generated by a sequential scheme that maps 2 bits of unconstrained data (s) into 3 bits of constrained date (y). The encoder comprises a fairly simple logic network (20) and is a finite state machine whose internal state description requires 3 bits (x). It possesses the attractive feature of certain reset data blocks which reset it to a fixed state. The error propagation due to a random error is 5 bits. The hardware implementation is extremely simple and can operate at very high data speeds.,IBM,ADLER ROY LEE;;HASSNER MARTIN;;MOUSSOURIS JOHN PETER,,https://lens.org/160-806-506-124-380,Patent Application,yes,0,19,7,7,0,G06T9/005;;G11B20/1426;;G06T9/005;;G11B20/1426,H03M7/14;;G06T9/00;;G11B20/14;;H04L25/49,,0,0,,,,EXPIRED
285,DE,A1,DE 102004045245 A1,161-493-194-325-846,2006-04-06,2006,DE 102004045245 A,2004-09-17,DE 102004045245 A,2004-09-17,Vorrichtung und Verfahren zur Herstellung von Silanen,"Die Erfindung betrifft eine Vorrichtung zur Herstellung von Silanen der allgemeinen Formel H¶n¶SiCl¶4-n¶ mit n = 1, 2, 3 und/oder 4 durch Dismutierung mindestens eines höher chlorierten Silans in Gegenwart eines Katalysators, die auf mindestens einer Destillationskolonne (1) mit einem Kolonnensumpf (1.1) und einem Kolonnenkopf (1.2), mindestens einem Seitenreaktor (2) mit Katalysatorbett (3), mindestens einer Eduktaufgabe (1.3), einer Produktentnahme (1.4) und mindestens einer weiteren Produktentnahme (1.5 bzw. 1.8) basiert, wobei die Destillationskolonne (1) mit mindestens einem Kaminboden (4) ausgestattet ist und mindestens ein Seitenreaktor (2) über mindestens drei Rohrleitungen (5, 6, 7) mit der Destillationskolonne (1) derart verbunden ist, dass der Übergang der Leitung (5) in die Destillationskolonne (1) für den Ablauf des Kondensats vom Kaminboden (4, 4.1) höher liegt als die Oberkante des Katalysatorbetts (3, 3.1 bzw. 3.2), die Leitung (6) für die Abführung der Flüssigphase aus dem Seitenreaktor (2) unterhalb des Kaminbodens (4) in die Destillationskolonne (1) einmündet (6.1) und diese Einmündung (6, 6.1) tiefer liegt als die Oberkante des Katalysatorbetts (3, 3.1 bzw. 3.2) sowie die Leitung (7) für die Abführung der Gasphase aus dem dazugehörigen Seitenreaktor (2) oberhalb der Ebene (4.1) des Kaminbodens (4) in die Destillationskolonne (1) mündet (7.1). DOLLAR A Ferner betrifft die vorliegende Erfindung ein Verfahren zur Herstellung besagter Silane in der ...",DEGUSSA,SONNENSCHEIN RAYMUND;;ADLER PETER;;POEPKEN TIM;;KAHSNITZ JOHN,"EVONIK DEGUSSA GMBH, 40474 DUESSELDORF, DE (2007-12-27);;DEGUSSA GMBH, 40474 DUESSELDORF, DE (2007-04-19)",https://lens.org/161-493-194-325-846,Patent Application,no,0,5,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,C01B33/04;;C01B33/107,,0,0,,,,INACTIVE
286,CN,B,CN 1774397 B,152-241-223-466-49X,2012-07-04,2012,CN 200580000298 A,2005-07-21,EP 2005053544 W;;DE 102004045245 A,2004-09-17,Apparatus and process for preparing silanes,"The invention relates to an apparatus, for preparing silanes of the general formula HnSiCl4-n where n = 1, 2, 3 and/or 4 by dismutation of at least one relatively highly chlorinated silane in the presence of a catalyst, which is based on at least one distillation column (1) having a column bottom (1.1) and a column top (1.2), at least one side reactor (2) with catalyst bed (3), at least one feed inlet (1.3), a product offtake (1.4) and at least one further product offtake (1.5 or 1.8), where the distillation column (1) is provided with at least one chimney tray (4) and at least one side reactor (2) is connected to the distillation column (1) via at least three pipes (5, 6, 7) in such a way that the connection point of the line (5) to the distillation column (1) for the discharge of the condensate from the chimney tray (4, 4.1) is at a higher level than the upper edge of the catalyst bed (3, 3.1 or 3.2), the line (6) for the discharge of the liquid phase from the side reactor (2) opens (6.1) into the distillation column (1) below the chimney tray (4) and this opening (6, 6.1) is at a lower level than the upper edge of the catalyst bed (3, 3.1 or 3.2) and the line (7) for the discharge of the gas phase from the associated side reactor (2) opens (7.1) into the distillation column (1) above the level (4.1) of the chimney tray (4). Furthermore, the present invention provides a process for preparing the silanes in the apparatus of the invention.",EVONIK DEGUSSA GMBH,JOHN KAHSNITZ;;RAYMUND SONNENSCHEIN;;TIM POEPKEN;;PETER ADLER,,https://lens.org/152-241-223-466-49X,Granted Patent,no,0,0,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,C01B33/04;;C01B33/107,,0,0,,,,ACTIVE
287,EP,A4,EP 0604621 A4,154-842-405-293-231,1994-12-07,1994,EP 93915214 A,1993-06-04,US 9305356 W;;US 90062292 A,1992-06-18,FOOTBALL WITH FINS THAT PROMOTE ROTATION IN FLIGHT.,,ADLER ALAN JOHN;;BOYLE BRENDAN J;;MANDELBAUM FERN,ADLER ALAN JOHN;;BOYLE BRENDAN J;;MANDELBAUM FERN,,https://lens.org/154-842-405-293-231,Search Report,no,4,0,6,6,0,A63B43/002;;A63B43/002;;A63B2243/007;;A63B2243/007;;Y10S273/20;;Y10S273/20,A63B43/00;;A63B43/02,,1,0,,,See also references of WO 9400202A1,DISCONTINUED
288,US,B2,US 8514269 B2,148-998-801-276-541,2013-08-20,2013,US 73291810 A,2010-03-26,US 73291810 A,2010-03-26,De-aliasing depth images,Techniques are provided for de-aliasing depth images. The depth image may have been generated based on phase differences between a transmitted and received modulated light beam. A method may include accessing a depth image that has a depth value for a plurality of locations in the depth image. Each location has one or more neighbor locations. Potential depth values are determined for each of the plurality of locations based on the depth value in the depth image for the location and potential aliasing in the depth image. A cost function is determined based on differences between the potential depth values of each location and its neighboring locations. Determining the cost function includes assigning a higher cost for greater differences in potential depth values between neighboring locations. The cost function is substantially minimized to select one of the potential depth values for each of the locations.,ADLER AVISHAI;;KATZ SAGI;;GILBOA GUY;;TARDIF JOHN;;MICROSOFT CORP,ADLER AVISHAI;;KATZ SAGI;;GILBOA GUY;;TARDIF JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-03-25),https://lens.org/148-998-801-276-541,Granted Patent,yes,103,10,4,4,0,G06T2207/10028;;G06T5/70;;G06T2207/10028;;G06T5/70,G06K9/00,348/46;;348/51;;353/28;;382/154,55,17,056-210-833-459-797;;083-238-685-765-998;;109-661-205-595-492;;072-397-402-810-250;;047-783-735-714-266;;042-138-195-222-637;;043-793-949-201-646;;153-065-582-428-985;;123-142-523-178-152;;058-694-806-455-404;;077-335-876-952-865;;029-078-551-513-551;;000-036-793-543-51X;;080-341-345-902-534;;103-170-105-553-522;;011-377-277-382-283;;050-768-644-354-392,10.1109/avss.2008.54;;10.1109/tcsvt.2007.909975;;10.1109/cvpr.2004.291;;10.1109/cvprw.2008.4563171;;10.1109/ictai.2007.115;;10.1109/cvprw.2008.4563165;;10.1109/icip.2007.4379992;;10.1109/5.899059;;10.1109/cvpr.1996.517074;;10.1109/16.628817;;10.1109/namw.1997.609859;;10.1007/bfb0053007;;10.1109/34.598236;;10.1109/afgr.2000.840627;;10.1109/34.598226;;10.1109/34.216730;;10.1145/319120.319127,"Chinese Voluntary Amendments dated Dec. 15, 2011, Chinese Patent Application No. 201110081374.7 filed Mar. 24, 2011, 9 pages.;;Partial English Translation of Chinese Voluntary Amendments dated Dec. 15, 2011, Chinese Patent Application No. 201110081374.7 filed Mar. 24, 2011, 5 pages.;;Shivappa, et al., ""Person Tracking With Audio-visual Cues Using the Iterative Decoding Framework,"" IEEE 5th International Conference on Advanced Video and Signal Based Surveillance, 2008, pp. 260-267.;;Toyama, et al., ""Probabilistic Tracking in a Metric Space,"" Eighth International Conference on Computer Vision, Vancouver, Canada, vol. 2, Jul. 2001, 8 pages.;;Stoykova, ""3-D Time-varying Scene Capture Technologies-a Survey"", IEEE Transactions on Circuits and Systems for Video Technology, Nov. 2007, vol. 17, No. 11, pp. 1568-1586.;;Gokturk, ""A Time-Of-Flight Depth Sensor-System Description, Issues and Solutions"", Conference on Computer Vision and Pattern Recognition Workshop, vol. 3, p. 35, Jun.-Jul. 2004, IEEE Computer Society, Washington, DC, USA.;;Schuon, ""High-Quality Scanning Using Time-Of-Flight Depth Superresolution"", IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops, Jun. 2008, Anchorage, AK, USA.;;Krumm, ""Local Spatial Frequency Analysis for Computer Vision"", Technical Report CMU-RI-TR-90-11, Robotics Institute,Carnegie Mellon University, May 1990.;;Parvizi, ""Real-time 3D Head Tracking Based on Time-of-flight Depth Sensor"", 19th IEEE International Conference on Tools with Artificial Intelligence, pp. 517-521, Oct. 2007, IEEE Computer Society, Washington, DC, USA.;;Gallo, ""Robust Curb and Ramp Detection for Safe Parking Using the Canesta TOF Camera"", IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops, Jun. 2008, Anchorage, AK, USA.;;Suresh, ""Super-Resolution Using Motion and Defocus Cues"", IEEE International Conference on Image Processing, Nov. 12, 2007, pp. IV-213-IV-216, San Antonio, TX, USA.;;Murino, ""Three-Dimensional Image Generation and Processing in Underwater Acoustic Vision"", Invited Paper, Proceedings of the IEEE, pp. 1903-1946, vol. 88, No. 12, Dec. 2000.;;Benko, ""Depth Touch: Using Depth-Sensing Camera to Enable , Freehand Interactions on and Above the Interactive Surface"", Technical Report, MSR-TR-2009-23, Mar. 2009, 8 pages.;;Kolmogorov, ""Comparison of Energy Minimization Algorithms for Highly Connected Graphs"", Proceedings of the European Conference in Computer Vision, Jun. 2006, Springer-Verlag.;;Szeliski, ""A Comparative Study of Energy Minimization Methods for Markov Random Fields"", Proceedings of the European Conference in Computer Vision, Jun. 2006, Springer-Verlag.;;Kanade et al., ""A Stereo Machine for Video-rate Dense Depth Mapping and Its New Applications"", IEEE Computer Society Conference on Computer Vision and Pattern Recognition, 1996, pp. 196-202,The Robotics Institute, Carnegie Mellon University, Pittsburgh, PA.;;Miyagawa et al., ""CCD-Based Range Finding Sensor"", Oct. 1997, pp. 1648-1652, vol. 44 No. 10, IEEE Transactions on Electron Devices.;;Rosenhahn et al., ""Automatic Human Model Generation"", 2005, pp. 41-48, University of Auckland (CITR), New Zealand.;;Aggarwal et al., ""Human Motion Analysis: A Review"", IEEE Nonrigid and Articulated Motion Workshop, 1997, University of Texas at Austin, Austin, TX.;;Shao et al., ""An Open System Architecture for a Multimedia and Multimodal User Interface"", Aug. 24, 1998, Japanese Society for Rehabilitation of Persons with Disabilities (JSRPD), Japan.;;Kohler, ""Special Topics of Gesture Recognition Applied in Intelligent Home Environments"", In Proceedings of the Gesture Workshop, 1998, pp. 285-296, Germany.;;Kohler, ""Vision Based Remote Control in Intelligent Home Environments"", University of Erlangen-Nuremberg/Germany, 1996, pp. 147-154, Germany.;;Kohler, ""Technical Details and Ergonomical Aspects of Gesture Recognition applied in Intelligent Home Environments"", 1997, Germany.;;Hasegawa et al., ""Human-Scale Haptic Interaction with a Reactive Virtual Human in a Real-Time Physics Simulator"", Jul. 2006, vol. 4, No. 3, Article 6C, ACM Computers in Entertainment, New York, NY.;;Qian et al., ""A Gesture-Driven Multimodal Interactive Dance System"", Jun. 2004, pp. 1579-1582, IEEE International Conference on Multimedia and Expo (ICME), Taipei, Taiwan.;;Zhao, ""Dressed Human Modeling, Detection, and Parts Localization"", 2001, The Robotics Institute, Carnegie Mellon University, Pittsburgh, PA.;;HE, ""Generation of Human Body Models"", Apr. 2005, University of Auckland, New Zealand.;;Isard et al., ""Condensation-Conditional Density Propagation for Visual Tracking"", 1998, pp. 5-28, International Journal of Computer Vision 29(1), Netherlands.;;Livingston, ""Vision-based Tracking with Dynamic Structured Light for Video See-through Augmented Reality"", 1998, University of North Carolina at Chapel Hill, North Carolina, USA.;;Wren et al., ""Pfinder: Real-Time Tracking of the Human Body"", MIT Media Laboratory Perceptual Computing Section Technical Report No. 353, Jul. 1997, vol. 19, No. 7, pp. 780-785, IEEE Transactions on Pattern Analysis and Machine Intelligence, Caimbridge, MA.;;Breen et al., ""Interactive Occlusion and Collusion of Real and Virtual Objects in Augmented Reality"", Technical Report ECRC-95-02, 1995, European Computer-Industry Research Center GmbH, Munich, Germany.;;Freeman et al., ""Television Control by Hand Gestures"", Dec. 1994, Mitsubishi Electric Research Laboratories, TR94-24, Caimbridge, MA.;;Hongo et al., ""Focus of Attention for Face and Hand Gesture Recognition Using Multiple Cameras"", Mar. 2000, pp. 156-161, 4th IEEE International Conference on Automatic Face and Gesture Recognition, Grenoble, France.;;Pavlovic et al., ""Visual Interpretation of Hand Gestures for Human-Computer Interaction: A Review"", Jul. 1997, pp. 677-695, vol. 19, No. 7, IEEE Transactions on Pattern Analysis and Machine Intelligence.;;Azarbayejani et al., ""Visually Controlled Graphics"", Jun. 1993, vo1.15, No. 6, IEEE Transactions on Pattern Analysis and Machine Intelligence.;;Granieri et al., ""Simulating Humans in VR"", The British Computer Society, Oct. 1994, Academic Press.;;Brogan et al., ""Dynamically Simulated Characters in Virtual Environments"", Sep./Oct. 1998, pp. 2-13, vol. 18, Issue 5, IEEE Computer Graphics and Applications.;;Fisher et al., ""Virtual Environment Display System"", ACM Workshop on Interactive 3D Graphics, Oct. 1986, Chapel Hill, NC.;;""Virtual High Anxiety"", Tech Update, Aug. 1995, pp. 22.;;Sheridan et al., ""Virtual Reality Check"", Technology Review, Oct. 1993, pp. 22-28, vol. 96, No. 7.;;Stevens, ""Flights into Virtual Reality Treating Real World Disorders"", The Washington Post, Mar. 27, 1995, Science Psychology, 2 pages.;;""Simulation and Training"", 1994, Division Incorporated.;;English Machine-translation of Japanese Publication No. JP08-044490 published on Feb. 16, 1996.;;Response to Chinese Office Action dated Dec. 3, 2012, Chinese Patent Application No. 201110081374.7, filed Mar. 24, 2011, 21 pages.;;Chinese Office Action dated Mar. 13, 2013, Chinese Applications No. 201110081374.7, filed Mar. 24, 2011, 9 pages.;;Partial English Translation of Chinese Office Action dated Mar. 13, 2013, Chinese Application No. 201110081374.7, filed Mar. 24, 2011, 3 pages.;;Chinese Office Action dated Nov. 5, 2012, Chinese Patent Application No. 201110081374.7, filed Mar. 24, 2011, 10 pages.;;Partial English Translation of Chinese Office Action dated Nov. 5, 2012, Chinese Patent Application No. 201110081374.7, filed Mar. 24, 2011, 3 pages.;;Response to Chinese Office Action dated Dec. 2, 2012, Chinese Patent Application No. 201110081374.7, filed Mar. 24, 2011, 12 pages.;;Partial English Translation of Response to Chinese Office Action dated Dec. 2, 2012, Chinese Patent Application No. 201110081374.7, filed Mar. 24, 2011, 6 pages.;;English Abstract of Foreign Patent Document CN 101556696, published Oct. 14, 2009, Univ Zhejiang.;;English Abstract of Foreign Patent Document CN 101605270, published Dec. 16, 2009, Univ Tsinghua.;;English Abstract of Foreign Patent Document CN 101640809, published Feb. 3, 2010, Univ Zhejiang.;;Response to Chinese Office Action dated May 7, 2013, Chinese Patent Application No. 201110081374.7 filed Mar. 24, 2011, 11 pages.;;English Summary and Claim Amendments of the Response to Chinese Office Action dated May 7, 2013, Chinese Patent Application No. 201110081374.7 filed Mar. 24, 2011, 6 pages.",INACTIVE
289,EP,B1,EP 0070387 B1,168-557-614-943-515,1987-09-09,1987,EP 82105020 A,1982-06-08,US 28375881 A,1981-07-16,"METHOD AND APPARATUS FOR GENERATING A NOISELESS SLIDING BLOCK CODE FOR A (1,7) CHANNEL WITH RATE 2/3",,INTERNATIONAL BUSINESS MACHINES CORPORATION,"ADLER, ROY LEE;;HASSNER, MARTIN;;MOUSSOURIS, JOHN PETER",,https://lens.org/168-557-614-943-515,Granted Patent,yes,0,0,7,7,0,G06T9/005;;G11B20/1426;;G06T9/005;;G11B20/1426,H03M7/14;;G06T9/00;;G11B20/14;;H04L25/49,,0,0,,,,EXPIRED
290,CN,B,CN 102538758 B,016-953-230-456-104,2015-04-01,2015,CN 201110428489 A,2011-12-19,US 97367110 A,2010-12-20,Plural detector time-of-flight depth mapping,,MICROSOFT CORP,KATZ SAGI;;ADLER AVISHAI;;YAHAV GIORA;;TARDIF JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2015-07-24),https://lens.org/016-953-230-456-104,Granted Patent,no,0,0,4,4,0,A63F2300/1087;;G01S17/87;;G01S17/894;;A63F13/213;;A63F2300/66;;A63F13/52;;A63F2300/1031;;A63F13/235;;A63F13/213;;A63F2300/1087;;G01S17/87;;G01S17/894,G01C11/00;;G01S17/894;;G01S17/87,,0,0,,,,ACTIVE
291,US,A,US 3627495 A,075-740-842-960-839,1971-12-14,1971,US 3627495D A,1970-05-25,US 4006370 A,1970-05-25,DECANTATION FITTING,,TECHNICON INSTR,ADLER STANFORD L JR;;PEOPLES JOHN C A,,https://lens.org/075-740-842-960-839,Granted Patent,no,0,3,1,1,0,G01N35/08;;G01N35/08,G01N35/08,B1D DPFA          DPFA,0,0,,,,EXPIRED
292,EP,A2,EP 0373863 A2,103-311-975-659-810,1990-06-20,1990,EP 89312931 A,1989-12-11,US 28265788 A,1988-12-12,Analytical test device.,"An analytical device (10) for the qualitative and/or quantitative determination of an analyte in a liquid test sample, comprises a base (12) supporting a porous member (16) which has an analyte-responsive substance therein, the substance being capable of undergoing a detectable response to the presence and/or concentration of analyte in the test sample. A cover (18) integral with the base (12) is provided with a reaction well (28) formed therein for storing a dried reaction component (34) and for receiving the liquid test sample to form (with the reaction component) a liquid reaction mixture therein. The reaction well has a passage (30) which is normally spaced from the porous member (16) and effectively closed to transfer therethrough of the reaction mixture, but which is movable towards the porous member effectively to open the passage to allow flow therethrough of the reaction mixture into the porous member (16). The analyte responsive substance in the porous member will undergo a detectable response to any analyte present in the liquid reaction mixture. The base can be provided with a suitable viewing port (54) to permit monitoring of the detectable response generated in the porous member.  ",TECHNICON INSTR,ADLER STANFORD L;;CAMPISI JOHN;;LEONG KOON-WAH,MILES INC.(AN INDIANA CORP.) (1992-05-06),https://lens.org/103-311-975-659-810,Patent Application,yes,0,4,13,13,0,G01N33/525;;G01N33/528;;Y10T436/255;;Y10T436/255;;G01N33/525;;G01N33/528,G01N31/22;;G01N21/78;;G01N33/52,,0,0,,,,EXPIRED
293,HK,A1,HK 1177922 A1,126-821-502-034-25X,2013-08-30,2013,HK 13104960 A,2013-04-24,IB 2011051033 W;;US 72848210 A,2010-03-22,CHILD RESISTANT BULK DOSE DISPENSING UNIT,,WYETH LLC,AT ARI TAO ADLER;;RJ ROBERT JOHN MCCAFFREY,,https://lens.org/126-821-502-034-25X,Patent Application,no,0,0,44,44,0,B65D50/046;;B65D43/20;;B65B69/00;;B65D50/046;;B65D50/04;;B65D43/20;;B65D45/00;;B65D50/046;;B65B69/00;;B65D43/20,B65D/,,0,0,,,,PENDING
294,US,B2,US 11511614 B2,159-413-116-797-667,2022-11-29,2022,US 202016743658 A,2020-01-15,US 202016743658 A;;US 201962859392 P,2019-06-10,Rotor carrier connection,"A rotor for a hybrid drivetrain includes a rotor carrier, at least one rotor segment, and a torque converter. The rotor carrier has a first tubular portion with an outer surface, and an annular portion with a first through hole. The at least one rotor segment is installed on the outer surface. The torque converter has an impeller with a first shell and a plurality of first blades fixed to the first shell, a cover with a second shell fixed to the first shell to form a hydraulic chamber and a fastener fixed to the second shell and extending through the first through hole, and a turbine disposed in the hydraulic chamber and including a third shell and a plurality of second blades fixed to the second shell.",SCHAEFFLER TECHNOLOGIES AG,MOASHER MOHAMMAD;;RAMSEY JOHN;;HECK THOMAS;;ADLER CARL,SCHAEFFLER TECHNOLOGIES AG & CO. KG (2019-09-23),https://lens.org/159-413-116-797-667,Granted Patent,yes,9,0,5,6,0,F16H41/04;;F16H41/24;;B60K17/02;;H02K7/006;;H02K5/203;;B60K2006/4825;;B60K6/387;;B60K6/405;;B60K6/48;;F16H45/02;;Y02T10/62;;B60K17/02;;B60K6/26;;B60K6/405;;B60K2006/4825;;B60Y2200/92;;B60Y2400/426;;H02K1/28;;H02K7/006,B60K17/02;;B60K6/26;;B60K6/405;;B60K6/48;;H02K1/28;;H02K7/00,,0,0,,,,ACTIVE
295,CN,A,CN 112065949 A,165-209-475-386-607,2020-12-11,2020,CN 202010517417 A,2020-06-09,US 201962859392 P;;US 202016743658 A,2019-06-10,P1 HYBRID MODULE,"The invention relates to rotor carrier connection. In particular, a rotor for a hybrid powertrain is provided, the rotor comprising a rotor carrier, at least one rotor section and a torque converter.The rotor carrier includes a first tubular portion having an outer surface and an annular portion having a first through hole. At least one rotor section is mounted on the outer surface. The torque converter includes: an impeller having a first housing and a plurality of first blades fixed to the first housing; a cover having a second housing fixed to the first housing to form a hydraulic chamberand a fastener fixed to the second housing and extending through the first through hole; and a turbine disposed in the hydraulic chamber and including a third housing and a plurality of second bladesfixed to the second housing.",SCHAEFFLER TECHNOLOGIES AG,MOASHER MOHAMMAD;;RAMSEY JOHN;;HECK THOMAS;;ADLER CARL,,https://lens.org/165-209-475-386-607,Patent Application,no,6,0,5,6,0,F16H41/04;;F16H41/24;;B60K17/02;;H02K7/006;;H02K5/203;;B60K2006/4825;;B60K6/387;;B60K6/405;;B60K6/48;;F16H45/02;;Y02T10/62;;B60K17/02;;B60K6/26;;B60K6/405;;B60K2006/4825;;B60Y2200/92;;B60Y2400/426;;H02K1/28;;H02K7/006,F16H41/04;;F16H41/24,,0,0,,,,PENDING
296,WO,A1,WO 2018/164877 A1,169-043-154-499-393,2018-09-13,2018,US 2018/0019863 W,2018-02-27,US 201715454042 A,2017-03-09,ADAPTIVE DIGITIZED CARDS,"A digitized card data structure is stored in association with a digital card environment. The digitized card data structure corresponds to a card issued to a card holder. The digitized card data structure has a component for providing output to the card holder. Under a first condition the component provides a first output and under a second condition, the component provides a second output different from the first output.",MASTERCARD INTERNATIONAL INC,TRYON KERRY;;BAKER JOHN;;ADLER GARY;;RAYNOR NIGEL,,https://lens.org/169-043-154-499-393,Patent Application,yes,1,0,3,3,0,G06Q20/3224;;G06Q20/405;;G06Q20/351;;G06Q20/36;;G06Q30/0226;;G06Q20/351;;G06Q20/36;;G06Q20/10;;G06Q20/24;;G06Q30/0226;;G06Q20/3224;;G06Q20/405,G06Q20/32;;G06Q20/34;;G06Q20/36;;G06Q20/40,,0,0,,,,PENDING
297,US,A,US 1906832 A,191-416-249-135-492,1933-05-02,1933,US 51808831 A,1931-02-25,US 51808831 A,1931-02-25,Vertical filing cabinet,,LYON METAL PRODUCTS INC,BALES JAMES E;;CHRISTENSEN CARL T;;JOHN HALLBERG;;ADLER JOHN B,,https://lens.org/191-416-249-135-492,Granted Patent,no,0,6,1,2,0,A47B2210/0043;;A47B2210/0059;;A47B2210/01;;A47B88/43;;A47B88/493;;A47B88/493;;A47B2210/0043;;A47B2210/01;;A47B2210/0059;;A47B88/43,A47B88/04;;A47B88/493,,0,0,,,,EXPIRED
298,US,A1,US 2018/0178042 A1,038-295-385-779-991,2018-06-28,2018,US 201815904095 A,2018-02-23,US 201815904095 A;;US 201615238472 A;;US 201414266090 A;;US 201213708076 A;;US 26134708 A;;US 98463607 P,2007-11-01,"RADIOSURGICAL NEUROMODULATION DEVICES, SYSTEMS, AND METHODS FOR TREATMENT OF BEHAVIORAL DISORDERS BY EXTERNAL APPLICATION OF IONIZING RADIATION","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;ADLER JR JOHN R,SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS III DOYLE JOHN,ADLER JR. JOHN R. M.D (2009-06-02);;SCHNEIDER M. BRET M.D (2009-06-02);;ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/038-295-385-779-991,Patent Application,yes,0,1,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,,0,0,,,,ACTIVE
299,US,B2,US 8747292 B2,172-284-008-581-490,2014-06-10,2014,US 201213708076 A,2012-12-07,US 201213708076 A;;US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical neuromodulation devices, systems, and methods for treatment of behavioral disorders by external application of ionizing radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;ADLER JR JOHN R,SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS III DOYLE JOHN,ADLER JR. JOHN R. M.D (2009-06-02);;SCHNEIDER M. BRET M.D (2009-06-02);;ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/172-284-008-581-490,Granted Patent,yes,8,4,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,600/1,10,6,105-163-612-129-619;;088-605-253-045-077;;025-580-865-305-112;;004-229-238-641-491;;016-423-074-261-904;;030-019-655-024-002,10.1016/s0166-4328(01)00364-3;;11718882;;2336467;;10.2307/3577608;;11229981;;10.1176/appi.ajp.158.3.405;;11584307;;10.1038/35094560;;7632622;;10.1016/0920-9964(94)00055-d;;15627591;;10.1016/j.neuroimage.2004.08.041,"Tracy AL, Jarrard LE, Davidson TL, The Hippocampus and Motivation Revisited: Appetite and Activity. Behavioral Brain Research 2001 127: 13-23.;;Pellmar TC, Schauer DA, and Zeman GH, Time- and Dose-Dependent Changes in Neuronal Activity Produced by X Radiation in Brain Slices. Radiation Research 1990; 122: 209-214.;;Pizzagali D, Pascual-Marqui, RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, and Davidson R J, Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis. American Journal of Psychiatry 2001 ; 158:405-415.;;Hyman SE and Malenka RC, Addiction and the Brain: The Neurobiology of Compulsion and Its Persistence. Nature Reviews: Neuroscience 2001; 2: 695-703.;;Kandel ER, Schwartz JH, and Jessell TM, Principles of Neural Science 4th Edition. New York: McGraw-Hill Companies Inc, 2000. 1002-1006.;;Lewine RRJ, Hudgins P, Brown F, Caudle J, Risch SC, Differences in Qualitative Brain Morphology Findings in Schizophrenia, Major Depression, Bipolar Disorder, and Normal Volunteers. Schizophrenia Research 1995; 15: 253-259.;;Maltby N, Tolin DF, Worhunsky P, O'Keefe TM, Kiehl KA, Dysfunctional Action Monitoring Hyperactivates Frontal-striatal Circuits in Obsessive-compulsive Disorder: an Event-related fMRI study. Neuroimage 2005; 24:495-503.;;Pellmar TC, Schauer DA, and Zeman GH, Time- and Dose- Dependent Changes in Neuronal Activity Produced by X Radiation in Brain Slices. Radiation Research 1990; 122: 209-214.;;Pizzagali D, Pascual-Marqui, RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, and Davidson RJ, Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis. American Journal of Psychiatry 2001; 158: 405-415.;;Tracy AL, Jarrard LE, Davidson TL, The Hippocampus and Motivation Revisited: Appetite and Activity. Behavioral Brain Research 2001; 127: 13-23.",ACTIVE
300,US,A1,US 2013/0184511 A1,054-521-145-023-32X,2013-07-18,2013,US 201213708076 A,2012-12-07,US 201213708076 A;;US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical Neuromodulation Devices, Systems, and Methods for Treatment of Behavioral Disorders by External Application of Ionizing Radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;ADLER JR JOHN R,SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS III DOYLE JOHN,ADLER JR. JOHN R. M.D (2009-06-02);;SCHNEIDER M. BRET M.D (2009-06-02);;ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/054-521-145-023-32X,Patent Application,yes,3,2,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,600/1,3,3,105-163-612-129-619;;088-605-253-045-077;;025-580-865-305-112,10.1016/s0166-4328(01)00364-3;;11718882;;2336467;;10.2307/3577608;;11229981;;10.1176/appi.ajp.158.3.405,"Tracy AL, Jarrard LE, Davidson TL, The Hippocampus and Motivation Revisited: Appetite and Activity. Behavioral Brain Research 2001 127: 13-23.;;Pellmar TC, Schauer DA, and Zeman GH, Time- and Dose-Dependent Changes in Neuronal Activity Produced by X Radiation in Brain Slices. Radiation Research 1990; 122: 209-214.;;Pizzagali D, PascuaI-Marqui, RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, and Davidson R J, Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis. American Journal of Psychiatry 2001 ; 158:405-415.",ACTIVE
301,US,A1,US 2014/0235920 A1,017-670-225-992-005,2014-08-21,2014,US 201414266090 A,2014-04-30,US 201414266090 A;;US 201213708076 A;;US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical Neuromodulation Devices, Systems, and Methods for Treatment of Behavioral Disorders by External Application of Ionizing Radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;BORCHERS III DOYLE JOHN;;ADLER JR JOHN R,SCHNEIDER M BRET;;BORCHERS III DOYLE JOHN;;ADLER JR JOHN R,ADLER JOHN R. JR (2009-06-02);;SCHNEIDER M. BRET (2009-06-02),https://lens.org/017-670-225-992-005,Patent Application,yes,1,2,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,600/1,2,2,025-580-865-305-112;;028-225-259-495-123,11229981;;10.1176/appi.ajp.158.3.405;;10.1007/978-3-7091-6117-3_4;;12379003,"Pizzagali D, PascuaI-Marqui, RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, and Davidson R J, Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis. American Journal of Psychiatry 2001 ; 158:405-415.;;Regis J, Bartolomei F, Hayashi M, and Chauvel P. Gamma Knife Surgery,a Neuromodulation Therapy in Epilepsy Surgery. Advances in Epilepsy Surgery and Radiosurgery: Acta Neurochirurgica Supplements Volume 84, 2002, pp 37-47.",DISCONTINUED
302,US,B2,US 10682529 B2,097-772-921-869-608,2020-06-16,2020,US 201815904095 A,2018-02-23,US 201815904095 A;;US 201615238472 A;;US 201414266090 A;;US 201213708076 A;;US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical neuromodulation devices, systems, and methods for treatment of behavioral disorders by external application of ionizing radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;ADLER JR JOHN R;;ZAP SURGICAL SYSTEMS INC,SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS III DOYLE JOHN,ADLER JR. JOHN R. M.D (2009-06-02);;SCHNEIDER M. BRET M.D (2009-06-02);;ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/097-772-921-869-608,Granted Patent,yes,14,0,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,,10,8,080-337-013-541-750;;028-225-259-495-123;;004-229-238-641-491;;016-423-074-261-904;;030-019-655-024-002;;088-605-253-045-077;;025-580-865-305-112;;105-163-612-129-619,11117846;;10.3171/jns.2000.93.6.1033;;10.1007/978-3-7091-6117-3_4;;12379003;;11584307;;10.1038/35094560;;7632622;;10.1016/0920-9964(94)00055-d;;15627591;;10.1016/j.neuroimage.2004.08.041;;2336467;;10.2307/3577608;;11229981;;10.1176/appi.ajp.158.3.405;;10.1016/s0166-4328(01)00364-3;;11718882,"Satoshi Maesawa, Douglas Kondziolka, C. Edward Dixon, Jeffrey Balzer, Wendy Fellows, L. Dade Lunsford. “Subnecrotic stereotactic radiosurgery controlling epilepsy produced by kainic acid injection in rats”. (2000) J Neurosurg 93: 1033-1040 (Year: 2000).;;Brain Stereotactic Radiosurgery—Mayo Clinic https://www.mayoclinic.org/tests-procedures/brain-stereotactic-radiosurgery/about/pac-20384679 Accessed Aug. 8, 2019 (Year: 2018).;;“Gamma Knife Surgery,a Neuromodulation Therapy in Epilepsy Surgery”, Advances in Epilepsy Surgery and Radiosurgery: Acta Neurochirurgica Supplements vol. 84, 2002, pp. 37-47.;;Hyman et al., “The Neurobiology of Compulsion and Its Persistence”, Nature Reviews:Neuroscience, vol. 2(10), Oct. 2001, pp. 695-703.;;Kandel et al., “Principles of Neural Science”, 4th Edition. New York: McGraw-Hili Companies Inc,, 2000, 1002-1006.;;Lewine et al., “Differences in Qualitative Brain Morphology Fidnings in Schizophrenia, Major Depression, Bipolar Disorder, and Normal Volunteers”, Schizophrenia Research, vol. 15, May 1995, pp. 253-259.;;Maltby et al., “Dysfunctional Action Monitoring Hyperactivates Frontal-striatal Circuits in Obsessive-compulsive Disorder: an Event-related fMRI study”, Neuroimage, vol. 24, Issue 2, Jan. 2005, pp. 495-503.;;Pellmar et al., “Time- and Dose-Dependent Changes in Neuronal ACtivity Produced by X Radiation in Brain Slices”, Radiation Research 122, 1990, 209-214.;;Pizzagali et al., “Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis”, American Journal of Psychiatry, vol. 158, No. 3, Mar. 2001, pp. 405-415.;;Tracy et al., “The Hippocampus and Motivation Revisited: Appetite and Activity”, Behavioral Brain Research 127, 2001, 13-23.",ACTIVE
303,US,A,US 1934397 A,000-237-458-969-688,1933-11-07,1933,US 57985031 A,1931-12-09,US 57985031 A;;US 51808831 A,1931-02-25,Latching mechanism,,LYON METAL PRODUCTS INC,BALES JAMES E;;CHRISTENSEN CARL T;;JOHN HALLBERG;;ADLER JOHN B,,https://lens.org/000-237-458-969-688,Granted Patent,no,0,15,1,2,0,A47B2210/0043;;A47B2210/0059;;A47B2210/01;;E05C1/10;;Y10T292/0997;;Y10T292/0997;;E05C1/10;;A47B2210/0043;;A47B2210/01;;A47B2210/0059,E05C1/10,,0,0,,,,EXPIRED
304,US,B2,US 9333318 B2,064-531-859-137-97X,2016-05-10,2016,US 201313860926 A,2013-04-11,US 201313860926 A;;US 201261623855 P;;US 201361775430 P,2012-04-13,Sleep apnea device,"A system for treating a patient suffering from obstructive sleep apnea may include a mask, a portable air flow generator configured to generate air flow at a relatively low flow rate, and a tube connecting the air flow generator and the mask such that air flow from the generator passes through an air flow generator valve on the mask. The mask may include a contact surface for forming a seal between the mask and the patient's face such that the mask surrounds the patient's nostrils, an expiration valve that opens during expiration, and an air flow generator valve that opens during inspiration. In some embodiments, the mask may further include an inspiration valve that opens during inspiration to allow air from outside the system to enter the mask.",FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;TRUSHEIM JOHN;;NOLTING JOHN;;CHEN EUGENE;;ADLER MARK,FRESCA MEDICAL INC (2013-10-07),https://lens.org/064-531-859-137-97X,Granted Patent,yes,106,14,3,63,0,A61M16/06;;A61M16/0683;;A61M16/0875;;A61M16/20;;A61M2016/0039;;A61M2016/0661;;A61M2205/8206;;A61M2209/088;;A61M2230/205;;A61M16/0833;;A61M16/0069;;A61M16/0688;;A61M16/0866;;A61M16/202;;A61M16/209;;A61M2205/42;;A61M16/0063;;A61M2205/0266;;A61M16/0605;;A61M16/205;;A61M16/024;;A61M16/0057;;A61M16/208;;A61M2205/42;;A61M16/0683;;A61M16/0875;;A61M16/20;;A61M2016/0039;;A61M2016/0661;;A61M2205/8206;;A61M2209/088;;A61M2230/205;;A61M16/0833;;A61M16/0069;;A61M16/0688;;A61M16/0866;;A61M16/202;;A61M16/209;;A61M16/06;;A61M16/0605;;A61M16/0063;;A61M2205/0266;;A61M16/205;;A61M16/024;;A61M16/0057;;A61M16/208,A61M16/06;;A61M16/00;;A61M16/08;;A61M16/20,,23,14,023-109-794-556-389;;042-128-006-798-241;;007-045-192-604-187;;122-010-198-411-561;;045-286-057-199-903;;061-402-023-432-338;;108-130-529-314-66X;;013-462-197-978-430;;112-851-198-167-275;;009-737-419-491-448;;007-858-906-781-774;;110-180-300-633-512;;002-949-493-297-985;;106-465-845-644-363,10.1152/jappl.1996.81.1.470;;8828699;;3530040;;10.1177/0310057x8601400304;;10.1097/00003246-197809000-00004;;363357;;333990;;10.1213/00000539-197709000-00006;;pmc2276743;;10.1093/sleep/31.3.429;;18363320;;11405527;;10.1183/09031936.01.17304670;;3514166;;10.1378/chest.89.4.517;;10.1016/s0954-6111(99)90007-0;;10464877;;2198134;;10.1378/chest.98.2.317;;10.1097/00000542-198110000-00013;;7027830;;10.1097/00003246-197707000-00010;;326485;;2187849;;10.1152/jappl.1990.68.3.1075;;20822;;10.1213/00000539-197709000-00007;;10.1097/00000542-197306000-00017;;4574882,"CPAP Systems and Accessories: Comfort Accuracy and High Flows. Vital Signs, Inc. General Electric Healthcare Company. 2009, 2 pages.;;Deegan, P., et al. Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. Journal of Applied Physiol. Jul. 1996; 81(1): 470-9.;;Duncan, A., et al. PEEP and CPAP. Anaesth Intensive Care. Aug. 1986; 14(3): 236-50.;;Garrard, C., et al. The effects of expiratory positive airway pressure on functional residual capacity in normal subjects. Crit Care Med. Sep.-Oct. 1978; 6(5): 320-2.;;Gillick, JS. Spontaneous positive end-expiratory pressure (sPEEP). Anesthesia & Analgesia. Sep.-Oct. 1977; 56(5): 627-32. PubMed PMID: 333990.;;Heinzer R, et al. Effect of expiratory positive airway pressure on sleep disordered breathing. Sleep. Mar. 2008; 31(3): 429-32.;;Juhasz, J. et al. Proportional positive airway pressure: a new concept to treat obstructive sleep apnoea. European Respiratory Journal. 2001; 17: 467-473.;;Layon, J., et al. Continuous positive airway pressure and expiratory positive airway pressure increase functional residual capacity equivalently. Chest. Apr. 1986;89(4):517-21.;;Resta, O., et al. The role of the expiratory phase in obstructive sleep apnoea. Respir Med. Mar. 1999;93(3):190-5.;;Sanders, M., et al. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications. Chest. Aug. 1990; 98(2): 317-24.;;Schlobohm, R., et al. Lung volumes, mechanics, and oxygenation during spontaneous positive-pressure ventilation: the advantage of CPAP over EPAP. Anesthesiology. Oct. 1981;55(4):416-22.;;Schmidt, G., et al. EPAP without intubation. Crit Care Med. Jul.-Aug. 1977; 5(4): 207-9.;;Series, F., et al. Changes in upper airway resistance with lung inflation and positive airway pressure. American Physiological Society. Mar. 1990; 68(3): 1075-1079.;;Sturgeon, C. Jr, et al. PEEP and CPAP: cardiopulmonary effects during spontaneous ventilation. Anesth Analg. Sep.-Oct. 1977; 56(5):633-41. PubMed PMID: 20822.;;Tummons, J. A positive end-expiratory pressure-nasal-assist device (PEEP-NAD) for treatment of respiratory distress syndrome. Anesthesiology. Jun. 1973; 38(6):592-5.;;U.S. Appl. No. 29/448,107, filed Mar. 8, 2013, Gordon et al.;;U.S. Appl. No. 29/461,138, filed Jul. 18, 2013, Chen et al.;;U.S. Appl. No. 29/461,144, filed Jul. 18, 2013, Chen et al.;;U.S. Appl. No. 29/461,143, filed Jul. 18, 2013, Chen et al.;;U.S. Appl. No. 29/464,533, filed Aug. 16, 2013, Chen et al.;;U.S. Appl. No. 29/465,007, filed Aug. 22, 2013, Chen et al.;;Search Report and Written Opinion issued in PCT/US13/36246 mailed Sep. 6, 2013.;;International Search Report issued Nov. 18, 2014 in PCT/US2014/038215 (6 pages).",ACTIVE
305,US,A,US 5367561 A,043-593-054-017-366,1994-11-22,1994,US 83297892 A,1992-02-10,US 83297892 A,1992-02-10,Cash access system and method of operation,"A cash access system is provided for disbursing funds to consumers, such as the guest of a hotel, according to instructions of the consumer. The system comprises circuitry for receiving instructions associated with the request from a selected one of a plurality of input terminals, for validating the request with the relevant authority, for instructing the management associated with the input terminals to disburse the funds to the consumer and for billing the consumer for the withdrawal.",FIRST CITY TEXAS DALLAS,ADLER B MICHAEL;;HIRD JOHN A;;OWEN LINDSEY D,INTELLICALL INC (1994-08-09);;NOMURA HOLDING AMERICA INC (1994-08-11);;FIRST INTERSTATE BANK OF TEXAS N.A. A NATIONAL BANKING ASSOCIATION AS SUCCESSOR AGENT FOR THE LENDERS UNDER THE AGENCY AGREEMENT (1993-08-30);;FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR NEW FIRST CITY TEXAS-DALLAS N.A. AS AGENT FOR THE LENDERS UNDER THE AGENCY AGREEMENT (1993-08-23);;INTELLICALL INC. A DE CORPORATION (1992-02-04);;FIRST CITY TEXAS-DALLAS (1992-07-29),https://lens.org/043-593-054-017-366,Granted Patent,yes,11,49,1,1,0,G06Q20/108;;G06Q30/04;;G07F19/20;;G07F19/202;;G06Q30/04;;G06Q20/108;;G07F19/20;;G07F19/202,G06Q20/10;;G06Q30/04;;G07F19/00,379/93;;379/91;;379/97;;364/405;;364/408,0,0,,,,EXPIRED
306,EP,A1,EP 0143343 A1,007-737-822-378-282,1985-06-05,1985,EP 84112938 A,1984-10-26,US 54654283 A,1983-10-28,Wear and corrosion resistant coatings and method for producing the same.,"A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 6.5 to about 9.0 weight percent cobalt, from about 2.0 to about 4.0 weight percent chromium, from about 3.0 to about 4.0 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE,,https://lens.org/007-737-822-378-282,Patent Application,yes,4,4,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
307,BR,A,BR PI0515468 A,053-019-163-914-791,2008-07-22,2008,BR PI0515468 A,2005-07-21,DE 102004045245 A;;EP 2005053544 W,2004-09-17,processo e aparelho para preparação de silanos,"PROCESSO E APARELHO PARA PREPARAçãO DE SILANOS. A presente invenção refere-se a um aparelho para preparação de silanos da fórmula geral fórmula geral H~ n~SiCI~ 4-n~ onde n = 1, 2, 3 e/ou 4 por desmutação de pelo menos um silano relativa e altamente clorado na presença de um catalisador, que tem como base pelo menos uma coluna de destilação (1) possuindo uma parte inferior de coluna (1.1) e uma parte superior de coluna (1.2), pelo menos um reator lateral (2) com um leito de catalisador (3), pelo menos uma entrada de alimentação (1.3), uma saída de produto (1.4) e pelo menos uma saída de produto adicional (1.5 ou 1.8), onde a coluna de destilação (1) é provida com pelo menos uma bandeja de chaminé (4) e pelo menos um reator lateral (2) é conectado à coluna de destilação (1) através de pelo menos três tubos (5, 6, 7) de tal modo que o ponto de conexão da tubulação (5) à coluna de destilação (1) para a descarga do condensado da bandeja de chaminé (4, 4.1) está em um nível mais alto que a borda superior do leito de catalisador (3, 3.1 ou 3.2), a tubulação (6) para a descarga da fase líquida do reator lateral (2) se abre (6.1) para dentro da coluna de destilação (1) abaixo da bandeja de chaminé (4) e essa abertura (6, 6.1) está a um nível inferior em relação à borda superior do leito de cata- lisador (3, 3.1 ou 3.2) e a tubulação (7) para a descarga da fase gasosa do reator lateral associado (2) se abre (7.1) para a coluna de destilação (1) acima do nível (4.1) da bandeja de chaminé (4). Adicionalmente, a presente invenção provê um processo para preparação dos silanos no aparelho da invenção.",DEGUSSA,SONNENSCHEIN RAYMUND;;ADLER PETER;;PKEN TIM P;;KAHSNITZ JOHN,,https://lens.org/053-019-163-914-791,Patent Application,no,0,0,17,17,0,B01D3/00;;B01D3/009;;B01D3/009;;B01J8/02;;B01J8/025;;B01J8/025;;C01B33/107;;C01B33/107;;C01B33/107;;C01B33/04;;C01B33/1071;;C01B33/1071;;C01B33/10773;;C01B33/10773;;Y02P20/10;;Y02P20/10;;Y10S203/06;;Y10S203/06,B01D3/00;;B01J8/02;;C01B33/107,,0,0,,,,DISCONTINUED
308,US,B2,US 11330982 B2,199-623-601-906-464,2022-05-17,2022,US 202016843970 A,2020-04-09,US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,Systems and methods for real-time target validation for image-guided radiation therapy,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/199-623-601-906-464,Granted Patent,yes,29,1,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,G06K9/00;;A61B5/00;;A61B6/00;;A61B6/02;;A61B6/12;;A61N5/10,,5,5,012-667-555-559-504;;034-891-604-485-05X;;062-298-666-510-335;;014-120-520-883-13X;;013-110-619-366-76X,21452713;;10.1118/1.3539725;;10.1117/1.3080134;;19256707;;10.1016/0360-3016(95)02082-9;;7493831;;10.21236/ada497867;;10.1002/mrm.21391;;17969013,"Hissoiny et al. “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, Physics. med-ph, Jan. 6, 2011.;;Lo et al. “Hardware acceleration of a Monte Carlo simulation for photodynamic therapy treatment planning”, Journal of Biomedical Optics, Jan./Feb. 2009, vol. 14(1).;;Dong et al “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, pp. 1053-1060, 1995.;;Osher et al. Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising, 2008.;;Lustig, Michael, David Donoho, and John M. Pauly, “Sparse MRI: The application of compresses sensing for rapid MR imaging”, Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, 58.6 (2007): (Year:2007).",ACTIVE
309,US,B2,US 10674915 B2,056-764-242-792-082,2020-06-09,2020,US 201615066050 A,2016-03-10,US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,Systems and methods for real-time target validation for image-guided radiation therapy,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/056-764-242-792-082,Granted Patent,yes,29,0,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,G06K9/00;;A61B5/00;;A61B6/00;;A61B6/02;;A61B6/12;;A61N5/10,,5,5,013-110-619-366-76X;;012-667-555-559-504;;034-891-604-485-05X;;062-298-666-510-335;;014-120-520-883-13X,10.1002/mrm.21391;;17969013;;21452713;;10.1118/1.3539725;;10.1117/1.3080134;;19256707;;10.1016/0360-3016(95)02082-9;;7493831;;10.21236/ada497867,"Lustig, Michael, David Donoho, and John M. Pauly. “Sparse MRI: The application of compressed sensing for rapid MR imaging.” Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine 58.6 (2007): (Year: 2007).;;Hissoiny et al. “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, Physics. med-ph, Jan. 6, 2011.;;Lo et al. “Hardware acceleration of a Monte Carlo simulation for photodynamic therapy treatment planning”, Journal of Biomedical Optics, Jan./Feb. 2009, vol. 14(1).;;Dong et al “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, pp. 1053-1060, 1995.;;Osher et al. (Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising, 2008).",ACTIVE
310,HK,A,HK 35888 A,131-256-321-522-969,1988-05-20,1988,HK 35888 A,1988-05-12,US 54654283 A,1983-10-28,WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE,,https://lens.org/131-256-321-522-969,Granted Patent,no,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
311,KR,B1,KR 890005129 B1,169-132-011-244-531,1989-12-11,1989,KR 840006699 A,1984-10-27,US 54654283 A,1983-10-28,WEAR AND CORROSION RESISTANT COATINGS AND ARTICLES AND METHOD FOR PRODUCING THE SAME,,UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETS JEAN M,,https://lens.org/169-132-011-244-531,Granted Patent,no,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
312,IN,B,IN 167503 B,125-069-903-485-757,1990-11-10,1990,IN 835DE1984 A,1984-10-27,US 54654283 A,1983-10-28,AN UNSINTERED POWDERED COATING COMPOSITION FOR APPLYING A WEAR AND CORROSION RESISTANT COATING TO A SUBSTRATE,,UNION CARBIDE CORP,JECKSON JOHN ERIC;;ADLER THOMES ALLEN;;QUETS JEAN MARIE,,https://lens.org/125-069-903-485-757,Granted Patent,no,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
313,US,A,US 5351006 A,181-715-584-111-540,1994-09-27,1994,US 13514393 A,1993-10-12,US 13514393 A;;US 83417892 A,1992-02-07,Method and apparatus for correcting spatial distortion in magnetic resonance images due to magnetic field inhomogeneity including inhomogeneity due to susceptibility variations,"An in-vivo correction method for the non-linear, shape dependent spatial distortion in MR images due to magnetic field inhomogeneity including inhomogeneity due to susceptibility variations is disclosed. Geometric distortion at the air/tissue and tissue/bone interfaces before and after the correction is quantified using a phantom. The results are also compared to the ""distortion-free"" CT images of the same phantom. Magnetic susceptibility of cortical cattle bone was measured using a SQUID magnetometer and found to be -8.86 ppm which is quite similar to that of tissue (-9 ppm). The distortion at the bone/tissue boundary was negligible while that at the air/tissue boundary created displacements of about 2.0 mm with a1.5T main magnetic field and a 3.13 mT/m gradient field, a significant value if MR images are used to localize targets with the high accuracy expected for stereotaxic surgery. The correction method reduces the errors to at least the same level of accuracy as CT.",UNIV LELAND STANFORD JUNIOR,SUMANAWEERA THILAKA S;;GLOVER GARY H;;ADLER JOHN R,,https://lens.org/181-715-584-111-540,Granted Patent,yes,2,49,1,1,0,G01R33/56527;;G01R33/56563;;A61B90/10;;G01R33/56563;;G01R33/56527;;A61B90/10,A61B19/00;;G01R33/565,324/309;;324/307,3,1,071-659-514-898-227,10.1118/1.596162;;3352554,"Geometrical Image Transformation to Compensate for MRI Distortions by Chang et al. SPIE vol. 1233 Med. Imaging IV (1990) (month of pub. unknown).;;Total Inhomogeneity Correction Including Chem. Shifts and Susceptibility by View Angle Tilting Med. Physics vol. 15 No. 1 Jan. 1988, Cho, Z. H. et al.;;MR Susceptibility Distortion Quantification and Correction for Steroetaoxy by Sunumaweera et al. Proc. SPIE/SPSE Feb. 9 14, 1992.",EXPIRED
314,US,A,US 4626477 A,162-799-409-260-17X,1986-12-02,1986,US 83132586 A,1986-02-20,US 83132586 A;;US 54654283 A,1983-10-28,Wear and corrosion resistant coatings and method for producing the same,"A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 6.5 to about 9.0 weight percent cobalt, from about 2.0 to about 4.0 weight percent chromium, from about 3.0 to about 4.0 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETS JEAN M,PRAXAIR S.T. TECHNOLOGY INC (1990-01-02);;UNION CARBIDE CORPORATION A CORP. OF NEW YORK (1986-02-17),https://lens.org/162-799-409-260-17X,Granted Patent,yes,6,22,1,32,0,C22C29/08;;C22C29/08;;C23C4/067;;C23C4/067;;Y10T428/31678;;Y10T428/31678;;Y10T442/2148;;Y10T442/2148;;Y10T442/273;;Y10T442/273,C22C29/08;;C23C4/06,428/457;;106/1.05;;420/431;;427/34;;427/422;;427/427;;427/436;;428/244;;428/472;;428/698;;428/699,0,0,,,,EXPIRED
315,US,A1,US 2024/0041326 A1,179-791-164-367-921,2024-02-08,2024,US 202318381403 A,2023-10-18,US 202318381403 A;;US 202318108713 A;;US 202217707290 A;;US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,SYSTEMS AND METHODS FOR REAL-TIME TARGET VALIDATION FOR IMAGE-GUIDED RADIATION THERAPY,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/179-791-164-367-921,Patent Application,yes,0,0,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00;;A61B6/00;;A61B6/12;;A61N5/10,,0,0,,,,PENDING
316,CA,A,CA 999263 A,036-361-658-212-596,1976-11-02,1976,CA 156260 A,1972-11-09,US 23257672 A,1972-03-07,GAS DISPENSING DEVICE,,NEW ENGLAND NUCLEAR CORP AN IN,ADLER NORMAN;;MORGENTHAU JOHN L JR;;GOLD PAUL A,,https://lens.org/036-361-658-212-596,Granted Patent,no,0,1,2,2,0,A61M5/00;;A61M5/00,A61M5/00;;B67B7/48,222-31,0,0,,,,EXPIRED
317,US,A1,US 2020/0237226 A1,103-851-576-223-419,2020-07-30,2020,US 202016843970 A,2020-04-09,US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,SYSTEMS AND METHODS FOR REAL-TIME TARGET VALIDATION FOR IMAGE-GUIDED RADIATION THERAPY,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/103-851-576-223-419,Patent Application,yes,0,2,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00;;A61B6/00;;A61B6/12;;A61N5/10,,0,0,,,,ACTIVE
318,US,B2,US 11819308 B2,123-008-714-962-102,2023-11-21,2023,US 202318108713 A,2023-02-13,US 202318108713 A;;US 202217707290 A;;US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,Systems and methods for real-time target validation for image-guided radiation therapy,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/123-008-714-962-102,Granted Patent,yes,29,0,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00;;A61B6/00;;A61B6/02;;A61B6/12;;A61N5/10,,5,5,012-667-555-559-504;;034-891-604-485-05X;;062-298-666-510-335;;014-120-520-883-13X;;013-110-619-366-76X,21452713;;10.1118/1.3539725;;10.1117/1.3080134;;19256707;;10.1016/0360-3016(95)02082-9;;7493831;;10.21236/ada497867;;10.1002/mrm.21391;;17969013,"Hissoiny et al. “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, Physics. med-ph, Jan. 6, 2011.;;Lo et al. “Hardware acceleration of a Monte Carlo simulation for photodynamic therapy treatment planning”, Journal of Biomedical Optics, Jan./Feb. 2009, vol. 14(1).;;Dong et al “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, pp. 1053-1060, 1995.;;Osher et al. (Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising, 2008).;;Lustig, Michael, David Donoho, and John M. Pauly, “Sparse MRI: The application of compresses sensing for rapid MR imaging”, Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, 58.6 (2007): (Year:2007).",ACTIVE
319,DE,D1,DE 3466251 D1,138-612-888-810-729,1987-10-22,1987,DE 3466251 T,1984-10-26,US 54654283 A,1983-10-28,WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE,,https://lens.org/138-612-888-810-729,Granted Patent,no,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
320,US,A1,US 2013/0188856 A1,007-078-886-152-85X,2013-07-25,2013,US 201213691502 A,2012-11-30,US 201213691502 A;;US 201161565900 P,2011-12-01,SYSTEMS AND METHODS FOR REAL-TIME TARGET VALIDATION FOR IMAGE-GUIDED RADIATION THERAPY,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC;;VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/007-078-886-152-85X,Patent Application,yes,10,78,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00,382/132,1,1,014-120-520-883-13X,10.21236/ada497867,"Osher et al (""Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising"", 2008).",ACTIVE
321,WO,A1,WO 2019/036228 A1,164-669-071-079-273,2019-02-21,2019,US 2018/0045573 W,2018-08-07,US 201762546212 P,2017-08-16,SORBENTS COMPRISING ACTIVATED CARBON AND AMMONIUM PHOSPHATES,"Disclosed herein are particulate sorbents, such as sorbents that can be used for mercury removal applications. The sorbent can comprise at least one ammonium phosphate and at least one activated carbon selected from unhalogenated activated carbon and halogenated activated carbon, wherein the halogenated activated carbon contains at least one halogen impregnant on its surface. Also disclosed are methods of making sorbents, and methods of mercury removal, e.g., from flue gas generated by coal combustion.",CABOT CORP,ADLER GERALD D;;SATTERFIELD JOHN M;;KOEHLERT KENNETH C,,https://lens.org/164-669-071-079-273,Patent Application,yes,5,0,4,4,0,B01J20/0259;;B01J20/20;;B01D53/02;;B01D53/02;;B01D53/508;;B01D53/64;;B01D53/64;;B01D53/81;;B01D2251/108;;B01D2251/206;;B01D2251/206;;B01D2251/61;;B01D2251/61;;B01D2253/102;;B01D2253/102;;B01D2253/25;;B01D2253/25;;B01D2257/302;;B01D2257/602;;B01D2257/602;;B01D2258/0283;;B01J20/0292;;B01J20/0292;;B01J20/046;;B01J20/20;;B01J20/28004;;B01J20/28016;;B01J20/3021;;B01J20/3204;;B01J20/3234;;F23J15/003;;F23J15/003;;F23J2215/60;;F23J2215/60,B01J20/04;;B01J20/02;;B01J20/20;;B01J20/30;;B01J20/32,,0,0,,,,PENDING
322,US,A1,US 2016/0342720 A1,029-569-017-267-019,2016-11-24,2016,US 201615158801 A,2016-05-19,US 201615158801 A;;US 201562165544 P,2015-05-22,"METHOD, SYSTEM, AND COMPUTER PROGRAM FOR IDENTIFYING DESIGN REVISIONS IN HARDWARE DESIGN DEBUGGING","The present invention provides a method, system and computer program for ranking suspect components in a hardware design that fails verification, based on their likelihood of being actual error sources, and identifying design revisions or branches that are likely to contain actual error sources. The method is implemented as a suspect and revision ranking engine. The ranking engine involves the input of an engineer to provide an initial set of suspects or it can use the application of at least one automated debugging tool for each failure exposed by verification, and collects suspect sets returned by these tools. These tools can be based on simulation, path tracing, ATPG, BDDs, SAT, and QBF techniques. The engine applies either an analytical or statistical process on the suspects that are collected, to identify suspect components that are likely responsible for a large number of design failures. The process to rank suspect components can use various analytical or statistical techniques, such as cluster analysis, branch-and-bound, classification, and counting methods. The engine also involves the use of a parser to collect information from design revisions or branches and revision metadata. The information that is collected from the parser program is used by either a statistical or analytical system to classify which revisions or branches are likely to contain actual error sources. The above system can be implemented by using techniques, such as Support Vector Machines, logistic regression, the perceptron algorithm, and dictionary-based search. The engine finally involves a method to match ranked revisions or branches to ranked suspects. This process further refines the ranks of revisions or branches and outputs ranked lists of suspects and ranked lists of revisions or branches for further analysis by the engineer(s).",VENERIS ANDREAS;;POULOS ZISIS PARASKEVAS;;MAKSIMOVIC DJORDJE;;ADLER JOHN,VENERIS ANDREAS;;POULOS ZISIS PARASKEVAS;;MAKSIMOVIC DJORDJE;;ADLER JOHN,VENNSA TECHNOLOGIES INC (2016-05-18),https://lens.org/029-569-017-267-019,Patent Application,yes,5,11,1,1,0,G06F30/3323;;G06F30/30;;G06F30/20;;G06F2111/10;;G06F30/3308,G06F17/50,,0,0,,,,DISCONTINUED
323,US,A1,US 2004/0208025 A1,181-559-908-166-782,2004-10-21,2004,US 35720003 A,2003-02-04,US 35720003 A,2003-02-04,Loosely coupled parallel resonant converter,"
   A new power supply topology is described consisting of an input h-bridge or half-h-bridge, a coupling coefficient transformer such as an air core transformer, a secondary resonant and a voltage multiplier which includes a series output capacitance. The topology is advantageous for high voltages since the reduced coupling leads to large spacings reduced insulation requirements. 
",ADLER RICHARD JOHN;;ASHCRAFT BRUCE;;RICHTER-SAND ROBERT J.,ADLER RICHARD JOHN;;ASHCRAFT BRUCE;;RICHTER-SAND ROBERT J,APPLIED ENERGETICS INC (2008-02-13);;NORTH STAR RESEARCH CORP (2003-01-30);;NORTH STAR POWER ENGINEERING INC (2005-02-04);;NORTH STAR RESEARCH CORPORATION (2005-01-21),https://lens.org/181-559-908-166-782,Patent Application,yes,5,1,2,2,0,Y02B70/10;;H02M3/33573;;H02M3/01;;Y02B70/10;;H02M3/33573;;H02M3/01,H02M3/337,363/21.01,0,0,,,,EXPIRED
324,US,A,US 5154778 A,129-667-590-243-305,1992-10-13,1992,US 58331390 A,1990-09-17,US 58331390 A,1990-09-17,Lithium loss suppression in alloys using hydrogen atmosphere,"The invention utilizes a hydrogen atmosphere during the heat treatment of an Al-Li alloy. The presence of such a reducing atmosphere prevents the reaction of surface lithium atoms with atmosphere components that would cause a diffusion and subsequent depletion of lithium atoms in the region near the surface. As a result, the present invention suppresses lithium loss and consequently prevents the formation of agglomerated lithium atom vacancies which would otherwise develop into microscopic metallic porosity. The prevention of such a condition maintains high fatigue resistance and corrosion resistance in association with metallic strength.",GRUMMAN AEROSPACE CORP,PAPAZIAN JOHN M;;SCHULTE ROBERT L;;ADLER PHILIP N,GRUMMAN AEROSPACE CORPORATION (1990-08-10),https://lens.org/129-667-590-243-305,Granted Patent,yes,2,2,1,1,0,C22F1/02;;C22F1/02,C22F1/02,148/703,0,0,,,,EXPIRED
325,AU,B2,AU 564804 B2,154-314-202-216-261,1987-08-27,1987,AU 1984/034731 A,1984-10-26,US 54654283 A,1983-10-28,WEAR RESISTANT COATINGS OF W-CD-CRJC 0,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE,,https://lens.org/154-314-202-216-261,Granted Patent,no,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
326,IN,B,IN 167209 B,082-030-410-033-852,1990-09-22,1990,IN 624DE1987 A,1987-07-22,IN 624DE1987 A;;IN 835DE1984 A;;US 54654283 A,1983-10-28,A PROCESS FOR PREPARING A COATING CORPORATION,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE,,https://lens.org/082-030-410-033-852,Granted Patent,no,0,0,1,32,0,,C23C4/06,,0,0,,,,EXPIRED
327,EP,A1,EP 3668639 A1,096-716-180-823-174,2020-06-24,2020,EP 18759514 A,2018-08-07,US 201762546212 P;;US 2018/0045573 W,2017-08-16,SORBENTS COMPRISING ACTIVATED CARBON AND AMMONIUM PHOSPHATES,,CABOT CORP,ADLER GERALD D;;SATTERFIELD JOHN M;;KOEHLERT KENNETH C,,https://lens.org/096-716-180-823-174,Patent Application,yes,0,0,4,4,0,B01J20/0259;;B01J20/20;;B01D53/02;;B01D53/02;;B01D53/508;;B01D53/64;;B01D53/64;;B01D53/81;;B01D2251/108;;B01D2251/206;;B01D2251/206;;B01D2251/61;;B01D2251/61;;B01D2253/102;;B01D2253/102;;B01D2253/25;;B01D2253/25;;B01D2257/302;;B01D2257/602;;B01D2257/602;;B01D2258/0283;;B01J20/0292;;B01J20/0292;;B01J20/046;;B01J20/20;;B01J20/28004;;B01J20/28016;;B01J20/3021;;B01J20/3204;;B01J20/3234;;F23J15/003;;F23J15/003;;F23J2215/60;;F23J2215/60,B01J20/04;;B01J20/02;;B01J20/20;;B01J20/30;;B01J20/32,,1,0,,,See references of WO 2019036228A1,DISCONTINUED
328,US,A1,US 2016/0184608 A1,035-654-678-116-537,2016-06-30,2016,US 201615066050 A,2016-03-10,US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,SYSTEMS AND METHODS FOR REAL-TIME TARGET VALIDATION FOR IMAGE-GUIDED RADIATION THERAPY,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/035-654-678-116-537,Patent Application,yes,17,3,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61N5/10,,0,0,,,,ACTIVE
329,CA,A1,CA 3072896 A1,049-856-900-213-391,2019-02-21,2019,CA 3072896 A,2018-08-07,US 201762546212 P;;US 2018/0045573 W,2017-08-16,SORBENTS COMPRISING ACTIVATED CARBON AND AMMONIUM PHOSPHATES,"Disclosed herein are particulate sorbents, such as sorbents that can be used for mercury removal applications. The sorbent can comprise at least one ammonium phosphate and at least one activated carbon selected from unhalogenated activated carbon and halogenated activated carbon, wherein the halogenated activated carbon contains at least one halogen impregnant on its surface. Also disclosed are methods of making sorbents, and methods of mercury removal, e.g., from flue gas generated by coal combustion.",CABOT CORP,ADLER GERALD D;;SATTERFIELD JOHN M;;KOEHLERT KENNETH C,,https://lens.org/049-856-900-213-391,Patent Application,no,0,0,4,4,0,B01J20/046;;B01J20/20;;B01J20/3021;;B01J20/3204;;B01J20/3234;;B01J20/0292;;B01D53/02;;B01D53/64;;B01D2251/108;;B01D2251/206;;B01D2251/61;;B01D2253/102;;B01D2253/25;;B01D2257/602;;B01D2258/0283;;F23J15/003;;F23J2215/60;;B01D53/02;;B01D53/508;;B01D53/64;;B01D53/81;;B01D2251/206;;B01D2251/61;;B01D2253/102;;B01D2253/25;;B01D2257/302;;B01D2257/602;;B01J20/0259;;B01J20/0292;;B01J20/20;;B01J20/28004;;B01J20/28016;;F23J15/003;;F23J2215/60,B01J20/04;;B01J20/02;;B01J20/20;;B01J20/30;;B01J20/32,,0,0,,,,DISCONTINUED
330,EP,B1,EP 0143343 B1,085-077-424-721-151,1987-09-16,1987,EP 84112938 A,1984-10-26,US 54654283 A,1983-10-28,WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME,,UNION CARBIDE CORPORATION,"JACKSON, JOHN ERIC;;ADLER, THOMAS ALLEN;;QUETS, JEAN MARIE",,https://lens.org/085-077-424-721-151,Granted Patent,yes,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
331,US,B2,US 11607130 B2,126-163-899-303-953,2023-03-21,2023,US 202217707290 A,2022-03-29,US 202217707290 A;;US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,Systems and methods for real-time target validation for image-guided radiation therapy,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/126-163-899-303-953,Granted Patent,yes,29,0,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00;;A61B6/00;;A61B6/02;;A61B6/12;;A61N5/10,,5,5,012-667-555-559-504;;034-891-604-485-05X;;062-298-666-510-335;;014-120-520-883-13X;;013-110-619-366-76X,21452713;;10.1118/1.3539725;;10.1117/1.3080134;;19256707;;10.1016/0360-3016(95)02082-9;;7493831;;10.21236/ada497867;;10.1002/mrm.21391;;17969013,"Hissoiny et al. “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, Physics, med-ph, Jan. 6, 2011.;;Lo et al. “Hardware acceleration of a Monte Carlo simulation for photodynamic therapy treatment planning”, Journal of Biomedical Optics, Jan./Feb. 2009, vol. 14(1).;;Dong et al. “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, pp. 1053-1060, 1995.;;Osher et al. “Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising”, 2008.;;Lustig, Michael, David Donoho, and John M. Pauly, “Sparse MRI: The application of compresses sensing for rapid MR imaging”, Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, 58.6 (2007): (Year:2007).",ACTIVE
332,IN,B,IN 167208 B,135-528-548-399-880,1990-09-22,1990,IN 623DE1987 A,1987-07-22,IN 623DE1987 A;;IN 835DE1984 A;;US 54654283 A,1983-10-28,A METHOD FOR COATING A SUBSTRATE,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE,,https://lens.org/135-528-548-399-880,Granted Patent,no,0,0,1,32,0,,C23C4/06,,0,0,,,,EXPIRED
333,US,B2,US 9314160 B2,064-827-201-919-900,2016-04-19,2016,US 201213691502 A,2012-11-30,US 201213691502 A;;US 201161565900 P,2011-12-01,Systems and methods for real-time target validation for image-guided radiation therapy,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/064-827-201-919-900,Granted Patent,yes,10,18,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,G06K9/00;;A61B5/00;;A61B6/00;;A61B6/02;;A61B6/12;;A61N5/10,,4,4,014-120-520-883-13X;;012-667-555-559-504;;034-891-604-485-05X;;062-298-666-510-335,10.21236/ada497867;;21452713;;10.1118/1.3539725;;10.1117/1.3080134;;19256707;;10.1016/0360-3016(95)02082-9;;7493831,"Osher et al (""Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising"", 2008).;;Hissoiny et al. ""GPUMCD: A new GPU-Oriented Monte Carlo dose calculation platform"", Physics. med-ph, Jan. 6, 2011.;;Lo et al. ""Hardware acceleration of a Monte Carlo simulation for photodynamic therapy treatment planning"", Journal of Biomedical Optics, Jan./Feb. 2009, vol. 14(1).;;Dong et al ""An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images"", Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, pp. 1053-1060, 1995.",ACTIVE
334,US,A1,US 2023/0200651 A1,071-529-921-817-652,2023-06-29,2023,US 202318108713 A,2023-02-13,US 202318108713 A;;US 202217707290 A;;US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,SYSTEMS AND METHODS FOR REAL-TIME TARGET VALIDATION FOR IMAGE-GUIDED RADIATION THERAPY,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/071-529-921-817-652,Patent Application,yes,26,0,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00;;A61B6/00;;A61B6/12;;A61N5/10,,0,0,,,,ACTIVE
335,AU,A,AU 1984/034731 A,124-679-851-424-697,1985-05-02,1985,AU 1984/034731 A,1984-10-26,US 54654283 A,1983-10-28,WEAR RESISTANT COATINGS OF W-CD-CRJC,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;QUETS JEAN MARIE;;ADLER THOMAS ALLEN,,https://lens.org/124-679-851-424-697,Patent Application,no,0,0,13,32,0,C22C29/08;;C23C4/067;;C23C4/04,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,,0,0,,,,EXPIRED
336,CH,A,CH 431822 A,099-228-371-574-517,1967-03-15,1967,CH 185465 A,1965-02-11,US 34630964 A,1964-02-20,Verfahren zum Desodorieren von Luft,,AMERICAN CYANAMID CO,ROBERT HENRY EBEL;;STEPHEN FRED ADLER;;JANIS JOHN KEGGI,,https://lens.org/099-228-371-574-517,Granted Patent,no,0,0,2,5,0,A61L9/01,A61L9/01,"30I,5/01",0,0,,,,EXPIRED
337,US,B2,US 6934165 B2,120-849-752-376-478,2005-08-23,2005,US 35720003 A,2003-02-04,US 35720003 A,2003-02-04,Loosely coupled parallel resonant converter,"A new power supply topology is described consisting of an input h-bridge or half-h-bridge, a low coupling coefficient transformer such as an air core transformer, a secondary resonant circuit, and a voltage multiplier which includes a series output capacitance. The topology is advantageous for high voltages since the reduced coupling leads to large spacings reduced insulation requirements.",NORTH STAR POWER ENGINEERING I,ADLER RICHARD JOHN;;ASHCRAFT BRUCE;;RICHTER-SAND ROBERT J,APPLIED ENERGETICS INC (2008-02-13);;NORTH STAR RESEARCH CORP (2003-01-30);;NORTH STAR POWER ENGINEERING INC (2005-02-04);;NORTH STAR RESEARCH CORPORATION (2005-01-21),https://lens.org/120-849-752-376-478,Granted Patent,yes,9,2,2,2,0,Y02B70/10;;H02M3/33573;;H02M3/01;;Y02B70/10;;H02M3/33573;;H02M3/01,H02M3/337,363/17;;363/60;;363/132,0,0,,,,EXPIRED
338,US,A1,US 2022/0218204 A1,048-906-253-298-785,2022-07-14,2022,US 202217707290 A,2022-03-29,US 202217707290 A;;US 202016843970 A;;US 201615066050 A;;US 201213691502 A;;US 201161565900 P,2011-12-01,SYSTEMS AND METHODS FOR REAL-TIME TARGET VALIDATION FOR IMAGE-GUIDED RADIATION THERAPY,Systems and methods for real-time target validation during radiation treatment therapy based on real-time target displacement and radiation dosimetry measurements.,VARIAN MED SYS INC,ADLER JR JOHN RODENBECK;;SHI JIANING;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-11-29),https://lens.org/048-906-253-298-785,Patent Application,yes,27,0,11,11,0,A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61N5/1049;;A61B5/0036;;A61B6/025;;A61B6/12;;A61B6/463;;A61B6/466;;A61N5/1064;;A61N5/1067;;A61N5/107;;A61N2005/1062;;A61B5/0036;;A61N5/1049,A61B5/00;;A61B6/00;;A61B6/12;;A61N5/10,,0,0,,,,ACTIVE
339,CA,A,CA 1229204 A,168-796-729-110-159,1987-11-17,1987,CA 465336 A,1984-10-12,US 54654283 A,1983-10-28,WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME,"WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 6.5 to about 9.0 weight percent cobalt, from about 2.0 to about 4.0 weight percent chromium, from about 3.0 to abut 4.0 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETS JEAN M,,https://lens.org/168-796-729-110-159,Granted Patent,no,0,0,13,32,0,C22C29/08;;C23C4/04;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06;;C23C4/08,6-3,0,0,,,,EXPIRED
340,US,A1,US 2009/0114849 A1,188-151-903-392-09X,2009-05-07,2009,US 26134708 A,2008-10-30,US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical neuromodulation devices, systems, and methods for treatment of behavioral disorders by external application of ionizing radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS DOYLE JOHN;;BORCHERS MICHELE,SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS DOYLE JOHN;;BORCHERS MICHELE,ADLER JR. JOHN R. M.D (2009-06-02);;SCHNEIDER M. BRET M.D (2009-06-02);;ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/188-151-903-392-09X,Patent Application,yes,6,40,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/00,250/492.1,7,6,088-605-253-045-077;;016-423-074-261-904;;025-580-865-305-112;;105-163-612-129-619;;030-019-655-024-002;;004-229-238-641-491,2336467;;10.2307/3577608;;7632622;;10.1016/0920-9964(94)00055-d;;11229981;;10.1176/appi.ajp.158.3.405;;10.1016/s0166-4328(01)00364-3;;11718882;;15627591;;10.1016/j.neuroimage.2004.08.041;;11584307;;10.1038/35094560,"Pellmar TC, Schauer DA, and Zeman GH. Time- and Dose-Dependent Changes in Neuronal ACtivity Produced by X Radiation in Brain Slices. Radiaton Research 1990; 122: 209-214.;;Lewine RRJ, Hudgins P, Brown F, Caudle J, Risch SC. Differences in Qualitative Brain Morphology Fidnings in Schizophrenia, Major Depression, Bipolar Disorder, and Normal Volunteers. Schizophrenia Research 1995; 15: 253-259 .;;Pizzagali D, Pascual-Marqui, RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, and Davidson RJ. Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis. American Journal of Psychiatry 2001; 158: 405-415.;;Tracy AL, Jarrard LE, Davidson TL. The Hippocampus and Motivation Revisited: Appetite and Activity. Behavioral Brain Research 2001; 127: 13-23.;;Maltby N, Tolin DF, Worhunsky P, O'Keefe TM, Kiehl KA. Dysfunctional Action Monitoring Hyperactivates Frontal-striatal Circuits in Obsessive-compulsive Disorder: an Event-related fMRI study. Neuroimage 2005; 24:495-503.;;Hyman Se and Malenka RC. Addiciton and the Brain: The Neurobiology of Compulsion and Its Persistence. Nature Reviews: Neuroscience 2001; 2: 695-703;;Kandel ER, Schwartz JH, and Jessell TM. Principles of Neural Science 4th Edition. New York: McGraw-Hill Companies Inc, 2000. 1002-1006. Print.",ACTIVE
341,US,A1,US 2023/0333756 A1,107-305-178-177-709,2023-10-19,2023,US 202318159764 A,2023-01-26,US 202318159764 A;;US 202117245298 A;;US 201916246771 A,2019-01-14,MANAGING PERMISSIONS FOR PROCESSING INPUT/OUTPUT (I/O) OPERATIONS IN A STORAGE SYSTEM,"A method, apparatus, and computer program product for managing permissions for processing input/output (I/O) operations in a storage system is disclosed that includes a plurality of storage system controllers and a plurality of storage devices. The method comprises determining that a permission associated with a storage system controller for issuing I/O operations to the storage devices should be invalidated and, in response to the determination, modifying at least one I/O capability of the storage system controller.",PURE STORAGE INC,MANN SANDEEP;;ADLER JOHN;;LEE JAESOO;;SCHOLBROCK BENJAMIN;;BERNAT ANDREW,PURE STORAGE INC (2022-11-10),https://lens.org/107-305-178-177-709,Patent Application,yes,0,0,1,3,0,G06F3/067;;G06F3/0622;;G06F3/0637;;G06F3/0632;;G06F9/4401;;G06F3/0673;;G06F3/0604,G06F3/06;;G06F9/4401,,0,0,,,,PENDING
342,CA,A1,CA 2613564 A1,027-396-006-355-632,2008-06-19,2008,CA 2613564 A,2007-12-05,US 61284906 A,2006-12-19,PERSONAL CARE PRODUCTS AND ASSEMBLIES THEREOF,,JOHNSON & JOHNSON CONSUMER,ADLER ARI TAO;;JUDSON JARED ALDEN;;ULMAN JOHN;;BELFORT JONATHAN,,https://lens.org/027-396-006-355-632,Patent Application,no,0,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,B65D65/12;;A45D44/00;;A61F13/02;;B65D83/00;;B65D85/07,,0,0,,,,DISCONTINUED
343,US,A1,US 2004/0235605 A1,046-520-440-249-909,2004-11-25,2004,US 44403203 A,2003-05-22,US 44403203 A,2003-05-22,Power transfer unit,"
   A motor vehicle power transfer unit for distributing torque from a transmission assembly between a front wheel drive line and rear wheel drive line. The power transfer unit includes a housing that encloses a parallel gear set and a non-parallel gear set, which are coupled between an input portion and an output portion of the power transfer unit. The parallel gear set includes a driving gear, and idler gear and a driven gear and the idler gear is rotatably supported on a non-rotating support member that extends through the idler gear. Constructed in this manner, reduced lateral compactness of the power transfer unit is achieved. 
",VISTEON GLOBAL TECH INC,COOK DENNIS;;LEPOSKY GEORGE;;BLACK DERRICK;;JENNINGS JOHN;;ADLER JONATHAN,VISTEON GLOBAL TECHNOLOGIES INC (2003-05-21);;FORD GLOBAL TECHNOLOGIES LLC (2009-04-14);;AUTOMOTIVE COMPONENTS HOLDINGS LLC (2006-06-30);;FORD MOTOR COMPANY (2006-02-14),https://lens.org/046-520-440-249-909,Patent Application,yes,11,6,4,4,0,B60K17/344;;B60K17/344;;F16H1/203;;F16H1/203;;F16H1/08;;F16H1/08;;F16H1/14;;F16H1/14;;F16H2057/02086;;F16H2057/02086;;Y10T74/19093;;Y10T74/19093;;Y10T74/19107;;Y10T74/19107;;Y10T74/19647;;Y10T74/19647;;Y10T74/19674;;Y10T74/19674,B60K17/344;;F16H1/08;;F16H1/14;;F16H1/20;;F16H48/06;;F16H57/02,47522,0,0,,,,EXPIRED
344,US,A1,US 2008/0142403 A1,088-487-145-681-186,2008-06-19,2008,US 61284906 A,2006-12-19,US 61284906 A,2006-12-19,PERSONAL CARE PRODUCTS AND ASSEMBLIES THEREOF,"The invention is directed to personal care products that include a top surface, a bottom surface, and a release liner adjacent at least a portion of the bottom surface, where the liner is folder over onto itself at a fold line thereof so as to provide a first section extending between the fold line and a proximal end of the liner and a second section extending between the fold line and a distal end of the liner, where the second section of the liner is longer than the first section of the liner, and to assemblies of such products that include a first product, a second product and multiple other products disposed between the first and second products.",ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JARED ALDEN;;ULMAN JOHN,ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JARED ALDEN;;ULMAN JOHN,JOHNSON & JOHNSON CONSUMER COMPANIES INC (2007-01-02),https://lens.org/088-487-145-681-186,Patent Application,yes,14,8,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A61F15/00;;A61F13/02;;B65D85/07,206/570;;602/57,0,0,,,,DISCONTINUED
345,US,B2,US 10201291 B2,127-637-122-990-457,2019-02-12,2019,US 201314040609 A,2013-09-27,US 201314040609 A;;US 201261719304 P;;US 201361798066 P,2012-10-26,Apparatus and method for real-time tracking of bony structures,"A method for measuring skin thickness. The method includes at a first 3D point on an outer surface of a patient, exposing the first point to near infrared (NIR) energy from an NIR source. The method includes measuring reflected energy emanating near the first 3D point, or beam incident point. The method includes determining a pattern of the reflected energy based on a distance from a center of the reflected energy, wherein the center is approximated by the first 3D point. The method includes determining a skin thickness measurement based on the pattern.",VARIAN MED SYS INC;;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH,ADLER JR JOHN R;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM,VARIAN MEDICAL SYSTEMS INC (2013-10-10);;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH (2013-09-30);;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH & CO. KG (2021-02-09),https://lens.org/127-637-122-990-457,Granted Patent,yes,14,1,2,20,0,A61B5/1079;;A61B5/1079;;A61B5/0035;;A61B5/0035;;A61B5/0036;;A61B5/0036;;A61B5/0075;;A61B5/0075;;A61B5/055;;A61B5/055;;A61B5/1075;;A61B5/441;;A61B5/441;;A61B5/4504;;A61B5/4504;;A61B5/4887;;A61B5/4887;;A61B5/72;;A61B5/72;;A61B6/032;;A61B6/032;;A61B6/501;;A61B6/501;;A61B6/505;;A61B6/505;;A61B6/5247;;A61B6/5247;;A61B2090/061;;A61B2090/061,A61B5/00;;A61B5/055;;A61B5/107;;A61B6/00;;A61B6/03;;A61B90/00,,0,0,,,,ACTIVE
346,US,A1,US 2009/0152152 A1,157-771-334-646-557,2009-06-18,2009,US 36624009 A,2009-02-05,US 36624009 A;;US 61284906 A,2006-12-19,PERSONAL CARE PRODUCTS AND ASSEMBLIES THEREOF,"The invention is directed to personal care products that include a top surface, a bottom surface, and a release liner adjacent at least a portion of the bottom surface, where the liner is folder over onto itself at a fold line thereof so as to provide a first section extending between the fold line and a proximal end of the liner and a second section extending between the fold line and a distal end of the liner, where the second section of the liner is longer than the first section of the liner, and to assemblies of such products that include a first product, a second product and multiple other products disposed between the first and second products.",ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JARED ALDEN;;ULMAN JOHN,ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JARED ALDEN;;ULMAN JOHN,,https://lens.org/157-771-334-646-557,Patent Application,yes,18,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A61B19/02;;B65D85/07,206/440,0,0,,,,DISCONTINUED
347,EP,A2,EP 0978487 A2,031-429-200-442-96X,2000-02-09,2000,EP 99113418 A,1999-07-12,US 9574198 P,1998-08-07,Method of making fused silica glass,"Burners (40) for producing fused silica boules are provided. The burners employ a tube-in-tube (301-306) design with flats (56, 50) on some of the tubes (305, 301) being used to limit the cross-sectional area of certain passages (206, 202) within the burner and/or to atomize a silicon-containing, liquid source material, such as OMCTS. To avoid the possibility of flashback, the burner has separate passages for fuel (205) and oxygen (204, 206), i.e., the burner employs nozzle mixing, rather than premixing, of the fuel and oxygen. The burners are installed in burner holes (26) formed in the crown (20) of a furnace and form a seal with those holes so that ambient air cannot be entrained into the furnace through the holes. An external air cooled jacket (60) can be used to hold the temperature of the burner below a prescribed upper limit, e.g., 400°C.",CORNING INC,ADLER MERYL D W;;BROWN JOHN T;;MISRA MAHENDRA K,,https://lens.org/031-429-200-442-96X,Patent Application,yes,0,9,4,4,0,C03B19/1407;;C03B19/1423;;C03B2207/06;;C03B2207/08;;C03B2207/12;;C03B2207/14;;C03B2207/20;;C03B2207/22;;C03B2207/26;;C03B2207/32;;C03B2207/34;;C03B2207/36;;C03B2207/42;;C03B2207/46;;C03B2207/52;;F23C2900/06043;;F23D14/22;;F23D14/32;;F23D14/52;;F23D2900/00018;;F23L7/00;;F23L2900/07002;;F23L7/00;;C03B2207/42;;F23D2900/00018;;C03B2207/32;;C03B2207/14;;F23D14/52;;C03B2207/20;;C03B2207/06;;C03B2207/46;;C03B2207/12;;C03B2207/52;;C03B2207/26;;C03B19/1423;;F23C2900/06043;;C03B2207/08;;F23D14/22;;F23L2900/07002;;C03B2207/36;;F23D14/32;;C03B2207/22;;C03B19/1407;;C03B2207/34,C03B8/04;;C03B19/14;;F23D14/22;;F23D14/32;;F23D14/52;;F23D14/56;;F23D23/00;;F23L7/00,,0,0,,,,DISCONTINUED
348,ZA,B,ZA 200710967 B,056-400-788-490-118,2009-10-28,2009,ZA 200710967 A,2007-12-18,US 61284906 A,2006-12-19,Personal care products and assemblies thereof,,JOHNSON & JOHNSON CONSUMER,TAO ADLER ARI;;ALDEN JUDSON JARED;;JONATHAN BELFORT;;JOHN ULMAN,,https://lens.org/056-400-788-490-118,Granted Patent,no,0,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A61F/;;B65D/;;B65D85/07,,0,0,,,,ACTIVE
349,BR,A,BR PI0704690 A,190-285-569-225-389,2008-08-12,2008,BR PI0704690 A,2007-12-18,US 61284906 A,2006-12-19,produtos para cuidado pessoal e conjuntos dos mesmos,"""PRODUTOS PARA CUIDADO PESSOAL E CONJUNTOS DOS MESMOS"". A presente invenção refere-se aos produtos de cuidado pessoal que incluem uma superfície de topo, uma superfície de fundo, e um forro que se solta adjacente a pelo menos uma porção da superfície fundo, onde o forro é vincado sobre ele próprio em uma linha de vinco dele de modo a fornecer uma primeira seção que se estende entre a linha de vinco e uma extremidade proximal do forro e uma segunda seção que se estende entre a linha de vinco e a extremidade distal do forro, onde a segunda seção do forro é mais longa do que a primeira seção do forro, e a conjuntos de tais produtos que incluem um primeiro produto, um segundo produto e múltiplos outros produtos dispostos entre o primeiro e o segundo produtos.",JOHNSON & JOHNSON,ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JERED ALDEN;;ULMAN JOHN,,https://lens.org/190-285-569-225-389,Patent Application,no,0,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A47K10/02;;A61F13/00;;B65D85/07,,0,0,,,,DISCONTINUED
350,US,A1,US 2019/0194139 A1,013-156-190-246-012,2019-06-27,2019,US 201716083189 A,2017-03-08,US 201716083189 A;;US 201662306026 P;;US 2017/0021285 W,2016-03-09,CYCLIC KETO-AMIDE COMPOUNDS AS CALPAIN MODULATORS AND METHODS OF PRODUCTION AND USE THEREOF,"The present technology relates to cyclic keto-amide compounds of general formulae I to XXXII, compositions and kits thereof as calpain modulators and methods useful for the treatment of various diseases or disorders such as fibrotic disease or cancer which are associated or mediated, by calpains, such as CAPN1, CAPN2, and/or CAPN9. The present technology is also applicable to cyclic keto-amide compounds which inhibit myofibroblast differentiation.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/013-156-190-246-012,Patent Application,yes,0,2,5,5,0,A61K38/00;;A61K38/00;;A61P19/04;;A61P19/04;;C07D223/12;;C07D223/12;;C07D211/58;;C07D211/58;;C07D225/02;;C07D225/02;;C07K5/06034;;C07K5/06034,C07D223/12;;A61P19/04;;C07D211/58;;C07D225/02,,0,0,,,,ACTIVE
351,DE,B4,DE 102004025469 B4,147-475-989-369-483,2008-10-30,2008,DE 102004025469 A,2004-05-21,US 44403203 A,2003-05-22,Kraftübertragungseinheit,,AUTOMOTIVE COMPONENTS HOLDINGS,COOK DENNIS;;LEPOSKY GEORGE;;BLACK DERICK;;JENNINGS JOHN;;ADLER JONATHAN,"AUTOMOTIVE COMPONENTS HOLDINGS, LLC., DEARBORN, MI (2006-02-16);;VISTEON GLOBAL TECHNOLOGIES, INC., VAN BUREN TOWNS (2005-05-12)",https://lens.org/147-475-989-369-483,Granted Patent,no,4,1,4,4,0,B60K17/344;;B60K17/344;;F16H1/203;;F16H1/203;;F16H1/08;;F16H1/08;;F16H1/14;;F16H1/14;;F16H2057/02086;;F16H2057/02086;;Y10T74/19093;;Y10T74/19093;;Y10T74/19107;;Y10T74/19107;;Y10T74/19647;;Y10T74/19647;;Y10T74/19674;;Y10T74/19674,F16H1/06;;B60K17/04;;B60K17/344;;F16H1/08;;F16H1/14;;F16H1/20;;F16H48/06;;F16H57/02,,0,0,,,,INACTIVE
352,JP,A,JP 2008212633 A,057-162-066-189-142,2008-09-18,2008,JP 2007325588 A,2007-12-18,US 61284906 A,2006-12-19,PERSONAL CARE PRODUCTS AND ASSEMBLY THEREOF,"<P>PROBLEM TO BE SOLVED: To provide a personal care products, and assemblies of the personal care products usable for storing and dispensing the personal care products. <P>SOLUTION: The personal care product includes a top surface, a bottom surface, and a release liner close to at least part of the bottom surface. The release liner is folded along a folding line, forming a first part extended between the folding line and a close end of the release liner, and a second part extended between the folding line and a far end of the release liner. The second part of the release liner is longer than the first part of the release liner. The assembly includes a first personal care product, a second personal care product, and a plurality of other personal care products disposed between the first personal care products and the second personal care products. <P>COPYRIGHT: (C)2008,JPO&INPIT",JOHNSON & JOHNSON CONSUMER,ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JARED ALDEN;;ULMAN JOHN,,https://lens.org/057-162-066-189-142,Patent Application,no,0,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A61F13/02;;B65D83/08;;B65D85/07,,0,0,,,,PENDING
353,US,B2,US 7127967 B2,111-961-530-932-831,2006-10-31,2006,US 44403203 A,2003-05-22,US 44403203 A,2003-05-22,Power transfer unit,"A motor vehicle power transfer unit for distributing torque from a transmission assembly between a front wheel drive line and rear wheel drive line. The power transfer unit includes a housing that encloses a parallel gear set and a non-parallel gear set, which are coupled between an input portion and an output portion of the power transfer unit. The parallel gear set includes a driving gear, and idler gear and a driven gear and the idler gear is rotatably supported on a non-rotating support member that extends through the idler gear. Constructed in this manner, reduced lateral compactness of the power transfer unit is achieved.",AUTOMOTIVE COMPONENTS HOLDINGS,COOK DENNIS;;LEPOSKY GEORGE;;BLACK DERRICK;;JENNINGS JOHN;;ADLER JONATHAN,VISTEON GLOBAL TECHNOLOGIES INC (2003-05-21);;FORD GLOBAL TECHNOLOGIES LLC (2009-04-14);;AUTOMOTIVE COMPONENTS HOLDINGS LLC (2006-06-30);;FORD MOTOR COMPANY (2006-02-14),https://lens.org/111-961-530-932-831,Granted Patent,yes,14,4,4,4,0,B60K17/344;;B60K17/344;;F16H1/203;;F16H1/203;;F16H1/08;;F16H1/08;;F16H1/14;;F16H1/14;;F16H2057/02086;;F16H2057/02086;;Y10T74/19093;;Y10T74/19093;;Y10T74/19107;;Y10T74/19107;;Y10T74/19647;;Y10T74/19647;;Y10T74/19674;;Y10T74/19674,F16H37/06;;B60K17/344;;F16H1/08;;F16H1/14;;F16H1/20;;F16H48/06;;F16H57/02,74665GC;;74/413;;74/420;;X 74665 H,0,0,,,,EXPIRED
354,CN,A,CN 101219080 A,144-942-433-506-99X,2008-07-16,2008,CN 200710300507 A,2007-12-19,US 61284906 A,2006-12-19,Personal care products and assemblies thereof,,JOHNSON & JOHNSON CONSUMER,TAO ADLER ARI;;JONATHAN BELFORT;;ALDEN JUDSON JARED;;JOHN ULMAN,,https://lens.org/144-942-433-506-99X,Patent Application,no,0,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A61F15/00;;A45D33/38;;A61F13/00;;B65D83/00;;B65D85/07;;B65H3/02,,0,0,,,,DISCONTINUED
355,AU,A1,AU 2007/249095 A1,032-437-992-931-281,2008-07-03,2008,AU 2007/249095 A,2007-12-18,US 61284906 A,2006-12-19,Personal care products and assemblies thereof,,JOHNSON & JOHNSON CONSUMER COMPANIES INC,ULMAN JOHN;;ADLER ARI TAO;;JUDSON JARED ALDEN;;BELFORT JONATHAN,,https://lens.org/032-437-992-931-281,Patent Application,no,0,0,10,10,0,A61F13/0203;;A61F15/001;;A61F2013/008;;A61F15/001;;A61F13/0203;;A61F2013/008,A61F13/00;;A47K10/16;;A61F13/15;;A61F15/00;;B65D83/08;;B65D85/07;;B65D85/62,,0,0,,,,DISCONTINUED
356,AU,A,AU 1991/071407 A,146-300-964-251-031,1991-07-24,1991,AU 1991/071407 A,1990-12-19,US 45509189 A,1989-12-22,METHOD AND APPARATUS FOR WARMING FOOD,,IIT RES INST,SRESTY GUGGILAM C;;DEV HARSH;;GINSBERG ROBERT JAMES;;ADLER JOHN,,https://lens.org/146-300-964-251-031,Patent Application,no,0,0,2,2,0,A47J36/28,A47J36/28,,0,0,,,,PENDING
357,US,B1,US 6588230 B1,139-694-840-511-592,2003-07-08,2003,US 36414999 A,1999-07-30,US 36414999 A;;US 9574198 P,1998-08-07,"Sealed, nozzle-mix burners for silica deposition","
    Burners (  40  ) for producing fused silica boules are provided. The burners employ a tube-in-tube (  301-306  ) design with flats (  56, 50  ) on some of the tubes (  305, 301  ) being used to limit the cross-sectional area of certain passages (  206, 202  ) within the burner and/or to atomize a silicon-containing, liquid source material, such as OMCTS. To avoid the possibility of flashback, the burner has separate passages for fuel (  205  ) and oxygen (  204, 206  ), i.e., the burner employs nozzle mixing, rather than premixing, of the fuel and oxygen. The burners are installed in burner holes (  26  ) formed in the crown (  20  ) of a furnace and form a seal with those holes so that ambient air cannot be entrained into the furnace through the holes. An external air cooled jacket (  60  ) can be used to hold the temperature of the burner below a prescribed upper limit, e.g., 400 C. 
",CORNING INC,ADLER MERYLE D M;;BROWN JOHN T;;MISRA MAHENDRA K,CORNING INCORPORATED (1999-07-26),https://lens.org/139-694-840-511-592,Granted Patent,yes,20,33,4,4,0,C03B19/1407;;C03B19/1423;;C03B2207/06;;C03B2207/08;;C03B2207/12;;C03B2207/14;;C03B2207/20;;C03B2207/22;;C03B2207/26;;C03B2207/32;;C03B2207/34;;C03B2207/36;;C03B2207/42;;C03B2207/46;;C03B2207/52;;F23C2900/06043;;F23D14/22;;F23D14/32;;F23D14/52;;F23D2900/00018;;F23L7/00;;F23L2900/07002;;F23L7/00;;C03B2207/42;;F23D2900/00018;;C03B2207/32;;C03B2207/14;;F23D14/52;;C03B2207/20;;C03B2207/06;;C03B2207/46;;C03B2207/12;;C03B2207/52;;C03B2207/26;;C03B19/1423;;F23C2900/06043;;C03B2207/08;;F23D14/22;;F23L2900/07002;;C03B2207/36;;F23D14/32;;C03B2207/22;;C03B19/1407;;C03B2207/34,C03B8/04;;C03B19/14;;F23D14/22;;F23D14/32;;F23D14/52;;F23D14/56;;F23D23/00;;F23L7/00,65/17.3;;65/413;;65/531;;239/416;;239/416.1;;239/416.4;;239/533.2;;423/337,6,0,,,"English translation of Japanese Patent Publication No. 54-030853 (1979).;;English translation of Japanese Patent Publication No. 58-002171 (1983).;;English translation of Japanese Patent Publication No. 63-274637 (1988).;;English translation of Japanese Patent Publication No. 3-069527 (1991).;;U.S. Patent application Ser. No. 08/767,653, filed Dec. 17, 1996.;;U.S. Patent application Ser. No. 08/903, 501, filed Jul. 30, 1997.",EXPIRED
358,EP,A2,EP 1935387 A2,183-460-980-397-254,2008-06-25,2008,EP 07254839 A,2007-12-12,US 61284906 A,2006-12-19,Personal care products and assemblies thereof,"The invention is directed to personal care products (60) that include a top surface, a bottom surface, and a release liner (64) adjacent at least a portion of the bottom surface, where the liner is folder over onto itself at a fold line thereof so as to provide a first section extending between the fold line and a proximal end of the liner and a second section extending between the fold line and a distal end of the liner, where the second section of the liner is longer than the first section of the liner, and to assemblies of such products that include a first product, a second product and multiple other products disposed between the first and second products.
",JOHNSON & JOHNSON CONSUMER,ADLER ARI TAO;;BELFORT JONATHAN;;JUDSON JARED ALDEN;;ULMAN JOHN,,https://lens.org/183-460-980-397-254,Patent Application,yes,1,0,10,10,0,A61F15/001;;A61F15/001;;A61F13/0203;;A61F13/0203;;A61F2013/008;;A61F2013/008,A61F15/00;;B65D85/07,,0,0,,,,DISCONTINUED
359,US,A,US 3996796 A,080-349-825-020-06X,1976-12-14,1976,US 55681075 A,1975-03-10,US 55681075 A,1975-03-10,Flow meter,"A flow metering apparatus comprising an elongated vortex generating element disposed transversely in a stream of fluid to produce on opposite sides thereof vortices which are shed in alternating fashion and a sensor disposed downstream of the generating element and aligned therewith in such a manner that the vortices alternately pass along opposite sides of the sensor. The sensor comprises an elongated, cylindrically shaped support having two high TCR resistive films longitudinally disposed on the surface thereof which faces the vortex generating element. This combination of vortex shedder and sensor produces a strong, highly reliable electrical signal.",CORNING GLASS WORKS,ADLER MERYLE D W;;BROWN JOHN T;;WEETMAN RONALD J,,https://lens.org/080-349-825-020-06X,Granted Patent,yes,9,21,1,1,0,G01F1/3266;;G01F1/3266,G01F1/32,73194VS,1,0,,,"Michiyoshi et al., ""Measurement of Flowrate Using Temperature Fluctuation Caused by Vortex Street"", Journal of Nuclear Science & Tech., pp. 511-517, vol. 7, No. 10.",EXPIRED
360,US,B2,US 10590084 B2,008-463-540-080-358,2020-03-17,2020,US 201716083189 A,2017-03-08,US 201716083189 A;;US 201662306026 P;;US 2017/0021285 W,2016-03-09,Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof,"The present technology relates to cyclic keto-amide compounds of general formulae I to XXXII, compositions and kits thereof as calpain modulators and methods useful for the treatment of various diseases or disorders such as fibrotic disease or cancer which are associated or mediated, by calpains, such as CAPN1, CAPN2, and/or CAPN9. The present technology is also applicable to cyclic keto-amide compounds which inhibit myofibroblast differentiation.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/008-463-540-080-358,Granted Patent,yes,104,13,5,5,0,A61K38/00;;A61K38/00;;A61P19/04;;A61P19/04;;C07D223/12;;C07D223/12;;C07D211/58;;C07D211/58;;C07D225/02;;C07D225/02;;C07K5/06034;;C07K5/06034,C07D223/12;;A61K38/00;;A61P19/04;;C07D211/58;;C07D225/02;;C07K5/062,,83,53,048-639-884-454-955;;080-750-233-057-521;;066-092-492-334-256;;010-626-131-088-514;;022-411-096-178-940;;038-893-656-153-713;;061-330-223-146-889;;122-442-336-796-885;;072-994-322-434-772;;003-261-888-417-997;;077-008-425-179-22X;;013-556-469-253-589;;054-167-535-212-696;;008-799-202-681-459;;032-421-248-192-752;;114-918-900-251-802;;050-062-160-596-331;;005-582-329-281-579;;090-595-759-639-249;;078-776-607-842-828;;006-136-522-900-040;;047-156-535-940-645;;099-850-489-020-528;;034-987-888-849-578;;002-974-951-283-009;;010-248-616-848-483;;099-744-749-713-381;;075-813-686-060-816;;005-836-557-552-913;;010-402-858-128-027;;010-725-579-810-871;;036-746-562-702-221;;034-514-021-515-444;;078-382-889-771-789;;035-995-301-512-762;;009-043-118-551-826;;044-878-082-973-49X;;159-695-952-917-570;;036-393-576-918-372;;019-747-883-890-065;;052-664-611-823-937;;046-483-357-440-702;;023-684-266-623-526;;111-761-539-590-464;;021-045-743-874-448;;000-647-626-022-090;;002-499-291-773-300;;071-099-297-091-853;;039-317-916-201-269;;046-864-680-028-207;;016-958-339-591-097;;153-408-674-284-984;;048-382-748-962-92X,10.1016/s1570-0232(02)00782-1;;12650749;;10.1016/s0960-894x(99)00392-3;;10476871;;10.1021/co400102v;;24377264;;15261274;;10.1016/j.bmcl.2004.06.013;;10.1021/acsmedchemlett.7b00494;;29541364;;pmc5846052;;10.1021/jm950541c;;8831774;;10.6023/cjoc201407016;;10.1038/srep08783;;pmc4350077;;25740631;;10.1021/jm0210717;;12773044;;29089532;;10.1038/s41598-017-14719-9;;pmc5663911;;18701765;;10.1124/jpet.108.142679;;10.1021/ol070294u;;17373804;;10.1016/j.bmcl.2011.06.017;;21741835;;10.1016/j.bmcl.2015.07.059;;26238321;;24171628;;10.1021/jo4020613;;26216521;;pmc4748423;;10.1038/npp.2015.225;;10.1107/s1600536805022373;;10.1002/anie.200805014;;19145612;;10.1016/j.dmpk.2017.11.068;;10.1002/cbdv.201200320;;23161629;;10.1021/acs.jmedchem.5b01464.s001;;26823007;;pmc5156532;;10.1021/acs.jmedchem.5b01464;;10.1074/jbc.m108893200;;11602605;;10.1152/physrev.00029.2002;;12843408;;15041468;;10.1016/j.bcp.2003.12.021;;10.1071/ch09101;;24130198;;10.1002/cmdc.201300387;;10.1071/ch14121;;10.1016/j.ejmech.2011.02.025;;21397369;;10.1016/j.bmc.2015.02.035;;25797164;;28759231;;10.1021/acs.jmedchem.7b00731;;pmc4240281;;24556840;;10.1038/nrm3758;;10.1016/j.bmcl.2005.03.095;;15911268;;10.1016/j.biocel.2006.04.012;;16971167;;27148623;;10.1021/acs.jmedchem.6b00267;;11992771;;10.1016/s0960-894x(02)00176-2;;10.1016/j.bmcl.2013.05.021;;23727045;;pmc3750990;;23211821;;10.1167/iovs.12-11088;;18024028;;10.1016/j.bmcl.2007.10.097;;10.5731/pdajpst.2011.00634;;22293237;;23606616;;10.1002/chem.201204260;;9846074;;19215300;;10.1111/j.1742-4658.2008.06833.x;;25007318;;10.1038/ncomms5365;;10.1039/c6sc00197a;;27540460;;pmc4987086;;22432027;;pmc3303840;;10.1371/journal.pone.0033468;;11853546;;pmc1222398;;10.1042/bj3620383;;10.1042/0264-6021:3620383;;21955158;;10.1021/jm200471r;;10.1016/s0040-4039(01)01134-0;;10.1021/jm010178b;;11585453;;24900305;;pmc4018096;;10.1021/ml100260x;;pmc2856976;;10.1074/jbc.r109.091306;;20147747;;10.1016/s0040-4039(00)79671-7;;10.1071/ch09150,"Blum et al., 2003, Complementary use of ion trap / time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: Early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat. J Chromatography B. 787:255-270.;;CAS Registry No. 1309010-71-6; STN entry date: Jun. 13, 2011; D-Alanine, N-[(1-phenyl-1H-imidazol-5-yl)carbonyl] in 1 page.;;CAS Registry No. 2094533-75-0; STN entry date: May 2, 2017; Benzamide, N-(2-amino-1,1-dimethyl-2-oxoethyl)-2-bromo-5-chloro-3-fluoro-, in 1 page.;;CAS Registry No. 1629446-68-9; STN entry date: Oct. 21, 2014; Benzamide, 3-cyano-N-[(1S)-1-formyl-2-phenylethyl], in 1 page.;;CAS Registry No. 2094410-58-7; STN entry date: May 2, 2017; Benzamide, 2-bromo-5-chloro-N-(1-cyano-2-methoxy-1-methylethyl)-3-fluoro-, in 1 page.;;CAS Registry No. 2037707-18-7; STN entry date: Nov. 25, 2016; Alanine, 3-fluoro-N-(2-fluoro-6-methoxybenzoyl)-, in 1 page.;;CAS Registry No. 1938924-09-4; STN entry date: Jun. 24, 2016; D-Leucine, N-(2-bromo-6-fluoro-3-methylbenzoyl)-, in 1 page.;;CAS Registry No. 2048401-56-3; STN entry date: Dec. 14, 2016; 4-Hexenoic acid, 2-[(4,5-dichloro-2-methoxybenzoyl)amino]-, in 1 page,;;CAS Registry No. 2026949-92-6; STN entry date: Nov. 8, 2016; D-Leucine, N-[(6-bromo-3,4-dihydro-3-oxo-2H-1,4-benzoxazin-7-yl)carbonyl]-, in 1 page.;;CAS Registry No. 1031704-04-7; STN entry date: Jun. 30, 2008; L-Valine, N-[(5,7,8,10-tetrahydro-7,8-dioxo-6-undecyl-2-phenazinyl)carbonyl]-, in 1 page.;;CAS Registry No. 566157-42-4; STN entry date: Aug. 14, 2003; Alanine, N-[(9,10-dihydro-9-oxo-3-acridinyl)carbonyl]-2-methyl-, in 1 page.;;CAS Registry No. 289062-66-4; STN entry date: Sep. 14, 2000; Acetic acid, [(2,4-dichlorobenzoyl)amino](phenylthio)-, in 1 page.;;CAS Registry No. 15643-65-9; STN entry date: Nov. 16, 1984; Acetic acid, [(3,4-dichlorobenzoyl)amino]phenoxy-, in 1 page.;;CAS Registry No. 1347051-33-5, Entered STN: Dec. 1, 2011; 1 H-Imidazole-5-hexanoic acid, β-[[[(6S,8aS)-octahydro-4-oxo-2-(phenylmethyl)sulfonyl]pyrrolo[1,2-a]pyrazin-6-yl]carbonyl]amino]-a-oxo-, methyl ester, 1 p.;;CAS Registry No. 1026166-23-3, Entered STN: Jun. 8, 2008 ; Hexanoic acid, 3-[[[(1R,2S,5S)-3-[(2S)-2-cyclohexyl-2-[(3,3-dimethyl-1-oxobutyl)amino]acetyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-2-yl]carbonyl]amino]-6,6,6-trifluoro-2-oxo-, 1 page.;;CAS Registry No. 2026817-08-1, Entered STN: Nov. 8, 2016; D-Leucine, N-[[3-(3-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Registry No. 2049278-49-9, Entered STN: Dec. 15, 2016; 4-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Registry No. 2039960-52-4, Entered STN: Nov. 28, 2016; 5-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Registry No. 2026895-95-2, Entered STN:Nov. 8, 2016; L-Norleucine, N-[[3-(5-chloro-2-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Registry No. 2026863-64-7, Entered STN: Nov. 8, 2016; L-Norleucine, N-[[4-(5-chloro-2-thienyl)-1H-pyrrol-3-yl]carbonyl]-, 1 page.;;CAS Registry No. 1796920-43-8, Entered STN: Jul. 8, 2015; 1H-Pyrrole-3-carboxamide, N-(2-amino-1-methyl-2-oxoethyl)-4-(5-chloro-2-thienyl)-, 1 page.;;Chatterjee et al., 1999, P2-achiral, P′-extended alpha-ketoamide inhibitors of calpain I. Bioorg Med Chem Lett. 9(16):2371-2374.;;Cohrt A. Emil. 2014, Solid-phase synthesis of peptide thioureas and thiazole-containing macrocycles through Ru-catalyzed ring-closing metathesis, ACS Comb Sci. 16(2):71-77 and Supporting Information in 55 pages.;;Gopalsamy et al., 2004, Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorg Med Chem Lett. 14(16):4221-4224.;;Kling et al., 2018, Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1′ Extension, ACS Med Chem Lett. 9(3):221-226.;;Li et al., 1996, Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases, J Med Chem. 39(20):4089-4098.;;Li et al., 2015, Synthesis and Cytotoxic Activities of Novel Amino Acid-Conjugates of Pyrrole Derivatives. Youji Huaxue. 35:167-174.;;Lu et al., 2015, Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors, Sci Rep. 5:8783 in 8 pages.;;Lubisch et al., 2003, Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability, J Med Chem. 46(12):2404-2412.;;Muniappan et al., 2017, Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice, Sci Rep. 7:14398.;;Nimmrich et al., 2008, Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction, J Pharmacol Exp Ther. 327(2):343-352.;;Oh et al., 2007, Thalassospiramides A and B, Immunosuppressive Peptides from the Marine Bacterium thalassospira sp., Org Ltts. 9(8):1525-1528.;;Sasmal et al., 2011, Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists. Bioorg Med Chem Lett. 21(16):4913-4918.;;Singh et al., 2015, Identification of amino acid appended acridines as potential leads to anti-cancer drugs. Bioorg Med Chem Lett. 25(18):3854-3858.;;Skogh et al., 2013, Aminocarbonylation of 4-lodo-1H-imidazoles with an Amino Acid Amide Nucleophile: Synthesis of Constrained H-Phe-Phe-NH2 Analogues. J Org Chem. 78:12251-12256.;;Vengeliene et al., 2016, The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile, Neuropsychopharmacology. 41(4):979-988 [online published Jul. 28, 2015].;;Zhong et al., 2005, 3-(2-Chlorophenyl)-N-(2-cyano-4-methyl-2-pentyl)-5-methylisoxazole-4-carboxamide. Acta Cryst. Section E. E61:o2621-o2622 in 7 pages.;;European Extended Search Report dated Jul. 12, 2019 for Application No. EP 17763962.2, filed Oct. 9, 2018.;;Abell et al., 2009, Molecular Modeling, Synthesis, and Biological Evaluation of Macrocyclic Calpain Inhibitors, Angew Chem Int Ed Engl. 48(8):1455-1458.;;Bihovsky et al., 2004, 1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors, Bioorg Med Chem Lett. 14(4):1035-1038.;;Brodney et al., 2015, Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors, J Med Chem. 58:3223-3252.;;Chen et al., 2012, New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N-Alkylation of Histidine, Chem Biodiver. 9(11):2473-2484.;;Damalanka et al., 2016, Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3Cl Protease, J Med Chem. 59(5):1899-1913.;;Dourdin et al., 2001, Reduced Cell Migration and Disruption of the Actin Cytoskeleton in Calpain-deficient embryonic Fibroblasts, J Biol Chem. 276(51):48382-48388.;;Gardiner et al., 2006, Ring closing metathesis of α- and β-amino acid derived dienes, J Organomet Chem. 691:5487-5496.;;Goll et al., 2003, The Calpain System, Physiol Rev. 83(3):731-801.;;Halland et al., 2014, Small Macrocycles as Highly Active Integrin α2β1 Antagonists, ACS Med Chem Lett. 5(2):193-198.;;Jánossy et al., 2004, Calpain as a multi-site regulator of cell cycle, Biochem Pharmacol. 67(8):1513-1521.;;Jones et al., 2009, Efficient Large-Scale Synthesis of CAT811, a Potent Calpain Inhibitor of Interest in the Treatment of Cataracts, Aust J Chem. 62:671-675.;;Jones et al., 2013, A Template-Based Approach to Inhibitors of Calpain 1, 20S Proteasome, and HIV-1 Protease, Chem Med Chem. 8(12):1918-1921.;;Jones et al., 2014, The Preparation of Macrocyclic Calpain Inhibitors by Ring Closing Metathesis and Cross Metathesis, Aust J. Chem. 67:1257-1263.;;Kim et al., 2011, Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties, Eur J Med Chem. 46(5):1721-1728.;;Kim et al., 2015, Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor, Bioorg Med Chem. 23:1808-1816.;;Kling et al., 2017, Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides, J Med Chem. 60:7123-7138.;;Lamouille et al., 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol. 15(3):178-196 in 46 pages.;;Lee et al., 2005, Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 15(11):2857-2860.;;Leloup et al., 2006, Involvement of calpains in growth factor-mediated migration, Int J Biochem Cell Biol. 38(12):2049-2063.;;Low et al., 2016, Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics, J Med Chem. 59(11):5403-5415.;;Lubisch et al., 2002, Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors, Bioorg Med Chem Lett., 12(10):1335-1338.;;Mandadapu et al., 2013, Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus, Bioorg Med Chem Lett. 23(13):3709-3712.;;Miettinen et al., 1994, TGF-β Induced Transdifferentiation of Mammary Epithelial Cells to Mesenchymal Cells: Involvement of Type I Receptors, J Cell Biol. 127(6 Pt 2):2021-2036.;;Morton et al., 2013, A Macrocyclic Caplain Inhibitor Slows the Development of Inherited Cortical Cataracts in a Sheep Model, Invest Ophthal Visual Science. 54(1):389-395.;;Nam et al., 2008, Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 18(1):205-209.;;Nema et al., 2011, Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions, PDA J Pharm Sci Technol. 65(3):287-332.;;Pegorier et al., 2010, Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF), Respir Res. 11:85 in 11 pages.;;Pehere et al., 2012, New β-Strand Templates Constrained bt Huisgen Cycloaddition, Org Lett. 14(5):1330-1333.;;Pehere et al., 2013, New cylindrical peptide assemblies defined by extended parallel β-sheets, Org Biomol Chem. 11(3):425-429.;;Pehere et al., 2013, Synthesis and Extended Activity of Triazole-Containing Macrocyclic Protease Inhibitors, Chem Eur J. 19:7975-7981.;;Powell et al., 1998, Compendium of Excipients for Parenteral Formulations, pDA; J Pharm Sci Technol. 52(5):238-311.;;Ravulapalli et al., 2009, Distinguishing between calpain heterodimerization and homodimerization, FEBS J. 276(4):973-982.;;Rotstein et al., 2014, Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics, Nature Comm. 5:4365-4371.;;Rotstein et al., 2016, Mechanistic Studies and Radiofluorination of Structurally Diverse Pharmaceuticals with Spiroyclic Iodonium(III) Ylides, Chem Sci. 7(7):4407-4417.;;Santos et al., 2012, Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation, PLoS One 7(3):e33468 in 12 pages.;;Schád et al., 2002, A novel human small subuit of calpains, Biochem J 342(Pt 2):383-388.;;Stuart et al., 2011, Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis, J Med Chem. 54(21):7503-7522.;;Walker et al., 2001, General method for the synthesis of cyclic peptidomimetic compounds, Tetrahed Letts. 42(34):5801-5804.;;Wells et al., 2001, 1,2-Benzothiazine 1,1-Dioxide P2-P3 Peptide Mimetic Aldehyde Calpain I Inhibitors, J Med Chem. 44:3488-3503.;;Woon et al., 2011, Structure guided development of potent reversibly binding penicillin binding protein inhibitors, ACS Med Chem Lett., 2(3):219-223 and Supporting Information, S1-S46.;;Young et al., 2010, Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon, J Biol Chem. 285(15):11039-11044.;;Donald et al., “C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Peptidyl-Prolyl Cis-Trans Isomerization,” Tetrahedron Letters, 1991, vol. 32 (10), pp. 1375-1378.;;International Search report and Written Opinion received in PCT Application No. PCT/US2017/021285, dated Jun. 21, 2017.;;Stoermer, et al., “Base Sensitivity of Arginine Alpha-Ketoamide Inhibitors of Serine Proteases,” Aust. J. Chem., 2009, vol. 62(9), pp. 988-992.;;Von Dobeneck, et al. “Diaminopyrrolinone,” Liebigs Ann. Chem., 1976, vol. 3, pp. 476-486.",ACTIVE
361,US,A1,US 2019/0246954 A1,127-612-401-154-688,2019-08-15,2019,US 201916274039 A,2019-02-12,US 201916274039 A;;US 201314040609 A;;US 201261719301 P;;US 201361798066 P,2012-10-26,APPARATUS AND METHOD FOR REAL-TIME TRACKING OF BONY STRUCTURES,"A method for measuring skin thickness. The method includes at a first 3D point on an outer surface of a patient, exposing the first point to near infrared (NIR) energy from an NIR source. The method includes measuring reflected energy emanating near the first 3D point, or beam incident point. The method includes determining a pattern of the reflected energy based on a distance from a center of the reflected energy, wherein the center is approximated by the first 3D point. The method includes determining a skin thickness measurement based on the pattern.",VARIAN MEDICAL SYSTEMS;;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH,ADLER JR JOHN R;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM,VARIAN MEDICAL SYSTEMS INC (2013-10-16);;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH & CO. KG (2013-09-30),https://lens.org/127-612-401-154-688,Patent Application,yes,0,3,2,20,0,A61B6/505;;A61B6/501;;A61B6/032;;A61B5/0064;;A61B2090/061;;A61N5/1049;;A61N2005/1059;;A61B5/0036;;A61B5/0035;;A61B5/055;;A61B5/0075;;A61B5/1075;;A61B5/1079;;A61B5/441;;A61B5/442;;A61B5/4504;;A61B5/4887;;G16H30/40;;G16H50/50;;G16H40/63;;A61B5/1079;;A61B6/032;;A61B6/5247;;A61B5/0035;;A61B5/0075;;A61B5/441;;A61B5/4504;;A61B5/4887;;A61B5/4836;;A61B6/505;;A61B2090/061;;A61B5/055;;A61B6/501;;A61B5/72;;A61B5/1075;;A61B5/0064,A61B5/107;;A61B5/00;;A61B6/00,,0,0,,,,ACTIVE
362,JP,A,JP 2000063127 A,168-851-548-390-066,2000-02-29,2000,JP 22572699 A,1999-08-09,US 9574198 P,1998-08-07,NOZZLE MIXING BURNER FOR ADHERENCE OF SEALING TYPE SILICA,"PROBLEM TO BE SOLVED: To decrease the accumulation of soot on the front side of a burner for producing a quartz glass boule, improve the safety of movement and the efficiency of cooling, and stabilize the quality of the quartz glass boule. SOLUTION: A burner having a structure of multiple composite cylindrical tubes 301-306 is adopted. The sectional area of some flow paths 206 and 202 in the certain cylindrical tubes 305 and 301 in the burner is limited, and/or flats usable to atomize a silicon-containing liquid raw material such as OMCTS are installed. The burner has an independent flow path 205 for a fuel and flow paths 204 and 206 for oxygen. The nozzle mixing is adopted to avoid flashing back. The burner is attached by sealing to the burner hole installed in the crown of a furnace to prevent the atmosphere to be inhaled in the furnace. The outside air-cooling jacket can be used so that the temperature of the burner may not exceed the upper limit, for instance 400 deg.C.",CORNING INC,ADLER MERYL D W;;BROWN JOHN T;;MISRA MAHENDRA K,,https://lens.org/168-851-548-390-066,Patent Application,no,0,2,4,4,0,C03B19/1407;;C03B19/1423;;C03B2207/06;;C03B2207/08;;C03B2207/12;;C03B2207/14;;C03B2207/20;;C03B2207/22;;C03B2207/26;;C03B2207/32;;C03B2207/34;;C03B2207/36;;C03B2207/42;;C03B2207/46;;C03B2207/52;;F23C2900/06043;;F23D14/22;;F23D14/32;;F23D14/52;;F23D2900/00018;;F23L7/00;;F23L2900/07002;;F23L7/00;;C03B2207/42;;F23D2900/00018;;C03B2207/32;;C03B2207/14;;F23D14/52;;C03B2207/20;;C03B2207/06;;C03B2207/46;;C03B2207/12;;C03B2207/52;;C03B2207/26;;C03B19/1423;;F23C2900/06043;;C03B2207/08;;F23D14/22;;F23L2900/07002;;C03B2207/36;;F23D14/32;;C03B2207/22;;C03B19/1407;;C03B2207/34,C03B8/04;;C03B19/14;;F23D14/22;;F23D14/32;;F23D14/52;;F23D14/56;;F23D23/00;;F23L7/00,,0,0,,,,DISCONTINUED
363,WO,A1,WO 1991/010102 A1,142-088-105-759-32X,1991-07-11,1991,US 9007529 W,1990-12-19,US 45509189 A,1989-12-22,METHOD AND APPARATUS FOR WARMING FOOD,"A warmer pack (11) is disclosed for maintaining fast food or carry-out food warm for an extended period of time, e.g., 20 to 30 minutes. The prewarmed food is kept warm at about its serving temperature, usually about 140°-150 °F. The preferred warmer pack (11) is inexpensively formed of parallel flat sheets of plastic defining a package. The preferred package includes two or more exothermic materials (25) and (29) separated by an internal frangible seal (21) which is broken by compressing the pack. The warmer pack is either initially preheated, or uses the heat of the prewarmed food, or has a first fast exothermic reaction to raise the temperature of the other compound therein and thereafter an exothermic reaction of the second compound continues over the extended period of time at a rate to offset the cooling rate of the prewarmed food. The warmer pack is food safe, inexpensive and provides heat transfer in a controlled manner to the prewarmed food.",IIT RES INST,SRESTY GUGGILAM C;;DEV HARSH;;GINSBERG ROBERT JAMES;;ADLER JOHN,,https://lens.org/142-088-105-759-32X,Patent Application,yes,9,9,2,2,0,A47J36/28,A47J36/28,,0,0,,,,PENDING
364,US,B2,US 11076776 B2,026-236-721-453-240,2021-08-03,2021,US 201916274039 A,2019-02-12,US 201916274039 A;;US 201314040609 A;;US 201261719301 P;;US 201361798066 P,2012-10-26,Apparatus and method for real-time tracking of bony structures,"A method for measuring skin thickness. The method includes at a first 3D point on an outer surface of a patient, exposing the first point to near infrared (NIR) energy from an NIR source. The method includes measuring reflected energy emanating near the first 3D point, or beam incident point. The method includes determining a pattern of the reflected energy based on a distance from a center of the reflected energy, wherein the center is approximated by the first 3D point. The method includes determining a skin thickness measurement based on the pattern.",VARIAN MEDICAL SYSTEMS;;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH;;VARIAN MED SYS INC,ADLER JR JOHN R;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM,VARIAN MEDICAL SYSTEMS INC (2013-10-16);;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH & CO. KG (2013-09-30),https://lens.org/026-236-721-453-240,Granted Patent,yes,15,0,2,20,0,A61B6/505;;A61B6/501;;A61B6/032;;A61B5/0064;;A61B2090/061;;A61N5/1049;;A61N2005/1059;;A61B5/0036;;A61B5/0035;;A61B5/055;;A61B5/0075;;A61B5/1075;;A61B5/1079;;A61B5/441;;A61B5/442;;A61B5/4504;;A61B5/4887;;G16H30/40;;G16H50/50;;G16H40/63;;A61B5/1079;;A61B6/032;;A61B6/5247;;A61B5/0035;;A61B5/0075;;A61B5/441;;A61B5/4504;;A61B5/4887;;A61B5/4836;;A61B6/505;;A61B2090/061;;A61B5/055;;A61B6/501;;A61B5/72;;A61B5/1075;;A61B5/0064,A61B5/00;;A61B5/055;;A61B5/107;;A61B6/00;;A61B6/03;;A61B90/00,,0,0,,,,ACTIVE
365,DE,A1,DE 102004025469 A1,057-791-801-294-793,2004-12-16,2004,DE 102004025469 A,2004-05-21,US 44403203 A,2003-05-22,Kraftübertragungseinheit,"Die Erfindung betrifft eine Kraftübertragungseinheit (10) für ein Kraftfahrzeug, die ein von einer Getriebebaugruppe bereitgestelltes Drehmoment zwischen einem Vorderradantriebssystem und einem Hinterradantriebssystem verteilt. Die Kraftübertragungseinheit (10) umfasst ein Gehäuse (12), das die Kraftübertragungseinheit (10) umschließt. Weiterhin umfasst es ein Antriebsglied, das mit dem Abtrieb der Getriebebaugruppe verbunden werden kann, und ein Abtriebsglied, das mit einem Antriebsglied (18) der Getriebebaugruppe verbunden werden kann. Weiterhin weist es ein Parallelgetriebe (16) und ein Nichtparallelgetriebe (14) auf, die miteinander verbunden und zwischen dem Antriebsglied (18) und dem Abtriebsglied angeordnet sind.",VISTEON GLOBAL TECH INC,COOK DENNIS;;LEPOSKY GEORGE;;BLACK DERICK;;JENNINGS JOHN;;ADLER JONATHAN,"AUTOMOTIVE COMPONENTS HOLDINGS, LLC., DEARBORN, MI (2006-02-16);;VISTEON GLOBAL TECHNOLOGIES, INC., VAN BUREN TOWNS (2005-05-12)",https://lens.org/057-791-801-294-793,Patent Application,no,0,2,4,4,0,B60K17/344;;B60K17/344;;F16H1/203;;F16H1/203;;F16H1/08;;F16H1/08;;F16H1/14;;F16H1/14;;F16H2057/02086;;F16H2057/02086;;Y10T74/19093;;Y10T74/19093;;Y10T74/19107;;Y10T74/19107;;Y10T74/19647;;Y10T74/19647;;Y10T74/19674;;Y10T74/19674,B60K17/344;;F16H1/08;;F16H1/14;;F16H1/20;;F16H48/06;;F16H57/02,,0,0,,,,INACTIVE
366,US,A1,US 2014/0121527 A1,098-529-552-885-712,2014-05-01,2014,US 201314040609 A,2013-09-27,US 201314040609 A;;US 201261719304 P;;US 201361798066 P,2012-10-26,APPARATUS AND METHOD FOR REAL-TIME TRACKING OF BONY STRUCTURES,"A method for measuring skin thickness. The method includes at a first 3D point on an outer surface of a patient, exposing the first point to near infrared (NIR) energy from an NIR source. The method includes measuring reflected energy emanating near the first 3D point, or beam incident point. The method includes determining a pattern of the reflected energy based on a distance from a center of the reflected energy, wherein the center is approximated by the first 3D point. The method includes determining a skin thickness measurement based on the pattern.",VARIAN MED SYS INC,ADLER JR JOHN R;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM,VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH (2013-09-30);;VARIAN MEDICAL SYSTEMS PARTICLE THERAPY GMBH & CO. KG (2013-10-10),https://lens.org/098-529-552-885-712,Patent Application,yes,5,9,2,20,0,A61B5/1079;;A61B5/1079;;A61B5/0035;;A61B5/0035;;A61B5/0036;;A61B5/0036;;A61B5/0075;;A61B5/0075;;A61B5/055;;A61B5/055;;A61B5/1075;;A61B5/441;;A61B5/441;;A61B5/4504;;A61B5/4504;;A61B5/4887;;A61B5/4887;;A61B5/72;;A61B5/72;;A61B6/032;;A61B6/032;;A61B6/501;;A61B6/501;;A61B6/505;;A61B6/505;;A61B6/5247;;A61B6/5247;;A61B2090/061;;A61B2090/061,A61B5/107;;A61B5/00;;A61B5/055;;A61B6/03,600/473,0,0,,,,ACTIVE
367,EP,A3,EP 0978487 A3,174-910-216-587-131,2001-02-21,2001,EP 99113418 A,1999-07-12,US 9574198 P,1998-08-07,"Sealed, nozzle-mix burners for silica deposition","Burners (40) for producing fused silica boules are provided. The burners employ a tube-in-tube (301-306) design with flats (56, 50) on some of the tubes (305, 301) being used to limit the cross-sectional area of certain passages (206, 202) within the burner and/or to atomize a silicon-containing, liquid source material, such as OMCTS. To avoid the possibility of flashback, the burner has separate passages for fuel (205) and oxygen (204, 206), i.e., the burner employs nozzle mixing, rather than premixing, of the fuel and oxygen. The burners are installed in burner holes (26) formed in the crown (20) of a furnace and form a seal with those holes so that ambient air cannot be entrained into the furnace through the holes. An external air cooled jacket (60) can be used to hold the temperature of the burner below a prescribed upper limit, e.g., 400°C.",CORNING INC,ADLER MERYL D W;;BROWN JOHN T;;MISRA MAHENDRA K,,https://lens.org/174-910-216-587-131,Search Report,yes,6,0,4,4,0,C03B19/1407;;C03B19/1423;;C03B2207/06;;C03B2207/08;;C03B2207/12;;C03B2207/14;;C03B2207/20;;C03B2207/22;;C03B2207/26;;C03B2207/32;;C03B2207/34;;C03B2207/36;;C03B2207/42;;C03B2207/46;;C03B2207/52;;F23C2900/06043;;F23D14/22;;F23D14/32;;F23D14/52;;F23D2900/00018;;F23L7/00;;F23L2900/07002;;F23L7/00;;C03B2207/42;;F23D2900/00018;;C03B2207/32;;C03B2207/14;;F23D14/52;;C03B2207/20;;C03B2207/06;;C03B2207/46;;C03B2207/12;;C03B2207/52;;C03B2207/26;;C03B19/1423;;F23C2900/06043;;C03B2207/08;;F23D14/22;;F23L2900/07002;;C03B2207/36;;F23D14/32;;C03B2207/22;;C03B19/1407;;C03B2207/34,C03B8/04;;C03B19/14;;F23D14/22;;F23D14/32;;F23D14/52;;F23D14/56;;F23D23/00;;F23L7/00,,6,0,,,"PATENT ABSTRACTS OF JAPAN vol. 17, no. 285 2 June 1993 (1993-06-02);;PATENT ABSTRACTS OF JAPAN vol. 14, no. 14 12 January 1990 (1990-01-12);;PATENT ABSTRACTS OF JAPAN vol. 10, no. 178 21 June 1986 (1986-06-21);;PATENT ABSTRACTS OF JAPAN vol. 96, no. 10 31 October 1996 (1996-10-31);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 10 30 November 1995 (1995-11-30);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 10 30 November 1995 (1995-11-30)",DISCONTINUED
368,CA,A,CA 765120 A,188-695-859-611-368,1967-08-08,1967,CA 765120D A,,CA 765120T A,,ELECTRON BEAM DEVICES,,ZENITH RADIO CORP,LINDLEY JOHN P;;ADLER ROBERT;;FOSTER LEIGH C;;CRUMLY CHARLES B,,https://lens.org/188-695-859-611-368,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
369,FR,A1,FR 2677569 A1,153-588-004-621-735,1992-12-18,1992,FR 9206968 A,1992-06-10,US 71557191 A,1991-06-14,PROCEDE ET APPAREIL POUR FORMER UNE CAVITE DANS UN CORPS MASSIF EN MATIERE RIGIDE.,"<P>Dans cet appareil de fraisage, un outil (12) est monté sur une broche (16) à paliers à air comprimé, montée elle-même sur un support oscillant (26). Un flan (38) est monté sur un support (40) coulissant sur un bloc (46). Le bloc (46) a une surface inférieure concave (50) montée inclinable sur un second bloc (52) coulissant sur une table (56). Le bloc (46) est apte à se déplacer angulairement par rapport au bloc (52). Des moyens (24) sont prévus pour entraîner l'outil en rotation, et des moyens (32, 33, 34) sont prévus pour l'entraîner, simultanément, suivant un arc de cercle d'axe perpendiculaire à celui de l'outil. <BR/> L'appareil convient pour l'usinage de flancs de verres de lunettes en matière plastique.</P>",CORNING INC,WALTER ADLER MERYLE DANIEL;;WALTER NELSON JOHN;;GORDON SHAFER JR HAROLD,,https://lens.org/153-588-004-621-735,Patent Application,no,3,0,4,4,0,B24B13/0012;;B24B41/04;;B24B41/04;;B24B13/0012,B24B13/00;;B24B41/04,,0,0,,,,PENDING
370,US,A1,US 2022/0241613 A1,139-626-857-469-795,2022-08-04,2022,US 202217590609 A,2022-02-01,US 202217590609 A;;US 202163144411 P;;US 202163213380 P,2021-02-01,Inverse Planning Device and Methods for Radiation Treatment,"Devices and methods that allow a user to elect between performing treament planning by inverse planning or to be accomplished by utilizing one or more parameters input that are typically associated with forward planning are described herein. The systems can be configured to produce a treatment plan in a single iteration upon initiation of treatment planning or in response to determining or receiving a target geometry. While the system may be used iteratively in an extensively interactive fashion, viable inverse plans can be generated with a single user interaction, such as a single click, or optionally with no click at all. Advantageously, the system can optionally allows a clinnician to add or adjust parameters or constraints, for example in another iteration, to provide additional autonomy if desired.",ZAP SURGICAL SYSTEMS INC,BODDULURI RADHIKA MOHAN;;LOYSEL THIBAUT;;SCHWEIKARD ACHIM;;ADLER JR JOHN R,ZAP SURGICAL SYSTEMS INC (2021-11-22),https://lens.org/139-626-857-469-795,Patent Application,yes,1,0,4,5,0,A61N5/103;;A61N5/1039;;A61N2005/1074;;A61N5/1049,A61N5/10,,0,0,,,,PENDING
371,US,B1,US 6808493 B1,005-612-753-649-410,2004-10-26,2004,US 22943502 A,2002-08-28,US 22943502 A,2002-08-28,Adjustable ratchet retractor support apparatus,"
    An adjustable ratchet retractor support apparatus includes in one aspect a rotatable locking mount having first and second surfaces and an axis of rotation perpendicular to the surfaces. First and second rotatable pivot members are disposed respectively on the first and second surfaces for rotation around the axis of rotation. Each of the pivot members include ratchet teeth. First and second curved arm members are mounted respectively on and associated respectively with the first and second pivot members. Each of the arm members is rotatable about a respective axis of rotation perpendicular to the axis of rotation of the locking mount. Each arm member has mounted thereon a ratchet pawl for engagement with the ratchet teeth of the associated pivot member. First and second rotatable clamps are disposed respectively on the first and second pivot members for restraining rotation of the pivot members. 
",FLEXBAR MACHINE CORP,BOOKWALTER JOHN R;;ADLER JONATHAN;;ASCHER BERND D;;CORACI JR LEONARD,FLEXBAR MACHINE CORPORATION (2002-08-21),https://lens.org/005-612-753-649-410,Granted Patent,yes,18,69,1,1,0,A61B17/02;;A61B17/02;;A61B17/0293;;A61B17/0293;;A61B90/50;;A61B90/50,A61B1/32;;A61B17/02;;A61B19/00,600/233;;600/231,0,0,,,,EXPIRED
372,US,A1,US 2010/0095219 A1,012-641-248-559-330,2010-04-15,2010,US 25233608 A,2008-10-15,US 25233608 A,2008-10-15,SELECTIVE HISTORY DATA STRUCTURES,"Methods and apparatuses which create and use selective history data structures are disclosed. In one embodiment, a method includes monitoring presentations accessed by a user, automatically selecting some of the presentations accessed by the user according to, at least in part, the user's access patterns, and displaying representations of the some of the presentations in a pattern of an n×n array, wherein n is greater than 1. Other methods are disclosed, and various apparatuses and machine readable media are also disclosed.",STACHOWIAK MACIEJ;;DECKER KEVIN;;SULLIVAN JOHN W;;ADLER DARIN;;ROBEN ADAM,STACHOWIAK MACIEJ;;DECKER KEVIN;;SULLIVAN JOHN W;;ADLER DARIN;;ROBEN ADAM,APPLE INC (2008-10-07),https://lens.org/012-641-248-559-330,Patent Application,yes,24,124,3,3,0,G06F16/9562;;G06F16/9562,G06F3/048,715/745,0,0,,,,DISCONTINUED
373,US,A,US 5148632 A,044-937-235-853-657,1992-09-22,1992,US 71557191 A,1991-06-14,US 71557191 A,1991-06-14,Cavity forming in plastic body,"An apparatus and method for forming a cavity in a rigid, organic plastic body comprises an abrading tool mounted on a carrier, an air spindle for imparting a rotary motion to the tool, and a second air spindle on which the tool carrier is mounted and which has a force applied to it to move the tool through an arc that passes through the plastic body.",CORNING INC,ADLER MERYLE D W;;NELSON JOHN W;;SHAFER JR HAROLD G,CORNING INCORPORATED (1991-06-10),https://lens.org/044-937-235-853-657,Granted Patent,yes,10,21,4,4,0,B24B13/0012;;B24B41/04;;B24B41/04;;B24B13/0012,B24B13/00;;B24B41/04,51/55;;X 51124L;;51/125;;X 51284R,0,0,,,,EXPIRED
374,CN,A,CN 101699458 A,111-674-677-175-175,2010-04-28,2010,CN 200910222182 A,2005-12-13,US 64234005 P;;US 5149905 A,2005-01-07,Accessory authentication for electronic devices,"The invention relates to accessory authentication for electronic devices. Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE COMPUTER,FADELL ANTHONY M;;MITCHELL ADLER;;JAKE RUBINSTEIN JONATHAN;;WESLEY ARCHIBALD JOHN,,https://lens.org/111-674-677-175-175,Patent Application,no,0,7,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/00;;G10L19/00,,0,0,,,,ACTIVE
375,US,A1,US 2011/0258535 A1,116-280-399-984-14X,2011-10-20,2011,US 91262510 A,2010-10-26,US 91262510 A;;US 32616610 P;;US 33016110 P,2010-04-20,INTEGRATED DOCUMENT VIEWER WITH AUTOMATIC SHARING OF READING-RELATED ACTIVITIES ACROSS EXTERNAL SOCIAL NETWORKS,"In various embodiments of the present invention, documents (such as PDF documents) are converted into HTML 5 (and CSS 3) formats and integrated into existing HTML 5 web pages in a manner that preserves the original fonts embedded within the documents. The fonts can also be integrated or embedded (e.g., via the standard HTML “iframe” tag) into other web pages. The original appearance of the source document is maintained, the text is preserved as searchable text, and the document is integrated into a web page that can be searched, zoomed, scrolled, printed, etc., utilizing standard web browser controls. As a result, a significantly increased “ad inventory” is enabled, wherein advertisements can be integrated between the individual pages (or even within a page) of the document. In addition, the resulting document (independent of its format) can be passively shared with desired members of a user's external social networks (as well as any social network within the host website), along with other activities and behavior performed by the user on the website hosting the document.",SCRIBD INC,ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW,SCRIBD INC (2010-09-08),https://lens.org/116-280-399-984-14X,Patent Application,yes,6,100,4,4,0,G06F40/126;;G06F40/126;;G06F40/109;;G06F40/109;;G06F40/151;;G06F40/151,G06F17/21,715/235,0,0,,,,DISCONTINUED
376,CA,A1,CA 2066334 A1,074-460-264-152-473,1992-12-15,1992,CA 2066334 A,1992-04-16,US 71557191 A,1991-06-14,CAVITY FORMING IN PLASTIC BODY,"An apparatus and method for forming a cavity in a rigid, organic plastic body comprises an abrading tool mounted on a carrier, and means for driving the tool while it is moved through an arc. In a preferred embodiment, the organic plastic body is an ophthalmic lens blank, and the cavity has the size and shape of a segment for a multifocal lens.",CORNING INC,ADLER MERYLE D W;;NELSON JOHN W;;SHAFER HAROLD G JR,,https://lens.org/074-460-264-152-473,Patent Application,no,0,0,4,4,0,B24B13/0012;;B24B41/04;;B24B41/04;;B24B13/0012,B24B13/00;;B24B41/04,,0,0,,,,DISCONTINUED
377,US,A1,US 2012/0110436 A1,198-657-068-124-526,2012-05-03,2012,US 201213343695 A,2012-01-04,US 201213343695 A;;US 201113278176 A;;US 201113235362 A;;US 201113189372 A;;US 91262510 A;;US 32616610 P;;US 33016110 P,2010-04-20,INTEGRATED DOCUMENT VIEWER,"In various embodiments of the present invention, documents (eg, PDFs) are converted into HTML 5 (and CSS 3) formats and integrated into existing HTML 5 web pages to preserve the original embedded fonts. The fonts can also be integrated or embedded (e.g., via the standard HTML “iframe” tag) into other web pages. The original appearance of the source document is maintained, the text is preserved as searchable text, and the document is integrated into a web page that can be searched, zoomed, scrolled, and printed utilizing standard web browser controls. A significantly increased “ad inventory” is thereby enabled, wherein advertisements can be integrated between pages, or even within a page. Moreover, the resulting document can be passively shared with members of a user's external social networks (including those within the host website), along with other activities and behaviors performed by the user on the hosting website.",ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW;;SCRIBD INC,ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW,SCRIBD INC (2014-03-18),https://lens.org/198-657-068-124-526,Patent Application,yes,31,64,4,4,0,G06F40/126;;G06F40/126;;G06F40/109;;G06F40/109;;G06F40/151;;G06F40/151,G06F17/21,715/234,6,1,092-413-243-465-367,10.1007/978-1-4302-2666-6_4,"v-render, ""Using css3 @font-face"", 2/27/2010, v-render studio, p1-5 + 1 page from Wayback; http://web.archive.org/web/20100227050531/http://www.v-render.co.in/2010/02/24/using-css3-font-face-property/;;Hardmeierm, Sandi, ""Zoom - Internet Explorer 7"", 12/17/2008, IE-Vista, p1-2; http://www.ie-vista.com/zoom.html;;Lehigh University, ""Zoom Feature - An eye toward greater readability"", 2008, pg 1-2;http://web.archive.org/web/20080604095631/http://www.lehigh.edu/helpdesk/docs/ie7/zoom.html;;Korpela, Jukka, ""Using inline frames (iframe elements) to embed documents into HTML documents"", 2/27/2004, 12 pages, http://www.cs.tut.fi/~jkorpela/html/iframe.html;;Urbain-Lurain, Mark, ""Embedding a PDF File on a Web Page"", 2008, MSU, 2 pages; https://www.msu.edu/~urban/sme865/resources/embedded_pdf.html;;Jonathan, ""Embed Google Docs document within your web page"", 4/1/2010, 4 pages, http://jonathancamp.com/2010/04/01/embed-google-docs-document-within-your-web-page/",INACTIVE
378,DE,B,DE 1166900 B,151-432-659-945-729,,,DE 1166900D A,,US 57833356 A;;US 20157X A;;US 110357X A;;US 67625957 A,1957-01-02,Anordnung zum Steuern eines elektrischen Geraetes mit Hilfe von in elektrische Signale umgewandelten Ultraschallschwingungen,,ZENITH RADIO CORP,ADLER ROBERT;;SPRACKLEN JOHN G;;EHLERS ROBERT C;;WANDREY CLARENCE W,,https://lens.org/151-432-659-945-729,Patent Application,no,0,4,4,4,0,B06B3/02;;B06B3/04;;H04N5/58;;H04Q9/00;;Y10S116/30;;H04N5/58;;B06B3/04;;H04Q9/00;;B06B3/02;;Y10S116/30,B06B3/02;;B06B3/04;;H04N5/58;;H04Q9/00,,0,0,,,,UNKNOWN
379,US,A1,US 2012/0042236 A1,118-695-011-829-168,2012-02-16,2012,US 201113278176 A,2011-10-20,US 201113278176 A;;US 91262510 A;;US 201113189372 A;;US 32616610 P;;US 33016110 P,2010-04-20,INTEGRATED DOCUMENT VIEWER,"In various embodiments of the present invention, documents (eg, PDFs) are converted into HTML 5 (and CSS 3) formats and integrated into existing HTML 5 web pages to preserve the original embedded fonts. The fonts can also be integrated or embedded (e.g., via the standard HTML “iframe” tag) into other web pages. The original appearance of the source document is maintained, the text is preserved as searchable text, and the document is integrated into a web page that can be searched, zoomed, scrolled, and printed utilizing standard web browser controls. A significantly increased “ad inventory” is thereby enabled, wherein advertisements can be integrated between pages, or even within a page. Moreover, the resulting document can be passively shared with members of a user's external social networks (including those within the host website), along with other activities and behaviors performed by the user on the hosting website.",ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW;;SCRIBD INC,ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW,,https://lens.org/118-695-011-829-168,Patent Application,yes,17,23,4,4,0,G06F40/126;;G06F40/126;;G06F40/109;;G06F40/109;;G06F40/151;;G06F40/151,G06F17/00,715/234,2,0,,,"v-render, ""Using css3 @font-face"", 2/27/2010, v-render studio, p1-5 + 1 page from Wayback; http://web.archive.org/web/20100227050531/http://www.v-render.co.in/2010/02/24/using-css3-font-face-property/;;Hardmeierm, Sandi, ""Zoom - Internet Explorer 7"", 12/17/2008, IE-Vista, p1-2; http://www.ie-vista.com/zoom.html",DISCONTINUED
380,US,B2,US 8707164 B2,168-856-387-314-881,2014-04-22,2014,US 201213343695 A,2012-01-04,US 201213343695 A;;US 201113278176 A;;US 201113235362 A;;US 201113189372 A;;US 91262510 A;;US 32616610 P;;US 33016110 P,2010-04-20,Integrated document viewer,"In various embodiments of the present invention, documents (eg, PDFs) are converted into HTML 5 (and CSS 3) formats and integrated into existing HTML 5 web pages to preserve the original embedded fonts. The fonts can also be integrated or embedded (e.g., via the standard HTML “iframe” tag) into other web pages. The original appearance of the source document is maintained, the text is preserved as searchable text, and the document is integrated into a web page that can be searched, zoomed, scrolled, and printed utilizing standard web browser controls. A significantly increased “ad inventory” is thereby enabled, wherein advertisements can be integrated between pages, or even within a page. Moreover, the resulting document can be passively shared with members of a user's external social networks (including those within the host website), along with other activities and behaviors performed by the user on the hosting website.",ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW;;SCRIBD INC,ADLER III JOHN;;FRIEDMAN JARED;;KRAMM MATTHIAS;;LEWIS MICHAEL;;RILEY MATTHEW,SCRIBD INC (2014-03-18),https://lens.org/168-856-387-314-881,Granted Patent,yes,32,11,4,4,0,G06F40/126;;G06F40/126;;G06F40/109;;G06F40/109;;G06F40/151;;G06F40/151,G06F17/00,715/239;;715/200;;715/201;;715/234;;715/255;;715/256;;715/269,9,1,092-413-243-465-367,10.1007/978-1-4302-2666-6_4,"V-render, ""Using css3 @font-face"", Feb. 27, 2010, v-render studio, p. 1-5 + 1 page from Wayback; http://web.archive.org/web/20100227050531/http://www.v-render.co.in/2010/02/24/using-css3-font-face-property/.;;Hardmeierm, Sandi, ""Zoom-Internet Explorer 7"", Dec. 17, 2008, IE-Vista, p. 1-2; http://www.ie-vista.com/zoom.html.;;Lehigh University, ""Zoom Feature-An eye toward greater readability"", 2008, p. 1-2; http://web.archive.org/web/20080604095631/http://www.lehigh.edu/helpdesk/docs/ie7/zoom.html.;;Korpela, Jukka, ""Using inline frames (iframe elements) to embed documents into HTML documents"", Feb. 27, 2004, 12 pages, http://www.cs.tut.fi/~jkorpela/html/iframe.html.;;Urbain-Lurain, Mark, ""Embedding a PDF File on a Web Page"", 2008, MSU, 2 pages; https://www.msu.edu/~urban/sme865/resources/embedded-pdf.html.;;Jonathan, ""Embed Google Docs document within your web page"", Apr. 1, 2010, 4 pages, http://jonathancamp.com/2010/04/01/embed-google-docs-document-within-your-web-page/.;;Anonymous; Note-Title Not Relevant-The wePage web page is cited to show use of viewer within web page, not the text on the page. Web page is at: http:i/web.archive.org/web/20090410150631/http:/lwww.wepapers.com/papers/1544/linux.c++programming.HOWTO. Date of archive: Apr. 10, 2009, Publisher: Internet Archive Wayback Machine, USA. Viewer screen shows: Table of Contents of article on C++ Programming, (2 pages, one submitted in color, one submitted in black & white).;;Anonymous; Note-Title Not Relevant-The wePage web page is cited to show use of viewer within web page, not the text on the page. Web page is at: http:i/web.archive.org/web/20090410150631/http:i/www.wepapers.com/papers/1544/linux.c++programmming.HOWTO. Date of archive: Apr. 10, 2009, Publisher: Internet Archive Wayback Machine, USA. Viewer screen shows: Text from article on C++ Programming with highlighted term ""functions"". (2 pages, one submitted in color, one submitted in black & white).;;Anonymous; Note-Title Not Relevant-The wePage web page is cited to show use of viewer within web page, not the text on the page. Web page is at: http:i/web.archive.org/web/20090410150631/http:i/www.wepapers.com/papers/1544/linux.c++ programming.HOWTO. Date of archive: Apr. 10, 2009, Publisher: Internet Archive Wayback Machine, USA Viewer screen shows: Screenshot from article on C++ Programming with Adobe Flash Player Settings box displayed, (2 pages, one submitted in color, one submitted in black.",INACTIVE
381,DE,A1,DE 102013103419 A1,086-767-312-260-586,2013-10-17,2013,DE 102013103419 A,2013-04-05,US 201213446176 A,2012-04-13,Systeme und Verfahren zum Steuern von Röntgenbildgebungssystemen,"Es werden System und Verfahren zum Steuern eines Röntgenbildgebungssystems beschrieben. Die Systeme und Verfahren beinhalten typischerweise einen Tragarm mit einem ersten Ende und einem zweiten Ende. Das erste Ende des Tragarms ist mit einer Gelenkarmbaugruppe verbunden und das zweite Ende des Tragarms ist schwenkbar an einem Röntgenbildgebungsarm an einem Drehgelenk so befestigt, dass das Drehgelenk als eine Kreisbahndrehachse für den Röntgenbildgebungsarm funktioniert. Eine oder mehrere Steuerungen für das Röntgenbildgebungssystem sind auf dem Tragarm für das Röntgenbildgebungssystem angeordnet. Die Steuerungen können daher feststehend bleiben, während sich der Röntgenbildgebungsarm auf der Kreisbahn dreht. Der Tragarm kann ein einzelnes Element oder ein Doppelelement enthalten und eine oder mehrere Steuerungen können auf jedem Ele ment des Tragarms angeordnet sein. Weitere Ausführungsformen werden ebenfalls beschrieben.",GEN ELECTRIC,SIMMONS JOHN MATTHEW;;BARKER DAVID;;ADLER SAMUEL;;NICHOLSON BRET;;SPRATT JR,,https://lens.org/086-767-312-260-586,Patent Application,no,0,0,5,5,0,A61B6/4405;;A61B6/4441;;A61B6/467;;A61B6/487;;A61B6/548;;A61B6/4405;;A61B6/4441;;A61B6/467;;A61B6/487;;A61B6/548;;G01N23/04;;H05G1/02,H05G1/02,,0,0,,,,DISCONTINUED
382,US,A,US 3271731 A,109-262-544-780-563,1966-09-06,1966,US 33619764 A,1964-01-07,US 33619764 A,1964-01-07,Electron beam parametric amplifier with positive ion elimination,,ZENITH RADIO CORP,ROBERT ADLER;;CRUMLY CHARLES B;;FOSTER LEIGH C;;LINDLEY JOHN P,,https://lens.org/109-262-544-780-563,Granted Patent,no,0,2,1,1,0,H01J25/49;;H01J25/49,H01J25/49,,0,0,,,,EXPIRED
383,US,B2,US 8337382 B2,199-351-674-040-351,2012-12-25,2012,US 26134708 A,2008-10-30,US 26134708 A;;US 98463607 P,2007-11-01,"Radiosurgical neuromodulation devices, systems, and methods for treatment of behavioral disorders by external application of ionizing radiation","Radiosurgical techniques and systems treat behavioral disorders (such as depression, Obsessive-Compulsive Disorder (“OCD”), addiction, hyperphagia, and the like) by directing radiation from outside the patient toward a target tissue within the patient's brain, typically without imposing surgical trauma. The target will often be included in a neural circuit associated with the behavioral disorder. A cellularly sub-lethal dose of the radiation may be applied and the radiation can mitigate the behavioral disorder, obesity, or the like, by modulating the level of neural activity within the target and in associated tissues. Hypersensitive and/or hyperactive neuronal tissue may be targeted, with the radiation downwardly modulating hyperactive neuronal activity. By down-regulating the activity of a target that normally exerts negative feedback or a limiting effect on a relevant neural circuit, the activity of the circuit may be increased.",SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS III DOYLE JOHN;;BORCHERS LEGAL REPRESENTATIVE MICHELE,SCHNEIDER M BRET;;ADLER JR JOHN R;;BORCHERS III DOYLE JOHN;;BORCHERS LEGAL REPRESENTATIVE MICHELE,ADLER JR. JOHN R. M.D (2009-06-02);;SCHNEIDER M. BRET M.D (2009-06-02);;ZAP SURGICAL SYSTEMS INC (2019-10-29),https://lens.org/199-351-674-040-351,Granted Patent,yes,6,5,8,8,0,A61N5/1084;;A61N5/1084;;A61N5/10;;A61N5/10;;A61N5/1039;;A61N5/1049;;A61N5/1049;;A61N5/1077,A61N5/10,600/1,7,6,088-605-253-045-077;;016-423-074-261-904;;025-580-865-305-112;;105-163-612-129-619;;030-019-655-024-002;;004-229-238-641-491,2336467;;10.2307/3577608;;7632622;;10.1016/0920-9964(94)00055-d;;11229981;;10.1176/appi.ajp.158.3.405;;10.1016/s0166-4328(01)00364-3;;11718882;;15627591;;10.1016/j.neuroimage.2004.08.041;;11584307;;10.1038/35094560,"Pellmar TC, Schauer DA, and Zeman GH. Time- and Dose-Dependent Changes in Neuronal ACtivity Produced by X Radiation in Brain Slices. Radiaton Research 1990; 122: 209-214.;;Lewine RRJ, Hudgins P, Brown F, Caudle J, Risch SC. Differences in Qualitative Brain Morphology Fidnings in Schizophrenia, Major Depression, Bipolar Disorder, and Normal Volunteers. Schizophrenia Research 1995; 15: 253-259.;;Pizzagali D, Pascual-Marqui, RD, Nitschke JB, Oakes TR, Larson CL, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, and Davidson RJ. Anterior Cingulate Activity as a Predictor of Degree of Treatment Response in Major Depression: Evidence from Brain Electrical Tomography Analysis. American Journal of Psychiatry 2001; 158: 405-415.;;Tracy AL, Jarrard LE, Davidson TL. The Hippocampus and Motivation Revisited: Appetite and Activity. Behavioral Brain Research 2001; 127: 13-23.;;Maltby N, Tolin DF, Worhunsky P, O'Keefe TM, Kiehl KA. Dysfunctional Action Monitoring Hyperactivates Frontal-striatal Circuits in Obsessive-compulsive Disorder: an Event-related fMRI study. Neuroimage 2005; 24:495-503.;;Hyman Se and Malenka RC. Addiciton and the Brain: The Neurobiology of Compulsion and Its Persistence. Nature Reviews: Neuroscience 2001; 2: 695-703.;;Kandel ER, Schwartz JH, and Jessell TM. Principles of Neural Science 4th Edition. New York: McGraw-Hill Companies Inc, 2000. 1002-1006. Print.",ACTIVE
384,US,A1,US 2013/0312757 A1,114-102-602-519-143,2013-11-28,2013,US 201313860926 A,2013-04-11,US 201313860926 A;;US 201261623855 P;;US 201361775430 P,2012-04-13,SLEEP APNEA DEVICE,"A system for treating a patient suffering from obstructive sleep apnea may include a mask, a portable air flow generator configured to generate air flow at a relatively low flow rate, and a tube connecting the air flow generator and the mask such that air flow from the generator passes through an air flow generator valve on the mask. The mask may include a contact surface for forming a seal between the mask and the patient's face such that the mask surrounds the patient's nostrils, an expiration valve that opens during expiration, and an air flow generator valve that opens during inspiration. In some embodiments, the mask may further include an inspiration valve that opens during inspiration to allow air from outside the system to enter the mask.",FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;TRUSHEIM JOHN;;NOLTING JOHN;;CHEN EUGENE G;;GORDON ALAN;;WU SAMUEL;;ADLER MARK,FRESCA MEDICAL INC (2013-10-07),https://lens.org/114-102-602-519-143,Patent Application,yes,7,21,3,63,0,A61M16/06;;A61M16/0683;;A61M16/0875;;A61M16/20;;A61M2016/0039;;A61M2016/0661;;A61M2205/8206;;A61M2209/088;;A61M2230/205;;A61M16/0833;;A61M16/0069;;A61M16/0688;;A61M16/0866;;A61M16/202;;A61M16/209;;A61M2205/42;;A61M16/0063;;A61M2205/0266;;A61M16/0605;;A61M16/205;;A61M16/024;;A61M16/0057;;A61M16/208;;A61M2205/42;;A61M16/0683;;A61M16/0875;;A61M16/20;;A61M2016/0039;;A61M2016/0661;;A61M2205/8206;;A61M2209/088;;A61M2230/205;;A61M16/0833;;A61M16/0069;;A61M16/0688;;A61M16/0866;;A61M16/202;;A61M16/209;;A61M16/06;;A61M16/0605;;A61M16/0063;;A61M2205/0266;;A61M16/205;;A61M16/024;;A61M16/0057;;A61M16/208,A61M16/00;;A61M16/20;;A61M16/06,128/205.24,0,0,,,,ACTIVE
385,US,A1,US 2006/0206454 A1,019-039-862-078-783,2006-09-14,2006,US 7647305 A,2005-03-08,US 7647305 A,2005-03-08,Immediate search feedback,"Providing immediate search feedback is disclosed. Search input is received within a search field of a web browser application. Based on characteristics of the search input, a determination is made whether to automatically submit a query to a search engine. In one aspect, the query is automatically submitted to the search engine. The query is based on the received first search input. Results are displayed within the web browser application, the results web page returned from the query submitted to the search engine.",FORSTALL SCOTT J;;MELTON DONALD D;;SULLIVAN JOHN W;;ADLER DARIN B,FORSTALL SCOTT J;;MELTON DONALD D;;SULLIVAN JOHN W;;ADLER DARIN B,APPLE INC (2005-05-25),https://lens.org/019-039-862-078-783,Patent Application,yes,7,462,4,4,0,G06F16/951;;G06F16/951;;G06F16/953,G06F17/30,707/3,0,0,,,,ACTIVE
386,DE,D1,DE 3466250 D1,148-401-064-412-00X,1987-10-22,1987,DE 3466250 T,1984-10-26,US 54648083 A,1983-10-28,"HIGH STRENGTH, WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME",,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;TUCKER ROBERT CLARK,,https://lens.org/148-401-064-412-00X,Granted Patent,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
387,US,B2,US 7788248 B2,168-142-886-221-597,2010-08-31,2010,US 7647305 A,2005-03-08,US 7647305 A,2005-03-08,Immediate search feedback,"Providing immediate search feedback is disclosed. Search input is received within a search field of a web browser application. Based on characteristics of the search input, a determination is made whether to automatically submit a query to a search engine. In one aspect, the query is automatically submitted to the search engine. The query is based on the received first search input. Results are displayed within the web browser application, the results web page returned from the query submitted to the search engine.",APPLE INC,FORSTALL SCOTT JAMES;;MELTON DONALD D;;SULLIVAN JOHN WILLIAM;;ADLER DARIN BENJAMIN,APPLE INC (2005-05-25),https://lens.org/168-142-886-221-597,Granted Patent,yes,7,78,4,4,0,G06F16/951;;G06F16/951;;G06F16/953,G06F7/00,707/706;;707/736,7,0,,,"Internet Explorer 6. ""How and Why to Clear your Cache"", Windows, Mar. 2004.;;Google~Guide. ""An Interactive Tutorial on Making Searching Even Easier"", 2004.;;Watanabe, David, Inquisitor. Web Search Revelation, Nov. 23, 2003, 2 pages, http://www.inquisitorx.com/.;;Watanabe, David, Screenshot of Inquisitor, After Jan. 5, 2004, 1 page, Version 0.67.;;Author Unkown, Livesearch from Bitflux Blog Wiki, date unknown, Not After Sep. 21, 2004, 3 pages, http://blog.bitflux.ch/wiki/LiveSearch.;;Watanabe, David, Spotlight-like livesearch added, May 7, 2004, 9 pages, http://blog.bitflux.ch/archive/spotlight13 like-livesearch-added.html.;;Watanabe, David, Sciforums.com Inquisitor, May 24, 2004, 1 page, http://sciforums.com/showthread.php?t=36621.",ACTIVE
388,CN,A,CN 104883974 A,043-051-498-430-614,2015-09-02,2015,CN 201380068061 A,2013-10-28,US 2013/0067127 W;;US 201261719301 P;;US 201361798066 P;;US 201314040609 A;;US 201314040604 A,2012-10-26,Nir image guided targeting,"A method for treatment. The method includes performing an in-treatment optical scan on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. The method further includes detecting a plurality of detected signals from the optical scan. The method further includes filtering out skin characteristics from the plurality of detected signals. The method further includes determining skeletal anatomy associated with the region from the plurality of signals that is filtered.",VARIAN MEDICAL SYSTEM INC,ADLER JOHN R JR;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM;;SHARDA AGAM,,https://lens.org/043-051-498-430-614,Patent Application,no,8,1,7,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4836;;A61B6/032;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4836;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B6/00;;A61B5/055;;A61B6/03;;A61N5/00,,2,0,,,"JAMES R. MANSFIELD 等: ""Autofluorescence removal,multiplexing,and automated analysis methods for in-vivo fluorescence imaging"", 《JOURNAL OF BIOMEDICAL OPTICS》;;SNOEKS T J A 等: ""Optical advances in skeletal imaging applied to bone metastases"", 《BONE》",ACTIVE
389,WO,A1,WO 2014/066906 A1,131-982-752-798-568,2014-05-01,2014,US 2013/0067127 W,2013-10-28,US 201361798066 P;;US 201261719301 P;;US 201314040609 A;;US 201314040604 A,2012-10-26,NIR IMAGE GUIDED TARGETING,"A method for treatment. The method includes performing an in-treatment optical scan on a region of a patient, wherein the in-treatment optical scan comprises a near infrared (NIR) energy source. The method further includes detecting a plurality of detected signals from the optical scan. The method further includes filtering out skin characteristics from the plurality of detected signals. The method further includes determining skeletal anatomy associated with the region from the plurality of signals that is filtered.",VARIAN MED SYS INC;;ADLER JOHN R JR;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM;;SHARDA AGAM,ADLER JOHN R JR;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM;;SHARDA AGAM,,https://lens.org/131-982-752-798-568,Patent Application,yes,5,11,7,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4836;;A61B6/032;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4836;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61B6/00;;A61B5/055;;A61B6/03;;A61N5/00,,1,0,,,See also references of EP 2911587A4,PENDING
390,US,A1,US 2020/0026850 A1,064-969-244-353-939,2020-01-23,2020,US 201816144347 A,2018-09-27,US 201816144347 A;;US 201862700586 P,2018-07-19,TECHNIQUES FOR SERVERLESS RUNTIME APPLICATION SELF-PROTECTION,"A system and method for serverless runtime application self-protection. The method includes embedding a serverless defender function into a function serverless bundle containing an application deployment bundle of a serverless application, wherein the embedding further comprises modifying the function serverless bundle to include a serverless defender shared library and a security policy, wherein the serverless defender shared library is configured to install at least one hook into at least one system call of the serverless application when the serverless application is executed, wherein each hook only allows running of system calls and library functions that satisfy the security policy during execution of the serverless application, wherein the serverless defender function is loaded at a system when the serverless application is initiated by the system, wherein the serverless defender function is configured to perform at least one mitigation action when the security policy is violated during execution of the serverless application.",TWISTLOCK LTD,LEVIN LIRON;;STOPEL DIMA;;VELBAUM MICHAEL;;ADLER ALON;;KLETSELMAN MICHAEL;;MORELLO JOHN,TWISTLOCK LTD (2018-09-26),https://lens.org/064-969-244-353-939,Patent Application,yes,0,13,13,13,0,G06F9/455;;G06F21/552;;H04L63/1408;;H04L63/20;;G06F9/45558;;H04L63/20;;G06F2009/45591;;G06F2009/45587;;G06F2009/45583;;G06F2009/45595;;G06F16/2379;;G06N20/00;;G06F21/53;;G06F9/44505;;G06F21/51;;G06F21/54;;G06F18/214;;G06F9/455,G06F21/54;;G06F9/445;;G06F21/51;;H04L29/06,,0,0,,,,ACTIVE
391,EP,A4,EP 2911587 A4,068-468-833-691-231,2016-06-22,2016,EP 13849715 A,2013-10-28,US 201261719301 P;;US 201361798066 P;;US 201314040609 A;;US 201314040604 A;;US 2013/0067127 W,2012-10-26,NIR IMAGE GUIDED TARGETING,,VARIAN MED SYS INC,ADLER JOHN R JR;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM;;SHARDA AGAM,,https://lens.org/068-468-833-691-231,Search Report,no,2,0,7,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4836;;A61B6/032;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4836;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61N5/00;;A61B6/03,,6,5,033-711-534-975-725;;007-084-070-302-780;;080-865-111-362-448;;040-609-010-642-121;;087-790-488-376-664,10.1016/j.bone.2010.07.027;;20688203;;10.1117/1.2032458;;16178631;;10.1038/nbt1201-1148;;11731784;;22547491;;10.1088/0031-9155/57/10/3123;;18941911;;10.1007/s10585-008-9217-8,"SNOEKS T J A ET AL: ""Optical advances in skeletal imaging applied to bone metastases"", BONE, PERGAMON PRESS., OXFORD, GB, vol. 48, no. 1, 1 January 2011 (2011-01-01), pages 106 - 114, XP027568405, ISSN: 8756-3282, [retrieved on 20100803];;JAMES R. MANSFIELD ET AL: ""Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging"", JOURNAL OF BIOMEDICAL OPTICS, vol. 10, no. 4, 1 January 2005 (2005-01-01), US, pages 041207, XP055269855, ISSN: 1083-3668, DOI: 10.1117/1.2032458;;ATIF ZAHEER ET AL: ""In vivo near-infrared fluorescence imaging of osteoblastic activity"", NATURE BIOTECHNOLOGY, vol. 19, no. 12, 1 December 2001 (2001-12-01), US, pages 1148 - 1154, XP055269648, ISSN: 1087-0156, DOI: 10.1038/nbt1201-1148;;OSCAR R BROUWER ET AL: ""Image navigation as a means to expand the boundaries of fluorescence-guided surgery;Image navigation as a means to expand the boundaries of fluorescence-guided surgery"", PHYSICS IN MEDICINE AND BIOLOGY, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL GB, vol. 57, no. 10, 1 May 2012 (2012-05-01), pages 3123 - 3136, XP020221940, ISSN: 0031-9155, DOI: 10.1088/0031-9155/57/10/3123;;ERIC L KAIJZEL ET AL: ""Multimodal imaging and treatment of bone metastasis"", CLINICAL & EXPERIMENTAL METASTASIS ; OFFICIAL JOURNAL OF THEMETASTASIS RESEARCH SOCIETY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 26, no. 4, 22 October 2008 (2008-10-22), pages 371 - 379, XP019672682, ISSN: 1573-7276;;See also references of WO 2014066906A1",ACTIVE
392,US,A1,US 2014/0171725 A1,098-559-739-753-944,2014-06-19,2014,US 201314017992 A,2013-09-04,US 201314017992 A;;US 201261697218 P,2012-09-05,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,A radiation system includes: a first support; a first structure rotatably coupled to the first support so that the first structure is rotatable about a first axis relative to the first support; a second structure rotatably coupled to the first structure so that the second structure is rotatable about a second axis that forms a non-zero angle relative to the first structure; and a first radiation source connected to the second structure; wherein the first structure and the second structure are parts of a capsule for accommodating at least a portion of a patient.,VARIAN MED SYS INC,ADLER JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2014-02-05),https://lens.org/098-559-739-753-944,Patent Application,yes,4,25,2,2,0,A61N5/1082;;A61N5/1082;;A61N2005/1094;;A61N2005/1094;;G21F3/00;;G21F3/00,A61N5/10;;G21F3/00;;H05G1/02,600/1;;378/196;;378/145,1,0,,,Definition of Capsule from dictionary.com printed from internet 12/26/2016,ACTIVE
393,US,B2,US 11036534 B2,033-974-025-376-403,2021-06-15,2021,US 201816144347 A,2018-09-27,US 201816144347 A;;US 201862700586 P,2018-07-19,Techniques for serverless runtime application self-protection,"A system and method for serverless runtime application self-protection. The method includes embedding a serverless defender function into a function serverless bundle containing an application deployment bundle of a serverless application, wherein the embedding further comprises modifying the function serverless bundle to include a serverless defender shared library and a security policy, wherein the serverless defender shared library is configured to install at least one hook into at least one system call of the serverless application when the serverless application is executed, wherein each hook only allows running of system calls and library functions that satisfy the security policy during execution of the serverless application, wherein the serverless defender function is loaded at a system when the serverless application is initiated by the system, wherein the serverless defender function is configured to perform at least one mitigation action when the security policy is violated during execution of the serverless application.",TWISTLOCK LTD,LEVIN LIRON;;STOPEL DIMA;;VELBAUM MICHAEL;;ADLER ALON;;KLETSELMAN MICHAEL;;MORELLO JOHN,TWISTLOCK LTD (2018-09-26),https://lens.org/033-974-025-376-403,Granted Patent,yes,31,1,13,13,0,G06F9/455;;G06F21/552;;H04L63/1408;;H04L63/20;;G06F9/45558;;H04L63/20;;G06F2009/45591;;G06F2009/45587;;G06F2009/45583;;G06F2009/45595;;G06F16/2379;;G06N20/00;;G06F21/53;;G06F9/44505;;G06F21/51;;G06F21/54;;G06F18/214;;G06F9/455,G06F9/455;;G06F9/445;;G06F16/23;;G06F21/51;;G06F21/53;;G06F21/54;;G06K9/62;;G06N20/00;;H04L29/06,,0,0,,,,ACTIVE
394,SG,A,SG 10201912574W A,119-671-615-011-64X,2020-02-27,2020,SG 10201912574W A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,,BLADE THERAPEUTICS INC,BUCKMAN BRAD;;NICHOLAS JOHN;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG,,https://lens.org/119-671-615-011-64X,Unknown,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,,0,0,,,,PENDING
395,US,B2,US 8185529 B2,098-316-834-790-018,2012-05-22,2012,US 87072510 A,2010-08-27,US 87072510 A;;US 7647305 A,2005-03-08,Immediate search feedback,"Providing immediate search feedback is disclosed. Search input is received within a search field of a web browser application. Based on characteristics of the search input, a determination is made whether to automatically submit a query to a search engine. In one aspect, the query is automatically submitted to the search engine. The query is based on the received first search input. Results are displayed within the web browser application, the results web page returned from the query submitted to the search engine.",FORSTALL SCOTT JAMES;;MELTON DONALD D;;SULLIVAN JOHN WILLIAM;;ADLER DARIN BENJAMIN;;APPLE INC,FORSTALL SCOTT JAMES;;MELTON DONALD D;;SULLIVAN JOHN WILLIAM;;ADLER DARIN BENJAMIN,,https://lens.org/098-316-834-790-018,Granted Patent,yes,10,8,4,4,0,G06F16/951;;G06F16/951;;G06F16/953,G06F17/30,707/736,7,0,,,"Internet Explorer 6. ""How and Why to Clear your Cache"", Windows, Mar. 2004.;;Google-Guide. ""An Interactive Tutorial on Making Searching Even Easier"", 2004.;;Watanabe, David, Inquisitor. Web Search Revelation, Nov. 23, 2003, 2 pages, http://www.inquisitorx.com/.;;Watanabe, David, Screenshot of Inquisitor, After Jan. 5, 2004, 1 page, Version 0.67.;;Author Unknown, Livesearch from Bitflux Blog Wiki, date unknown, Not After Sep. 21, 2004, 3 pages, http://blog.bitflux.ch/wiki/LiveSearch.;;Watanabe, David, Spotlight-like livesearch added, May 7, 2004, 9 pages, http://blog.bitflux.ch/wiki/LiveSearch.;;Watanabe, David, Sciforums.com Inquisitor, May 24, 2004, 1 page, http://sciforums.com/showthread.php?t=36621.",ACTIVE
396,US,A,US 5485085 A,125-506-672-417-345,1996-01-16,1996,US 34551894 A,1994-11-28,US 34551894 A,1994-11-28,Method for correcting magnetic field inhomogeneity distortion in MRI images having disconnected regions,"Disclosed is a method to correct the geometric distortion caused by field inhomogeneity in MR images such as images of patients wearing MR-compatible stereotaxic frames. A previous distortion correction method derives patient-dependent error maps by computing the phase-difference of 3D images acquired at different T.sub.E 's. The time difference (.DELTA.T.sub.E =4.9 ms at 1.5 T) is chosen such that the water and fat signals are in phase. However, .DELTA.T.sub.E is long enough to permit phase wraps in the difference images for frequency offsets greater than 205 Hz. Phase unwrapping techniques resolve these only for connected structures; therefore the phase difference for fiducial rods may be off by multiples of 2 .pi. relative to the head. This uncertainty is removed by using an additional single 2D phase-difference image with .DELTA.T.sub.E =1 ms (during which time no phase-wraps are typically expected) to determine the correct multiple of 2 .pi. for each rod. The method was tested in a cadaver and in a patient using CT as a reference. Targets in the frame coordinates were chosen from CT and compared to their locations in MR. Localizing errors were as large as 3.7 mm before correction and were reduced to less than 1.11 mm after correction.",UNIV LELAND STANFORD JUNIOR,SUMANAWEERA THILAKA;;NAPEL SANDY A;;GLOVER GARY H;;ADLER JR JOHN R,BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (1995-01-11),https://lens.org/125-506-672-417-345,Granted Patent,yes,2,31,1,1,0,G01R33/243;;G01R33/56563;;G01R33/56563;;G01R33/243,G01R33/24;;G01R33/567,324/307;;324/309,2,2,068-408-265-228-390;;121-436-757-147-886,10.1097/00006123-199410000-00016;;10.1227/00006123-199410000-00016;;7808613;;18218412;;10.1109/42.232253,"Sumanaweera, et al., Characterization of Spatial Distortion in Magnetic Resonance Imaging and its Implications for Stereotactic Surgery, Neurosurgery, vol. 35, No. 4, Oct. 1994, p. 696.;;Suamanaweera, et al., MR Susceptibility Misregistration Correction, IEEE Trans. on Medical Imaging, vol. 12, No. 2, Jun. 1993, p. 251.",EXPIRED
397,US,A1,US 2004/0038312 A1,179-258-564-364-740,2004-02-26,2004,US 36486103 A,2003-02-10,US 36486103 A;;US 39363499 A,1999-09-10,"T2R, a novel family of taste receptors","
   The invention provides isolated nucleic acid and amino acid sequences of taste cell specific G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of taste cell specific G-protein coupled receptors. 
",ZUKER CHARLES S.;;ADLER JOHN ELLIOT;;HOON MARK;;RYBA NICK;;MUELLER KEN,ZUKER CHARLES S;;ADLER JOHN ELLIOT;;HOON MARK;;RYBA NICK;;MUELLER KEN,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (2003-06-03);;GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES THE (2003-06-11),https://lens.org/179-258-564-364-740,Patent Application,yes,0,5,17,48,95,C07K14/705;;C07K14/705,C07K14/705;;C12N5/02,435/7.2,0,0,,,,EXPIRED
398,US,B1,US 6315265 B1,189-894-593-628-792,2001-11-13,2001,US 54863500 A,2000-04-13,US 54863500 A;;US 12925699 P,1999-04-14,Variable valve timing actuator,"The invention involves a variable valve timing actuator that allows the opening and closing of engine valves to be variably and individually controlled without using a camshaft. The invention utilizes energy regeneration so energy delivered to a valve while accelerating it is recovered while it is decelerating. Regeneration is preferably provided by potential energy storage devices such as springs. Energy losses are made up by adding energy to the actuator while the valve is stationary (or nearly so) in an open or closed state. This is done by (1) moving the spring seats in relation to the valve, thereby ""charging"" the springs in relation to the valve, and/or by (2) moving the valve with respect to the spring seats to ""charge"" the springs with respect to the valve. This energy addition is extremely efficient because it is performed after the potential energy within the springs has already been expended and the valve is sitting stationary in its open and closed positions. To hold the valve stationary when desired, a latch (e.g., a one-way clutch) is used to releasably fix the valve in place.",WISCONSIN ALUMNI RES FOUND,ADLER SCOTT PETER;;BEACHLEY NORMAN HENRY;;FRONCZAK FRANK JOHN;;SABRI AHMAD MOHAMMAD,WISCONSIN ALUMNI RESEARCH FOUNDATION (2000-05-02),https://lens.org/189-894-593-628-792,Granted Patent,yes,17,22,1,1,0,F16K31/003;;F16K31/122;;F01L9/10;;F16K31/122;;F16K31/003;;F01L9/10,F01L9/10;;F16K31/00;;F16K31/122,251/28;;251/32;;123/90.12,8,1,050-745-202-054-980,10.4271/891676,"Ahmad, T. and Theobald, M.A., A Survey of Variable-Valve-Actuation Technology, 1989 Society of Automotive Engineers, Inc. #891674, pp. 1-27.;;Chapter 11, Clutches and Brakes, Commercially Available One-Way Clutches, pp. 684-686.;;Dresner, Thomas and Barkan, Philip, A Review and Classification of Variable Valve Timing Mechanisms, 1989 Society of Automotive Engineers, Inc. #890674, pp. 1-14.;;Dresner, Thomas and Barkan, Philip, A Review of Variable Valve Timing Benefits and Modes of Operation, 1989 Society of Automotive Engineers, Inc. #891676, pp. 1-9.;;Gray, C., A Review of Variable Engine Valve Timing, 1988 Society of Automotive Engineers, Inc., #880386, pp. 1-11.;;Schecter, Michael M. and Levin, Michael B., Camless Engines, 1996 Society of Automotive Engineers, Inc. #960581, pp. 17-31.;;Stone, Richard and Kwan, Eric, Variable Valve Actuation Mechanisms and the Potential for their Application, 1989 Society of Automotive Engineers, Inc. #890673, pp. 1-17.;;Van Valkenburgh, Paul, Electric Valves, Road & Track, pp. 170 and 174.",EXPIRED
399,US,A1,US 2010/0325100 A1,085-161-348-774-121,2010-12-23,2010,US 87072510 A,2010-08-27,US 87072510 A;;US 7647305 A,2005-03-08,IMMEDIATE SEARCH FEEDBACK,"Providing immediate search feedback is disclosed. Search input is received within a search field of a web browser application. Based on characteristics of the search input, a determination is made whether to automatically submit a query to a search engine. In one aspect, the query is automatically submitted to the search engine. The query is based on the received first search input. Results are displayed within the web browser application, the results web page returned from the query submitted to the search engine.",FORSTALL SCOTT JAMES;;MELTON DONALD D;;SULLIVAN JOHN WILLIAM;;ADLER DARIN BENJAMIN,FORSTALL SCOTT JAMES;;MELTON DONALD D;;SULLIVAN JOHN WILLIAM;;ADLER DARIN BENJAMIN,,https://lens.org/085-161-348-774-121,Patent Application,yes,6,57,4,4,0,G06F16/951;;G06F16/951;;G06F16/953,G06F17/30,707/706;;X707E17108,0,0,,,,ACTIVE
400,EP,B1,EP 2911587 B1,068-045-874-452-988,2018-10-17,2018,EP 13849715 A,2013-10-28,US 201261719301 P;;US 201361798066 P;;US 201314040609 A;;US 201314040604 A;;US 2013/0067127 W,2012-10-26,NIR IMAGE GUIDED TARGETING,,VARIAN MED SYS INC,ADLER JOHN R JR;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM;;SHARDA AGAM,,https://lens.org/068-045-874-452-988,Granted Patent,yes,7,0,7,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4836;;A61B6/032;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4836;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61N5/00;;A61B6/03,,5,0,,,"SNOEKS T J A ET AL: ""Optical advances in skeletal imaging applied to bone metastases"", BONE, PERGAMON PRESS., OXFORD, GB, vol. 48, no. 1, 1 January 2011 (2011-01-01), pages 106-114, XP027568405, ISSN: 8756-3282 [retrieved on 2010-08-03];;JAMES R. MANSFIELD ET AL: ""Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging"", JOURNAL OF BIOMEDICAL OPTICS, vol. 10, no. 4, 1 January 2005 (2005-01-01), page 041207, XP055269855, US ISSN: 1083-3668, DOI: 10.1117/1.2032458;;ATIF ZAHEER ET AL: ""In vivo near-infrared fluorescence imaging of osteoblastic activity"", NATURE BIOTECHNOLOGY, vol. 19, no. 12, 1 December 2001 (2001-12-01), pages 1148-1154, XP055269648, US ISSN: 1087-0156, DOI: 10.1038/nbt1201-1148;;OSCAR R BROUWER ET AL: ""Image navigation as a means to expand the boundaries of fluorescence-guided surgery;Image navigation as a means to expand the boundaries of fluorescence-guided surgery"", PHYSICS IN MEDICINE AND BIOLOGY, INSTITUTE OF PHYSICS PUBLISHING, BRISTOL GB, vol. 57, no. 10, 1 May 2012 (2012-05-01), pages 3123-3136, XP020221940, ISSN: 0031-9155, DOI: 10.1088/0031-9155/57/10/3123;;ERIC L KAIJZEL ET AL: ""Multimodal imaging and treatment of bone metastasis"", CLINICAL & EXPERIMENTAL METASTASIS ; OFFICIAL JOURNAL OF THEMETASTASIS RESEARCH SOCIETY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 26, no. 4, 22 October 2008 (2008-10-22), pages 371-379, XP019672682, ISSN: 1573-7276",ACTIVE
401,US,S,US D0699353 S,138-404-085-096-705,2014-02-11,2014,US 201129393156 F,2011-05-31,US 201129393156 F,2011-05-31,Imaging system pivot arm,,SIMMONS JOHN MATTHEW;;ADLER SAMUEL LEE;;BARKER DAVID ELLIS;;BRUENING JAN DAVID;;GEN ELECTRIC,SIMMONS JOHN MATTHEW;;ADLER SAMUEL LEE;;BARKER DAVID ELLIS;;BRUENING JAN DAVID,GENERAL ELECTRIC COMPANY (2011-07-26),https://lens.org/138-404-085-096-705,Design Right,no,0,0,2,2,0,,,2401;;D24/158,0,0,,,,ACTIVE
402,EP,A1,EP 2911587 A1,187-937-225-587-864,2015-09-02,2015,EP 13849715 A,2013-10-28,US 201261719301 P;;US 201361798066 P;;US 201314040609 A;;US 201314040604 A;;US 2013/0067127 W,2012-10-26,NIR IMAGE GUIDED TARGETING,,VARIAN MED SYS INC,ADLER JOHN R JR;;BRUDER RALF;;ERNST FLORIS;;SCHWEIKARD ACHIM;;SHARDA AGAM,,https://lens.org/187-937-225-587-864,Patent Application,yes,0,0,7,20,0,A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4836;;A61B6/032;;A61B5/0064;;A61N5/1049;;A61N2005/0626;;A61B5/0036;;A61B5/0035;;A61B5/0071;;A61B5/0075;;A61B5/055;;A61B5/441;;A61B5/4504;;A61B5/4836;;A61B5/4887;;A61B5/7235;;A61B6/032;;A61B6/485,A61N5/00;;A61B6/03,,0,0,,,,ACTIVE
403,WO,A8,WO 2018/064119 A8,127-075-116-121-130,2019-04-25,2019,US 2017/0053629 W,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN;;NICHOLAS JOHN,,https://lens.org/127-075-116-121-130,Amended Application,yes,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
404,US,B2,US 9757593 B2,120-763-035-218-621,2017-09-12,2017,US 201314017992 A,2013-09-04,US 201314017992 A;;US 201261697218 P,2012-09-05,Radiation systems with minimal or no shielding requirement on building,A radiation system includes: a first support; a first structure rotatably coupled to the first support so that the first structure is rotatable about a first axis relative to the first support; a second structure rotatably coupled to the first structure so that the second structure is rotatable about a second axis that forms a non-zero angle relative to the first structure; and a first radiation source connected to the second structure; wherein the first structure and the second structure are parts of a capsule for accommodating at least a portion of a patient.,VARIAN MED SYS INC,ADLER JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2014-02-05),https://lens.org/120-763-035-218-621,Granted Patent,yes,29,8,2,2,0,A61N5/1082;;A61N5/1082;;A61N2005/1094;;A61N2005/1094;;G21F3/00;;G21F3/00,A61N5/00;;A61N5/10;;G21F3/00,,12,0,,,"Definition of Capsule from dictionary.com printed from internet Dec. 26, 2016.;;International Search Report and Written Opinion dated Feb. 5, 2013 for related PCT Patent Application No. PCT/US2012/067453.;;First Chinese Office Action and Search Report dated Dec. 28, 2015, for related Chinese Patent Application No. 201280068583.0,13 pages.;;Extended European Search Report dated Dec. 23, 2014 for related EP Patent Application No. 12854268.5, 9 pages.;;Non-final Office Action dated Jan. 24, 2014 for related U.S. Appl. No. 13/310,582.;;Final Office Action dated Aug. 27, 2014 for related U.S. Appl. No. 13/310,582.;;Advisory Action dated Nov. 21, 2014 for related U.S. Appl. No. 13/310,582.;;Non-final Office Action dated Apr. 6, 2015 for related U.S. Appl. No. 13/310,582.;;Final Office Action dated Sep. 11, 2015 for related U.S. Appl. No. 13/310,582.;;Notice of Allowance and Fee(s) due dated Dec. 4, 2015 for related U.S. Appl. No. 13/310,582.;;Communication pursuant to Article 94(3) EPC dated Sep. 20, 2016, for related European Patent Application No. 12 854 268.5, 4 pages.;;Notification of Second Office Action dated Aug. 25, 2016 for related Chinese Patent Application No. 201280068583.0, 6 pages.",ACTIVE
405,US,A1,US 2013/0255280 A1,132-980-074-038-734,2013-10-03,2013,US 201213438368 A,2012-04-03,US 201213438368 A,2012-04-03,PORTABLE WATER-GENERATING AND FILTERING APPARATUS,"A portable water-generating device for obtaining water from ambient air including a thermoelectric cooling device having a cold side and a hot side, a thermally-conductive cold sink having multiple cold sink fins of a first size thermally coupled to the cold side and a thermally-conductive heat sink with multiple heat sink fins of a second size thermally coupled to the hot side. Air-movement devices move ambient air into the device and over the cold sink fins. The ambient air is cooled as it passes over the cold sink fins causing water to condense on the cold sink fins and to collect into a collecting tray. The water is then pumped through a multi-stage filtration and mineralization system and into a dispensing water reservoir for immediate or later use.",MURPHY THOMAS JOHN;;JEAN DENIS NAPOLEON;;MURPHY MARIETTA SUE;;ADLER JOHANNA JULIA,MURPHY THOMAS JOHN;;JEAN DENIS NAPOLEON;;MURPHY MARIETTA SUE;;ADLER JOHANNA JULIA,,https://lens.org/132-980-074-038-734,Patent Application,yes,11,27,1,1,0,B01D5/0042;;B01D5/0042;;C02F1/045;;C02F1/045;;E03B3/28;;E03B3/28;;F25B21/02;;F25B21/02;;Y02A20/00;;Y02A20/00;;Y02W10/37;;Y02W10/37,F25B21/02,62/3.4,1,0,,,"Machine Translation of WO2009044593 to Kazuhisa, Espacenet, 2009.04.09, all",DISCONTINUED
406,IN,B,IN 167502 B,174-136-529-150-168,1990-11-10,1990,IN 834DE1984 A,1984-10-27,US 54648083 A,1983-10-28,AN UNSINTERED POWDERED COATING COMPOSITION FOR APPLYING A HIGH STRENGH WEAR AND CORROSION RESISTANT COATING ONTO A SUBSTRATE,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;ROBERT CLARK TUCKER,,https://lens.org/174-136-529-150-168,Granted Patent,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
407,WO,A1,WO 2013/155349 A1,113-298-596-762-411,2013-10-17,2013,US 2013/0036246 W,2013-04-11,US 201261623855 P;;US 201361775430 P,2012-04-13,SLEEP APNEA DEVICE,"A system for treating a patient suffering from obstructive sleep apnea may include a mask, a portable air flow generator configured to generate air flow at a relatively low flow rate, and a tube connecting the air flow generator and the mask such that air flow from the generator passes through an air flow generator valve on the mask. The mask may include a contact surface for forming a seal between the mask and the patient's face such that the mask surrounds the patient's nostrils, an expiration valve that opens during expiration, and an air flow generator valve that opens during inspiration. In some embodiments, the mask may further include an inspiration valve that opens during inspiration to allow air from outside the system to enter the mask.",FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;CHEN EUGENE G;;GORDON ALAN;;WU SAMUEL;;ADLER MARK,,https://lens.org/113-298-596-762-411,Patent Application,yes,6,3,3,63,0,A61M16/06;;A61M16/0683;;A61M16/0875;;A61M16/20;;A61M2016/0039;;A61M2016/0661;;A61M2205/8206;;A61M2209/088;;A61M2230/205;;A61M16/0833;;A61M16/0069;;A61M16/0688;;A61M16/0866;;A61M16/202;;A61M16/209;;A61M2205/42;;A61M16/0063;;A61M2205/0266;;A61M16/0605;;A61M16/205;;A61M16/024;;A61M16/0057;;A61M16/208;;A61M2205/42;;A61M16/0683;;A61M16/0875;;A61M16/20;;A61M2016/0039;;A61M2016/0661;;A61M2205/8206;;A61M2209/088;;A61M2230/205;;A61M16/0833;;A61M16/0069;;A61M16/0688;;A61M16/0866;;A61M16/202;;A61M16/209;;A61M16/06;;A61M16/0605;;A61M16/0063;;A61M2205/0266;;A61M16/205;;A61M16/024;;A61M16/0057;;A61M16/208,A61M16/06;;A61M15/08,,0,0,,,,PENDING
408,KR,B1,KR 950009641 B1,012-265-296-409-488,1995-08-25,1995,KR 880700400 A,1988-04-14,US 89679286 A;;US 8702029 W,1986-08-15,PIEZOELECTRIC SWITCH,,PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES LEWOOD;;ADLER MICHAEL STUART,,https://lens.org/012-265-296-409-488,Granted Patent,no,0,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,EXPIRED
409,EP,A1,EP 2178004 A1,025-415-834-367-565,2010-04-21,2010,EP 09173177 A,2009-10-15,US 25233608 A,2008-10-15,Selective history data structures,"Methods and apparatuses which create and use selective history data structures are disclosed. In one embodiment, a method includes monitoring presentations accessed by a user, automatically selecting some of the presentations accessed by the user according to, at least in part, the user's access patterns, and displaying representations of the some of the presentations in a pattern of an n x n array, wherein n is greater than 1. Other methods are disclosed, and various apparatuses and machine readable media are also disclosed.
",APPLE INC,STACHOWIAK MACIEJ;;DECKER KEVIN;;SULLIVAN JOHN W;;ADLER DARIN;;ROBEN ADAM;;NIEDERAUER CHRIS,,https://lens.org/025-415-834-367-565,Patent Application,yes,3,0,3,3,0,G06F16/9562;;G06F16/9562,G06F17/30,,18,0,,,"JASON HINER: ""Google Chrome: The five best new features"", 3 September 2008 (2008-09-03), XP002561528, Retrieved from the Internet <URL:http://blogs.zdnet.com/BTL/?p=9878> [retrieved on 20091218];;GLENN DERENE: ""How Google's Simple Chrome Could Steer Web's Complex Future: Analysis"", 2 September 2008 (2008-09-02), XP002561529, Retrieved from the Internet <URL:http://www.popularmechanics.com/technology/industry/4280717.html> [retrieved on 20091222];;JOSH LOWENSOHN: ""FoxTab turns your browser tabs into a spectacle"", 17 September 2008 (2008-09-17), XP002561530, Retrieved from the Internet <URL:http://news.cnet.com/8301-17939_109-10044366-2.html> [retrieved on 20091222];;""Customizing your computer - To display hidden files and folders"", 30 December 2007 (2007-12-30), XP002561535, Retrieved from the Internet <URL:http://web.archive.org/web/20071230045607/http://www.microsoft.com/resources/documentation/windows/xp/all/proddocs/en-us/win_fcab_show_file_extensions.mspx?mfr=true> [retrieved on 20091221];;""Find and Return to Web Pages You've Recently Visited"", 23 August 2006 (2006-08-23), XP002561531, Retrieved from the Internet <URL:http://www.microsoft.com/windows/ie/ie6/using/howto/basics/history/button.mspx> [retrieved on 20091221];;TOMMY A. OLSEN: ""Speed dial tips"", 1 March 2007 (2007-03-01), XP002561536, Retrieved from the Internet <URL:http://my.opera.com/toman/blog/show.dml/788600> [retrieved on 20091222];;ANONYMOUS: ""Awasu - Features"", 3 January 2007 (2007-01-03), XP002561537, Retrieved from the Internet <URL:http://web.archive.org/web/20070103184812/www.awasu.com/features.php> [retrieved on 20091222];;KAASTEN S ET AL: ""DESIGNING AN INTEGRATED BOOKMARK/HISTORY SYSTEM FOR WEB BROWSING"", 1 March 2000, PROCEEDINGS WESTERN COMPUTER GRAPHICS SYMPOSIUM, XX, XX, PAGE(S) 1 - 04, XP008031090;;GOOGLE CHROME: THE FIVE BEST NEW FEATURES, 3 September 2008 (2008-09-03);;HOW GOOGLE'S SIMPLE CHROME COULD STEER WEB'S COMPLEX FUTURE: ANALYSIS, 2 September 2008 (2008-09-02);;FOXTAB TURNS YOUR BROWSER TABS INTO A SPECTACLE, 17 September 2008 (2008-09-17);;CUSTOMIZING YOUR COMPUTER - TO DISPLAY HIDDEN FILES AND FOLDERS, 30 December 2007 (2007-12-30);;FIND AND RETURN TO WEB PAGES YOU'VE RECENTLY VISITED, 23 August 2006 (2006-08-23);;SPEED DIAL TIPS, 1 March 2007 (2007-03-01);;AWASU - FEATURES, 3 January 2007 (2007-01-03);;""DESIGNING AN INTEGRATED BOOKMARK/HISTORY SYSTEM FOR WEB BROWSING"", PROCEEDINGS WESTERN COMPUTER GRAPHICS SYMPOSIUM, 1 March 2000 (2000-03-01), pages 1 - 04;;ANONYMOUS: ""FoxTab Tab Switching Firefox Add-on"", 7 October 2008 (2008-10-07), pages 1 - 3, XP055014379, Retrieved from the Internet <URL:http://www.youtube.com/watch?v=JJhvGqj5yNM> [retrieved on 20110125];;ANONYMOUS: ""How to Use GridLayou"", 8 May 2008 (2008-05-08), pages 1, XP007919820, Retrieved from the Internet <URL:http://web.archive.org/web/20080508190452/http://journals.ecs.soton.a c.uk/java/tutorial/ui/layout/grid.html>",DISCONTINUED
410,US,B1,US 6724757 B1,057-448-872-104-928,2004-04-20,2004,US 23239599 A,1999-01-15,US 23239599 A,1999-01-15,Configurable network router,"
    A signal router, configured to receive information carried by a first signal and transmit the information on a second signal, is described. The signal router, using routing information it gathers, selects the second signal from a number of signals, with the first and the second signals differing in at least one physical characteristic. The signal router operates in a network of a number of such signal routers, and so each one of the signal routers is coupled to at least one of the other signal routers. The routing information is used to create a circuit from a first one of the signal routers to a second one of the signal routers. Once the circuit is created, the information is routed over the circuit. According to one aspect of the present invention, the signals are optical signals. 
",CISCO TECH IND,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,CISCO SYSTEMS INC (1999-09-28);;CISCO TECHNOLOGY INC. A CORPORATION OF CALIFORNIA (1999-08-25);;MONTEREY NETWORKS INC (1999-03-26),https://lens.org/057-448-872-104-928,Granted Patent,yes,31,103,5,8,0,H04J14/0227;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04L45/583;;H04L49/101;;H04L49/15;;H04L49/254;;H04L49/255;;H04L49/30;;H04L49/3081;;H04L49/351;;H04L49/357;;H04L49/45;;H04L49/55;;H04L2012/5605;;H04L2012/5627;;H04Q11/0005;;H04Q11/0071;;H04Q11/0478;;H04Q2011/0039;;H04Q2011/0043;;H04Q2011/0045;;H04Q2011/0047;;H04Q2011/0052;;H04Q2011/0081;;H04Q2011/0088;;H04J14/0241;;H04L49/3081;;H04Q11/0478;;H04Q2011/0045;;H04L2012/5627;;H04L49/15;;H04L2012/5605;;H04Q11/0005;;H04L49/101;;H04J14/0227;;H04J14/0284;;H04L49/55;;H04J14/0294;;H04J14/0295;;H04L49/45;;H04L49/254;;H04L49/351;;H04Q11/0071;;H04Q2011/0047;;H04Q2011/0088;;H04Q2011/0043;;H04L49/30;;H04L49/357;;H04L45/583;;H04Q2011/0052;;H04Q2011/0081;;H04L49/255;;H04Q2011/0039;;H04J14/0241,H04J14/02;;H04L12/56;;H04Q11/00;;H04Q11/04,370/388;;370/400;;370/351,10,1,049-323-070-605-721,10.1109/glocom.1990.116554,"Zhang, et al., ""On Fundamental Issues in IP Over WDM Multicast,""IEEE, Computer Communications and Networks, Sep. 1999.;;Ali Saleh; H. Michael Zadikian; Zareh Baghdasarian; Vahid Parsi, ""A Method For Routing Information Over A Network"", Jan. 15, 1999; Ser. No. 09/232,397.;;H. Michael Zadikian; Steven E. Plote; John C. Adler; David Parish Autry; Ali Saleh, ""Method of Providing Network Services"", Jan. 4, 2000, Ser. No. 09/477,498.;;Ali Saleh, ""A Method For Path Selection In A Network"", Jan. 4, 2000, Ser. No. 09/478,235.;;Ali N. Saleh and Stevan E. Plote, ""A Network Addressing Scheme for Reducing Protocol Overhead In An Optical Network"", Sep. 2, 1999; Ser. No. 09/389,302.;;Ali N. Saleh; Douglas E. Duschatko; Lane Byron Quibodeaux, ""Method and Apparatus for a Rearrangeably Non-Blocking Switching Matrix"", Jan. 4, 2000; Ser. No. 09/477,166.;;Michael H. Zadikian; Ali Saleh; John C. Adler; Zareh Baghdasarian; Vahid Parsi, ""Configurable Network Router"", Jan. 15, 1999; Ser. No. 09/232,396.;;Michael H. Zadikian; Ali Saleh; John C. Adler; Zareh Baghdasarian; Vahid Parsi, ""A Resource Management Protocol For A Configurable Network Router"", Jan. 4, 2000; Ser. No. 60/174,323.;;Ronald Alan Russell and Michael Kevin Anthony, ""A Method And Apparatus For Isolating Faults In A Switching Matrix,"" Jan. 4, 2000; Ser. No. 09/477,217.;;Komine, et al., ""A Distributed Restoration Algorithm for Multiple-Link and Node Failures of Transport Networks,"" IEEE, Globecom '90, Apr. 1990.",EXPIRED
411,EP,B1,EP 0143342 B1,063-800-366-350-437,1987-09-16,1987,EP 84112936 A,1984-10-26,US 54648083 A,1983-10-28,"HIGH STRENGTH, WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME",,UNION CARBIDE CORPORATION,"JACKSON, JOHN ERIC;;ADLER, THOMAS ALLEN;;QUETS, JEAN MARIE;;TUCKER, ROBERT CLARK, JR.",,https://lens.org/063-800-366-350-437,Granted Patent,yes,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
412,AU,A,AU 1987/079116 A,094-259-472-679-123,1988-03-08,1988,AU 1987/079116 A,1987-08-14,US 89679286 A,1986-08-15,PIEZOELECTRIC SWITCH,,PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/094-259-472-679-123,Patent Application,no,0,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,EXPIRED
413,US,A1,US 2016/0127304 A1,098-553-811-190-561,2016-05-05,2016,US 201614993873 A,2016-01-12,US 201614993873 A;;US 201213713991 A,2012-12-13,AUTOMATIC SCHEDULING OF CONTENT DELIVERY,"A content delivery system coupled to a computer network can provide large volumes of content to large numbers of recipients. The content is collected into digests and individual articles to be sent in email via an email channel established by the content delivery system to the recipients through the computer network. Content producers submit content for aggregation into various email deliveries and submit initial scheduling information. The scheduling information may specify target characteristics of preferred recipients of the content as well as general and initial scheduling preferences for email delivery. The content delivery system utilizes the initial scheduling information as a starting point for scheduling email deliveries. The system measures levels of content interaction by the recipients to gauge corresponding interest levels in the content. Using recipient interest levels as feedback, the content delivery system is able to modify and extend scheduling details to optimally schedule further deliveries of content.",LINKEDIN CORP,REILLY JOHN;;LEE ALEXANDRE;;MELICK RUSSELL;;ADLER JOSEPH;;LAU JAMES TAC;;BELLISTER JESSE,LINKEDIN CORPORATION (2013-02-02);;MICROSOFT TECHNOLOGY LICENSING LLC (2017-10-18),https://lens.org/098-553-811-190-561,Patent Application,yes,11,2,3,3,0,H04L12/1881;;H04L67/62;;H04L12/1881;;H04L51/234;;H04L67/60;;H04L67/62,H04L12/58,,0,0,,,,DISCONTINUED
414,NO,D0,NO 881588 D0,140-528-665-059-341,1988-04-13,1988,NO 881588 A,1988-04-13,US 89679286 A;;US 8702029 W,1986-08-15,PIEZOELEKTRISK BRYTER.,,PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/140-528-665-059-341,Patent Application,no,0,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,DISCONTINUED
415,AU,B2,AU 564763 B2,139-886-950-766-736,1987-08-27,1987,AU 1984/034730 A,1984-10-26,US 54648083 A,1983-10-28,WEAR RESISTANT COATING OF W-C-CO-CR,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;TUCKER ROBERT CLARK JR,,https://lens.org/139-886-950-766-736,Granted Patent,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
416,EP,A2,EP 2411537 A2,065-650-189-334-04X,2012-02-01,2012,EP 10718294 A,2010-03-24,IL 2010000246 W;;US 20266509 P,2009-03-24,METHODS OF PREDICTING PAIRABILITY AND SECONDARY STRUCTURES OF RNA MOLECULES,,YEDA RES & DEV;;UNIV LELAND STANFORD JUNIOR,SEGAL ERAN;;KERTESZ MICHAEL;;CHANG HOWARD Y;;RINN JOHN;;ADLER ADAM;;WAN YUE,,https://lens.org/065-650-189-334-04X,Patent Application,yes,0,0,4,4,0,C12Q1/6809;;C12Q1/6811;;C12Q1/6827;;C12Q1/6869;;Y10T436/143333;;Y10T436/143333;;C12Q1/6827;;C12Q1/6811;;C12Q1/6869;;C12Q1/6809,C12Q1/68,,1,1,035-796-902-195-983,10.1038/nbt1417;;18542052,"GERMAN MARCELO A ET AL: ""Global identification of microRNA-target RNA pairs by parallel analysis of RNA ends"", NATURE BIOTECHNOLOGY, vol. 26, no. 8, August 2008 (2008-08-01), pages 941 - 946, ISSN: 1087-0156",DISCONTINUED
417,EP,A1,EP 0277224 A1,103-895-852-842-115,1988-08-10,1988,EP 87905842 A,1987-08-14,US 89679286 A,1986-08-15,PIEZOELECTRIC SWITCH.,"Dans un commutateur (20), un élément piézoélectrique bimorphe (22) forme plusieurs contacts commutables rapprochés et réglables séparément. L'élément comprend au moins deux doigts (22a) qui s'étendent dans des directions opposées et sont reliés par un support comun (22b). L'élément de support est monté sur un boîtier (24), les doigts étant écartés d'une surface intérieure du boîtier. Des circuits électroniques sont montés sur l'élément de support pour appliquer un potentiel électrique séparé à chaque doigt. Des contacts électriques mobiles (42) séparés sont placés sur chaque doigt, écartés de l'élément de support et isolés des dispositifs d'application des potentiels électriques séparés aux doigts. Des contacts fixes séparés (44) sont montés sur une surface intérieure du boîtier en face des contacts mobiles. Lorsque le commutateur est en fonctionnement, des potentiels électriques séparés sont appliqués à chaque doigt de façon à les faire fléchir et à forcer les contacts mobiles qu'ils portent à connecter électriquement le contact fixe opposé.",PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/103-895-852-842-115,Patent Application,yes,0,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,DISCONTINUED
418,US,A1,US 2010/0279302 A1,138-643-618-065-046,2010-11-04,2010,US 77397710 A,2010-05-05,US 77397710 A;;IL 2010000246 W;;US 20266509 P,2009-03-24,METHODS OF PREDICTING PAIRABILITY AND SECONDARY STRUCTURES OF RNA MOLECULES,"Provided are methods of predicting a pairability of nucleotides of a plurality of RNA polynucleotides by (a) simultaneously determining a paired state or an unpaired state of nucleotides of the plurality of RNA polynucleotides; and (b) corresponding the paired state or the unpaired state of the nucleotides to a database of nucleic acid sequences, the database comprises nucleic acid sequences representing the plurality of RNA polynucleotides, thereby determining the pairability of nucleotides of the plurality of RNA polynucleotides. Also provided are methods of determining a secondary structure of a plurality of RNA molecules; methods of determining if a molecule is capable of modulating a secondary structure of at least one RNA polynucleotide of a plurality of RNA polynucleotides; and methods of screening for a marker associated with a pathology.",YEDA RES & DEV;;UNIV LELAND STANFORD JUNIOR,SEGAL ERAN;;KERTESZ MICHAEL;;CHANG HOWARD Y;;RINN JOHN;;ADLER ADAM;;WAN YUE,THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (2010-04-28);;YEDA RESEARCH AND DEVELOPMENT CO. LTD (2010-04-25),https://lens.org/138-643-618-065-046,Patent Application,yes,3,12,4,4,3219,C12Q1/6809;;C12Q1/6811;;C12Q1/6827;;C12Q1/6869;;Y10T436/143333;;Y10T436/143333;;C12Q1/6827;;C12Q1/6811;;C12Q1/6869;;C12Q1/6809,C12Q1/68;;G01N33/50,435/6;;436/94,4,3,018-837-012-317-100;;119-116-056-663-875;;006-561-462-309-28X,pmc2441812;;10.1093/nar/gkn267;;18477638;;14734309;;10.1093/bioinformatics/btg388;;10.1099/vir.0.80141-0;;15448367,"Mitra (NUCLEIC ACIDS RESEARCH, vol. 36, no. 11, June 2008);;FRIEDLAENDER (NATURE BIOTECHNOLOGY, vol. 26, no. 4, April 2008, pg 407-415);;HOFACKER (BIOINFORMATICS, vol. 20, no. 2, 22 January 2004 pg 186-190);;Tuplin (JOURNAL OF GENERAL VIROLOGY, vol. 85, no. Part 10, October 2004, pg 3037-3047)",DISCONTINUED
419,AU,B2,AU 594818 B2,169-032-047-669-437,1990-03-15,1990,AU 1987/079116 A,1987-08-14,US 89679286 A,1986-08-15,PIEZOELECTRIC SWITCH,,PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/169-032-047-669-437,Granted Patent,no,3,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,EXPIRED
420,WO,A3,WO 2010/109463 A3,022-421-249-431-644,2010-11-25,2010,IL 2010000246 W,2010-03-24,US 20266509 P,2009-03-24,METHODS OF PREDICTING PAIRABILITY AND SECONDARY STRUCTURES OF RNA MOLECULES,"Provided are methods of predicting a pairability of nucleotides of a plurality of RNA polynucleotides by (a) simultaneously determining a paired state or an unpaired state of nucleotides of the plurality of RNA polynucleotides; and (b) corresponding the paired state or the unpaired state of the nucleotides to a database of nucleic acid sequences, the database comprises nucleic acid sequences representing the plurality of RNA polynucleotides, thereby determining the pairability of nucleotides of the plurality of RNA polynucleotides. Also provided are methods of determining a secondary structure of a plurality of RNA molecules; methods of determining if a molecule is capable of modulating a secondary structure of at least one RNA polynucleotide of a plurality of RNA polynucleotides; and methods of screening for a marker associated with a pathology.",YEDA RES & DEV;;UNIV LELAND STANFORD JUNIOR;;SEGAL ERAN;;KERTESZ MICHAEL;;CHANG HOWARD Y;;RINN JOHN;;ADLER ADAM;;WAN YUE,SEGAL ERAN;;KERTESZ MICHAEL;;CHANG HOWARD Y;;RINN JOHN;;ADLER ADAM;;WAN YUE,,https://lens.org/022-421-249-431-644,Search Report,yes,2,0,4,4,0,C12Q1/6809;;C12Q1/6811;;C12Q1/6827;;C12Q1/6869;;Y10T436/143333;;Y10T436/143333;;C12Q1/6827;;C12Q1/6811;;C12Q1/6869;;C12Q1/6809,C12Q1/68,,4,4,018-837-012-317-100;;145-191-151-433-966;;006-561-462-309-28X;;119-116-056-663-875,pmc2441812;;10.1093/nar/gkn267;;18477638;;18392026;;10.1038/nbt1394;;10.1099/vir.0.80141-0;;15448367;;14734309;;10.1093/bioinformatics/btg388,"MITRA SOMDEB ET AL: ""High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis"", NUCLEIC ACIDS RESEARCH, vol. 36, no. 11, June 2008 (2008-06-01), XP002586894, ISSN: 0305-1048;;FRIEDLAENDER MARC R ET AL: ""Discovering microRNAs from deep sequencing data using miRDeep"", NATURE BIOTECHNOLOGY, vol. 26, no. 4, April 2008 (2008-04-01), pages 407 - 415, XP002586895, ISSN: 1087-0156;;TUPLIN A ET AL: ""Detailed mapping of RNA secondary structures in core and NS5B-encoding region sequences of hepatitis C virus by RNase cleavage and novel bioinformatic prediction methods"", JOURNAL OF GENERAL VIROLOGY, vol. 85, no. Part 10, October 2004 (2004-10-01), pages 3037 - 3047, XP002586896, ISSN: 0022-1317;;HOFACKER I L ET AL: ""Prediction of locally stable RNA secondary structures for genome-wide surveys."", BIOINFORMATICS (OXFORD), vol. 20, no. 2, 22 January 2004 (2004-01-22), pages 186 - 190, XP002586897, ISSN: 1367-4803",PENDING
421,NO,L,NO 881588 L,187-015-073-478-800,1988-06-15,1988,NO 881588 A,1988-04-13,US 89679286 A;;US 8702029 W,1986-08-15,PIEZOELEKTRISK OMKOBLER.,,PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/187-015-073-478-800,Abstract,no,0,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,DISCONTINUED
422,CA,A,CA 1269129 A,006-905-952-624-625,1990-05-15,1990,CA 544605 A,1987-08-14,US 89679286 A,1986-08-15,PIEZOELECTRIC SWITCH,"PIEZOELECTRIC SWITCH of the Invention A switch is provided wherein a piezoelectric bimorph element is used to provide many separately controllable, closely spaced switchable contacts. The element includes at least two oppositely extending fingers connected by a common spine. The element spine is mounted to a case with the fingers spaced from an inner case surface. Electronic circuit means are mounted on the element spine for applying a separate electrical potential to each of the element fingers. A separate movable electrical contact is disposed on each of the element fingers spaced from the spine and insulated from the means for applying the separate electrical potentials to the fingers. A separate stationary contact is provided on an inner case surface opposite each of the movable contacts. In operation, a separate electrical potential is applied to each of the element fingers for selectively causing each finger to deflect and force its movable contact into electrical connection with the opposing stationary contact.",PACIFIC BELL,HARNDEN JOHN D JR;;KORNRUMPF WILLIAM P;;KOHL JAMES E;;ADLER MICHAEL S,,https://lens.org/006-905-952-624-625,Granted Patent,no,0,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,306-10,0,0,,,,EXPIRED
423,CN,A,CN 106823161 A,057-619-448-175-229,2017-06-13,2017,CN 201710084465 A,2012-11-30,US 201113310582 A;;CN 201280068583 A,2011-12-02,Radiation systems with minimal or no shielding requirement on building,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5 mR/hr or less within 3 meters from an isocenter.",VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,,https://lens.org/057-619-448-175-229,Patent Application,no,5,2,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10;;A61B6/10;;G21F3/00;;G21F5/02;;G21F7/00,,0,0,,,,ACTIVE
424,US,B1,US 6631134 B1,178-930-082-807-939,2003-10-07,2003,US 23239699 A,1999-01-15,US 23239699 A,1999-01-15,Method for allocating bandwidth in an optical network,"
    A method is provided to allocate bandwidth from a first node to a second node in a optical network. The method begins by accepting a request from an end-user, who requests a virtual path between the first node and the second node. The first and second nodes are ones of a number of such nodes. Each one of the nodes is coupled to at least one other node by at least one of a number of optical links. The nodes and links form the optical network. The virtual path has a bandwidth requirement associated therewith. Next, the service provider determines an amount of bandwidth available between the first and the second nodes. The service provider then allocates at least a portion of the amount of bandwidth available between the first and second nodes equal to the bandwidth requirement, so long as the bandwidth requirement is not greater than the amount of bandwidth available between the first and second nodes. 
",CISCO TECH IND,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,CISCO TECHNOLOGY INC. A CORPORATION OF CALIFORNIA (1999-08-25);;MONTEREY NETWORKS INC (1999-03-26),https://lens.org/178-930-082-807-939,Granted Patent,yes,22,156,6,7,0,H04J14/0227;;H04J14/0282;;H04J14/0283;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04J14/0297;;H04L47/15;;H04L47/741;;H04L47/743;;H04L47/746;;H04L47/748;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04J14/0241;;H04J14/0228;;H04L47/70;;H04J14/0295;;H04Q2011/0084;;H04Q2011/0058;;H04J14/0284;;H04L47/805;;H04Q11/0062;;H04L47/15;;H04Q2011/0081;;H04J14/0227;;H04L47/746;;H04J14/0282;;H04J14/0297;;H04L47/748;;H04Q11/0005;;H04L47/741;;H04Q2011/0086;;H04L47/743;;H04Q2011/0088;;H04J14/0283;;H04L47/822;;H04L47/826;;H04L47/825;;H04J14/0294;;H04J14/0241;;H04J14/0228;;H04L47/70,H04L12/56;;H04Q11/00,370/395.21;;370/468;;370/409;;370/252,8,0,,,"H. Michael Zadikian, Ali Saleh; John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""A Resource Management Protocol For A Configurable Network Router"", filed Jan. 4, 2000; Ser. No. 60/174,323.;;Ronald Alan Russell and Michael Kevin Anthony, ""A Method And Apparatus For Isolating Faults In A Switching Matrix"", filed Jan. 4, 2000; Serial No. 09/477,217.;;Ali N. Saleh and Stevan E. Plote, ""A Network Addressing Scheme For Reducing Protocol Overhead In An Optical Network"", filed Sep. 2, 1999; Serial No.09/389,302.;;Ali Saleh, H. Michael Zadikian; John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""Configurable Network Router"", filed Jan. 15, 1999; Serial No. 09/232,395.;;Ali N. Saleh, Douglas E. Duschatko, Lane Byron Quibodeaux, ""Method And Apparatus For A Rearrangeably Non-Blocking Switching Matrix"", filed Jan. 4, 2000; Serial No. 09/477,166.;;Ali Saleh; H. Michael Zadikian; Zareh Baghdasarian, Vahid Parsi, ""A Method For Routing Information Over A Network"", filed Jan. 15, 1999; Serial No. 09/232,397.;;H. Michael Zadikian; Steven E. Plote, John C. Adler, David Parish Autry, Ali Saleh, ""Method of Providing Network Services"", Filed Jan. 4, 2000; Ser. No. 09/477,498.;;Ali Saleh, ""A Method For Path Selection In A Network"", filed Jan. 4, 2000; Ser. No. 09/478,235.",EXPIRED
425,US,A1,US 2004/0196838 A1,165-961-155-856-775,2004-10-07,2004,US 82824604 A,2004-04-20,US 82824604 A;;US 23239599 A,1999-01-15,Configurable network router,"
   A signal router, configured to receive information carried by a first signal and transmit the information on a second signal, is described. The signal router, using routing information it gathers, selects the second signal from a number of signals, with the first and the second signals differing in at least one physical characteristic. The signal router operates in a network of a number of such signal routers, and so each one of the signal routers is coupled to at least one of the other signal routers. The routing information is used to create a circuit from a first one of the signal routers to a second one of the signal routers. Once the circuit is created, the information is routed over the circuit. According to one aspect of the present invention, the signals are optical signals. 
",ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/165-961-155-856-775,Patent Application,yes,62,20,5,8,0,H04J14/0227;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04L45/583;;H04L49/101;;H04L49/15;;H04L49/254;;H04L49/255;;H04L49/30;;H04L49/3081;;H04L49/351;;H04L49/357;;H04L49/45;;H04L49/55;;H04L2012/5605;;H04L2012/5627;;H04Q11/0005;;H04Q11/0071;;H04Q11/0478;;H04Q2011/0039;;H04Q2011/0043;;H04Q2011/0045;;H04Q2011/0047;;H04Q2011/0052;;H04Q2011/0081;;H04Q2011/0088;;H04J14/0241;;H04L49/3081;;H04Q11/0478;;H04Q2011/0045;;H04L2012/5627;;H04L49/15;;H04L2012/5605;;H04Q11/0005;;H04L49/101;;H04J14/0227;;H04J14/0284;;H04L49/55;;H04J14/0294;;H04J14/0295;;H04L49/45;;H04L49/254;;H04L49/351;;H04Q11/0071;;H04Q2011/0047;;H04Q2011/0088;;H04Q2011/0043;;H04L49/30;;H04L49/357;;H04L45/583;;H04Q2011/0052;;H04Q2011/0081;;H04L49/255;;H04Q2011/0039;;H04J14/0241,H04J14/02;;H04L12/56;;H04Q11/00;;H04Q11/04,37036,0,0,,,,EXPIRED
426,WO,A1,WO 1988/001438 A1,028-793-098-533-20X,1988-02-25,1988,US 8702029 W,1987-08-14,US 89679286 A,1986-08-15,PIEZOELECTRIC SWITCH,"A switch (20) wherein a piezoelectric bimorph element (22) is used to provide many separately controllable, closely spaced switchable contacts. The element includes at least two oppositely extending fingers (22a) connected by a common spine (22b). The element spine is mounted to a case (24) with the fingers spaced from an inner case surface. Electronic circuit means are mounted on the element spine for applying a separate electrical potential to each of the element fingers. A separate movable electrical contact (42) is disposed on each of the element fingers spaced from the spine and insulated from the means for applying the separate electrical potentials to the fingers. A separate stationary contact (44) is provided on an inner case surface opposite each of the movable contacts. In operation, a separate electrical potential is applied to each of the element fingers for selectively causing each finger to deflect and force its movable contact into electrical connection with the opposing stationary contact.",PACIFIC BELL,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/028-793-098-533-20X,Patent Application,yes,10,2,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,H1N NBG           NBG861-9;;H1N N626          NBG861-9;;H1N N637          NBG861-9;;H1N N639          NBG861-9;;H1N N700          NBG861-9;;H1N N704          NBG861-9;;H1N N868          NBG861-9,1,0,,,See also references of EP 0277224A4,PENDING
427,AU,A,AU 1989/040497 A,074-340-525-926-961,1991-02-22,1991,AU 1989/040497 A,1989-07-24,AU 1989/040497 A;;CA 606464 A,1989-07-24,LOCK ADJUSTABLE TO OPERATE WITH DIFFERENT KEYS,,RICHARD STEVEN ADLER,ADLER RICHARD STEVEN;;MORRIS PAUL FREDERICK;;KIRK KARL DALLAS;;MILICH JOHN;;PERICHON JERRY,,https://lens.org/074-340-525-926-961,Patent Application,no,0,0,1,5,0,,E05B25/00,,0,0,,,,PENDING
428,US,B2,US 9264513 B2,115-077-729-798-72X,2016-02-16,2016,US 201213713991 A,2012-12-13,US 201213713991 A,2012-12-13,Automatic scheduling of content delivery,"A content delivery system coupled to a computer network can provide large volumes of content to large numbers of recipients. The content is collected into digests and individual articles to be sent in email via an email channel established by the content delivery system to the recipients through the computer network. Content producers submit content for aggregation into various email deliveries and submit initial scheduling information. The scheduling information may specify target characteristics of preferred recipients of the content as well as general and initial scheduling preferences for email delivery. The content delivery system utilizes the initial scheduling information as a starting point for scheduling email deliveries. The system measures levels of content interaction by the recipients to gauge corresponding interest levels in the content. Using recipient interest levels as feedback, the content delivery system is able to modify and extend scheduling details to optimally schedule further deliveries of content.",LINKEDIN CORP,REILLY JOHN;;LEE ALEXANDRE;;MELICK RUSSELL;;ADLER JOSEPH;;LAU JAMES TAC;;BELLISTER JESSE,LINKEDIN CORPORATION (2013-02-02);;MICROSOFT TECHNOLOGY LICENSING LLC (2017-10-18),https://lens.org/115-077-729-798-72X,Granted Patent,yes,11,1,3,3,0,H04L12/1881;;H04L67/62;;H04L12/1881;;H04L51/234;;H04L67/60;;H04L67/62,H04L29/08;;H04L12/18,,0,0,,,,ACTIVE
429,WO,A1,WO 1991/001425 A1,142-249-982-330-239,1991-02-07,1991,US 8903196 W,1989-07-24,US 8903196 W;;AU 1989/040497 A;;CA 606464 A;;US 9909987 A,1987-09-21,LOCK ADJUSTABLE TO OPERATE WITH DIFFERENT KEYS,"A lock which is rekeyable or programmable to operate with a different key from the exterior thereof without disassembling it or removing it from a lock assembly in which it is assembled is disclosed. The lock (250) may be rekeyed through the keyway so that the lock appears from the exterior thereof to be a conventional lock, or from the end opposite the keyway from the interior of a door, or from a side of the lock which requires disassembly of the lock from its lock assembly. The lock (250) includes structure defining a movable shear line that can be adjusted from the exterior of the lock without disassembling the lock itself. Such structure may comprise a rotatable cam (251) and a pin tumbler (262) and an axially adjustable set screw (284).",ADLER RICHARD STEVEN,ADLER RICHARD STEVEN;;MORRIS PAUL FREDERICK;;KIRK KARL DALLAS;;MILICH JOHN;;PERICHON JERRY,,https://lens.org/142-249-982-330-239,Patent Application,yes,19,1,2,5,0,E05B27/005;;E05B9/086;;Y10T70/7684;;Y10T70/7672;;Y10T70/7734;;Y10T70/7684;;Y10T70/7672;;Y10T70/7734;;E05B27/005;;E05B9/086,E05B27/00;;E05B27/04,,1,0,,,"ADVERTISEMENT-WINFIELD LOCKS, INC. 4 pages. KEYNOTES, March 1987, M. KIRKPATRICK, ""Capitalizing on Opportunity with the U-Change Locks"", pp. 10-13.",PENDING
430,WO,A2,WO 2010/109463 A2,082-740-949-954-23X,2010-09-30,2010,IL 2010000246 W,2010-03-24,US 20266509 P,2009-03-24,METHODS OF PREDICTING PAIRABILITY AND SECONDARY STRUCTURES OF RNA MOLECULES,"Provided are methods of predicting a pairability of nucleotides of a plurality of RNA polynucleotides by (a) simultaneously determining a paired state or an unpaired state of nucleotides of the plurality of RNA polynucleotides; and (b) corresponding the paired state or the unpaired state of the nucleotides to a database of nucleic acid sequences, the database comprises nucleic acid sequences representing the plurality of RNA polynucleotides, thereby determining the pairability of nucleotides of the plurality of RNA polynucleotides. Also provided are methods of determining a secondary structure of a plurality of RNA molecules; methods of determining if a molecule is capable of modulating a secondary structure of at least one RNA polynucleotide of a plurality of RNA polynucleotides; and methods of screening for a marker associated with a pathology.",YEDA RES & DEV;;UNIV LELAND STANFORD JUNIOR;;SEGAL ERAN;;KERTESZ MICHAEL;;CHANG HOWARD Y;;RINN JOHN;;ADLER ADAM;;WAN YUE,SEGAL ERAN;;KERTESZ MICHAEL;;CHANG HOWARD Y;;RINN JOHN;;ADLER ADAM;;WAN YUE,,https://lens.org/082-740-949-954-23X,Patent Application,yes,0,2,4,4,54,C12Q1/6809;;C12Q1/6811;;C12Q1/6827;;C12Q1/6869;;Y10T436/143333;;Y10T436/143333;;C12Q1/6827;;C12Q1/6811;;C12Q1/6869;;C12Q1/6809,C12Q1/68,,50,47,015-633-575-270-55X;;099-889-056-557-248;;071-621-954-271-758;;007-706-405-274-755;;015-633-575-270-55X;;128-039-291-435-493;;122-606-516-098-206;;023-242-685-408-355;;067-181-128-846-416;;007-977-536-712-908;;044-121-411-652-204;;007-706-405-274-755;;007-813-748-644-520;;012-297-829-649-086;;047-715-369-498-991;;071-717-370-340-39X;;070-750-535-264-347;;060-583-197-853-481;;144-974-865-568-859;;120-772-322-068-894;;000-619-146-577-961;;072-714-803-299-875;;081-392-967-082-83X;;105-231-256-028-169;;122-388-810-565-095;;025-949-519-935-995;;011-895-572-269-275;;034-162-713-374-447;;064-285-653-613-300;;065-028-510-887-194;;018-837-012-317-100;;138-647-364-180-869;;091-823-007-910-452;;066-936-990-251-581;;002-987-846-899-234;;109-406-078-211-290;;064-496-811-683-735;;000-031-742-505-924;;007-977-536-712-908;;087-927-021-890-621;;032-537-096-856-998;;089-108-900-703-611;;068-491-518-209-797;;064-383-410-471-239;;108-316-018-828-592;;005-029-104-061-790;;077-579-667-150-410,16873527;;10.1093/bioinformatics/btl246;;17367143;;10.1021/ja0704028;;pmc169194;;10.1093/nar/gkg595;;12824337;;12079347;;10.1016/s0022-2836(02)00308-x;;16873527;;10.1093/bioinformatics/btl246;;10.1126/science.1716375;;1716375;;pmc47577;;10.1073/pnas.90.20.9408;;8415714;;10.1016/j.sbi.2007.03.001;;17383172;;12824340;;10.1093/nar/gkg599;;pmc169005;;18451266;;pmc2951732;;10.1126/science.1158441;;17446895;;10.1038/nprot.2007.131;;12079347;;10.1016/s0022-2836(02)00308-x;;10.1073/pnas.0635171100;;12660367;;pmc153018;;15899876;;10.1128/mcb.25.11.4752-4766.2005;;pmc1140632;;10.1073/pnas.092538799;;pmc122867;;11972065;;10.1126/science.290.5490.341;;11030653;;10.1073/pnas.2033246100;;pmc208774;;13679573;;15919195;;10.1016/j.sbi.2005.05.003;;12416730;;10.1007/bf02982789;;pmc2574980;;10.1016/j.sbi.2008.05.002;;18555681;;10.1038/ng2135;;17893677;;19213877;;10.1126/science.1168978;;pmc2746483;;10.1016/j.cell.2007.04.037;;17632058;;19661910;;pmc2724670;;10.1038/nature08237;;875032;;10.1016/s0022-2836(77)80200-3;;10.1016/s0959-440x(02)00366-4;;12464318;;10.1021/bi052149z;;16800631;;3357778;;pmc338217;;10.1093/nar/16.5.2295;;10.1073/pnas.0806929106;;pmc2629221;;19109441;;pmc2393762;;10.1073/pnas.0709032105;;18322008;;pmc2441812;;10.1093/nar/gkn267;;18477638;;pmc2689691;;10.1371/journal.pbio.0060096;;18447581;;10.1006/jmbi.1999.2700;;10329189;;16500677;;10.1016/j.jmb.2006.01.067;;pmc2567462;;18815376;;10.1073/pnas.0803169105;;pmc442121;;10.1186/1471-2105-5-71;;15180907;;10.1186/1471-2105-5-105;;pmc514602;;15296519;;17604720;;10.1016/j.cell.2007.05.022;;pmc2084369;;18451266;;pmc2951732;;10.1126/science.1158441;;12504008;;10.1016/s1097-2765(02)00694-9;;pmc2441550;;18460470;;10.1074/jbc.m803109200;;pmc409911;;10.1073/pnas.0401799101;;15123812;;pmc1458515;;10.1093/nar/gkl287;;16682450;;10.1016/j.gene.2005.06.037;;16213112;;pmc3902468;;19359587;;10.1126/science.1170160;;18052610;;pmc2100149;;10.1371/journal.pbio.0050322;;7545072;;10.1038/nsb0594-273,"HOFACKER LI. ET AL.: ""Fast folding and comparison of RNA secondary structures"", MONATSHEFTE FR. CHEMIE., vol. 125, 1994, pages 167 - 188;;DO CB.; WOODS DA. ET AL.: ""CONTRAfold: RNA seconday structure prediction without physics-based models"", BIOINFOMATICS, vol. 22, 2006, pages 90 - 98;;MORTIMER SA, J. AM. CHEM. SOC., vol. 129, 2007, pages 4144 - 4145;;ZUKER, M.: ""Mfold web server for nucleic acid folding and hybridization prediction"", NUCLEIC ACIDS RES, vol. 31, 2003, pages 3406 - 15, XP002460708, DOI: doi:10.1093/nar/gkg595;;HOFACKER, I.L.; FEKETE, M.; STADLER, P.F.: ""Secondary structure prediction for aligned RNA sequences"", J MOL BIOL, vol. 319, 2002, pages 1059 - 66, XP004449685, DOI: doi:10.1016/S0022-2836(02)00308-X;;DO, C.B.; WOODS, D.A.; BATZOGLOU, S.: ""CONTRAfold: RNA secondary structure prediction without physics-based models"", BIOINFORMATICS, vol. 22, 2006, pages E90 - 8;;MAJOR F; TURCOTTE M; GAUTHERET D; LAPALME G; FILLION E; CEDERGREN R.: ""The combination of symbolic and numerical computation for three-dimensional modeling of RNA"", SCIENCE, vol. 253, no. 5025, 13 September 1991 (1991-09-13), pages 1255 - 60;;MAJOR F; GAUTHERET D; CEDERGREN R.: ""Reproducing the three-dimensional structure of a tRNA molecule from structural constraints"", PROC NATL ACAD SCI U S A., vol. 90, no. 20, 15 October 1993 (1993-10-15), pages 9408 - 12;;BRUCE A SHAPIRO ET AL.: ""Bridging the gap in RNA structure prediction"", CURRENT OPINION IN STRUCTURAL BIOLOGY, vol. 17, 2007, pages 157 - 165, XP022032054, DOI: doi:10.1016/j.sbi.2007.03.001;;HOFACKER I.L.: ""Vienna RNA secondary structure server"", NUCLEIC ACIDS RES., vol. 31, 2003, pages 3429 - 3431, XP002460707, DOI: doi:10.1093/nar/gkg599;;U. NAGALAKSHMI, SCIENCE, vol. 320, 2008, pages 1344 - 9;;O. EMANUELSSON; S. BRUNAK; G. VON HEIJNE; H. NIELSEN, NAT PROTOC, vol. 2, 2007, pages 953;;I. L. HOFACKER; M. FEKETE; P. F. STADLER, J MOL BIOL, vol. 319, 21 June 2002 (2002-06-21), pages 1059;;HOFACKER LI. ET AL.: ""Fast folding and comparison of RNA secondary structures"", MONATSHEFTE FR. CHEMIE, vol. 125, 1994, pages 167 - 188;;ARAVA, Y. ET AL.: ""Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiae"", PROC NATL ACAD SCI USA, vol. 100, 2003, pages 3889 - 94;;OLIVIER, C. ET AL.: ""Identification of a conserved RNA motif essential for She2p recognition and mRNA localization to the yeast bud"", MOL CELL BIOL, vol. 25, 2005, pages 4752 - 66;;WANG, Y. ET AL.: ""recision and functional specificity in mRNA decay"", PROC NATL ACAD SCI U S A, vol. 99, 2002, pages 5860 - 5;;TAKIZAWA, P.A.; DERISI, J.L.; WILHELM, J.E.; VALE, R.D.: ""Plasma membrane compartmentalization in yeast by messenger RNA transport and a septin diffusion barrier"", SCIENCE, vol. 290, 2000, pages 341 - 4;;SHEPARD, K.A. ET AL.: ""Widespread cytoplasmic mRNA transport in yeast: identification of 22 bud-localized transcripts using DNA microarray analysis"", PROC NATL ACAD SCI U S A, vol. 100, 2003, pages 11429 - 34;;TUCKER, B.J.; BREAKER, R.R.; RIBOSWITCHES AS VERSATILE GENE CONTROL ELEMENTS, CURR OPIN STRUCT BIOL, vol. 15, 2005, pages 342 - 8;;KATO, J.; NIITSU, Y.: ""Recent advance in molecular iron metabolism: translational disorders of ferritin"", INT J HEMATOL, vol. 76, 2002, pages 208 - 12;;CHU, V.B.; HERSCHLAG, D: ""Unwinding RNA's secrets: advances in the biology, physics, and modeling of complex RNAs"", CURR OPIN STRUCT BIOL, vol. 18, 2008, pages 305 - 14, XP022716235, DOI: doi:10.1016/j.sbi.2008.05.002;;KERTESZ, M.; IOVINO, N.; UNNERSTALL, U., GAUL; U. & SEGAL: ""E. The role of site accessibility in microRNA target recognition"", NAT GENET, vol. 39, 2007, pages 1278 - 84;;INGOLIA, N.T.; GHAEMMAGHAMI, S.; NEWMAN, J.R.S.; WEISSMAN, J.S.: ""Genome-Wide Analysis In Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling"", SCIENCE 1168978V1, 2009;;AMERES, S.L.; MARTINEZ, J.; SCHROEDER, R.: ""Molecular basis for target RNA recognition and cleavage by human RISC"", CELL, vol. 130, 2007, pages 101 - 12;;WATTS, J.M. ET AL.: ""Architecture and secondary structure of an entire HIV-1 RNA genome"", NATURE, vol. 460, 2009, pages 711 - 6;;BERNSTEIN, F.C. ET AL.: ""The Protein Data Bank: a computer-based archival file for macromolecular structures"", J MOL BIOL, vol. 112, 1977, pages 535 - 42;;BRENOWITZ, M.; CHANCE, M.R.; DHAVAN, G.; TAKAMOTO, K.: ""Probing the structural dynamics of nucleic acids by quantitative time-resolved and equilibrium hydroxyl radical ""footprinting"""", CURR OPIN STRUCT BIOL, vol. 12, 2002, pages 648 - 53;;ALKEMAR, G.; NYGARD, O.: ""Probing the secondary structure of expansion segment ES6 in 18S ribosomal RNA"", BIOCHEMISTRY, vol. 45, 2006, pages 8067 - 78;;ROMANIUK, P.J.; DE STEVENSON, I.L.; EHRESMANN, C.; ROMBY, P.; EHRESMANN, B.: ""A comparison of the solution structures and conformational properties of the somatic and oocyte 5S rRNAs of Xenopus laevis"", NUCLEIC ACIDS RES, vol. 16, 1988, pages 2295 - 312;;DEIGAN, K.E.; LI, T.W.; MATHEWS, D.H.; WEEKS, K.M.: ""Accurate SHAPE- directed RNA structure determination"", PROC NATL ACAD SCI USA, vol. 106, 2009, pages 97 - 102;;DAS, R. ET AL.: ""Structural inference of native and partially folded RNA by high-throughput contact mapping"", PROC NATL ACAD SCI U S A, vol. 105, 2008, pages 4144 - 9, XP055144355, DOI: doi:10.1073/pnas.0709032105;;MITRA, S.; SHCHERBAKOVA, LV.; ALTMAN, R.B.; BRENOWITZ, M.; LAEDERACH, A.: ""High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis"", NUCLEIC ACIDS RES, vol. 36, 2008, pages E63, XP002586894;;WILKINSON, K.A. ET AL.: ""High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states"", PLOS BIOL, vol. 6, 2008, pages E96;;MATHEWS, D.H.; SABINA, J.; ZUKER, M.; TURNER, D.H.: ""Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure"", J MOL BIOL, vol. 288, 1999, pages 911 - 40, XP025963084, DOI: doi:10.1006/jmbi.1999.2700;;MATHEWS, D.H.: ""Revolutions in RNA secondary structure prediction"", J MOL BIOL, vol. 359, 2006, pages 526 - 32, XP024951070, DOI: doi:10.1016/j.jmb.2006.01.067;;RABANI, M.; KERTESZ, M.; SEGAL, E.: ""Computational prediction of RNA structural motifs involved in posttranscriptional regulatory processes"", PROC NATL ACAD SCI USA, vol. 105, 2008, pages 14885 - 90;;DOWELL, R.D.; EDDY, S.R.: ""Evaluation of several lightweight stochastic context- free grammars for RNA secondary structure prediction"", BMC BIOINFORMATICS, vol. 5, 2004, pages 71, XP021000656, DOI: doi:10.1186/1471-2105-5-71;;DOSHI, K.J.; CANNONE, J.J.; COBAUGH, C.W.; GUTELL, R.R.: ""Evaluation of the suitability of free-energy minimization using nearest-neighbor energy parameters for RNA secondary structure prediction"", BMC BIOINFORMATICS, vol. 5, 2004, pages 105, XP021000487, DOI: doi:10.1186/1471-2105-5-105;;RINN, J.L. ET AL.: ""Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs"", CELL, vol. 129, 2007, pages 1311 - 23;;NAGALAKSHMI, U. ET AL.: ""The transcriptional landscape of the yeast genome defined by RNA sequencing"", SCIENCE, vol. 320, 2008, pages 1344 - 9;;CHARTRAND, P.; MENG, X.H.; HUTTELMAIER, S.; DONATO, D.; SINGER, R.H.: ""Asymmetric sorting of ashlp in yeast results from inhibition of translation by localization elements in the mRNA"", MOL CELL, vol. 10, 2002, pages 1319 - 30;;REINEKE, L.C.; KOMAR, A.A.; CAPRARA, M.G.; MERRICK, W.C.: ""A small stem loop element directs internal initiation of the URE2 internal ribosome entry site in Saccharomyces cerevisiae"", J BIOL CHEM, vol. 283, 2008, pages 19011 - 25;;MATHEWS, D.H. ET AL.: ""Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure"", PROC NATL ACAD SCI U S A, vol. 101, 2004, pages 7287 - 92;;SHABALINA, S.A.; OGURTSOV, A.Y.; SPIRIDONOV, N.A.: ""A periodic pattern of mRNA secondary structure created by the genetic code"", NUCLEIC ACIDS RES, vol. 34, 2006, pages 2428 - 37;;KOZAK, M.: ""Regulation of translation via mRNA structure in prokaryotes and eukaryotes"", GENE, vol. 361, 2005, pages 13 - 37, XP005130425, DOI: doi:10.1016/j.gene.2005.06.037;;KUDLA, G.; MURRAY, A.W.; TOLLERVEY, D.; PLOTKIN, J.B.: ""Coding-sequence determinants of gene expression in Escherichia coli"", SCIENCE, vol. 324, 2009, pages 255 - 8, XP055059425, DOI: doi:10.1126/science.1170160;;PALAZZO, A.F. ET AL.: ""The signal sequence coding region promotes nuclear export of mRNA"", PLOS BIOL, vol. 5, 2007, pages E322;;CECH, T.R.; DAMBERGER, S.H.; GUTELL, R.R.: ""Representation of the secondary and tertiary structure of group I introns"", NAT STRUCT BIOL, vol. 1, 1994, pages 273 - 80;;See also references of EP 2411537A2",PENDING
431,US,A1,US 2016/0220848 A1,041-580-821-292-356,2016-08-04,2016,US 201615095927 A,2016-04-11,US 201615095927 A;;US 201113310582 A,2011-12-02,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5 mR/hr or less within 5 meters from an isocenter.",VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-01-10),https://lens.org/041-580-821-292-356,Patent Application,yes,0,16,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10,,0,0,,,,ACTIVE
432,US,A,US 4742263 A,077-909-220-745-441,1988-05-03,1988,US 8882787 A,1987-08-24,US 8882787 A;;US 89679286 A,1986-08-15,Piezoelectric switch,"A switch is provided wherein a piezoelectric bimorph element is used to provide many separately controllable, closely spaced switchable contacts. The element includes at least two oppositely extending fingers connected by a common spine. The element spine is mounted to a case with the fingers spaced from an inner case surface. Electronic circuit means are mounted on the element spine for applying a separate electrical potential to each of the element fingers. A separate movable electrical contact is disposed on each of the element fingers spaced from the spine and insulated from the means for applying the separate electrical potentials to the fingers. A separate stationary contact is provided on an inner case surface opposite each of the movable contacts. In operations, a separate electrical potential is applied to each of the element fingers for selectively causing each finger to deflect and force its movable contact into electrical connection with the opposing stationary contact.",PACIFIC BELL,HARNDEN JR JOHN D;;KORNRUMPF WILLIAM P;;KOHL JAMES E;;ADLER MICHAEL S,PACIFIC BELL 140 NEW MONTGOMERY STREET SAN FRANCISCO CA 94105 A CA CORP (1988-01-07),https://lens.org/077-909-220-745-441,Granted Patent,yes,5,152,1,16,0,H01H57/00;;H10N30/2042;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/09,310/331;;310/330;;310/367;;200/181,0,0,,,,EXPIRED
433,IN,B,IN 167207 B,094-236-609-201-672,1990-09-22,1990,IN 565DE1987 A,1987-07-03,IN 565DE1987 A;;IN 834DE1984 A;;US 54648083 A,1983-10-28,A METHOD FOR COATINF A SUBSTRATE,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;TUCKER ROBERT CLARK JR,,https://lens.org/094-236-609-201-672,Granted Patent,no,0,0,1,16,0,,C23C4/06,,0,0,,,,EXPIRED
434,US,S,US D0952651 S,170-822-777-969-417,2022-05-24,2022,US 202029737587 F,2020-06-10,US 202029737587 F,2020-06-10,Display screen with graphical user interface,,BETTERWORKS SYSTEMS INC,YANAMANDRA RAVINDRANATH;;DANDAN MICHAEL JOHN SERRANO;;BROSE SARAH ROSE ADLER;;CLARK TODD MICHAEL,BETTERWORKS SYSTEMS INC (2020-09-10),https://lens.org/170-822-777-969-417,Design Right,no,12,0,1,1,0,,,1404;;D14/485,0,0,,,,ACTIVE
435,HK,A,HK 35788 A,034-472-842-235-623,1988-05-20,1988,HK 35788 A,1988-05-12,US 54648083 A,1983-10-28,"HIGH STRENGTH,WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME",,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;TUCKER ROBERT CLARK JR,,https://lens.org/034-472-842-235-623,Granted Patent,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
436,EP,B1,EP 2785417 B1,033-126-616-711-494,2018-05-23,2018,EP 12854268 A,2012-11-30,US 201113310582 A;;US 2012/0067453 W,2011-12-02,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,,VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,,https://lens.org/033-126-616-711-494,Granted Patent,yes,12,0,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10;;A61B6/10;;G21F3/00,,0,0,,,,ACTIVE
437,US,B2,US 9308395 B2,063-979-146-802-844,2016-04-12,2016,US 201113310582 A,2011-12-02,US 201113310582 A,2011-12-02,Radiation systems with minimal or no shielding requirement on building,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5 mR/hr or less within 3 meters from an isocenter.",ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E;;VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-01-10),https://lens.org/063-979-146-802-844,Granted Patent,yes,24,13,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/00;;A61B6/10;;A61N5/10;;G21F3/00;;G21F5/02;;G21F7/00,,3,0,,,"International Search Report and Written Opinion dated Feb. 5, 2013 for PCT Patent Application No. PCT/US2012/067453.;;Extended European Search Report dated Dec. 23, 2014 for corresponding EP Patent Application No. 12854268.5, 9 pages.;;First Chinese Office Action and Search Report dated Dec. 28, 2015, for corresponding Chinese Patent Application No. 201280068583.0, 13 pages.",ACTIVE
438,AU,A,AU 2000/028503 A,111-265-970-005-864,2000-08-01,2000,AU 2000/028503 A,2000-01-14,US 23239599 A;;US 0000970 W,1999-01-15,Configurable network router,,MONTEREY NETWORKS INC,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/111-265-970-005-864,Patent Application,no,0,0,5,8,0,H04J14/0227;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04L45/583;;H04L49/101;;H04L49/15;;H04L49/254;;H04L49/255;;H04L49/30;;H04L49/3081;;H04L49/351;;H04L49/357;;H04L49/45;;H04L49/55;;H04L2012/5605;;H04L2012/5627;;H04Q11/0005;;H04Q11/0071;;H04Q11/0478;;H04Q2011/0039;;H04Q2011/0043;;H04Q2011/0045;;H04Q2011/0047;;H04Q2011/0052;;H04Q2011/0081;;H04Q2011/0088;;H04J14/0241;;H04L49/3081;;H04Q11/0478;;H04Q2011/0045;;H04L2012/5627;;H04L49/15;;H04L2012/5605;;H04Q11/0005;;H04L49/101;;H04J14/0227;;H04J14/0284;;H04L49/55;;H04J14/0294;;H04J14/0295;;H04L49/45;;H04L49/254;;H04L49/351;;H04Q11/0071;;H04Q2011/0047;;H04Q2011/0088;;H04Q2011/0043;;H04L49/30;;H04L49/357;;H04L45/583;;H04Q2011/0052;;H04Q2011/0081;;H04L49/255;;H04Q2011/0039;;H04J14/0241,H04J14/02;;H04L12/56;;H04Q11/00;;H04Q11/04,,0,0,,,,DISCONTINUED
439,US,A,US 4519840 A,131-568-131-489-101,1985-05-28,1985,US 54648083 A,1983-10-28,US 54648083 A,1983-10-28,"High strength, wear and corrosion resistant coatings","A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 11.0 to about 18.0 weight percent cobalt, from about 2.0 to about 6.0 weight percent chromium, from about 3.0 to about 4.5 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETS JEAN M;;TUCKER JR ROBERT C,UNION CARBIDE CORPORATION (1984-10-25);;PRAXAIR S.T. TECHNOLOGY INC (1990-01-02),https://lens.org/131-568-131-489-101,Granted Patent,yes,7,44,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,106/1.05;;75/252;;75/255;;106/14.05;;420/431;;428/546;;428/551,0,0,,,,EXPIRED
440,CA,C,CA 1330399 C,035-145-326-903-005,1994-06-28,1994,CA 606464 A,1989-07-24,CA 606464 A;;AU 1989/040497 A;;US 9909987 A;;US 8903196 W;;US 80955492 A,1987-09-21,LOCK ADJUSTABLE TO OPERATE WITH DIFFERENT KEYS,"A lock which is rekeyable or programmable to operate with a different key from the exterior thereof without disassembling it or removing it from a lock assembly in which it is assembled is disclosed. The lock may be rekeyed through the keyway so that the lock appears from the exterior thereof to be a conventional lock, or from the end opposite the keyway from the interior of a door, or from a side of the lock which requires disassembly of the lock from its lock assembly. The lock includes structure defining a movable shear that can be adjusted from the exterior of the lock without disassembling the lock itself. Such structure may comprise a rotatable cam and a pin tumbler, a rack and pinion, and an axially adjustable set screw. The lock includes a plurality of pin tumbler sets and a plurality of cylinders disposed one in the other in the lock casing. The pin tumbler sets and the cylinders cooperate to from a plurality of common pin tumbler shear lines, i.e., shear lines formed by a number of individual shear lines of individual pin tumbler sets. To operate the lock, the adjustable shear line and a common pin tumbler shear line must be aligned. The lock may also include the following: structure which indicates that the adjustable shear line is in one of the positions with which a common tumbler shear line may be aligned; structure which locks the adjustable shear line in a given position; structure which prevents the lock from being rekeyed to a particular position after the lock has been rekeyed out of that position; and/or structure which selectively blocks access to the structure defining the adjustable shear line to increase security against unauthorized rekeying.",ADLER RICHARD S,ADLER RICHARD S;;MORRIS PAUL F;;KIRK KARL D;;MILICH JOHN;;PERICHON JERRY,,https://lens.org/035-145-326-903-005,Granted Patent,no,0,1,2,5,0,E05B27/005;;Y10T70/7734;;Y10T70/7672;;Y10T70/7684;;Y10T70/7734;;Y10T70/7672;;Y10T70/7684;;E05B27/005,E05B27/00;;E05B27/04,D40700055    M,0,0,,,,EXPIRED
441,CN,A,CN 104080516 A,114-218-922-201-286,2014-10-01,2014,CN 201280068583 A,2012-11-30,US 2012/0067453 W;;US 201113310582 A,2011-12-02,Radiation systems with minimal or no shielding requirement on building,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5mR/hr or less within 3 meters from an isocenter.",VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,,https://lens.org/114-218-922-201-286,Patent Application,no,3,3,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10,,0,0,,,,ACTIVE
442,US,A1,US 2007/0162850 A1,125-562-552-550-762,2007-07-12,2007,US 32849306 A,2006-01-06,US 32849306 A,2006-01-06,Sports-related widgets,"Systems, methods, computer-readable mediums, user interfaces and other implementations are disclosed for defining, installing, launching, managing, displaying and operating sports-related widgets in a display environment. The sports-related widgets can be configured to provide information related to sporting events.",ADLER DARIN;;ANZURES FREDDY A;;CAPRILE MATTHEW;;CHRISTIE GREGORY N;;LOUCH JOHN O,ADLER DARIN;;ANZURES FREDDY A;;CAPRILE MATTHEW;;CHRISTIE GREGORY N;;LOUCH JOHN O,APPLE INC (2006-06-14),https://lens.org/125-562-552-550-762,Patent Application,yes,100,166,1,1,0,G06F9/451;;G06F9/451,G06F9/00,715/700;;715/764;;715/810;;715/835,0,0,,,,DISCONTINUED
443,US,B2,US 10449393 B2,172-448-637-410-326,2019-10-22,2019,US 201615095927 A,2016-04-11,US 201615095927 A;;US 201113310582 A,2011-12-02,Radiation systems with minimal or no shielding requirement on building,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5 mR/hr or less within 5 meters from an isocenter.",VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-01-10),https://lens.org/172-448-637-410-326,Granted Patent,yes,33,0,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10;;A61B6/10;;G21F3/00;;G21F5/02;;G21F7/00,,19,0,,,"International Search Report and Written Opinion dated Feb. 5, 2013, for related PCT Patent Application No. PCT/US2012/067453.;;First Chinese Office Action and Search Report dated Dec. 28, 2015, for related Chinese Patent Application No. 201280068583.0, 13 pages.;;Extended European Search Report dated Dec. 23, 2014 for related EP Patent Application No. 12854268.5, 9 pages.;;Non-final Office Action dated Jan. 24, 2014 for related U.S. Appl. No. 13/310,582.;;Final Office Action dated Aug. 27, 2014 for related U.S. Appl. No. 13/310,582.;;Advisory Action dated Nov. 21, 2014 for related U.S. Appl. No. 13/310,582.;;Non-final Office Action dated Apr. 6, 2015 for related U.S. Appl. No. 13/310,582.;;Final Office Action dated Sep. 11, 2015 for related U.S. Appl. No. 13/310,582.;;Notice of Allowance and Fee(s) due dated Dec. 4, 2015 for related U.S. Appl. No. 13/310,582.;;Final Office Action dated Dec. 30, 2016, for related U.S. Appl. No. 14/017,992.;;Definition of Capsule from dictionary.com printed from Internet Dec. 26, 2016.;;Notice of Allowance—Notification of Grant dated Dec. 1, 2016, for corresponding Chinese Patent Application No. 201280068583.0, 2 pages.;;Intention to Grant dated Aug. 3, 2017 for related/corresponding European Patent Application No. 12854268.5, 66 pages.;;Notice of Allowance and Fee(s) due dated May 4, 2017 for related U.S. Appl. No. 14/017,992.;;Communication pursuant to Article 94(3) EPC dated Sep. 20, 2016, for corresponding European Patent Application No. 12 854 268.5, 4 pages.;;Notification of Second Office Action dated Aug. 25, 2016 for corresponding Chinese Patent Application No. 201280068583.0, 6 pages.;;Non-final Office Action dated Jun. 17, 2016 for related U.S. Appl. No. 14/017,992.;;First Chinese Office Action and Search Report dated Jan. 2, 2019 for related Chinese Patent Application No. 2017100844653, 15 pages.;;Second Chinese Office Action dated Jul. 9, 2019 for related Chinese Patent Application No. 2017100844653.",ACTIVE
444,US,B2,US 7602807 B2,047-089-732-586-756,2009-10-13,2009,US 23582005 A,2005-09-27,US 23582005 A;;US 68094003 A;;US 23239699 A,1999-01-15,Method of allocating bandwidth in an optical network,"A method is provided to allocate bandwidth from a first node to a second node in a optical network. The method begins by accepting a request from an end-user, who requests a virtual path between the first node and the second node. The first and second nodes are ones of a number of such nodes. Each one of the nodes is coupled to at least one other node by at least one of a number of optical links. The nodes and links form the optical network. The virtual path has a bandwidth requirement associated therewith. Next, the service provider determines an amount of bandwidth available between the first and the second nodes. The service provider then allocates at least a portion of the amount of bandwidth available between the first and second nodes equal to the bandwidth requirement, so long as the bandwidth requirement is not greater than the amount of bandwidth available between the first and second nodes.",CISCO TECH INC,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/047-089-732-586-756,Granted Patent,yes,82,15,6,7,0,H04J14/0227;;H04J14/0282;;H04J14/0283;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04J14/0297;;H04L47/15;;H04L47/741;;H04L47/743;;H04L47/746;;H04L47/748;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04J14/0241;;H04J14/0228;;H04L47/70;;H04J14/0295;;H04Q2011/0084;;H04Q2011/0058;;H04J14/0284;;H04L47/805;;H04Q11/0062;;H04L47/15;;H04Q2011/0081;;H04J14/0227;;H04L47/746;;H04J14/0282;;H04J14/0297;;H04L47/748;;H04Q11/0005;;H04L47/741;;H04Q2011/0086;;H04L47/743;;H04Q2011/0088;;H04J14/0283;;H04L47/822;;H04L47/826;;H04L47/825;;H04J14/0294;;H04J14/0241;;H04J14/0228;;H04L47/70,H04L12/28;;H04J3/16;;H04L12/56;;H04Q11/00,370/468;;370/395.21;;370/400,14,6,150-190-396-355-640;;078-345-689-354-97X;;154-622-772-822-209;;012-911-196-516-124;;032-538-043-490-608;;048-626-539-256-840,10.1109/glocom.1990.116551;;10.17487/rfc2328;;10.17487/rfc2174;;10.17487/rfc1850;;10.17487/rfc1638;;10.17487/rfc1493,"Zadikian, et al., U.S. Appl. No. 60/174,323.;;Hideki Sakauchi, et al., ""A Self-Healing Network With An Economical Spare-Channel Assignment"", Proceedings of the Globecom '90 IEEE Telecommunications Conference & Exhibition, vol. 1, 1991, pp. 438-443.;;Baruch Awerbuch, et al., ""Distributed Controls For Paris"", Proc. Annual ACM Symp. On Principles Of Distributed Computing, Aug. 22, 1999, pp. 145-159.;;Sujai Hajela, ""HP OEMF: Alarm Management In Telecommunications Networks"", Hewlett Packard Journal, Oct. 1996, vol. 47, No. 5, pp. 22-30.;;The ATM Forum Technical Committee, ""Interim Inter-switch Signaling Protocol (IISP) Specification v1.0"", af-pnni-0026.000, Dec. 1994, pp. 1-34.;;The ATM Forum Technical Committee, Private Network-Network Interface Specification Version 1.0 (PNNI 1.0), afpnni-0055.000, Mar. 1996, pp. v-xviii, pp. 19, 1-366.;;The ATM Forum Technical Committee, Private Network-Network Interface Specification Version 1.0 Addendum (Soft PVC MIB), af-pnni-0066.000, Sep. 1996.;;The ATM Forum Technical Committee, Addendum to PNNI V1.0 for ABR parameter negotiation, af-pnni-0075.000, Jan. 1997.pp. 2.3.;;The ATM Forum Technical Committee, PNNI V1.0 Errata and PICS, af-pnni-0081.000, May 1997, pp. 2-224.;;J. Moy, ""OSPF Version 2"", Ascend Communications, Inc., Apr. 1998.;;K. Murakami, et al., ""A MAPOS version 1 Extension-Switch-Switch Protocol"", NTT Laboratories, Jun. 1997.;;F. Baker, et al., ""OSPF Version 2 Management Information Base"", Cisco Systems, Nov. 1995.;;F. Baker, et al., ""PPP Bridging Control Protocol (BCP)"", IBM, Jun. 1994.;;E. Decker, ""Definitions of Managed Objects for Bridges"", Cisco Systems, Inc., Jul. 1993.",EXPIRED
445,US,A,US 4697118 A,048-955-987-702-426,1987-09-29,1987,US 89679286 A,1986-08-15,US 89679286 A,1986-08-15,Piezoelectric switch,"A switch is provided wherein a piezoelectric bimorph element is used to provide many separately controllable, closely spaced switchable contacts. The element includes at least two oppositely extending fingers connected by a common spine. The element spine is mounted to a case with the fingers spaced from an inner case surface. Electronic circuit means are mounted on the element spine for applying a separate electrical potential to each of the element fingers. A separate movable electrical contact is disposed on each of the element fingers spaced from the spine and insulated from the means for applying the separate electrical potentials to the fingers. A separate stationary contact is provided on an inner case surface opposite each of the movable contacts. In operation, a separate electrical potential is applied to each of the element fingers for selectively causing each finger to deflect and force its movable contact into electrical connection with the opposing stationary contact.",GEN ELECTRIC,HARNDEN JR JOHN D;;KORNRUMPF WILLIAM P;;KOHL JAMES E;;ADLER MICHAEL S,GENERAL ELECTRIC COMPANY A NEW YORK CORP (1986-08-01),https://lens.org/048-955-987-702-426,Granted Patent,yes,17,36,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,310/331;;310/330;;310/367;;200/181,0,0,,,,EXPIRED
446,US,A,US 4588608 A,081-283-040-760-727,1986-05-13,1986,US 71264985 A,1985-03-18,US 71264985 A;;US 54648083 A,1983-10-28,"High strength, wear and corrosion resistant coatings and method for producing the same","A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 11.0 to about 18.0 weight percent cobalt, from about 2.0 to about 6.0 weight percent chromium, from about 3.0 to about 4.5 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETS JEAN M;;TUCKER JR ROBERT C,PRAXAIR S.T. TECHNOLOGY INC (1990-01-02),https://lens.org/081-283-040-760-727,Granted Patent,yes,3,8,1,16,0,C22C29/08;;C23C4/067;;C22C29/08;;C23C4/067,C22C29/08;;C23C4/06,427/34;;427/423,0,0,,,,EXPIRED
447,WO,A1,WO 2013/082534 A1,087-812-618-655-229,2013-06-06,2013,US 2012/0067453 W,2012-11-30,US 201113310582 A,2011-12-02,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5mR/hr or less within 3 meters from an isocenter.",VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,,https://lens.org/087-812-618-655-229,Patent Application,yes,10,0,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10,,1,0,,,See also references of EP 2785417A4,PENDING
448,US,B1,US 7293090 B1,131-952-020-472-215,2007-11-06,2007,US 71478400 A,2000-11-15,US 71478400 A;;US 23239599 A;;US 17432300 P,1999-01-15,Resource management protocol for a configurable network router,"A method of managing a communications system is disclosed. The method begins with the creation of a resource control block corresponding to a resource of the communications system. The communications system includes, for example, a processor and a resource coupled to the processor. The resource control block maintains information regarding the resource. The method also provides for the maintenance of the resource control block. The processor is configured to maintain the resource control block, and the resource control block is maintained by the processor in response to communications (e.g., a keep-alive message) between the processor and the resource. This embodiment can also include the creation of a processor resource control block corresponding to the processor that is created by the controller in response to a power-up message from the resource. The resource can be, for example, a hardware component of the communications system.",CISCO TECH INC,SALEH ALI NAJIB;;ZADIKIAN H MICHAEL;;ADLER JOHN C;;BAGHDASARIAN ZAREH;;PARSI VAHID,CISCO TECHNOLOGY INC (2001-03-15),https://lens.org/131-952-020-472-215,Granted Patent,yes,41,57,1,8,0,H04L43/0817;;H04L45/00;;H04L45/60;;H04L45/00;;H04L45/60;;H04L43/0817,H04J3/16;;G06F11/00;;G06F15/173,709/226;;714/10;;714/12;;370/468;;370/412;;709/223,9,1,049-323-070-605-721,10.1109/glocom.1990.116554,"Ali Saleh; H. Michael Zadikian; Zareh Baghdasarian, Vahid Parsi, ""A Method For Routing Information Over A Network"", Jan. 15, 1999; U.S. Appl. No. 09/232,397.;;H. Michael Zadikian; Steven E. Plote, John C. Adler, David Parish Autry, Ali Saleh, ""Method of Providing Network Services"", Jan. 4, 2000; U.S. Appl. No. 09/477,498.;;Ali Saleh, ""A Method For Path Selection In A Network"", Jan. 4, 2000; U.S. Appl. No. 09/478,235.;;Ali N. Saleh and Stevan E. Plote, ""A Network Addressing Scheme For Reducing Protocol Overhead In An Optical Network"", Sep. 2, 1999; U.S. Appl. No. 09/389,302.;;Ali N. Saleh, Douglas E. Duschatko, Lane Byron Quibodeaux, ""Method And Apparatus For A Rearrangeably Non-Blocking Switching Matrix"", Jan. 4, 2000; U.S. Appl. No. 09/477,166.;;Michael H. Zadikian, Ali Saleh; John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""Configurable Network Router"", Jan. 15, 1999; U.S. Appl. No. 09/232,396.;;Ronald Alan Russell and Michael Kevin Anthony, ""A Method And Apparatus For Isolating Faults In A Switching Matrix"", Jan. 4, 2000; U.S. Appl. No. 09/477,217.;;Komine, et al., ""A Distributed Restoration Algorithm for Multiple-Link and Node Failures of Transport Networks,"" IEEE, Globecom'90, Apr. 1990.;;Zhang, et al., ""On Fundamental Issues in IP Over WDM Multicast,"" IEEE, Computer Communications and Networks, Sep. 1999.",EXPIRED
449,US,A1,US 2006/0251419 A1,147-354-643-738-842,2006-11-09,2006,US 23582005 A,2005-09-27,US 23582005 A;;US 68094003 A;;US 23239699 A,1999-01-15,Method of allocating bandwidth in an optical network,"A method is provided to allocate bandwidth from a first node to a second node in a optical network. The method begins by accepting a request from an end-user, who requests a virtual path between the first node and the second node. The first and second nodes are ones of a number of such nodes. Each one of the nodes is coupled to at least one other node by at least one of a number of optical links. The nodes and links form the optical network. The virtual path has a bandwidth requirement associated therewith. Next, the service provider determines an amount of bandwidth available between the first and the second nodes. The service provider then allocates at least a portion of the amount of bandwidth available between the first and second nodes equal to the bandwidth requirement, so long as the bandwidth requirement is not greater than the amount of bandwidth available between the first and second nodes.",CISCO TECH INC,ZADIKIAN HAIG M;;SALEH ALI N;;ADLER JOHN C;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/147-354-643-738-842,Patent Application,yes,76,89,6,7,0,H04J14/0227;;H04J14/0282;;H04J14/0283;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04J14/0297;;H04L47/15;;H04L47/741;;H04L47/743;;H04L47/746;;H04L47/748;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04J14/0241;;H04J14/0228;;H04L47/70;;H04J14/0295;;H04Q2011/0084;;H04Q2011/0058;;H04J14/0284;;H04L47/805;;H04Q11/0062;;H04L47/15;;H04Q2011/0081;;H04J14/0227;;H04L47/746;;H04J14/0282;;H04J14/0297;;H04L47/748;;H04Q11/0005;;H04L47/741;;H04Q2011/0086;;H04L47/743;;H04Q2011/0088;;H04J14/0283;;H04L47/822;;H04L47/826;;H04L47/825;;H04J14/0294;;H04J14/0241;;H04J14/0228;;H04L47/70,H04J14/00;;H04L12/56;;H04Q11/00,398/51,0,0,,,,EXPIRED
450,US,A1,US 2015/0154664 A1,183-313-486-537-127,2015-06-04,2015,US 201314095475 A,2013-12-03,US 201314095475 A,2013-12-03,AUTOMATED RECONCILIATION ANALYSIS MODEL,"A device including a memory with an automated collateral fraud and risk detection application installed thereon, wherein the application determines whether a final appraised value of an appraisal was correctly reconciled from comparable properties listed on the appraisal by extracting reconciliation information from the appraisal, the reconciliation information including adjusted sale prices for each comparable property listed on the appraisal and the final appraised value; applying a rule set to the reconciliation information to generate sub-scores; applying a heuristic to the sub-scores to generate a reconciliation score; and outputting a scorecard for the appraisal based on the reconciliation score.",FANNIE MAE,DAWSON ZACHARY;;ADLER REBECCA;;KUNDE PATRIA S;;TREADWELL JOHN;;WU WEIFENG;;ROSENBLATT ERIC,FANNIE MAE (2013-12-06),https://lens.org/183-313-486-537-127,Patent Application,yes,64,21,1,1,0,G06Q30/0278;;G06Q30/0278;;G06Q50/16;;G06Q50/16,G06Q30/02;;G06Q50/16,,0,0,,,,DISCONTINUED
451,WO,A1,WO 2010/045159 A1,021-810-878-935-274,2010-04-22,2010,US 2009/0060391 W,2009-10-12,US 25233608 A,2008-10-15,SELECTIVE HISTORY DATA STRUCTURES,"Methods and apparatuses which create and use selective history data structures are disclosed. In one embodiment, a method includes monitoring presentations accessed by a user, automatically selecting some of the presentations accessed by the user according to, at least in part, the user's access patterns, and displaying representations of the some of the presentations in a pattern of an n x n array, wherein n is greater than 1. Other methods are disclosed, and various apparatuses and machine readable media are also disclosed.",APPLE INC;;STACHOWIAK MACIEJ;;DECKER KEVIN;;SULLIVAN JOHN W;;ADLER DARIN;;ROBEN ADAM;;NIEDERAUER CHRIS,STACHOWIAK MACIEJ;;DECKER KEVIN;;SULLIVAN JOHN W;;ADLER DARIN;;ROBEN ADAM;;NIEDERAUER CHRIS,,https://lens.org/021-810-878-935-274,Patent Application,yes,8,0,3,3,0,G06F16/9562;;G06F16/9562,G06F17/00,,0,0,,,,PENDING
452,AU,A,AU 1984/034730 A,145-103-792-192-602,1985-05-30,1985,AU 1984/034730 A,1984-10-26,US 54648083 A,1983-10-28,WEAR RESISTANT COATING OF W-C-CO-CR,,UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;TUCKER ROBERT CLARK JR,,https://lens.org/145-103-792-192-602,Patent Application,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
453,EP,A4,EP 0277224 A4,085-756-898-089-754,1990-09-26,1990,EP 87905842 A,1987-08-14,US 89679286 A,1986-08-15,PIEZOELECTRIC SWITCH,,PACIFIC BELL,"HARNDEN, JOHN, DAVIS, JR.;;KORNRUMPF, WILLIAM, PAUL;;KOHL, JAMES, ELWOOD;;ADLER, MICHAEL, STUART",,https://lens.org/085-756-898-089-754,Search Report,no,5,0,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,1,0,,,See also references of WO 8801438A1,DISCONTINUED
454,KR,B1,KR 900004652 B1,101-442-302-407-501,1990-07-02,1990,KR 840006697 A,1984-10-27,US 54648083 A,1983-10-28,"HIGH STRENGTH,WEAR AND CORROSION RESISTANT COATINGS AND ITS COATING METHOD","Thermal spray coating composition consists of 11.0-18.0 wt.% Co, 2.0- 6.0 wt.% Cr, 3.0-5.5 wt.% C and the balance W. Coating is applied in a high velocity, high temperature gas stream at a temperature close to the melting point of the powdered composition feed material. The coating has a compressive strength above 20 K psi at a coating thickness of 0.006 inch and a hardness value above 900 DPH300.",UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETSU JANE M;;ALUCKY ROBERT C JR,,https://lens.org/101-442-302-407-501,Granted Patent,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
455,EP,A4,EP 2785417 A4,031-838-130-705-417,2015-01-21,2015,EP 12854268 A,2012-11-30,US 201113310582 A;;US 2012/0067453 W,2011-12-02,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,,VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,,https://lens.org/031-838-130-705-417,Search Report,no,4,0,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10;;A61B6/10;;G21F3/00,,1,0,,,See also references of WO 2013082534A1,ACTIVE
456,US,A1,US 2014/0173020 A1,161-450-142-217-544,2014-06-19,2014,US 201213713991 A,2012-12-13,US 201213713991 A,2012-12-13,AUTOMATIC SCHEDULING OF CONTENT DELIVERY,"A content delivery system coupled to a computer network can provide large volumes of content to large numbers of recipients. The content is collected into digests and individual articles to be sent in email via an email channel established by the content delivery system to the recipients through the computer network. Content producers submit content for aggregation into various email deliveries and submit initial scheduling information. The scheduling information may specify target characteristics of preferred recipients of the content as well as general and initial scheduling preferences for email delivery. The content delivery system utilizes the initial scheduling information as a starting point for scheduling email deliveries. The system measures levels of content interaction by the recipients to gauge corresponding interest levels in the content. Using recipient interest levels as feedback, the content delivery system is able to modify and extend scheduling details to optimally schedule further deliveries of content.",LINKEDIN CORP,REILLY JOHN;;LEE ALEXANDRE;;MELICK RUSSELL;;ADLER JOSEPH;;LAU JAMES TAC;;BELLISTER JESSE,LINKEDIN CORPORATION (2013-02-02);;MICROSOFT TECHNOLOGY LICENSING LLC (2017-10-18),https://lens.org/161-450-142-217-544,Patent Application,yes,11,14,3,3,0,H04L12/1881;;H04L67/62;;H04L12/1881;;H04L51/234;;H04L67/60;;H04L67/62,H04L29/08,709/217,0,0,,,,ACTIVE
457,EP,A2,EP 0257929 A2,148-233-841-484-631,1988-03-02,1988,EP 87307181 A,1987-08-14,US 89679286 A,1986-08-15,Piezoelectric switch.,"A switch is provided wherein a piezoelectric bimorph element (22) is used to provide many separately controllable, closely spaced switchable contacts. The element includes at least two oppositely extending fingers (22a) connected by a common spine (22b). The element spine is mounted to a case (24) with the fingers spaced from an inner case surface (24a, 24b). Electronic circuit means (50) are mounted on the element spine for applying a separate electrical potential to each of the element fingers. A separate movable electrical contact (42) is disposed on each of the element fingers spaced from the spine and insulated from the means (32, 34) for applying the separate electrical potentials to the fingers. A separate stationary contact (44) is provided on an inner case surface opposite each of the movable contacts. In operation, a separate electrical potential is applied to each of the element fingers for selectively causing each finger to deflect and force its movable contact (42) into electrical connection with the opposing stationary contact (44).  ",GEN ELECTRIC,HARNDEN JOHN DAVIS JR;;KORNRUMPF WILLIAM PAUL;;KOHL JAMES ELWOOD;;ADLER MICHAEL STUART,,https://lens.org/148-233-841-484-631,Patent Application,yes,0,4,15,16,0,H01H57/00;;H10N30/2042;;H10N30/00;;H01H57/00;;H10N30/2042,H01H57/00;;H01L41/04;;H01L41/09,,0,0,,,,DISCONTINUED
458,WO,A1,WO 2000/042811 A1,142-273-479-780-216,2000-07-20,2000,US 0000970 W,2000-01-14,US 23239599 A,1999-01-15,CONFIGURABLE NETWORK ROUTER,"A signal router, configured to receive information carried by a first signal and transmit the information on a second signal, is described. The signal router, using routing information it gathers, selects the second signal from a number of signals, with the first and the second signals differing in at least one physical characteristic. The signal router operates in a network of a number of such signal routers, and so each one of the signal routers is coupled to at least one of the other signal routers. The routing information is used to create a circuit from a first one of the signal routers to a second one of the signal routers. Once the circuit is created, the information is routed over the circuit. According to one aspect of the present invention, the signals are optical signals.",MONTEREY NETWORKS INC,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/142-273-479-780-216,Patent Application,yes,6,14,5,8,0,H04J14/0227;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04L45/583;;H04L49/101;;H04L49/15;;H04L49/254;;H04L49/255;;H04L49/30;;H04L49/3081;;H04L49/351;;H04L49/357;;H04L49/45;;H04L49/55;;H04L2012/5605;;H04L2012/5627;;H04Q11/0005;;H04Q11/0071;;H04Q11/0478;;H04Q2011/0039;;H04Q2011/0043;;H04Q2011/0045;;H04Q2011/0047;;H04Q2011/0052;;H04Q2011/0081;;H04Q2011/0088;;H04J14/0241;;H04L49/3081;;H04Q11/0478;;H04Q2011/0045;;H04L2012/5627;;H04L49/15;;H04L2012/5605;;H04Q11/0005;;H04L49/101;;H04J14/0227;;H04J14/0284;;H04L49/55;;H04J14/0294;;H04J14/0295;;H04L49/45;;H04L49/254;;H04L49/351;;H04Q11/0071;;H04Q2011/0047;;H04Q2011/0088;;H04Q2011/0043;;H04L49/30;;H04L49/357;;H04L45/583;;H04Q2011/0052;;H04Q2011/0081;;H04L49/255;;H04Q2011/0039;;H04J14/0241,H04J14/02;;H04L12/56;;H04Q11/00;;H04Q11/04,,2,2,049-323-070-605-721;;006-339-292-078-820,10.1109/glocom.1990.116554;;10.1109/icccn.1999.805500,"KOMINE,CHUJO,OGURA,MIYAZAKI,SOEJIMA: ""A distributed restoration algorithm for multiple-link and node failures of transport networks"", IEEE, GLOBECOM '90, April 1990 (1990-04-01), pages 459 - 463, XP002139230;;ZHANG,WEI,QIAO: ""On fundamental issues in IP over WDM Multicast"", IEEE, COMPUTER COMMUNICATIONS AND NETWORKS, September 1999 (1999-09-01), pages 84 - 90, XP002139231",PENDING
459,EP,A1,EP 2785417 A1,157-175-733-550-519,2014-10-08,2014,EP 12854268 A,2012-11-30,US 201113310582 A;;US 2012/0067453 W,2011-12-02,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,,VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,,https://lens.org/157-175-733-550-519,Patent Application,yes,0,0,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10;;A61B6/10;;G21F3/00,,0,0,,,,ACTIVE
460,CA,A,CA 1225205 A,003-509-774-417-039,1987-08-11,1987,CA 465339 A,1984-10-12,US 54648083 A,1983-10-28,"HIGH STRENGTH, WEAR AND CORROSION RESISTANT COATINGS AND METHOD FOR PRODUCING THE SAME","High Strength, Wear and Corrosion Resistant Coatings and Method for Producing the Same A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 11.0 to about 18.0 weight percent cobalt, from about 2.0 to about 6.0 weight percent chromium, from about 3.0 to about 4.5 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN E;;ADLER THOMAS A;;QUETS JEAN M;;TUCKER ROBERT C JR,,https://lens.org/003-509-774-417-039,Granted Patent,no,0,0,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,6-3,0,0,,,,EXPIRED
461,US,A1,US 2013/0144104 A1,057-420-589-847-473,2013-06-06,2013,US 201113310582 A,2011-12-02,US 201113310582 A,2011-12-02,RADIATION SYSTEMS WITH MINIMAL OR NO SHIELDING REQUIREMENT ON BUILDING,"A radiation system includes a support, a capsule rotatably coupled to the support, a radiation source movably coupled to the capsule, wherein the radiation source is configured to provide a treatment radiation beam, and is capable of being turned on or off in response to a control signal, and a collimator located next to the radiation source, wherein the capsule defines a space for accommodating a portion of a patient, and includes a shielding material for attenuating radiation resulted from an operation of the radiation source, and wherein the shielding material is configured to limit a radiation exposure level to 5 mR/hr or less within 3 meters from an isocenter.",ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E;;VARIAN MED SYS INC,ADLER JR JOHN R;;WHITTUM DAVID H;;PRINCE STEVEN W;;CLAYTON JAMES E,VARIAN MEDICAL SYSTEMS INC (2012-01-10),https://lens.org/057-420-589-847-473,Patent Application,yes,8,17,12,12,0,A61N5/1082;;G21F5/02;;G21F7/00;;G21F3/00;;A61B6/107;;A61N2005/1094;;A61N2005/1095;;A61N2005/1094;;A61N2005/1095;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N5/1082;;A61B6/107;;G21F3/00;;G21F5/02;;G21F7/00;;A61N2005/1094;;A61N2005/1095;;A61N5/1082;;A61N5/1081,A61N5/10,600/1,0,0,,,,ACTIVE
462,US,B2,US 7933266 B2,041-711-201-659-732,2011-04-26,2011,US 82824604 A,2004-04-20,US 82824604 A;;US 23239599 A,1999-01-15,Configurable network router,"A signal router, configured to receive information carried by a first signal and transmit the information on a second signal, is described. The signal router, using routing information it gathers, selects the second signal from a number of signals, with the first and the second signals differing in at least one physical characteristic. The signal router operates in a network of a number of such signal routers, and so each one of the signal routers is coupled to at least one of the other signal routers. The routing information is used to create a circuit from a first one of the signal routers to a second one of the signal routers. Once the circuit is created, the information is routed over the circuit. According to one aspect of the present invention, the signals are optical signals.",CISCO TECH INC,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/041-711-201-659-732,Granted Patent,yes,68,16,5,8,0,H04J14/0227;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04L45/583;;H04L49/101;;H04L49/15;;H04L49/254;;H04L49/255;;H04L49/30;;H04L49/3081;;H04L49/351;;H04L49/357;;H04L49/45;;H04L49/55;;H04L2012/5605;;H04L2012/5627;;H04Q11/0005;;H04Q11/0071;;H04Q11/0478;;H04Q2011/0039;;H04Q2011/0043;;H04Q2011/0045;;H04Q2011/0047;;H04Q2011/0052;;H04Q2011/0081;;H04Q2011/0088;;H04J14/0241;;H04L49/3081;;H04Q11/0478;;H04Q2011/0045;;H04L2012/5627;;H04L49/15;;H04L2012/5605;;H04Q11/0005;;H04L49/101;;H04J14/0227;;H04J14/0284;;H04L49/55;;H04J14/0294;;H04J14/0295;;H04L49/45;;H04L49/254;;H04L49/351;;H04Q11/0071;;H04Q2011/0047;;H04Q2011/0088;;H04Q2011/0043;;H04L49/30;;H04L49/357;;H04L45/583;;H04Q2011/0052;;H04Q2011/0081;;H04L49/255;;H04Q2011/0039;;H04J14/0241,H04L12/28;;H04B10/00;;H04J3/06;;H04J14/00;;H04J14/02;;H04L12/56;;H04Q11/00;;H04Q11/04,370/389;;370/350;;398/45;;398/123,3,0,,,"Komine , et al. ""A Distributed Restoration Algorithm for Multiple-Link and Node Failure of Transport Networks,"" IEEE, Globecom ' 90, Apr. 1990.;;Zhang, et al. ""On Fundamental Issues in IP Over WDM Multicast,"" IEEE Computer Communications and Networks, Sep. 1999.;;H Michael Zadikian, Ali Saleh; John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""A Resource Management Protocol For A Configurable Network Router"", filed Jan. 4, 2000; U.S. Appl. No. 60/174,323.",EXPIRED
463,EP,A1,EP 0143342 A1,092-311-446-540-024,1985-06-05,1985,EP 84112936 A,1984-10-26,US 54648083 A,1983-10-28,"High strength, wear and corrosion resistant coatings and method for producing the same.","A coating composition applied to a substrate by a thermal spray process which consists essentially of from about 11.0 to about 18.0 weight percent cobalt, from about 2.0 to about 6.0 weight percent chromium, from about 3.0 to about 4.5 weight percent carbon and the balance tungsten.",UNION CARBIDE CORP,JACKSON JOHN ERIC;;ADLER THOMAS ALLEN;;QUETS JEAN MARIE;;TUCKER ROBERT CLARK JR,,https://lens.org/092-311-446-540-024,Patent Application,yes,4,3,14,16,0,C22C29/08;;C23C4/067;;Y10T428/12049;;Y10T428/12014;;C22C27/04;;Y10T428/12049;;Y10T428/12014;;C22C29/08;;C23C4/067,C22C27/04;;C22C29/08;;C23C4/06,,0,0,,,,EXPIRED
464,US,B1,US 6950391 B1,141-491-485-321-920,2005-09-27,2005,US 68094003 A,2003-10-07,US 68094003 A;;US 23239699 A,1999-01-15,Configurable network router,"A method is provided to allocate bandwidth from a first node to a second node in a optical network. The method begins by accepting a request from an end-user, who requests a virtual path between the first node and the second node. The first and second nodes are ones of a number of such nodes. Each one of the nodes is coupled to at least one other node by at least one of a number of optical links. The nodes and links form the optical network. The virtual path has a bandwidth requirement associated therewith. Next, the service provider determines an amount of bandwidth available between the first and the second nodes. The service provider then allocates at least a portion of the amount of bandwidth available between the first and second nodes equal to the bandwidth requirement, so long as the bandwidth requirement is not greater than the amount of bandwidth available between the first and second nodes.",CISCO TECH IND,ZADIKIAN HAIG MICHAEL;;SALEH ALI NAJIB;;ADLER JOHN CONLON;;BAGHDASARIAN ZAREH;;PARSI VAHID,,https://lens.org/141-491-485-321-920,Granted Patent,yes,5,68,6,7,0,H04J14/0227;;H04J14/0282;;H04J14/0283;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04J14/0297;;H04L47/15;;H04L47/741;;H04L47/743;;H04L47/746;;H04L47/748;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04J14/0241;;H04J14/0228;;H04L47/70;;H04J14/0295;;H04Q2011/0084;;H04Q2011/0058;;H04J14/0284;;H04L47/805;;H04Q11/0062;;H04L47/15;;H04Q2011/0081;;H04J14/0227;;H04L47/746;;H04J14/0282;;H04J14/0297;;H04L47/748;;H04Q11/0005;;H04L47/741;;H04Q2011/0086;;H04L47/743;;H04Q2011/0088;;H04J14/0283;;H04L47/822;;H04L47/826;;H04L47/825;;H04J14/0294;;H04J14/0241;;H04J14/0228;;H04L47/70,H04L12/56;;H04Q11/00,370/219;;370/468;;370/395.21,0,0,,,,EXPIRED
465,AU,A4,AU 2009/100547 A4,070-010-403-017-738,2009-07-16,2009,AU 2009/100547 A,2009-06-05,AU 2008/101150 A;;AU 2009/100547 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;DOROGUSKER JESSE L;;ARCHIBALD JOHN WESLEY;;RUBINSTEIN JONATHON JAKE;;ADLER MITCHELL,,https://lens.org/070-010-403-017-738,Limited Patent,no,0,2,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
466,EP,A1,EP 4032496 A1,065-756-311-193-726,2022-07-27,2022,EP 22152150 A,2022-01-19,US 202117154530 A,2021-01-21,ENDOSCOPIC SHEATH HOLDING TIP AND STABILIZATION SYSTEM,"An endoscopic sheath holding tip and stabilization system is configured to be connected to a table mounted flexible or rigid arm or other surgical support device used over the patient during a surgical procedure. The sheath holder includes a hook structure configured to engage the underside of the scope sheath (e.g., inflow and outflow ports) , while a plunger mechanism engages the top surface of the sheath. The downward pressure of the plunger mechanism working against the upward forces of the hook structure operate to stabilize the scope sheath without requiring user intervention. In this manner, the scope and other instruments can be introduced into the stabilized scope sheath without requiring user assistance to hold the scope once positioned in the stabilized sheath.",MEDIFLEX SURGICAL PRODUCTS LLC,ADLER DANIEL;;CULVER STEVEN;;CARTER JOAN L;;SFAKIS JOHN M;;JOHNSTON III WILLIAM K,,https://lens.org/065-756-311-193-726,Patent Application,yes,2,0,2,2,0,A61B90/50;;A61B90/57;;A61B2090/571;;A61B1/00135;;A61B1/00149,A61B90/50,,0,0,,,,PENDING
467,US,A1,US 2016/0251403 A1,085-252-456-348-836,2016-09-01,2016,US 201415021775 A,2014-12-23,US 201415021775 A;;US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of CM a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK-ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WURTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (2016-05-12);;ALK-ABELLÓ A/S (2016-05-13),https://lens.org/085-252-456-348-836,Patent Application,yes,5,4,15,15,354,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,C07K14/435;;A61K39/35,,7,7,063-640-832-834-034;;073-212-088-312-095;;016-203-996-044-020;;024-410-221-639-40X;;064-530-633-815-972;;005-748-129-761-516;;132-088-915-552-897,10631780;;10.1016/s0167-7799(99)01398-0;;10.1101/gr.10.4.398;;10779480;;10.1016/s0168-9525(98)01486-3;;9635409;;9359093;;10.1038/nbt1197-1222;;8909140;;10.1016/0168-9525(96)60040-7;;10.1038/nbt1001-974;;11581666;;10.4049/jimmunol.1200850;;pmc3411923;;22786768,"Skolnick et al. (2000, Trends in Biotech. 18:34-39);;Bork (2000, Genome Research 10:398-400);;Doerks et al. (1998, Trends in Genetics 14:248-250);;Smith et al. (1997, Nature Biotechnology 15:1222-1223);;Bork et al. (1996, Trends in Genetics 12:425-427);;Cottingham et al., (Nature Biotechnology. 2001. 19:974 – 977);;Oseroff et al., (J Immunol. ePub 11 July 2012;189:1800-1811).",ACTIVE
468,AU,B4,AU 2008/101150 B4,100-173-118-850-168,2009-07-23,2009,AU 2008/101150 A,2008-11-26,AU 2005/323229 A;;AU 2008/101150 A;;US 2005/0045040 W;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;ADLER MITCHELL;;RUBINSTEIN JONATHAN JAKE;;DOROGUSKER JESSE L;;ARCHIBALD JOHN WESLEY,,https://lens.org/100-173-118-850-168,Limited Patent,no,2,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,2,1,078-438-431-493-828,10.1201/9781439821916.ch10,"MENEZES A ET AL: ""Handbook of Applied Cryptography , IDENTIFICATION AND ENTITY AUTHENTICATION"" HANDBOOK OF APPLIED CRYPTOGRAPHY, CRC PRESS SERIES ON DISCRETE MATHEMATICES AND ITS APPLICATIONS,;;BOCA RATON, FL, CRC PRESS, US, 1997",INACTIVE
469,US,S,US D0439823 S,124-376-735-532-22X,2001-04-03,2001,US 11665500 F,2000-01-10,US 11665500 F;;US 9951099 F,1999-01-22,Padlock,,MASTER LOCK CO,ADLER ARI TAO;;FIEGENER JOHN DARRIN;;THOMPSON ROY ALDEN;;GERINGER JOSEPH ROBERT;;WEST HARRY,MASTER LOCK COMPANY LLC (2000-01-18),https://lens.org/124-376-735-532-22X,Design Right,yes,38,7,1,1,0,,,D 8334,0,0,,,,EXPIRED
470,JP,A,JP 2014053966 A,148-371-898-339-377,2014-03-20,2014,JP 2013252930 A,2013-12-06,US 64234005 P;;US 5149905 A,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"PROBLEM TO BE SOLVED: To provide improved techniques to control utilization of accessory devices with electronic devices using cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another.SOLUTION: Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on a manufacturer or product basis by authenticating encrypted authentication information. Another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices that can receive accessory devices. One example of a media device is a media player, such as a music player that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/148-371-898-339-377,Patent Application,no,9,3,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,H04L9/32;;G06F21/44;;G10L19/00,,1,0,,,"梅田 勝司 他, 図解でわかる音楽配信ビジネス, vol. 初版, JPN6013036860, 1 October 2000 (2000-10-01), pages 178 - 187, ISSN: 0002916546",ACTIVE
471,US,B2,US 10934261 B2,165-914-587-880-312,2021-03-02,2021,US 201716337377 A,2017-09-27,US 201716337377 A;;US 201762554939 P;;US 201762459461 P;;US 201662401093 P;;US 2017/0053629 W,2016-09-28,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/165-914-587-880-312,Granted Patent,yes,142,8,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D233/90;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,179,129,048-639-884-454-955;;090-595-759-639-249;;005-836-557-552-913;;010-402-858-128-027;;061-330-223-146-889;;054-167-535-212-696;;032-421-248-192-752;;050-062-160-596-331;;005-582-329-281-579;;080-750-233-057-521;;078-776-607-842-828;;066-092-492-334-256;;006-136-522-900-040;;153-408-674-284-984;;047-156-535-940-645;;099-850-489-020-528;;034-987-888-849-578;;002-974-951-283-009;;010-248-616-848-483;;099-744-749-713-381;;075-813-686-060-816;;010-725-579-810-871;;036-746-562-702-221;;034-514-021-515-444;;078-382-889-771-789;;122-442-336-796-885;;035-995-301-512-762;;009-043-118-551-826;;044-878-082-973-49X;;159-695-952-917-570;;036-393-576-918-372;;013-556-469-253-589;;019-747-883-890-065;;052-664-611-823-937;;046-483-357-440-702;;023-684-266-623-526;;111-761-539-590-464;;021-045-743-874-448;;000-647-626-022-090;;048-382-748-962-92X;;002-499-291-773-300;;071-099-297-091-853;;039-317-916-201-269;;046-864-680-028-207;;016-958-339-591-097;;010-626-131-088-514;;022-411-096-178-940;;038-893-656-153-713;;072-994-322-434-772;;003-261-888-417-997;;077-008-425-179-22X;;021-003-404-471-569;;008-799-202-681-459;;114-918-900-251-802;;028-930-411-415-516;;039-581-629-931-843;;031-243-109-936-648;;112-361-501-662-497;;098-733-293-429-373;;042-939-733-208-454;;019-632-841-644-026;;034-331-211-704-877;;108-452-437-895-403;;119-687-205-724-766;;063-618-817-674-705;;009-186-473-238-939;;048-170-800-689-023;;041-931-386-444-790;;015-681-580-943-399;;000-094-688-465-084;;037-832-038-424-509;;001-576-828-082-834;;019-115-775-607-415;;012-830-491-824-205;;003-168-967-428-92X;;030-042-017-746-591;;131-046-096-401-339;;015-923-579-613-818;;074-458-381-494-234;;100-878-907-092-574;;141-914-263-639-943;;036-745-751-836-283;;048-916-440-146-479;;113-568-574-765-360;;065-285-521-497-72X;;063-460-415-904-574;;069-450-943-413-364;;023-301-052-611-166;;147-440-643-091-525;;007-730-440-068-99X;;004-052-426-270-084;;122-753-736-744-724;;027-995-839-963-178;;083-771-782-040-353;;052-649-373-150-312;;053-962-998-119-152;;048-205-769-302-325;;020-855-322-534-259;;064-406-626-054-484;;089-144-976-445-688;;151-919-600-413-52X;;041-940-476-987-371;;062-742-403-893-408;;129-297-815-048-32X;;085-234-268-089-786;;007-196-400-487-666;;009-406-912-144-89X;;030-033-993-640-765;;103-353-898-106-766;;041-625-114-141-248;;087-979-151-907-860;;007-432-529-089-951;;121-428-466-773-844;;053-490-223-664-742;;073-613-615-376-929;;030-524-564-810-697;;135-735-121-346-36X;;026-115-521-313-787;;164-224-116-012-039;;157-424-722-980-550;;089-950-113-895-743;;019-817-393-305-59X;;089-487-729-749-961;;111-320-010-409-764;;031-218-242-932-350;;018-562-302-914-931;;080-218-260-759-683;;015-358-399-529-695;;038-702-954-033-133,10.1016/s1570-0232(02)00782-1;;12650749;;10.1016/j.dmpk.2017.11.068;;10.1016/j.bmc.2015.02.035;;25797164;;28759231;;10.1021/acs.jmedchem.7b00731;;10.6023/cjoc201407016;;10.1016/j.bmcl.2011.06.017;;21741835;;24171628;;10.1021/jo4020613;;10.1107/s1600536805022373;;10.1002/anie.200805014;;19145612;;10.1016/s0960-894x(99)00392-3;;10476871;;10.1002/cbdv.201200320;;23161629;;10.1021/co400102v;;24377264;;10.1021/acs.jmedchem.5b01464.s001;;26823007;;pmc5156532;;10.1021/acs.jmedchem.5b01464;;10.1016/s0040-4039(00)79671-7;;10.1074/jbc.m108893200;;11602605;;10.1152/physrev.00029.2002;;12843408;;15041468;;10.1016/j.bcp.2003.12.021;;10.1071/ch09101;;24130198;;10.1002/cmdc.201300387;;10.1071/ch14121;;10.1016/j.ejmech.2011.02.025;;21397369;;pmc4240281;;24556840;;10.1038/nrm3758;;10.1016/j.bmcl.2005.03.095;;15911268;;10.1016/j.biocel.2006.04.012;;16971167;;27148623;;10.1021/acs.jmedchem.6b00267;;10.1038/srep08783;;pmc4350077;;25740631;;11992771;;10.1016/s0960-894x(02)00176-2;;10.1016/j.bmcl.2013.05.021;;23727045;;pmc3750990;;23211821;;10.1167/iovs.12-11088;;18024028;;10.1016/j.bmcl.2007.10.097;;10.5731/pdajpst.2011.00634;;22293237;;10.1021/ol070294u;;17373804;;23606616;;10.1002/chem.201204260;;9846074;;19215300;;10.1111/j.1742-4658.2008.06833.x;;25007318;;10.1038/ncomms5365;;10.1039/c6sc00197a;;27540460;;pmc4987086;;22432027;;pmc3303840;;10.1371/journal.pone.0033468;;11853546;;pmc1222398;;10.1042/bj3620383;;10.1042/0264-6021:3620383;;10.1071/ch09150;;21955158;;10.1021/jm200471r;;10.1016/s0040-4039(01)01134-0;;10.1021/jm010178b;;11585453;;24900305;;pmc4018096;;10.1021/ml100260x;;pmc2856976;;10.1074/jbc.r109.091306;;20147747;;15261274;;10.1016/j.bmcl.2004.06.013;;10.1021/acsmedchemlett.7b00494;;29541364;;pmc5846052;;10.1021/jm950541c;;8831774;;10.1021/jm0210717;;12773044;;29089532;;10.1038/s41598-017-14719-9;;pmc5663911;;18701765;;10.1124/jpet.108.142679;;23270364;;pmc3563429;;10.1021/ja3119674;;10.1016/j.bmcl.2015.07.059;;26238321;;26216521;;pmc4748423;;10.1038/npp.2015.225;;10.1074/jbc.m116.756858;;pmc5207150;;27875306;;8242144;;10.1385/0-89603-281-7:33;;10.1016/s0006-2952(00)00427-5;;11007946;;10611762;;10.1016/s1286-4579(99)00250-6;;10.1002/jcc.540030108;;10710438;;pmc102804;;10.1093/nar/28.7.e21;;22242975;;pmc3417452;;10.1111/j.1476-5381.2012.01855.x;;10.1038/352624a0;;1907718;;pmc136455;;12186906;;10.1128/jvi.76.18.9225-9231.2002;;10.1021/jm00165a001;;2407844;;10.1126/science.6879170;;6879170;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;17157313;;10.1016/j.jmb.2006.11.037;;10.1074/jbc.m900561200;;pmc2679455;;19269960;;10.1016/s1359-0278(97)00011-4;;9135979;;7692304;;10.1038/365566a0;;10.1126/scitranslmed.3004700;;23303606;;pmc396995;;2578661;;10.1073/pnas.82.1.178;;2443575;;10.1016/0022-1759(87)90085-8;;pmc345355;;6204335;;10.1073/pnas.81.13.3998;;14742441;;10.1074/jbc.m308759200;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;10.1371/journal.pgen.1001040;;20686710;;pmc2912385;;8689239;;10.1016/0968-0896(95)00171-9;;pmc151091;;10.1172/jci15518;;12163453;;10.1172/jci0215518;;10.1172/jci200215518;;pmc2199233;;10.1083/jcb.200109037;;11790801;;2025413;;10.1107/s0108767390010224;;10.1172/jci20530;;pmc297008;;10.1172/jci200320530;;14679171;;pmc53085;;1763028;;10.1073/pnas.88.24.11120;;10.1038/sj.onc.1204872;;11709702;;10.1107/s0021889891004399;;7154081;;10.1016/0022-2836(82)90153-x;;10.1126/science.257.5073.1078;;1509259;;10.1096/fj.03-1273rev;;15117886;;10.1038/nm.3218;;pmc4067127;;23817022;;pmc3989726;;10.1152/ajplung.00210.2013;;24583879;;10.1515/bchm.1998.379.2.175;;9524069;;10.1016/j.bbrc.2006.04.010;;16631603;;10.1021/bi00109a004;;1932005;;10.1080/02713680490516242;;15590481;;2027751;;10.1093/nar/19.7.1437;;pmc333898;;18485877;;10.1016/j.cell.2008.03.027;;pmc2728032;;1748994;;10.1016/0022-2836(91)90498-u;;10.1002/prot.340110104;;1961699;;10.2183/pjab.85.314;;19838011;;pmc3621568;;10.1016/0959-440x(92)90147-y;;8115163;;10.1007/bf01582083;;11994736;;10.1038/nrm757;;10.1016/s0040-4020(01)86503-0;;10.1371/journal.pone.0059348;;23565148;;pmc3614979;;10.1016/j.ajpath.2011.06.001;;21763673;;pmc3157273;;2447184;;10.4049/jimmunol.140.2.611;;20531305;;pmc3176718;;10.1038/onc.2010.215;;1370065;;10.1016/0958-1669(91)90032-z;;12649500;;10.1261/rna.2192803;;pmc1370415;;7615639;;pmc2199940;;10.1083/jcb.130.2.393;;10807004;;10.1016/s0167-4781(99)00150-5;;14749260;;10.2337/diabetes.53.2007.s12;;16271073;;10.1111/j.1349-7006.2005.00103.x;;10.1016/s0969-2126(00)00060-5;;7922037;;10805816;;10.1073/pnas.97.10.5633;;pmc25880;;10.1021/ja00315a051;;17631612;;10.1152/ajplung.00163.2007;;14627704;;10.1074/jbc.m309767200;;17207287;;pmc1781437;;10.1186/1465-9921-8-1;;pmc2693329;;10.1002/path.2277;;18161745;;12810675;;pmc1850509;;11583974;;10.1016/s0002-9440(10)62533-3;;10.1111/j.1349-7006.2000.tb00967.x;;10835488;;pmc5926377;;pmc1850511;;10.1016/s0002-9440(10)62518-7;;11583959;;10.1080/15216540050176610;;11087123;;10.1055/s-2008-1078210;;10.1021/jm201688n;;pmc3288238;;22243528;;10.1016/s0040-4039(02)01553-8,"Blum et al., 2003, Complementary use of ion trap / time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: Early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat. J Chromatography B. 787:255-270.;;Brodney et al., 2015, Utilizing Structures of CYP2D6 and BACE1 Complexes to Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors, J Med Chem. 58:3223-3252.;;CAS Registry No. 1309010-71-6; STN entry date: Jun. 13, 2011; D-Alanine, N-[(1-phenyl-1H-imidazol-5-yl)carbonyl] in 1 page.;;Gardiner et al., 2006, Ring closing metathesis of α- and β-amino acid derived dienes, J Organomet Chem. 691:5487-5496.;;Kim et al., 2015, Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor, Bioorg Med Chem. 23:1808-1816.;;Kling et al., 2017, Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 243-Phenyl-1H-pyrazol-1-yl)-nicotinamides, J Med Chem. 60:7123-7138.;;Li et al., 2015, Synthesis and Cytotoxic Activities of Novel Amino Acid-Conjugates of Pyrrole Derivatives. Youji Huaxue. 35:167-174.;;Sasmal et al., 2011, Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists. Bioorg Med Chem Lett. 21(16):4913-4918.;;Skogh et al., 2013, Aminocarbonylation of 4-lodo-1H-imidazoles with an Amino Acid Amide Nucleophile: Synthesis of Constrained H-Phe-Phe-NH2 Analogues. J Org Chem. 78:12251-12256.;;Zhong et al., 2005, 3-(2-Chloropheny1)-N-(2-cyano-4-methyl-2-pentyl)-5-methylisoxazole-4-carboxamide. Acta Cryst. Section E. E61:o2621-o2622 in 7 pages.;;International Search Report and Written Opinion dated Jan. 2, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Written Opinion (Rule 66) dated Aug. 28, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Written Opinion (Rule 66) dated Dec. 6, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;International Preliminary Report on Patentability dated Jan. 22, 2019 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Abell et al., 2009, Molecular Modeling, Synthesis, and Biological Evaluation of Macrocyclic Calpain Inhibitors, Angew Chem Int Ed Engl. 48(8):1455-1458.;;Bihovsky et al., 2004, 1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors, Bioorg Med Chem Lett. 14(4):1035-1038.;;Chatterjee et al., 1999, P2-achiral, P'-extended alpha-ketoamide inhibitors of calpain I. Bioorg Med Chem Lett. 9(16):2371-2374.;;Chen et al., 2012, New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N-Alkylation of Histidine, Chem Biodiver. 9(11):2473-2484.;;Cohrt A. Emil. 2014, Solid-phase synthesis of peptide thioureas and thiazole-containing macrocycles through Ru-catalyzed ring-closing metathesis, ACS Comb Sci. 16(2):71-77 and Supporting Information in 55 pages.;;Damalanka et al., 2016, Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease, J Med Chem. 59(5):1899-1913.;;Donald et al., 1991, C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Peptidyl-Prolyl Cis-Trans Isomerization, Tetrahedron Lett., 32(10):1375-1378.;;Dourdin et al., 2001, Reduced Cell Migration and Disruption of the Actin Cytoskeleton in Calpain-deficient embryonic Fibroblasts, J Biol Chem. 276(51):48382-48388.;;Goll et al., 2003, The Calpain System, Physiol Rev. 83(3):731-801.;;Halland et al., 2014, Small Macrocycles As Highly Active Integrin α2β1 Antagonists, ACS Med Chem Lett. 5(2):193-198.;;Jánossy et al., 2004, Calpain as a multi-site regulator of cell cycle, Biochem Pharmacol. 67(8):1513-1521.;;Jones et al., 2009, Efficient Large-Scale Synthesis of CAT811, a Potent Calpain Inhibitor of Interest in the Treatment of Cataracts, Aust J Chem. 62:671-675.;;Jones et al., 2013, A Template-Based Approach to Inhibitors of Calpain 2, 20S Proteasome, and HIV-1 Protease, Chem Med Chem. 8(12):1918-1921.;;Jones et al., 2014, The Preparation of Macrocyclic Calpain Inhibitors by Ring Closing Metathesis and Cross Metathesis, Aust J. Chem. 67:1257-1263.;;Kim et al., 2011, Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties, Eur J Med Chem. 46(5):1721-1728.;;Lamouille et al., 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol. 15(3):178-196 in 46 pages.;;Lee et al., 2005, Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 15(11):2857-2860.;;Leloup et al., 2006, Involvement of calpains in growth factor-mediated migration, Int J Biochem Cell Biol. 38(12):2049-2063.;;Low et al., 2016, Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics, J Med Chem. 59(11):5403-5415.;;Lu et al., 2015, Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors, Sci Rep. 5:8783 in 8 pages.;;Lubisch et al., 2002, Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors, Bioorg Med Chem Lett., 12(10):1335-1338.;;Mandadapu et al., 2013, Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus, Bioorg Med Chem Lett. 23(13):3709-3712.;;Miettinen et al., 1994, TGF-β Induced Transdifferentiation of Mammary Epithelial Cells to Mesenchymal Cells: Involvement of Type I Receptors, j Cell Biol. 127(6 Pt 2):2021-2036.;;Morton et al., 2013, A Macrocyclic Calpain Inhibitor Slows the Development of Inherited Cortical Cataracts in a Sheep Model, Invest Ophthal Visual Science. 54(1):389-395.;;Nam et al., 2008, Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 18(1):205-209.;;Nema et al., 2011, Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions, PDA J Pharm Sci Technol. 65(3):287-332.;;Oh et al., 2007, Thalassospiramides A and B, Immunosuppressive Peptides from the Marine Bacterium Thalassospira sp., Org Ltts. 9(8):1525-1528.;;Pegorier et al., 2010, Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF), Respir Res. 11:85 in 11 pages.;;Pehere et al., 2012, New β-Strand Templates Constrained by Huisgen Cycloaddition, Org Lett. 14(5):1330-1333.;;Pehere et al., 2013, New cylindrical peptide assemblies defined by extended parallel β-sheets, Org Biomol Chem. 11(3):425-429.;;Pehere et al., 2013, Synthesis and Extended Activity of Triazole-Containing Macrocyclic Protease Inhibitors, Chem Eur J. 19:7975-7981.;;Powell et al., 1998, Compendium of Excipients for Parenteral Formulations, pDA; J Pharm Sci Technol. 52(5):238-311.;;Ravulapalli et al., 2009, Distinguishing between calpain heterodimerization and homodimerization, FEBS J. 276(4):973-982.;;Rotstein et al., 2014, Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics, Nature Comm. 5:4365-4371.;;Rotstein et al., 2016, Mechanistic Studies and Radiofluorination of Structurally Diverse Pharmaceuticals with Spirocyclic lodonium(III) Ylides, Chem Sci. 7(7):4407-4417.;;Santos et al., 2012, Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation, PLoS One 7(3):e33468 in 12 pages.;;Schád et al., 2002, A novel human small subunit of calpains, Biochem J 342(Pt 2):383-388.;;Stoermer et al., 2009, Base-Sensitivity of Arginine Alpha-Ketoamide Inhibitors of Serine Proteases, Aust J Chem. 62(9):988-992.;;Stuart et al., 2011, Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis, J Med Chem. 54(21):7503-7522.;;Von Dobeneck et al., 1976, Diaminopyrrolinone, Liebigs Ann Chem., 3:476-486.;;Walker et al., 2001, General method for the synthesis of cyclic peptidomimetic compounds, Tetrahed Letts. 42(34):5801-5804.;;Wells et al., 2001, 1,2-Benzothiazine 1,1-Dioxide P2-P3 Peptide Mimetic Aldehyde Calpain I Inhibitors, J Med Chem. 44:3488-3503.;;Woon et al., 2011, Structure guided development of potent reversibly binding penicillin binding protein inhibitors, ACS Med Chem Lett., 2(3):219-223 and Supporting Information, S1-S46.;;Young et al., 2010, Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon, J Biol Chem. 285(15):11039-11044.;;CAS Registry No. 2094533-75-0; STN entry date: May 2, 2017; Benzamide, N-(2-amino-1,1-dimethyl-2-oxoethyl)-2-bromo-5-chloro-3-fluoro-, in 1 page.;;CAS Registry No. 1629446-68-9; STN entry date: Oct. 21, 2014; Benzamide, 3-cyano-N-[(1S)-1-formyl-2-phenylethyl], in 1 page.;;CAS Registry No. 2094410-58-7; STN entry date: May 2, 2017; Benzamide, 2-bromo-5-chloro-N-(1-cyano-2-methoxy-1-methylethyl)-3-fluoro-, in 1 page.;;CAS Registry No. 2037707-18-7; STN entry date: Nov. 25, 2016; Alanine, 3-fluoro-N-(2-fluoro-6-methoxybenzoyl)-, in 1 page.;;CAS Registry No. 1938924-09-4; STN entry date: Jun. 24, 2016; D-Leucine, N-(2-bromo-6-fluoro-3-methylbenzoyl)-, in 1 page.;;CAS Registry No. 2048401-56-3; STN entry date: Dec. 14 2016; 4-Hexenoic acid, 2-[(4,5-dichloro-2-methoxybenzoyl)amino]-, in 1 page.;;CAS Registry No. 2026949-92-6; STN entry date: Nov. 8, 2016; D-Leucine, N-[(6-bromo-3,4-dihydro-3-oxo-2H-1,4-benzoxazin-7-yl)carbonyl]-, in 1 page.;;CAS Registry No. 1031704-04-7; STN entry date: Jun. 30, 2008; L-Valine, N-[(5,7,8,10-tetrahydro-7,8-dioxo-6-undecyl-2-phenazinyl)carbonyl]-, in 1 page.;;CAS Registry No. 566157-42-4; STN entry date: Aug. 14, 2003; Alanine, N-[(9,10-dihydro-9-oxo-3-acridinyl)carbonyl]-2-methyl-, in 1 page.;;CAS Registry No. 289062-66-4; STN entry date: Sep. 14, 2000; Acetic acid, [(2,4-dichlorobenzoyl)amino](phenylthio)-, in 1 page.;;CAS Registry No. 15643-65-9; STN entry date: Nov. 16, 1984; Acetic acid, [(3,4-dichlorobenzoyl)amino]phenoxy-, in 1 page.;;CAS Reg. No. 1187056-39-8, Entered STN: Oct. 1, 2009; Acetic acid, 2-cyano-2-[(2,6-difluorobenzoyl)amino]-, ethyl ester in 1 page.;;CAS Reg. No. 885026-68-6, Entered STN: May 19, 2006; Benzamide, N-(2-butoxy-1-cyano-1-methylethyl)-2,6-dichloro- in 1 page.;;CAS Reg. No. 1825463-80-6; STN Entry Date Dec. 9, 2015; Benzamide, N-(cyanocyclopropylmethyl)-6-fluoro-2,3- in 1 page.;;CAS Reg No. 1551381-70-4, STN Entry Date: Feb. 20, 2014; Benzamide, N-(1-cyanopropyl)-2,6-difluoro-3-methyl- in 1 page.;;CAS Reg No. 1555291-73-0, STN Entry Date: Feb. 25, 2014; Benzamide, 4-chloro-N-(1-cyanobutyl)-2,5-difluoro- in 1 page.;;CAS Reg No. 1551443-75-4, STN Entry Date: Feb. 20, 2014; Benzamide, 4-chloro-N-(1-cyano-1-methylpropyl)-2,5-difluoro- in 1 page.;;CAS Reg. No. 1347051-33-5, Entered STN: Dec. 1, 2011; 1H-Imidazole-5-hexanoic acid, β-[[[(6S,8aS)-octahydro-4-oxo-2-(phenylmethyl)sulfonyl]pyrrolo[1,2-a]pyrazin-6-yl]carbonyl]amino]-a-oxo-, methyl ester, 1 page.;;CAS Reg. No. 1026166-23-3, Entered STN: Jun. 8, 2008 ; Hexanoic acid, 3[[[(1R,25,55)-3-[(2S)-2-cyclohexyl-2-[(3,3-dimethyl-1-oxobutyl)amino]acetyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-2-yl]carbonyl]amino]-6,6,6-trifluoro-2-oxo-, 1 page.;;CAS Reg. No. 2026817-08-1, Entered STN: Nov. 8, 2016; D-Leucine, N-[[3-(3-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Reg. No. 2049278-49-9, Entered STN: Dec. 15, 2016; 4-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Reg. No. 2039960-52-4, Entered STN: Nov. 28, 2016; 5-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Reg. No. 2026895-95-2, Entered STN:Nov. 8, 2016; L-Norleucine, N-[[3-(5-chloro-2-thienyl)-1H-pyrazol-4-yl]carbony1]-, 1 page.;;CAS Reg. No. 2026863-64-7, Entered STN: Nov. 8, 2016; L-Norleucine, N-[[4-(5-chloro-2-thienyl)-1H-pyrrol-3-yl]carbonyl]-, 1 page.;;CAS Reg. No. 1796920-43-8, Entered STN: Jul. 8, 2015; 1H-Pyrrole-3-carboxamide, N-(2-amino-1-methyl-2-oxoethyl)-4-(5-chloro-2-thienyl)-, 1 page.;;Gopalsamy et al., 2004, Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NSSB RNA dependent RNA polymerase. Bioorg Med Chem Lett. 14(16):4221-4224.;;Kling et al., 2018, Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1′ Extension, ACS Med Chem Lett. 9(3):221-226.;;Li et al., 1996, Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases, J Med Chem. 39(20):4089-4098.;;Lubisch et al., 2003, Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability, J Med Chem. 46(12):2404-2412.;;Muniappan et al., 2017, Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice, Sci Rep. 7:14398.;;Nimmrich et al., 2008, Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction, J Pharmacol Exp Ther. 327(2):343-352.;;Ross et al., 2013, Biosynthetic Multitasking Facilitates Thalassospiramide Structural Diversity in Marine Bacteria, J Am Chem Soc. 135(3):1155-1162.;;Singh et al., 2015, Identification of amino acid appended acridines as potential leads to anti-cancer drugs. Bioorg Med Chem Lett. 25(18):3854-3858.;;Vengeliene et al., 2016, The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile, Neuropsychopharmacology. 41(4):979-988 [online published Jul. 28, 2015].;;Zhang et al., 2016, Family-wide Structural Characterization and Genomic Comparisons Decode the Diversity-oriented Biosynthesis of Thalassospiramides by Marine Proteobacteria, J Biol Chem. 291(53):27228-27238.;;Beaucage S.L., Oligodeoxyribonucleotides synthesis. Phosphoramidite approach., (1993) Methods Mol. Biol., 20, 33-61.;;Boyer et al., Induction and regulation of epithelial-mesenchymal transitions., (2000) Biochem. Pharmacol, 60, 1091-1099.;;Branton et al., TGF-beta and fibrosis., (1999) Microbes Infect, 1(15), 1349-1365.;;Brooks et al., CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, (1983) J. Comp. Chem., 4, 187-217.;;Burkert et al., Pitfalls in the use of the torsion angle driving method for the calculation of conformational interconversions., (1982) J Comp. Chem, 3, 40-46.;;Capaldi et al., Signal amplification through nucleotide extension and excision on a dendritic Dna platform., (2000) Nucleic Acids Res., 28(7), e21.;;Chubanov et al., Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium- dependent activity of the kinase-coupled cation channel TRPM7., (2012) Br J Pharmacol, 166(4), 1357-1376.;;Clackson et al., Making antibody fragments using phage display libraries. (1991) Nature, 352: 624-628.;;Coburn et al., Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference., (2002) J. Virol., 76, 9225-9231.;;Cohen et al., Molecular Modeling Software and Methods for Medicinal Chemistry, (1990) Journal of Medicinal Chemistry, 33(3), 883-894.;;Connolly M.L., Solvent-Accessible Surfaces of Proteins and Nucleic Acids., (1983) Science, 221(4612), 709-713.;;Cwirla et al., Peptides on phage: a vast library of peptides for identifying ligands., (1990) Proc. Natl. Acad. Sci. USA, 87, 6378.;;Davis et al., The Crystal Structures of Human Calpains 1 and 9 Imply Diverse Mechanisms of Action and Auto inhibition., (2007) J. Mol. Biol., 366, 216-229.;;De Maria et al., Calpain Expression and Activity during Lens Fiber Cell Differentiation., (2009) J. Biol. Chem., 284 (20), 13542-50.;;Dunbrack et al., Meeting review: the Second Meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, Dec. 13-16, 1996., (1997) Folding and Design, 2, R27; 16 pages.;;Egholm et al., PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules., (1993) Nature, 365(6446), 566-568.;;Friedman et al., Therapy for fibrotic diseases: nearing the starting line., (2013) Sci. Transi. Med., 5(167), 167-17 pages.;;Geysen et al., Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein., (1985) Proc. Natl. Acad. Sci. USA, 82(1), 178-182.;;Geysen et al., Strategies for epitope analysis using peptide synthesis., (1987) Journal of Immunological Methods., 102(2), 259-274.;;Geysen et al., Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid., (1984) Proc. Natl. Acad. Sci. USA, 81, 3998-4002.;;Gooch et al., Invovlement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular maxtrix accumulation., (2004) J. Biol Chem., 279(15), 15561-70.;;Goodford P.J., A computational procedure for determining energetically favorable binding sites on biologically important macromolecules., (1985) J. Med. Chem, 28, 849-857.;;Goodsell et al., Automated docking of substrates to proteins by simulated annealing., (1990) Protein., 8(3): 195-202.;;Hata et al., Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense., (2010) PloS Genet., 6(7), e1001040 in 14 pages.;;Hyrup et al., Peptide nucleic acids (PNA): synthesis, properties and potential applications., (1996) Bioorg Med Chem., 4(1), 5-23.;;Iwano et al., Evidence that fibroblasts derive from epithelium during tissue fibrosis., (2002) J Chit Invest., 110(3): 341-350.;;Janda et al., RAS and TGF-beta cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways., (2002) J. Cell Biol, 156, 299-313.;;Jones et al. Improved methods for building protein models in electron density maps and the location of errors in these models., (1991) Acta Cryst., A47, 110-119.;;Kalluri et al., Epithelial-mesenchymal transition and its implications for fibrosis., (2003) J Clin Invest, 112(12), 1776-1784.;;Kang, et al., Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries., (1991) Proc. Natl. Acad. Sci. USA, 88, 11120-11123.;;Kiemer, et al., Identification of genes involved in epithelial-mesenchymal transition and tumor progression., (2001) Oncogene, 20, 6679-6688.;;Kim et al., Targeting Calpains: a Therapeutic Strategy for the Treatment of TGFbeta Mediated Mesenchymal Transition and Associated Pathologies., (2014) 64th Annual Meeting of the American Society of Human Genetics.;;Kraulis, Molscript: a program to produce both detailed and schematic plots of protein structures., (1991) J Appl Cryst., 24, 946-950.;;Kuntz et al., A geometric approach to macromolecule-ligand interactions., (1982) J. Mol. Biol., 161, 269-288.;;Kuntz I.D., Structure-Based Strategies for Drug Design and Discovery, (1992) Science 257:1078-1082.;;Leask et al., TGF-beta signaling and the fibrotic response., (2004) FASEB J., 18(7), 816-827.;;LeBleu et al., Origin and function of myofibroblasts in kidney fibrosis., (2013) Nat Med, 19(8), 1047-1053.;;Lee et al., Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease., (2014) Am J Physiol Lung Cell Mol Physiol, 306(8), L736-748.;;Lee et al., Molecular Cloning and Characterization of a Novel Tissue-Specific Calpain Predominantly Expressed in the Digestive Tract., (1998) Biol Chem., 379(2), 175-183.;;Li et al., Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice., (2006) Biochem Biophys Res Commun., 344(3): 701-707.;;Lowman et al., Selecting high-affinity binding proteins by monovalent phage display., (1991) Biochemistry, 30(45): 10832-10838.;;Ma et al., Expression of calpain small subunit 2 in mammalian tissues., (2004) Curr Eye Res., 29(4-5), 337-347.;;Mag et al., Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5′- phosphorothioate linkage., (1991) Nucleic Acids Res., 19(7): 1437-1441.;;Mani et al., The epithelia-mesenchymal transition generates cells with properties of stem cells., (2008) Cell, 122(4), 704-715.;;Marks et al., By-passing immunization. Human antibodies from V-gene libraries displayed on phage., (1991), J Mol Biol., 222, 581-597.;;McKay et al., Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α Expression., (1999) Biol. Chem., 274(3): 1715-1722.;;Miranker et al., Functionality maps of binding sites: a multiple copy simultaneous search method., (1991) Proteins. 11(1): 29-34.;;Miyazono K., Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer., (2009) Proc Jpn Acad Ser. B. Phys. Bio. Sci., 85(8), 314-323.;;Navia et al., Use of structural information in drug design., (1992) Current Opinion in Structural Biology, 2(2): 202-210.;;Nielsen, P.E., Peptide nucleic acid (PNA): A model structure for the primordial genetic material?, (1993) Origins of life and evolution of biospheres, 23(5), 323-327.;;Nieto M.A., The snail superfamily of zinc-finger transcription factors., (2002) Nat Rev Mol Cell Biol., 3, 155-166.;;Nishibata et al., Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation., (1991) Tetrahedron, 47(43), 8985-8990.;;Peng et al., Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: A model for “active” disease., (2013) Plos One, 8(4), e59348; 15 pages.;;Piccirillo et al., TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice., (1998) J Immunol., 161(8): 3950-3956.;;Piera-Velazquez et al., Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. (2011), Am J Pathol., 179(3), 1074-1080.;;Savary et al., Role of TGF-β signaling in EMT, cancer progression and metastasis., (2011) Drug Discovery Today: Disease Models, 8(2-3), 121-126.;;Schoofs et al., Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution., (1988) J Immunol., 140(2): 611-616.;;Singh et al., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer., (2010) Oncogene, 29(34), 4741-4751.;;Smith G.P., Surface presentation of protein epitopes using bacteriophage expression systems., (1991) Current Opin Blotechnol., 2, 668-673.;;Stewart et al., Lentivirus-delivered stable gene silencing by RNAi in primary cells., (2003) RNA, 9, 493-501.;;Strutz et al., Identification and characterization of a fibroblast marker: FSP1., (1995) J Cell Biol, 130(2): 393-405.;;Summerton J., Morpholino antisense oligomers: the case for an RNase H-independent structural type., (1999) Biochim Biophys Acta., 1489, 141-158.;;Suzuki et al., Structure, activity, and biology of calpain., (2004) Diabetes, 53(Suppl 1): S12-S18.;;Tojo et al., The ALK-5 Inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. (2005) Cancer Sci, 96(11), 791-800.;;Verlinde et al., Structure-based drug design: progress, results and challenges., (1994) Structure, 2, 577-587.;;Wahlestedt et al., Potent and nontoxic antisense oligonucleotides containing locked nucleic acids., (2000) PNAS USA, 97(10): 5633-5638.;;Weiner et al., A new force field for molecular mechanical simulation of nucleic acids and proteins., (1984) J Am Chem Soc. 106, 765-784.;;Willis et al., TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease., (2007) Amer J Physiol Lung Cell Mol Physiol, 293(3): L525-L534.;;Wu et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. (2004), J Biol Chem. 279(6), 4929-4940.;;Wu et al., Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an a-smooth muscle actin-Cre transgenic mouse., (2007) Respir Res., 8(1), 1; 11 pages.;;Wynn T., Cellular and molecular mechanisms of fibrosis., (2008) J Pathol., 214(2): 199-210.;;Xue et al., The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis., (2003) Cancer Res., 63, 3386-3394.;;Yang et al., Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis., (2001) Am J Pathol., 159(4): 1465-1475.;;Yoshikawa et al., Isolation of Two Novel Genes, Down-regulated in Gastric Cancer., (2000) Jpn J Cancer Res., 91(5), 459-463.;;Zeisberg et al., Renal Fibrosis: Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation., (2001) Am J Pathol., 159(4): 1313-1321.;;Zimmerman et al., The calpain small subunit gene is essential: its inactivation results in embryonic lethality. (2000) IUBMB Life, 50(1), 63-68.;;CAS Registry No. 1422551-25-4, N-[(1S)-2-amino-1-(1H-imidazol-5-ylmethyl)-2-oxoethyl]-3-(3-fluorophenyl)- 1H-Pyrazole-4-carboxamide, Entered STN Mar. 7, 2013; 1 page.;;Brouillette et al., Supporting Information for Valuable Versatile Reactivity of Thiaaisatoic Anhydrides: Expedient Solid-Phase Synthesis of Thieno [1,4]diazepine-2,5-diones, Synlett (2008) 15:2360-2364; Aug. 22, 2008 pp. 1-58.;;Wang et al., Synthesis and Biological Activity of 6-Substituted Pyrrolo [2,3- d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier. J Med Chem. (2012) 55(4):1758-1770.;;Partial Supplementary European Search Report dated Aug. 13, 2020 for Application No. 17857308.5, filed Apr. 26, 2019.;;Celatka et al., 2002, Asymmetric symhegis of a C1-C19 fragment of Ulapualide A. Tetrahed Lttrs, 43(39): 704-37046.;;Jansen et al., 1961. Some 4-Substituted Gxazoies. J Chem Society pp. 465-411 (see Reaxys-Abs).;;Reaxys Database, 2002, Database Accession No. 9305036, Eisevier Life Sciences IP Limited, 1 page.;;reaxys Database, 1961, Database Accession No. 849427, Eisevier Life Sciences IP Limited, 2 page.;;Extended European Search Report dated Dec. 14, 2020 for Application No. 17857308.5. filed Apr. 26, 2019.;;New Zealand Examination Report dated Dec. 2, 2020 for Application No. 752865, filed Apr. 24, 2019.",ACTIVE
472,NZ,A,NZ 752865 A,018-476-428-105-805,2021-05-28,2021,NZ 75286517 A,2017-09-27,US 2017/0053629 W;;US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;EMAYAN KUMARASWAMY;;YUAN SHENDONG;;ADLER MARC;;MA JINGYUAN,,https://lens.org/018-476-428-105-805,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
473,BR,A2,BR 112016011930 A2,073-584-180-372-186,2017-09-26,2017,BR 112016011930 A,2014-12-23,US 2014/0072228 W;;US 201361919925 P;;US 201462012690 P,2013-12-23,combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira,"a presente invenção refere-se a combinações de peptídeos ou suas variantes derivadas de uma porção de uma sequência de aminoácidos de um alérgeno de ácaro de poeira doméstica, por exemplo, os alérgenos der p 1, der f 1, der p 2, e/ou der f 2. tais peptídeos compreendem pelo menos um epitopo de célula t e um número alto significante de pacientes em uma população mundial terá alelos hla com o potencial para ligação de peptídeos das combinações de peptídeos. a invenção também refere-se ao uso de tais combinações de peptídeos em alívio de uma resposta imune causada por um ácaro de poeira.",ALK ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY,ALESSANDRO SETTE;;CLAUS LUNDEGAARD;;GITTE LUND;;JOHN SIDNEY;;LARS HARDER CHRISTENSEN;;PETER ADLER WÜRTZEN,,https://lens.org/073-584-180-372-186,Patent Application,no,0,0,15,15,0,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/35;;C07K14/435,,0,0,,,,DISCONTINUED
474,WO,A1,WO 2024/025784 A1,129-206-898-436-646,2024-02-01,2024,US 2023/0028195 W,2023-07-20,US 202217874100 A,2022-07-26,NON-VOLATILE MEMORY POWER CYCLE PROTECTION MECHANISM,"Techniques for protecting non-volatile memory (NVM) from power cycle interruptions during memory operations are disclosed. A power management integrated circuit (PMIC) coupled to a memory circuit with NVM implements the various techniques disclosed. When a power reset signal is asserted to a PMIC, the PMIC may delay initiation of the power reset cycle when it detects that the NVM coupled to the PMIC is active to prevent corruption of the NVM by the power reset cycle. The PMIC may detect the activity level of the NVM based on an activity output signal that indicates whether the NVM is active (e.g., programming or erasing) or inactive.",APPLE INC,SULLIVAN JOHN J;;HOLLABAUGH JAMES M;;BRINSFIELD JASON W;;RYAN CALVIN M;;ADLER ANDREAS,,https://lens.org/129-206-898-436-646,Patent Application,yes,5,0,2,2,0,G11C16/30;;G11C5/148;;G11C16/30;;G11C16/32;;G11C16/14;;G11C16/102,G11C16/30;;G06F1/3225,,0,0,,,,PENDING
475,US,B2,US 10894776 B2,146-167-774-775-520,2021-01-19,2021,US 16337377,2017-09-27,,,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.","Blade Therapeutics, Inc.",Brad Owen Buckman;;John Beamond Nicholas;;Shendong Yuan;;Marc Adler;;Kumaraswamy Emayan;;Jingyuan Ma,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/146-167-774-775-520,Granted Patent,yes,142,0,1,1,0,C07D233/90;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D233/90;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,173,0,,,"Blum et al., 2003, Complementary use of ion trap / time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: Early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat. J Chromatography B. 787:255-270.;;Brodney et al., 2015, Utilizing Structures of CYP2D6 and BACE1 Complexes to Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors, J Med Chem. 58:3223-3252.;;CAS Registry No. 1309010-71-6; STN entry date: Jun. 13, 2011; D-Alanine, N-[(1-phenyl-1H-imidazol-5-yl)carbonyl] in 1 page.;;Gardiner et al., 2006, Ring closing metathesis of α- and β-amino acid derived dienes, J Organomet Chem. 691:5487-5496.;;Kim et al., 2015, Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor, Bioorg Med Chem. 23:1808-1816.;;Kling et al., 2017, Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 243-Phenyl-1H-pyrazol-1-yl)-nicotinamides, J Med Chem. 60:7123-7138.;;Li et al., 2015, Synthesis and Cytotoxic Activities of Novel Amino Acid-Conjugates of Pyrrole Derivatives. Youji Huaxue. 35:167-174.;;Sasmal et al., 2011, Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists. Bioorg Med Chem Lett. 21(16):4913-4918.;;Skogh et al., 2013, Aminocarbonylation of 4-lodo-1H-imidazoles with an Amino Acid Amide Nucleophile: Synthesis of Constrained H-Phe-Phe-NH2 Analogues. J Org Chem. 78:12251-12256.;;Zhong et al., 2005, 3-(2-Chloropheny1)-N-(2-cyano-4-methyl-2-pentyl)-5-methylisoxazole-4-carboxamide. Acta Cryst. Section E. E61:o2621-o2622 in 7 pages.;;International Search Report and Written Opinion dated Jan. 2, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Written Opinion (Rule 66) dated Aug. 28, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Written Opinion (Rule 66) dated Dec. 6, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;International Preliminary Report on Patentability dated Jan. 22, 2019 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Abell et al., 2009, Molecular Modeling, Synthesis, and Biological Evaluation of Macrocyclic Calpain Inhibitors, Angew Chem Int Ed Engl. 48(8):1455-1458.;;Bihovsky et al., 2004, 1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors, Bioorg Med Chem Lett. 14(4):1035-1038.;;Chatterjee et al., 1999, P2-achiral, P'-extended alpha-ketoamide inhibitors of calpain I. Bioorg Med Chem Lett. 9(16):2371-2374.;;Chen et al., 2012, New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N-Alkylation of Histidine, Chem Biodiver. 9(11):2473-2484.;;Cohrt A. Emil. 2014, Solid-phase synthesis of peptide thioureas and thiazole-containing macrocycles through Ru-catalyzed ring-closing metathesis, ACS Comb Sci. 16(2):71-77 and Supporting Information in 55 pages.;;Damalanka et al., 2016, Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease, J Med Chem. 59(5):1899-1913.;;Donald et al., 1991, C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Peptidyl-Prolyl Cis-Trans Isomerization, Tetrahedron Lett., 32(10):1375-1378.;;Dourdin et al., 2001, Reduced Cell Migration and Disruption of the Actin Cytoskeleton in Calpain-deficient embryonic Fibroblasts, J Biol Chem. 276(51):48382-48388.;;Goll et al., 2003, The Calpain System, Physiol Rev. 83(3):731-801.;;Halland et al., 2014, Small Macrocycles As Highly Active Integrin α2β1 Antagonists, ACS Med Chem Lett. 5(2):193-198.;;Jánossy et al., 2004, Calpain as a multi-site regulator of cell cycle, Biochem Pharmacol. 67(8):1513-1521.;;Jones et al., 2009, Efficient Large-Scale Synthesis of CAT811, a Potent Calpain Inhibitor of Interest in the Treatment of Cataracts, Aust J Chem. 62:671-675.;;Jones et al., 2013, A Template-Based Approach to Inhibitors of Calpain 2, 20S Proteasome, and HIV-1 Protease, Chem Med Chem. 8(12):1918-1921.;;Jones et al., 2014, The Preparation of Macrocyclic Calpain Inhibitors by Ring Closing Metathesis and Cross Metathesis, Aust J. Chem. 67:1257-1263.;;Kim et al., 2011, Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties, Eur J Med Chem. 46(5):1721-1728.;;Lamouille et al., 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol. 15(3):178-196 in 46 pages.;;Lee et al., 2005, Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 15(11):2857-2860.;;Leloup et al., 2006, Involvement of calpains in growth factor-mediated migration, Int J Biochem Cell Biol. 38(12):2049-2063.;;Low et al., 2016, Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics, J Med Chem. 59(11):5403-5415.;;Lu et al., 2015, Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors, Sci Rep. 5:8783 in 8 pages.;;Lubisch et al., 2002, Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors, Bioorg Med Chem Lett., 12(10):1335-1338.;;Mandadapu et al., 2013, Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus, Bioorg Med Chem Lett. 23(13):3709-3712.;;Miettinen et al., 1994, TGF-β Induced Transdifferentiation of Mammary Epithelial Cells to Mesenchymal Cells: Involvement of Type I Receptors, j Cell Biol. 127(6 Pt 2):2021-2036.;;Morton et al., 2013, A Macrocyclic Calpain Inhibitor Slows the Development of Inherited Cortical Cataracts in a Sheep Model, Invest Ophthal Visual Science. 54(1):389-395.;;Nam et al., 2008, Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 18(1):205-209.;;Nema et al., 2011, Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions, PDA J Pharm Sci Technol. 65(3):287-332.;;Oh et al., 2007, Thalassospiramides A and B, Immunosuppressive Peptides from the Marine Bacterium Thalassospira sp., Org Ltts. 9(8):1525-1528.;;Pegorier et al., 2010, Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF), Respir Res. 11:85 in 11 pages.;;Pehere et al., 2012, New β-Strand Templates Constrained by Huisgen Cycloaddition, Org Lett. 14(5):1330-1333.;;Pehere et al., 2013, New cylindrical peptide assemblies defined by extended parallel β-sheets, Org Biomol Chem. 11(3):425-429.;;Pehere et al., 2013, Synthesis and Extended Activity of Triazole-Containing Macrocyclic Protease Inhibitors, Chem Eur J. 19:7975-7981.;;Powell et al., 1998, Compendium of Excipients for Parenteral Formulations, pDA; J Pharm Sci Technol. 52(5):238-311.;;Ravulapalli et al., 2009, Distinguishing between calpain heterodimerization and homodimerization, FEBS J. 276(4):973-982.;;Rotstein et al., 2014, Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics, Nature Comm. 5:4365-4371.;;Rotstein et al., 2016, Mechanistic Studies and Radiofluorination of Structurally Diverse Pharmaceuticals with Spirocyclic lodonium(III) Ylides, Chem Sci. 7(7):4407-4417.;;Santos et al., 2012, Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation, PLoS One 7(3):e33468 in 12 pages.;;Schád et al., 2002, A novel human small subunit of calpains, Biochem J 342(Pt 2):383-388.;;Stoermer et al., 2009, Base-Sensitivity of Arginine Alpha-Ketoamide Inhibitors of Serine Proteases, Aust J Chem. 62(9):988-992.;;Stuart et al., 2011, Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis, J Med Chem. 54(21):7503-7522.;;Von Dobeneck et al., 1976, Diaminopyrrolinone, Liebigs Ann Chem., 3:476-486.;;Walker et al., 2001, General method for the synthesis of cyclic peptidomimetic compounds, Tetrahed Letts. 42(34):5801-5804.;;Wells et al., 2001, 1,2-Benzothiazine 1,1-Dioxide P2-P3 Peptide Mimetic Aldehyde Calpain I Inhibitors, J Med Chem. 44:3488-3503.;;Woon et al., 2011, Structure guided development of potent reversibly binding penicillin binding protein inhibitors, ACS Med Chem Lett., 2(3):219-223 and Supporting Information, S1-S46.;;Young et al., 2010, Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon, J Biol Chem. 285(15):11039-11044.;;CAS Registry No. 2094533-75-0; STN entry date: May 2, 2017; Benzamide, N-(2-amino-1,1-dimethyl-2-oxoethyl)-2-bromo-5-chloro-3-fluoro-, in 1 page.;;CAS Registry No. 1629446-68-9; STN entry date: Oct. 21, 2014; Benzamide, 3-cyano-N-[(1S)-1-formyl-2-phenylethyl], in 1 page.;;CAS Registry No. 2094410-58-7; STN entry date: May 2, 2017; Benzamide, 2-bromo-5-chloro-N-(1-cyano-2-methoxy-1-methylethyl)-3-fluoro-, in 1 page.;;CAS Registry No. 2037707-18-7; STN entry date: Nov. 25, 2016; Alanine, 3-fluoro-N-(2-fluoro-6-methoxybenzoyl)-, in 1 page.;;CAS Registry No. 1938924-09-4; STN entry date: Jun. 24, 2016; D-Leucine, N-(2-bromo-6-fluoro-3-methylbenzoyl)-, in 1 page.;;CAS Registry No. 2048401-56-3; STN entry date: Dec. 14 2016; 4-Hexenoic acid, 2-[(4,5-dichloro-2-methoxybenzoyl)amino]-, in 1 page.;;CAS Registry No. 2026949-92-6; STN entry date: Nov. 8, 2016; D-Leucine, N-[(6-bromo-3,4-dihydro-3-oxo-2H-1,4-benzoxazin-7-yl)carbonyl]-, in 1 page.;;CAS Registry No. 1031704-04-7; STN entry date: Jun. 30, 2008; L-Valine, N-[(5,7,8,10-tetrahydro-7,8-dioxo-6-undecyl-2-phenazinyl)carbonyl]-, in 1 page.;;CAS Registry No. 566157-42-4; STN entry date: Aug. 14, 2003; Alanine, N-[(9,10-dihydro-9-oxo-3-acridinyl)carbonyl]-2-methyl-, in 1 page.;;CAS Registry No. 289062-66-4; STN entry date: Sep. 14, 2000; Acetic acid, [(2,4-dichlorobenzoyl)amino](phenylthio)-, in 1 page.;;CAS Registry No. 15643-65-9; STN entry date: Nov. 16, 1984; Acetic acid, [(3,4-dichlorobenzoyl)amino]phenoxy-, in 1 page.;;CAS Reg. No. 1187056-39-8, Entered STN: Oct. 1, 2009; Acetic acid, 2-cyano-2-[(2,6-difluorobenzoyl)amino]-, ethyl ester in 1 page.;;CAS Reg. No. 885026-68-6, Entered STN: May 19, 2006; Benzamide, N-(2-butoxy-1-cyano-1-methylethyl)-2,6-dichloro- in 1 page.;;CAS Reg. No. 1825463-80-6; STN Entry Date Dec. 9, 2015; Benzamide, N-(cyanocyclopropylmethyl)-6-fluoro-2,3- in 1 page.;;CAS Reg No. 1551381-70-4, STN Entry Date: Feb. 20, 2014; Benzamide, N-(1-cyanopropyl)-2,6-difluoro-3-methyl- in 1 page.;;CAS Reg No. 1555291-73-0, STN Entry Date: Feb. 25, 2014; Benzamide, 4-chloro-N-(1-cyanobutyl)-2,5-difluoro- in 1 page.;;CAS Reg No. 1551443-75-4, STN Entry Date: Feb. 20, 2014; Benzamide, 4-chloro-N-(1-cyano-1-methylpropyl)-2,5-difluoro- in 1 page.;;CAS Reg. No. 1347051-33-5, Entered STN: Dec. 1, 2011; 1H-Imidazole-5-hexanoic acid, β-[[[(6S,8aS)-octahydro-4-oxo-2-(phenylmethyl)sulfonyl]pyrrolo[1,2-a]pyrazin-6-yl]carbonyl]amino]-a-oxo-, methyl ester, 1 page.;;CAS Reg. No. 1026166-23-3, Entered STN: Jun. 8, 2008 ; Hexanoic acid, 3[[[(1R,25,55)-3-[(2S)-2-cyclohexyl-2-[(3,3-dimethyl-1-oxobutyl)amino]acetyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-2-yl]carbonyl]amino]-6,6,6-trifluoro-2-oxo-, 1 page.;;CAS Reg. No. 2026817-08-1, Entered STN: Nov. 8, 2016; D-Leucine, N-[[3-(3-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Reg. No. 2049278-49-9, Entered STN: Dec. 15, 2016; 4-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Reg. No. 2039960-52-4, Entered STN: Nov. 28, 2016; 5-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Reg. No. 2026895-95-2, Entered STN:Nov. 8, 2016; L-Norleucine, N-[[3-(5-chloro-2-thienyl)-1H-pyrazol-4-yl]carbony1]-, 1 page.;;CAS Reg. No. 2026863-64-7, Entered STN: Nov. 8, 2016; L-Norleucine, N-[[4-(5-chloro-2-thienyl)-1H-pyrrol-3-yl]carbonyl]-, 1 page.;;CAS Reg. No. 1796920-43-8, Entered STN: Jul. 8, 2015; 1H-Pyrrole-3-carboxamide, N-(2-amino-1-methyl-2-oxoethyl)-4-(5-chloro-2-thienyl)-, 1 page.;;Gopalsamy et al., 2004, Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NSSB RNA dependent RNA polymerase. Bioorg Med Chem Lett. 14(16):4221-4224.;;Kling et al., 2018, Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1′ Extension, ACS Med Chem Lett. 9(3):221-226.;;Li et al., 1996, Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases, J Med Chem. 39(20):4089-4098.;;Lubisch et al., 2003, Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability, J Med Chem. 46(12):2404-2412.;;Muniappan et al., 2017, Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice, Sci Rep. 7:14398.;;Nimmrich et al., 2008, Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction, J Pharmacol Exp Ther. 327(2):343-352.;;Ross et al., 2013, Biosynthetic Multitasking Facilitates Thalassospiramide Structural Diversity in Marine Bacteria, J Am Chem Soc. 135(3):1155-1162.;;Singh et al., 2015, Identification of amino acid appended acridines as potential leads to anti-cancer drugs. Bioorg Med Chem Lett. 25(18):3854-3858.;;Vengeliene et al., 2016, The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile, Neuropsychopharmacology. 41(4):979-988 [online published Jul. 28, 2015].;;Zhang et al., 2016, Family-wide Structural Characterization and Genomic Comparisons Decode the Diversity-oriented Biosynthesis of Thalassospiramides by Marine Proteobacteria, J Biol Chem. 291(53):27228-27238.;;Beaucage S.L., Oligodeoxyribonucleotides synthesis. Phosphoramidite approach., (1993) Methods Mol. Biol., 20, 33-61.;;Boyer et al., Induction and regulation of epithelial-mesenchymal transitions., (2000) Biochem. Pharmacol, 60, 1091-1099.;;Branton et al., TGF-beta and fibrosis., (1999) Microbes Infect, 1(15), 1349-1365.;;Brooks et al., CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, (1983) J. Comp. Chem., 4, 187-217.;;Burkert et al., Pitfalls in the use of the torsion angle driving method for the calculation of conformational interconversions., (1982) J Comp. Chem, 3, 40-46.;;Capaldi et al., Signal amplification through nucleotide extension and excision on a dendritic Dna platform., (2000) Nucleic Acids Res., 28(7), e21.;;Chubanov et al., Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium- dependent activity of the kinase-coupled cation channel TRPM7., (2012) Br J Pharmacol, 166(4), 1357-1376.;;Clackson et al., Making antibody fragments using phage display libraries. (1991) Nature, 352: 624-628.;;Coburn et al., Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference., (2002) J. Virol., 76, 9225-9231.;;Cohen et al., Molecular Modeling Software and Methods for Medicinal Chemistry, (1990) Journal of Medicinal Chemistry, 33(3), 883-894.;;Connolly M.L., Solvent-Accessible Surfaces of Proteins and Nucleic Acids., (1983) Science, 221(4612), 709-713.;;Cwirla et al., Peptides on phage: a vast library of peptides for identifying ligands., (1990) Proc. Natl. Acad. Sci. USA, 87, 6378.;;Davis et al., The Crystal Structures of Human Calpains 1 and 9 Imply Diverse Mechanisms of Action and Auto inhibition., (2007) J. Mol. Biol., 366, 216-229.;;De Maria et al., Calpain Expression and Activity during Lens Fiber Cell Differentiation., (2009) J. Biol. Chem., 284 (20), 13542-50.;;Dunbrack et al., Meeting review: the Second Meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, Dec. 13-16, 1996., (1997) Folding and Design, 2, R27; 16 pages.;;Egholm et al., PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules., (1993) Nature, 365(6446), 566-568.;;Friedman et al., Therapy for fibrotic diseases: nearing the starting line., (2013) Sci. Transi. Med., 5(167), 167-17 pages.;;Geysen et al., Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein., (1985) Proc. Natl. Acad. Sci. USA, 82(1), 178-182.;;Geysen et al., Strategies for epitope analysis using peptide synthesis., (1987) Journal of Immunological Methods., 102(2), 259-274.;;Geysen et al., Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid., (1984) Proc. Natl. Acad. Sci. USA, 81, 3998-4002.;;Gooch et al., Invovlement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular maxtrix accumulation., (2004) J. Biol Chem., 279(15), 15561-70.;;Goodford P.J., A computational procedure for determining energetically favorable binding sites on biologically important macromolecules., (1985) J. Med. Chem, 28, 849-857.;;Goodsell et al., Automated docking of substrates to proteins by simulated annealing., (1990) Protein., 8(3): 195-202.;;Hata et al., Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense., (2010) PloS Genet., 6(7), e1001040 in 14 pages.;;Hyrup et al., Peptide nucleic acids (PNA): synthesis, properties and potential applications., (1996) Bioorg Med Chem., 4(1), 5-23.;;Iwano et al., Evidence that fibroblasts derive from epithelium during tissue fibrosis., (2002) J Chit Invest., 110(3): 341-350.;;Janda et al., RAS and TGF-beta cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways., (2002) J. Cell Biol, 156, 299-313.;;Jones et al. Improved methods for building protein models in electron density maps and the location of errors in these models., (1991) Acta Cryst., A47, 110-119.;;Kalluri et al., Epithelial-mesenchymal transition and its implications for fibrosis., (2003) J Clin Invest, 112(12), 1776-1784.;;Kang, et al., Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries., (1991) Proc. Natl. Acad. Sci. USA, 88, 11120-11123.;;Kiemer, et al., Identification of genes involved in epithelial-mesenchymal transition and tumor progression., (2001) Oncogene, 20, 6679-6688.;;Kim et al., Targeting Calpains: a Therapeutic Strategy for the Treatment of TGFbeta Mediated Mesenchymal Transition and Associated Pathologies., (2014) 64th Annual Meeting of the American Society of Human Genetics.;;Kraulis, Molscript: a program to produce both detailed and schematic plots of protein structures., (1991) J Appl Cryst., 24, 946-950.;;Kuntz et al., A geometric approach to macromolecule-ligand interactions., (1982) J. Mol. Biol., 161, 269-288.;;Kuntz I.D., Structure-Based Strategies for Drug Design and Discovery, (1992) Science 257:1078-1082.;;Leask et al., TGF-beta signaling and the fibrotic response., (2004) FASEB J., 18(7), 816-827.;;LeBleu et al., Origin and function of myofibroblasts in kidney fibrosis., (2013) Nat Med, 19(8), 1047-1053.;;Lee et al., Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease., (2014) Am J Physiol Lung Cell Mol Physiol, 306(8), L736-748.;;Lee et al., Molecular Cloning and Characterization of a Novel Tissue-Specific Calpain Predominantly Expressed in the Digestive Tract., (1998) Biol Chem., 379(2), 175-183.;;Li et al., Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice., (2006) Biochem Biophys Res Commun., 344(3): 701-707.;;Lowman et al., Selecting high-affinity binding proteins by monovalent phage display., (1991) Biochemistry, 30(45): 10832-10838.;;Ma et al., Expression of calpain small subunit 2 in mammalian tissues., (2004) Curr Eye Res., 29(4-5), 337-347.;;Mag et al., Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5′- phosphorothioate linkage., (1991) Nucleic Acids Res., 19(7): 1437-1441.;;Mani et al., The epithelia-mesenchymal transition generates cells with properties of stem cells., (2008) Cell, 122(4), 704-715.;;Marks et al., By-passing immunization. Human antibodies from V-gene libraries displayed on phage., (1991), J Mol Biol., 222, 581-597.;;McKay et al., Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α Expression., (1999) Biol. Chem., 274(3): 1715-1722.;;Miranker et al., Functionality maps of binding sites: a multiple copy simultaneous search method., (1991) Proteins. 11(1): 29-34.;;Miyazono K., Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer., (2009) Proc Jpn Acad Ser. B. Phys. Bio. Sci., 85(8), 314-323.;;Navia et al., Use of structural information in drug design., (1992) Current Opinion in Structural Biology, 2(2): 202-210.;;Nielsen, P.E., Peptide nucleic acid (PNA): A model structure for the primordial genetic material?, (1993) Origins of life and evolution of biospheres, 23(5), 323-327.;;Nieto M.A., The snail superfamily of zinc-finger transcription factors., (2002) Nat Rev Mol Cell Biol., 3, 155-166.;;Nishibata et al., Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation., (1991) Tetrahedron, 47(43), 8985-8990.;;Peng et al., Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: A model for “active” disease., (2013) Plos One, 8(4), e59348; 15 pages.;;Piccirillo et al., TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice., (1998) J Immunol., 161(8): 3950-3956.;;Piera-Velazquez et al., Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. (2011), Am J Pathol., 179(3), 1074-1080.;;Savary et al., Role of TGF-β signaling in EMT, cancer progression and metastasis., (2011) Drug Discovery Today: Disease Models, 8(2-3), 121-126.;;Schoofs et al., Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution., (1988) J Immunol., 140(2): 611-616.;;Singh et al., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer., (2010) Oncogene, 29(34), 4741-4751.;;Smith G.P., Surface presentation of protein epitopes using bacteriophage expression systems., (1991) Current Opin Blotechnol., 2, 668-673.;;Stewart et al., Lentivirus-delivered stable gene silencing by RNAi in primary cells., (2003) RNA, 9, 493-501.;;Strutz et al., Identification and characterization of a fibroblast marker: FSP1., (1995) J Cell Biol, 130(2): 393-405.;;Summerton J., Morpholino antisense oligomers: the case for an RNase H-independent structural type., (1999) Biochim Biophys Acta., 1489, 141-158.;;Suzuki et al., Structure, activity, and biology of calpain., (2004) Diabetes, 53(Suppl 1): S12-S18.;;Tojo et al., The ALK-5 Inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. (2005) Cancer Sci, 96(11), 791-800.;;Verlinde et al., Structure-based drug design: progress, results and challenges., (1994) Structure, 2, 577-587.;;Wahlestedt et al., Potent and nontoxic antisense oligonucleotides containing locked nucleic acids., (2000) PNAS USA, 97(10): 5633-5638.;;Weiner et al., A new force field for molecular mechanical simulation of nucleic acids and proteins., (1984) J Am Chem Soc. 106, 765-784.;;Willis et al., TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease., (2007) Amer J Physiol Lung Cell Mol Physiol, 293(3): L525-L534.;;Wu et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. (2004), J Biol Chem. 279(6), 4929-4940.;;Wu et al., Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an a-smooth muscle actin-Cre transgenic mouse., (2007) Respir Res., 8(1), 1; 11 pages.;;Wynn T., Cellular and molecular mechanisms of fibrosis., (2008) J Pathol., 214(2): 199-210.;;Xue et al., The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis., (2003) Cancer Res., 63, 3386-3394.;;Yang et al., Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis., (2001) Am J Pathol., 159(4): 1465-1475.;;Yoshikawa et al., Isolation of Two Novel Genes, Down-regulated in Gastric Cancer., (2000) Jpn J Cancer Res., 91(5), 459-463.;;Zeisberg et al., Renal Fibrosis: Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation., (2001) Am J Pathol., 159(4): 1313-1321.;;Zimmerman et al., The calpain small subunit gene is essential: its inactivation results in embryonic lethality. (2000) IUBMB Life, 50(1), 63-68.;;CAS Registry No. 1422551-25-4, N-[(1S)-2-amino-1-(1H-imidazol-5-ylmethyl)-2-oxoethyl]-3-(3-fluorophenyl)- 1H-Pyrazole-4-carboxamide, Entered STN Mar. 7, 2013; 1 page.;;Brouillette et al., Supporting Information for Valuable Versatile Reactivity of Thiaaisatoic Anhydrides: Expedient Solid-Phase Synthesis of Thieno [1,4]diazepine-2,5-diones, Synlett (2008) 15:2360-2364; Aug. 22, 2008 pp. 1-58.;;Wang et al., Synthesis and Biological Activity of 6-Substituted Pyrrolo [2,3- d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier. J Med Chem. (2012) 55(4):1758-1770.;;Partial Supplementary European Search Report dated Aug. 13, 2020 for Application No. 17857308.5, filed Apr. 26, 2019.",UNKNOWN
476,EP,A4,EP 3481835 A4,024-707-205-097-775,2020-02-26,2020,EP 17824731 A,2017-06-29,US 201662358504 P;;US 2017/0040109 W,2016-07-05,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,,BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC;;NICHOLAS JOHN BEAMOND,,https://lens.org/024-707-205-097-775,Search Report,no,0,0,6,6,0,C07D225/06;;C07D413/12;;C07D471/04;;C07D471/14;;C07D273/01;;C07D498/04;;C07D498/14;;A61P35/00;;A61P17/00;;C07D498/06;;A61P1/16;;A61P13/12;;A61P11/00;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04;;C07D498/18,C07D498/14;;A61K31/395;;A61K31/404;;A61K31/4164;;A61K31/435;;A61P17/00;;A61P35/00;;C07D225/06;;C07D267/00;;C07D273/01;;C07D413/12;;C07D471/04;;C07D471/14;;C07D498/04,,1,0,,,No further relevant documents disclosed,DISCONTINUED
477,AU,A1,AU 2014/369866 A1,086-444-597-650-96X,2016-06-30,2016,AU 2014/369866 A,2014-12-23,US 201462012690 P;;US 201361919925 P;;US 2014/0072228 W,2013-12-23,Peptide combinations and uses thereof in treating dust mite allergy,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WURTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,,https://lens.org/086-444-597-650-96X,Patent Application,no,0,0,15,15,0,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,C07K14/435;;A61K39/35,,0,0,,,,DISCONTINUED
478,TW,A,TW 201823213 A,093-764-569-233-102,2018-07-01,2018,TW 106133478 A,2017-09-28,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,CALPAIN modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,,https://lens.org/093-764-569-233-102,Patent of Addition,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D231/14;;A61K31/4155;;A61K31/4178;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
479,US,A1,US 2020/0123114 A1,131-571-556-766-44X,2020-04-23,2020,US 201716337377 A,2017-09-27,US 201716337377 A;;US 201762554939 P;;US 201762459461 P;;US 201662401093 P;;US 2017/0053629 W,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/131-571-556-766-44X,Patent Application,yes,0,2,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D233/90;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,0,0,,,,ACTIVE
480,US,B2,US 8763079 B2,172-353-969-842-537,2014-06-24,2014,US 32836808 A,2008-12-04,US 32836808 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY;;APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/172-353-969-842-537,Granted Patent,yes,114,9,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,H04L9/32;;G06F17/30;;G10L19/00,726/2;;726/27;;726/17;;726/34,31,3,030-389-189-134-332;;030-389-189-134-332;;065-096-740-432-042,10.1109/hicss.2007.300;;10.1109/hicss.2007.300;;10.1109/icce.1997.625976,"German Patent Application No. 202005021674.7, German Search Report, 4 pages, Jan. 7, 2010.;;iPod Classic User's Guide, acquired from apple.com, 2002; 44 pages.;;iPod nano Features Guide, acquired from apple.com, 2008; 72 pages.;;iPod touch User's Guide, acquired from apple.com, 2008, 120 pages.;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [on line], [retrieved on Sep. 26, 2008]. Retrieved from the Internet . 2 pages.;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 23, 2008]. Retrieved from the Internet . 2 pages.;;""Universal Serial Bus Specification-Rev 2.0,"" Chapter 6, Compaq Hewlett-Packard, Apr. 27, 2000, pp. 85, 99-100.;;Decision to Refuse a European Patent Application dated Jan. 11, 2011 from European Patent Application No. 07 812 335.3-2212.;;First Office Action dated Jul. 15, 2010 from Chinese Patent Application No. 200780024247.5.;;Notice of Final Rejection dated Jan. 26, 2011 from Korean Patent Application No. 10-2008-7030334.;;European Patent Office, Office Action, Application No. 09 791 751.2, Mailed Oct. 19, 2012, 7 pages.;;European Patent Office, Office Action, Application No. 07 799 051.3, Mailed Sep. 24, 2012, 7 pages.;;Chen et al., ""Design and Implemeation of a Hard Disk-Based Entertainment Device for Managing Media Contents On The Go,"" Consumer Electonics, 1005. (ISCE 2005). Proceedings of the Ninth International Symposium on, pp. 328-333, Jun. 14-16, 2005 (6 pages).;;LSI Logic's Broadcast PC Card Brings New Multimedia Capabilities to Personal Computing. (Nov. 16). PR Newswire, 1. Retrieved Jun. 26, 2010, from Business Dateline (3 pages).;;Microsoft, ""Media Transport Protocol Implementation Details,"" 2005 (18 pages).;;Nomad II Player Version 1.0 (CLI) (User's Manual), Creative Technology, Ltd., Jan. 2000 (46 pages).;;Slay et al., ""iPod Forensics: Forencically Sound Examination of an Apple iPod,"" System Sciences, 2007. HICSS 2007. 40th Annual Hawaii Internation Conference on, pp. 1-9, Jan. 2007 (9 pages).;;Chen et al., ""Design and Implemeation of a Hard Disk-Based Entertainment Device for Managing Media Contents On The Go,"" Consumer Electonics, 1005. (ISCE 2005). Proceedings of the Ninth International Symposium on, pp. 328-333, Jun. 14-16, 2005, 6 pages.;;LSI Logic's Broadcast PC Card Brings New Multimedia Capabilities to Personal Computing. (Nov. 16). PR Newswire, 1. Retrieved Jun. 26, 2010, from Business Dateline, 3 pages.;;Microsoft, ""Media Transport Protocol Implementation Details,"" 2005, 18 pages.;;Nomad II Player Version 1.0 (CLI) (User's Manual), Creative Technology, Ltd., Jan. 2000, 46 pages.;;Slay et al., ""iPod Forensics: Forencically Sound Examination of an Apple iPod,"" System Sciences, 2007. HICSS 2007. 40th Annual Hawaii Internation Conference on, pp. 1-9, Jan. 2007.;;Japanese Patent Office; Office Action for Application No. 2010-011810, Mailed Jul. 9, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2010-011810, Mailed Dec. 11, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2011-526100 , Mailed Dec. 13, 2012. (4 pages).;;European Patent Office (EPO), Extended Search Report; Application No. 10194370.2, Mailed Feb. 6, 2012 (9 pages).;;Office Action for European Patent Application No. 10194377.7, mailed Apr. 15, 2013, 6 pages.;;Non-Final Office Action mailed Oct. 26, 2012; U.S. Appl. No. 13/474,552, filed May 17, 2012 (27 pages).;;The First Office Action in Chinese Application No. 200910222182.6, mailed Nov. 23, 2011 (36 pages).;;Umeda, Katsuji et al., ""Music Distribution Business Illustrated for Understanding,""; Japan Management Associate Management Center; Oct. 1, 2000, First Edition, pp. 179, 187, in Japanese.;;Janssen, Jan, ""A Single-Chip Universal Serial Bus D/A Converter for High-Quality Audio Signals,"" THPM 16.7 IEEE 19970611; 19970611-19970613, Jun. 11, 1997, (2 pages ).",ACTIVE
481,MX,A,MX 2016008305 A,182-049-816-508-489,2017-01-11,2017,MX 2016008305 A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY.,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK-ABELLÓ AS,ALESSANDRO SETTE;;CLAUS LUNDEGAARD;;LARS HARDER CHRISTENSEN;;PETER ADLER WÜRTZEN;;JOHN SIDNEY;;GITTE LUND,,https://lens.org/182-049-816-508-489,Patent Application,no,0,0,15,15,0,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/35;;C07K14/435,,0,0,,,,PENDING
482,CA,A1,CA 3067063 A1,022-361-891-922-860,2018-12-27,2018,CA 3067063 A,2018-06-19,US 201762524334 P;;US 2018/0038344 W,2017-06-23,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Small molecule calpain modulator compositions and pharmaceutical compositions can be prepared and used as therapeutic agents. Exemplary compositions include non-macrocyclic a-keto amide derivatives. The therarapeutic agents can be used for treating fibrotic disease or a resulting secondary disease state or condition. The small molecules can competitively bind with calpastatin and/or inhibit calpain through contact with CAPN1, CAPN2, and/or CAPN9 enzymes.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;EMAYAN KUMARASWAMY;;ADLER MARC;;NICHOLAS JOHN BEAMOND;;MA JINGYUAN,,https://lens.org/022-361-891-922-860,Patent Application,no,0,0,4,4,0,C07D311/84;;C07D317/68;;C07D319/24;;C07D265/38;;C07D209/86;;C07D209/88;;C07D307/91;;A61P35/00;;C07C233/76;;C07C235/60;;C07C235/80;;C07C2602/10;;C07C2601/16;;A61P19/04;;C07C233/62;;C07C233/76;;C07C233/78;;C07D209/90;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,C07C233/84;;A61K31/166;;A61K31/33;;A61P35/00;;C07D209/86;;C07D209/88;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,,0,0,,,,PENDING
483,WO,A1,WO 2015/100360 A1,037-897-197-571-060,2015-07-02,2015,US 2014/0072228 W,2014-12-23,US 201361919925 P;;US 201462012690 P,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK ABELLÓ AS;;JOLLA INST ALLERGY IMMUNOLOG,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WÜRTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,,https://lens.org/037-897-197-571-060,Patent Application,yes,18,5,15,15,354,A61K39/35;;A61K39/35;;C07K14/43531;;A61P37/08;;A61K39/35;;C07K14/43531;;A61K2039/555;;A61K39/35;;C07K14/43531,A61K39/35;;C07K14/435,,42,33,015-390-005-997-251;;032-728-154-591-070;;085-764-009-624-439;;056-201-471-905-934;;056-201-471-905-934;;085-764-009-624-439;;025-502-903-207-115;;028-373-705-126-470;;010-681-116-468-270;;115-754-820-400-589;;056-201-471-905-934;;010-681-116-468-270;;023-434-722-052-076;;000-084-161-082-58X;;009-293-561-193-754;;033-259-909-782-017;;058-567-300-315-349;;084-843-739-748-133;;048-901-477-921-123;;015-824-239-192-144;;015-054-897-877-526;;032-728-154-591-070;;018-208-239-340-186;;012-761-230-276-400;;085-764-009-624-439;;025-502-903-207-115;;039-689-051-287-055;;038-617-189-853-751;;042-712-328-153-588;;066-622-073-370-530;;052-672-768-311-542;;017-216-732-209-839;;009-293-561-193-754,21093025;;10.1016/j.jaci.2010.09.027;;10.1016/0022-2836(70)90057-4;;5420325;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;10.1385/1-59259-192-2:185;;10547837;;10.1016/0022-2836(81)90087-5;;7265238;;10.1016/s0006-291x(03)00585-0;;12711317;;10.1007/978-1-4615-1823-5_7;;7551218;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1016/s0006-291x(03)00585-0;;12711317;;10.1186/1471-2105-7-153;;pmc1513259;;16545123;;10.1007/s00251-011-0513-0;;pmc3626422;;21305276;;pmc2527365;;18647321;;10.1111/j.1365-2249.2008.03710.x;;pmc3573279;;10.1111/imm.12032;;23113712;;10.1007/s00251-013-0684-y;;23392739;;pmc3633633;;10.1034/j.1399-0039.2003.00062.x;;12753660;;21507007;;10.1111/j.1398-9995.2011.02610.x;;pmc1325229;;16351712;;10.1186/1745-7580-1-6;;pmc3809066;;10.1007/s00251-013-0720-y;;23900783;;10.1016/0022-2836(70)90057-4;;5420325;;21073747;;pmc2994798;;10.1186/1745-7580-6-9;;19765293;;pmc2753847;;10.1186/1471-2105-10-296;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;10.1385/1-59259-192-2:185;;10547837;;18432745;;10.1186/1745-7580-4-2;;pmc2248166;;18221540;;10.4049/jimmunol.1001006;;20810981;;pmc3307390;;10.4049/jimmunol.0903655;;pmc2935290;;20139279;;10.1002/0471142735.im1803s100;;10.1016/0196-8858(81)90046-4;;pmc2527365;;18647321;;10.1111/j.1365-2249.2008.03710.x,"SARA R PRICKETT ET AL: ""Ara h 2 peptides containing dominant CD4T-cell epitopes: Candidates for a peanut allergy therapeutic"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 127, no. 3, 23 September 2010 (2010-09-23), pages 608 - 615.e5, XP028196570, ISSN: 0091-6749, [retrieved on 20101004], DOI: 10.1016/J.JACI.2010.09.027;;SMITH; WATERMAN, ADV. APPL. MATH, vol. 2, 1981, pages 482;;NEEDLEMAN; WUNSCH, J. MOL, BIOL., vol. 48, 1970, pages 443;;PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10;;ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403;;PEARSON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444;;PEARSON, METHODS MOL BIOL., vol. 132, 2000, pages 185;;SMITH ET AL., J. MOL. BIOL., vol. 147, 1981, pages 195;;BOSTICK ET AL., BIOCHEM BIOPHYS RES COMMUN., vol. 304, 2003, pages 320;;""Pharmaceutical Biotechnology"", 1995, PLENUM PRESS, article ""Vaccine Design--the subunit and adjuvant approach"";;POWELL, M. F.; NEWMAN M., COMPENDIUM OF VACCINE ADJUVANTS AND EXCIPIENTS;;""Remington: The Science and Practice of Pharmacy"", 2003, MACK PUBLISHING CO.;;""Remington's Pharmaceutical Sciences"", 1990, MACK PUBLISHING CO.;;""The Merck Index"", 1996, MERCK PUBLISHING GROUP;;""Pharmaceutical Principles of Solid Dosage Forms"", 1993, TECHNONIC PUBLISHING CO., INC.;;ANSEL; SOKLOSA: ""Pharmaceutical Calculations"", 2001, LIPPINCOTT WILLIAMS & WILKINS;;POZNANSKY ET AL.: ""Drug Delivery Systems"", 1980, pages: 253 - 315;;ALTSCHUL, S.F.; GISH, W.; MILLER, W.; MYERS, E.W.; LIPMAN D.J.: ""Basic local alignment search tool"", J. MOL. BIOL., vol. 215, 1990, pages 403 - 410, XP002949123, DOI: doi:10.1006/jmbi.1990.9999;;BOSTICK D; VAISMAN II.: ""A new topological method to measure protein structure similarity"", BIOCHEM BIOPHYS RES COMMUN., vol. 304, 2003, pages 320 - 325;;BUI HH; SIDNEY J; DINH K; SOUTHWOOD S; NEWMAN MJ; SETTE A: ""Predicting population coverage of T-cell epitope-based diagnostics and vaccines."", BMC BIOINFORMATICS, vol. 7, 2006, pages 153, XP021013657, DOI: doi:10.1186/1471-2105-7-153;;GREENBAUM J; SIDNEY J; CHUNG J; BRANDER C; PETERS B; SETTE A.: ""Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes"", IMMUNOGENETICS, vol. 63, 2011, pages 325 - 335, XP019901974, DOI: doi:10.1007/s00251-011-0513-0;;HENMAR H; HENMAR H; UND G; LUND L; PETERSEN A; WURTZEN PA. ET AL.: ""Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy."", CLIN EXP IMMUNOL., vol. 153, no. 3, 2008, pages 316 - 23;;MACKENZIE KJ; FITCH PM; LEECH MD; ILCHMANN A; WILSON C; MCFARLANE AJ; HOWIE SE; ANDERTON SM; SCHWARZE J.: ""Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation"", IMMUNOLOGY, vol. 138, no. 3, 2013, pages 258 - 268;;MCKINNEY DM; SOUTHWOOD S; HINZ D; OSEROFF C; ARLEHAMN CS; SCHULTEN V ET AL.: ""A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population"", IMMUNOGENETICS, 2013, pages 65357 - 70;;MIDDLETON D; MENCHACA L; ROOD H; KOMEROFSKY R.: ""New allele frequency database"", TISSUE ANTIGENS, vol. 61, 2003, pages 403 - 7, Retrieved from the Internet <URL:http://www.allelefrequencies.net.>;;MEYER D; SINGE R; MACK S; LANCASTER A; NELSON M; ERLICH H; FRENANDEZ-VINA M; THOMSON G.: ""Single Locus Polymorphism of Classical HLA Genes. Immunobiology of the Human MHC"", PROCEEDINGS OF THE 13TH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE, 2007, pages 653 - 704;;MOLDAVER; LARCHE: ""Immunotherapy with peptides"", ALLERGY, vol. 66, no. 6, 2011, pages 784 - 791, XP055156354, DOI: doi:10.1111/j.1398-9995.2011.02610.x;;MURUGAN; DAI: ""Prediction of MHC class II binding peptides based on an iterative learning model."", IMMUNOME RESEARCH, vol. 1, 2005, pages 6, XP021011336, DOI: doi:10.1186/1745-7580-1-6;;KAROSIENE; EDITA; MICHAEL RASMUSSEN; THOMAS BLICHER; OLE LUND; SØREN BUUS; MORTEN NIELSEN: ""NetMHCIIpan-3.0, a Common Pan-specific MHC Class II Prediction Method Including All Three Human MHC Class II Isotypes, HLA-DR, HLA-DP and HLA-DQ"", IMMUNOGENETICS;;NEEDLEMAN SB; WUNSCH CD.: ""A general method applicable to the search for similarities in the amino acid sequence of two proteins"", J. MOL. BIOL., vol. 48, 1970, pages 443, XP024011703, DOI: doi:10.1016/0022-2836(70)90057-4;;NIELSEN; MORTEN; SUNE JUSTESEN; OLE LUND; CLAUS LUNDEGAARD; SOREN BUUS: ""NetMHCIIpan-2.0 - Improved Pan-specific HLA-DR Predictions Using a Novel Concurrent Alignment and Weight Optimization Training Procedure"", IMMUNOME RESEARCH, vol. 6, no. 1, 2010, XP021090118;;NIELSEN; MORTEN; OLE LUND: ""NN-align. An Artificial Neural Network-based Alignment Algorithm for MHC Class II Peptide Binding Prediction."", BMC BIOINFORMATICS, 2009;;PEARSON; LIPMAN; PEARSON WR; LIPMAN DJ.: ""Improved tools for biological sequence comparison"", PROC. NATL. ACAD. SCI. USA, vol. 85, no. 8, 1988, pages 2444 - 2448, XP002060460, DOI: doi:10.1073/pnas.85.8.2444;;PEARSON WR1: ""Flexible sequence similarity searching with the FASTA3 program package"", METHODS MOL BIOL, vol. 132, 2000, pages 185 - 219, XP008009508;;SIDNEY J; SOUTHWOOD S; OSEROFF C; DEL GUERCIO MF; SETTE A; GREY HM.: ""Measurement of MHC/peptide interactions by gel filtration"", CURR PROTOC IMMUNOL. CHAPTER, vol. 18, 2001;;SIDNEY J; ASSARSSON E; MOORE C; NGO S; PINILLA C; SETTE A; PETERS B.: ""Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries"", IMMUNOME RES., vol. 4, 2008, pages 2, XP021039204;;SIDNEY J; STEEN A; MOORE C; NGO S; CHUNG J; PETERS B; SETTE A.: ""Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population"", J IMMUNOL, vol. 185, no. 7, 2010, pages 4189 - 4198;;SIDNEY J; STEEN A; MOORE C; NGO S; CHUNG J; PETERS B; SETTE A.: ""Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity"", J IMMUNOL, vol. 184, no. 5, 2010, pages 2492 - 2503, XP055306325, DOI: doi:10.4049/jimmunol.0903655;;SIDNEY J; SOUTHWOOD S; GREY HM; MOORE C; OSEROFF C; PINILLA C; SETTE A. ET AL.: ""Current protocols in immunology"", 2013, article ""Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture"";;SMITH; WATERMAN: ""Comparison of biosequences"", ADV. APPL. MATH, vol. 2, 1981, pages 482, XP000869556, DOI: doi:10.1016/0196-8858(81)90046-4;;HENMAR H ET AL., CLIN EXP IMMUNOL, vol. 153, no. 3, 2008, pages 316 - 23",PENDING
484,AU,B2,AU 2005/323229 B2,062-425-873-101-744,2011-06-23,2011,AU 2005/323229 A,2005-12-13,US 5149905 A;;US 64234005 P;;US 2005/0045040 W,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,WESLEY ARCHIBALD JOHN;;DOROGUSKER JESSE L;;MITCHELL ADLER;;JAKE RUBINSTEIN JONATHAN;;FADELL ANTHONY M,,https://lens.org/062-425-873-101-744,Granted Patent,no,1,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,1,1,078-438-431-493-828,10.1201/9781439821916.ch10,"MENEZES A at al: ""Handbook of Applied Cryptography , IDENTIFICATION AND ENTITY AUTHENTICATION"" HANDBOOK OF APPLIED CRYPTOGRAPHY, CRC PRESS SERIES ON DISCRETE MATHEMATICES AND ITS APPLICATIONS, BOCA RATON, FL, CRC PRESS, US, 1997",ACTIVE
485,PE,A1,PE 20191153 A1,094-172-240-961-70X,2019-09-05,2019,PE 2019000732 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,MODULADORES DE CALPAINAS Y USOS TERAPEUTICOS DE LOS MISMOS,"Referido a un compuesto que tiene la estructura seleccionada de las formulas (I-a, I-b, I-c, I-d, I-e, I-f, I-g, I-h, I-m, I-n) o una de sus sales farmaceuticamente aceptables, en donde: A2 es heterociclilo opcionalmente sustituido de 3-10 miembros, arilo C6-10 opcionalmente sustituido, entre otros; A4 es arilo C6-10 opcionalmente sustituido, heteroarilo opcionalmente sustituido con 5-10 miembros, entre otros; A3 es arilo C6-10 opcionalmente sustituido, heteroarilo opcionalmente sustituido de 5-10 miembros, entre otros; A5 es heterociclilo opcionalmente sustituido de 3-10 miembros, arilo C6-10 opcionalmente sustituido, entre otros; A6 es arilo C6-10 opcionalmente sustituido, heteroarilo opcionalmente sustituido de 5-10 miembros, entre otros; A7 es arilo C6-10 opcionalmente sustituido, heteroarilo opcionalmente sustituido de 5-10 miembros. R1 es H, -COOH, -CH2NO2, entre otros; R6 es -H o alquilo C1-4opcionalmente sustituido; A, B, D, X y Z se seleccionan de modo independiente entre C(R4) y N; R4 es -H, alquilo C1-4, entre otros; Y es NR5, O, S o SO2. Estos compuestos de alfa-cetoamida no macrolidos son moduladores de calpaina de pequena molecula, utiles en el tratamiento de la enfermedad fibrotica o un estado secundario de la misma, artritis reumatoide, entre otros. Tambien se refiere a metodos de preparacion y una composicion farmaceutica que comprende dichos compuestos.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG,,https://lens.org/094-172-240-961-70X,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
486,AU,A1,AU 2018/289434 A1,179-235-368-238-825,2020-01-16,2020,AU 2018/289434 A,2018-06-19,US 201762524334 P;;US 2018/0038344 W,2017-06-23,Calpain modulators and therapeutic uses thereof,"Small molecule calpain modulator compositions and pharmaceutical compositions can be prepared and used as therapeutic agents. Exemplary compositions include non-macrocyclic a-keto amide derivatives. The therarapeutic agents can be used for treating fibrotic disease or a resulting secondary disease state or condition. The small molecules can competitively bind with calpastatin and/or inhibit calpain through contact with CAPN1, CAPN2, and/or CAPN9 enzymes.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;NICHOLAS JOHN BEAMOND;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC,,https://lens.org/179-235-368-238-825,Patent Application,no,0,0,4,4,0,C07D311/84;;C07D317/68;;C07D319/24;;C07D265/38;;C07D209/86;;C07D209/88;;C07D307/91;;A61P35/00;;C07C233/76;;C07C235/60;;C07C235/80;;C07C2602/10;;C07C2601/16;;A61P19/04;;C07C233/62;;C07C233/76;;C07C233/78;;C07D209/90;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,C07C233/84;;A61K31/166;;A61K31/33;;A61P35/00;;C07D209/86;;C07D209/88;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,,0,0,,,,DISCONTINUED
487,CN,A,CN 105848677 A,198-631-742-041-592,2016-08-10,2016,CN 201480070484 A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,Peptide combinations and uses thereof in treating dust mite allergy,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WURTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,,https://lens.org/198-631-742-041-592,Patent Application,no,5,2,15,15,0,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/35;;A61P37/08,,0,0,,,,ACTIVE
488,AU,B4,AU 2008/101148 B4,072-965-629-821-555,2009-08-20,2009,AU 2008/101148 A,2008-11-26,AU 2005/323229 A;;AU 2008/101148 A;;US 2005/0045040 W;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,DOROGUSKER JESSE L;;RUBINSTEIN JONATHAN JAKE;;ARCHIBALD JOHN WESLEY;;ADLER MITCHELL;;FADELL ANTHONY M,,https://lens.org/072-965-629-821-555,Limited Patent,no,2,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,1,1,078-438-431-493-828,10.1201/9781439821916.ch10,"MENEZES A ET AL: ""Handbook of Applied Cryptography , IDENTIFICATION AND ENTITY AUTHENTICATION"" HANDBOOK OF APPLIED CRYPTOGRAPHY, CRC PRESS SERIES ON DISCRETE MATHEMATICES AND ITS APPLICATIONS, BOCA RATON, FL, CRC PRESS, US, 1997",INACTIVE
489,KR,A,KR 20160096206 A,078-294-290-170-792,2016-08-12,2016,KR 20167020337 A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,"본 발명은 집먼지 진드기 알레르겐, 예컨대 알레르겐 Der p 1, Der f 1, Der p 2 및/또는 Der f 2의 아미노산 서열의 일부로부터 유래된 펩타이드 또는 그의 변이체의 조합에 관한 것이다. 이러한 펩타이드는 적어도 한 개의 T 세포 에피토프를 포함하며 전세계 인구집단의 유의적으로 많은 수의 환자들이 상기 펩타이드 조합의 펩타이드에 결합할 잠재능이 있는 HLA 대립유전자를 갖는 것이다. 본 발명은 또한 먼지 진드기에 의해 야기되는 면역 응답을 완화하는데 있어서 이러한 펩타이드 조합의 사용에 관한 것이기도 하다.",ALK ABELLO A;;JOLLA INST ALLERGY IMMUNOLOG,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WUERTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,,https://lens.org/078-294-290-170-792,Patent Application,no,0,0,15,15,708,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/00;;C07K14/435,,0,0,,,,DISCONTINUED
490,EP,A1,EP 3481835 A1,099-343-606-451-161,2019-05-15,2019,EP 17824731 A,2017-06-29,US 201662358504 P;;US 2017/0040109 W,2016-07-05,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,,BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC;;NICHOLAS JOHN BEAMOND,,https://lens.org/099-343-606-451-161,Patent Application,yes,0,0,6,6,0,C07D225/06;;C07D413/12;;C07D471/04;;C07D471/14;;C07D273/01;;C07D498/04;;C07D498/14;;A61P35/00;;A61P17/00;;C07D498/06;;A61P1/16;;A61P13/12;;A61P11/00;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04;;C07D498/18,C07D498/14;;A61K31/395;;A61K31/404;;A61K31/4164;;A61K31/435;;A61P17/00;;A61P35/00;;C07D225/06;;C07D267/00;;C07D273/01;;C07D413/12;;C07D471/04;;C07D471/14;;C07D498/04,,0,0,,,,DISCONTINUED
491,US,A1,US 2022/0225863 A1,005-048-095-398-669,2022-07-21,2022,US 202117154530 A,2021-01-21,US 202117154530 A,2021-01-21,ENDOSCOPIC SHEATH HOLDING TIP AND STABILIZATION SYSTEM,"An endoscopic sheath holding tip and stabilization system is configured to be connected to a table mounted flexible or rigid arm or other surgical support device used over the patient during a surgical procedure. The sheath holder includes a hook structure configured to engage the underside of the scope sheath (e.g., inflow and outflow ports), while a plunger mechanism engages the top surface of the sheath. The downward pressure of the plunger mechanism working against the upward forces of the hook structure operate to stabilize the scope sheath without requiring user intervention. In this manner, the scope and other instruments can be introduced into the stabilized scope sheath without requiring user assistance to hold the scope once positioned in the stabilized sheath.",MEDIFLEX SURGICAL PRODUCTS LLC,ADLER DANIEL;;CULVER STEVEN;;CARTER JOAN L;;SFAKIS JOHN M;;JOHNSTON III WILLIAM K,MEDIFLEX SURGICAL PRODUCTS LLC (2021-01-19),https://lens.org/005-048-095-398-669,Patent Application,yes,1,3,2,2,0,A61B90/50;;A61B90/57;;A61B2090/571;;A61B1/00135;;A61B1/00149,A61B1/00,,0,0,,,,PENDING
492,AU,B2,AU 2017/336523 B2,003-124-646-715-480,2022-07-21,2022,AU 2017/336523 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG,,https://lens.org/003-124-646-715-480,Granted Patent,no,1,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,ACTIVE
493,CN,B,CN 101493823 B,116-013-035-238-748,2012-06-13,2012,CN 200810166171 A,2008-10-06,US 97781107 A,2007-10-05,Identifying clusters of words according to word affinities,"In one embodiment, identifying clusters of words includes accessing a record that records affinities. An affinity between a first and second word describes a quantitative relationship between the first and second word. Clusters of words are identified according to the affinities. A cluster comprises words that are sufficiently affine with each other. A first word is sufficiently affine with a second word if the affinity between the first and second word satisfies one or more affinity criteria. A clustering analysis is performed using the clusters.",FUJITSU LTD,ALEX GILMAN;;THOMAS ADLER B;;JAWAHAR JAIN;;DAVID MARVIT;;STERGIOS STERGIOU;;JOHN J S,,https://lens.org/116-013-035-238-748,Granted Patent,no,0,0,2,7,0,,G06F17/30,,0,0,,,,ACTIVE
494,AU,A4,AU 2009/100750 A4,133-828-380-090-020,2009-09-10,2009,AU 2009/100750 A,2009-08-03,AU 2008/101150 A;;AU 2009/100750 A;;AU 2005/323229 A;;US 2005/0045040 W;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;ARCHIBALD JOHN WESLEY;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL,,https://lens.org/133-828-380-090-020,Limited Patent,no,0,2,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
495,AU,A4,AU 2009/100749 A4,128-553-978-721-447,2009-09-24,2009,AU 2009/100749 A,2009-08-03,AU 2008/101148 A;;AU 2009/100749 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY;;DOROGUSKER JESSE L;;RUBINSTEIN JONATHAN JAKE,,https://lens.org/128-553-978-721-447,Limited Patent,no,0,2,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G06F21/22;;G10L19/00,,0,0,,,,INACTIVE
496,AU,A1,AU 2017/336523 A1,130-999-693-457-142,2019-05-16,2019,AU 2017/336523 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG,,https://lens.org/130-999-693-457-142,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,ACTIVE
497,KR,A,KR 20090027777 A,163-921-870-091-792,2009-03-17,2009,KR 20097004222 A,2009-02-27,US 5149905 A;;US 64234005 P,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/163-921-870-091-792,Patent Application,no,0,3,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G06F21/00;;G10L19/00;;H04L9/32,,0,0,,,,DISCONTINUED
498,US,B2,US 9223958 B2,164-537-701-929-523,2015-12-29,2015,US 201414312672 A,2014-06-23,US 201414312672 A;;US 32836808 A;;US 5149905 A;;US 64234005 P;;US 5144105 A;;US 64227605 P;;US 64233405 P;;US 3154705 A;;US 3128805 A;;US 22046305 F;;US 22089205 F,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE LEE;;MITCHELL ADLER;;ARCHIBALD JOHN WESLEY,,https://lens.org/164-537-701-929-523,Granted Patent,yes,104,6,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/40;;G06F21/44;;G06F21/60;;G10L19/00,,71,4,065-096-740-432-042;;035-928-800-870-660;;119-609-365-875-818;;030-389-189-134-332,10.1109/icce.1997.625976;;10.1109/2.730740;;10.1109/percomw.2004.1276933;;10.1109/hicss.2007.300,"""A Serial Bus on Speed Diagram: Getting Connected with FireWire,"" downloaded Oct. 16, 2001, PC Magazine: PC Tech (A Serial Bus on Speed) wysiwyg://51http://www.zdnet.com/pctech/content/18/10/tu1810.007.html p. 7. (2 pages).;;""Cables to Go,"" download Oct. 16, 2001 http://www.cablestogo.com/product.asp?cat%5Fid=601&sku=27028 (1 page).;;""ExpressBus(TM) F5U0I0,"" User Guide Packing Checklist, Belkin Components Product Warranty. (2 pages).;;""Fire Wire Connector,"" downloaded Oct. 16, 2001, wysiwyg://76/http://developer.apple.com/ . . . es/Macintosh-CPUs-G3/ibook/ibook-27.html (2 pages).;;""FireWire"", downloaded Oct. 16, 2001; si wyg://42/http://developer.apple.-com/hardware/Fire-Wire (2 pages).;;""How to Connect Your Computer PC Hardware"", downloaded Oct. 16, 2001, http:///www.scar.utoronto.ca!~ccweb/faculty/connect-howto.html (5 pages).;;""IEEE 1394/USB Comparison,"" downloaded Oct. 16, 2001, www.genitech.com.aulLIBRARY/TechSupportiinfobits/firewirevsusb.html (4 pages).;;""Introduction to Public Key Cryptography,"" Oct. 9, 1998, printed from http://developer.netscape.com/docs/manuals/security/pkin/contents.html on Oct. 6, 2004. (21 pages).;;""iPodDock/iPod Cradle,"".www.bookendzdocks.com/bookendz/dock-cradle.html, downloaded Feb. 27, 2003. (2 pages).;;""MPV(TM) Music Profile Specification Revision 1.00"" Internet Citation [online] (Jan. 7, 2004) URL:http//www.osta.org/mpv/public/specs/MPVMusic-Prof-Spec-1.00.pdf> [retrieved Jun. 20, 2006] the whole ducument. (70 pages).;;""Neuros MP3 Digital Audio Computer,"" www.neurosaudio.com, downloaded Apr. 9, 2003. (6 pages).;;""PMC FW2 IEEE1394 FireWire Controller"", downloaded Oct. 16, 2001, http://www.bvmltd.co.uk/PMCfw2ds.html (10 pages).;;""The Authoritative Dictionary of IEEE Standards Terms, Seventh Edition,""Published by Standards Information Network, IEEE Press, 2000. (3 pages).;;""Universal Serial Bus Specification-Rev 2.0,"" Chapter 6: Compaq Hewlett-Packard, Apr. 27, 2000, pp. 85, 99-100. (7 pages).;;""Universal Serial Bus Specification-Rev 2.0,"" XP002474828, Chapter 9: USB Device Frameworkpp. 239-274. (36 pages).;;Altec Lansing, ""inMOTION Users Guide,"" Corp. Headquarters, 535 Rte.6 & 209, Milford, PA 18337. (8 pages).;;Anonymous, ""Future of Digital Music in Windows,"" Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001[Online], [retrieved on Jan. 15, 2008]. (3 pages).;;Anonymous, ""Introduction to Digital Audio,"" Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved on Jan. 15, 2008]. (2 pages).;;Anonymous, ""Windows and Red Book Audio,"" Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved Jan. 15, 2008]. (2 pages).;;Belkin iPod Voice Recorder, Product Specification Sheet, printed Jun. 16, 2004. (2 pages).;;Bindra, ""Standard Turns Monitor into I/O Hub,"" Electronic Engineering Times, vol. 918, Sep. 6, 1996, p. 14. (1 page).;;Brentrup, ""Introduction to Public Key Cryptography Demystified,"" Campus Technology, printed from http://www.campus-technology.com/article.asp?id=7626 on Oct. 6, 2004. (5 pages).;;Brown, ""Making USB Work,"" downloaded Oct. 16, 2001, PC Magazine: PC Tech wysiwyg:/155/http://www.zdnet.com/pcmag/pctech/content!18/04/tu1804.001.html (2 pages).;;Chen et al., ""Design and Implemeation of a Hard Disk-Based Entertainment Device for Managing Media Contents on the go,"" Consumer Electronics, 1005. (ISCE 2005). Proceedings of the Ninth International Symposium on, pp. 328-333, Jun. 14-16, 2005. (6 pages).;;Crawford et al., ""Sample rate conversion and bit rate reduction in the studio,"" IEEE Colloquium on Digital Audio Signal Processing, May 22, 1991, pp. 8/1-8/3. (3 pages).;;Derman, ""Monitors Make Net Connections,"" Electronic Engineering Times, vol. 933, 1996, pp. 60 and 69. (2 pages).;;European Patent Office, Decision to Refuse a European Patent Application; Application No. 07 812 335., Mailed Jan. 19, 2011 , 18 pages.;;European Patent Office, Extended Search Report; Application No. 10194370.2, Mailed Feb. 6, 2012, 9 pages.;;European Patent Office, Office Action, Application No. 07 799 051.3, Mailed Sep. 24, 2012, 7 pages.;;European Patent Office, Office Action, Application No. 09 791 751.2, Mailed Oct. 19, 2012, 7 pages.;;Fried, ""FireWire poised to become ubiquitous,"" downloaded Oct. 16, 2001, CNET News.com, 1394 Trade Association: Press, wysiwyg:/132/http:/-113-94ta.org/Press/200-1-Press/august!8.2 7.-b.html (3 pages).;;Fried, ""New Fire Wire to blaze faster trail,"" downloaded Oct. 16, 2011, CNET News.com, http://news.cnet.com/news/0-I006-200-6021210.html (5 pages).;;International Search Report dated Dec. 6, 2007 in PCT Application No. PCT/US2007/010888.;;iPod Classic User's Guide, acquired from apple.com, 2002. (44 pages).;;iPod nano Features Guide, acquired from apple.com, 2008. (72 pages).;;iPod touch User's Guide, acquired from apple.com, 2008. (120 pages).;;Janssen, Jan, ""A Single-Chip Universal Serial Bus D/A Converter for High-Quality Audio Signals, "" THPM 16.7 IEEE 19970611; 19970611 - 19970613, Jun. 11, 1997, (2 pages).;;Japanese Patent Office; Office Action for Application No. 2010-011810, Mailed Dec. 11, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2010-011810, Mailed Jul. 9, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2011-526100 , Mailed Dec. 13, 2012. (4 pages).;;Lambert, ""Digital Audio Interfaces,"" Journal of the Audio Engineering Society, Audio Engineering Society, New York, NY, vol. 38, No. 9, (Sep. 1, 1990), pp. 681-684, 686, 688, 690, 692 and 696, XP000175146 ISSN: 1549-4950 figures 9, 10. (10 pages).;;Lewis, ""On Technology"" Fortune Magazine, Dec. 9, 2002, p. 240. (1 page).;;LSI Logic's Broadcast PC Card Brings New Multimedia Capabilities to Personal Computing. (Nov. 16). PR Newswire, 1. Retrieved Jun. 26, 2010, from Business Dateline. (3 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 26, 2008]. Retrieved from the Internet . (2 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 23, 2008]. Retrieved from the Internet . (2 pages).;;Menezes et al., ""Handbook of Applied Cryptography, "" Identification and Entity Authentication, Jan. 1, 1997, pp. 385-424. (41 pages).;;Microsoft, ""Media Transport Protocol Implementation Details,"" 2005. (18 pages).;;Networking Tech Note, ""1394 Standards and Specifications,"" Oct. 16, 2001. (3 pages).;;NOMAD II Player Version 1.0 (CLI) (User's Manual), Creative Technology, Ltd., Jan. 2000. (46 pages).;;Non-Final Office Action for U.S. Appl. No. 13/474,552 mailed Oct. 26, 2012; 27 pp.;;Office Action dated Feb. 18, 2010 in Australian Patent Application No. 2007268239.;;Office Action for European Patent Application No. 10194377.7, mailed Apr. 15, 2013, 6 pages.;;Office Action in corresponding Japanese Application No. 2009-512018, mailed Apr. 5, 2011.;;Severance, ""FireWire Finally Comes Home,"" Michigan State University, Standard, Nov. 1998, pp. 117-118. (2 pages).;;Sinitsyn, ""Synchronization Framework for Personal Mobile Servers,"" Pervasive Computing and Communications Workshops (PERCOMW'04), Proceedings of the Second IEEE Annual Conference, Piscataway, NJ, USA, IEEE, Mar. 14, 2004, pp. 208-212. (3 pages).;;Slay et al., ""iPod Forensics: Forencically Sound Examination of an Apple iPod,"" System Sciences, 2007. HICSS 2007. 40th Annual Hawaii Internation Conference on, pp. 1-9, Jan. 2007. (9 pages).;;Teener, ""Understanding Fire Wire: The IEEE 1394 Standards and Specifications,"" downloaded Oct. 16, 2001, wysiwyg:119/http:1Iwww.chipcenter.com/networking/ieee-1394/main.html (5 pages).;;The First Office Action in Chinese Application No. 200910222182.6, mailed Nov. 23, 2011.;;Vitaliano, ""Why FireWire is Hot!Hot!Hot!"" downloaded Oct. 16, 2001, ""Impact.FireWire.SideBar"" http://www.vxm.com/21R.35.html (4 pages).;;Whittle, ""Public Key Authentication Framework: Tutorial,"" First Principles Consulting, Jun. 2, 1996, downloaded Oct. 6, 2004, http://www.ozemail.com.au/~firstpr/crypto/pkaftute.htm (7 pages).;;Written Opinion dated Dec. 6, 2007 in PCT Application No. PCT/US2007/010888.;;Umeda, Katsuji et al., ""Music Distribution Business Illustrated for Understanding,""; Japan Management Associate Management Center; Oct. 1, 2000, First Edition, pp. 179, 187, in Japanese.;;Non-Final Office Action mailed on Nov. 24, 2010 for U.S. Appl. No. 12/328,368, 28 pages.;;Final Office Action mailed on May 11, 2011 for U.S. Appl. No. 12/328,368, 39 pages.;;Non-Final Office Action mailed on Aug. 15, 2013 for U.S. Appl. No. 12/328,368, 13 pages.;;Notice of Allowance mailed on Feb. 7, 2014 for U.S. Appl. No. 12/328,368, 8 pages.;;Non-Final Office Action mailed on Sep. 16, 2008 for U.S. Appl. No. 11/051,499, 18 pages.;;Final Office Action mailed on Mar. 19, 2009 for U.S. Appl. No. 11/051,499, 16 pages.;;Non-Final Office Action mailed on Nov. 30, 2009 for U.S. Appl. No. 11/051,499, 19 pages.;;Notice of Allowance mailed on Jun. 24, 2010 for U.S. Appl. No. 11/051,499, 9 pages.;;International Search Report and Written Opinion of the International Searching Authority mailed on May 15, 2006 for PCT Patent Application No. PCT/US2005/045040, 10 pages.",ACTIVE
499,IL,A,IL 265564 A,186-791-426-686-265,2019-05-30,2019,IL 26556419 A,2019-03-24,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,Calpain modulators and therapeutic uses thereof,,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG;;BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG,,https://lens.org/186-791-426-686-265,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,,0,0,,,,PENDING
500,CN,B,CN 101699458 B,012-283-794-483-057,2013-05-29,2013,CN 200910222182 A,2005-12-13,US 64234005 P;;US 5149905 A,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/012-283-794-483-057,Granted Patent,no,0,1,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G10L19/00,,0,0,,,,ACTIVE
501,US,A1,US 2022/0324814 A1,062-042-736-218-69X,2022-10-13,2022,US 202217718728 A,2022-04-12,US 202217718728 A;;US 202017032529 A;;US 201916337377 A;;US 2017/0053629 W;;US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,,https://lens.org/062-042-736-218-69X,Patent Application,yes,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,A61P11/00;;C07D233/90;;C07C233/05;;C07D209/20;;C07D231/14;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,0,0,,,,DISCONTINUED
502,AU,A4,AU 2008/101148 A4,095-649-268-103-469,2009-02-05,2009,AU 2008/101148 A,2008-11-26,AU 2005/323229 A;;AU 2008/101148 A;;US 2005/0045040 W;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,DOROGUSKER JESSE L;;RUBINSTEIN JONATHAN JAKE;;ARCHIBALD JOHN WESLEY;;ADLER MITCHELL;;FADELL ANTHONY M,,https://lens.org/095-649-268-103-469,Limited Patent,no,0,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
503,US,A1,US 2024/0038310 A1,113-410-468-813-816,2024-02-01,2024,US 202217874100 A,2022-07-26,US 202217874100 A,2022-07-26,Non-Volatile Memory Power Cycle Protection Mechanism,"Techniques for protecting non-volatile memory (NVM) from power cycle interruptions during memory operations are disclosed. A power management integrated circuit (PMIC) coupled to a memory circuit with NVM implements the various techniques disclosed. When a power reset signal is asserted to a PMIC, the PMIC may delay initiation of the power reset cycle when it detects that the NVM coupled to the PMIC is active to prevent corruption of the NVM by the power reset cycle. The PMIC may detect the activity level of the NVM based on an activity output signal that indicates whether the NVM is active (e.g., programming or erasing) or inactive.",APPLE INC,SULLIVAN JOHN J;;HOLLABAUGH JAMES M;;BRINSFIELD JASON W;;RYAN CALVIN M;;ADLER ANDREAS,APPLE INC (2022-07-19),https://lens.org/113-410-468-813-816,Patent Application,yes,2,0,2,2,0,G11C16/30;;G11C5/148;;G11C16/30;;G11C16/32;;G11C16/14;;G11C16/102,G11C16/30;;G11C16/10;;G11C16/14;;G11C16/32,,0,0,,,,PENDING
504,US,B2,US 11292801 B2,139-829-087-604-881,2022-04-05,2022,US 201716312916 A,2017-06-29,US 201716312916 A;;US 201662358504 P;;US 2017/0040109 W,2016-07-05,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to macrocyclic α-keto amide derivatives and their use as therapeutic agents.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;NICHOLAS JOHN BEAMOND;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/139-829-087-604-881,Granted Patent,yes,152,0,6,6,0,C07D225/06;;C07D413/12;;C07D471/04;;C07D471/14;;C07D273/01;;C07D498/04;;C07D498/14;;A61P35/00;;A61P17/00;;C07D498/06;;A61P1/16;;A61P13/12;;A61P11/00;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04;;C07D498/18,C07D498/18;;A61P1/16;;A61P11/00;;A61P13/12;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04,,181,135,010-626-131-088-514;;022-411-096-178-940;;038-893-656-153-713;;072-994-322-434-772;;003-261-888-417-997;;077-008-425-179-22X;;021-003-404-471-569;;008-799-202-681-459;;114-918-900-251-802;;028-930-411-415-516;;039-581-629-931-843;;031-243-109-936-648;;112-361-501-662-497;;098-733-293-429-373;;042-939-733-208-454;;019-632-841-644-026;;034-331-211-704-877;;108-452-437-895-403;;119-687-205-724-766;;063-618-817-674-705;;009-186-473-238-939;;048-170-800-689-023;;041-931-386-444-790;;015-681-580-943-399;;000-094-688-465-084;;037-832-038-424-509;;001-576-828-082-834;;019-115-775-607-415;;012-830-491-824-205;;003-168-967-428-92X;;030-042-017-746-591;;131-046-096-401-339;;015-923-579-613-818;;074-458-381-494-234;;100-878-907-092-574;;141-914-263-639-943;;036-745-751-836-283;;048-916-440-146-479;;113-568-574-765-360;;065-285-521-497-72X;;063-460-415-904-574;;069-450-943-413-364;;023-301-052-611-166;;147-440-643-091-525;;007-730-440-068-99X;;004-052-426-270-084;;122-753-736-744-724;;027-995-839-963-178;;083-771-782-040-353;;052-649-373-150-312;;053-962-998-119-152;;048-205-769-302-325;;020-855-322-534-259;;064-406-626-054-484;;089-144-976-445-688;;151-919-600-413-52X;;041-940-476-987-371;;062-742-403-893-408;;129-297-815-048-32X;;085-234-268-089-786;;007-196-400-487-666;;009-406-912-144-89X;;030-033-993-640-765;;103-353-898-106-766;;041-625-114-141-248;;087-979-151-907-860;;007-432-529-089-951;;121-428-466-773-844;;053-490-223-664-742;;073-613-615-376-929;;030-524-564-810-697;;135-735-121-346-36X;;026-115-521-313-787;;164-224-116-012-039;;157-424-722-980-550;;089-950-113-895-743;;019-817-393-305-59X;;089-487-729-749-961;;111-320-010-409-764;;031-218-242-932-350;;018-562-302-914-931;;048-639-884-454-955;;090-595-759-639-249;;080-750-233-057-521;;078-776-607-842-828;;006-136-522-900-040;;153-408-674-284-984;;047-156-535-940-645;;010-432-639-580-299;;099-850-489-020-528;;034-987-888-849-578;;002-974-951-283-009;;010-248-616-848-483;;099-744-749-713-381;;075-813-686-060-816;;005-836-557-552-913;;010-402-858-128-027;;010-725-579-810-871;;036-746-562-702-221;;034-514-021-515-444;;061-330-223-146-889;;122-442-336-796-885;;035-995-301-512-762;;009-043-118-551-826;;044-878-082-973-49X;;159-695-952-917-570;;036-393-576-918-372;;013-556-469-253-589;;019-747-883-890-065;;052-664-611-823-937;;046-483-357-440-702;;023-684-266-623-526;;111-761-539-590-464;;021-045-743-874-448;;054-167-535-212-696;;000-647-626-022-090;;032-421-248-192-752;;048-382-748-962-92X;;071-099-297-091-853;;046-864-680-028-207;;016-958-339-591-097;;050-062-160-596-331;;033-395-860-645-21X;;080-218-260-759-683;;038-702-954-033-133;;032-087-655-109-978;;134-153-606-136-532;;015-358-399-529-695;;009-010-393-743-32X;;005-582-329-281-579;;066-092-492-334-256;;078-382-889-771-789;;002-499-291-773-300;;039-317-916-201-269;;000-350-112-609-276,15261274;;10.1016/j.bmcl.2004.06.013;;10.1021/acsmedchemlett.7b00494;;29541364;;pmc5846052;;10.1021/jm950541c;;8831774;;10.1021/jm0210717;;12773044;;29089532;;10.1038/s41598-017-14719-9;;pmc5663911;;18701765;;10.1124/jpet.108.142679;;23270364;;pmc3563429;;10.1021/ja3119674;;10.1016/j.bmcl.2015.07.059;;26238321;;26216521;;pmc4748423;;10.1038/npp.2015.225;;10.1074/jbc.m116.756858;;pmc5207150;;27875306;;8242144;;10.1385/0-89603-281-7:33;;10.1016/s0006-2952(00)00427-5;;11007946;;10611762;;10.1016/s1286-4579(99)00250-6;;10.1002/jcc.540030108;;10710438;;pmc102804;;10.1093/nar/28.7.e21;;22242975;;pmc3417452;;10.1111/j.1476-5381.2012.01855.x;;10.1038/352624a0;;1907718;;pmc136455;;12186906;;10.1128/jvi.76.18.9225-9231.2002;;10.1021/jm00165a001;;2407844;;10.1126/science.6879170;;6879170;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;17157313;;10.1016/j.jmb.2006.11.037;;10.1074/jbc.m900561200;;pmc2679455;;19269960;;10.1016/s1359-0278(97)00011-4;;9135979;;7692304;;10.1038/365566a0;;10.1126/scitranslmed.3004700;;23303606;;pmc396995;;2578661;;10.1073/pnas.82.1.178;;2443575;;10.1016/0022-1759(87)90085-8;;pmc345355;;6204335;;10.1073/pnas.81.13.3998;;14742441;;10.1074/jbc.m308759200;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;10.1371/journal.pgen.1001040;;20686710;;pmc2912385;;8689239;;10.1016/0968-0896(95)00171-9;;pmc151091;;10.1172/jci15518;;12163453;;10.1172/jci0215518;;10.1172/jci200215518;;pmc2199233;;10.1083/jcb.200109037;;11790801;;2025413;;10.1107/s0108767390010224;;10.1172/jci20530;;pmc297008;;10.1172/jci200320530;;14679171;;pmc53085;;1763028;;10.1073/pnas.88.24.11120;;10.1038/sj.onc.1204872;;11709702;;10.1107/s0021889891004399;;7154081;;10.1016/0022-2836(82)90153-x;;10.1126/science.257.5073.1078;;1509259;;10.1096/fj.03-1273rev;;15117886;;10.1038/nm.3218;;pmc4067127;;23817022;;pmc3989726;;10.1152/ajplung.00210.2013;;24583879;;10.1515/bchm.1998.379.2.175;;9524069;;10.1016/j.bbrc.2006.04.010;;16631603;;10.1021/bi00109a004;;1932005;;10.1080/02713680490516242;;15590481;;2027751;;10.1093/nar/19.7.1437;;pmc333898;;18485877;;10.1016/j.cell.2008.03.027;;pmc2728032;;1748994;;10.1016/0022-2836(91)90498-u;;10.1002/prot.340110104;;1961699;;10.2183/pjab.85.314;;19838011;;pmc3621568;;10.1016/0959-440x(92)90147-y;;8115163;;10.1007/bf01582083;;11994736;;10.1038/nrm757;;10.1016/s0040-4020(01)86503-0;;10.1371/journal.pone.0059348;;23565148;;pmc3614979;;10.1016/j.ajpath.2011.06.001;;21763673;;pmc3157273;;2447184;;10.4049/jimmunol.140.2.611;;20531305;;pmc3176718;;10.1038/onc.2010.215;;1370065;;10.1016/0958-1669(91)90032-z;;12649500;;10.1261/rna.2192803;;pmc1370415;;7615639;;pmc2199940;;10.1083/jcb.130.2.393;;10807004;;10.1016/s0167-4781(99)00150-5;;14749260;;10.2337/diabetes.53.2007.s12;;16271073;;10.1111/j.1349-7006.2005.00103.x;;10.1016/s0969-2126(00)00060-5;;7922037;;10805816;;10.1073/pnas.97.10.5633;;pmc25880;;10.1021/ja00315a051;;17631612;;10.1152/ajplung.00163.2007;;14627704;;10.1074/jbc.m309767200;;17207287;;pmc1781437;;10.1186/1465-9921-8-1;;pmc2693329;;10.1002/path.2277;;18161745;;12810675;;pmc1850509;;11583974;;10.1016/s0002-9440(10)62533-3;;10.1111/j.1349-7006.2000.tb00967.x;;10835488;;pmc5926377;;pmc1850511;;10.1016/s0002-9440(10)62518-7;;11583959;;10.1080/15216540050176610;;11087123;;10.1016/s1570-0232(02)00782-1;;12650749;;10.1016/j.dmpk.2017.11.068;;10.1016/s0960-894x(99)00392-3;;10476871;;10.1002/cbdv.201200320;;23161629;;10.1021/acs.jmedchem.5b01464.s001;;26823007;;pmc5156532;;10.1021/acs.jmedchem.5b01464;;10.1016/s0040-4039(00)79671-7;;10.1074/jbc.m108893200;;11602605;;10.1016/j.jorganchem.2006.09.061;;10.1152/physrev.00029.2002;;12843408;;15041468;;10.1016/j.bcp.2003.12.021;;10.1071/ch09101;;24130198;;10.1002/cmdc.201300387;;10.1071/ch14121;;10.1016/j.ejmech.2011.02.025;;21397369;;10.1016/j.bmc.2015.02.035;;25797164;;28759231;;10.1021/acs.jmedchem.7b00731;;pmc4240281;;24556840;;10.1038/nrm3758;;10.1016/j.bmcl.2005.03.095;;15911268;;10.1016/j.biocel.2006.04.012;;16971167;;10.6023/cjoc201407016;;10.1038/srep08783;;pmc4350077;;25740631;;11992771;;10.1016/s0960-894x(02)00176-2;;10.1016/j.bmcl.2013.05.021;;23727045;;pmc3750990;;23211821;;10.1167/iovs.12-11088;;18024028;;10.1016/j.bmcl.2007.10.097;;10.5731/pdajpst.2011.00634;;22293237;;10.1021/ol070294u;;17373804;;23606616;;10.1002/chem.201204260;;9846074;;19215300;;10.1111/j.1742-4658.2008.06833.x;;25007318;;10.1038/ncomms5365;;10.1039/c6sc00197a;;27540460;;pmc4987086;;22432027;;pmc3303840;;10.1371/journal.pone.0033468;;10.1016/j.bmcl.2011.06.017;;21741835;;11853546;;pmc1222398;;10.1042/bj3620383;;10.1042/0264-6021:3620383;;24171628;;10.1021/jo4020613;;10.1071/ch09150;;10.1016/s0040-4039(01)01134-0;;24900305;;pmc4018096;;10.1021/ml100260x;;pmc2856976;;10.1074/jbc.r109.091306;;20147747;;10.1107/s1600536805022373;;10.1021/jm801632a;;19456105;;10.1055/s-2008-1078210;;10.1016/s0040-4039(02)01553-8;;12077181;;10.1523/jneurosci.22-12-04842.2002;;pmc6757710;;10.1039/jr9610000405;;10.1021/jm201688n;;pmc3288238;;22243528;;10.2147/ndt.s78226;;pmc4327398;;25709452;;10.1002/anie.200805014;;19145612;;10.1021/co400102v;;24377264;;27148623;;10.1021/acs.jmedchem.6b00267;;21955158;;10.1021/jm200471r;;10.1021/jm010178b;;11585453;;27454655;;10.1016/j.carres.2016.07.004,"CAS Registry No. 2094533-75-0; STN entry date: May 2, 2017; Benzamide, N-(2-amino-1,1-dimethyl-2-oxoethyl)-2-bromo-5-chloro-3-fluoro-, in 1 page.;;CAS Registry No. 1629446-68-9; STN entry date: Oct. 21, 2014; Benzamide, 3-cyano-N-[(1S)-1-formyl-2-phenylethyl], in 1 page.;;CAS Registry No. 2094410-58-7; STN entry date: May 2, 2017; Benzamide, 2-bromo-5-chloro-N-(1-cyano-2-methoxy-1-methylethyl)-3-fluoro-, in 1 page.;;CAS Registry No. 2037707-18-7; STN entry date: Nov. 25, 2016; Alanine, 3-fluoro-N-(2-fluoro-6-methoxybenzoyl)-, in 1 page.;;CAS Registry No. 1938924-09-4; STN entry date: Jun. 24, 2016; D-Leucine, N-(2-bromo-6-fluoro-3-methylbenzoyl)-, in 1 page.;;CAS Registry No. 2048401-56-3; STN entry date: Dec. 14, 2016; 4-Hexenoic acid, 2-[(4,5-dichloro-2-methoxybenzoyl)amino]-, in 1 page.;;CAS Registry No. 2026949-92-6; STN entry date: Nov. 8, 2016; D-Leucine, N-[(6-bromo-3,4-dihydro-3-oxo-2H-1,4-benzoxazin-7-yl)carbonyl]-, in 1 page.;;CAS Registry No. 1031704-04-7; STN entry date: Jun. 30, 2008; L-Valine, N-[(5,7,8,10-tetrahydro-7,8-dioxo-6-undecyl-2-phenazinyl)carbonyl]-, in 1 page.;;CAS Registry No. 566157-42-4; STN entry date: Aug. 14, 2003; Alanine, N-[(9,10-dihydro-9-oxo-3-acridinyl)carbonyl]-2-methyl-, in 1 page.;;CAS Registry No. 289062-66-4; STN entry date: Sep. 14, 2000; Acetic acid, [(2,4-dichlorobenzoyl)amino](phenylthio)-, in 1 page.;;CAS Registry No. 15643-65-9; STN entry date: Nov. 16, 1984; Acetic acid, [(3,4-dichlorobenzoyl)amino]phenoxy-, in 1 page.;;CAS Reg. No. 1187056-39-8, Entered STN: Oct. 1, 2009; Acetic acid, 2-cyano-2-[(2,6-difluorobenzoyl)amino]-, ethyl ester in 1 page.;;CAS Reg. No. 885026-68-6, Entered STN: May 19, 2006; Benzamide, N-(2-butoxy-1-cyano-1-methylethyl)-2,6-dichloro- in 1 page.;;CAS Reg. No. 1825463-80-6; STN Entry Date Dec. 9, 2015; Benzamide, N-(cyanocyclopropylmethyl)-6-fluoro-2,3- in 1 page.;;CAS Reg No. 1551381-70-4, STN Entry Date: Feb. 20, 2014; Benzamide, N-(1-cyanopropyl)-2,6-difluoro-3-methyl- in 1 page.;;CAS Reg No. 1555291-73-0, STN Entry Date: Feb. 25, 2014; Benzamide, 4-chloro-N-(1-cyanobutyl)-2,5-difluoro- in 1 page.;;CAS Reg No. 1551443-75-4, STN Entry Date: Feb. 20, 2014; Benzamide, 4-chloro-N-(1-cyano-1-methylpropyl)-2,5-difluoro- in 1 page.;;CAS Registry No. 1347051-33-5, Entered STN: Dec. 1, 2011; 1H-Imidazole-5-hexanoic acid, β-[[[(6S,8aS)-octahydro-4-oxo-2-(phenylmethyl)sulfonyl]pyrrolo[1,2-a]pyrazin-6-yl]carbonyl]amino]-a-oxo-, methyl ester, 1 page.;;CAS Registry No. 1026166-23-3, Entered STN: Jun. 8, 2008 ; Hexanoic acid, 3-[[[(1R,2S,5S)-3-[(2S)-2-cyclohexyl-2-[(3,3-dimethyl-1-oxobutyl)amino]acetyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-2-yl]carbonyl]amino]-6,6,6-trifluoro-2-oxo-, 1 page.;;CAS Registry No. 2026817-08-1, Entered STN: Nov. 8, 2016; D-Leucine, N-[[3-(3-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Registry No. 2049278-49-9, Entered STN: Dec. 15, 2016; 4-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Registry No. 2039960-52-4, Entered STN: Nov. 28, 2016; 5-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Registry No. 2026895-95-2, Entered STN:Nov. 8, 2016; L-Norleucine, N-[[3-(5-chloro-2-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Registry No. 2026863-64-7, Entered STN: Nov. 8, 2016; L-Norleucine, N-[[4-(5-chloro-2-thienyl)-1H-pyrrol-3-yl]carbonyl]-, 1 page.;;CAS Registry No. 1796920-43-8, Entered STN: Jul. 8, 2015; 1H-Pyrrole-3-carboxamide, N-(2-amino-1-methyl-2-oxoethyl)-4-(5-chloro-2-thienyl)-, 1 page.;;Gopalsamy et al., 2004, Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorg Med Chem Lett. 14(16):4221-4224.;;Kling et al., 2018, Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1′ Extension, ACS Med Chem Lett. 9(3):221-226.;;Li et al., 1996, Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases, J Med Chem. 39(20):4089-4098.;;Lubisch et al., 2003, Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability, J Med Chem. 46(12):2404-2412.;;Muniappan et al., 2017, Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice, Sci Rep. 7:14398.;;Nimmrich et al., 2008, Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction, J Pharmacol Exp Ther. 327(2):343-352.;;Ross et al., 2013, Biosynthetic Multitasking Facilitates Thalassospiramide Structural Diversity in Marine Bacteria, J Am Chem Soc. 135(3):1155-1162.;;Singh et al., 2015, Identification of amino acid appended acridines as potential leads to anti-cancer drugs. Bioorg Med Chem Lett. 25(18):3854-3858.;;Vengeliene et al., 2016, The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile, Neuropsychopharmacology. 41(4):979-988 [online published Jul. 28, 2015].;;Zhang et al., 2016, Family-wide Structural Characterization and Genomic Comparisons Decode the Diversity-oriented Biosynthesis of Thalassospiramides by Marine Proteobacteria, J Biol Chem. 291(53):27228-27238.;;European Extended Search Report dated Jan. 23, 2020 for Application No. EP 17824731.8, filed Feb. 4, 2019.;;Beaucage S.L., Oligodeoxyribonucleotides synthesis. Phosphoramidite approach., (1993) Methods Mol. Biol., 20, 33-61.;;Boyer et al., Induction and regulation of epithelial-mesenchymal transitions., (2000) Biochem. Pharmacol, 60, 1091-1099.;;Branton et al., TGF-beta and fibrosis., (1999) Microbes Infect, 1(15), 1349-1365.;;Brooks et al., CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, (1983) J. Comp. Chem., 4, 187-217.;;Burkert et al., Pitfalls in the use of the torsion angle driving method for the calculation of conformational interconversions., (1982) J Comp. Chem, 3, 40-46.;;Capaldi et al., Signal amplification through nucleotide extension and excision on a dendritic DNA platform., (2000) Nucleic Acids Res., 28(7), e21.;;Chubanov et al., Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7., (2012) Br J Pharmacol, 166(4), 1357-1376.;;Clackson et al., Making antibody fragments using phage display libraries. (1991) Nature, 352:624-628.;;Coburn et al., Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference., (2002) J. Virol., 76, 9225-9231.;;Cohen et al., Molecular Modeling Software and Methods for Medicinal Chemistry, (1990) Journal of Medicinal Chemistry, 33(3), 883-894.;;Connolly M.L., Solvent-Accessible Surfaces of Proteins and Nucleic Acids., (1983) Science, 221(4612), 709-713.;;Cwirla et al., Peptides on phage: a vast library of peptides for identifying ligands., (1990) Proc. Natl. Acad. Sci. USA, 87, 6378.;;Davis et al., The Crystal Structures of Human Calpains 1 and 9 Imply Diverse Mechanisms of Action and Auto inhibition., (2007) J. Mol. Biol., 366, 216-229.;;De Maria et al., Calpain Expression and Activity during Lens Fiber Cell Differentiation., (2009) J. Biol. Chem., 284 (20), 13542-50.;;Dunbrack et al., Meeting review: the Second Meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, Dec. 13-16, 1996., (1997) Folding and Design, 2, R27; 16 pages.;;Egholm et al., PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules., (1993) Nature, 365(6446), 566-568.;;Friedman et al., Therapy for fibrotic diseases: nearing the starting line., (2013) Sci. Transi. Med., 5(167), 167-17 pages.;;Geysen et al., Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein., (1985) Proc. Natl. Acad. Sci. USA, 82(1), 178-182.;;Geysen et al., Strategies for epitope analysis using peptide synthesis., (1987) Journal of Immunological Methods., 102(2), 259-274.;;Geysen et al., Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid., (1984) Proc. Natl. Acad. Sci. USA, 81, 3998-4002.;;Gooch et al., Invovlement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular maxtrix accumulation., (2004) J. Biol Chem., 279(15), 15561-70.;;Goodford P.J., A computational procedure for determining energetically favorable binding sites on biologically important macromolecules., (1985) J. Med. Chem, 28, 849-857.;;Goodsell et al., Automated docking of substrates to proteins by simulated annealing., (1990) Protein., 8(3): 195-202.;;Hata et al., Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense., (2010) PloS Genet., 6(7), e1001040 in 14 pages.;;Hyrup et al., Peptide nucleic acids (PNA): synthesis, properties and potential applications., (1996) Bioorg Med Chem., 4(1), 5-23.;;Iwano et al., Evidence that fibroblasts derive from epithelium during tissue fibrosis., (2002) J Chit Invest., 110(3): 341-350.;;Janda et al., Ras and TGF-beta cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways., (2002) J. Cell Biol, 156, 299-313.;;Jones et al. Improved methods for building protein models in electron density maps and the location of errors in these models., (1991) Acta Cryst., A47, 110-119.;;Kalluri et al., Epithelial-mesenchymal transition and its implications for fibrosis., (2003) J Clin Invest, 112(12), 1776-1784.;;Kang, et al., Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries., (1991) Proc. Natl. Acad. Sci. USA, 88, 11120-11123.;;Kiemer, et al., Identification of genes involved in epithelial-mesenchymal transition and tumor progression., (2001) Oncogene, 20, 6679-6688.;;Kim et al., Targeting Calpains: a Therapeutic Strategy for the Treatment of TGFbeta Mediated Mesenchymal Transition and Associated Pathologies., (2014) 64th Annual Meeting of the American Society of Human Genetics.;;Kraulis, MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures., (1991) J Appl Cryst., 24, 946-950.;;Kuntz et al., A geometric approach to macromolecule-ligand interactions., (1982) J. Mol. Biol., 161, 269-288.;;Kuntz I.D., Structure-Based Strategies for Drug Design and Discovery, (1992) Science 257:1078-1082.;;Leask et al., TGF-beta signaling and the fibrotic response., (2004) FASEB J., 18(7), 816-827.;;LeBleu et al., Origin and function of myofibroblasts in kidney fibrosis., (2013) Nat Med, 19(8), 1047-1053.;;Lee et al., Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease., (2014) Am J Physiol Lung Cell Mol Physiol, 306(8), L736-748.;;Lee et al., Molecular Cloning and Characterization of a Novel Tissue-Specific Calpain Predominantly Expressed in the Digestive Tract., (1998) Biol Chem., 379(2), 175-183.;;Li et al., Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice., (2006) Biochem Biophys Res Commun., 344(3): 701-707.;;Lowman et al., Selecting high-affinity binding proteins by monovalent phage display., (1991) Biochemistry, 30(45): 10832-10838.;;Ma et al., Expression of calpain small subunit 2 in mammalian tissues., (2004) Curr Eye Res., 29(4-5), 337-347.;;Mag et al., Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5′-phosphorothioate linkage., (1991) Nucleic Acids Res., 19(7): 1437-1441.;;Mani et al., The epithelia-mesenchymal transition generates cells with properties of stem cells., (2008) Cell, 122(4), 704-715.;;Marks et al., By-passing immunization. Human antibodies from V-gene libraries displayed on phage., (1991), J Mol Biol., 222, 581-597.;;McKay et al., Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α Expression., (1999) Biol. Chem., 274(3): 1715-1722.;;Miranker et al., Functionality maps of binding sites: a multiple copy simultaneous search method., (1991) Proteins. 11(1): 29-34.;;Miyazono K., Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer., (2009) Proc Jpn Acad Ser. B. Phys. Bio. Sci., 85(8), 314-323.;;Navia et al., Use of structural information in drug design., (1992) Current Opinion in Structural Biology, 2(2): 202-210.;;Nielsen, P.E., Peptide nucleic acid (PNA): A model structure for the primordial genetic material?, (1993) Origins of life and evolution of biospheres, 23(5), 323-327.;;Nieto M.A., The snail superfamily of zinc-finger transcription factors., (2002) Nat Rev Mol Cell Biol., 3, 155-166.;;Nishibata et al., Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation., (1991) Tetrahedron, 47(43), 8985-8990.;;Peng et al., Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: A model for “active” disease., (2013) PLOS One, 8(4), e59348; 15 pages.;;Piccirillo et al., TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice., (1998) J Immunol., 161 (8): 3950-3956.;;Piera-Velazquez et al., Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. (2011), Am J Pathol., 179(3), 1074-1080.;;Savary et al., Role of TGF-β signaling in EMT, cancer progression and metastasis., (2011) Drug Discovery Today: Disease Models, 8(2-3), 121-126.;;Schoofs et al., Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution., (1988) J Immunol., 140(2): 611-616.;;Singh et al., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer., (2010) Oncogene, 29(34), 4741-4751.;;Smith G.P., Surface presentation of protein epitopes using bacteriophage expression systems., (1991) Current Opin Blotechnol., 2, 668-673.;;Stewart et al., Lentivirus-delivered stable gene silencing by RNAi in primary cells., (2003) RNA, 9, 493-501.;;Strutz et al., Identification and characterization of a fibroblast marker: FSP1., (1995) J Cell Biol, 130(2): 393-405.;;Summerton J., Morpholino antisense oligomers: the case for an RNase H-independent structural type., (1999) Biochim Biophys Acta., 1489, 141-158.;;Suzuki et al., Structure, activity, and biology of calpain., (2004) Diabetes, 53(Suppl 1): S12-S18.;;Tojo et al., The ALK-5 Inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. (2005) Cancer Sci, 96(11), 791-800.;;Verlinde et al., Structure-based drug design: progress, results and challenges., (1994) Structure, 2, 577-587.;;Wahlestedt et al., Potent and nontoxic antisense oligonucleotides containing locked nucleic acids., (2000) PNAS USA, 97(10): 5633-5638.;;Weiner et al., A new force field for molecular mechanical simulation of nucleic acids and proteins., (1984) J Am Chem Soc. 106, 765-784.;;Willis et al., TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease., (2007) Amer J Physiol Lung Cell Mol Physiol, 293(3): L525-L534.;;Wu et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. (2004), J Biol Chem. 279(6), 4929-4940.;;Wu et al., Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an a-smooth muscle actin-Cre transgenic mouse., (2007) Respir Res., 8(1), 1; 11 pages.;;Wynn T., Cellular and molecular mechanisms of fibrosis., (2008) J Pathol., 214(2): 199-210.;;Xue et al., The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis., (2003) Cancer Res., 63, 3386-3394.;;Yang et al., Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis., (2001) Am J Pathol., 159(4): 1465-1475.;;Yoshikawa et al., Isolation of Two Novel Genes, Down-regulated in Gastric Cancer., (2000) Jpn J Cancer Res., 91(5), 459-463.;;Zeisberg et al., Renal Fibrosis: Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation., (2001) Am J Pathol., 159(4): 1313-1321.;;Zimmerman et al., The calpain small subunit gene is essential: its inactivation results in embryonic lethality. (2000) IUBMB Life, 50(1), 63-68.;;Bihovsky et al., 2004, 1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors, Bioorg Med Chem Lett. 14(4):1035-1038.;;Blum et al., 2003, Complementary use of ion trap / time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: Early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat. J Chromatography B. 787:255-270.;;Brodney et al., 2015, Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug—Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors, J Med Chem. 58:3223-3252.;;CAS Registry No. 1309010-71-6; STN entry date: Jun. 13, 2011; D-Alanine, N-[(1-phenyl-1H-imidazol-5-yl)carbonyl] in 1 page.;;Chatterjee et al., 1999, P2-achiral, P′-extended alpha-ketoamide inhibitors of calpain I. Bioorg Med Chem Lett. 9(16):2371-2374.;;Chen et al., 2012, New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N-Alkylation of Histidine, Chern Biodiver. 9(11):2473-2484.;;Damalanka et al., 2016, Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease, J Med Chem. 59(5):1899-1913.;;Donald et al., 1991, C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Peptidyl-Prolyl Cis-Trans Isomerization, Tetrahedron Lett., 32(10):1375-1378.;;Dourdin et al., 2001, Reduced Cell Migration and Disruption of the Actin Cytoskeleton in Calpain-deficient embryonic Fibroblasts, J Biol Chem. 276(51):48382-48388.;;Gardiner et al., 2006, Ring closing metathesis of a- and b-amino acid derived dienes, J Organomet Chem. 691:5487-5496.;;Goll et al., 2003, The Calpain System, Physiol Rev. 83(3):731-801.;;Jánossy et al., 2004, Calpain as a multi-site regulator of cell cycle, Biochem Pharmacol. 67(8):1513-1521.;;Jones et al., 2009, Efficient Large-Scale Synthesis of CAT811, a Potent Calpain Inhibitor of Interest in the Treatment of Cataracts, Aust J Chem. 62:671-675.;;Jones et al., 2013, A Template-Based Approach to Inhibitors of Calpain 2, 20S Proteasome, and HIV-1 Protease, Chem Med Chem. 8(12):1918-1921.;;Jones et al., 2014, The Preparation of Macrocyclic Calpain Inhibitors by Ring Closing Metathesis and Cross Metathesis, Aust J. Chem. 67:1257-1263.;;Kim et al., 2011, Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties, Eur J Med Chem. 46(5):1721-1728.;;Kim et al., 2015, Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor, Bioorg Med Chem. 23:1808-1816.;;Kling et al., 2017, Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2□(3-Phenyl□1H□pyrazol-1-yl)-nicotinamides, J Med Chem. 60:7123-7138.;;Lamouille et al., 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol. 15(3):178-196 in 46 pages.;;Lee et al., 2005, Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 15(11):2857-2860.;;Leloup et al., 2006, Involvement of calpains in growth factor-mediated migration, Int J Biochem Cell Biol. 38(12):2049-2063.;;Li et al., 2015, Synthesis and Cytotoxic Activities of Novel Amino Acid-Conjugates of Pyrrole Derivatives. Youji Huaxue. 35:167-174.;;Lu et al., 2015, Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors, Sci Rep. 5:8783 in 8 pages.;;Lubisch et al., 2002, Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors, Bioorg Med Chem Lett., 12(10):1335-1338.;;Mandadapu et al., 2013, Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus, Bioorg Med Chem Lett. 23(13):3709-3712.;;Miettinen et al., 1994, TGF-β Induced Transdifferentiation of Mammary Epithelial Cells to Mesenchymal Cells: Involvement of Type I Receptors, j Cell Biol. 127(6 Pt 2):2021-2036.;;Morton et al., 2013, A Macrocyclic Calpain Inhibitor Slows the Development of Inherited Cortical Cataracts in a Sheep Model, Invest Ophthal Visual Science. 54(1):389-395.;;Nam et al., 2008, Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 18(1):205-209.;;Nema et al., 2011, Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions, Pda J Pharm Sci Technol. 65(3):287-332.;;Oh et al., 2007, Thalassospiramides A and B, Immunosuppressive Peptides from the Marine Bacterium Thalassospira sp., Org Ltts. 9(8):1525-1528.;;Pegorier et al., 2010, Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF), Respir Res. 11:85 in 11 pages.;;Pehere et al., 2012, New β-Strand Templates Constrained by Huisgen Cycloaddition, Org Lett. 14(5):1330-1333.;;Pehere et al., 2013, New cylindrical peptide assemblies defined by extended parallel β-sheets, Org Biomol Chem. 11(3):425-429.;;Pehere et al., 2013, Synthesis and Extended Activity of Triazole-Containing Macrocyclic Protease Inhibitors, Chem Eur J. 19:7975-7981.;;Powell et al., 1998, Compendium of Excipients for Parenteral Formulations, pDA; J Pharm Sci Technol. 52(5):238-311.;;Ravulapalli et al., 2009, Distinguishing between calpain heterodimerization and homodimerization, FEBS J. 276(4):973-982.;;Rotstein et al., 2014, Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics, Nature Comm. 5:4365-4371.;;Rotstein et al., 2016, Mechanistic Studies and Radiofluorination of Structurally Diverse Pharmaceuticals with Spirocyclic Iodonium(III) Ylides, Chem Sci. 7(7):4407-4417.;;Santos et al., 2012, Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation, PLoS One 7(3):e33468 in 12 pages.;;Sasmal et al., 2011, Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists. Bioorg Med Chem Lett. 21(16):4913-4918.;;Schád et al., 2002, A novel human small subunit of calpains, Biochem J 342(Pt 2):383-388.;;Skogh et al., 2013, Aminocarbonylation of 4□lodo□1H□imidazoles with an Amino Acid Amide Nucleophile: Synthesis of Constrained H□Phe-Phe-NH2 Analogues. J Org Chem. 78:12251-12256.;;Stoermer et al., 2009, Base-Sensitivity of Arginine Alpha-Ketoamide Inhibitors of Serine Proteases, Aust J Chem. 62(9):988-992.;;Von Dobeneck et al., 1976, Diaminopyrrolinone, Liebigs Ann Chem., 3:476-486.;;Walker et al., 2001, General method for the synthesis of cyclic peptidomimetic compounds, Tetrahed Letts. 42(34):5801-5804.;;Woon et al., 2011, Structure guided development of potent reversibly binding penicillin binding protein inhibitors, ACS Med Chem Lett., 2(3):219-223 and Supporting Information, S1-S46.;;Young et al., 2010, Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon, J Biol Chem. 285(15):11039-11044.;;Zhong et al., 2005, 3-(2-Chlorophenyl)-N-(2-cyano-4-methyl-2-pentyl)-5-methylisoxazole-4-carboxamide. Acta Cryst. Section E. E61:o2621-o2622 in 7 pages.;;Bogen et al., Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles. J Med Chem. (2009) 52(12): 3679-3688.;;Brouillette et al., Supporting Information for Valuable Versatile Reactivity of Thiaaisatoic Anhydrides: Expedient Solid-Phase Synthesis of Thieno [1,4]diazepine-2,5-diones, Synlett (2008) 15:2360-2364; Aug. 22, 2008 pp. 1-58.;;CAS Registry No. 1422551-25-4, N-[(1S)-2-amino-1-(1H-imidazol-5-ylmethyl)-2-oxoethyl]-3-(3-fluorophenyl)-1H-Pyrazole-4-carboxamide, Entered STN Mar. 7, 2013.;;Celatka et al., 2002, Asymmetric synthesis of a C1-C19 fragment of Ulapualide A. Tetrahed Lttrs. 43(39): 7043-7046.;;Gafni et al., “Calpain Activation in Huntington's Desearse”. J Neuroscience (2002) 22(12): 4842-4849.;;Jansen et al., 1961. Some 4-Substituted Oxazoles. J Chem Society pp. 405-411. (see Reaxys-Abs).;;REAXYS Database, 2002, Database Accession No. 9305036, Elsevier Life Sciences IP Limited, 1 page.;;REAXYS Database, 1961, Database Accession No. 849427, Elsevier Life Sciences IP Limited, 2 page.;;Wang et al., Synthesis and Biological Activity of 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier. J Med Chem. (2012) 55(4):1758-1770.;;Yildiz-Unal et al., “Neuroprotective Strategies Against Calpain-Mediated Neurodegernation”. Neuropsychiatr Dis Treat. (2015) 11:297-310.;;Abell et al., 2009, Molecular Modeling, Synthesis, and Blological Evaluation of Macrocyclic Calpain Inhibitors, Angew Chem Int Ed Engl. 48(8):1455-1458.;;Cohrt A. Emil. 2014, Solid-phase synthesis of peptide thioureas and thiazole-containing macrocycles through Ru-catalyzed ring-closing metathesis, ACS Comb Sci. 16(2):71-77 and Supporting Information in 55 pages.;;Halland et al., 2014, Small Macrocycles As Highly Active Integrin α2β1 Antagonists, ACS Med Chem Lett. 5(2):193-198.;;Low et al., 2016, Rational Design of Calpain inhibitors Based on Calpastatin Peptidomimetics, J Med Chem. 59(11):5403-5415.;;Stuart et al., 2011, Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis, J Med Chem. 54(21):7503-7522.;;Wells et al., 2001, 1,2-Benzothiazine 1,1-Dioxide P2-P3 Peptide Mimetic Aldehyde Calpain I Inhibitors, J Med Chem. 44:3488-3503.;;International Search Report and Written Opinion dated Aug. 31, 2017 for Application No. PCT/US2017/040109, filed Jun. 29, 2017.;;International Preliminary Report on Patentability [Corrected] dated Aug. 2, 2018 for Application No. PCT/US2017/040109, filed Jun. 29, 2017.;;Cao et al., Novel Biologically Active Series of N-acetylglucosamine Derivatives for the suppressive activities on GAG Release. Carbohydrate Res. (2016) 443: 73-79.;;CAS Registry No. 1980787-62-9/-71-0/-72-1; “D-Glucose”, Entered STN Aug. 26, 2016 in 3 pages.;;Australian Examination Report dated Mar. 25, 2021 for Application No. 2017292646, filed Jan. 21, 2019.",ACTIVE
505,AU,B4,AU 2009/100750 B4,159-013-150-986-59X,2010-04-01,2010,AU 2009/100750 A,2009-08-03,AU 2008/101150 A;;AU 2009/100750 A;;AU 2005/323229 A;;US 2005/0045040 W;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;ARCHIBALD JOHN WESLEY;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL,,https://lens.org/159-013-150-986-59X,Limited Patent,no,2,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
506,US,S,US D0426763 S,156-683-165-079-742,2000-06-20,2000,US 099508,1999-01-22,,,Padlock,,,Adler; Ari Tao;;Fiegener; John Darrin;;Thompson; Roy Alden;;Geringer; Joseph Robert;;West; Harry,MASTER LOCK COMPANY LLC (1999-05-10),https://lens.org/156-683-165-079-742,Design Right,yes,38,13,1,1,0,,,D 8334,0,0,,,,UNKNOWN
507,AU,A2,AU 2005/323229 A2,160-621-089-531-290,2006-07-13,2006,AU 2005/323229 A,2005-12-13,US 5149905 A;;US 64234005 P;;US 2005/0045040 W,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,ARCHIBALD JOHN WESLEY;;DOROGUSKER JESSE L;;ADLER MITCHELL;;RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M,,https://lens.org/160-621-089-531-290,Patent Application,no,0,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,ACTIVE
508,KR,A,KR 20190063473 A,184-975-881-510-513,2019-06-07,2019,KR 20197012279 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,칼페인 조정자 및 그 치료학적 용도,"저분자 칼페인 조정자(small molecule calpain modulator) 조성물들, 약학적 조성물들, 그의 용도 및 제조에 관한여 개시된다.",BLADE THERAPEUTICS INC,BRAD OWEN BUCKMAN;;JOHN BEAMOND NICHOLAS;;SHENDONG YUAN;;MARC ADLER;;KUMARASWAMY EMAYAN;;JINGYUAN MA,,https://lens.org/184-975-881-510-513,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D277/56;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14,,0,0,,,,ACTIVE
509,WO,A1,WO 2018/236913 A1,021-235-327-243-222,2018-12-27,2018,US 2018/0038344 W,2018-06-19,US 201762524334 P,2017-06-23,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Small molecule calpain modulator compositions and pharmaceutical compositions can be prepared and used as therapeutic agents. Exemplary compositions include non-macrocyclic a-keto amide derivatives. The therarapeutic agents can be used for treating fibrotic disease or a resulting secondary disease state or condition. The small molecules can competitively bind with calpastatin and/or inhibit calpain through contact with CAPN1, CAPN2, and/or CAPN9 enzymes.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC;;NICHOLAS JOHN BEAMOND,,https://lens.org/021-235-327-243-222,Patent Application,yes,9,6,4,4,0,A61P35/00;;A61P19/04;;C07C233/78;;C07C233/62;;C07C233/76;;C07C233/76;;C07C235/60;;C07C235/80;;C07C2601/16;;C07C2602/10;;C07D209/86;;C07D209/88;;C07D209/90;;C07D265/38;;C07D265/38;;C07D307/91;;C07D307/91;;C07D311/84;;C07D311/84;;C07D317/68;;C07D317/68;;C07D319/24;;C07D319/24,C07C233/84;;A61K31/166;;A61K31/33;;A61P35/00;;C07D209/86;;C07D209/88;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,,7,7,035-995-301-512-762;;039-317-916-201-269;;075-813-686-060-816;;036-746-562-702-221;;159-695-952-917-570;;046-864-680-028-207;;038-275-611-642-056,11992771;;10.1016/s0960-894x(02)00176-2;;10.1021/jm010178b;;11585453;;10.1016/j.ejmech.2011.02.025;;21397369;;10.1016/j.bmcl.2005.03.095;;15911268;;18024028;;10.1016/j.bmcl.2007.10.097;;24900305;;pmc4018096;;10.1021/ml100260x;;15013018;;10.1016/j.bmcl.2003.11.037,"LUBISCH, W. ET AL.: ""Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 12, no. 10, May 2002 (2002-05-01), pages 1335 - 1338, XP001150391;;WELLS, G. J. ET AL.: ""1,2-Benzothiazine 1,1-dioxide P2-P3 peptide mimetic aldehyde calpain I inhibitors"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 44, no. 21, October 2001 (2001-10-01), pages 3488 - 3503, XP055555347;;KIM, S. H. ET AL.: ""Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties"", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, no. 5, 12 February 2011 (2011-02-12), pages 1721 - 1728, XP028370940;;LEE, K. S. ET AL.: ""Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 15, no. 11, June 2005 (2005-06-01), pages 2857 - 2860, XP055555348;;NAM, D. H. ET AL.: ""Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 18, no. 1, 30 October 2008 (2008-10-30), pages 205 - 209, XP022410884;;WOON, E. C. Y. ET AL.: ""Structure guided development of potent reversibly binding penicillin binding protein inhibitors"", ACS MEDICINAL CHEMISTRY LETTERS, vol. 2, 2011, pages 219 - 223, XP055555353;;BIHOVSKY, R. ET AL.: ""1,2-Benzothiazine 1,1-dioxide alpha-ketoamide analogues as potent calpain I inhibitors"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 4, 2004, pages 1035 - 1038, XP085048615",PENDING
510,CA,A1,CA 2933552 A1,028-818-825-470-275,2015-07-02,2015,CA 2933552 A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK-ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WURTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,,https://lens.org/028-818-825-470-275,Patent Application,no,0,0,15,15,354,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/35;;C07K14/435,,0,0,,,,DISCONTINUED
511,CL,A1,CL 2020002024 A1,069-478-323-913-354,2020-12-18,2020,CL 2020002024 A,2020-08-03,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,Moduladores de calpaínas y usos terapeuticos de los mismos. (divisional solicitud 201900793),"Se revelan en la presente composiciones moduladoras de calpaína de molécula pequeña, composiciones farmacéuticas, su uso y preparación.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG;;YUAN SHENDONG,,https://lens.org/069-478-323-913-354,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,A61K31/4155;;A61K31/4178;;A61P7/04;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D285/06;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/14;;C07D407/04,,0,0,,,,PENDING
512,US,B1,US 11339130 B1,189-835-655-321-324,2022-05-24,2022,US 202017032529 A,2020-09-25,US 202017032529 A;;US 201716337377 A;;US 2017/0053629 W;;US 201762554939 P;;US 201762459461 P;;US 201662401093 P,2016-09-28,Calpain modulators and therapeutic uses thereof,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/189-835-655-321-324,Granted Patent,yes,155,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,A61P11/00;;C07D233/90;;C07C233/05;;C07D209/20;;C07D231/14;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,,185,134,000-350-112-609-276;;005-582-329-281-579;;039-581-629-931-843;;048-639-884-454-955;;031-243-109-936-648;;112-361-501-662-497;;090-595-759-639-249;;080-218-260-759-683;;098-733-293-429-373;;042-939-733-208-454;;080-750-233-057-521;;078-776-607-842-828;;019-632-841-644-026;;034-331-211-704-877;;108-452-437-895-403;;119-687-205-724-766;;066-092-492-334-256;;063-618-817-674-705;;009-186-473-238-939;;006-136-522-900-040;;048-170-800-689-023;;041-931-386-444-790;;153-408-674-284-984;;047-156-535-940-645;;015-681-580-943-399;;000-094-688-465-084;;037-832-038-424-509;;010-432-639-580-299;;001-576-828-082-834;;019-115-775-607-415;;012-830-491-824-205;;099-850-489-020-528;;003-168-967-428-92X;;030-042-017-746-591;;131-046-096-401-339;;010-626-131-088-514;;015-923-579-613-818;;074-458-381-494-234;;100-878-907-092-574;;141-914-263-639-943;;034-987-888-849-578;;036-745-751-836-283;;002-974-951-283-009;;010-248-616-848-483;;099-744-749-713-381;;048-916-440-146-479;;113-568-574-765-360;;065-285-521-497-72X;;075-813-686-060-816;;005-836-557-552-913;;010-402-858-128-027;;022-411-096-178-940;;063-460-415-904-574;;069-450-943-413-364;;023-301-052-611-166;;010-725-579-810-871;;147-440-643-091-525;;007-730-440-068-99X;;036-746-562-702-221;;004-052-426-270-084;;122-753-736-744-724;;034-514-021-515-444;;038-893-656-153-713;;061-330-223-146-889;;027-995-839-963-178;;078-382-889-771-789;;083-771-782-040-353;;035-995-301-512-762;;072-994-322-434-772;;052-649-373-150-312;;053-962-998-119-152;;009-043-118-551-826;;048-205-769-302-325;;020-855-322-534-259;;064-406-626-054-484;;089-144-976-445-688;;044-878-082-973-49X;;003-261-888-417-997;;159-695-952-917-570;;151-919-600-413-52X;;036-393-576-918-372;;041-940-476-987-371;;062-742-403-893-408;;077-008-425-179-22X;;129-297-815-048-32X;;013-556-469-253-589;;004-723-753-859-683;;019-747-883-890-065;;085-234-268-089-786;;007-196-400-487-666;;052-664-611-823-937;;046-483-357-440-702;;023-684-266-623-526;;111-761-539-590-464;;021-045-743-874-448;;054-167-535-212-696;;000-647-626-022-090;;009-406-912-144-89X;;008-799-202-681-459;;030-033-993-640-765;;032-421-248-192-752;;103-353-898-106-766;;041-625-114-141-248;;048-382-748-962-92X;;087-979-151-907-860;;002-499-291-773-300;;007-432-529-089-951;;121-428-466-773-844;;053-490-223-664-742;;114-918-900-251-802;;073-613-615-376-929;;030-524-564-810-697;;071-099-297-091-853;;015-358-399-529-695;;135-735-121-346-36X;;039-317-916-201-269;;026-115-521-313-787;;046-864-680-028-207;;164-224-116-012-039;;157-424-722-980-550;;089-950-113-895-743;;019-817-393-305-59X;;089-487-729-749-961;;111-320-010-409-764;;016-958-339-591-097;;031-218-242-932-350;;050-062-160-596-331;;018-562-302-914-931;;033-395-860-645-21X;;038-702-954-033-133;;032-087-655-109-978;;134-153-606-136-532;;009-010-393-743-32X;;080-218-260-759-683,27454655;;10.1016/j.carres.2016.07.004;;10.1002/anie.200805014;;19145612;;8242144;;10.1385/0-89603-281-7:33;;10.1016/s1570-0232(02)00782-1;;12650749;;10.1016/s0006-2952(00)00427-5;;11007946;;10611762;;10.1016/s1286-4579(99)00250-6;;10.1016/j.dmpk.2017.11.068;;10.1055/s-2008-1078210;;10.1002/jcc.540030108;;10710438;;pmc102804;;10.1093/nar/28.7.e21;;10.1016/s0960-894x(99)00392-3;;10476871;;10.1002/cbdv.201200320;;23161629;;22242975;;pmc3417452;;10.1111/j.1476-5381.2012.01855.x;;10.1038/352624a0;;1907718;;pmc136455;;12186906;;10.1128/jvi.76.18.9225-9231.2002;;10.1021/jm00165a001;;2407844;;10.1021/co400102v;;24377264;;10.1126/science.6879170;;6879170;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;10.1021/acs.jmedchem.5b01464.s001;;26823007;;pmc5156532;;10.1021/acs.jmedchem.5b01464;;17157313;;10.1016/j.jmb.2006.11.037;;10.1074/jbc.m900561200;;pmc2679455;;19269960;;10.1016/s0040-4039(00)79671-7;;10.1074/jbc.m108893200;;11602605;;10.1016/s1359-0278(97)00011-4;;9135979;;7692304;;10.1038/365566a0;;10.1126/scitranslmed.3004700;;23303606;;10.1016/j.jorganchem.2006.09.061;;pmc396995;;2578661;;10.1073/pnas.82.1.178;;2443575;;10.1016/0022-1759(87)90085-8;;pmc345355;;6204335;;10.1073/pnas.81.13.3998;;10.1152/physrev.00029.2002;;12843408;;14742441;;10.1074/jbc.m308759200;;10.1021/jm00145a002;;3892003;;10.1002/prot.340080302;;2281083;;15261274;;10.1016/j.bmcl.2004.06.013;;10.1371/journal.pgen.1001040;;20686710;;pmc2912385;;8689239;;10.1016/0968-0896(95)00171-9;;pmc151091;;10.1172/jci15518;;12163453;;10.1172/jci0215518;;10.1172/jci200215518;;pmc2199233;;10.1083/jcb.200109037;;11790801;;15041468;;10.1016/j.bcp.2003.12.021;;2025413;;10.1107/s0108767390010224;;10.1071/ch09101;;24130198;;10.1002/cmdc.201300387;;10.1071/ch14121;;10.1172/jci20530;;pmc297008;;10.1172/jci200320530;;14679171;;pmc53085;;1763028;;10.1073/pnas.88.24.11120;;10.1038/sj.onc.1204872;;11709702;;10.1016/j.ejmech.2011.02.025;;21397369;;10.1016/j.bmc.2015.02.035;;25797164;;28759231;;10.1021/acs.jmedchem.7b00731;;10.1021/acsmedchemlett.7b00494;;29541364;;pmc5846052;;10.1107/s0021889891004399;;7154081;;10.1016/0022-2836(82)90153-x;;10.1126/science.257.5073.1078;;1509259;;pmc4240281;;24556840;;10.1038/nrm3758;;10.1096/fj.03-1273rev;;15117886;;10.1038/nm.3218;;pmc4067127;;23817022;;10.1016/j.bmcl.2005.03.095;;15911268;;pmc3989726;;10.1152/ajplung.00210.2013;;24583879;;10.1515/bchm.1998.379.2.175;;9524069;;10.1016/j.biocel.2006.04.012;;16971167;;10.1021/jm950541c;;8831774;;10.6023/cjoc201407016;;10.1016/j.bbrc.2006.04.010;;16631603;;27148623;;10.1021/acs.jmedchem.6b00267;;10.1021/bi00109a004;;1932005;;11992771;;10.1016/s0960-894x(02)00176-2;;10.1021/jm0210717;;12773044;;10.1080/02713680490516242;;15590481;;2027751;;10.1093/nar/19.7.1437;;pmc333898;;10.1016/j.bmcl.2013.05.021;;23727045;;pmc3750990;;18485877;;10.1016/j.cell.2008.03.027;;pmc2728032;;1748994;;10.1016/0022-2836(91)90498-u;;10.1002/prot.340110104;;1961699;;10.2183/pjab.85.314;;19838011;;pmc3621568;;23211821;;10.1167/iovs.12-11088;;29089532;;10.1038/s41598-017-14719-9;;pmc5663911;;18024028;;10.1016/j.bmcl.2007.10.097;;10.1016/0959-440x(92)90147-y;;10.5731/pdajpst.2011.00634;;22293237;;8115163;;10.1007/bf01582083;;11994736;;10.1038/nrm757;;18701765;;10.1124/jpet.108.142679;;10.1016/s0040-4020(01)86503-0;;10.1021/ol070294u;;17373804;;10.1021/ol3002199;;22339212;;23606616;;10.1002/chem.201204260;;10.1371/journal.pone.0059348;;23565148;;pmc3614979;;10.1016/j.ajpath.2011.06.001;;21763673;;pmc3157273;;9846074;;19215300;;10.1111/j.1742-4658.2008.06833.x;;25007318;;10.1038/ncomms5365;;10.1039/c6sc00197a;;27540460;;pmc4987086;;22432027;;pmc3303840;;10.1371/journal.pone.0033468;;10.1016/j.bmcl.2011.06.017;;21741835;;11853546;;pmc1222398;;10.1042/bj3620383;;10.1042/0264-6021:3620383;;2447184;;10.4049/jimmunol.140.2.611;;10.1016/j.bmcl.2015.07.059;;26238321;;20531305;;pmc3176718;;10.1038/onc.2010.215;;24171628;;10.1021/jo4020613;;1370065;;10.1016/0958-1669(91)90032-z;;12649500;;10.1261/rna.2192803;;pmc1370415;;10.1071/ch09150;;7615639;;pmc2199940;;10.1083/jcb.130.2.393;;21955158;;10.1021/jm200471r;;10807004;;10.1016/s0167-4781(99)00150-5;;14749260;;10.2337/diabetes.53.2007.s12;;16271073;;10.1111/j.1349-7006.2005.00103.x;;26216521;;pmc4748423;;10.1038/npp.2015.225;;10.1016/s0969-2126(00)00060-5;;7922037;;10805816;;10.1073/pnas.97.10.5633;;pmc25880;;10.1016/s0040-4039(01)01134-0;;10.1021/jm201688n;;pmc3288238;;22243528;;10.1021/ja00315a051;;10.1021/jm010178b;;11585453;;17631612;;10.1152/ajplung.00163.2007;;24900305;;pmc4018096;;10.1021/ml100260x;;14627704;;10.1074/jbc.m309767200;;17207287;;pmc1781437;;10.1186/1465-9921-8-1;;pmc2693329;;10.1002/path.2277;;18161745;;12810675;;pmc1850509;;11583974;;10.1016/s0002-9440(10)62533-3;;10.1111/j.1349-7006.2000.tb00967.x;;10835488;;pmc5926377;;pmc2856976;;10.1074/jbc.r109.091306;;20147747;;pmc1850511;;10.1016/s0002-9440(10)62518-7;;11583959;;10.1107/s1600536805022373;;10.1080/15216540050176610;;11087123;;10.1021/jm801632a;;19456105;;10.1016/s0040-4039(02)01553-8;;12077181;;10.1523/jneurosci.22-12-04842.2002;;pmc6757710;;10.1039/jr9610000405;;10.2147/ndt.s78226;;pmc4327398;;25709452;;10.1055/s-2008-1078210,"Cao et al. “Novel biologically active series of N-acetylglucosamine derivatives for the suppressive activities on GAG release” Carbohydrate Research, 2016, vol. 433, pp. 73-79.;;Abell et al., 2009, Molecular Modeling, Synthesis, and Biological Evaluation of Macrocyclic Calpain Inhibitors, Angew Chem Int Ed Engl. 48(8):1455-1458.;;Beaucage S.L., Oligodeoxyribonucleotides synthesis. Phosphoramidite approach., (1993) Methods Mol. Biol., 20, 33-61.;;Bihovsky et al., 2004, 1,2-Benzothiazine 1,1-dioxide α-ketoamide analogues as potent calpain I inhibitors, Bioorg Med Chem Lett. 14(4):1035-1038.;;Blum et al., 2003, Complementary use of ion trap / time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: Early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat. J Chromatography B. 787(2):255-270.;;Boyer et al., Induction and regulation of epithelial-mesenchymal transitions., (2000) Biochem. Pharmacol, 60, 1091-1099.;;Branton et al., TGF-beta and fibrosis., (1999) Microbes Infect, 1(15), 1349-1365.;;Brodney et al., 2015, Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug—Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors, J Med Chem. 58:3223-3252.;;Brooks et al., CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, (1983) J. Comp. Chem., 4, 187-217.;;Brouillette et al., Supporting Information for Valuable Versatile Reactivity of Thiaaisatoic Anhydrides: Expedient Solid-Phase Synthesis of Thieno [1,4]diazepine-2,5-diones, Synlett (2008) 15:2360-2364; Aug. 22, 2008 pp. 1-58.;;Burkert et al., Pitfalls in the use of the torsion angle driving method for the calculation of conformational interconversions., (1982) J Comp. Chem, 3, 40-46.;;Capaldi et al., Signal amplification through nucleotide extension and excision on a dendritic DNA platform., (2000) Nucleic Acids Res., 28(7), e21.;;CAS Registry No. 15643-65-9; STN entry date: Nov. 16, 1984; Acetic acid, [(3,4-dichlorobenzoyl)amino]phenoxy-, in 1 page.;;CAS Reg No. 1551381-70-4, STN Entry Date: Feb. 20, 2014; Benzamide, N-(1-cyanopropyl)-2,6-difluoro-3-methyl- in 1 page.;;CAS Reg No. 1551443-75-4, STN Entry Date: Feb. 20, 2014; Benzamide, 4-chloro-N-(1-cyano-1-methylpropyl)-2,5-difluoro- in 1 page.;;CAS Reg No. 1555291-73-0, STN Entry Date: Feb. 25, 2014; Benzamide, 4-chloro-N-(1-cyanobutyl)-2,5-difluoro- in 1 page.;;CAS Reg. No. 1187056-39-8, Entered STN: Oct. 1, 2009; Acetic acid, 2-cyano-2-[(2,6-difluorobenzoyl)amino]-, ethyl ester in 1 page.;;CAS Reg. No. 1825463-80-6; STN Entry Date Dec. 9, 2015; Benzamide, N-(cyanocyclopropylmethyl)-6-fluoro-2,3- in 1 page.;;CAS Reg. No. 885026-68-6, Entered STN: May 19, 2006; Benzamide, N-(2-butoxy-1-cyano-1-methylethyl)-2,6-dichloro- in 1 page.;;CAS Registry No. 1026166-23-3, Entered STN: Jun. 8, 2008 ; Hexanoic acid, 3-[[[(1R,2S,5S)-3-[(2S)-2-cyclohexyl-2-[(3,3-dimethyl-1-oxobutyl)amino]acetyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hex-2-yl]carbonyl]amino]-6,6,6-trifluoro-2-oxo-, 1 page.;;CAS Registry No. 1031704-04-7; STN entry date: Jun. 30, 2008; L-Valine, N-[(5,7,8,10-tetrahydro-7,8-dioxo-6-undecyl-2-phenazinyl)carbonyl]-, in 1 page.;;CAS Registry No. 1309010-71-6; STN entry date: Jun. 13, 2011; D-Alanine, N-[(1-phenyl-1H-imidazol-5-yl)carbonyl] in 1 page.;;CAS Registry No. 1347051-33-5, Entered STN: Dec. 1, 2011; 1 H-Imidazole-5-hexanoic acid, β[[[(6S,8aS)-octahydro-4-oxo-2-(phenylmethyl)sulfonyl]pyrrolo[1,2-a]pyrazin-6-yl]carbonyl]amino]-a-oxo-, methyl ester, 1 page.;;CAS Registry No. 1629446-68-9; STN entry date: Oct. 21, 2014; Benzamide, 3-cyano-N-[(1S)-1-formyl-2-phenylethyl], in 1 page.;;CAS Registry No. 1796920-43-8, Entered STN: Jul. 8, 2015; 1 H-Pyrrole-3-carboxamide, N-(2-amino-1-methyl-2-oxoethyl)-4-(5-chloro-2-thienyl)-, 1 page.;;CAS Registry No. 1938924-09-4; STN entry date: Jun. 24, 2016; D-Leucine, N-(2-bromo-6-fluoro-3-methylbenzoyl)-, in 1 page.;;CAS Registry No. 2026817-08-1, Entered STN: Nov. 8, 2016; D-Leucine, N-[[3-(3-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Registry No. 2026863-64-7, Entered STN: Nov. 8, 2016; L-Norleucine, N-[[4-(5-chloro-2-thienyl)-1H-pyrrol-3-yl]carbonyl]-, 1 page.;;CAS Registry No. 2026895-95-2, Entered STN:Nov. 8, 2016; L-Norleucine, N-[[3-(5-chloro-2-thienyl)-1H-pyrazol-4-yl]carbonyl]-, 1 page.;;CAS Registry No. 2026949-92-6; STN entry date: Nov. 8, 2016; D-Leucine, N-[(6-bromo-3,4-dihydro-3-oxo-2H-1,4-benzoxazin-7-yl)carbonyl]-, in 1 page.;;CAS Registry No. 2037707-18-7; STN entry date: Nov. 25, 2016; Alanine, 3-fluoro-N-(2-fluoro-6-methoxybenzoyl)-, in 1 page.;;CAS Registry No. 2039960-52-4, Entered STN: Nov. 28, 2016; 5-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Registry No. 2048401-56-3; STN entry date: Dec. 14, 2016; 4-Hexenoic acid, 2-[(4,5-dichloro-2-methoxybenzoyl)amino]-, in 1 page.;;CAS Registry No. 2049278-49-9, Entered STN: Dec. 15, 2016; 4-Hexenoic acid, 2-[[[1-methyl-3-(2-thienyl)-1H-pyrazol-4-yl]carbonyl]amino]-, 1 page.;;CAS Registry No. 2094410-58-7; STN entry date: May 2, 2017; Benzamide, 2-bromo-5-chloro-N-(1-cyano-2-methoxy-1-methylethyl)-3-fluoro-, in 1 page.;;CAS Registry No. 2094533-75-0; STN entry date: May 2, 2017; Benzamide, N-(2-amino-1,1-dimethyl-2-oxoethyl)-2-bromo-5-chloro-3-fluoro-, in 1 page.;;CAS Registry No. 289062-66-4; STN entry date: Sep. 14, 2000; Acetic acid, [(2,4-dichlorobenzoyl)amino](phenylthio)-, in 1 page.;;CAS Registry No. 566157-42-4; STN entry date: Aug. 14, 2003; Alanine, N-[(9,10-dihydro-9-oxo-3-acridinyl)carbonyl]-2-methyl-, in 1 page.;;CAS Registry No. 1422551-25-4, N-[(1S)-2-amino-1-(1H-imidazol-5-ylmethyl)-2-oxoethyl]-3-(3-fluorophenyl)-1H-Pyrazole-4-carboxamide, Entered STN Mar. 7, 2013.;;Chatterjee et al., 1999, P2-achiral, P′-extended alpha-ketoamide inhibitors of calpain I. Bioorg Med Chern Lett. 9(16):2371-2374.;;Chen et al., 2012, New Tripeptide-Based Macrocyclic Calpain Inhibitors Formed by N-Alkylation of Histidine, Chem Biodiver. 9(11):2473-2484.;;Chubanov et al., Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium- dependent activity of the kinase-coupled cation channel TRPM7., (2012) Br J Pharmacol, 166(4), 1357-1376.;;Clackson et al., Making antibody fragments using phage display libraries. (1991) Nature, 352:624-628.;;Coburn et al., Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference., (2002) J. Virol., 76, 9225-9231.;;Cohen et al., Molecular Modeling Software and Methods for Medicinal Chemistry, (1990) Journal of Medicinal Chemistry, 33(3), 883-894.;;Cohrt A. Emil. 2014, Solid-phase synthesis of peptide thioureas and thiazole-containing macrocycles through Ru-catalyzed ring-closing metathesis, ACS Comb Sci. 16(2):71-77 and Supporting Information in 55 pages.;;Connolly M.L., Solvent-Accessible Surfaces of Proteins and Nucleic Acids., (1983) Science, 221(4612), 709-713.;;Cwirla et al., Peptides on phage: a vast library of peptides for identifying ligands., (1990) Proc. Natl. Acad. Sci. USA, 87, 6378.;;Damalanka et al., 2016, Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease, J Med Chem. 59(5):1899-1913.;;Davis et al., The Crystal Structures of Human Calpains 1 and 9 Imply Diverse Mechanisms of Action and Auto inhibition., (2007) J. Mol. Biol., 366, 216-229.;;De Maria et al., Calpain Expression and Activity during Lens Fiber Cell Differentiation., (2009) J. Biol. Chem., 284 (20), 13542-50.;;Donald et al., 1991, C10 N-Acyl Modified FK-506: A Possible Hybrid Analogue of the Transition State of Peptidyl-Prolyl Cis-Trans Isomerization, Tetrahedron Lett., 32(10):1375-1378.;;Dourdin et al., 2001, Reduced Cell Migration and Disruption of the Actin Cytoskeleton in Calpain-deficient embryonic Fibroblasts, J Biol Chem. 276(51):48382-48388.;;Dunbrack et al., Meeting review: the Second Meeting on the Critical Assessment of Techniques for Protein Structure Prediction (CASP2), Asilomar, California, Dec. 13-16, 1996., (1997) Folding and Design, 2, R27; 16 pages.;;Egholm et al., PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules., (1993) Nature, 365(6446), 566-568.;;Friedman et al., Therapy for fibrotic diseases: nearing the starting line., (2013) Sci. Transi. Med., 5(167), 167-17 pages.;;Gardiner et al., 2006, Ring closing metathesis of a- and b-amino acid derived dienes, J Organomet Chem. 691:5487-5496.;;Geysen et al., Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein., (1985) Proc. Natl. Acad. Sci. USA, 82(1), 178-182.;;Geysen et al., Strategies for epitope analysis using peptide synthesis., (1987) Journal of Immunological Methods., 102(2), 259-274.;;Geysen et al., Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid., (1984) Proc. Natl. Acad. Sci. USA, 81, 3998-4002.;;Goll et al., 2003, The Calpain System, Physiol Rev. 83(3):731-801.;;Gooch et al., Invovlement of calcineurin in transforming growth factor-beta-mediated regulation of extracellular maxtrix accumulation., (2004) J. Biol Chem., 279(15), 15561-70.;;Goodford P.J., A computational procedure for determining energetically favorable binding sites on biologically important macromolecules., (1985) J. Med. Chem, 28, 849-857.;;Goodsell et al., Automated docking of substrates to proteins by simulated annealing., (1990) Protein., 8(3): 195-202.;;Gopalsamy et al., 2004, Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. Bioorg Med Chem Lett. 14(16):4221-4224.;;Halland et al., 2014, Small Macrocycles As Highly Active Integrin α2β1 Antagonists, ACS Med Chem Lett. 5(2):193-198.;;Hata et al., Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense., (2010) PloS Genet., 6(7), e1001040 in 14 pages.;;Hyrup et al., Peptide nucleic acids (PNA): synthesis, properties and potential applications., (1996) Bioorg Med Chem., 4(1), 5-23.;;Iwano et al., Evidence that fibroblasts derive from epithelium during tissue fibrosis., (2002) J Chit Invest., 110(3): 341-350.;;Janda et al., Ras and TGF-beta cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways., (2002) J. Cell Biol, 156, 299-313.;;Jánossy et al., 2004, Calpain as a multi-site regulator of cell cycle, Biochem Pharmacol. 67(8):1513-1521.;;Jones et al. Improved methods for building protein models in electron density maps and the location of errors in these models., (1991) Acta Cryst., A47, 110-119.;;Jones et al., 2009, Efficient Large-Scale Synthesis of CAT811, a Potent Calpain Inhibitor of Interest in the Treatment of Cataracts, Aust J Chem. 62:671-675.;;Jones et al., 2013, A Template-Based Approach to Inhibitors of Calpain 2, 20S Proteasome, and HIV-1 Protease, Chem Med Chem. 8(12):1918-1921.;;Jones et al., 2014, The Preparation of Macrocyclic Calpain Inhibitors by Ring Closing Metathesis and Cross Metathesis, Aust J. Chem. 67(8-9):1257-1263.;;Kalluri et al., Epithelial-mesenchymal transition and its implications for fibrosis., (2003) J Clin Invest, 112(12), 1776-1784.;;Kang, et al., Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries., (1991) Proc. Natl. Acad. Sci. USA, 88, 11120-11123.;;Kiemer, et al., Identification of genes involved in epithelial-mesenchymal transition and tumor progression., (2001) Oncogene, 20, 6679-6688.;;Kim et al., 2011, Synthesis of chromone carboxamide derivatives with antioxidative and calpain inhibitory properties, Eur J Med Chem. 46(5):1721-1728.;;Kim et al., 2015, Discovery and structure-activity relationships of pyrazolodiazepine derivatives as the first small molecule agonists of the Drosophila sex peptide receptor, Bioorg Med Chem. 23:1808-1816.;;Kim et al., Targeting Calpains: a Therapeutic Strategy for the Treatment of TGFbeta Mediated Mesenchymal Transition and Associated Pathologies., (2014) 64th Annual Meeting of the American Society of Human Genetics; Oct. 8-22, 2014 San Diego, CA; Abstract in 1 pages.;;Kling et al., 2017, Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides, J Med Chem. 60:7123-7138.;;Kling et al., 2018, Mitigating the Metabolic Liability of Carbonyl Reduction: Novel Calpain Inhibitors with P1′ Extension, ACS Med Chem Lett. 9(3):221-226.;;Kraulis, Molscript: a program to produce both detailed and schematic plots of protein structures., (1991) J Appl Cryst., 24, 946-950.;;Kuntz et al., A geometric approach to macromolecule-ligand interactions., (1982) J. Mol. Biol., 161, 269-288.;;Kuntz I.D., Structure-Based Strategies for Drug Design and Discovery, (1992) Science 257:1078-1082.;;Lamouille et al., 2014, Molecular mechanisms of epithelial-mesenchymal transition, Nat Rev Mol Cell Biol. 15(3):178-196 in 46 pages.;;Leask et al., TGF-beta signaling and the fibrotic response., (2004) FASEB J., 18(7), 816-827.;;LeBleu et al., Origin and function of myofibroblasts in kidney fibrosis., (2013) Nat Med, 19(8), 1047-1053.;;Lee et al., 2005, Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 15(11):2857-2860.;;Lee et al., Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease., (2014) Am J Physiol Lung Cell Mol Physiol, 306(8), L736-748.;;Lee et al., Molecular Cloning and Characterization of a Novel Tissue-Specific Calpain Predominantly Expressed in the Digestive Tract., (1998) Biol Chem., 379(2), 175-183.;;Leloup et al., 2006, Involvement of calpains in growth factor-mediated migration, Int J Biochem Cell Biol. 38(12):2049-2063.;;Li et al., 1996, Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases, J Med Chem. 39(20):4089-4098.;;Li et al., 2015, Synthesis and Cytotoxic Activities of Novel Amino Acid-Conjugates of Pyrrole Derivatives. Youji Huaxue. 35:167-174.;;Li et al., Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice., (2006) Biochem Biophys Res Commun., 344(3): 701-707.;;Low et al., 2016, Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics, J Med Chem. 59(11):5403-5415.;;Lowman et al., Selecting high-affinity binding proteins by monovalent phage display., (1991) Biochemistry, 30(45): 10832-10838.;;Lubisch et al., 2002, Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors, Bioorg Med Chem Lett., 12(10):1335-1338.;;Lubisch et al., 2003, Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability, J Med Chem. 46(12):2404-2412.;;Ma et al., Expression of calpain small subunit 2 in mammalian tissues., (2004) Curr Eye Res., 29(4-5), 337-347.;;Mag et al., Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5′-phosphorothioate linkage., (1991) Nucleic Acids Res., 19(7): 1437-1441.;;Mandadapu et al., 2013, Macrocyclic Inhibitors of 3C and 3C-like Proteases of Picornavirus, Norovirus, and Coronavirus, Bioorg Med Chem Lett. 23(13):3709-3712.;;Mani et al., The epithelia-mesenchymal transition generates cells with properties of stem cells., (2008) Cell, 122(4), 704-715.;;Marks et al., By-passing immunization. Human antibodies from V-gene libraries displayed on phage., (1991), J Mol Biol., 222, 581-597.;;McKay et al., Characterization of a Potent and Specific Class of Antisense Oligonucleotide Inhibitor of Human Protein Kinase C-α Expression., (1999) Biol. Chem., 274(3): 1715-1722.;;Miettinen et al., 1994, TGF-β Induced Transdifferentiation of Mammary Epithelial Cells to Mesenchymal Cells: Involvement of Type I Receptors, j Cell Biol. 127(6 Pt 2):2021-2036.;;Miranker et al., Functionality maps of binding sites: a multiple copy simultaneous search method., (1991) Proteins. 11(1): 29-34.;;Miyazono K., Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer., (2009) Proc Jpn Acad Ser. B. Phys. Bio. Sci., 85(8), 314-323.;;Morton et al., 2013, A Macrocyclic Calpain Inhibitor Slows the Development of Inherited Cortical Cataracts in a Sheep Model, Invest Ophthal Visual Science. 54(1):389-395.;;Muniappan et al., 2017, Calpain Inhibition Attenuates Adipose Tissue Inflammation and Fibrosis in Diet-induced Obese Mice, Sci Rep. 7:14398.;;Nam et al., 2008, Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors, Bioorg Med Chem Lett., 18(1):205-209.;;Navia et al., Use of structural information in drug design., (1992) Current Opinion in Structural Biology, 2(2): 202-210.;;Nema et al., 2011, Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions, PDA J Pharm Sci Technol. 65(3):287-332.;;Nielsen, P.E., Peptide nucleic acid (PNA): A model structure for the primordial genetic material?, (1993) Origins of life and evolution of biospheres, 23(5), 323-327.;;Nieto M.A., The snail superfamily of zinc-finger transcription factors., (2002) Nat Rev Mol Cell Biol., 3, 155-166.;;Nimmrich et al., 2008, Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction, J Pharmacol Exp Ther. 327(2):343-352.;;Nishibata et al., Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation., (1991) Tetrahedron, 47(43), 8985-8990.;;Oh et al., 2007, Thalassospiramides A and B, Immunosuppressive Peptides from the Marine Bacterium Thalassospirasp., Org Ltts. 9(8):1525-1528.;;Pegorier et al., 2010, Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-β1 in normal human lung fibroblasts (NHLF), Respir Res. 11:85 in 11 pages.;;Pehere et al., 2012, New 3-Strand Templates Constrained by Huisgen Cycloaddition, Org Lett. 14(5):1330-1333.;;Pehere et al., 2013, New cylindrical peptide assemblies defined by extended parallel β-sheets, Org Biomol Chem. 11(3):425-429.;;Pehere et al., 2013, Synthesis and Extended Activity of Triazole-Containing Macrocyclic Protease Inhibitors, Chem Eur J. 19:7975-7981.;;Peng et al., Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: A model for “active” disease., (2013) PLOS One, 8(4), e59348; 15 pages.;;Piccirillo et al., TGF-β1 Somatic Gene Therapy Prevents Autoimmune Disease in Nonobese Diabetic Mice., (1998) J Immunol., 161 (8): 3950-3956.;;Piera-Velazquez et al., Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. (2011), Am J Pathol., 179(3), 1074-1080.;;Powell et al., 1998, Compendium of Excipients for Parenteral Formulations, pDA; J Pharm Sci Technol. 52(5):238-311.;;Ravulapalli et al., 2009, Distinguishing between calpain heterodimerization and homodimerization, FEBS J. 276(4):973-982.;;Rotstein et al., 2014, Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics, Nature Comm. 5:4365-4371.;;Rotstein et al., 2016, Mechanistic Studies and Radiofluorination of Structurally Diverse Pharmaceuticals with Spirocyclic lodonium(III) Ylides, Chem Sci. 7(7):4407-4417.;;Santos et al., 2012, Distinct Regulatory Functions of Calpain 1 and 2 during Neural Stem Cell Self-Renewal and Differentiation, PLoS One 7(3):e33468 in 12 pages.;;Sasmal et al., 2011, Structure-activity relationship studies of novel pyrazole and imidazole carboxamides as cannabinoid-1 (CB1) antagonists. Bioorg Med Chem Lett. 21 (16):4913-4918.;;Savary et al., Role of TGF-β signaling in EMT, cancer progression and metastasis., (2011) Drug Discovery Today: Disease Models, 8(2-3), 121-126.;;Schád et al., 2002, A novel human small subunit of calpains, Biochem J 342(Pt 2):383-388.;;Schoofs et al., Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution., (1988) J Immunol., 140(2): 611-616; Abstract in 1 page.;;Singh et al., 2015, Identification of amino acid appended acridines as potential leads to anti-cancer drugs. Bioorg Med Chem Lett. 25(18):3854-3858.;;Singh et al., EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer., (2010) Oncogene, 29(34), 4741-4751.;;Skogh et al., 2013, Aminocarbonylation of 4-lodo-1H-imidazoles with an Amino Acid Amide Nucleophile: Synthesis of Constrained H-Phe-Phe-NH2 Analogues. J Org Chem. 78(23):12251-12256.;;Smith G.P., Surface presentation of protein epitopes using bacteriophage expression systems., (1991) Current Opin Blotechnol., 2, 668-673.;;Stewart et al., Lentivirus-delivered stable gene silencing by RNAi in primary cells., (2003) RNA, 9, 493-501.;;Stoermer et al., 2009, Base-Sensitivity of Arginine Alpha-Ketoamide Inhibitors of Serine Proteases, Aust J Chem. 62(9):988-992.;;Strutz et al., Identification and characterization of a fibroblast marker: FSP1., (1995) J Cell Biol, 130(2): 393-405.;;Stuart et al., 2011, Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis, J Med Chem. 54(21):7503-7522.;;Summerton J., Morpholino antisense oligomers: the case for an RNase H-independent structural type., (1999) Biochim Biophys Acta., 1489, 141-158.;;Suzuki et al., Structure, activity, and biology of calpain., (2004) Diabetes, 53(Suppl 1): S12-S18.;;Tojo et al., The ALK-5 Inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. (2005) Cancer Sci, 96(11), 791-800.;;Vengeliene et al., 2016, The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile, Neuropsychopharmacology. 41(4):979-988 [online published Jul. 28, 2015].;;Verlinde et al., Structure-based drug design: progress, results and challenges., (1994) Structure, 2, 577-587.;;Von Dobeneck et al., 1976, Diaminopyrrolinone, Liebigs Ann Chem., 3:476-486.;;Wahlestedt et al., Potent and nontoxic antisense oligonucleotides containing locked nucleic acids., (2000) PNAS USA, 97(10): 5633-5638.;;Walker et al., 2001, General method for the synthesis of cyclic peptidomimetic compounds, Tetrahed Letts. 42(34):5801-5804.;;Wang et al., Synthesis and Biological Activity of 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier. J Med Chem. (2012) 55(4): 1758-1770.;;Weiner et al., A new force field for molecular mechanical simulation of nucleic acids and proteins., (1984) J Am Chem Soc. 106, 765-784.;;Wells et al., 2001, 1,2-Benzothiazine 1,1-Dioxide P2-P3 Peptide Mimetic Aldehyde Calpain I Inhibitors, J Med Chem. 44:3488-3503.;;Willis et al., TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease., (2007) Amer J Physiol Lung Cell Mol Physiol, 293(3): L525-L534.;;Woon et al., 2011, Structure guided development of potent reversibly binding penicillin binding protein inhibitors, ACS Med Chem Lett., 2(3):219-223 and Supporting Information, S1-S46.;;Wu et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. (2004), J Biol Chem. 279(6), 4929-4940.;;Wu et al., Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an a-smooth muscle actin-Cre transgenic mouse., (2007) Respir Res., 8(1), 1; 11 pages.;;Wynn T., Cellular and molecular mechanisms of fibrosis., (2008) J Pathol., 214(2): 199-210.;;Xue et al., The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis., (2003) Cancer Res., 63, 3386-3394.;;Yang et al., Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis., (2001) Am J Pathol., 159(4): 1465-1475.;;Yoshikawa et al., Isolation of Two Novel Genes, Down-regulated in Gastric Cancer., (2000) Jpn J Cancer Res., 91(5), 459-463.;;Young et al., 2010, Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon, J Biol Chem. 285(15):11039-11044.;;Zeisberg et al., Renal Fibrosis: Collagen Composition and Assembly Regulates Epithelial-Mesenchymal Transdifferentiation., (2001) Am J Pathol., 159(4): 1313-1321.;;Zhong et al., 2005, 3-(2-Chlorophenyl)-N-(2-cyano-4-methyl-2-pentyl)-5-methylisoxazole-4-carboxamide. Acta Cryst. Section E. E61 :o2621-o2622 in 7 pages.;;Zimmerman et al., The calpain small subunit gene is essential: its inactivation results in embryonic lethality. (2000) IUBMB Life, 50(1), 63-68.;;International Search Report and Written Opinion dated Jan. 2, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Written Opinion (Rule 66) dated Aug. 28, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Written Opinion (Rule 66) dated Dec. 6, 2018 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;International Preliminary Report on Patentability dated Jan. 22, 2019 for Application No. PCT/US2017/053629, filed Sep. 27, 2017.;;Partial Supplementary European Search Report dated Aug. 13, 2020 for Application No. 17857308.5, filed Apr. 26, 2019.;;Bogen et al., Toward the Back-Up of Boceprevir (SCH 503034): Discovery of New Extended P4-Capped Ketoamide Inhibitors of Hepatitis C virus NS3 Serine Protease with Improved Potency and Pharmacokinetic Profiles. J Med Chem. (2009) 52(12): 3679-3688.;;Celatka et al., 2002, Asymmetric synthesis of a C1-C19 fragment of Ulapualide A. Tetrahed Lttrs. 43(39): 7043-7046.;;Gafni et al., “Calpain Activation in Huntington's Desearse”. J Neuroscience (2002) 22(12): 4842-4849.;;Jansen et al., 1961. Some 4-Substituted Oxazoles. J Chem Society pp. 405-411. (see Reaxys-Abs).;;REAXYS Database, 2002, Database Accession No. 9305036, Elsevier Life Sciences IP Limited, 1 page.;;REAXYS Database, 1961, Database Accession No. 849427, Elsevier Life Sciences IP Limited, 2 page.;;Yildiz-Unal et al., “Neuroprotective Strategies Against Calpain-Mediated Neurodegernation”. Neuropsychiatr Dis Treat. (2015) 11:297-310.;;Extended European Search Report dated Dec. 14, 2020 for Application No. 17857308.5, filed Apr. 26, 2019.;;New Zealand Examination Report dated Dec. 2, 2020 for Application No. 752865, filed Apr. 24, 2019.;;India Examination Report dated Dec. 29, 2020 for Application No. 201917016742, filed Apr. 26, 2019.;;Russian Office Action dated Jan. 28, 2021 for Application No. 2019110034, filed Apr. 4, 2019.;;Brouillette et al., Valuable Versatile Reactivity of Thiaaisatoic Anhydrides: Expedient Solid-Phase Synthesis of Thieno [1,4]diazepine-2,5-diones, Synlett (2008) 15:2360-2364.;;CAS Registry No. 1980787-62-9/-71-0/-72-1; “D-Glucose”, Entered STN Aug. 26, 2016 in 3 pages.;;CAS Registry No. 247061-69-4; “Benzamide”, Entered STN Nov. 11, 1999 in 1 page.",ACTIVE
513,CA,A1,CA 3038331 A1,004-873-211-480-103,2018-04-05,2018,CA 3038331 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG,,https://lens.org/004-873-211-480-103,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
514,CO,A2,CO 2019004113 A2,058-736-889-501-383,2019-05-31,2019,CO 2019004113 A,2019-04-25,US 2017/0053629 W;;US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,Moduladores de calpaínas y usos terapeuticos de los mismos.,"Se revelan en la presente composiciones moduladoras de calpaína de molécula pequeña, composiciones farmacéuticas, su uso y preparación.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,,https://lens.org/058-736-889-501-383,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D231/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D401/04;;C07D401/14;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
515,CA,A1,CA 2591164 A1,111-148-375-130-30X,2006-07-13,2006,CA 2591164 A,2005-12-13,US 64234005 P;;US 5149905 A;;US 2005/0045040 W,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,,APPLE COMPUTER,FADELL ANTHONY M;;DOROGUSKER JESSE L;;RUBINSTEIN JONATHAN JAKE;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/111-148-375-130-30X,Patent Application,no,0,2,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,ACTIVE
516,US,A1,US 2016/0110536 A1,105-951-421-571-313,2016-04-21,2016,US 201514979456 A,2015-12-27,US 201514979456 A;;US 201414312672 A;;US 32836808 A;;US 5149905 A;;US 64234005 P;;US 5144105 A;;US 64227605 P;;US 64233405 P;;US 3154705 A;;US 3128805 A;;US 22046305 F;;US 22089205 F,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE LEE;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/105-951-421-571-313,Patent Application,yes,5,4,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G10L19/00,,0,0,,,,ACTIVE
517,BR,A2,BR 112019006110 A2,019-268-633-533-833,2019-09-10,2019,BR 112019006110 A,2017-09-27,US 2017/0053629 W;;US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,moduladores de calpaína e usos terapêuticos dos mesmos,"são descritas aqui composições moduladoras de calpaína de molécula pequena, composições farmacêuticas, o uso e preparação das mesmas.",BLADE THERAPEUTICS INC,BRAD OWEN BUCKMAN;;JINGYUAN MA;;JOHN BEAMOND NICHOLAS;;KUMARASWAMY EMAYAN;;MARC ADLER;;SHENDONG YUAN,,https://lens.org/019-268-633-533-833,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,A61K31/44;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
518,AU,B4,AU 2009/100547 B4,062-333-850-327-507,2010-03-18,2010,AU 2009/100547 A,2009-06-05,AU 2008/101150 A;;AU 2009/100547 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;DOROGUSKER JESSE L;;ARCHIBALD JOHN WESLEY;;RUBINSTEIN JONATHAN JAKE;;ADLER MITCHELL,,https://lens.org/062-333-850-327-507,Limited Patent,no,2,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
519,EP,A1,EP 1834273 A1,097-099-687-410-710,2007-09-19,2007,EP 05853866 A,2005-12-13,US 2005/0045040 W;;US 64234005 P;;US 5149905 A,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/097-099-687-410-710,Patent Application,yes,0,3,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G10L19/00,,0,0,,,,ACTIVE
520,US,A1,US 2011/0061113 A1,172-965-715-143-274,2011-03-10,2011,US 89567510 A,2010-09-30,US 89567510 A;;US 5149905 A;;US 64234005 P,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/172-965-715-143-274,Patent Application,yes,101,20,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/00;;G10L19/00,726/34,0,0,,,,ACTIVE
521,CN,A,CN 110023304 A,073-706-064-487-595,2019-07-16,2019,CN 201780073419 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,,https://lens.org/073-706-064-487-595,Patent Application,no,3,5,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,DISCONTINUED
522,SG,A,SG 11201604892Y A,007-784-373-648-911,2016-07-28,2016,SG 11201604892Y A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,,ALK ABELLÓ AS;;JOLLA INST ALLERGY IMMUNOLOG,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WÜRTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE,,https://lens.org/007-784-373-648-911,Unknown,no,0,0,15,15,0,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/35;;C07K14/435,,0,0,,,,PENDING
523,JP,A,JP 2010183571 A,015-144-643-189-394,2010-08-19,2010,JP 2010011810 A,2010-01-22,US 64234005 P;;US 5149905 A,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICE,"<P>PROBLEM TO BE SOLVED: To provide improved techniques to control utilization of accessory devices with electronic devices by using cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. <P>SOLUTION: By authenticating encrypted authentication information, different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a music player, that can present (e.g., play) media items (or media assets). <P>COPYRIGHT: (C)2010,JPO&INPIT",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/015-144-643-189-394,Patent Application,no,22,5,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,H04L9/32;;G06F13/38;;G06F21/20;;G09C1/00;;G10L19/00;;G11B20/10,,2,0,,,"JPN6013036860; 梅田 勝司 他: 図解でわかる音楽配信ビジネス 初版, 20001001, ｐ．１７８〜１８７, 日本能率協会マネジメントセンター;;CSNB200100292001; 梅田 勝司 他: 図解でわかる音楽配信ビジネス 初版, 20001001, ｐ．１７８〜１８７, 日本能率協会マネジメントセンター",PENDING
524,WO,A1,WO 2018/009417 A1,055-348-825-859-198,2018-01-11,2018,US 2017/0040109 W,2017-06-29,US 201662358504 P,2016-07-05,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to macrocyclic α-keto amide derivatives and their use as therapeutic agents.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC;;NICHOLAS JOHN BEAMOND,,https://lens.org/055-348-825-859-198,Patent Application,yes,6,2,6,6,0,C07D225/06;;C07D413/12;;C07D471/04;;C07D471/14;;C07D273/01;;C07D498/04;;C07D498/14;;A61P35/00;;A61P17/00;;C07D498/06;;A61P1/16;;A61P13/12;;A61P11/00;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04;;C07D498/18,C07D498/14;;A61K31/395;;A61K31/404;;A61K31/4164;;A61K31/435;;A61P17/00;;A61P35/00;;C07D225/06;;C07D267/00;;C07D273/01;;C07D413/12;;C07D471/04;;C07D471/14;;C07D498/04,,24,11,078-382-889-771-789;;005-582-329-281-579;;039-317-916-201-269;;002-499-291-773-300;;021-351-603-362-809;;031-266-058-151-075;;052-664-611-823-937;;036-393-576-918-372;;021-567-898-232-851;;010-725-579-810-871;;181-131-749-980-332,27148623;;10.1021/acs.jmedchem.6b00267;;10.1002/anie.200805014;;19145612;;10.1021/jm010178b;;11585453;;21955158;;10.1021/jm200471r;;24900800;;10.1021/ml4004556;;pmc4027761;;10.1201/b15115-23;;9846074;;10.5731/pdajpst.2011.00634;;22293237;;10.1083/jcb.127.6.2021;;7806579;;pmc2120317;;pmc4240281;;24556840;;10.1038/nrm3758;;10.1186/1465-9921-11-85;;20573231;;pmc2898775,"LOW K.E. ET AL.: ""Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics"", J. MED. CHEM., vol. 59, no. 11, 2016, pages 5403 - 5415, XP055452019;;ABELL A.D. ET AL.: ""Molecular Modeling, Synthesis, and Biological Evaluation of Macrocyclic Calpain Inhibitors"", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 48, no. 8, 2009, pages 1455 - 1458, XP055415505;;WELLS G.J. ET AL.: ""1,2-Benzothiazine 1,1-dioxide P2-P3 peptide mimetic aldehyde calpain I inhibitors"", J. MED. CHEM., vol. 44, no. 21, 2001, pages 3488 - 3503, XP055452021;;STUART B.G. ET AL.: ""Molecular Modeling: A Search for a Calpain Inhibitor as a New Treatment for Cataractogenesis"", J. MED. CHEM., vol. 54, no. 21, 2011, pages 7503 - 7522, XP055261342;;HALLAND, N. ET AL.: ""Small Macrocycles As Highly Active Integrin alpha2beta1 Antagonists"", ACS MED. CHEM. LETT., vol. 5, no. 2, 2014, pages 193 - 198, XP055452023;;""Design of Prodrugs,"", 1985, ELSEVIER;;T. HIGUCHIV. STELLA: ""A.C.S. Symposium Series"", vol. 14, 1975, AMERICAN CHEMICAL SOCIETY, article ""Pro-drugs as Novel Delivery Systems"";;""Bioreversible Carriers in Drug Design: Theory and Application"", 1987, PERGAMON PRESS, pages: 14 - 21;;""Protective Groups in Organic Chemistry"", 1973, PLENUM PRESS;;P.G.M. GREENT.W. WUTTS: ""Protecting Groups in Organic Synthesis"", 2007, JOHN WILEY & SONS;;LIEBERMAN ET AL., PHARMACEUTICAL DOSAGE FORMS: TABLETS, vol. 1-5, 1989;;""Encyclopedia of Reagents for Organic Synthesis"", 1995, JOHN WILEY AND SONS;;FIESER: ""Fieser's Reagents for Organic Synthesis"", vol. 1-40, 1991, JOHN WILEY, AND SONS;;""March's Advanced Organic Chemistry"", 2001, JOHN WILEY, AND SONS;;""Remington's The Science and Practice of Pharmacy"", 2005, LIPPINCOTT WILLIAMS & WILKINS;;""Modern Pharmaceutics"", 2002;;ANSEL, INTRODUCTION TO PHARMACEUTICAL DOSAGE FORMS, 2004;;POWELL ET AL.: ""Compendium of Excipients for Parenteral Formulations"", PDA J PHARM SCI AND TECH, vol. 52, 1998, pages 238 - 311, XP009119027;;NEMA ET AL.: ""Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions"", PDA J PHARM SCI AND TECH, vol. 65, 2011, pages 287 - 332, XP009166667, DOI: 10.5731/pdajpst.2011.00634;;CAREYSUNDBERG: ""Advanced Organic Chemistry and the like"", WILEY, article ""March Advanced Organic Chemistry"";;MIETTINEN ET AL.: ""TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors"", J CELL BIOL, vol. 127, no. 6, 1994, pages 2021 - 36, XP000651428, DOI: 10.1083/jcb.127.6.2021;;LAMOUILLE ET AL.: ""Molecular mechanisms of epithelial-mesenchymal transition"", NAT REV MOL CELL BIOL, vol. 15, no. 3, 2014, pages 178 - 96, XP055234947, DOI: 10.1038/nrm3758;;PEGORIER ET AL.: ""Bone Morphogenetic Protein (BMP)-4 and BMP-7 regulate differentially Transforming Growth Factor (TGF)-B 1 in normal human lung fibroblasts (NHLF"", RESPIR RES, vol. 11, 2010, pages 85;;See also references of EP 3481835A4",PENDING
525,EC,A,EC SP19029982 A,065-687-213-234-305,2019-06-30,2019,EC DI201929982 A,2019-04-26,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,MODULADORES DE CALPAÍNAS Y USOS TERAPEUTICOS DE LOS MISMOS,"Se revelan en la presente composiciones moduladoras de calpaína de molécula pequeña, composiciones farmacéuticas, su uso y preparación.",BLADE THERAPEUTICS INC,YUAN SHENDONG;;MA JINGYUANG;;ADLER MARC;;EMAYAN KUMARASWAMY;;NICHOLAS JOHN BEAMOND;;BUCKMAN BRAD OWEN,,https://lens.org/065-687-213-234-305,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
526,CL,A1,CL 2019000793 A1,092-149-124-492-864,2019-08-02,2019,CL 2019000793 A,2019-03-26,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,Moduladores de calpaínas y usos terapéuticos de los mismos.,"SE REVELAN EN LA PRESENTE COMPOSICIONES MODULADORAS DE CALPAÍNA DE MOLÉCULA PEQUEÑA, COMPOSICIONES FARMACÉUTICAS, SU USO Y PREPARACIÓN.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG,,https://lens.org/092-149-124-492-864,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D403/14;;C07D405/04,,0,0,,,,PENDING
527,US,A,US 5325690 A,099-317-507-932-323,1994-07-05,1994,US 80955492 A,1992-02-24,US 80955492 A;;AU 1989/040497 A;;CA 606464 A;;US 8903196 W;;US 9909987 A,1987-09-21,Lock adjustable to operate with different keys,"A lock which is rekeyable or programmable to operate with a different key from the exterior thereof without disassembling it or removing it from a lock assembly in which it is assembled is disclosed. The lock may be rekeyed through the keyway so that the lock appears from the exterior thereof to be a conventional lock, or from the end opposite the keyway from the interior of a door, or from a side of the lock which requires disassembly of the lock from its lock assembly. The lock includes structure defining a movable shear line that can be adjusted from the exterior of the lock without disassembling the lock itself. Such structure may comprise a rotatable cam and a pin tumbler and an axially adjustable set screw. Security of the lock is improved by selectively restricting or blocking access to the rekeying of the lock in the interior thereof with a gate or shutter, or various combinations of gates or shutters.",ADLER RICHARD S,ADLER RICHARD S;;MORRIS PAUL F;;KIRK KARL D;;MILICH JOHN;;PERICHON GERARD M,ADLER RICHARD S (1992-10-28);;ADLER RICHARD STEVEN (1992-03-17),https://lens.org/099-317-507-932-323,Granted Patent,yes,8,81,2,5,0,E05B27/005;;Y10T70/7734;;Y10T70/7672;;Y10T70/7684;;Y10T70/7734;;Y10T70/7672;;Y10T70/7684;;E05B27/005,E05B27/00;;E05B27/04,70/383;;70/373;;70/375,0,0,,,,EXPIRED
528,KR,A,KR 20070104393 A,157-001-933-311-440,2007-10-25,2007,KR 20077018101 A,2007-08-06,US 5149905 A;;US 64234005 P,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/157-001-933-311-440,Patent Application,no,0,4,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G10L19/00;;H04L9/32,,0,0,,,,DISCONTINUED
529,AU,A1,AU 2005/323229 A1,189-363-496-006-569,2006-07-13,2006,AU 2005/323229 A,2005-12-13,US 5149905 A;;US 64234005 P;;US 2005/0045040 W,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,ARCHIBALD JOHN WESLEY;;DOROGUSKER JESSE L;;ADLER MITCHELL;;RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M,,https://lens.org/189-363-496-006-569,Patent Application,no,0,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,ACTIVE
530,US,B2,US 8161567 B2,058-295-969-394-206,2012-04-17,2012,US 89567510 A,2010-09-30,US 89567510 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY;;APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/058-295-969-394-206,Granted Patent,yes,102,22,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G08B29/00;;G10L19/00,726/34,44,2,035-928-800-870-660;;030-389-189-134-332,10.1109/2.730740;;10.1109/hicss.2007.300,"Anonymous, ""Future of Digital Music in Windows,"" Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001[Online], [retrieved on Jan. 15, 2008]. (3 pages).;;Anonymous, ""Introduction to Digital Audio,"" Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved on Jan. 15, 2008]. (2 pages).;;Anonymous, ""Windows and Red Book Audio,"" Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved Jan. 15, 2008]. (2 pages).;;""A Serial Bus on Speed Diagram: Getting Connected with FireWire,"" downloaded Oct. 16, 2001, PC Magazine: PC Tech (A Serial Bus on Speed) wysiwyg://51http://www.zdnet.com/pctech/content/18/10/tu1810.007.html p. 7.(2 pages).;;Belkin iPod Voice Recorder, Product Specification Sheet, printed Jun. 16, 2004. (2 pages).;;Bindra, ""Standard Turns Monitor into I/O Hub,"" Electronic Engineering Times, vol. 918, Sep. 6, 1996, p. 14 (1 page).;;Brentrup, ""Introduction to Public Key Cryptography Demystified,"" Campus Technology, printed from http://www.campus-technology.com/article.asp?id=7626 on Oct. 6, 2004. (5 pages).;;Brown, ""Making USB Work,"" downloaded Oct. 16, 2001, PC Magazine: PC Tech wysiwyg:/155/http://www.zdnet.com/pcmag/pctech/content!18/04/tu1804.001.html (2 pages).;;""Cables to Go,"" download Oct. 16, 2001 http://www.cablestogo.com/product.asp?cat%5Fid=601&sku=27028 (1 page).;;Chen et al., ""Design and Implemeation of a Hard Disk-Based Entertainment Device for Managing Media Contents On the Go,"" Consumer Electonics, 1005. (ISCE 2005). Proceedings of the Ninth International Symposium on, pp. 328-333, Jun. 14-16, 2005. (6 pages).;;Crawford et al., ""Sample rate conversion and bit rate reduction in the studio,"" IEEE Colloquium on Digital Audio Signal Processing, May 22, 1991, pp. 8/1-8/3. (3 pages).;;Derman, ""Monitors Make Net Connections,"" Electronic Engineering Times, vol. 933, 1996, pp. 60 and 69.;;""FireWire"", downloaded Oct. 16,2001; si-wyg:/-/4-2/http://developer.apple.-com/hardware/Fire-Wire (2 pages).;;""Fire Wire Connector,"" downloaded Oct. 16, 2001, wysiwyg://76/http://developer.apple.com/-...es/Macintosh-CPUs-G3/ibook/ibook-27.html. (2 pages).;;Fried, ""FireWire poised to become ubiquitous,"" downloaded Oct. 16, 2001, CNET News.com, 1394 Trade Association: Press, wysiwyg:/132/http:/-113-94ta.org/Press/200-1-Press/august!8.2-7.-b.html (5 pages).;;Fried, ""New Fire Wire to blaze faster trail,"" downloaded Oct. 16, 2001, CNET News.com, http://news.cnet.com/news/0-I006-200-6021210.html (5 pages).;;""How to Connect Your Computer PC Hardware"", downloaded Oct. 16, 2001, http:///www.scar.utoronto.ca!~ccweb/faculty/connect-howto.html (5 pages).;;""IEEE 1394/USB Comparison,"" downloaded Oct. 16, 2001, www.genitech.com.aulLIBRARY/TechSupportiinfobits/firewirevsusb.html (4 pages).;;""Introduction to Public Key Cryptography,"" Oct. 9, 1998, printed from http://developer.netscape.com/docs/manuals/security/pkin/contents.html on Oct. 6, 2004. (21 pages).;;iPod Classic User's Guide, acquired from apple.com, 2002 (44 pages).;;iPod nano Features Guide, acquired from apple.com, 2008 (72 pages).;;iPod touch User's Guide, acquired from apple.com, 2008 (120 pages).;;""iPodDock/iPod Cradle,"" www.bookendzdocks.com/bookendz/dock-cradle.html, downloaded Feb. 27, 2003 (2 pages).;;Lambert, ""Digital Audio Interfaces,"" Journal of the Audio Engineering Society, Audio Engineering Society, New York, NY, vol. 38, No. 9, (Sep. 1, 1990), pp. 681-684, 686, 688, 690, 692 and 696, XP000175146 ISSN: 1549-4950 figures 9, 10.;;Lewis, ""On Technology"" Fortune Magazine, Dec. 9, 2002, p. 240.;;LSI Logic's Broadcast PC Card Brings New Multimedia Capabilities to Personal Computing. (Nov. 16). PR Newswire, 1. Retrieved Jun. 26, 2010, from Business Dateline.;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [on line], [retrieved on Sep. 26, 2008]. Retrieved from the Internet (2 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 23, 2008]. Retrieved from the Internet . 2 pages.;;Menezes et al., ""Handbook of Applied Cryptography,"" Identification and Entity Authentication, Jan. 1, 1997, pp. 385-424. (41 pages).;;Microsoft, ""Media Transport Protocol Implementation Details,"" 2005 (18 pages).;;""MPV(TM) Music Profile Specification Revision 1.00"" Internet Citation [online] (Jan. 7, 2004) URL:http//www.osta.org/mpv/public/specs/MPVMusic-Prof-Spec-1.00.pdf> [retrieved Jun. 20, 2006] the whole document (70 pages).;;""Neuros MP3 Digital Audio Computer,"" www.neurosaudio.com, downloaded Apr. 9, 2003 (6 pages).;;NOMAD II Player Version 1.0 (CLI) (User's Manual), Creative Technology, Ltd., Jan. 2000 (46 pages).;;""PMC FW2 IEEE1394 FireWire Controller"", downloaded Oct. 16, 2001, http://www.bvmltd.co.uk/PMCfw2ds.html (10 pages).;;Severance, ""FireWire Finally Comes Home,"" Michigan State University, Standards, Nov. 1998, pp. 117-118 (2 pages).;;Slay et al., ""iPod Forensics: Forencically Sound Examination of an Apple iPod,"" System Sciences, 2007. HICSS 2007. 40th Annual Hawaii Internation Conference on, pp. 1-9, Jan. 2007. (9 pages).;;Teener, ""Understanding Fire Wire: The IEEE 1394 Standards and Specifications,"" downloaded Oct. 16,2001, wysiwyg:119/http:1-Iwww.chipcenter.com/networking/ieee-1394/main.html (5 pages).;;""The Authoritative Dictionary of IEEE Standards Terms, Seventh Edition,"" Published by Standards Information Network, IEEE Press, 2000. (3 pages).;;""Universal Serial Bus Specification-Rev 2.0,"" Chapter 6: Compaq Hewlett-Packard, Apr. 27, 2000, pp. 85, 99-100.(3 pages).;;Vitaliano, ""Why FireWire is Hot!Hot!Hot!"" downloaded Oct. 16, 2001, ""Impact.FireWire.SideBar"" http://www.vxm.com/21R.35.html (4 pages).;;Whittle, ""Public Key Authentication Framework: Tutorial,"" First Principles Consulting, Jun. 2, 1996, downloaded Oct. 6, 2004, http://www.ozemail.com.au/~firstpr/crypto/pkaftute.htm, (7 pages).;;Examiners First Report of Mar. 25, 2010 for Australian Patent Application No. 2005323229.;;International Search Report mailed May 15, 2006 for PCT Application No. PCT/US05/045040.;;International Preliminary Report on Patentability with Written Opinion of Jul. 10, 2007 for PCT Application No. PCT/US05/045040.",ACTIVE
531,CA,C,CA 2591164 C,151-130-852-238-985,2017-06-13,2017,CA 2591164 A,2005-12-13,US 64234005 P;;US 5149905 A;;US 2005/0045040 W,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE COMPUTER,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/151-130-852-238-985,Granted Patent,no,0,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G06F21/82;;G10L19/00,,0,0,,,,ACTIVE
532,CL,A1,CL 2021000405 A1,190-924-453-029-00X,2021-09-10,2021,CL 2021000405 A,2021-02-16,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,Moduladores de calpaínas y usos terapeuticos de los mismos (divisional sol. 201900793),"Se revelan en la presente composiciones moduladoras de calpaína de molécula pequeña, composiciones farmacéuticas, su uso y preparación.",BLADE THERAPEUTICS INC,NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG;;BUCKMAN BRAD OWEN,,https://lens.org/190-924-453-029-00X,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
533,EP,B1,EP 1834273 B1,009-136-184-856-380,2013-07-24,2013,EP 05853866 A,2005-12-13,US 2005/0045040 W;;US 64234005 P;;US 5149905 A,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/009-136-184-856-380,Granted Patent,yes,1,1,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G10L19/00,,1,0,,,"MENEZES A ET AL: ""Handbook of Applied Cryptography , IDENTIFICATION AND ENTITY AUTHENTICATION"" HANDBOOK OF APPLIED CRYPTOGRAPHY, CRC PRESS SERIES ON DISCRETE MATHEMATICES AND ITS APPLICATIONS, BOCA RATON, FL, CRC PRESS, US, 1997, pages 385-424, XP002262234 ISBN: 0-8493-8523-7",ACTIVE
534,AU,B4,AU 2009/100749 B4,045-359-065-327-092,2010-04-01,2010,AU 2009/100749 A,2009-08-03,AU 2008/101148 A;;AU 2009/100749 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY;;DOROGUSKER JESSE L;;RUBINSTEIN JONATHAN JAKE,,https://lens.org/045-359-065-327-092,Limited Patent,no,1,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G06F21/22;;G10L19/00,,0,0,,,,INACTIVE
535,AU,A6,AU 2009/100547 A6,132-634-341-779-608,2009-09-24,2009,AU 2009/100547 A,2009-06-05,AU 2008/101150 A;;AU 2009/100547 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;DOROGUSKER JESSE L;;ARCHIBALD JOHN WESLEY;;RUBINSTEIN JONATHAN JAKE;;ADLER MITCHELL,,https://lens.org/132-634-341-779-608,Limited Patent,no,2,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
536,WO,A1,WO 2006/073702 A1,182-889-635-719-465,2006-07-13,2006,US 2005/0045040 W,2005-12-13,US 64234005 P;;US 5149905 A,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE COMPUTER;;RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/182-889-635-719-465,Patent Application,yes,2,34,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,1,0,,,"MENEZES A ET AL: ""Handbook of Applied Cryptography , IDENTIFICATION AND ENTITY AUTHENTICATION"", HANDBOOK OF APPLIED CRYPTOGRAPHY, CRC PRESS SERIES ON DISCRETE MATHEMATICES AND ITS APPLICATIONS, BOCA RATON, FL, CRC PRESS, US, 1997, pages 385 - 424, XP002262234, ISBN: 0-8493-8523-7",PENDING
537,CN,B,CN 101099157 B,176-723-199-510-069,2012-01-11,2012,CN 200580046121 A,2005-12-13,US 2005/0045040 W;;US 64234005 P;;US 5149905 A,2005-01-07,Portable electronic device accepting accessory devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,DOROGUSKER JESSE L;;FADELL ANTHONY M;;MITCHELL ADLER;;WESLEY ARCHIBALD JOHN;;JAKE RUBINSTEIN JONATHAN,,https://lens.org/176-723-199-510-069,Granted Patent,no,0,1,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,ACTIVE
538,US,A1,US 2009/0083834 A1,018-615-697-937-615,2009-03-26,2009,US 32836808 A,2008-12-04,US 32836808 A;;US 5149905 A;;US 64234005 P,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/018-615-697-937-615,Patent Application,yes,102,42,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,H04L9/32;;G10L19/00,726/2,0,0,,,,ACTIVE
539,US,A1,US 2015/0082049 A1,040-462-448-300-480,2015-03-19,2015,US 201414312672 A,2014-06-23,US 201414312672 A;;US 32836808 A;;US 5149905 A;;US 64234005 P;;US 5144105 A;;US 64227605 P;;US 64233405 P;;US 3154705 A;;US 3128805 A;;US 22046305 F;;US 22089205 F,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE LEE;;MITCHELL ADLER;;ARCHIBALD JOHN WESLEY,,https://lens.org/040-462-448-300-480,Patent Application,yes,5,12,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G06F21/60;;G10L19/00,713/189;;726/19,0,0,,,,ACTIVE
540,US,B2,US 7823214 B2,090-006-394-119-620,2010-10-26,2010,US 5149905 A,2005-02-03,US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,APPLE INC (2005-05-02),https://lens.org/090-006-394-119-620,Granted Patent,yes,116,105,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G08B29/00;;G10L19/00,726/34;;726/17;;726/21;;713/170,43,3,166-314-222-246-746;;035-928-800-870-660;;119-609-365-875-818,10.1201/9781439821916-10;;10.1109/2.730740;;10.1109/percomw.2004.1276933,"Altec Lansing, ""inMotion Users Guide,"" Corp. Headquarters, 535 Rte.6 & 209, Milford, PA 18337.;;""ipodDock/iPod Cradle,"" www.bookendzdocks.com/bookendz/dock-cradle.htm, downloaded Feb. 27, 2003.;;""Introduction to Public Key Cryptography,"" Oct. 9, 1998, printed from http://developer.netscape.com/docs/manuals/security/pkin/contents.htm on Oct. 6, 2004.;;Brentrup, ""Public Key Cryptography Demystified,"" Campus Technology, printed from http://www.campus-technology.com/article.asp?id=7626 on Oct. 6, 2004.;;Whittle, ""Public Key Authentication Framework: Tutorial,"" First Principles Consulting, Jun. 2, 1996.;;Belkin iPod Voice Recorder, Product Specification Sheet, printed Jun. 16, 2004.;;iPod Classic User's Guide, acquired from apple.com, 2002; 44 pages.;;iPod nano Features Guide, acquired from apple.com, 2008; 72 pages.;;iPod touch User's Guide, acquired from apple.com, 2008, 120 pages.;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [on line], [retrieved on Sep. 26, 2008]. Retrieved from the Internet . 2 pages.;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 23, 2008]. Retrieved from the Internet . 2 pages.;;""Universal Serial Bus Specification-Rev 2.0,"" Chapter 6, Compaq Hewlett-Packard, Apr. 27, 2000, pp. 85, 99-100.;;""A Serial Bus on Speed Diagram: Getting Connected with FireWire"", downloaded Oct. 16, 2001, PC Magazine: PC Tech (a Serial Bus on Speed), wysiwyg://51/http://www.zdnet.com/pctech/content/18/10/tu1810.007.html.;;""Cables to Go"", download Oct. 16, 2001, http://www.cablestogo.com/product.asp?cat%5Fid=601&sku=27028.;;""ExpressBus(TM) FU010 User Guide Packing Checklist"", Belkin Components, 2006.;;""FireWire Connector"", downloaded Oct. 16, 2001, wysiwyg://76/http://developer.apple.com/...es/Macintosh-CPUs-G3/ibook/ibook-27.html.;;""FireWire"", downloaded Oct. 16, 2001, wysiwyg://42/http://developer.apple.com/hardware/FireWire.;;""How to Connect Your Computer, PC Hardware"", downloaded Oct. 16, 2001, http:///www.scar.utoronto.ca/~ccweb/faculty/connect-howto.html.;;""IEEE 1394/USB Comparison"", downloaded Oct. 16, 2001, www.genitech.com.au/Library/TechSupport/infobits/firewire-vs-usb.htm.;;""Making USB Work"", downloaded Oct. 16, 2001, PC Magazine: PC Tech (Making USB Work) wysiwyg://55/http://www.zdnet.com/pcmag/pctech/content/18/04/tu1804.001. html.;;""PMC FW2 IEEE1394 FireWire Controller"", downloaded Oct. 16, 2001, http://www.bvmltd.co.uk/PMCfw2ds.html.;;""Why FireWire is Hot!Hot!Hot!"", downloaded Oct. 16, 2001, ""Impact.FireWire.SideBar"", http://www.vxm.com/21R.35.html.;;Ian Fried, ""FireWire poised to become ubiquitous"", downloaded Oct. 16, 2001, CNET News.com, 1394 Trade Association: Press, wysiwyg://32/http://1394ta.org/Press/2001Press/august/8.27.b.html.;;Ian Fried, ""New FireWire to blaze faster trail"", downloaded Oct. 16, 2001, CNET News.com, http://news.cnet.com/news/0-1006-200-6021210.html.;;Michael D. Johas Teener, ""Understanding Fire Wire: The IEEE 1394 Standards and Specifications"", downloaded Oct. 16, 2001, wysiwyg://9/http://www.chipcenter.com/networking/ieee1394/main.html.;;Networking Tech Note, ""1394 Standards and Specifications,"" 3 pgs, 2001.;;International Search Report and Written Opinion for corresponding PCT Application No. PCT/US2005/045040 mailed May 15, 2006.;;Menezes et al., ""Handbook of Applied Cryptography,"" Identification and Entity Authentication, pp. 385-424, 1997.;;Anonymous, ""Future of Digital Music in Windows,"" Microsoft Windows Hardware Developer Central Archive, [Online] Dec. 4, 2001 URL:http:-www.microsoft.com-whdc-archive-digitaudio.mspx> [retrieved on Jan. 15, 2008], 3 pages.;;Anonymous, ""Introduction to Digital Audio,"" Microsoft Windows Hardware Developer Central Archive, [Online] Dec. 4, 2001 URL:http:-www.microsoft.com-whdc-archive-digitaudio.mspx> [retrieved on Jan. 15, 2008], 2 pages.;;Anonymous, ""Windows and Red Book Audio,"" Microsoft Windows Hardware Developer Central Archive, [Online] Dec. 4, 2001 URL:http:-www.microsoft.com-whdc-archive-Dmfuture.mspx> [retrieved Jan. 15, 2008], 2 pages.;;Bindra, ""Standard Turns Monitor into I-O HuB,"" Electronic Engineering Times, vol. 918, Sep. 6, 1996, p. 14.;;Crawford et al., ""Sample rate conversion and bit rate reduction in the studio,"" IEE Colloquim on Digital Audio Signal Processing, May 22, 1991, pp. 8-1-8-3.;;Derman, ""Monitors Make Net Connections,"" Electronic Engineering Times, vol. 933, 1996, pp. 60 and 69.;;Lambert, ""Digital Audio Interfaces,"" Journal of the Audio Engineering Society, Audio Engineering Society, New York, NY, vol. 38, No. 9, (Sep. 1, 1990), pp. 681-684, 686, 688, 690, 692 and 696, ISSN: 1549-4950 figures 9, 10.;;Lewis, ""On Technology"" Fortune Magazine, Dec. 9, 2002, p. 240.;;""MPV(TM) Music Profile Specification Revision 1.00"" Internet Citation [online] (Jan. 7, 2004) URL:http-www.osta.org-mpv-public-specs-MPVMusic-Prof-Spec-1.00.pdf> [retrieved Jun. 20, 2006] the whole document, 70 pages.;;""Neuros MP3 Digital Audio Computer,"" www.neurosaudio.com, downloaded Apr. 9, 2003, 6 pages.;;Severance, ""FireWire Finally Comes Home,"" Michigan State University, Standards, Nov. 1998, pp. 117-118.;;Sinitsyn, ""Synchronization Framework for Personal Mobile Servers,"" Pervasive Computing and Communications Workshops (PERCOMW'04), Proceedings of the Second IEEE Annual Conference, Piscataway, NJ, USA, IEEE, Mar. 14, 2004, pp. 208-212.;;""The Authoritative Dictionary of IEEE Standards Terms, Seventh Edition,"" Published by Standards Information Network, IEEE Press, 2000, 3 pages.;;""Universal Serial Bus Specification-Rev 2.0,"" Chapter 9, USB Device Framework, no date, pp. 239-274.;;German Patent Application No. 202005021674.7, German Search Report, 4 pages, Jan. 7, 2010.",ACTIVE
541,KR,A,KR 20120102783 A,105-486-395-839-038,2012-09-18,2012,KR 20127018797 A,2005-12-13,US 5149905 A;;US 64234005 P,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/105-486-395-839-038,Patent Application,no,0,2,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G10L19/00;;H04L9/32,,0,0,,,,DISCONTINUED
542,PH,A1,PH 12019500637 A1,107-940-524-240-698,2019-08-19,2019,PH 12019500637 A,2019-03-22,US 201662401093 P;;US 201762554939 P;;US 201762459461 P;;US 2017/0053629 W,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;NICHOLAS JOHN BEAMOND;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUAN,,https://lens.org/107-940-524-240-698,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D409/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
543,US,A1,US 2006/0156415 A1,194-076-478-717-550,2006-07-13,2006,US 5149905 A,2005-02-03,US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN W,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE L;;ADLER MITCHELL;;ARCHIBALD JOHN W,APPLE INC (2005-05-02),https://lens.org/194-076-478-717-550,Patent Application,yes,99,218,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,H04L9/32;;G10L19/00,726/27,0,0,,,,ACTIVE
544,WO,A1,WO 2018/064119 A1,047-609-654-906-510,2018-04-05,2018,US 2017/0053629 W,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;ADLER MARC;;EMAYAN KUMARASWAMY;;MA JINGYUANG;;NICHOLAS JOHN BEAMOND,,https://lens.org/047-609-654-906-510,Patent Application,yes,9,26,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,1,1,010-402-858-128-027,28759231;;10.1021/acs.jmedchem.7b00731,"KLING, A. ET AL.: ""Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer's Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 60, 2017, pages 7123 - 7138, XP055497543",PENDING
545,US,A1,US 2020/0392157 A1,044-881-525-284-464,2020-12-17,2020,US 201716312916 A,2017-06-29,US 201716312916 A;;US 201662358504 P;;US 2017/0040109 W,2016-07-05,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to macrocyclic α-keto amide derivatives and their use as therapeutic agents.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;NICHOLAS JOHN BEAMOND;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC,BLADE THERAPEUTICS INC (2017-10-09),https://lens.org/044-881-525-284-464,Patent Application,yes,0,1,6,6,0,C07D225/06;;C07D413/12;;C07D471/04;;C07D471/14;;C07D273/01;;C07D498/04;;C07D498/14;;A61P35/00;;A61P17/00;;C07D498/06;;A61P1/16;;A61P13/12;;A61P11/00;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04;;C07D498/18,C07D498/18;;A61P1/16;;A61P11/00;;A61P13/12;;C07D245/06;;C07D267/00;;C07D405/12;;C07D407/12;;C07D413/12;;C07D471/18;;C07D498/04,,0,0,,,,ACTIVE
546,US,A1,US 2021/0347727 A1,088-673-302-302-653,2021-11-11,2021,US 201816624849 A,2018-06-19,US 201816624849 A;;US 201762524334 P;;US 2018/0038344 W,2017-06-23,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF,"Small molecule calpain modulator compositions and pharmaceutical compositions can be prepared and used as therapeutic agents. Exemplary compositions include non-macrocyclic a-keto amide derivatives. The therarapeutic agents can be used for treating fibrotic disease or a resulting secondary disease state or condition. The small molecules can competitively bind with calpastatin and/or inhibit calpain through contact with CAPN1, CAPN2, and/or CAPN9 enzymes.",BLADE THERAPEUTICS INC,BUCKMAN BRAD OWEN;;YUAN SHENDONG;;NICHOLAS JOHN BEAMOND;;MA JINGYUAN;;EMAYAN KUMARASWAMY;;ADLER MARC,BLADE THERAPEUTICS INC (2018-09-17),https://lens.org/088-673-302-302-653,Patent Application,yes,0,1,4,4,0,C07D311/84;;C07D317/68;;C07D319/24;;C07D265/38;;C07D209/86;;C07D209/88;;C07D307/91;;A61P35/00;;C07C233/76;;C07C235/60;;C07C235/80;;C07C2602/10;;C07C2601/16;;A61P19/04;;C07C233/62;;C07C233/76;;C07C233/78;;C07D209/90;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,C07C233/78;;A61P19/04;;C07C233/62;;C07C233/76;;C07D209/90;;C07D265/38;;C07D307/91;;C07D311/84;;C07D317/68;;C07D319/24,,1,0,,,"Chemical Abstract Registry No.1645311-45-0, indexed in the Registry File on STN CAS ONLINE February 6, 2015.",DISCONTINUED
547,AU,A8,AU 2009/100547 A8,096-178-299-936-218,2009-10-01,2009,AU 2009/100547 A,2009-06-05,AU 2008/101150 A;;AU 2009/100547 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;DOROGUSKER JESSE L;;ARCHIBALD JOHN WESLEY;;RUBINSTEIN JONATHAN JAKE;;ADLER MITCHELL,,https://lens.org/096-178-299-936-218,Patent Application,no,2,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
548,US,B2,US 9754099 B2,127-342-902-657-278,2017-09-05,2017,US 201514979456 A,2015-12-27,US 201514979456 A;;US 201414312672 A;;US 32836808 A;;US 5149905 A;;US 64234005 P;;US 5144105 A;;US 64227605 P;;US 64233405 P;;US 3154705 A;;US 3128805 A;;US 22046305 F;;US 22089205 F,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE LEE;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/127-342-902-657-278,Granted Patent,yes,567,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G06F21/60;;G10L19/00,,122,4,065-096-740-432-042;;035-928-800-870-660;;119-609-365-875-818;;030-389-189-134-332,10.1109/icce.1997.625976;;10.1109/2.730740;;10.1109/percomw.2004.1276933;;10.1109/hicss.2007.300,"Chinese Office Action mailed on Dec. 8, 2015 for CN Patent Application No. 20120136876.X, with English translation, 15 pages.;;“A Serial Bus on Speed Diagram: Getting Connected with FireWire,” downloaded Oct. 16, 2001, PC Magazine: PC Tech (A Serial Bus on Speed) wysiwyg://51http://www.zdnet.com/pctech/content/18/10/tu1810.007.html p. 7. (2 pages).;;“Cables to Go,” download Oct. 16, 2001 http://www.cablestogo.com/product.asp?cat%5Fid=601&sku=27028 (1 page).;;“DMR Software v1.3 for Mac OS X—User Manual”, Copyright 2002, Keyspan, rev. D 04.09.01AI, 50 pages.;;“ExpressBus™ F5U0I0,” User Guide Packing Checklist, Belkin Components Product Warranty. (2 pages).;;“Fire Wire Connector,” downloaded Oct. 16, 2001, wysiwyg://76/http://developer.apple.com/...es/Macintosh—CPUs-G3/ibook/ibook-27.html (2 pages).;;“FireWire”, downloaded Oct. 16, 2001; si—wyg:/—/42/http://developer.apple.—com/hardware/Fire—Wire (2 pages).;;“How to Connect Your Computer PC Hardware”, downloaded Oct. 16, 2001, http:///www.scar.utoronto.ca!˜ccweb/faculty/connect-howto.html (5 pages).;;“IEEE 1394/USB Comparison,” downloaded Oct. 16, 2001, www.genitech.com.aulLIBRARY/TechSupportiinfobits/firewirevsusb.html (4 pages).;;“Introduction to Public Key Cryptography,” Oct. 9, 1998, printed from http://developer.netscape.com/docs/manuals/security/pkin/contents.html on Oct. 6, 2004. (21 pages).;;“iPodDock/iPod Cradle,” www.bookendzdocks.com/bookendz/dock—cradle.html downloaded Feb. 27, 2003. (2 pages).;;“MPV™ Music Profile Specification Revision 1.00” Internet Citation [online] (Jan. 7, 2004) URL:http//www.osta.org/mpv/public/specs/MPVMusic-Prof-Spec-1.00.pdf> [retrieved Jun. 20, 2006] the whole document. (70 pages).;;“Neuros MP3 Digital Audio Computer,” www.neurosaudio.com.downloaded Apr. 9, 2003. (6 pages).;;“PMC FW2 IEEE1394 FireWire Controller”, downloaded Oct. 16, 2001, http://www.bvmltd.co.uk/PMCfw2ds.html (10 pages).;;“The Authoritative Dictionary of IEEE Standards Terms, Seventh Edition,” Published by Standards Information Network, IEEE Press, 2000. (3 pages).;;“Universal Serial Bus Specification—Rev 2.0 ” Chapter 6: Compaq Hewlett-Packard Apr. 27, 2000, pp. 85, 99-100. (7 pages).;;""Universal serial bus specification - rev 2.0"", UNIVERSAL SERIAL BUS SPECIFICATION, 27 April 2000 (2000-04-27), pages 239 - 274, XP002474828;;Altec Lansing, “inMOTION Users Guide,” Corp. Headquarters, 535 Rte.6 & 209, Milford, PA 18337. (8 pages).;;Anonymous, “Future of Digital Music in Windows,” Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved on Jan. 15, 2008]. <URL:http://www.microsoft.com/whdc/archive/digitaudio.mspx> (3 pages).;;Anonymous, “Introduction to Digital Audio,” Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved on Jan. 15, 2008]. <URL:http://www.microsoft.com/whdc/archive/digitaudio.mspx> (2 pages).;;Anonymous, “Windows and Red Book Audio,” Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved Jan. 15, 2008]. <URL:http://www.microsoft.com/whdc/archive/Dmfuture.mspx> (2 pages).;;Belkin iPod Voice Recorder, Product Specification Sheet, printed Jun. 16, 2004. (2 pages).;;Bindra, “Standard Turns Monitor into I/O Hub,” Electronic Engineering Times, vol. 918, Sep. 6, 1996, p. 14. (1 page).;;Brentrup, “Introduction to Public Key Cryptography Demystified,” Campus Technology, printed from http://www.campus-technology.com/article.asp?id=7626 on Oct. 6, 2004. (5 pages).;;Brown, “Making USB Work,” downloaded Oct. 16, 2001, PC Magazine: PC Tech wysiwyg:/155/http://www.zdnet.com/pcmag/pctech/content!18/04/tu1804.001.html (2 pages).;;Chen et al., “Design and Implemeation of a Hard Disk-Based Entertainment Device for Managing Media Contents on the Go,” Consumer Electonics, 1005. (ISCE 2005). Proceedings of the Ninth International Symposium on, pp. 328-333, Jun. 14-16, 2005. (6 pages).;;Crawford et al., “Sample rate conversion and bit rate reduction in the studio,” IEEE Colloquium on Digital Audio Signal Processing, May 22, 1991, pp. 8/1-8/3. (3 pages).;;Derman, “Monitors Make Net Connections,” Electronic Engineering Times, vol. 933, 1996, pp. 60 and 69. (2 pages).;;European Patent Office, Decision to Refuse a European Patent Application; Application No. 07 812 335., Mailed Jan. 19, 2011 , 18 pages.;;European Patent Office, Extended Search Report; Application No. 10194370.2, Mailed Feb. 6, 2012, 9 pages.;;European Patent Office, Office Action, Application No. 07 799 051.3, Mailed Sep. 24, 2012, 7 pages.;;European Patent Office, Office Action, Application No. 09 791 751.2, Mailed Oct. 19, 2012, 7 pages.;;Fried, “FireWire poised to become ubiquitous,” downloaded Oct. 16, 2001, CNET News.com, 1394 Trade Association: Press, wysiwyg:/132/http:/—113—94ta.org/Press/200—1—Press/august!8.2 7.—b.html (3 pages).;;Fried, “New Fire Wire to blaze faster trail,” downloaded Oct. 16, 2001, CNET News.com, http://news.cnet.com/news/0/I006-200-6021210.html (5 pages).;;International Search Report dated Dec. 6, 2007 in PCT Application No. PCT/US2007/010888.;;iPod Classic User's Guide, acquired from apple.com, 2002. (44 pages).;;iPod nano Features Guide, acquired from apple.com, 2008. (72 pages).;;iPod touch User's Guide, acquired from apple.com, 2008. (120 pages).;;Janssen, Jan, “A Single-Chip Universal Serial Bus D/A Converter for High-Quality Audio Signals, ” THPM 16.7 IEEE Jun. 11, 1997; Jun. 11, 1997-Jun. 13, 1997, Jun. 11, 1997, (2 pages ).;;Japanese Patent Office; Office Action for Application No. 2010-011810, Mailed Dec. 11, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2010-011810, Mailed Jul. 9, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2011-526100 , Mailed Dec. 13, 2012. (4 pages).;;Keyspan, “Express Remote Supports Apple's Airport Express,” Press Release, Nov. 10, 2004, Copyright 2005,Keyspan, 2 pages.;;Keyspan, “Keyspan Express Remote,” Product Fact Sheet, Oct. 2004, 1 page.;;Keyspan, Express Remote; Remote Control for your Mac or PC (URM-17A), product information AU datasheet, Copyright 2005, Keyspan, http://www.keyspan.com/products/usb/urm17a/, downloaded Sep. 25, 2005, 2 pages.;;Keyspan, Remote for iTunes; Controls ITunes, DVD, CD and more! (URM-15T), product AT information datasheet, Keyspan, http://www.keyspan.com/products/usb/urm15t, downloaded Sep. 25, 2005, 2 pages.;;LAMBERT M.: ""DIGITAL AUDIO INTERFACES."", JOURNAL OF THE AUDIO ENGINEERING SOCIETY., AUDIO ENGINEERING SOCIETY, NEW YORK, NY., US, vol. 38., no. 09., 1 September 1990 (1990-09-01), US, pages 681 - 684 + 686 + 68, XP000175146, ISSN: 1549-4950;;Lewis, “On Technology” Fortune Magazine, Dec. 9, 2002, p. 240. (1 page).;;LSI Logic's Broadcast PC Card Brings New Multimedia Capabilities to Personal Computing. (Nov. 16). PR Newswire, 1. Retrieved Jun. 26, 2010, from Business Dateline. (3 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [on line], [retrieved on Sep. 26, 2008]. Retrieved from the Internet <URL: http://web.archive.org/web/20000930170634.maxtech.com.hk/t-details.htm>. (2 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 23, 2008]. Retrieved from the Internet <URL: http://web.archive.org/web/20010223230441/www.maxtech.com.hk/g-p06.htm>. (2 pages).;;Menezes et al., “Handbook of Applied Cryptography,” Identification and Entity Authentication, Jan. 1, 1997, pp. 385-424. (41 pages).;;Microsoft, “Media Transport Protocol Implementation Details,” 2005. (18 pages).;;Networking Tech Note, “1394 Standards and Specifications,” Ocober 16, 2001. (3 pages).;;Nomad II Player Version 1.0 (CLI) (User's Manual), Creative Technology, Ltd., Jan. 2000. (46 pages).;;Non-Final Office Action for U.S. Appl. No. 10/833,689 mailed Dec. 28, 2007; 15 pps.;;Non-Final Office Action for U.S. Appl. No. 10/833,689 mailed Jun. 20, 2007; 11 pps.;;Non-Final Office Action for U.S. Appl. No. 10/833689 mailed Oct. 4, 2006; 11 pps.;;Non-Final Office Action for U.S. Appl. No. 13/474,552 mailed Oct. 26, 2012; 27 pp.;;Notice of Allowance for U.S. Appl. No. 12/209,970 mailed on Jun. 10, 2009; 7 pps.;;Office Action dated Feb. 18, 2010 in Australian Patent Application No. 2007268239.;;Office Action for European Patent Application No. 10194377.7, mailed Apr. 15, 2013, 6 pages.;;Office Action for Korean Patent Application No. 10-2012-7018797, mailed Apr. 25, 2013, 5 pages.;;Office Action in corresponding Japanese Application No. 2009-512018, mailed Apr. 5, 2011.;;Salling, “Sailing Clicker 2.2.1”, User Manual, Copyright 2003-2005 Sailing Software AB, 45 pages.;;Severance, “FireWire Finally Comes Home,” Michigan State University, Standards, Nov. 1998, pp. 117-118. (2 pages).;;Sinitsyn, “Synchronization Framework for Personal Mobile Servers,” Pervasive Computing and Communications Workshops (PERCOMW'04), Proceedings of the Second IEEE Annual Conference, Piscataway, NJ, USA, IEEE, Mar. 14, 2004, pp. 208-212. (3 pages).;;Slay et al., “iPod Forensics: Forencically Sound Examination of an Apple iPod,” System Sciences, 2007. HICSS 2007. 40th Annual Hawaii Internation Conference on, pp. 1-9, Jan. 2007. (9 pages).;;Teener, “Understanding Fire Wire: The IEEE 1394 Standards and Specifications,” downloaded Oct. 16, 2001, wysiwyg:119/http:1lwww.chipcenter.com/networking/ieee—1394/main.html (5 pages).;;The First Office Action in Chinese Application No. 200910222182.6, mailed Nov. 23, 2011 (P3503CND1, 90911-778213).;;Vitaliano, “Why FireWire is Hot!Hot!Hot!” downloaded Oct. 16, 2001, “Impact FireWire.SideBar” http://www.vxm.com/21R.35.html (4 pages).;;Whittle, “Public Key Authentication Framework: Tutorial,” First Principles Consulting, Jun. 2, 1996, downloaded Oct. 6, 2004, http://www.ozemail.com.au/˜firstpr/crypto/pkaftute.htm (7 pages).;;Written Opinion dated Dec. 6, 2007 in PCT Application No. PCT/US2007/010888.;;International Search Report, dated Aug. 21, 2008, for PCT Patent Application No. PCT/US2007/072127, 5 pages.;;Written Opinion, dated Dec. 27, 2008, for PCT Patent Application No. PCT/US2007/072127, 5 pages.;;International Preliminary Report on Patentability dated Jan. 6, 2009, for PCT Patent Application No. PCT/US2007/072127, 6 pages.;;International Search Report, dated Mar. 17, 2011, for PCT Patent Application No. PCT/US2010/048130, 3 pages.;;Written Opinion, dated Mar. 9, 2012, for PCT Patent Application No. PCT/US2010/048130, 8 pages.;;International Preliminary Report on Patentability, dated Mar. 13, 2012, for PCT Patent Application No. PCT/US2010/048130, 9 pages.;;Notice of Allowance for U.S. Appl. No. 13/474,552, mailed May 1, 2013, 23 pages.;;Notice of Allowability for U.S. Appl. No. 13/474,552, mailed May 31, 2013, 3 pages.;;European Office Action mailed on Apr. 9, 2013 for EP Patent Application No. 10194370.2, 7 pages.;;Australian Office Action mailed on Jul. 9, 2013 for AU Patnet Application No. 2011253604, 2 pages.;;Australian Office Action mailed on Feb. 19, 2013 for AU Patent Application No. 2010292318, 3 pages.;;Australian Notice of Acceptance mailed on May 2, 2013 for AU Patent Application No. 2010292318, 2 pages.;;Canadian Office Action mailed on Aug. 1, 2013 for CA Patent Application No. 2,651,048, 5 pages.;;Indian Office Action mailed on Sep. 6, 2013 for IN Patent Application No. 4519/KOLNP/2008, 2 pages.;;Japanese Office Action mailed on Aug. 6, 2013 for JP Patent Application No. 2010-011810, with English translation, 9 pages.;;Korean Office Action mailed on Oct. 1, 2013 for KR Patent Application No. 10-2012-7008925, with English Translation, 8 pages.;;Japanese Notice of Allowance mailed on Oct. 15, 2013 for JP Patent Application No. 2012*528878, 3 pages.;;Umeda, Katsuji et al., “Music Distribution Business Illustrated for Understanding,”; Japan Management Associate Management Center; Oct. 1, 2000, First Edition, pp. 179, 187, in Japanese.;;Notice of Allowance mailed on Sep. 11, 2013 for U.S. Appl. No. 13/538,941, 8 pages.;;Canadian Office Action mailed on Deceber 17, 2013 for CA Patent Application No. 2,591,164, 3 pages.;;Japanese Office Action mailed on Mar. 10, 2014 for JP Patent Application No. 2013-055601, 4 pages.;;Korean Notice of Allowance mailed on Apr. 7, 2014 for KR Patent Application No. 10-2012-7008925, 2 pages.;;Chinese Office Action mailed on Jan. 30, 2014 for CN Patent Application No. 201080039625.9, with English Trranslation, 34 pages.;;Chinese Office Action mailed on May 29, 2014 for CN Patent Application No. 2012101598.4, with English Translation, 22 pages.;;Chinese Office Action mailed on May 27, 2014 for CN Patent Application No. 20121036876.x, with English Translation, 20 pages.;;Non-Final Office Action mailed on Nov. 24, 2010 for U.S. Appl. No. 12/328,368, 28 pages.;;Final Office Action mailed on May 11, 2011 for U.S. Appl. No. 12/328,368, 39 pages.;;Non-Final Office Action mailed on Aug. 15, 2013 for U.S. Appl. No. 12/328,368, 13 pages.;;Notice of Allowance mailed on Feb. 7, 2014 for U.S. Appl. No. 12/328,368, 8 pages.;;Non-Final Office Action mailed on Sep. 16, 2008 for U.S. Appl. No. 11/051,499, 18 pages.;;Final Office Action mailed on Mar. 19, 2009 for U.S. Appl. No. 11/051,499, 16 pages.;;Non-Final Office Action mailed on Nov. 30, 2009 for U.S. Appl. No. 11/051,499, 19 pages.;;Notice of Allowance mailed on Jun. 24, 2010 for U.S. Appl. No. 11/051,499, 9 pages.;;International Search Report and Written Opinion of the International Searching Authority mailed on May 15, 2006 for PCT Patent Application No. PCT/US2005/045040, 10 pages.;;Canadian Office Action mailed on Oct. 7, 2014 for CA Patent Application No. 2,651,048, 4 pages.;;Australian Office Action mailed on Nov. 5, 2014 for AU Patent Application No. 2013203800, 2 pages.;;Japanese Office Action mailed on Oct. 14, 2014 for JP Patent Application No. 2013-252930, with English translation, 9 pages.;;Chinese Office Action mailed on Nov. 3, 2014 for CN Patent Application No. 201210136878.9, 15 pages.;;Chinese Office Action mailed on Nov. 24, 2014 for CN Patent Application No. 201080039625.9, 6 pages.;;Non-Final Office Action mailed on Feb. 23, 2015 for U.S. Appl. No. 14/084,545, 6 pages.;;Chinese Office Action mailed on Feb. 16, 2015 for CN Patent Application No. 201080039625.9, 6 pages.;;Chinese Office Action mailed on Feb. 13, 2015 for CN Patent Application No. 201210101598.4, 19 pages.;;Canadian Office Action mailed on Mar. 11, 2015 for CA Patent Application No. 2,591,164, 4 pages.;;Chinese Office Action mailed on Mar. 31, 2015 for CN Patent Application No. 201210136876.X, 18 pages.;;Notice of Allowance mailed on Jun. 12, 2015 for U.S. Appl. No. 14/084,545, 5 pages.;;Chinese Office Action mailed on Jul. 8, 2015 for CN Patent Application No. 201210136878.9, 12 pages.;;Chinese Office Action mailed on Aug. 5, 2015 for CN Patent Application No. 201210101598.4, with English translation, 16 pages.;;Notice of Allowance mailed on Aug. 19, 2015 for U.S. Appl. No. 14/312,672, 10 pages.;;Canadian Office Action mailed on Oct. 22, 2015 for CA Patent Application No. 2,651,048, 7 pages.",ACTIVE
549,AU,A4,AU 2008/101150 A4,136-970-001-566-372,2009-02-05,2009,AU 2008/101150 A,2008-11-26,AU 2005/323229 A;;AU 2008/101150 A;;US 2005/0045040 W;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,,APPLE INC,FADELL ANTHONY M;;ADLER MITCHELL;;RUBINSTEIN JONATHAN JAKE;;DOROGUSKER JESSE L;;ARCHIBALD JOHN WESLEY,,https://lens.org/136-970-001-566-372,Limited Patent,no,0,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/20;;G10L19/00,,0,0,,,,INACTIVE
550,US,B2,US 7633949 B2,137-170-869-899-324,2009-12-15,2009,US 11151305 A,2005-04-21,US 11151305 A;;US 47749800 A;;US 23239699 A,1999-01-15,Method of providing network services,"A method of providing network services is described. The network includes a number of nodes, each one of which is coupled to at least one other of the nodes by at least one of a number of optical links. The network is preferably capable of supporting a number of virtual circuits. The method begins with the receiving of a request for a virtual circuit between a first node and a second node of the network. Preferably, the request specifies a quality of service of the virtual circuit. Next, the availability of network resources for supporting a virtual circuit at the requested quality of service is determined. Assuming sufficient network resources are available for support of the virtual circuit, the request is then serviced by provisioning (and maintaining) the requested virtual circuit. Servicing the request preferably includes actions such as provisioning, maintaining, and restoring the virtual circuit, using the requested parameters.",CISCO TECH INC,ZADIKIAN H MICHAEL;;PLOTE STEVEN E;;ADLER JOHN C;;AUTRY DAVID P;;SALEH ALI NAJIB,,https://lens.org/137-170-869-899-324,Granted Patent,yes,82,13,6,7,0,H04J14/0227;;H04J14/0282;;H04J14/0283;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04J14/0297;;H04L47/15;;H04L47/741;;H04L47/743;;H04L47/746;;H04L47/748;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04J14/0241;;H04J14/0228;;H04L47/70;;H04J14/0295;;H04Q2011/0084;;H04Q2011/0058;;H04J14/0284;;H04L47/805;;H04Q11/0062;;H04L47/15;;H04Q2011/0081;;H04J14/0227;;H04L47/746;;H04J14/0282;;H04J14/0297;;H04L47/748;;H04Q11/0005;;H04L47/741;;H04Q2011/0086;;H04L47/743;;H04Q2011/0088;;H04J14/0283;;H04L47/822;;H04L47/826;;H04L47/825;;H04J14/0294;;H04J14/0241;;H04J14/0228;;H04L47/70,H04L12/28;;G06F15/173;;H04J3/16;;H04L12/56;;H04Q11/00,370/396;;370/468;;370/395.21;;370/389;;709/226,13,5,150-190-396-355-640;;078-345-689-354-97X;;154-622-772-822-209;;012-911-196-516-124;;032-538-043-490-608,10.1109/glocom.1990.116551;;10.17487/rfc2328;;10.17487/rfc2174;;10.17487/rfc1850;;10.17487/rfc1638,"Zadikian, et al., U.S. Appl. No. 60/174,323.;;Hideki Sakauchi, et al., ""A Self-Healing Network With An Economical Spare-Channel Assignment"", Proceedings of the Globecom '90 IEEE Telecommunications Conference & Exhibition, vol. 1, 1991, pp. 438-443.;;Baruch Awerbuch, et al., ""Distributed Controls For Paris"", Proc. Annual ACM Symp. On Principles Of Distributed Computing, Aug. 22, 1999, pp. 145-159.;;Sujai Hajela, ""HP OEMF: Alarm Management In Telecommunications Networks"", Hewlett Packard Journal, Oct. 1996, vol. 47, No. 5, pp. 22-30.;;The ATM Forum Technical Committee, ""Interim Inter-switch Signaling Protocol (IISP) Specification v1.0"", af-pnni-0026.000, Dec. 1994, pp. 1-34.;;The ATM Forum Technical Committee, Private Network-Network Interface Specification Version 1.0 (PNNI 1.0), afpnni-0055.000, Mar. 1996, pp. v-xviii, pp. 19, 1-366.;;The ATM Forum Technical Committee, Private Network-Network Interface Specification Version 1.0 Addendum (Soft PVC MIB), af-pnni-0066.000, Sep. 1996.;;The ATM Forum Technical Committee, Addendum to PNNI V1.0 for ABR parameter negotiation, af-pnni-0075.000, Jan. 1997.pp. 2.3.;;The ATM Forum Technical Committee, PNNI V1.0 Errata and PICS, af-pnni-0081.000, May 1997, pp. 2-224.;;J. Moy, ""OSPF Version 2"", Ascend Communications, Inc., Apr. 1998.;;K. Murakami, et al., ""A MAPOS version 1 Extension-Switch-Switch Protocol"", NTT Laboratories, Jun. 1997.;;F. Baker, et al., ""OSPF Version 2 Management Information Base"", Cisco Systems, Nov. 1995.;;F. Baker, et al., ""PPP Bridging Control Protocol (BCP)"", IBM, Jun. 1994.",EXPIRED
551,US,B1,US 6912221 B1,059-427-448-787-379,2005-06-28,2005,US 47749800 A,2000-01-04,US 47749800 A;;US 23239699 A;;US 13747199 P,1999-01-15,Method of providing network services,"A method of providing network services is described. The network includes a number of nodes, each one of which is coupled to at least one other of the nodes by at least one of a number of optical links. The network is preferably capable of supporting a number of virtual circuits. The method begins with the receiving of a request for a virtual circuit between a first node and a second node of the network. Preferably, the request specifies a quality of service of the virtual circuit. Next, the availability of network resources for supporting a virtual circuit at the requested quality of service is determined. Assuming sufficient network resources are available for support of the virtual circuit, the request is then serviced by provisioning (and maintaining) the requested virtual circuit. Servicing the request preferably includes actions such as provisioning, maintaining, and restoring the virtual circuit, using the requested parameters.",CISCO TECH IND,ZADIKIAN H MICHAEL;;PLOTE STEVEN E;;ADLER JOHN C;;AUTRY DAVID P;;SALEH ALI NAJIB,CISCO TECHNOLOGY INC (2000-04-11),https://lens.org/059-427-448-787-379,Granted Patent,yes,45,189,1,7,0,H04L47/15;;H04L47/746;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04L47/70;;H04L47/825;;H04L47/826;;H04L47/805;;H04Q2011/0084;;H04Q2011/0086;;H04Q11/0062;;H04Q2011/0058;;H04L47/822;;H04L47/15;;H04Q2011/0081;;H04Q2011/0088;;H04L47/746;;H04Q11/0005;;H04L47/70,H04L12/56;;H04Q11/00,370/395.21;;370/219;;370/397;;370/409;;709/226;;709/221,21,6,150-190-396-355-640;;078-345-689-354-97X;;154-622-772-822-209;;012-911-196-516-124;;032-538-043-490-608;;048-626-539-256-840,10.1109/glocom.1990.116551;;10.17487/rfc2328;;10.17487/rfc2174;;10.17487/rfc1850;;10.17487/rfc1638;;10.17487/rfc1493,"Hideki Sakauchi, et al., ""A Self-Healing Network With An Economical Spare-Channel Assignment"", Proceedings of the Globecom '90 IEEE Telecommunications Conference & Exhibition, vol. 1, 1991, pp. 438-443.;;Baruch Awerbuch, et al., ""Distributed Controls For PARIS"", Proc. Annual ACM Symp. On Principles Of Distributed Computing, Aug. 22, 1999, pp. 145-159.;;Sujai Hajela, ""HP OEMF: Alarm Management In Telecommunications Networks"", Hewlett Packard Journal, Oct., 1996, vol. 47, No. 5, pp. 22-30.;;Ali Saleh; H. Michael Zadikian; Zareh Baghdasarian, Vahid Parsi, ""A Method For Routing Information Over A Network"", filed Jan. 15, 1999; U.S. Appl. No. 09/232,397.;;Ali Saleh, ""A Method For Path Selection In A Network"", filed Jan. 4, 2000; U.S. Appl. No. 09/478,235.;;Ali N. Saleh and Stevan E. Plote, ""A Network Addressing Scheme For Reducing Protocol Overhead In An Optical Network"", filed Sep. 2, 1999; U.S. Appl. No. 09/389,302.;;Ali Saleh, H. Michael Zadikian; John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""Configurable Network Router"", filed Jan. 15, 1999; U.S. Appl. No. 09/232,395.;;Ali N. Saleh, Douglas E. Duschatko, Lane Byron Quibodeaux, ""Method And Apparatus For A Rearrangeably Non-Blocking Switching Matrix"", filed Jan. 4, 2000; U.S. Appl. No. 09/477,166.;;H. Michael Zadikian, Ali Saleh; John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""A Resource Management Protocol For A Configurable Network Router"", filed Jan. 4, 2000; U.S. Appl. No. 60/174,323.;;Ronald Alan Russell and Michael Kevin Anthony, ""A Method And Apparatus For Isolating Faults In A Switching Matrix"", filed Jan. 4, 2000; U.S. Appl. No. 09/477,217.;;H. Michael Zadikian, Ali Saleh, John C. Adler, Zareh Baghdasarian, Vahid Parsi, ""A Method of Allocating Bandwidth in an Optical Network"" (as amended), filed Jan. 15, 1999, U.S. Appl. No. 09/232,396.;;The ATM Forum Technical Committee, ""Interim Inter-switch Signaling Protocol (IISP) Specification v1.0"", af-pnni-0026.000, Dec. 1994, pp. 1-34.;;The ATM Forum Technical Committee, Private Network-Network Interface Specification Version 1.0 (PNNI 1.0), afpnni-0055.000, Mar. 1996, pp. v-xviii, pp. 19, 1-366.;;The ATM Forum Technical Committee, Private Network-Network Interface Specification Version 1.0 Addendum (Soft PVC MIB), af-pnni-0066.000, Sep. 1996.;;The ATM Forum Technical Committee, Addendum to PNNI V1.0 for ABR parameter negotiation, af-pnni-0075.000, Jan. 1997.pp. 2.3.;;The ATM Forum Technical Committee, PNNI V1.0 Errata and PICS, af-pnni-0081.000, May 1997, pp. 2-224.;;J. Moy, ""OSPF Version 2"", Ascend Communications, Inc., Apr. 1998.;;K. Murakami, et al., ""A MAPOS version 1 Extension-Switch-Switch Protocol"", NTT Laboratories, Jun. 1997.;;F. Baker, et al., ""OSPF Version 2 Management Information Base"", Cisco Systems, Nov. 1995.;;F. Baker, et al., ""PPP Bridging Control Protocol (BCP)"", IBM, Jun. 1994.;;E. Decker, ""Definitions of Managed Objects for Bridges"", Cisco Systems, Inc., Jul. 1993.",EXPIRED
552,US,B2,US 10049206 B2,148-203-987-254-110,2018-08-14,2018,US 201715671012 A,2017-08-07,US 201715671012 A;;US 201514979456 A;;US 201414312672 A;;US 32836808 A;;US 5149905 A;;US 64234005 P,2005-01-07,Accessory authentication for electronic devices,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE LEE;;ADLER MITCHELL D;;ARCHIBALD JOHN WESLEY,,https://lens.org/148-203-987-254-110,Granted Patent,yes,675,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G06F21/60;;G10L19/00,,200,4,065-096-740-432-042;;035-928-800-870-660;;119-609-365-875-818;;030-389-189-134-332,10.1109/icce.1997.625976;;10.1109/2.730740;;10.1109/percomw.2004.1276933;;10.1109/hicss.2007.300,"“A Serial Bus on Speed Diagram: Getting Connected with FireWire,” downloaded Oct. 16, 2001, PC Magazine: PC Tech (A Serial Bus on Speed) wysiwyg://51http://www.zdnet.com/pctech/content/18/10/tu1810.007.html p. 7. (2 pages).;;“Cables to Go,” download Oct. 16, 2001 http://www.cablestogo.com/product.asp?cat%5Fid=601&sku=27028 (1 page).;;“DMR Software v1.3 for Mac OS X—User Manual”, Copyright 2002, Keyspan, rev. D 04.09.01AI, 50 pages.;;“ExpressBus™ F5U0I0,” User Guide Packing Checklist, Belkin Components Product Warranty. (2 pages).;;“Fire Wire Connector,” downloaded Oct. 16, 2001, wysiwyg://76/http://developer.apple.com/...es/Macintosh_CPUs-G3/ibook/ibook-27.html (2 pages).;;“FireWire”, downloaded Oct. 16, 2001. si wyg:/_/42/http://developer.apple._com/hardware/Fire_Wire (2 pages).;;“How to Connect Your Computer PC Hardware”, downloaded Oct. 16, 2001. http:///www.scar.utoronto.ca!˜ccweb/faculty/connect-howto.html (5 pages).;;“IEEE 1394/USB Comparison,” downloaded Oct. 16, 2001, www.genitech.com.aulLIBRARY/TechSupportiinfobits/firewirevsusb.html (4 pages).;;“Introduction to Public Key Cryptography,” Oct. 9, 1998, printed from http://developer.netscape.com/docs/manuals/security/pkin/contents.html on Oct. 6, 2004. (21 pages).;;“iPodDock/iPod Cradle,” www.bookendzdocks.com/bookendz/dock_cradle.html, downloaded Feb. 27, 2003. (2 pages).;;“MPV™ Music Profile Specification Revision 1.00” Internet Citation [online] (Jan. 7, 2004) URL:http//www.osta.org/mpv/public/specs/MPVMusic-Prof-Spec-1.00.pdf> [retrieved Jun. 20, 2006] the whole document. (70 pages).;;“Neuros MP3 Digital Audio Computer,” www.neurosaudio.com, downloaded Apr. 9, 2003. (6 pages).;;“PMC FW2 IEEE1394 FireWire Controller”, downloaded Oct. 16, 2001, http://www.bvmltd.co.uk/PMCfw2ds.html (10 pages).;;“The Authoritative Dictionary of IEEE Standards Terms, Seventh Edition,” Published by Standards Information Network, IEEE Press, 2000. (3 pages).;;“Universal Serial Bus Specification—Rev 2.0,” Chapter 6: Compaq Hewlett-Packard, Apr. 27, 2000, pp. 85, 99-100. (7 pages).;;""Universal serial bus specification - rev 2.0"", UNIVERSAL SERIAL BUS SPECIFICATION, 27 April 2000 (2000-04-27), pages 239 - 274, XP002474828;;Altec Lansing, “inMOTION Users Guide,” Corp. Headquarters, 535 Rte.6 & 209, Milford, PA 18337. (8 pages).;;Anonymous, “Future of Digital Music in Windows,” Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved on Jan. 15, 2008]. <URL:http://www.microsoft.com/whdc/archive/digitaudio.mspx> (3 pages).;;Anonymous, “Introduction to Digital Audio,” Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved on Jan. 15, 2008]. <URL:http://www.microsoft.com/whdc/archive/digitaudio.mspx> (2 pages).;;Anonymous, “Windows and Red Book Audio,” Microsoft Windows Hardware Developer Central Archive, Dec. 4, 2001 [Online], [retrieved Jan. 15, 2008]. <URL:http://www.microsoft.com/whdc/archive/Dmfuture.mspx> (2 pages).;;Belkin iPod Voice Recorder, Product Specification Sheet, printed Jun. 16, 2004. (2 pages).;;Bindra, “Standard Turns Monitor into I/O Hub,” Electronic Engineering Times, vol. 918, Sep. 6, 1996, p. 14. (1 page).;;Brentrup, “Introduction to Public Key Cryptography Demystified,” Campus Technology, printed from http://www.campus-technology.com/article.asp?id=7626 on Oct. 6, 2004. (5 pages).;;Brown, “Making USB Work,” downloaded Oct. 16, 2001, PC Magazine: PC Tech wysiwyg:/155/http://www.zdnet.com/pcmag/pctech/content!18/04/tu1804.0.01.html (2 pages).;;Chen et al., “Design and Implemeation of a Hard Disk-Based Entertainment Device for Managing Media Contents on the Go,” Consumer Electonics, 1005. (ISCE 2005). Proceedings of the Ninth International Symposium on, pp. 328-333, Jun. 14-16, 2005. (6 pages).;;Crawford et al., “Sample rate conversion and bit rate reduction in the studio,” IEEE Colloquium on Digital Audio Signal Processing, May 22, 1991, pp. 8/1-8/3. (3 pages).;;Derman, “Monitors Make Net Connections,” Electronic Engineering Times, vol. 933, 1996, pp. 60 and 69. (2 pages).;;European Patent Office, Decision to Refuse a European Patent Application; Application No. 07 812 335., dated Jan. 19, 2011 , 18 pages.;;European Patent Office, Extended Search Report; Application No. 10194370.2, dated Feb. 6, 2012, 9 pages.;;European Patent Office, Office Action, Application No. 07 799 051.3, dated Sep. 24, 2012, 7 pages.;;European Patent Office, Office Action, Application No. 09 791 751.2, dated Oct. 19, 2012, 7 pages.;;Fried, “FireWire poised to become ubiquitous,” downloaded Oct. 16, 2001, CNET News.com, 1394 Trade Association: Press, wysiwyg:/132/http:/_113_94ta.org/Press/200_1_Press/august!8.2_7._b.html. (3 pages).;;Fried, “New Fire Wire to blaze faster trail,” downloaded Oct. 16, 2001, CNET News.com, http://news.cnet.com/news/0/I006-200-6021210.html (5 pages).;;International Search Report dated Dec. 6, 2007 in PCT Application No. PCT/US2007/010888.;;iPod Classic User's Guide, acquired from apple.com, 2002. (44 pages).;;iPod nano Features Guide, acquired from apple.com, 2008. (72 pages).;;iPod touch User's Guide, acquired from apple.com, 2008. (120 pages).;;Janssen, Jan, “A Single-Chip Universal Serial Bus D/A Converter for High-Quality Audio Signals, ” THPM 16.7 IEEE 19970611; 19970611-19970613, Jun. 11, 1997, (2 pages).;;Japanese Patent Office; Office Action for Application No. 2010-011810, dated Dec. 11, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2010-011810, dated Jul. 9, 2012. (5 pages).;;Japanese Patent Office; Office Action for Application No. 2011-526100 , dated Dec. 13, 2012. (4 pages).;;Keyspan, “Express Remote Supports Apple's Airport Express,” Press Release, Nov. 10, 2004, Copyright 2005,Keyspan, 2 pages.;;Keyspan, “Keyspan Express Remote,” Product Fact Sheet, Oct. 2004, 1 page.;;Keyspan, Express Remote; Remote Control for your Mac or PC (URM-17A), product information AU datasheet, Copyright 2005, Keyspan, http://www.keyspan.com/products/usb/urm17a/, downloaded Sep. 25, 2005, 2 pages.;;Keyspan, Remote for iTunes; Controls ITunes, DVD, CD and more! (URM-15T), product AT information datasheet, Keyspan, http://www.keyspan.com/products/usb/urm15t, downloaded Sep. 25, 2005, 2 pages.;;LAMBERT M.: ""DIGITAL AUDIO INTERFACES."", JOURNAL OF THE AUDIO ENGINEERING SOCIETY., AUDIO ENGINEERING SOCIETY, NEW YORK, NY., US, vol. 38., no. 09., 1 September 1990 (1990-09-01), US, pages 681 - 684 + 686 + 68, XP000175146, ISSN: 1549-4950;;Lewis, “On Technology” Fortune Magazine, Dec. 9, 2002, p. 240. (1 page).;;LSI Logic's Broadcast PC Card Brings New Multimedia Capabilities to Personal Computing. (Nov. 16). PR Newswire, 1. Retrieved Jun. 26, 2010, from Business Dateline. (3 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [on line], [retrieved on Sep. 26, 2008]. Retrieved from the Internet <URL: http://web.archive.org/web/20000930170634/www.maxtech.com.hk/t-details.htm>. (2 pages).;;MAXTech Technology Ltd., CES 2000/Las Vegas, Jan. 6-9, 2000, [online], [retrieved on Sep. 23, 2008]. Retrieved from the Internet <URL: http://web.archive.org/web/20010223230441/www.maxtech.com.hk/g-p06.htm>. (2 pages).;;Menezes et al., “Handbook of Applied Cryptography ” Identification and Entity Authentication, Jan. 1, 1997, pp. 385-424. (41 pages).;;Microsoft, “Media Transport Protocol Implementation Details,” 2005. (18 pages).;;Networking Tech Note, “1394 Standards and Specifications,” Oct. 16, 2001. (3 pages).;;Nomad II Player Version 1.0 (CLI) (User's Manual), Creative Technology, Ltd., Jan. 2000. (46 pages).;;Non-Final Office Action for U.S. Appl. No. 10/833,689, dated Dec. 28, 2007; 15 pps.;;Non-Final Office Action for U.S. Appl. No. 10/833,689, dated Jun. 20, 2007; 11 pps.;;Non-Final Office Action for U.S. Appl. No. 10/833,689, dated Oct. 4, 2006; 11 pps.;;Non-Final Office Action for U.S. Appl. No. 13/474,552, dated Oct. 26, 2012; 27 pp.;;Notice of Allowance for U.S. Appl. No. 12/209,970, dated Jun. 10, 2009; 7 pps.;;Office Action dated Feb. 18, 2010 in Australian Patent Application No. 2007268239.;;Office Action for European Patent Application No. 10194377.7, dated Apr. 15, 2013, 6 pages.;;Office Action for Korean Patent Application No. 10-2012-7018797, dated Apr. 25, 2013, 5 pages.;;Office Action in corresponding Japanese Application No. 2009-512018, dated Apr. 5, 2011.;;Salling, “Salling Clicker 2.2.1”, User Manual, Copyright 2003-2005 Salling Software AB, 45 pages.;;Severance, “FireWire Finally Comes Home,” Michigan State University, Standards, Nov. 1998, pp. 117-118. (2 pages).;;Sinitsyn, “ Synchronization Framework for Personal Mobile Servers,” Pervasive Computing and Communications Workshops (PERCOMW'04), Proceedings of the Second IEEE Annual Conference, Piscataway, NJ, USA, IEEE, Mar. 14, 2004, pp. 208-212. (3 pages).;;Slay et al., “iPod Forensics: Forencically Sound Examination of an Apple iPod,” System Sciences. 2007. HICSS 2007. 40th Annual Hawaii Internation Conference on, pp. 1-9, Jan. 2007. (9 pages).;;Teener, “Understanding Fire Wire: The IEEE 1394 Standards and Specifications,” downloaded Oct. 16, 2001, wysiwyg:119/http:1lwww.chipcenter.com/networking/ieee_1394/main.html (5 pages).;;The First Office Action in Chinese Application No. 200910222182.6, dated Nov. 23, 2011.;;Vitaliano, “Why FireWire is Hot!Hot!Hot!” downloaded Oct. 16, 2001, “Impact.FireWire.SideBar” http://www.vxm.com/21R.35.html (4 pages).;;Whittle, “Public Key Authentication Framework: Tutorial,” First Principles Consulting, Jun. 2, 1996, downloaded Oct. 6, 2004, http://www.ozemail.com.au/˜firstpr/crypto/pkaftute.htm (7 pages).;;Written Opinion dated Dec. 6, 2007 in PCT Application No. PCT/US2007/010888.;;International Search Report, dated Aug. 21, 2008, for PCT Patent Application No. PCT/US2007/072127, 5 pages.;;Written Opinion, dated Dec. 27, 2008, for PCT Patent Application No. PCT/US2007/072127, 5 pages.;;International Preliminary Report on Patentability dated Jan. 6, 2009, for PCT Patent Application No. PCT/US2007/072127, 6 pages.;;International Search Report, dated Mar. 17, 2011, for PCT Application No. PCT/US2010/048130, 3 pages.;;Written Opinion, dated Mar. 9, 2012, for PCT Patent Application No. PCT/US2010/048130, 8 pages.;;International Preliminary Report on Patentability, dated Mar. 13, 2012, for PCT Patent Application No. PCT/US2010/048130, 9 pages.;;Notice of Allowance for U.S. Appl. No. 13/474,552, dated May 1, 2013, 23 pages.;;Notice of Allowability for U.S. Appl. No. 13/474,552, dated May 31, 2013, 3 pages.;;European Office Action dated Apr. 9, 2013 for EP Patent Application No. 10194370.2, 7 pages.;;Australian Office Action dated Jul. 9, 2013 for AU Patnet Application No. 2011253604, 2 pages.;;Australian Office Action dated Feb. 19, 2013 for AU Patent Application No. 2010292318, 3 pages.;;Australian Notice of Acceptance dated May 2, 2013 for AU Patent Application No. 2010292318, 2 pages.;;Canadian Office Action dated Aug. 1, 2013 for CA Patent Application No. 2,651,048, 5 pages.;;Indian Office Action dated Sep. 6, 2013 for IN Patent Application No. 4519/KOLNP/2008, 2 pages.;;Japanese Office Action dated Aug. 6, 2013 for JP Patent Application No. 2010-011810, with English translation, 9 pages.;;Korean Office Action dated Oct. 1, 2013 for KR Patent Application No. 10-2012-7008925, with English Translation, 8 pages.;;Japanese Notice of Allowance dated Oct. 15, 2013 for JP Patent Application No. 2012*528878, 3 pages.;;Umeda, Katsuji et al., “Music Distribution Business Illustrated for Understanding,”; Japan Management Associate Management Center; Oct. 1, 2000, First Edition, pp. 179, 187, in Japanese.;;Notice of Allowance dated Sep. 11, 2013 for U.S. Appl. No. 13/538,941, 8 pages.;;Canadian Office Action dated Dec. 17, 2013 for CA Patent Application No. 2,591,164, 3 pages.;;Japanese Office Action dated Mar. 10, 2014 for JP Patent Application No. 2013-055601, 4 pages.;;Korean Notice of Allowance dated Apr. 7, 2014 for KR Patent Application No. 10-2012-7008925, 2 pages.;;Chinese Office Action dated Jan. 30, 2014 for CN Patent Application No. 201080039625.9, with English Trranslation, 34 pages.;;Chinese Office Action dated May 29, 2014 for CN Patent Application No. 2012101598.4, with English Translation, 22 pages.;;Chinese Office Action dated May 27, 2014 for CN Patent Application No. 20121036876.x, with English Translation, 20 pages.;;Non-Final Office Action dated Nov. 24, 2010 for U.S. Appl. No. 12/328,368, 28 pages.;;Final Office Action dated May 11, 2011 for U.S. Appl. No. 12/328,368, 39 pages.;;Non-Final Office Action dated Aug. 15, 2013 for U.S. Appl. No. 12/328,368, 13 pages.;;Notice of Allowance dated Feb. 7, 2014 for U.S. Appl. No. 12/328,368, 8 pages.;;Non-Final Office Action dated Sep. 16, 2008 for U.S. Appl. No. 11/051,499, 18 pages.;;Final Office Action dated Mar. 19, 2009 for U.S. Appl. No. 11/051,499, 16 pages.;;Non-Final Office Action dated Nov. 30, 2009 for U.S. Appl. No. 11/051,499, 19 pages.;;Notice of Allowance dated Jun. 24, 2010 for U.S. Appl. No. 11/051,499, 9 pages.;;International Search Report and Written Opinion of the International Searching Authority dated May 15, 2006 for PCT Patent Application No. PCT/US2005/045040, 10 pages.;;Canadian Office Action dated Oct. 7, 2014 for CA Patent Application No. 2,651,048, 4 pages.;;Australian Office Action dated Nov. 5, 2014 for AU Patent Application No. 2013203800, 2 pages.;;Japanese Office Action dated Oct. 14, 2014 for JP Patent Application No. 2013-252930, with English translation, 9 pages.;;Chinese Office Action dated Nov. 3, 2014 for CN Patent Application No. 201210136878.9, 15 pages.;;Chinese Office Action dated Nov. 24, 2014 for CN Patent Application No. 201080039625.9, 6 pages.;;Non-Final Office Action dated Feb. 23, 2015 for U.S. Appl. No. 14/084,545, 6 pages.;;Chinese Office Action dated Feb. 16, 2015 for CN Patent Application No. 201080039625.9, 6 pages.;;Chinese Office Action dated Feb. 13, 2015 for CN Patent Application No. 201210101598.4, 19 pages.;;Canadian Office Action dated Mar. 11, 2015 for CA Patent Application No. 2,591,164, 4 pages.;;Chinese Office Action dated Mar. 31, 2015 for CN Patent Application No. 201210136876.X, 18 pages.;;Notice of Allowance dated Jun. 12, 2015 for U.S. Appl. No. 14/084,545, 5 pages.;;Chinese Office Action dated Jul. 8, 2015 for CN Patent Application No. 201210136878.9, 12 pages.;;Chinese Office Action dated Aug. 5, 2015 for CN Patent Application No. 201210101598.4, with English translation, 16 pages.;;Notice of Allowance dated Aug. 19, 2015 for U.S. Appl. No. 14/312,672, 10 pages.;;Canadian Office Action dated Oct. 22, 2015 for CA Patent Application No. 2,651,048, 7 pages.;;Notice of Allowance dated Jun. 26, 2015 in Japanese Patent Application No. 2013-252930. 9 pages (6 pages English Translation).;;Notice of Allowance dated Nov. 7, 2016 in Canadian Application No. 2,591,164. 1 page.;;International Search Report dated Dec. 21, 2010 for PCT Patent Application No. PCT/US2010/048130. 3 pages.;;Notice of Allowance dated Oct. 20, 2011 for Taiwanese Patent Application No. 096123296. 5 pages.;;Office Action dated Nov. 2, 2011 for U.S. Appl. No. 12/137,426. 42 pages.;;Office Action dated Nov. 1, 2011 for U.S. Appl. No. 12/953,172. 30 pages.;;Notice of Allowance dated Oct. 28, 2011 for U.S. Appl. No. 12/424,515. 8 pages.;;Office Action dated Nov. 18, 2011 for U.S. Appl. No. 12/895,675. 44 pages.;;Notice of Allowance dated Nov. 22, 2011 for U.S. Appl. No. 12/537,751. 8 pages.;;Office Action dated Nov. 9, 2011 for Chinese Patent Application No. 200910171786.2. 7 pages.;;Office Action dated Jan. 1, 2012 for U.S. Appl. No. 13/288,876. 15 pages.;;Office Action response dated Apr. 2, 2012 for U.S. Appl. No. 13/288,876. 13 pages.;;Notice of Allowance dated Jan. 10, 2012 for U.S. Appl. No. 12/857,230. 8 pages.;;Notice of Allowance dated Jan. 10, 2012 for U.S. Appl. No. 12/857,218. 8 pages.;;Office Action Response dated Jan. 30, 2012 for GB Patent Application No. GB1015018.3. 23 pages.;;Office Action dated Dec. 28, 2011 for GB Patent Application No. GB1015018.3. 3 pages.;;Office Action dated Apr. 9, 2012 for Chinese Application No. CN200910222182.6. 11 pages.;;Notice of Allowance dated Jan. 23, 2012 for U.S. Appl. No. 12/556,507. 9 pages.;;Notice of Allowance dated Feb. 24, 2012 for U.S. Appl. No. 12/895,675. 8 pages.;;Office Action dated Mar. 1, 2012 for U.S. Appl. No. 12/953,167. 6 pages.;;Notice of Allowance dated May 17, 2012 for U.S. Appl. No. 12/953,167. 6 pages.;;Office Action dated Mar. 2, 2012 for U.S. Appl. No. 12/953,172. 7 pages.;;Office Action Response dated May 1, 2012 for U.S. Appl. No. 12/953,172. 10 pages.;;Notice of Allowance dated May 11, 2012 for U.S. Appl. No. 12/953,172. 6 pages.;;Office Action dated Mar. 21, 2012 for U.S. Appl. No. 12/137,426. 10 pages.;;Notice of Allowance dated Apr. 4, 2012 for U.S. Appl. No. 12/349,984. 10 pages.;;Office Action dated Jun. 26, 2012 for U.S. Appl. No. 13/366,203. 5 pages.;;Office Action dated Apr. 12, 2012 for U.S. Appl. No. 13/331,446. 5 pages.;;Office Action dated Feb. 23, 2012 for Korean Patent Application No. KR 10-2007-7018101. 16 pages.;;Office Action dated Mar. 5, 2012 Korean Patent Application No. KR 10-2008-7030334. 1 page.;;Nokia, “Quick guide: Accessories guide,” 1999, 36 pages, 9357169, Issue 3 EN.;;Extended EP Search Report dated Feb. 3, 2012 for European Patent Application No. EP 10194377.7. 9 pages.;;Office Action dated May 24, 2012 for U.S. Appl. No. 13/296,554. 28 pages.;;Final Office Action dated Mar. 29, 2012 for Korean Patent Application No. KR 10-2009-7004222. 8 pages.;;Notice of Allowance dated Jun. 8, 2012 for U.S. Appl. No. 13/288,876. 5 pages.;;Office Action Response dated Jul. 17, 2012 for Chinese Patent Application No. CN200910222182.6. 7 pages.;;Office Action received May 16, 2012 for Canadian Patent Application No. CA 2,591,164. 3 pages.;;Notice of Allowance dated May 1, 2012 for Korean Patent Application No. 10-2008-7030334. 10 pages.;;Office Action dated Jun. 5, 2012 for Japanese Patent Application No. JP 2010011810. 5 pages.;;Notice of Allowance dated Oct. 26, 2012 for U.S. Appl. No. 13/331,446. 23 pages.;;Office Action dated Oct. 25, 2012 for Korean Patent Application No. KR 10-2012-7018797. 3 pages.;;Notice of Allowance dated Nov. 27, 2102 for U.S. Appl. No. 13/296,554. 5 pages.;;Notice of Allowance dated Dec. 10, 2012 for U.S. Appl. No. 13/366,203. 23 pages.;;Office Action dated Dec. 17, 2012 for Japanese Patent Application No. JP 2011-121858. 2 pages.;;Office Action dated Jan. 23, 2013 for Japanese Patent Application No. JP 2011-526100. 4 pages.;;Office Action dated Mar. 1, 2013 for U.S. Appl. No. 13/538,941. 12 pages.;;Office Action dated Mar. 6, 2013 for U.S. Appl. No. 13/347,511. 6 pages.;;Notice of Allowance dated Jul. 11, 2013 for U.S. Appl. No. 13/347,511. 6 pages.;;Notice of Allowance dated Sep. 11, 2013 for U.S. Appl. No. 13/538,941. 8 pages.;;Office Action dated Mar. 3, 2014 for Japanese Patent Application No. JP 2013-55601. 4 pages.;;Office Action dated May 29, 2014 for Chinese Patent Application No. CN201210101598.4. 13 pages.;;Office Action dated May 27, 2014 for Chinese Patent Application No. CN201210136876.X. 13 pages.;;Office Action dated Nov. 7, 2014 for Japanese Patent Application No. JP 2013-55601. 3 pages.;;Office Action dated Nov. 12, 2014 for Japanese Patent Application No. JP 2013-252930. 3 pages.;;Office Action dated Dec. 8, 2015 for Chinese Patent Application No. CN201210136876.X. 15 pages.;;Office Action dated Feb. 4, 2016 for Canadian Patent Application No. CA 2,591,164. 3 pages.;;Extended European Search Report dated Apr. 26, 2016 for European Patent Application No. EP 15173491.0. 14 pages.;;Non-Final Office Action dated Jun. 27, 2016 for U.S. Appl. No. 14/159,422. 13 pages.;;Office Action dated Mar. 1, 2010 for European Patent Application No. EP 05853866.1. 5 pages.;;Office Action dated Sep. 29, 2011 for European Patent Application No. EP 05853866.1. 5 pages.;;Office Action dated Mar. 14, 2011 for Korean Patent Application No. KR 10-2007-7018101. 3 pages.;;Office Action dated Mar. 10, 2011 for Korean Application No. KR 10-2009-7004222. 11 pages.;;Notice of Acceptance dated Jun. 26, 2011 for Australian Patent Application No. AU 2005323229. 2 pages.;;Office Action dated Apr. 12, 2011 for Chinese Patent Application No. CN200580046121.9. 10 pages.;;Office Action dated May 24, 2012 for Chinese Patent Application No. CN200910222182.6. 5 pages.;;Office Action dated Aug. 3, 2012 for Chinese Patent Application No. CN200910222182.6. 10 pages.;;International Preliminary Report on Patentability dated Jul. 10, 2007 for PCT Patent Application PCT/US2005/045040. 9 pages.;;International Search Report and Written Opinion dated Jul. 1, 2008 for PCT Patent Application PCT/US2007/072127. 8 pages.;;International Search Report and Written Opinion dated Feb. 6, 2008 for PCT Patent Application PCT/US2007/072154. 9 pages.;;International Preliminary Report on Patentability dated Jan. 6, 2009 for PCT Patent Application PCT/US2007/072154. 7 pages.;;International Search Report and Written Opinion dated Apr. 8, 2008 for PCT Patent Application PCT/US2007/072155. 7 pages.;;International Search Report and Written Opinion dated May 20, 2008 for PCT Patent Application PCT/US2007/078056. 6 pages.;;International Preliminary Report on Patentability dated Mar. 17, 2009 for PCT Patent Application PCT/US2007/078056. 5 pages.;;International Search Report and Written Opinion dated Apr. 24, 2008 for PCT Patent Application PCT/US2007/078072. 11 pages.;;International Preliminary Report on Patentability dated Mar. 17, 2009 for PCT Patent Application PCT/US2007/078072. 8 pages.;;International Search Report and Written Opinion dated Nov. 30, 2009 for PCT Patent Application PCT/US2009/054509. 10 pages.;;International Preliminary Report on Patentability dated Mar. 17, 2011 for PCT Patent Application PCT/US2008/054509. 9 pages.;;Non-Final Office Action dated Dec. 22, 2016 for U.S. Appl. No. 14/979,456. 8 pages.;;Notice of Allowance dated May 12, 2017 for U.S. Appl. No. 14/979,456. 8 pages.",ACTIVE
553,US,A1,US 2009/0094207 A1,054-146-573-184-697,2009-04-09,2009,US 24295708 A,2008-10-01,US 24295708 A;;US 97781107 P,2007-10-05,Identifying Clusters Of Words According To Word Affinities,"In one embodiment, identifying clusters of words includes accessing a record that records affinities. An affinity between a first and second word describes a quantitative relationship between the first and second word. Clusters of words are identified according to the affinities. A cluster comprises words that are sufficiently affine with each other. A first word is sufficiently affine with a second word if the affinity between the first and second word satisfies one or more affinity criteria. A clustering analysis is performed using the clusters.",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J,FUJITSU LIMITED (2008-09-17),https://lens.org/054-146-573-184-697,Patent Application,yes,11,49,4,5,0,G06F16/367;;G06F16/367,G06F17/30,707/3;;X707E17089,0,0,,,,ACTIVE
554,US,B2,US 8108392 B2,078-916-685-675-406,2012-01-31,2012,US 24295708 A,2008-10-01,US 24295708 A;;US 97781107 P,2007-10-05,Identifying clusters of words according to word affinities,"In one embodiment, identifying clusters of words includes accessing a record that records affinities. An affinity between a first and second word describes a quantitative relationship between the first and second word. Clusters of words are identified according to the affinities. A cluster comprises words that are sufficiently affine with each other. A first word is sufficiently affine with a second word if the affinity between the first and second word satisfies one or more affinity criteria. A clustering analysis is performed using the clusters.",MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J,FUJITSU LIMITED (2008-09-17),https://lens.org/078-916-685-675-406,Granted Patent,yes,13,17,4,5,0,G06F16/367;;G06F16/367,G06F17/30,707/737;;704/9,13,4,035-952-865-141-303;;009-662-265-360-918;;010-208-611-034-37X;;108-311-283-244-843,10.1109/icassp.1995.479390;;10.1016/s0306-4573(96)00068-4;;10.1109/eee.2004.1287329;;10.1016/s0306-4573(02)00035-3,"Tamoto, Masafumi et al., ""Clustering Word Category Based on Binomial Posteriori Co-Occurrence Distribution"", Acoustics, Speech, and Signal Processing, 0-7803-2431-5/95, pp. 165-168, May 9, 1995.;;Schütze, Hinrich, et al., ""A Cooccurrence-Based Thesaurus and Two Applications to Information Retrieval"", Information Processing & Management, vol. 33, No. 3, © Elsevier Science Ltd., 0306-4573/97, pp. 307-318, May 1, 1997.;;Isogai, Shuntaro, et al., ""Multi-Class Composite N-gram Language Model Using Multiple Word Clusters and Word Successions"", Eurospeech 2001-Scandinavia, 4 pages, 2001.;;Chen, Libo, et al., ""Increasing the Customer's Choice: Query Expansion based on the Layer-Seeds Method and its Application in E-Commerce"", Proceedings of the 2004 IEEE International Conference on e-Technology, e-Commerce and e-Service, 0-7695-2073-1/04, 8 pages, Mar. 28, 2004.;;Momtazi, S., et al., ""A Pos-Based Fuzzy Word Clustering Algorithm for Continuous Speech Recognition Systems"", IEEE, 1-4244-0779-6/07, 4 pages, Feb. 12, 2007.;;Communication from the European Patent Office, European Search Report for European Patent Application No. 08165809.8-1527, 7 pages, Jan. 26, 2009.;;U.S. Appl. No. 12/243,267, by inventors David L. Marvit et al., entitled ""Modeling Topics Using Statistical Distributions,"", 52 pages filed, Oct. 1, 2008.;;Li, Hang, et al., ""Topic analysis using a finite mixture model"", Information Processing and Management, vol. 39 , No. 4, pp. 521-541, Jul. 1, 2003.;;European Patent Office Communication, European Search Report and Annex to the European Search Report; Application No. EP 08 16 5836; Ref. P111733EP00/CLH; 5 pages, Aug. 4, 2009.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166172.0, 14 pages, Aug. 10, 2010.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166171.6, Chinese Office Action and English Translation, 13 pages, Nov. 9, 2010.;;The State Intellectual Property Office of China, 2nd Notification of Office Action, Patent Application No. 200810166171.6, Chinese Office Action and English Translation, 11 pages, Apr. 13, 2011.;;Marvit, U.S. Appl. No. 12/243,267, Non-Final Office Action mailed by the U.S. Patent and Trademark office on Apr. 18, 2011, 20 pages.",ACTIVE
555,US,A1,US 2005/0185654 A1,119-858-681-068-409,2005-08-25,2005,US 11151305 A,2005-04-21,US 11151305 A;;US 47749800 A;;US 23239699 A,1999-01-15,Method of providing network services,"A method of providing network services is described. The network includes a number of nodes, each one of which is coupled to at least one other of the nodes by at least one of a number of optical links. The network is preferably capable of supporting a number of virtual circuits. The method begins with the receiving of a request for a virtual circuit between a first node and a second node of the network. Preferably, the request specifies a quality of service of the virtual circuit. Next, the availability of network resources for supporting a virtual circuit at the requested quality of service is determined. Assuming sufficient network resources are available for support of the virtual circuit, the request is then serviced by provisioning (and maintaining) the requested virtual circuit. Servicing the request preferably includes actions such as provisioning, maintaining, and restoring the virtual circuit, using the requested parameters.",ZADIKIAN H. M.;;PLOTE STEVAN E.;;ADLER JOHN C.;;AUTRY DAVID P.;;SALEH ALI N.,ZADIKIAN H M;;PLOTE STEVAN E;;ADLER JOHN C;;AUTRY DAVID P;;SALEH ALI N,,https://lens.org/119-858-681-068-409,Patent Application,yes,79,63,6,7,0,H04J14/0227;;H04J14/0282;;H04J14/0283;;H04J14/0284;;H04J14/0294;;H04J14/0295;;H04J14/0297;;H04L47/15;;H04L47/741;;H04L47/743;;H04L47/746;;H04L47/748;;H04L47/805;;H04L47/822;;H04L47/825;;H04L47/826;;H04Q11/0005;;H04Q11/0062;;H04Q2011/0058;;H04Q2011/0081;;H04Q2011/0084;;H04Q2011/0086;;H04Q2011/0088;;H04J14/0241;;H04J14/0228;;H04L47/70;;H04J14/0295;;H04Q2011/0084;;H04Q2011/0058;;H04J14/0284;;H04L47/805;;H04Q11/0062;;H04L47/15;;H04Q2011/0081;;H04J14/0227;;H04L47/746;;H04J14/0282;;H04J14/0297;;H04L47/748;;H04Q11/0005;;H04L47/741;;H04Q2011/0086;;H04L47/743;;H04Q2011/0088;;H04J14/0283;;H04L47/822;;H04L47/826;;H04L47/825;;H04J14/0294;;H04J14/0241;;H04J14/0228;;H04L47/70,H04L12/56;;H04Q11/00,370/395.21,0,0,,,,EXPIRED
556,MX,A,MX 2019003425 A,183-796-406-312-462,2019-08-16,2019,MX 2019003425 A,2017-09-27,US 201662401093 P;;US 201762459461 P;;US 201762554939 P;;US 2017/0053629 W,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF.,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,SHENDONG YUAN;;BRAD OWEN BUCKMAN;;KUMARASWAMY EMAYAN;;JOHN BEAMOND NICHOLAS (FINADO);;MARC ADLER;;JINGYUAN MA,,https://lens.org/183-796-406-312-462,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
557,US,A1,US 2001/0035977 A1,164-935-185-864-965,2001-11-01,2001,US 88793001 A,2001-06-21,US 88793001 A;;US 80389897 A,1997-02-21,Facsimile network,"
    A facsimile network includes a plurality of nodes ( 10 )-( 14 ) which are disposed at different locations in the world. An originating fax machine ( 16 ) is associated with one of the nodes ( 10 ) for transmitting a fax over a local public telephone network (PSTN) ( 18 ). When the node ( 10 ) receives the fax transmission in the normal transmission mode, it then converts it to a digitized compressed and encrypted image which is transmitted over a primary network ( 24 ), such as the Internet, to a destination node ( 14 ) by a predetermined route. The node ( 14 ) then decompresses and de-encrypts the image and converts it to a facsimile image for transmission to a destination fax ( 20 ) in a normal mode over a local PSTN ( 22 ). A node ( 12 ) operates as a central node which can also receive the transmission for routing directly to the fax or for directing via another network link to the node ( 14 ). 
",WORLDQUEST NETWORK INC,ADLER B MICHAEL;;QUAID TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,VOIP ACQUISITION COMPANY (2005-10-05),https://lens.org/164-935-185-864-965,Patent Application,yes,0,19,5,5,0,H04N1/32406;;H04N1/32406;;H04N1/00209;;H04N1/00209;;H04N1/32358;;H04N1/32358;;H04N2201/0017;;H04N2201/0017;;H04N2201/0093;;H04N2201/0093,H04N1/00;;H04N1/32,358/1.15;;X3584,0,0,,,,EXPIRED
558,EP,A2,EP 2996753 A2,085-117-079-295-078,2016-03-23,2016,EP 14730367 A,2014-05-15,US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P;;US 2014/0038215 W,2013-05-15,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEVE;;CHEN KEVIN,,https://lens.org/085-117-079-295-078,Patent Application,yes,0,1,4,63,0,A61M16/20;;A61M15/002;;A61M16/0051;;A61M16/0066;;A61M16/0069;;A61M16/024;;A61M16/06;;A61M16/0666;;A61M16/0683;;A61M16/0688;;A61M16/0816;;A61M16/0833;;A61M16/0875;;A61M16/107;;A61M16/201;;A61M16/202;;A61M16/205;;A61M16/206;;A61M16/208;;A61M2016/0027;;A61M2016/0033;;A61M2016/0661;;A61M2205/0216;;A61M2205/0238;;A61M2205/0266;;A61M2205/3553;;A61M2205/3569;;A61M2205/3584;;A61M2205/3592;;A61M2205/42;;A61M2205/505;;A61M2205/52;;A61M2205/8206;;A61M2205/8237;;A61M2205/8281;;A61M2209/06;;A61M2209/086;;A61M2209/088;;A61M2230/63,A61M16/20;;A61M16/00;;A61M16/06;;A61M16/08,,1,0,,,See references of WO 2014186584A2,ACTIVE
559,US,A1,US 2014/0246025 A1,103-078-125-465-958,2014-09-04,2014,US 201414278587 A,2014-05-15,US 201414278587 A;;US 201313860926 A;;US 201261623855 P;;US 201361775430 P;;US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P,2012-04-13,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEVE;;CHEN KEVIN,FRESCA MEDICAL INC (2014-01-23),https://lens.org/103-078-125-465-958,Patent Application,yes,11,52,4,63,0,A61M16/208;;A61M16/208;;A61B5/11;;A61B5/4809;;A61B5/4818;;A61B5/4836;;A61B5/4836;;A61M16/0057;;A61M16/0057;;A61M16/0069;;A61M16/0069;;A61M16/06;;A61M16/06;;A61M16/0683;;A61M16/0683;;A61M16/0688;;A61M16/0688;;A61M16/0833;;A61M16/0833;;A61M16/0866;;A61M16/0866;;A61M16/0875;;A61M16/0875;;A61M16/107;;A61M16/107;;A61M16/201;;A61M16/201;;A61M16/202;;A61M16/202;;A61M16/206;;A61M16/206;;A61M16/209;;A61M16/209;;A61M2016/0027;;A61M2016/0027;;A61M2016/0039;;A61M2016/0039;;A61M2016/0661;;A61M2016/0661;;A61M2205/18;;A61M2205/18;;A61M2205/3375;;A61M2205/3375;;A61M2205/3553;;A61M2205/3553;;A61M2205/3561;;A61M2205/3561;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/42;;A61M2205/42;;A61M2205/505;;A61M2205/505;;A61M2205/52;;A61M2205/52;;A61M2205/8206;;A61M2205/8206;;A61M2205/8237;;A61M2205/8237;;A61M2205/8281;;A61M2205/8281;;A61M2209/06;;A61M2209/06;;A61M2209/088;;A61M2209/088;;A61M2230/04;;A61M2230/04;;A61M2230/18;;A61M2230/18;;A61M2230/205;;A61M2230/205;;A61M2230/63;;A61M2230/63;;Y10T29/49412;;Y10T29/49412,A61M16/20;;A61B5/00;;A61B5/11;;A61M16/00;;A61M16/06;;A61M16/08,128/204.19;;128/205.18;;128/205.24;;128/204.21;;128/204.23;;29/890.124,0,0,,,,INACTIVE
560,WO,A3,WO 2014/186584 A3,163-117-375-409-41X,2015-01-08,2015,US 2014/0038215 W,2014-05-15,US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P,2013-05-15,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,A device (1500) for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve (1502) connected to a manifold. The expiratory valve can include a body portion including a feedback port (1518) configured to be connected to an air flow generator. The expiratory valve can include a plunger (1504) at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber (1516) positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEVE;;CHEN KEVIN,,https://lens.org/163-117-375-409-41X,Search Report,yes,7,0,4,63,0,A61M16/0066;;A61M16/06;;A61M16/0666;;A61M16/0683;;A61M16/0816;;A61M16/0875;;A61M16/20;;A61M16/208;;A61M2016/0027;;A61M2016/0033;;A61M2016/0661;;A61M2205/0216;;A61M2205/0238;;A61M2205/0266;;A61M2205/3553;;A61M2205/3569;;A61M2205/3584;;A61M2205/3592;;A61M2205/42;;A61M2205/505;;A61M2205/52;;A61M2205/8206;;A61M2205/8237;;A61M2205/8281;;A61M2209/06;;A61M2209/086;;A61M2209/088;;A61M2230/63;;A61M16/0833;;A61M15/002;;A61M16/0069;;A61M16/0688;;A61M16/201;;A61M16/205;;A61M16/206;;A61M16/107;;A61M16/202;;A61M16/024;;A61M16/0051,A61M16/20;;A61M16/00;;A61M16/06;;A61M16/08,,0,0,,,,PENDING
561,US,A1,US 2014/0246024 A1,186-343-817-694-706,2014-09-04,2014,US 201414278398 A,2014-05-15,US 201414278398 A;;US 201313860926 A;;US 201261623855 P;;US 201361775430 P;;US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P,2012-04-13,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEVE;;CHEN KEVIN,FRESCA MEDICAL INC (2014-01-23),https://lens.org/186-343-817-694-706,Patent Application,yes,9,22,2,63,0,A61M16/208;;A61M16/208;;A61B5/11;;A61B5/4809;;A61B5/4836;;A61B5/4836;;A61M16/0057;;A61M16/0057;;A61M16/0069;;A61M16/0069;;A61M16/06;;A61M16/06;;A61M16/0683;;A61M16/0683;;A61M16/0688;;A61M16/0688;;A61M16/0833;;A61M16/0833;;A61M16/0866;;A61M16/0866;;A61M16/0875;;A61M16/0875;;A61M16/107;;A61M16/107;;A61M16/201;;A61M16/201;;A61M16/202;;A61M16/202;;A61M16/206;;A61M16/206;;A61M16/209;;A61M16/209;;A61M2016/0027;;A61M2016/0027;;A61M2016/0039;;A61M2016/0039;;A61M2016/0661;;A61M2016/0661;;A61M2205/18;;A61M2205/18;;A61M2205/3375;;A61M2205/3375;;A61M2205/3553;;A61M2205/3553;;A61M2205/3561;;A61M2205/3561;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/42;;A61M2205/42;;A61M2205/505;;A61M2205/505;;A61M2205/52;;A61M2205/52;;A61M2205/8206;;A61M2205/8206;;A61M2205/8237;;A61M2205/8237;;A61M2205/8281;;A61M2205/8281;;A61M2209/06;;A61M2209/06;;A61M2209/088;;A61M2209/088;;A61M2230/04;;A61M2230/04;;A61M2230/18;;A61M2230/18;;A61M2230/205;;A61M2230/205;;A61M2230/63;;A61M2230/63;;Y10T29/49826;;Y10T29/49826,A61M16/20;;A61B5/00;;A61B5/11;;A61M16/00;;A61M16/08,128/204.19;;128/205.24;;128/204.23;;29/428,0,0,,,,INACTIVE
562,WO,A2,WO 2014/186584 A2,060-745-331-862-485,2014-11-20,2014,US 2014/0038215 W,2014-05-15,US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P,2013-05-15,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEVE;;CHEN KEVIN,,https://lens.org/060-745-331-862-485,Patent Application,yes,3,15,4,63,0,A61M16/20;;A61M15/002;;A61M16/0051;;A61M16/0066;;A61M16/0069;;A61M16/024;;A61M16/06;;A61M16/0666;;A61M16/0683;;A61M16/0688;;A61M16/0816;;A61M16/0833;;A61M16/0875;;A61M16/107;;A61M16/201;;A61M16/202;;A61M16/205;;A61M16/206;;A61M16/208;;A61M2016/0027;;A61M2016/0033;;A61M2016/0661;;A61M2205/0216;;A61M2205/0238;;A61M2205/0266;;A61M2205/3553;;A61M2205/3569;;A61M2205/3584;;A61M2205/3592;;A61M2205/42;;A61M2205/505;;A61M2205/52;;A61M2205/8206;;A61M2205/8237;;A61M2205/8281;;A61M2209/06;;A61M2209/086;;A61M2209/088;;A61M2230/63,A61M16/20,,0,0,,,,PENDING
563,US,A1,US 2017/0357797 A1,104-905-758-197-888,2017-12-14,2017,US 201715671012 A,2017-08-07,US 201715671012 A;;US 201514979456 A;;US 201414312672 A;;US 32836808 A;;US 5149905 A;;US 64234005 P,2005-01-07,ACCESSORY AUTHENTICATION FOR ELECTRONIC DEVICES,"Improved techniques to control utilization of accessory devices with electronic devices are disclosed. The improved techniques can use cryptographic approaches to authenticate electronic devices, namely, electronic devices that interconnect and communicate with one another. One aspect pertains to techniques for authenticating an electronic device, such as an accessory device. Another aspect pertains to provisioning software features (e.g., functions) by or for an electronic device (e.g., a host device). Different electronic devices can, for example, be provisioned differently depending on different degrees or levels of authentication, or depending on manufacturer or product basis. Still another aspect pertains to using an accessory (or adapter) to convert a peripheral device (e.g., USB device) into a host device (e.g., USB host). The improved techniques are particularly well suited for electronic devices, such as media devices, that can receive accessory devices. One example of a media device is a media player, such as a hand-held media player (e.g., music player), that can present (e.g., play) media items (or media assets).",APPLE INC,RUBINSTEIN JONATHAN J;;FADELL ANTHONY M;;DOROGUSKER JESSE LEE;;ADLER MITCHELL D;;ARCHIBALD JOHN WESLEY,,https://lens.org/104-905-758-197-888,Patent Application,yes,0,3,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G06F21/44;;G06F21/60;;G10L19/00,,0,0,,,,ACTIVE
564,US,A1,US 2004/0075872 A1,111-548-167-596-124,2004-04-22,2004,US 42137903 A,2003-04-22,US 42137903 A;;US 88793001 A;;US 80389897 A,1997-02-21,Facsimile network,"
    A facsimile network includes a plurality of nodes ( 10 )-( 14 ) which are disposed at different locations in the world. An originating fax machine ( 16 ) is associated with one of the nodes ( 10 ) for transmitting a fax over a local public telephone network (PSTN) ( 18 ). When the node ( 10 ) receives the fax transmission in the normal transmission mode, it then converts it to a digitized compressed and encrypted image which is transmitted over a primary network ( 24 ), such as the Internet, to a destination node ( 14 ) by a predetermined route. The node ( 14 ) then decompresses and de-encrypts the image and converts it to a facsimile image for transmission to a destination fax ( 20 ) in a normal mode over a local PSTN ( 22 ). A node ( 12 ) operates as a central node which can also receive the transmission for routing directly to the fax or for directing via another network link to the node ( 14 ). 
",ADLER B. MICHAEL;;QUAID TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,ADLER B MICHAEL;;QUAID TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,,https://lens.org/111-548-167-596-124,Patent Application,yes,25,11,5,5,0,H04N1/32406;;H04N1/32406;;H04N1/00209;;H04N1/00209;;H04N1/32358;;H04N1/32358;;H04N2201/0017;;H04N2201/0017;;H04N2201/0093;;H04N2201/0093,H04N1/00;;H04N1/32,358/442,0,0,,,,EXPIRED
565,EP,B1,EP 2996753 B1,065-180-790-954-158,2019-12-11,2019,EP 14730367 A,2014-05-15,US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P;;US 2014/0038215 W,2013-05-15,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEVE;;CHEN KEVIN,,https://lens.org/065-180-790-954-158,Granted Patent,yes,7,0,4,63,0,A61M16/0066;;A61M16/06;;A61M16/0666;;A61M16/0683;;A61M16/0816;;A61M16/0875;;A61M16/20;;A61M16/208;;A61M2016/0027;;A61M2016/0033;;A61M2016/0661;;A61M2205/0216;;A61M2205/0238;;A61M2205/0266;;A61M2205/3553;;A61M2205/3569;;A61M2205/3584;;A61M2205/3592;;A61M2205/42;;A61M2205/505;;A61M2205/52;;A61M2205/8206;;A61M2205/8237;;A61M2205/8281;;A61M2209/06;;A61M2209/086;;A61M2209/088;;A61M2230/63;;A61M16/0833;;A61M15/002;;A61M16/0069;;A61M16/0688;;A61M16/201;;A61M16/205;;A61M16/206;;A61M16/107;;A61M16/202;;A61M16/024;;A61M16/0051,A61M16/20;;A61M16/00;;A61M16/06;;A61M16/08,,0,0,,,,ACTIVE
566,MX,A,MX 2022010168 A,077-460-585-085-661,2022-09-12,2022,MX 2022010168 A,2019-03-25,US 201662401093 P;;US 201762459461 P;;US 201762554939 P,2016-09-28,CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF.,"Disclosed herein are small molecule calpain modulator compositions, pharmaceutical compositions, the use and preparation thereof.",BLADE THERAPEUTICS INC,EMAYAN KUMARASWAMY;;ADLER MARC;;YUAN SHENDONG;;BUCKMAN BRAD OWEN;;NICHOLAS (FINADO) JOHN BEAMOND;;MA JINGYUANG,,https://lens.org/077-460-585-085-661,Patent Application,no,0,0,30,31,0,C07D403/12;;C07D401/14;;C07D405/14;;C07D413/14;;C07D319/08;;C07D231/14;;C07D333/38;;C07D233/90;;C07D401/04;;C07D235/18;;C07D403/04;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D417/04;;C07D417/14;;C07D249/06;;C07D261/18;;C07D487/04;;C07D263/34;;C07D207/16;;C07D271/08;;C07D275/03;;C07D277/56;;C07D209/42;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;A61P35/00;;A61P7/04;;A61P7/04;;A61P35/00;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/426;;A61K31/427;;A61K31/433;;A61K31/44;;C07D207/16;;C07D209/42;;C07D231/14;;C07D233/90;;C07D235/18;;C07D249/06;;C07D261/18;;C07D263/34;;C07D271/08;;C07D275/03;;C07D277/56;;C07D285/06;;C07D285/10;;C07D307/68;;C07D307/84;;C07D319/08;;C07D333/38;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D405/14;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/12;;C07D413/14;;C07D417/04;;C07D417/14;;C07D487/04;;A61P11/00;;C07C233/05;;C07D209/20;;C07D231/14;;C07D233/90;;C07D249/06;;C07D263/34;;C07D271/04;;C07D275/03;;C07D285/06;;C07D307/68;;C07D401/04;;C07D401/14;;C07D403/04;;C07D403/14;;C07D417/04;;C07D417/14,C07D403/14;;A61K31/4155;;A61K31/4178;;A61K31/422;;A61K31/427;;A61K31/433;;A61K31/44;;A61P7/04;;A61P35/00;;C07D231/14;;C07D233/66;;C07D261/10;;C07D263/16;;C07D275/03;;C07D277/30;;C07D285/06;;C07D403/04;;C07D405/04;;C07D405/14;;C07D407/04;;C07D409/04;;C07D409/14;;C07D413/04;;C07D413/14;;C07D417/04;;C07D417/14,,0,0,,,,PENDING
567,US,B2,US 11090458 B2,110-710-980-867-042,2021-08-17,2021,US 201916354137 A,2019-03-14,US 201916354137 A;;US 201414278587 A;;US 201313860926 A;;US 201361838191 P;;US 201361823553 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P;;US 201261623855 P;;US 201361775430 P,2012-04-13,Auto-feedback valve for a sleep apnea device,"The system includes an air flow generator configured to deliver an air flow at a positive therapeutic pressure during the treatment, and an expiratory valve with an open pressure connected to the air flow generator. The open pressure is dependent on the therapeutic pressure from the air flow generator. The expiratory valve further exerts a back pressure upon each exhalation from the patient sufficient to create a pneumatic splint in the patient's respiratory tract. The exhalation from the patient has a first half followed by a second half, and the back pressure is varied such that during the start of the first half, the back pressure is between 0 and 50% of a peak back pressure, and increases to a peak back pressure in the second half.",FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEPHEN WILLIAM;;CHEN KEVIN,,https://lens.org/110-710-980-867-042,Granted Patent,yes,6,3,4,63,0,A61M16/208;;A61M16/208;;A61B5/11;;A61B5/4809;;A61B5/4818;;A61B5/4836;;A61B5/4836;;A61M16/0057;;A61M16/0057;;A61M16/0069;;A61M16/0069;;A61M16/06;;A61M16/06;;A61M16/0683;;A61M16/0683;;A61M16/0688;;A61M16/0688;;A61M16/0833;;A61M16/0833;;A61M16/0866;;A61M16/0866;;A61M16/0875;;A61M16/0875;;A61M16/107;;A61M16/107;;A61M16/201;;A61M16/201;;A61M16/202;;A61M16/202;;A61M16/206;;A61M16/206;;A61M16/209;;A61M16/209;;A61M2016/0027;;A61M2016/0027;;A61M2016/0039;;A61M2016/0039;;A61M2016/0661;;A61M2016/0661;;A61M2205/18;;A61M2205/18;;A61M2205/3375;;A61M2205/3375;;A61M2205/3553;;A61M2205/3553;;A61M2205/3561;;A61M2205/3561;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/42;;A61M2205/42;;A61M2205/505;;A61M2205/505;;A61M2205/52;;A61M2205/52;;A61M2205/8206;;A61M2205/8206;;A61M2205/8237;;A61M2205/8237;;A61M2205/8281;;A61M2205/8281;;A61M2209/06;;A61M2209/06;;A61M2209/088;;A61M2209/088;;A61M2230/04;;A61M2230/04;;A61M2230/18;;A61M2230/18;;A61M2230/205;;A61M2230/205;;A61M2230/63;;A61M2230/63;;Y10T29/49412;;Y10T29/49412,A61M16/20;;A61B5/00;;A61B5/11;;A61M16/00;;A61M16/06;;A61M16/08;;A61M16/10,,0,0,,,,ACTIVE
568,US,A1,US 2019/0224440 A1,144-519-339-865-007,2019-07-25,2019,US 201916354137 A,2019-03-14,US 201916354137 A;;US 201414278587 A;;US 201313860926 A;;US 201361838191 P;;US 201361823553 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P;;US 201261623855 P;;US 201361775430 P,2012-04-13,AUTO-FEEDBACK VALVE FOR A SLEEP APNEA DEVICE,"A system for treating a patient suffering from obstructive sleep apnea or snoring is diclsoed. The system includes an air flow generator configured to deliver an air flow at a positive therapeutic pressure during the treatment, and an expiratory valve with an open pressure connected air flow generator. The open pressure is dependent on the therapeutic pressure from the air flow generator. The expiratory valve further exerts a back pressure upon each exhalation from the patient sufficient to create a pneumatic splint in the patient's respiratory tract. The exhalation from the patient has a first half followed by a second half and the back pressure is varied such that during the start of the first half the back pressure is between 0 and 50% of a peak back pressure and increases to a peak back pressure in the second half.",FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD;;ADLER MARK;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN;;ANDERSON STEPHEN WILLIAM;;CHEN KEVIN,,https://lens.org/144-519-339-865-007,Patent Application,yes,0,1,4,63,0,A61M16/208;;A61M16/208;;A61B5/11;;A61B5/4809;;A61B5/4818;;A61B5/4836;;A61B5/4836;;A61M16/0057;;A61M16/0057;;A61M16/0069;;A61M16/0069;;A61M16/06;;A61M16/06;;A61M16/0683;;A61M16/0683;;A61M16/0688;;A61M16/0688;;A61M16/0833;;A61M16/0833;;A61M16/0866;;A61M16/0866;;A61M16/0875;;A61M16/0875;;A61M16/107;;A61M16/107;;A61M16/201;;A61M16/201;;A61M16/202;;A61M16/202;;A61M16/206;;A61M16/206;;A61M16/209;;A61M16/209;;A61M2016/0027;;A61M2016/0027;;A61M2016/0039;;A61M2016/0039;;A61M2016/0661;;A61M2016/0661;;A61M2205/18;;A61M2205/18;;A61M2205/3375;;A61M2205/3375;;A61M2205/3553;;A61M2205/3553;;A61M2205/3561;;A61M2205/3561;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/42;;A61M2205/42;;A61M2205/505;;A61M2205/505;;A61M2205/52;;A61M2205/52;;A61M2205/8206;;A61M2205/8206;;A61M2205/8237;;A61M2205/8237;;A61M2205/8281;;A61M2205/8281;;A61M2209/06;;A61M2209/06;;A61M2209/088;;A61M2209/088;;A61M2230/04;;A61M2230/04;;A61M2230/18;;A61M2230/18;;A61M2230/205;;A61M2230/205;;A61M2230/63;;A61M2230/63;;Y10T29/49412;;Y10T29/49412,A61M16/20;;A61B5/00;;A61B5/11;;A61M16/00;;A61M16/06;;A61M16/08,,0,0,,,,ACTIVE
569,US,B2,US 7411703 B2,161-125-231-090-38X,2008-08-12,2008,US 42137903 A,2003-04-22,US 42137903 A;;US 88793001 A;;US 80389897 A,1997-02-21,Facsimile network,"A facsimile network includes a plurality of nodes ( 10 )-( 14 ) which are disposed at different locations in the world. An originating fax machine ( 16 ) is associated with one of the nodes ( 10 ) for transmitting a fax over a local public telephone network (PSTN) ( 18 ). When the node ( 10 ) receives the fax transmission in the normal transmission mode, it then converts it to a digitized compressed and encrypted image which is transmitted over a primary network ( 24 ), such as the Internet, to a destination node ( 14 ) by a predetermined route. The node ( 14 ) then decompresses and de-encrypts the image and converts it to a facsimile image for transmission to a destination fax ( 20 ) in a normal mode over a local PSTN ( 22 ). A node ( 12 ) operates as a central node which can also receive the transmission for routing directly to the fax or for directing via another network link to the node ( 14 ).",ADLER B MICHAEL;;QUAID JR TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,ADLER B MICHAEL;;QUAID JR TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,,https://lens.org/161-125-231-090-38X,Granted Patent,yes,25,6,5,5,0,H04N1/32406;;H04N1/32406;;H04N1/00209;;H04N1/00209;;H04N1/32358;;H04N1/32358;;H04N2201/0017;;H04N2201/0017;;H04N2201/0093;;H04N2201/0093,H04N1/32;;H04N1/00,358/442,0,0,,,,EXPIRED
570,US,A1,US 2005/0108359 A1,198-477-274-812-057,2005-05-19,2005,US 70188603 A,2003-11-05,US 70188603 A,2003-11-05,Remote mail management system,"In a method for reducing notifications associated with incoming emails destined to a user using a wireless device, after receiving an incoming email, a relay server checks whether there is undelivered email destined to the user. If there is no undelivered email, then a notification is sent to the user's wireless device. If there are undelivered emails, then the relay server calculates a lapse time since the last notification was sent to the user. If the lapse time is greater than a predefined period, a notification is sent to the user.",HYDER ROBERT;;ADLER ALFRED;;LYONS AMANDA;;MCCONNELL RICHARD;;MODAK VINAY;;MOORE JOHN;;PAUL ALICIA;;TALWAR HRISHI,HYDER ROBERT;;ADLER ALFRED;;LYONS AMANDA;;MCCONNELL RICHARD;;MODAK VINAY;;MOORE JOHN;;PAUL ALICIA;;TALWAR HRISHI,MOTOROLA INC (2003-09-29),https://lens.org/198-477-274-812-057,Patent Application,yes,19,18,1,1,0,G06Q10/10;;G06Q10/10,G06F15/16;;G06Q10/00,709/217,0,0,,,,DISCONTINUED
571,US,A1,US 2021/0208783 A1,055-042-291-266-715,2021-07-08,2021,US 202117205512 A,2021-03-18,US 202117205512 A;;US 201916355317 A;;US 201862751458 P,2018-10-26,DYNAMICALLY SELECTING SEGMENT HEIGHTS IN A HETEROGENEOUS RAID GROUP,"A system includes a solid-state storage array having a plurality of solid-state storage devices and a storage controller coupled to the solid-state storage array, the storage controller including a processing device, the processing device to select a segment height based on erase block sizes of the plurality of solid-state storage devices. The processing device is further to program a data segment using the segment height to a data stripe across two or more of the plurality of solid-state storage devices and store the segment height in metadata associated with the data segment.",PURE STORAGE INC,BERNAT ANDREW R;;ASTER RADEK;;SCHOLBROCK BENJAMIN;;HAFFNER CONNER;;DUAN YUNPENG;;ADLER JOHN;;CHANG TSU-HAO,,https://lens.org/055-042-291-266-715,Patent Application,yes,13,0,3,3,0,G06F3/0688;;G06F3/064;;G06F3/0619;;G06F3/0652;;G06F3/064;;G06F3/0689;;G06F3/065;;G06F16/907;;G06F3/0619;;G06F3/0652,G06F3/06;;G06F16/907,,0,0,,,,PENDING
572,US,B2,US 10976947 B2,190-885-122-107-924,2021-04-13,2021,US 201916355317 A,2019-03-15,US 201916355317 A;;US 201862751458 P,2018-10-26,Dynamically selecting segment heights in a heterogeneous RAID group,"A system includes a solid-state storage array having a plurality of solid-state storage devices and a storage controller coupled to the solid-state storage array, the storage controller including a processing device, the processing device to select a segment height based on erase block sizes of the plurality of solid-state storage devices. The processing device is further to program a data segment using the segment height to a data stripe across two or more of the plurality of solid-state storage devices and store the segment height in metadata associated with the data segment.",PURE STORAGE INC,BERNAT ANDREW R;;ASTER RADEK;;SCHOLBROCK BENJAMIN;;HAFFNER CONNER;;DUAN YUNPENG;;ADLER JOHN;;CHANG TSU-HAO,PURE STORAGE INC (2019-03-13),https://lens.org/190-885-122-107-924,Granted Patent,yes,261,0,3,3,0,G06F3/064;;G06F3/0688;;G06F3/0619;;G06F3/0619;;G06F3/064;;G06F3/065;;G06F3/0652;;G06F3/0652;;G06F3/0689;;G06F16/907,G11C16/16;;G06F3/06;;G06F16/907,,25,2,015-146-371-470-72X;;057-252-254-323-694,10.5573/ieie.2014.51.2.085;;10.1145/2379436.2379438,"Hwang, Kai, et al. “RAID-x: A New Distributed Disk Array for I/O-Centric Cluster Computing,” HPDC '00 Proceedings of the 9th IEEE International Symposium on High Performance Distributed Computing, IEEE, 2000, pp. 279-286.;;Schmid, Patrick: “RAID Scaling Charts, Part 3:4-128 kB Stripes Compared”, Tom's Hardware, Nov. 27, 2007 (http://www.tomshardware.com/reviews/RAID-SCALING-CHARTS.1735-4.html), See pp. 1-2.;;Storer, Mark W. et al., “Pergamum: Replacing Tape with Energy Efficient, Reliable, Disk-Based Archival Storage,” Fast '08: 6th USENIX Conference on File and Storage Technologies, San Jose, CA, Feb. 26-29, 2008 pp. 1-16.;;Ju-Kyeong Kim et al., “Data Access Frequency based Data Replication Method using Erasure Codes in Cloud Storage System”, Journal of the Institute of Electronics and Information Engineers, Feb. 2014, vol. 51, No. 2, pp. 85-91.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2015/018169, dated May 15, 2015.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2015/034302, dated Sep. 11, 2015.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2015/039135, dated Sep. 18, 2015.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2015/039136, dated Sep. 23, 2015.;;International Search Report, PCT/US2015/039142, dated Sep. 24, 2015.;;International Search Report, PCT/US2015/034291, dated Sep. 30, 2015.;;International Search Report and the Written Opinion of the International Searching Authority, PCT/US2015/039137, dated Oct. 1, 2015.;;International Search Report, PCT/US2015/044370, dated Dec. 15, 2015.;;International Search Report amd the Written Opinion of the International Searching Authority, PCT/US2016/031039, dated May 5, 2016.;;International Search Report, PCT/US2016/014604, dated May 19, 2016.;;International Search Report, PCT/US2016/014361, dated May 30, 2016.;;International Search Report, PCT/US2016/014356, dated Jun. 28, 2016.;;International Search Report, PCT/US2016/014357, dated Jun. 29, 2016.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/016504, dated Jul. 6, 2016.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/024391, dated Jul. 12, 2016.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/026529, dated Jul. 19, 2016.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/023485, dated Jul. 21, 2016.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/033306, dated Aug. 19, 2016.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/047808, dated Nov. 25, 2016.;;Stalzer, Mark A., “FlashBlades: System Architecture and Applications,” Proceedings of the 2nd Workshop on Architectures and Systems for Big Data, Association for Computing Machinery, New York, NY, 2012, pp. 10-14.;;International Seach Report and the Written Opinion of the International Searching Authority, PCT/US2016/042147, dated Nov. 30, 2016.",ACTIVE
573,HK,A1,HK 1114196 A1,140-415-459-569-833,2008-10-24,2008,HK 08103946 A,2008-04-09,US 2005/0045040 W;;US 64234005 P;;US 5149905 A,2005-01-07,PORTABLE ELECTRONIC DEVICE FOR RECEIVING ACCESSORY DEVICES,,APPLE INC,RUBINSTEIN JONATHAN JAKE;;ANTHONY M FADELL M;;JESSE L DOROGUSKER L;;ADLER MITCHELL;;ARCHIBALD JOHN WESLEY,,https://lens.org/140-415-459-569-833,Patent Application,no,0,0,46,46,0,G06F21/445;;G06F2221/2129;;H04L9/32;;G06F21/445;;G06F2221/2129;;G06F21/44;;G06F21/602,G10L19/00,,0,0,,,,PENDING
574,DE,T2,DE 69404502 T2,121-602-463-914-892,1997-12-04,1997,DE 69404502 T,1994-02-17,US 2125593 A,1993-02-23,Rotierende Strangpressdüse zum Extrudieren von Wabenstrukturen,,CORNING INC,ADLER MERYLE DANIEL WALTER;;FROST RODNEY IRVING;;BAGLEY RODNEY DELANO;;LANNING JOHN GUSTIN;;SHAFER HAROLD GORDON,,https://lens.org/121-602-463-914-892,Granted Patent,no,0,0,9,9,0,B28B3/269;;B28B3/269;;B28B3/269,B28B3/26;;B28B3/20,,0,0,,,,EXPIRED
575,US,A1,US 2009/0228779 A1,093-058-245-324-042,2009-09-10,2009,US 39761709 A,2009-03-04,US 39761709 A;;US 3376708 P,2008-03-04,USE OF REMOTE SERVICES BY A LOCAL WIRELESS ELECTRONIC DEVICE,"The present disclosure generally relates to enabling web applications to use application programming interfaces (APIs) to display content on a mobile computing device. In some embodiments, the APIs can include services to enable web applications to simulate a native application that runs natively on the mobile computing device. In some embodiments, the APIs can include services to annotate a map with an overlay on the display of the mobile computing device. In some embodiments, a caching module is provided for caching resources associated with a web application on the mobile computing device.",WILLIAMSON RICHARD JOHN;;ADLER DARIN;;GOLDEN AARON ELIEZER;;BLUMENBERG CHRISTOPHER;;STACHOWIAK MACIEJ;;CARLSSON ANDERS;;PROSKURYAKOV ALEXEY,WILLIAMSON RICHARD JOHN;;ADLER DARIN;;GOLDEN AARON ELIEZER;;BLUMENBERG CHRISTOPHER;;STACHOWIAK MACIEJ;;CARLSSON ANDERS;;PROSKURYAKOV ALEXEY,APPLE INC (2009-03-25),https://lens.org/093-058-245-324-042,Patent Application,yes,15,83,1,1,0,G06F9/54;;H04L67/306;;H04L67/04;;H04L67/02;;H04L67/289;;G06F16/9577;;H04L67/561;;H04L67/5681;;H04L67/289;;G06F9/54;;H04L67/02;;H04L67/04;;H04L67/306;;G06F16/9577;;H04L67/561;;H04L67/5681,G06F3/048;;G06F3/01;;G06F9/46;;G06F17/00;;G06F17/30,715/233;;719/328;;715/733;;707/200;;715/835;;715/234;;715/205;;715/781;;707/10,3,0,,,"Microsoft Corporation, ""Microsoft Internet Explorer 5 Resource Kit"", published January 19, 2000, Microsoft Press, p142;;Malek, ""View Websites in Full Screen Mode - Microsoft Internet Explorer 7"", archived April 27, 2007 by the Wayback Machine and retrieved October 22, 2012 from http://web.archive.org/web/20070427023352/http://malektips.com/internet_explorer_7_0023.html;;Java (programming language) - Wikipedia, the free encyclopedia.pdf, archived by the Internet Archive Wayback Machine on June 16, 2007 and retrieved from https://web.archive.org/web/20070616124939/http://en.wikipedia.org/wiki/Java_%28programming_language%29 on June 27, 2014",DISCONTINUED
576,US,B2,US 6552826 B2,104-051-059-292-601,2003-04-22,2003,US 88793001 A,2001-06-21,US 88793001 A;;US 80389897 A,1997-02-21,Facsimile network,"
    A facsimile network includes a plurality of nodes (  10  )-(  14  ) which are disposed at different locations in the world. An originating fax machine (  16  ) is associated with one of the nodes (  10  ) for transmitting a fax over a local public telephone network (PSTN) (  18  ). When the node (  10  ) receives the fax transmission in the normal transmission mode, it then converts it to a digitized compressed and encrypted image which is transmitted over a primary network (  24  ), such as the Internet, to a destination node (  14  ) by a predetermined route. The node (  14  ) then decompresses and de-encrypts the image and converts it to a facsimile image for transmission to a destination fax (  20  ) in a normal mode over a local PSTN (  22  ). A node (  12  ) operates as a central node which can also receive the transmission for routing directly to the fax or for directing via another network link to the node (  14  ). 
",WORLDQUEST NETWORK INC,ADLER B MICHAEL;;QUAID JR TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,VOIP ACQUISITION COMPANY (2005-10-05),https://lens.org/104-051-059-292-601,Granted Patent,yes,4,43,5,5,0,H04N1/32406;;H04N1/32406;;H04N1/00209;;H04N1/00209;;H04N1/32358;;H04N1/32358;;H04N2201/0017;;H04N2201/0017;;H04N2201/0093;;H04N2201/0093,H04N1/00;;H04N1/32,358/442;;358/407;;358/439;;379/100.17,0,0,,,,EXPIRED
577,US,A1,US 2020/0133492 A1,149-638-511-522-422,2020-04-30,2020,US 201916355317 A,2019-03-15,US 201916355317 A;;US 201862751458 P,2018-10-26,DYNAMICALLY SELECTING SEGMENT HEIGHTS IN A HETEROGENEOUS RAID GROUP,"A system includes a solid-state storage array having a plurality of solid-state storage devices and a storage controller coupled to the solid-state storage array, the storage controller including a processing device, the processing device to select a segment height based on erase block sizes of the plurality of solid-state storage devices. The processing device is further to program a data segment using the segment height to a data stripe across two or more of the plurality of solid-state storage devices and store the segment height in metadata associated with the data segment.",PURE STORAGE INC,BERNAT ANDREW R;;ASTER RADEK;;SCHOLBROCK BENJAMIN;;HAFFNER CONNER;;DUAN YUNPENG;;ADLER JOHN;;CHANG TSU-HAO,PURE STORAGE INC (2019-03-13),https://lens.org/149-638-511-522-422,Patent Application,yes,6,9,3,3,0,G06F3/064;;G06F3/0688;;G06F3/0619;;G06F3/0619;;G06F3/064;;G06F3/065;;G06F3/0652;;G06F3/0652;;G06F3/0689;;G06F16/907,G06F3/06;;G06F16/907,,0,0,,,,ACTIVE
578,US,B1,US 6978462 B1,147-546-651-388-287,2005-12-20,2005,US 33226399 A,1999-06-11,US 33226399 A;;US 23919499 A,1999-01-28,Profiling execution of a sequence of events occuring during a profiled execution interval that matches time-independent selection criteria of events to be profiled,"A computer having an instruction pipeline and profile circuitry. The profile circuitry detects and records, without compiler assistance for execution profiling, profile information describing a sequence of events occurring in the instruction pipeline. The sequence includes every event occurring during a profiled execution interval that matches time-independent selection criteria of events to be profiled. The recording continues until a predetermined stop condition is reached. The profile circuitry detects the occurrence of a predetermined condition, after a non-profiled interval of execution, and then commences the profiled execution interval.",ATI INT SRL,ADLER MICHAEL C;;YATES JR JOHN S;;REESE DAVID L;;HOHENSEE PAUL H;;PURCELL STEPHEN C,ATI TECHNOLOGIES ULC (2009-11-18);;ADVANCED SILICON TECHNOLOGIES LLC (2015-09-25);;ATI INTERNATIONAL SRL (1999-05-20),https://lens.org/147-546-651-388-287,Granted Patent,yes,104,67,1,44,0,G06F9/30149;;G06F9/3017;;G06F9/30174;;G06F11/348;;G06F9/30189;;G06F9/3851;;G06F11/348;;G06F9/3017;;G06F9/30174;;G06F9/30149;;G06F9/3851;;G06F9/30189,G06F3/00,719/318,93,39,186-516-786-937-607;;075-342-053-493-525;;028-220-312-974-893;;018-143-348-068-519;;091-353-662-970-458;;016-910-196-606-550;;072-347-385-255-885;;044-844-517-876-264;;130-350-443-518-41X;;057-297-650-367-655;;091-353-662-970-458;;016-910-196-606-550;;044-844-517-876-264;;130-350-443-518-41X;;057-297-650-367-655;;015-758-695-716-105;;059-659-618-002-996;;075-342-053-493-525;;028-220-312-974-893;;015-758-695-716-105;;016-910-196-606-550;;072-347-385-255-885;;044-844-517-876-264;;130-350-443-518-41X;;057-297-650-367-655;;059-684-516-167-68X;;059-303-941-387-358;;018-143-348-068-519;;110-665-794-578-802;;100-333-843-182-609;;078-202-280-715-209;;008-365-435-790-391;;059-840-938-991-355;;081-888-099-868-777;;013-506-437-826-738;;085-932-986-952-802;;010-102-665-681-112;;092-534-115-621-127;;107-308-369-806-751,10.1109/40.671403;;10.1109/micro.1996.566448;;10.1145/192724.192726;;10.1109/micro.1997.645821;;10.1145/264107.264126;;10.1109/t-c.1971.223350;;10.1109/t-c.1971.223342;;10.1145/356556.356559;;10.1145/361532.361550;;10.1145/1479992.1480074;;10.1145/264107.264126;;10.1109/t-c.1971.223350;;10.1145/356556.356559;;10.1145/361532.361550;;10.1145/1479992.1480074;;10.1109/6.842131;;10.1109/hicss.1994.323226;;10.1109/micro.1996.566448;;10.1145/192724.192726;;10.1109/6.842131;;10.1109/t-c.1971.223350;;10.1109/t-c.1971.223342;;10.1145/356556.356559;;10.1145/361532.361550;;10.1145/1479992.1480074;;10.1145/258915.258924;;10.1109/micro.1997.645816;;10.1109/micro.1997.645821;;10.1109/hsc.1997.584593;;10.1109/71.730530;;10.1145/859551.859553;;10.1109/micro.1998.742768;;10.1145/139669.139702;;10.1145/207110.207163;;10.1109/micro.1996.566464;;10.1109/simsym.1995.393593;;10.1109/real.1995.495195;;10.1145/224486.224531;;10.1145/27633.28055,"Burroughs, Preliminary Edition, B 1700 Systems Reference Manual, Burroughs Corporation (1972).;;Burroughs, B 1700 Systems Micro Implementation Language (MIL) Reference Manual, Burroughs Corporation (1973).;;Anton Chernoff, et al., FX!32, A Profile-Directed Binary Translator, IEEE Micro, vol. 18 No. 2 pp. 56-64 (Mar./Apr., 1998).;;T.M. Conte, et al., ""Accurate and practical profile-driven compilation using the profile buffer,"" Procedings of the 29<SUP>th </SUP>Annual International Symposium on Microarchitecture, Paris, France, pp. 36-45 (Dec. 1996).;;T.M. Conte, et al., ""Hardware based profiling: An effective technique for profile-driven optimization,"" International Journal of Parallel Programming, vol. 24, No. 2 (Feb. 1996).;;T.M. Conte, et al., ""Using branch handling hardware to support profile-driven optimization,"" Proceedings of the 27<SUP>th </SUP>Annual International Symposium on Microarchitecture San Jose, CA (Dec. 1994).;;J.S. Cox et al., ""Commercializing profile-driven optimization."" Proceedings of the 28<SUP>th </SUP>Hawaii International Conference on System Sciences, vol. 1 Maui, HI, pp. 221-228 (Jan. 1995).;;Dean, ProfileMe: Hardware Support for Instruction-Level Profiling on Out-of-Order Processors, IEEE 1997, pp. 292-302.;;Digital Equipment Corp., White Paper: How Digital FX!32 Works (Sep. 1997) http://www.digital.com/semiconductor/amt/fx32/fx-white.htm.;;Ebcioglu and Altman, IBM Research Report, DAISY: Dynamic Compilation for 100% Architectural Compatibility, IBM Research Division (1996).;;Ronald M. Guffin, Microdiagnostics for the Standard Computer MLP-900 Processor, IEEE Transactions on Computers, vol. C-20 No. 7, pp. 803-808 (Jul. 1971).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64 Technology and Market Forecast, IA-64 Software Model-Chapter 3 excerpt Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64: Technology and Market Forecast, Executive Summary, Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;Linley Gwennap, First Merced Patent Surfaces, Intel Document Reveals Processors With Dual Instruction Sets, Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;R.E. Hank, et al., Proceedings of the 28<SUP>th </SUP>Annual International Symposium on Microarchitecture, pp. 158-168 (Dec. 1995).;;Raymond J. Hookway, et al., Combining Emulation and Binary Translation (Aug. 28, 1997) http://www.digital.com/info/DTJ01HM.HTM.;;Harold W. Lawson, Jr., et al., Functional Characteristics of a Multilingual Processor, IEEE Transactions on Computers, vol. C-20, No. 7, pp. 732-742 (Jul., 1971).;;K.N.P. Menezes, ""Hardware-based profiling for program optimization,"" Ph.D. thesis, Department of Electrical and Computer Engineering, North Carolina State University, Raleigh, North Carolina (1997).;;Nanodata Corporation, QM-1 Hardware level User's Manual (1975).;;Nanodata Corporation, QM-2 Processor (1976).;;Robert F. Rosin, Contemporary Concepts of Microprogramming and Emulation, Computing Surveys, vol. 1 No. 4, pp. 197-212 (Dec. 1969).;;Robert F. Rosin, An Environment for Research in Microprogramming and Emulation, Communications of the ACM, vol. 15 No. 8, pp. 748-760 (Aug. 1972).;;Standard Computer Corp., IC-9000 Central Processing Unit-Principles of Operation (undated-possibly 1969).;;W.T. Wilner, Design of the Burroughs B1700, Fall Joint Computer Conference, pp. 489-497 (1972).;;W.T. Wilner, Burroughs B1700 Memory Utilization, Fall Joint Computer Conference, pp. 579-586 (1972).;;J.S. Cox et al., ""Commercializing profile-driven optimization."" Proceedings of the 28<SUP>th </SUP>Hawaii International Conference on System Sciences, vol. 1 Maui, HI, pp. 221-228 (Jan. 1995).;;Digital Equipment Corp., White Paper: How DIGITAL FX!32 Works (Sep. 1997) http://www.digital.com/semiconductor/amt/fx 32/fx-white.htm.;;Ebcioglu and Altman, IBM Research Report, DAISY: Dynamic Compilation for 100% Architectural Compatibility, IBM Research Division (1996).;;Ronald M. Guffin, Microdiagnostics for the Standard Computer MLP-900 Processor, IEEE Transactions on Computers, vol. C-20 No. 7, pp. 803-808 (Jul. 1971).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64 Technology and Market Forecast, IA-64 Software Model-Chapter 3 excerpt Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64: Technology and Market Forecast, Executive Summary, Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;Linley Gwennap, First Merced Patent Surfaces, Intel Document Reveals Processors With Dual Instruction Sets, Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;R.E. Hank, et al., Proceeding of the 28<SUP>th </SUP>Annual International Symposium on Microarchitecture, pp. 158-168 (Dec. 1995).;;Raymond J. Hookway, et al., Combining Emulation and Binary Translation (Aug. 28, 1997) http://www.digital.com/info/DTJP01HM.HTM.;;Harold W. Lawson, Jr., et al., Functional Characterisitcs of a Multilingual Processor, IEEE Transactions on Computers, vol. C-20, No. 7, pp. 732-742 (Jul., 1971).;;K.N.P. Menezes, ""Hardware-based profilling for program optimization,"" Ph.D. thesis, Department of Electrical and Computer Engineering, North Carolina State University, Raleigh, North Carolina (1997).;;Nanodata Corporation, QM-1 Hardware level User's Manual (1975).;;Nanodata Corporation, QM-2 Processor (1976).;;Robert F. Rosin, Contemporary Concepts of Microprogramming and Emulation, Computing Surveys, vol. 1 No. 4, pp. 197-212 (Dec. 1969).;;Robert F. Rosin, An Environment for Research in Microprogramming and Emulation, Communications of the ACM, vol. 15 No. 8, pp. 748-760 (Aug. 1972).;;Standard Computer Corp., IC-9000 Central Processing Unit-Principles of Operation (undated-possibly 1969).;;W.T. Wilner, Design of the Burroughs B1700, Fall Joint Computer Conference, pp. 489-497 (1972).;;W.T. Wilner, Burroughs B1700 Memory Utilization, Fall Joint Computer Conference, pp. 579-586 (1972).;;Compaq Computer Corp., Compiler Writer's Guide for the Alpha 21264 (1999).;;Linda Geppert et al., Transmeta's Magic Show, IEEE Spectrum, vol. 37 No. 5, pp. 26-33 (May 2000).;;Intel Corporation, Intel Architecture Software Developer's Manual, passim (1997).;;Kavi et al., A Performability Model for Soft Real-Time Systems, IEEE Jan. 1994.;;Burroughs, Preliminary Edition, B 1700 Systems Reference Manual, Burroughs Corporation (1972).;;Burroughs, B 1700 Systems Micro Implementation Language (MIL) Reference Manual, Burroughs Corporation (1973).;;Anton Chernoff, et al., FX!32, A Profile-Directed Binary Translator, IEEE Micro, vol. 18 No. 2 pp. 56-64 (Mar./Apr. 1998).;;Compaq Computer Corp., Compiler Writer's Guide for the Alpha 21264, 1999.;;T.M. Conte, et al., ""Accurate and practical profile-driven compilation using the profile buffer,"" Proceedings of the 29<SUP>th </SUP>Annual International Symposium on Microarchitecture, Paris, France, pp. 36-45 (Dec. 1996).;;T.M. Conte, et al., ""Hardware based profiling: An effect technique for profile-driven optimization,"" International Journal of Parallel Programming, vol. 24, No. 2 (Feb. 1996).;;T.M. Conte, et al., ""Using branch handling hardware to support profile-driven optimization,"" Proceedings of the 27<SUP>th </SUP>Annual International Symposium on Microarchitecture San Jose, CA (Dec. 1994).;;J.S. Cox et al., ""Commercializing profile-driven optimization."" Proceedings of the 28<SUP>th </SUP>Hawaii International Conference on System Sciences, vol. 1 Maui, HI, pp. 221-228 (Jan. 1995).;;Digital Equipment Corp., White Paper: How DIGITAL FX!32 Works (Sep. 1997) http://www.digital.com/semiconductor/amt/fx32/fx-white.htm.;;Ebcioglu and Altman, IBM Research Report, DAISY: Dyanmic Compilation for 100% Architectural Compatibility, IBM Research Division (1996).;;Linda Geppert et al., Transmeta's Magic Show, IEEE Spectrum, vol. 37 No. 5, pp. 26-33 (May 2000).;;Donald M. Guffin, Microdiagnostics for the Standard Computer MLP-900 Processor, IEEE Transactions on Computers, vol. C-20 No. 7, pp. 803-808 (Jul. 1971).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64 Technology and Market Forecast, IA-64 Software Model-Chapter 3 excerpt Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64: Technology and Market Forecast, Executive Summary, Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;Linley Gwennap, MDR Technical Library Special Report, Intel's Merced and IA-64 Technology and Market Forecast, IA-64 Software Model-Chapter 3 excerpt Microprocessor Report, MicroDesign Resources (Jul. 20, 1998).;;R.E. Hank, et al., Proceeding of the 28<SUP>th </SUP>Annual International Symposium on Microarchitecture, pp. 158-168 (Dec. 1995).;;Raymond J. Hookway, et al., Combining Emulation and Binary Translation (Aug. 28, 1997) http://www.digital.com/info/DTJP01HM.HTM.;;Harold W. Lawson, Jr., et al., Functional Characteristics of a Multilingual Processor, IEEE Transactions on Computers, vol. C-20, No. 7, pp. 732-742 (Jul., 1971).;;K.N.P. Menezes, ""Hardware-based profiling for program optimization,"" Ph.D. thesis, Department of Electrical and Computer Engineering, North Carolina State University, Raleigh, North Carolina (1997).;;Nanodata Corporation, QM-1 Hardware level User's Manual (1975).;;Nanodata Corporation, QM-2 Processor (1976).;;Robert F. Rosin, Contemporary Concepts of Microprogramming and Emulation, Computing Surveys, vol. 1 No. 4, pp. 197-212 (Dec. 1969).;;Robert F. Rosin, An Environment for Research in Microprogramming and Emulation, Communications of the ACM, vol. 15 No. 8, pp. 748-760 (Aug. 1972).;;Standard Computer Corp., IC-9000 Central Processing Unit-Principles of Operation (undated-possibly 1969).;;W.T. Wilner, Design of the Burroughs B1700, Fall Joint Computer Conference, pp. 489-497 (1972).;;W.T. Wilner, Burroughs B1700 Memory Utilization, Fall Joint Computer Conference, pp. 579-586 (1972).;;Ammons, Ball and Larus: Exploiting Hardware Performance Counters with Flow and Context Sensitive Profiling, Proceedings of the ACM SIGPLAN 1997 Conference on Programming Language Design and Implementation, pp. 85-96 (1997).;;Brad Calder, Peter Feller, Alan Eustace, Value Profiling, Proceedings of 30th International Symposium on Microarchitecture (Micro-30), IEEE, pp. 259-269 (Dec. 1-3, 1997).;;Compaq Computer Corp., Compiler Writer's Guide for Alpha 21264 (1999) www.alphalinux.org/archives/axp-list/June1999/0475.html.;;Dean, ProfileMe: Hardware Support for Instruction-Level Profiling on Out-of-Order Processors, Proceedings of 30th Annual Intl. IEEE/ACM Symp. on Microarchitecture, pp. 292-302 (Dec. 1997).;;Reiner W. Hartenstein, Jurgen Becker: Performance Analysis in CoDe-X Partitioning for Structural Programmable Accelerators; Proc. of 5th Int'l Workshop on Hardware/Software Co-Design CODES/CASHE '97, Braunschweig, Germany, p. 141 (Mar. 1997).;;Hollingsworth, Critcal Path Profiling of Message Passing and Shared-Memory Programs, IEEE Transactions on Parallel and Distributed Systems vol. 9, No. 10, pp. 1029-1040 (Oct. 1998).;;Intel Corporation, Intel Processor Family Developer's Manual (1997), pp. 1-1 to 1-6, 2-1 to 2-20.;;Intel Corporation, Intel Processor Family Developer's Manual (1997), vol. 3, (Architecture and Programming Manual), pp. 3-1 to 3-3, 3-10 to 3-13, 12-1 to 12-27, 14-1 to 14-30.;;Jones, Puzzling with Microcode, ACM SIGARCH Computer Architecture News, vol. 11, No. 5, pp. 8-12 (1983).;;Kavi et al., A Performability Model for Soft Real-Time Systems, IEEE Proceedings of the 27th Annual Hawaii International Conference on System Sciences, pp. 571-599 (1994).;;Kim and Tyson: Analyzing the Working Set Characteristics of Branch Execution. Proceedings of the 31st Annual ACM/IEEE International Symposium on Microarchitecture, pp. 49-58 (Dec. 1998).;;Monica S. Lam, Robert P. Wilson, Limits of Control Flow on Parallelism, Proceedings of the 19th Annual International Symposium on Computer Architecture, pp. 46-57 (May 1992).;;Larus and Schnarr: EEL: Machine-Independent Executable Editing, EEL: Machine-independent executable editing. In Proceedings of the ACM SIGPLAN Conference on Programming Language Design and Implementation (PLDI), 1995.;;M. Lipasti and J. Shen. Exceeding the Data-Flow Limit Via Value Prediction, 29trh International Symposium on Microarchitecture, pp. 226-237, IEEE (Dec. 1996).;;Magnusson and Werner, Efficient Memory Simulation in SimICS, Proceedings of the 28th Annual Simulation Symposium, IEEE, pp. 62-73 (1995).;;Mueller, Rustagi and Baker: MiThOS -A Real-Time Micro-Kernel Threads Operating System, IEEE Real-Time Systems Symposium 1995: pp. 49-55 (1995).;;Park et al., Evaluation of Scheduling Techniques on a SPARC-Based VLIW Testbed, Proceedings of the 30th Annual ACM/IEEE international symposium on Microarchitecture, pp. 104-113 (1997).;;Parkinson and Parameswaran, Profiling in the ASP Codesign Environment, Proceedings of the 8th International Symposium on System Synthesis, Cannes, France, pp. 128-133 (Sep. 1995).;;Rizvi et al., Execution-Driven Simulation of a Superscalar Processor, IEEE Proceedings of the 27th Annual Hawaii International Conference on System Sciences, pp. 185-194 (1994).;;Veen: Dataflow Machine Architecture, ACM Computing Surveys vol. 18, No. 4, pp. 365-96 (Dec. 1986).",EXPIRED
579,DE,D1,DE 69404502 D1,129-789-144-238-667,1997-09-04,1997,DE 69404502 T,1994-02-17,US 2125593 A,1993-02-23,Rotierende Strangpressdüse zum Extrudieren von Wabenstrukturen,,CORNING INC,ADLER MERYLE DANIEL WALTER;;FROST RODNEY IRVING;;BAGLEY RODNEY DELANO;;LANNING JOHN GUSTIN;;SHAFER HAROLD GORDON,,https://lens.org/129-789-144-238-667,Granted Patent,no,0,0,9,9,0,B28B3/269;;B28B3/269;;B28B3/269,B28B3/26;;B28B3/20,,0,0,,,,EXPIRED
580,US,B1,US 6256115 B1,057-997-873-485-365,2001-07-03,2001,US 80389897 A,1997-02-21,US 80389897 A,1997-02-21,Facsimile network,"A facsimile network includes a plurality of nodes (10)-(14) which are disposed at different locations in the world. An originating fax machine (16) is associated with one of the nodes (10) for transmitting a fax over a local public telephone network (PSTN) (18). When the node (10) receives the fax transmission in the normal transmission mode, it then converts it to a digitized compressed and encrypted image which is transmitted over a primary network (24), such as the Internet, to a destination node (14) by a predetermined route. The node (14) then decompresses and de-encrypts the image and converts it to a facsimile image for transmission to a destination fax (20) in a normal mode over a local PSTN (22). A node (12) operates as a central node which can also receive the transmission for routing directly to the fax or for directing via another network link to the node (14).",WORLDQUEST NETWORK INC,ADLER B MICHAEL;;QUAID JR TOMMY WAYNE;;GRAHAM BRUCE WILLARD;;POSS JOHN CLAYBRON;;THORN DAVID WAYNE,VOIP ACQUISITION COMPANY (2005-10-05);;WABEC LLC (2008-10-31);;VOIP INC (2007-08-15),https://lens.org/057-997-873-485-365,Granted Patent,yes,25,45,5,5,0,H04N1/32406;;H04N1/32406;;H04N1/00209;;H04N1/00209;;H04N1/32358;;H04N1/32358;;H04N2201/0017;;H04N2201/0017;;H04N2201/0093;;H04N2201/0093,H04N1/00;;H04N1/32,358/442;;358/407,1,1,019-265-979-718-209,10.1109/mmcs.1994.292475,"Patel et al. ""Multimedia fax-MIME Interworking"" Proc. of IEEE International conference on Multimedia computing and Systems 1994 pp. 325-330, May 1994.",EXPIRED
581,EP,A1,EP 0612599 A1,033-628-846-256-722,1994-08-31,1994,EP 94102402 A,1994-02-17,US 2125593 A,1993-02-23,Rotary die for extruding honeycombs.,"The present invention relates to an extrusion die (2) for producing ceramic honeycomb materials. It is particularly useful in producing such extrudates in sheet form (E) by configuring the die (2) in the form of a cylinder and providing a cutting device (6) proximate to the exterior of the cylinder (4) so that when relative rotation is imparted between the cutter (6) and the cylinder, a honeycomb sheet (E) is removed. A cover can be provided over the exterior surface of the cylindrically-shaped die to permit formation of honeycomb extrudates in pellet form.",CORNING INC,ADLER MERYLE DANIEL WALTER;;FROST RODNEY IRVING;;BAGLEY RODNEY DELANO;;LANNING JOHN GUSTIN;;SHAFER HAROLD GORDON JR,,https://lens.org/033-628-846-256-722,Patent Application,yes,4,0,9,9,0,B28B3/269;;B28B3/269;;B28B3/269,B28B3/26;;B28B3/20,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 14, no. 231 (M - 974) 16 May 1990 (1990-05-16);;SOVIET INVENTIONS ILLUSTRATED Week 8418, 13 June 1984 Derwent World Patents Index; AN 84-112418/18",EXPIRED
582,US,A1,US 2019/0347007 A1,091-888-343-555-530,2019-11-14,2019,US 201916427235 A,2019-05-30,US 201916427235 A;;US 201514872022 A;;US 201562172127 P;;US 201562168893 P,2015-05-31,DYNAMIC GROUP MEMBERSHIP FOR DEVICES,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/091-888-343-555-530,Patent Application,yes,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06;;G06Q10/06;;G06Q10/10;;G06Q90/00;;H04L9/32;;H04L29/08;;H04W4/08,,0,0,,,,ACTIVE
583,US,A,US 5314650 A,111-576-798-566-27X,1994-05-24,1994,US 2125593 A,1993-02-23,US 2125593 A,1993-02-23,Method for extruding honeycombs,"An extrusion die is used for producing ceramic honeycomb materials. It is particularly useful in producing such extrudates in sheet form by configuring the die in the form of a cylinder and providing a cutting device proximate to the exterior of the cylinder so that when relative rotation is imparted between the cutter and the cylinder, a honeycomb sheet is removed. A cover can be provided over the exterior surface of the cylindrically-shaped die to permit formation of honeycomb extrudates in pellet form.",CORNING INC,ADLER MERYLE D W;;BAGLEY RODNEY D;;FROST RODNEY I;;LANNING JOHN G;;SHAFER JR H GORDON,CORNING INCORPORATED (1993-05-12),https://lens.org/111-576-798-566-27X,Granted Patent,yes,15,13,9,9,0,B28B3/269;;B28B3/269;;B28B3/269,B28B3/26;;B28B3/20,264/56;;264/142;;264/177.12;;264/211.11;;264/67;;425/308;;425/461,0,0,,,,EXPIRED
584,US,A1,US 2020/0223571 A1,103-171-353-150-268,2020-07-16,2020,US 202016833575 A,2020-03-28,US 202016833575 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/103-171-353-150-268,Patent Application,yes,8,0,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,ACTIVE
585,KR,A,KR 20200015821 A,140-106-548-994-357,2020-02-12,2020,KR 20207003179 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872013 A;;US 2016/0025431 W,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,"중첩되는 기능을 가진 다수의 디바이스들을 소유한 사용자가 점점 더 보편화되고 있다. 스마트폰들, 태블릿, 및 컴퓨터들은 모두 웹에 액세스하고, 사용자가 사진들 등을 프로세싱하게 하고, 사용자들은 여러 개의 그러한 디바이스들을 가지려는 경향이 있다. 따라서, 디바이스들 사이에서 데이터를 공유하고 다수의 디바이스들 상의 데이터로의 액세스를 갖기는 원하는 사용자도 또한 점점 더 보편화되고 있다. 사용자들은, 통상적으로, 플래시 메모리 스틱들, 이메일 등과 같이, 디바이스들 사이에서 데이터를 전송하기 위한 모든 종류들의 상이한 기법들을 사용할 수 있다. 사용자의 디바이스들 사이에서 데이터를 자동으로 공유하기 위한 더 효율적인 기법들이 요망된다.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/140-106-548-994-357,Patent Application,no,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L29/08;;H04L9/32,,0,0,,,,ACTIVE
586,EP,A3,EP 2045739 A3,160-715-795-484-53X,2009-09-02,2009,EP 08165836 A,2008-10-03,US 97785507 P;;US 24326708 A,2007-10-05,Modeling topics using statistical distributions,"In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. Words of a document are selected as keywords of the document. The documents are clustered according to the keywords to yield clusters, where each cluster corresponds to a topic. A statistical distribution is generated for a cluster from words of the documents of the cluster. A topic is modeled using the statistical distribution generated for the cluster corresponding to the topic.
",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,,https://lens.org/160-715-795-484-53X,Search Report,yes,1,0,7,7,0,G06F16/355;;G06F16/355;;G06F16/313;;G06F16/313,G06F17/30,,1,1,108-311-283-244-843,10.1016/s0306-4573(02)00035-3,"LI H ET AL: ""Topic analysis using a finite mixture model"", INFORMATION PROCESSING & MANAGEMENT, ELSEVIER, BARKING, GB, vol. 39, no. 4, 1 July 2003 (2003-07-01), pages 521 - 541, XP004425282, ISSN: 0306-4573",DISCONTINUED
587,US,B2,US 10747435 B2,036-600-581-894-351,2020-08-18,2020,US 201916250890 A,2019-01-17,US 201916250890 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/036-600-581-894-351,Granted Patent,yes,23,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06;;G06Q10/06;;G06Q10/10;;G06Q90/00;;H04L9/32;;H04L29/08;;H04W4/08,,6,0,,,"International Patent Application No. PCT/US2016/025431—International Search Report and Written Opinion dated Jul. 4, 2016.;;Author Unknown, “iOS Security,” Oct. 1, 2014, pp. 1-50, Apple Inc., US, available at https://www.apple.com/br/privacy/docs/iOS_Security_Guide_Oct. 2014.pdf.;;Taşkin, Halil Kemal, “End-to-end Encrypted Communication Between Multi-devise Users,” 7th International Conference on Information Security and Cryptology, Oct. 14, 2014, pp. 173-177, Istanbul, Turkey, available at http://iscturkey.org/wpcontent/uploads/2016/03/isc2014-51.pdf.;;International Patent Application No. PCT/US2016/025440—International Search Report and Written Opinion dated Jul. 1, 2016.;;Korean Patent Application No. 10-2019-7023625—Notice of Preliminary Rejection dated Aug. 19, 2019.;;European Patent Application No. 16718754.1—Examination Report dated Sep. 23, 2019.",ACTIVE
588,US,B2,US 10946992 B2,041-691-648-796-092,2021-03-16,2021,US 201715803383 A,2017-11-03,US 201715803383 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P,2009-06-30,"Catheter tray, packaging system, instruction insert, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,MEDLINE INDUSTRIES LP (2021-09-07),https://lens.org/041-691-648-796-092,Granted Patent,yes,269,6,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,A61M25/00;;A61B42/00;;A61B46/00;;A61B50/30;;A61B50/33;;A61M5/00;;B65B11/00,,472,3,098-777-794-605-077;;008-481-422-937-006;;055-945-454-377-987,10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610;;10.1097/00000542-200701000-00013;;17197846,"Pothier, Andrew. Office Action, Canadian Application No. 2,822,905; dated Aug. 31, 2018.;;Poon, Robert. Non-Final Office Action, U.S. Appl. No. 15/703,514; dated Jun. 22, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit J to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc; Exhibit I to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216: Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit O to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Poon, Robert, Non-Final Office Action, U.S. Appl. No. 15/804,520, dated Jun. 6, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit A to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit B to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit C to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit D to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit E to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit F to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit G to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit H to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit I to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit J to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit K to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit L to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit M to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit N to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit O to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit P to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit Q to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit R to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit S to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; Civil Action No. 1:17-cv-7216; Exhibit T to C.R. Bard's LPR 2.3 Contentions, dated Jul. 24, 2018.;;Poon, Robert. Appeal Decision, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; mailed Aug. 1, 2018.;;Poon, Robert. Appeal Decision, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; mailed Jan. 19, 2018.;;Ortega, Rafael, M.D. et al., Female Urethral Catheterization, N. Engl. J. Med. vol. 358:e15 (2008).;;Thomsen, Todd W., M.D., and Gary S. Setnik, M.D., Male Urethral Catheterization, N. Engl. J. Med. vol. 354:e22 (2006).;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,745,088; Inter Partes Review No. IPR2019-00035; Filed Jan. 11, 2019.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,745,088; Inter Partes Review No. IPR2019-00036; Filed Jan. 11, 2019.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Jan. 11, 2019; IPR2019-00035, IPR2019-00036.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Jan. 11, 2019; IPR2019-00035, IPR2019-00036.;;Petition for Inter Partes Review for U.S. Pat. No. 9,795,761; IPR2019-00109, filed Oct. 24, 2018.;;IPR Petition Exhibit 1002, Declaration of Plishka; IPR2019-00109, filed Oct. 24, 2018.;;IPR Petition Exhibit 1003, Declaration of Yun; IPR2019-00109, filed Oct. 24, 2018.;;IPR Petition Exhibit 1026, Bard's Opening Claim Construction Brief Case 1:17-cv-07216, filed Oct. 24, 2018.;;IPR Petition Exhibit 1030, Medline's Final Infringement Contentions Case 1:17-cv-07216, IPR2019-00109, filed Oct. 24, 2018.;;IPR Petition Exhibit 1031, Jennifer Tomes Declaration in U.S. Appl. No. 12/647,515, IPR2019-00109, signed Dec. 7, 2012, filed Oct. 24, 2018.;;Petition for Inter Partes Review for U.S. Pat. No. 9,808,400; IPR2019-00208, filed Nov. 7, 2018.;;Petition for Inter Partes Review for U.S. Pat. No. 9,808,596; IPR2019-00223, filed Nov. 7, 2018.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:17-cv-7216; Medline's Objection and Response to Bard's First Set of Interrogatories (redacted), dated Oct. 1, 2018; filed as IPR Petition Exhibit 2012 in IPR2019-00035 and IPR2019-00036.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline's Supplemental Responses to Bard's Interrogatory Nos. 1-24 (redacted), dated Apr. 20, 2016; filed as IPR Petition Exhibit 2013 in IPR2019-00035 and IPR2019-00036.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:16-cv-3539; Medline's Second Supplemental Responses to Bard's Interrogatory Nos. 1-10 and First Supplemental Responses to Bard's Interrogatory Nos. 11,14, and 15 (redacted), dated Oct. 26, 2017; filed as IPR Petition Exhibit 2014 in IPR2019-00035 and IPR2019-00036.;;Webster's Dictionary Definition of “Intend;” Webster's Third New International Dictionary of the English Language unabridged (1961); filed as IPR Petition Exhibit 2016 in IPR2019-00035.;;Medline Industries Inc. vs C.R. Bard, Inc.; Memorandum Opinion and Order re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 28, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Opinion and Order re Claim Construction; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Jan. 28, 2019; filed as IPR Petition Exhibit 2027 in IPR2019-00109, IPR2019-00208, and IPR2019-00223.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,795,761; Inter Partes Review No. IPR2019-00109; Filed Feb. 22, 2019.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,596; Inter Partes Review No. IPR2019-00223; Filed Mar. 7, 2019.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,400; Inter Partes Review No. IPR2019-00208; Filed Mar. 7, 2019.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Mar. 7, 2019; IPR2019-00223.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00223.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Feb. 22, 2019; IPR2019-00109.;;IPR2019-00035 Decision Instituting Inter Partes Review; U.S. Pat. No. 9,745,088 B2; Entered Apr. 10, 2019.;;IPR2019-00036 Decision Instituting Inter Partes Review; U.S. Pat. No. 9,745,088 B2; Entered Apr. 10, 2019.;;Klein, Benjamin Jacob. Non-Final Office Action, U.S. Appl. No. 15/051,964, dated Jan. 7, 2019.;;Poon, Robert. Non-Final Office Action, U.S. Appl. No. 15/804,520; dated Nov. 2, 2018.;;Poon, Robert. Notice of Allowance, U.S. Appl. No. 14/265,920; dated Nov. 28, 2018.;;Pothier, Andrew. Non-Final Office Action, Canadian Application No. 2,837,289; dated Oct. 29, 2018.;;Marcetich, Adam M., Notice of Allowance, U.S. Appl. No. 15/684,787, dated Feb. 27, 2020.;;Lawrence, Samantha Q. Notice of Allowance, U.S. Appl. No. 29/479,600, dated Feb. 24, 2020.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit A lo Declaration of Bnan Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc. Exhibit 4 to Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1:16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard. Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee: Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Declaration of Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z, Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, inc; Exhibit A—C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!17-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 2 lo Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-03518; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surrepiy: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit i to Declaration of Nicole M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 I6-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 4 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit A to Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1;16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv 03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit E to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F lo Declaration of Kevin A Lake: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1. I4-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries inc vs C.R Bard, Inc.; Exhibit G to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole Smith in Support ofBard Reply to Medline Claim Construction Brief: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit H to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit H to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action Mo. 1:16-cv-Q3529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit I to Declaration of Kevin A. Lake; Civil Action No. 1:14-sv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit N to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Medline Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1;14-cv-03618; Judge John Z. Lee. Filed Jan. 25, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Medline Surreply to Claim Construction Brief; Civil Action No. 1:14-CV-Q3618: Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Transcript of Deposition of Richard Meyst; Civil Action No. 1:16-W-03529. Jan. 20, 2017.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit G to C.R Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit 3 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-CV-7216; Judge Sara L Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit C to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit D to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit E to C R. Bard's LPR 2.3 Contentions; Civil Action No. 1;17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc, Exhibit H loC.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-CV-7216; Judge Sara L. Ellis: Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc., Declaration of Bnan Eutermoser in Support of Medline Surreply. Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 8 lo Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618: Judge John Z. Lee: Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Barbara Weintraub Regarding Claim Construction: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Nicole Smith in Support of Bard Repiy lo Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit B to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit E to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard. Inc. Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc. Exhibit 11 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc. Exhibit A to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1;14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc. Medline Motion lo Supplement Record on Claim Construction with Leinsing Testimony; Civil Action No. 1:14-w-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Bard Reply Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc.; Bard Response to Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Feb. 8, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Karl R. Ieinsing in Support of Bard Reply io Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 3 to Declaration ofPeter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618: Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 8 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Kevin A. Lake; Civil Action No. 1 14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration ofBrian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit H to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Barbara A Weinlraub; Civil Action Mo. 1:16-cv-03529; Jan. 20, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Transcript ofDeposition of Karl Leinsing; Civil Action No. 1:16-cv-03529; Feb. 17, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 9 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Bard Response to Medline Surreply re Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 13, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit 2 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit B to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit J to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civii Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit K to Declaration of Bnan Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civii Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc. Exhibit 1 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc. Exhibit 9 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc. Exhibit L to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc. Medline Response to Bard Claim Construction Brief. Civil Action No. 1:14˜cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.: Exhibit 2 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 117-CV-7216; Judge Sara L Eiiis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Barbara Weintraub re Claim Construction: Civil Action No. 1:16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. I:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 10 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 2 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 5 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman, Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 6 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 7 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Bnan Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit M to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016. et al.",ACTIVE
589,US,A1,US 2016/0349999 A1,085-692-667-565-442,2016-12-01,2016,US 201514872013 A,2015-09-30,US 201514872013 A;;US 201562168893 P;;US 201562172127 P,2015-05-31,Synchronization And Verification Groups Among Related Devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,APPLE INC (1997-06-20),https://lens.org/085-692-667-565-442,Patent Application,yes,0,69,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06,,0,0,,,,ACTIVE
590,EP,A1,EP 3086806 A1,091-631-869-451-097,2016-11-02,2016,EP 14824746 A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,,ALK ABELLÓ AS;;JOLLA INST ALLERGY IMMUNOLOG,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WÜRTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE;;ANDERSEN PETER SEJER,,https://lens.org/091-631-869-451-097,Patent Application,yes,0,0,15,15,0,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/35;;C07K14/435,,1,0,,,See references of WO 2015100360A1,ACTIVE
591,EP,A1,EP 3304947 A1,131-711-761-795-161,2018-04-11,2018,EP 16718754 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872013 A;;US 2016/0025431 W,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,APPLE INC. (2018-08-01),https://lens.org/131-711-761-795-161,Patent Application,yes,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,PENDING
592,US,B2,US 9317593 B2,158-173-018-066-178,2016-04-19,2016,US 24326708 A,2008-10-01,US 24326708 A;;US 97785507 P,2007-10-05,Modeling topics using statistical distributions,"In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. Words of a document are selected as keywords of the document. The documents are clustered according to the keywords to yield clusters, where each cluster corresponds to a topic. A statistical distribution is generated for a cluster from words of the documents of the cluster. A topic is modeled using the statistical distribution generated for the cluster corresponding to the topic.",MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS;;FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,FUJITSU LIMITED (2008-09-18),https://lens.org/158-173-018-066-178,Granted Patent,yes,12,19,7,7,0,G06F16/355;;G06F16/355;;G06F16/313;;G06F16/313,G06F17/30,,16,4,108-311-283-244-843;;035-952-865-141-303;;009-662-265-360-918;;010-208-611-034-37X,10.1016/s0306-4573(02)00035-3;;10.1109/icassp.1995.479390;;10.1016/s0306-4573(96)00068-4;;10.1109/eee.2004.1287329,"U.S. Appl. No. 12/242,957, by inventors David L. Marvit et al., entitled ""Identifying Clusters of Words According to Word Affinities,"" 35 pages, filed Oct. 1, 2008.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166172.0, 14 pages, Aug. 10, 2010.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166171.6, Chinese Office Action and English Translation, 13 pages, Nov. 9, 2010.;;Li, Hang, et al., ""Topic analysis using a finite mixture model"", Information Processing and Management, vol. 39 , No. 4, pp. 521-541, Jul. 1, 2003.;;European Patent Office Communication, European Search Report and Annex to the European Search Report; Application No. EP 08 16 5836; 5 pages, Aug. 4, 2009.;;Marvit, U.S. Appl. No. 12/242,957, Non-Final Office Action mailed by the U.S. Patent and Trademark office on Dec. 13, 2010, 21 pages.;;Tamoto, Masafumi et al., ""Clustering Word Category Based on Binomial Posteriori Co-Occurrence Distribution"", Acoustics, Speech, and Signal Processing, 0-7803-2431-5/95, pp. 165-168, May 9, 1995.;;Schütze, Hinrich, et al., ""A Cooccurrence-Based Thesaurus and Two Applications to Information Retrieval"", Information Processing & Management, vol. 33, No. 3, © Elsevier Science Ltd., 0306-4573/97, pp. 307-318, May 1, 1997.;;Isogai, Shuntaro, et al., ""Multi-Class Composite N-gram Language Model Using Multiple Word Clusters and Word Successions"", Eurospeech 2001-Scandinavia, 4 pages, 2001.;;Chen, Libo, et al., ""Increasing the Customer's Choice: Query Expansion based on the Layer-Seeds Method and its Application in E-Commerce"", Proceedings of the 2004 IEEE International Conference on e-Technology, e-Commerce and e-Service, 0-7695-2073-1/04, 8 pages, Mar. 28, 2004.;;Momtazi, S., et al., ""A Pos-Based Fuzzy Word Clustering Algorithm for Continuous Speech Recognition Systems"", IEEE, 1-4244-0779-6/07, 4 pages, Feb. 12, 2007.;;Communication from the European Patent Office, European Search Report for European Patent Application No. 08165809.8-1527, 7 pages, Jan. 26, 2009.;;The State Intellectual Property Office of China, 2nd Notification of Office Action, Patent Application No. 200810166171.6, Chinese Office Action and English Translation, 11 pages, Apr. 13, 2011.;;Chinese Office Action with English Translation; Patent Application No. 200810166172.0; pp. 8, Nov. 9, 2011.;;Chinese Office Action with English Translation; Patent Application No. 200810166172.0; pp. 6, May 16, 2012.;;European Office Action; Application No. 08165836.1, 8 pages. Sep. 28, 2015.",ACTIVE
593,US,B2,US 11661219 B2,174-249-341-489-056,2023-05-30,2023,US 202016833575 A,2020-03-28,US 202016833575 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 18362909 P,2009-06-03,"Catheter tray, packaging system, instruction insert, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND LP,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/174-249-341-489-056,Granted Patent,yes,286,0,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B42/00;;A61B46/00;;A61B50/30;;A61B50/33;;A61M5/00;;A61M25/00,,492,4,044-145-043-807-87X;;098-777-794-605-077;;008-481-422-937-006;;055-945-454-377-987,10.4135/9781412963855.n765;;10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610;;10.1097/00000542-200701000-00013;;17197846,"“Final Written Decision”, IPR 2019-00035; U.S. Pat. No. 9,745,008; Entered Apr. 8, 2020.;;“Final Written Decision”, IPR 2019-00036; U.S. Pat. No. 9,745,008; Entered Apr. 8, 2020.;;“Final Written Decision”, IPR 2019-00109; dated May 4, 2020; U.S. Pat. No. 9,795,761.;;“Final Written Decision”, IPR 2019-00208; U.S. Pat. No. 9,808,400; Entered Jun. 3, 2020.;;“Final Written Decision”, IPR 2019-00223; U.S. Pat. No. 9,808,596; Entered Jun. 3, 2020.;;Pothier, Andrew , “Office Action”, Canadian Application No. 2,837,289; dated Feb. 27, 2020.;;Pothier, Andrew , “Office Action”, Canadian Application No. 2822905; dated Feb. 27, 2020.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; dated Aug. 18, 2015.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,795,761; Inter Partes Review No. IPR2019-00109; Filed Feb. 22, 2019.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,400; Inter Partes Review No. IPR2019-00208; Filed Mar. 7, 2019.;;IPR Petition 2001, Declaration of Meyst dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036.;;IPR Petition 2002, Declaration of Weintraub dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Feb. 22, 2019; IPR2019-00109.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2001; Declaration of Meyst dated Mar. 7, 2019; IPR2019-00223.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00223.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit A lo Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Bnef; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15. 2016.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 4 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc; Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries inc. vs C R. Bard, Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline industnes Inc, vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee: Filed Jun. 4, 2016.;;Medline industnes Inc. vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industnes Inc. vs C R. Bard, Inc; Declaration oi Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline industnes Inc. vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industnes inc. vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industnes Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2, Lee; Filed Jun. 4, 2016.;;Medline Industnes Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industnes Inc. vs C R. Bard, Inc; Exhibit A-C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!7-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 2 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline industries Inc. vs C.R Bard, inc., Exhibit F to Declaration of Dyian J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Bard Opening Claim Construction Bnef; Civil Action No. 1″ 16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-03518; Judge John 2. Lee; Fiied Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surrepiy: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit i to Declaration of Nicoie M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 I6-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1.14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, P016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 4 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit A to Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1;16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration ot Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv 03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1.14-cv-03618; Judge John Z. Lee. Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit E to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F lo Declaration of Kevin A Lake: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1. I4-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action Mo. 1:16-cv-Q3529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit I to Declaration of Kevin A. Lake; Civil Action No. 1.14-sv-03618; Judge John 2. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit N to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Medline Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1;14-cv-03618; Judge John Z. Lee. Filed Jan. 25, 2017.;;Medline industries Inc. vs C.R Bard, Inc.; Medline Surreply to Claim Construction Bnef; Civil Action No. 1.14-CV-Q3618: Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Transcript of Deposition ot Richard Meyst; Civil Action No. 1:16-W-03529. Jan. 20, 2017.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit G to C.R Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L Ellis; Fiied Jan. 16, 2013.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit 3 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-CV-7216; Judge Sara L Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit C to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit D to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Etlis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit E to C R. Bard's LPR 2.3 Contentions; Civil Action No. 1;17-cv-7216; Judge Sara L. Ellis; Fiied Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc, Exhibit H IoC.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-CV-7216; Judge Sara L. Ellis: Filed Jan. 16, 2018.;;Medline industries Inc. vs C.R Bard. Inc., Declaration of Brian Eutermoser in Support of Medline Surreply. Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 8 lo Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618: Judge John Z. Lee: Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Barbara Weintraub Regarding Claim Construction: Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Nicole Smith in Support of Bard Repiy lo Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit B to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit E to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 11 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit A to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1;14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Medline Motion lo Supplement Record on Claim Construction with Leinsing Testimony; Civil Action No. 1:14-w-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Bard Reply Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc.; Bard Response to Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Feb. 8, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Karl R. leinsing in Support of Bard Reply io Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 3 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618: Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 8 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Kevin A. Lake; Civil Action No. 1 14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline industries Inc. vs C.R Bard. Inc.; Exhibit H to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Barbara A Weinlraub; Civil Action Mo. 1:16-cv-03529; Jan. 20, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Karl Leinsing; Civil Action No. 1:16-cv-03529; Feb. 17, 2017.;;Medline industries Inc. vs C.R Sard, Inc.; Exhibit 9 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Bard Response to Medline Surrepiy re Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 13, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit 2 to Declaration of Karl L. Lansing in Support of Bard's Rebuttal on Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit B to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit J to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit K to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit 1 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit 9 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit L to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.. Medline Response to Bard Claim Construction Brief. Civil Action No. 1:14˜cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.: Exhibit 2 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 117-CV-7216; Judge Sara L Eiiis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Barbara Weintraub re Claim Construction: Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. I:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 10 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 2 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 5 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman, Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 6 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 7 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit M to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc., Exhibit 2 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John 2. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 5 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 6 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline industries Inc. vs C.R. Bard. Inc.; Medline Response to Bard Opening Claim Construction Brief; Civil Action No. t:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs OR. Bard, Inc.; Exhibit E to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc, Exhibit I to C.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 11 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Kevin A. Lake in Support of Medline Response to Bard Claim Construction Brief: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Barbara Weintraub Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, inc.; Exhibit D to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 1 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc, Exhibit 4 to C.R. Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline IndustriesfInc. vs C.R. Bard, Inc., Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D lo Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc., Exhibit 1 to Declaration of Brian Eutermoser in Support of Medline Surrepiy; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit B to Declaration of Nicole M. Smith; Civil Action No. 1:14˜cv43618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, inc.; Exhibit D to Declaration of Nicole M Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit E to Declaration oi Nicole M. Smith; Civil Action No. 1:14-cv-03618: Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit F to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C R. Bard's Opening Claim Construction Bnel; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, inc; C.R Bard's Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Declaration of Dylan Raife in Support of Motion for Leave to Add CounterClaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Eliis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit C to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline industries Inc. vs C R. Bard. Inc; Exhibit 1 to C R. Bard's LPR 2.3 Contentions, Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis. Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B lo Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; C R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit B—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. et al.",ACTIVE
594,US,B2,US 10640243 B2,000-475-947-954-130,2020-05-05,2020,US 201715684787 A,2017-08-23,US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P,2009-06-30,"Catheter tray, packaging system, instruction insert, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/000-475-947-954-130,Granted Patent,yes,256,9,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,A61M25/00;;A61B42/00;;A61B46/00;;A61B50/30;;A61B50/33;;A61M5/00;;B65B5/00;;B65B11/00,,443,4,012-034-811-109-693;;098-777-794-605-077;;008-481-422-937-006;;055-945-454-377-987,10.7748/ns.23.29.47.s52;;19385401;;10.7748/ns2009.03.23.29.47.c6927;;10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610;;10.1097/00000542-200701000-00013;;17197846,"Madeo, M.; Roodhouse, A. J. “Reducing the risks associated with urinary catheters,” Nursing Standard. Mar. 25, 2009.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; dated Aug. 18, 2015.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;Medline Industries Inc. vs C.R. Bard, Inc; C.R. Bard's LPR 3.1 Contentions; Civil Action No. 1:16-cs-3529; Judge Sharon Johnson Coleman; Filed Aug. 26, 2016.;;Medline Industries vs. CR Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 3.1 Contentions; Filed Nov. 24, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Defendant C.R. Bards, Inc's Second Amended Answer to Second Amended Complaint; Filed Sep. 25, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries Inc's Opposition to C.R.Bard Inc's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Oct. 20, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Initial Invalidity Contentions; Exhibits A-H; Dated Sep. 19, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Notice of Medline Industries Inc's Motion to Dismiss C.R. Bard Inc's Inequitable Conduct Counterclaim and to strike affirmative defense for the '786 Patent; Filed Oct. 20, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatories; Dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; Dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 2.3 Contentions—Initial Non-Infringement; Exhibits 1 and A-H; Dated Sep. 5, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; Memorandum in Support of C.R. Bard's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Sep. 25, 2015.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown_bear_brown_bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013.;;Notice of Allowance; EP Application No. 10251025.2-1501; Reference P112645EP00; dated Feb. 18, 2016.;;“Appeal Decision”, U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed May 18, 2016.;;“Article 94(3) EPC Examination”, European Application No. 10 251 025.2-1501; Reference P112645EP00; Mailed Mar. 13, 2015.;;“Australian First Exam Report”, AU Patent Application No. 2011351971; Patent Examination Report No. 1; dated Jul. 25, 2015.;;“Bard IPR Exhibit”, “Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Bard Medical Division Care & Catheterization Script”, Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Catheterization Techniques; Copyright 2006; AV0512-06 R12/05 XXX.;;“Bard Publication”, “A few important words about Catheter Care”; C.R. Bard, Inc; Copyright 2001 C.R. Bard, Inc.;;“Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System”, Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006.;;“Bardex I.C. Infection Control 350ml Urine Meter Foley Tray”, Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006.;;“Bardex I.C. Infection Control Foley Tray”, Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006.;;“DVD”, Entitiled “Preventing UTI: Care and Catheterization Techniques”; Publication Date unknown but believed to be prior to 2007.;;“EPO Intent to Grant”, EPO Application No. 10251024.5; Filed Jun. 2, 2010; dated Nov. 2, 2012.;;“Examiner's Answer”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Dec. 17, 2013.;;“Extended EPO Exam Report”, EPO App No. 10251025.2; Filed Jun. 2, 2010; dated Dec. 17, 2013.;;“Instructions”, Naming a character website. URL: <https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>. 2008.Retreived from Internet Dec. 10, 2013.;;“Intent to Grant”, Chinese Application No. 201180066491.4; Flied Dec. 30, 2011; dated Jul. 6, 2016.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00513; Filed Apr. 21, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,448,786; IPR2015-00509; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00511; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,678,190; Inter Partes Review No. IPR2015-00514; Filed Apr. 21, 2015.;;“Inter Partes Review Petition”, Exhibit—Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Bard DFU; Bardex Infection Control Foley Tray; Copyright 2006, publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Declaration of Susan Carrow for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—EC Guideline 1998; “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Published Sep. 29, 1998 (Sep. 29, 1998); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008.;;“Inter Partes Review Petition”, Exhibit—Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010.;;“Inter Partes Review Petition”, Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Medical News Today Article; ‘Getting to Zero:’ Medlines' Erase Cauti Program Helps Hospitals Reduce Catheter Use by 20 Percent; Article Date Apr. 13, 2011.;;“Inter Partes Review Petition”, Exhibit—Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014.;;“Inter Partes Review Petition”, Exhibit—Morning Start Article; “Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent”; Published Jan. 2011.;;“Inter Partes Review Petition”, Exhibit—Nursing Standard; Article in Learning Zone—Continue Professional Development; “Reducing the risks associated with urinary catheters”; Published Mar. 25, 2009.;;“Inter Partes Review Petition”, Exhibit—RCE Filed Nov. May 31, 2011 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Response to Office Action in U.S. Appl. No. 12/495,148, filed June 30, 2009; Response Filed Nov. 19, 2010.;;“Inter Partes Review Petition”, Exhibit—The Journal of Healthcare Contracting, Oct. 2012; “Catheter-associated urinary tract infections”.;;“Inter Partes Review Petition”, Exhibit—Websters Dictionary Definition of Dispose; Webster's Third New International Dictionary; Copyright 2003; publication date unknown.;;“Inter Partes Review Petition”, Exhibit; Carrow CV—Susan Carrow CV; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; EC Guideline 2009; “Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use”; Revision 1 Published Jan. 12, 2009 (Jan. 12, 2009); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Kimmel CV—Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration U.S. Pat. No. 8,448,786 Patent; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Susan Carrow Declaration U.S. Pat. No. 8,448,786 patent; mailed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,448,786”, U.S. Pat. No. 8,448,786; Filed Dec. 30, 2014; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition for 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,678,190”, Inter Partes Review Petition for U.S. Pat. No. 8,678,190; Filed Dec. 30, 2014.;;“IPR 2015-00514—Patent Owner's Objection to Evidence”, IPR 2015-00514—Patent Owner's Objection to Evidence Submitted During a Preliminary Proceeding; U.S. Pat. No. 8,678,190; Mailed Jul. 13, 2015.;;“IPR 2015-00514—Patent Owner's Request for Adverse Judgement”, U.S. Pat. No. 8,678,190; Mailed Jul. 23, 2015.;;“IPR 2015-00514—Request for Rehearing Denied”, IPR2015-00514; U.S. Pat. No. 8,678,190; Decision on Request for Rehearing—Denied; Mailed Jul. 16, 2015.;;“IPR 2015-00514 Petitioner's Request for Rehearing”, IPR 2015-00514 Petitioner's Request for Rehearing; U.S. Pat. No. 8,678,190; Dated Jul. 10, 2015.;;“IPR0215-00513 Scheduling Order”, U.S. Pat. No. 8,631,935; Mailed Jul. 15, 2015.;;“IPR2015-00509 Institution Decision”, IPR2015-00509; U.S. Pat. No. 8,448,786; Mailed Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR2015-00511 Institution Decision”, IPR2015-00511; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR2015-00513—Request for Adverse Judgement”, IPR2015-00513—Request for Adverse Judgement; Granted—Proceedings Terminated; U.S. Pat. No. 8,631,935; Entered Aug. 11, 2015.;;“IPR2015-00513—Patent Owner's Request for Adverse Judgement”, U.S. Pat. No. 8,631,935; Mailed Jul. 23, 2015.;;“IPR2015-00513 Institution Decision”, IPR2015-00513 Institution Decision; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Institution of Inter Partes Review.;;“IPR2015-00514—Scheduling Order”, U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015.;;“IPR2015-00514 Decision Institution of Inter Partes Review”, IPR2015-00514; U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015; Decision Institution of Inter Partes Review.;;“IPR2015-00514 Judgement—Termination of Proceeding”, U.S. Pat. No. 8,678,190; Mailed Jul. 24, 2015.;;“NonFinal Office Action”, U.S. Appl. No. 13/680,902, filed Apr. 11, 2014; dated Dec. 2, 2014.;;“Notice of Acceptance”, Australian Application No. 2011351971; Filed Dec. 30, 2011; dated May 13, 2016.;;“Office Action”, Australian Application No. 2011351971; Reference No. 35204298/GP; dated Feb. 18, 2016.;;“Office Action”, Chinese Application No. 201180066491.4; dated Mar. 24, 2015.;;“Office Action”, Chinese Application No. 201180066491.4; dated Nov. 11, 2015.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Jul. 15, 2016.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Nov. 28, 2016.;;“Office Action Received”, Chinese App No. 201280035246.1; NonFinal OA; dated Sep. 16, 2015.;;“Publication”, European Commission: Pharmaceutical Committee “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Dated Sep. 29, 1998.;;“Second Office Action”, Chinese Application No. 201280035240.4; dated Jun. 23, 2016.;;“Third Office Action”, Chinese Application No. 201280035240.4; dated Apr. 1, 2017.;;Byun, Sung C. , “PCT Search Report”, PCT/US2011/068193; Filed Dec. 30, 2011; dated Aug. 22, 2012.;;Byun, Sung C. , “PCT Search Report”, PCT/US2012/039311; Filed May 24, 2011; dated Oct. 25, 2012.;;Byun, Sung Cheal , “PCT Search Report and Written Opinion”, PCT/US2012/037524; Filed May 11, 2012; dated Nov. 16, 2012.;;Cavanna, Mark , “Ex Parte Quayle Action”, U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012.;;Cavanna, Mark , “Final OA”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; Mailed Jun. 1, 2017.;;Cavanna, Mark , “NonFinal Office Action”, U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; dated Mar. 27, 2012.;;Cavanna, Mark , “Non-Final Office Action”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Sep. 26, 2016.;;Cavanna, Mark , “Notice of Allowance”, U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; dated Oct. 1, 2009.;;Cavanna, Mark , “Notice of Allowance”, U.S. Appl. No. 29/362,279, filed May 21, 2010, dated Sep. 19, 2011.;;Cavanna, Mark , “Notice of Allowance”, U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; dated Oct. 17, 2013.;;European Patent Office, , “Extended EPO Search Report”, Application No. 10251024.5, In the Name of Medline Industries, dated Oct. 18, 2010.;;European Patent Office, , “Extended EPO Search Report”, EPO Application No. 10251025.2, In the Name of Medline Industries, dated Sep. 29, 2010.;;Examiner, Chinese Patent Office , “First Office Action”, CN Application No. 2010202197859; dated November 18, 2010; Filed Jun. 3, 2010.;;Gilligan, C. Luke , “Notice of Allowance”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jun. 15, 2017.;;Gimenez Burgos, R , “European Examination Report”, European Application No. 11 854 003.8-1659; Ref SJG/P128064EP00; dated Jan. 22, 2015.;;Gimenez Burgos, R , “Extended European Search Report”, 11854003.8; Filed Dec. 30, 2011; dated Jun. 3, 2014.;;Gimenez Burgos, R , “Extended European Search Report”, EPO App No. 12 79 3939; Reference No. SJG/P130269EP00; dated Jan. 27, 2015.;;Gimenez Burgos, R , “Extended European Search Report”, EU App No. 12792423.1-1659/2713933; PCT/US2012039311; REference No. SJG/P130270EP00; dated Jan. 27, 2015.;;Hand, Melanie J. , “Final OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Jun. 5, 2013.;;Hand, Melanie J. , “NonFinal OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Feb. 1, 2013.;;Hand, Melanie J. , “NonFinal OA”, U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; Mailed May 9, 2013.;;Hand, Melanie J. , “NonFinal OA”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Nov. 30, 2012.;;Hand, Melanie J. , “NonFinal OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; Mailed Apr. 1, 2016.;;Hand, Melanie J. , “NonFinal OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; Mailed Oct. 26, 2015.;;Hand, Melanie J. , “Notice of Allowance”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Feb. 1, 2013.;;Hand, Melanie J. , “Notice of Allowance”, U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; dated Oct. 28, 2013.;;Hand, Melanie J. , “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Aug. 4, 2015.;;Hand, Melanie Jo , “Appeal Decision”, U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed May 18, 2016.;;Hand, Melanie Jo , “Final OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; Mailed May 22, 2015.;;Long, Fonya M , “Appeal Decision”, U.S. Appl. No. 13/154,265, filed Jun. 3, 2011; Mailed Oct. 6, 2016.;;Mackenzie, Kristian , “Office Action”, Canadian Application No. 2,705,647; Ref No. 15486-P37235CA00 10055U CA; dated Feb. 10, 2017.;;Mackenzie, Kristian , “Office Action”, Canadian Application No. 2,705,647; Ref No. 15468-P37235CA00; dated Apr. 21, 2016.;;Mackenzie, Kristian , “Office Action”, Canadian Application No. 2,705,670; dated Feb. 10, 2017.;;Mackenzie, Kristian , “Office Action”, Canadian Application No. 2,705,670; Ref No. 15468-8; dated Apr. 25, 2016.;;Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Nov. 8, 2016.;;Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Sep. 14, 2016.;;Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Feb. 28, 2017.;;Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 14/793,455, filed Jul. 7, 2015; dated Jul. 20, 2017.;;Marcetich, Adam M. , “Final OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; Mailed Aug. 11, 2016.;;Marcitech, Adam , “NonFinal OA”, U.S. Appl. No. 14/793,455, filed Jul. 7, 2015; Mailed May 3, 2017.;;Medline, , “Medline Aritcle/Brochure”, Published 2008.;;Pass, Natalie , “Final OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Jul. 12, 2013.;;Pass, Natalie , “NonFinal OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Mar. 5, 2013.;;Poon, Robert , “Appeal Decision”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Oct. 12, 2016.;;Poon, Robert , “Appeal Decision”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Oct. 24, 2016.;;Poon, Robert , “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Apr. 7, 2015.;;Poon, Robert , “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 13, 2013.;;Poon, Robert , “Final OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Dec. 18, 2013.;;Poon, Robert , “Final OA”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Aug. 6, 2013.;;Poon, Robert , “Final OA”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Aug. 6, 2013.;;Poon, Robert , “Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; Mailed Jan. 10, 2017.;;Poon, Robert , “Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2015; Mailed Oct. 5, 2015.;;Poon, Robert , “Final OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; Mailed Oct. 2, 2015.;;Poon, Robert , “Final OA”, U.S. Appl. No. 14/718,792, filed May 21, 2015; Mailed Jan. 5, 2016.;;Poon, Robert , “Final OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; Mailed Jan. 13, 2017.;;Poon, Robert , “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, dated Mar. 3, 2011.;;Poon, Robert , “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Jul. 31, 2013.;;Poon, Robert , “Final Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 26, 2012.;;Poon, Robert , “Final Office Action”, U.S. Appl. No. 14/718,912, filed May 21, 2015; dated Jan. 5, 2016.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Oct. 4, 2012.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Dec. 18, 2013.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Sep. 10, 2013.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; Mailed Sep. 12, 2016,.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; Mailed Dec. 31, 2014.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; Mailed Dec. 30, 2014.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 14/718,792, filed May 21, 2015; Mailed Nov. 19, 2015.;;Poon, Robert , “NonFinal OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; Mailed Jun. 30, 2016.;;Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Jun. 28, 2012.;;Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 22, 2011.;;Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 1, 2012.;;Poon, Robert , “NonFinal Office Action”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 2, 2012.;;Poon, Robert , “Non-Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; dated: Aug. 4, 2010.;;Poon, Robert , “Notice of Allowance”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Nov. 20, 2013.;;Poon, Robert , “Notice of Allowance”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Apr. 30, 2014.;;Poon, Robert , “Notice of Allowance”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Feb. 2, 2016.;;Poon, Robert , “Restriction Requirement”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 23, 2012.;;Pothier, Andrew , “Office Action”, Canadian Application No. 2,822,905; Reference No. 15468-P44352CA00; Mailed May 1, 2017.;;Prange, Sharon M. , “Response to First Office Action”, U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; dated Oct. 28, 2009.;;Schultz, Ottmar , “Extended European Search Report”, EP Application No. 16177903.8-1501; Filed Jun. 30, 2009; dated Oct. 27, 2016.;;Vasat, Peter , “Notice of Allowance”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Sep. 12, 2016.;;Yuan, Minqiang , “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Sep. 9, 2010.;;Yuan, Minquiang , “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Jun. 4, 2010.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit A lo Declaration of Bnan Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 4 to Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1:16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc., vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee: Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Declaration of Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z, Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vsC R. Bard, inc; Exhibit A—C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!7-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 2 lo Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-03518; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surrepiy: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc. Exhibit i to Declaration of Nicole M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 l6-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Jul. 8, 2016. et al.",ACTIVE
595,US,B2,US 11661220 B2,013-019-798-218-81X,2023-05-30,2023,US 202016944667 A,2020-07-31,US 202016944667 A;;US 202016833575 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 18362909 P,2009-06-03,"Catheter tray, packaging system, instruction insert, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND LP,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/013-019-798-218-81X,Granted Patent,yes,287,0,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B42/00;;A61B46/00;;A61B50/30;;A61B50/33;;A61M5/00;;A61M25/00,,485,4,044-145-043-807-87X;;098-777-794-605-077;;008-481-422-937-006;;055-945-454-377-987,10.4135/9781412963855.n765;;10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610;;10.1097/00000542-200701000-00013;;17197846,"Medline Industries Inc. vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; Mailed Aug. 18, 2015.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,795,761; Inter Partes Review No. IPR2019-00109; Filed Feb. 22, 2019.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,400; Inter Partes Review No. IPR2019-00208; Filed Mar. 7, 2019.;;IPR Petition 2001, Declaration of Meyst dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036.;;IPR Petition 2002, Declaration of Weintraub dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Feb. 22, 2019; IPR2019-00109.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2001; Declaration of Meyst dated Mar. 7, 2019; IPR2019-00223.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00223.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit A lo Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Bnef; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 4 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc; Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries inc. vs C R. Bard, Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline industnes Inc, vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee: Filed Jun. 4, 2016.;;Medline industnes Inc. vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industnes Inc. vs C R. Bard, Inc; Declaration oi Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline industnes Inc. vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industnes inc. vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industnes Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2, Lee; Filed Jun. 4, 2016.;;Medline Industnes Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industnes Inc. vs C R. Bard, Inc; Exhibit A—C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!7-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 2 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline industries Inc. vs C.R Bard, inc., Exhibit F to Declaration of Dyian J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Bard Opening Claim Construction Bnef; Civil Action No. 1 16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-03518; Judge John 2. Lee; Fiied Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surrepiy: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit i to Declaration of Nicoie M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 I6-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1.14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, P016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit 4 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit A to Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1;16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration ot Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv 03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1.14-cv-03618; Judge John Z. Lee. Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit E to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F lo Declaration of Kevin A Lake: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1. I4-CV-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action Mo. 1:16-cv-Q3529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit I to Declaration of Kevin A. Lake; Civil Action No. 1.14-sv-03618; Judge John 2. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit N to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Medline Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1;14-cv-03618; Judge John Z. Lee. Filed Jan. 25, 2017.;;Medline industries Inc. vs C.R Bard, Inc.; Medline Surreply to Claim Construction Bnef; Civil Action No. 1.14-CV-Q3618: Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Transcript of Deposition ot Richard Meyst; Civil Action No. 1:16-W-03529. Jan. 20, 2017.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit G to C.R Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L Ellis; Fiied Jan. 16, 2013.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit 3 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-CV-7216; Judge Sara L Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit C to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit D to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Etlis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc; Exhibit E to C R. Bard's LPR 2.3 Contentions; Civil Action No. 1;17-cv-7216; Judge Sara L. Ellis; Fiied Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc, Exhibit H loC.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-CV-7216; Judge Sara L. Ellis: Filed Jan. 16, 2018.;;Medline industries Inc. vs C.R Bard. Inc., Declaration of Brian Eutermoser in Support of Medline Surreply. Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 8 lo Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618: Judge John Z. Lee: Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Barbara Weintraub Regarding Claim Construction: Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit A to Declaration of Nicole Smith in Support of Bard Repiy lo Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit B to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit E to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 11 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit A to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1;14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.. Medline Motion lo Supplement Record on Claim Construction with Leinsing Testimony; Civil Action No. 1:14-w-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Bard Reply Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc.; Bard Response to Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Feb. 8, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Declaration of Karl R. leinsing in Support of Bard Reply io Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 3 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618: Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 8 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Kevin A. Lake; Civil Action No. 1 14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit G to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline industries Inc. vs C.R Bard. Inc.; Exhibit H to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Barbara A Weinlraub; Civil Action Mo. 1:16-cv-03529; Jan. 20, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Transcript of Deposition of Karl Leinsing; Civil Action No. 1:16-cv-03529; Feb. 17, 2017.;;Medline industries Inc. vs C.R Sard, Inc.; Exhibit 9 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Bard Response to Medline Surreply re Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 13, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit 2 to Declaration of Karl L. Lansing in Support of Bard's Rebuttal on Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit B to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit J to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit Kto Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit 1 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit 9 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.. Exhibit L to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.. Medline Response to Bard Claim Construction Brief. Civil Action No. 1:14˜cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.: Exhibit 2 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 117-CV-7216; Judge Sara L Eiiis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Barbara Weintraub re Claim Construction: Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 10 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 2 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 5 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman, Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 6 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 7 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit M to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc., Exhibit 2 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John 2. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 5 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 6 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline industries Inc. vs C.R. Bard. Inc.; Medline Response to Bard Opening Claim Construction Brief; Civil Action No. t:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs OR. Bard, Inc.; Exhibit E to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc, Exhibit I to C.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 11 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Kevin A. Lake in Support of Medline Response to Bard Claim Construction Brief: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Declaration of Barbara Weintraub Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, inc.; Exhibit D to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit 1 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-036I8; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc, Exhibit 4 to C.R. Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline IndustriesfInc. vs C.R. Bard, Inc., Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D lo Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc., Exhibit 1 to Declaration of Brian Eutermoser in Support of Medline Surreply; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit B to Declaration of Nicole M. Smith; Civil Action No. 1:14˜cv43618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, inc.; Exhibit D to Declaration of Nicole M Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit E to Declaration oi Nicole M. Smith; Civil Action No. 1:14-cv-03618: Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit F to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C R. Bard's Opening Claim Construction Bnel; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, inc; C.R Bard's Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Declaration of Dylan Raife in Support of Motion for Leave to Add CounterClaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Eiiis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit C to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline industries Inc. vs C R. Bard. Inc; Exhibit 1 to C R. Bard's LPR 2.3 Contentions, Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis. Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B lo Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; C R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit B—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John 2. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit G—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit H—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit I—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit J—C. R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. et al.",ACTIVE
596,US,A1,US 2020/0385153 A1,040-509-430-452-537,2020-12-10,2020,US 202016944667 A,2020-07-31,US 202016944667 A;;US 202016833575 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/040-509-430-452-537,Patent Application,yes,3,0,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,ACTIVE
597,US,B2,US 10318154 B2,102-806-010-814-077,2019-06-11,2019,US 201514872022 A,2015-09-30,US 201514872022 A;;US 201562168893 P;;US 201562172127 P,2015-05-31,Dynamic group membership for devices,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,APPLE INC (1997-06-20),https://lens.org/102-806-010-814-077,Granted Patent,yes,20,2,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L9/32;;G06F3/06;;G06Q90/00;;H04L29/08;;H04W4/08,,4,0,,,"International Search Report and Written Opinion for PCT/US2016/025440, dated Jul. 1, 2016, Apple Inc.;;Author Unknown, “iOS Security,” Oct. 1, 2014, pp. 1-50, Apple Inc., US, available at https://www.apple.com/br/privacy/docs/iOS_Security_Guide_Oct_2014.pdf.;;Taşkin, Halil Kemal, “End-to-end Encrypted Communication Between Multi-devise Users,” 7th International Conference on Information Security and Cryptology, Oct. 14, 2014, pp. 173-177, Istanbul, Turkey, available at http://iscturkey.org/wp-content/uploads/2016/03/isc2014-51.pdf.;;International Patent Application No. PCT/US2016/025431—International Search Report and Written Opinion dated Jul. 4, 2016.",ACTIVE
598,US,A1,US 2009/0094233 A1,199-823-308-915-51X,2009-04-09,2009,US 24326708 A,2008-10-01,US 24326708 A;;US 97785507 P,2007-10-05,Modeling Topics Using Statistical Distributions,"In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. Words of a document are selected as keywords of the document. The documents are clustered according to the keywords to yield clusters, where each cluster corresponds to a topic. A statistical distribution is generated for a cluster from words of the documents of the cluster. A topic is modeled using the statistical distribution generated for the cluster corresponding to the topic.",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,FUJITSU LIMITED (2008-09-18),https://lens.org/199-823-308-915-51X,Patent Application,yes,10,113,7,7,0,G06F16/355;;G06F16/355;;G06F16/313;;G06F16/313,G06F17/30,707/5;;X707E17001,0,0,,,,ACTIVE
599,US,A1,US 2017/0349305 A1,037-394-891-406-343,2017-12-07,2017,US 201715684787 A,2017-08-23,US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P,2009-06-30,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/037-394-891-406-343,Patent Application,yes,0,12,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B42/00;;A61B46/00;;A61B50/30;;A61B50/33;;A61M5/00;;A61M25/00,,0,0,,,,ACTIVE
600,KR,A,KR 20170140372 A,044-952-904-055-704,2017-12-20,2017,KR 20177034263 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872022 A;;US 2016/0025440 W,2015-05-31,디바이스들에 대한 동적 그룹 멤버십,"일부 실시예들은 디바이스들의 상이한 그룹들의 정의들을 식별하는 제 1 디바이스에 대한 방법을 제공하고, 디바이스들 각각은 디바이스가 멤버일 것을 필요로 하는 속성들의 세트에 의해 정의된다. 방법은 그룹 내에서의 멤버십에 대해 디바이스가 적격할 때를 판정하기 위해 제1 디바이스의 속성들을 모니터링한다. 디바이스가 멤버가 아닌 제1 그룹 내에서의 멤버십에 대해 제1 디바이스가 적격할 때, 방법은, 제1 그룹의 멤버인 적어도 하나의 다른 디바이스로, 적어도 디바이스의 개인 키로 서명되는 제1 그룹 내에서의 멤버십을 위한 신청서를 전송한다. 제1 디바이스가 멤버인 제2 그룹 내에서의 멤버십에 대해 제1 디바이스가 부적격하게 될 때, 방법은 제2 그룹으로부터 디바이스를 제거하고 제2 그룹의 멤버들인 다른 디바이스들에게 통지한다.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/044-952-904-055-704,Patent Application,no,3,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L9/32;;H04L29/08;;H04W12/06,,0,0,,,,ACTIVE
601,US,B2,US 9522753 B2,063-956-492-323-967,2016-12-20,2016,US 201313860902 A,2013-04-11,US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 201161437796 P;;US 201061428944 P;;US 35215510 P;;US 35214010 P;;US 479607 A,2007-12-21,"Catheter tray, packaging system, instruction insert, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/063-956-492-323-967,Granted Patent,yes,106,48,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,A61M5/00;;A61M25/00;;B65B11/00,,100,0,,,"Bower, Gordon H. ""Analysis of a mnemonic device: Modern psychology uncovers the powerful components of an ancient system for improving memory."" American Scientist 58.5 (1970): 496-510.;;Poon, Robert ""NonFinal OA"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Sep. 10, 2013.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; Mailed Oct. 17, 2013.;;""Notice of Allowance"", U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; Mailed Oct. 28, 2013.;;Poon, Robert ""Notice of Allowance"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Nov. 20, 2013.;;Poon, Robert ""Non-Final Office Action"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; art unit: 3728; mailed: Aug. 4, 2010.;;Yuan, Minqiang ""Non-Final Office Action"", Chinese Application No. 200920267201.2, Mailed Sep. 9, 2010.;;European Patent Office, ""Extended EPO Search Report"", EPO Application No. 10251025.2, In the Name of Medline Industries, Mailed Sep. 29, 2010.;;Medline, ""Medline Aritcle/Brochure"", Published 2008.;;Yuan, Minquiang ""Non-Final Office Action"", Chinese Application No. 200920267201.2, Mailed Jun. 4, 2010.;;European Patent Office, ""Extended EPO Search Report"", Application No. 10251024.5, In the Name of Medline Industries, Mailed Oct. 18, 2010.;;Chinese Patent Office ""First Office Action"", CN Application No. 201020219785.9; Mailed Nov. 18, 2010; Filed Jun. 3, 2010.;;Poon, Robert ""Final Office Action"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, Art Unit 3788, Mailed Mar. 3, 2011.;;Prange, Sharon M., ""Response to First Office Action"", U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; Mailed Oct. 28, 2009.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/362,279, filed May 21, 2010; Mailed Dec. 22, 2011.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Dec. 22, 2011.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; Mailed Oct. 1, 2009.;;Cavanna, Mark ""NonFinal Office Action"", U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; Mailed Mar. 27, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Jun. 28, 2012.;;Cavanna, Mark ""Ex Parte Quayle Action"", U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012.;;Poon, Robert ""Restriction Requirement"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 23, 2012.;;Byun, Sung C., ""PCT Search Report"", PCT/US2011/068193; Filed Dec. 30, 2011; Mailed Aug. 22, 2012.;;Poon, Robert ""Final Office Action"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Sep. 26, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Oct. 2, 2013.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Oct. 4, 2012.;;Poon, Robert ""NonFinal OA"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Oct. 4, 2012.;;Byun, Sung C., ""PCT Search Report"", PCT/US2012/039311; Filed May 24, 2011; Mailed Oct. 25, 2012.;;""NonFinal OA"", U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Nov. 30, 2012.;;Byun, Sung Cheal ""PCT Search Report and Written Opinion"", PCT/US2012/037524; Filed May 11, 2012; Mailed Nov. 16, 2012.;;""EPO Intent to Grant"", EPO Application No. 10251024.5; Filed Jun. 2, 2010; Mailed Nov. 2, 2012.;;""NonFinal OA"", U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Feb. 1, 2013.;;Pass, Natalie ""NonFinal OA"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Mar. 5, 2013.;;""Notice of Allowance"", U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Feb. 1, 2013.;;""NonFinal OA"", U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; Mailed May 9, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 13, 2013.;;""Final OA"", U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Jun. 5, 2013.;;Pass, Natalie ""Final OA"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Jul. 12, 2013.;;Poon, Robert ""Final Office Action"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Jul. 31, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Aug. 6, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Aug. 6, 2013.;;""Instructions"", Naming a character website. URL: <https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>. 2008.Retreived from Internet Dec. 10, 2013.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown-bear-brown-bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013.;;Dictionary definition m-w. URL:. Retrieved fro Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:. Retrieved from Internet Dec. 10, 2013.;;Lion King Sticker website. URL: . 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: . 1998 Retrieved from Internet Dec. 10, 2013.;;U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Dec. 17, 2013.;;Poon, Robert ""NonFinal OA"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Dec. 18, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Dec. 18, 2013.;;""Extended EPO Exam Report"", EPO App No. 10251025.2; Filed Jun. 2, 2010; Mailed Dec. 17, 2013.;;Poon, Robert ""Notice of Allowance"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Apr. 30, 2014.;;Gimenez Burgos, R ""Extended European Search Report"", 11854003.8; Filed Dec. 30, 2011; Mailed Jun. 3, 2014.;;""Bardex I.C. Infection Control Foley Tray"", Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006.;;""Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System"", Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006.;;""Bardex I.C. Infection Control 350ml Urine Meter Foley Tray"", Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006.;;""Bard Medical Division Care & Catheterization Script"", Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Catheterization Techniques; Copyright 2006; AV0512-06 R12/05 XXX.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 2.3 Contentions-Initial Non-Infringement; Exhibits 1 and A-H; Dated Sep. 5, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Initial Invalidity Contentions; Exhibits A-H; Dated Sep. 19, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; Dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatories; Dated Sep. 26, 2014.;;""Publication"", European Commission: Pharmaceutical Committee ""A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use""; Dated Sep. 29, 1998.;;""Bard Publication"", ""A few important words about Catheter Care""; C.R. Bard, Inc; Copyright 2001 C.R. Bard, Inc.;;Dover Intermittent Catheter Tray-14 fr, Red Rubber; Website http://tinyurl.com/o4esrwh; Unknown Publication Date.;;""YouTube Training Video"", https://www.youtube.com/watch?v=ISBya-5cIM.;;""YouTube Training Video"", https://www.youtube.com/watch?v=YwqcRUP35nl&list=UUG7a6tFPh1wvF0QDM-Z3DarQ.;;""Inter Partes Review Petition for U.S. Pat. No. 8,448,786"", U.S. Pat. No. 8,448,786; Filed Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", IPR Exhibit-Kimmel Declaration U.S. Pat. No. 8,448,786; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014.;;""Inter Partes Review Petition"", Exhibit; Kimmel CV-Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", IPR Exhibit-Susan Carrow Declaration U.S. Pat. No. 8,448,786; mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", Exhibit; Carrow CV-Susan Carrow CV; Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", Exhibit; EC Guideline 2009; ""Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use""; Revision 1 Published Jan. 12, 2009 (Jan. 12, 2009); Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", Exhibit-EC Guideline 1998; ""A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use""; Published Sep. 29, 1998 (Sep. 29, 1998); Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", Exhibit-Soroka Glossary-wrap; Illustrated Glossary of Packaging Terminology; second edition; publication date unknown,.;;""Inter Partes Review Petition"", Exhibit-Soroka Glossary 'Bag'; Illustrated Glossary of Packaging Terminology, second edition; Walter Soroka; publication unknown.;;""Inter Partes Review Petition"", Exhibit-Encyclopedia Dictionary of Medicine,""bag"" definition, Nursing and Allied Health; Miller Keane, Seventh Edition.;;""Inter Partes Review Petition"", Exhibit-Dorland's Definition of Bag; Dorland's Illustrated Medical Dictionary; 31st Edition; Publication Date Unknown.;;""Inter Partes Review Petition"", Exhibit-Nursing Standard; Article in Learning Zone-Continue Professional Development; ""Reducing the risks associated with urinary catheters""; Published Mar. 25, 2009.;;""Inter Partes Review Petition"", Exhibit-Websters Dictionary Definition of Dispose; Webster's Third New International Dictionary; Copyright 2003; publication date unknown.;;""Inter Partes Review Petition"", Exhibit-Bard DFU; Bardex Infection Control Foley Tray; Copyright 2006, publication date unknown.;;""Inter Partes Review Petition"", Exhibit-Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014.;;""Inter Partes Review Petition"", Exhibit-FDA Article; Guidance for the Content of Premarkt Notifications fro Conventional and Antimicrobial Foley Catheters; http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm080884.htm; Unknown Publication Date.;;""Inter Partes Review Petition"", Exhibit-Bardex DFU; Directions for Use/Patient Education Information-Urology; Unknown Publication Date.;;""Inter Partes Review Petition"", Exhibit-Mosby's Pocket Guide Excerpt; Mosby's Pocket Guide to Basic Skills and Procedures; Sixth Edition; Perry & Potter; ""Urinary Catheter: Indwelling, Straight, Care and Removal""; Unknown Publication Date.;;""Inter Partes Review Petition"", Exhibit-Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008.;;""Inter Partes Review Petition"", Exhibit-FAQs ""Catheter-Associated Urinary Tract Infection""; Unknown Publisher; Unknown Publication Date.;;""Inter Partes Review Petition for U.S. Pat. No. 8,631,935"", Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014.;;""Inter Partes Review Petition for U.S. Pat. No. 8,631,935"", Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014.;;""Inter Partes Review Petition for U.S. Pat. No. 8,678,190"", Inter Partes Review Petition for U.S. Pat. No. 8,678,190; Filed Dec. 30, 2014.;;""Inter Partes Review Petition"", Exhibit-Response to Office Action in U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Response Filed Nov. 19, 2010.;;""Inter Partes Review Petition"", Exhibit-RCE Filed Nov. May 31, 2011 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;""Inter Partes Review Petition"", Exhibit-Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;""Inter Partes Review Petition"", Exhibit-Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010.;;""Inter Partes Review Petition"", Exhibit-Morning Start Article; ""Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent""; Published Jan. 2011.;;""Inter Partes Review Petition"", Exhibit-Medical News Today Article; 'Getting To Zero:' Medlines' Erase Cauti Program Helps Hospitals Reduce Catheter Use by 20 Percent; Article Date Apr. 13, 2011.;;""Inter Partes Review Petition"", Exhibit-The Journal of Healthcare Contracting, Oct. 2012; ""Catheter-associated urinary tract infections"".;;""Inter Partes Review Petition"", IPR Exhibit-Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", IPR Exhibit-Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", IPR Exhibit-Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", IPR Exhibit-Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;""Inter Partes Review Petition"", IPR Exhibit-Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; Mailed Dec. 30, 2014.",ACTIVE
602,CN,A,CN 115484275 A,074-560-098-897-549,2022-12-16,2022,CN 202211112949 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872022 A;;CN 201680031639 A;;US 2016/0025440 W,2015-05-31,Dynamic group membership for devices,"The invention relates to dynamic group membership of a device. Some embodiments of the present invention provide a method for identifying a defined first device of different device groups, each defined by a set of attributes required by a device as a member. The method monitors an attribute of the first device to determine when the device is eligible to obtain a member identity in a group. When the first device is eligible to obtain a member identity of a first group of which the device is not a member, the method will send an application to obtain a member identity of the first group to at least one other device that is a member of the first group, the application being signed with at least one private key of the device. When the first device becomes ineligible to obtain a member identity in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/074-560-098-897-549,Patent Application,no,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L67/1095;;G06F3/06;;G06Q10/06;;G06Q10/10;;G06Q90/00;;H04L9/32;;H04L67/1042;;H04L67/30;;H04W4/08;;H04W12/06,,0,0,,,,PENDING
603,AU,B2,AU 2020/203360 B2,125-177-765-433-024,2020-11-19,2020,AU 2020/203360 A,2020-05-22,AU 2020/203360 A;;AU 2019/201374 A;;AU 2016/271071 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/125-177-765-433-024,Granted Patent,no,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
604,AU,A1,AU 2021/200403 A1,193-199-093-832-121,2021-03-18,2021,AU 2021/200403 A,2021-01-21,AU 2021/200403 A;;AU 2020/203360 A;;AU 2019/201374 A;;AU 2016/271071 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/193-199-093-832-121,Patent Application,no,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
605,AU,A1,AU 2020/203360 A1,059-239-614-398-646,2020-06-11,2020,AU 2020/203360 A,2020-05-22,AU 2020/203360 A;;AU 2019/201374 A;;AU 2016/271071 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/059-239-614-398-646,Patent Application,no,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
606,US,A1,US 2022/0009657 A1,149-420-014-413-696,2022-01-13,2022,US 202117483610 A,2021-09-23,US 202117483610 A;;US 202016833575 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/149-420-014-413-696,Patent Application,yes,0,1,2,95,0,A61B46/00;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B2050/3015;;A61M25/00;;A61M25/002;;A61B42/40;;A61M5/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,PENDING
607,EP,A3,EP 2045737 A3,160-218-600-339-045,2013-07-03,2013,EP 08165829 A,2008-10-03,US 97787707 P;;US 24298408 A,2007-10-05,Selecting tags for a document by analysing paragraphs of the document,"In one embodiment, assigning tags to a document includes accessing the document, where the document comprises text units that include words. The following is performed for each text unit: a subset of words of a text unit is selected as candidate tags, relatedness is established among the candidate tags, and certain candidate tags are selected according to the established relatedness to yield a candidate tag set for the text unit. Relatedness between the candidate tags of each candidate tag set and the candidate tags of other candidate tag sets is determined. At least one candidate tag is assigned to the document according to the determined relatedness.
",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,,https://lens.org/160-218-600-339-045,Search Report,yes,8,0,8,8,0,G06F16/313;;G06F40/117;;G06F40/242;;G06F40/284;;G06F16/313;;G06F40/284;;G06F40/117;;G06F40/242,G06F17/30;;G06F17/21;;G06F17/27,,1,1,082-723-405-116-073,10.1145/1135777.1135869,"BROOKS H B ET AL: ""Improved annotation of the blogosphere via autotagging and hierarchical clustering"", WWW '06 PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, ACM, NEW YORK, NY, USA, 23 May 2006 (2006-05-23), pages 625 - 631, XP002486141, ISBN: 978-1-59593-323-2, [retrieved on 20060523], DOI: 10.1145/1135777.1135869",DISCONTINUED
608,WO,A1,WO 2016/195798 A1,187-578-521-310-155,2016-12-08,2016,US 2016/0025431 W,2016-03-31,US 201514872013 A;;US 201562172127 P;;US 201562168893 P,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,"A user that owns multiple devices with overlapping functionality is becoming increasingly common. Smartphones, tablets, and computers all access the web, allow a user to process photos, etc., and users tend to have several such devices. Thus, a user wanting to share data between their devices and have access to data on multiple devices is increasingly common as well. Users may commonly use all sorts of different techniques to transfer data between devices, such as flash memory sticks, e-mail, etc. More efficient techniques for automatically sharing data between a user's devices are desired.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/187-578-521-310-155,Patent Application,yes,7,2,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,1,0,,,"""iOS Security Contents"", 1 October 2014 (2014-10-01) - 1 October 2014 (2014-10-01), pages 1 - 50, XP055145007, Retrieved from the Internet <URL:http://images.apple.com/privacy/docs/iOS_Security_Guide_Oct_2014.pdf>",PENDING
609,AU,B2,AU 2016/271071 B2,047-530-835-982-115,2018-11-29,2018,AU 2016/271071 A,2016-03-31,US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,"A user that owns multiple devices with overlapping functionality is becoming increasingly common. Smartphones, tablets, and computers all access the web, allow a user to process photos, etc., and users tend to have several such devices. Thus, a user wanting to share data between their devices and have access to data on multiple devices is increasingly common as well. Users may commonly use all sorts of different techniques to transfer data between devices, such as flash memory sticks, e-mail, etc. More efficient techniques for automatically sharing data between a user's devices are desired.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/047-530-835-982-115,Granted Patent,no,3,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
610,CN,A,CN 107667515 A,065-308-157-590-627,2018-02-06,2018,CN 201680031832 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872013 A;;US 2016/0025431 W,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,"A user that owns multiple devices with overlapping functionality is becoming increasingly common. Smartphones, tablets, and computers all access the web, allow a user to process photos, etc., and users tend to have several such devices. Thus, a user wanting to share data between their devices and have access to data on multiple devices is increasingly common as well. Users may commonly use all sorts of different techniques to transfer data between devices, such as flash memory sticks, e-mail, etc. More efficient techniques for automatically sharing data between a user's devices are desired.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/065-308-157-590-627,Patent Application,no,16,5,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L29/08;;H04L9/32;;H04W4/08,,0,0,,,,ACTIVE
611,EP,B1,EP 3086806 B1,156-545-059-333-49X,2019-12-11,2019,EP 14824746 A,2014-12-23,US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,PEPTIDE COMBINATIONS AND USES THEREOF IN TREATING DUST MITE ALLERGY,,ALK ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WÜRTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE;;ANDERSEN PETER SEJER,,https://lens.org/156-545-059-333-49X,Granted Patent,yes,6,0,15,15,0,A61K39/35;;A61K39/35;;C07K14/43531;;A61P37/08;;A61K39/35;;C07K14/43531;;A61K2039/555;;A61K39/35;;C07K14/43531,A61K39/35;;C07K14/435,,1,0,,,"SARA R PRICKETT ET AL: ""Ara h 2 peptides containing dominant CD4T-cell epitopes: Candidates for a peanut allergy therapeutic"", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 127, no. 3, 23 September 2010 (2010-09-23), pages 608-615.e5, XP028196570, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2010.09.027 [retrieved on 2010-10-04]",ACTIVE
612,EP,A2,EP 2045737 A2,010-629-594-997-873,2009-04-08,2009,EP 08165829 A,2008-10-03,US 97787707 P;;US 24298408 A,2007-10-05,Selecting tags for a document by analysing paragraphs of the document,"In one embodiment, assigning tags to a document includes accessing the document, where the document comprises text units that include words. The following is performed for each text unit: a subset of words of a text unit is selected as candidate tags, relatedness is established among the candidate tags, and certain candidate tags are selected according to the established relatedness to yield a candidate tag set for the text unit. Relatedness between the candidate tags of each candidate tag set and the candidate tags of other candidate tag sets is determined. At least one candidate tag is assigned to the document according to the determined relatedness.
",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,,https://lens.org/010-629-594-997-873,Patent Application,yes,1,2,8,8,0,G06F16/313;;G06F40/117;;G06F40/242;;G06F40/284;;G06F16/313;;G06F40/284;;G06F40/117;;G06F40/242,G06F17/30;;G06F17/21;;G06F17/27,,0,0,,,,DISCONTINUED
613,AU,A1,AU 2016/271071 A1,042-860-735-205-298,2017-12-21,2017,AU 2016/271071 A,2016-03-31,US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,"A user that owns multiple devices with overlapping functionality is becoming increasingly common. Smartphones, tablets, and computers all access the web, allow a user to process photos, etc., and users tend to have several such devices. Thus, a user wanting to share data between their devices and have access to data on multiple devices is increasingly common as well. Users may commonly use all sorts of different techniques to transfer data between devices, such as flash memory sticks, e-mail, etc. More efficient techniques for automatically sharing data between a user's devices are desired.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/042-860-735-205-298,Patent Application,no,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
614,AU,B2,AU 2019/201374 B2,059-445-448-655-009,2020-03-05,2020,AU 2019/201374 A,2019-02-27,AU 2019/201374 A;;AU 2016/271071 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/059-445-448-655-009,Granted Patent,no,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
615,US,A1,US 2015/0335855 A1,080-631-010-715-02X,2015-11-26,2015,US 201514793455 A,2015-07-07,US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 479607 A,2007-12-21,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/080-631-010-715-02X,Patent Application,yes,15,13,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,A61M25/00,,0,0,,,,ACTIVE
616,KR,A,KR 20180006397 A,133-918-507-026-19X,2018-01-17,2018,KR 20177034699 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872013 A;;US 2016/0025431 W,2015-05-31,관련 디바이스들 간의 동기화 및 검증 그룹들,"중첩되는 기능을 가진 다수의 디바이스들을 소유한 사용자가 점점 더 보편화되고 있다. 스마트폰들, 태블릿, 및 컴퓨터들은 모두 웹에 액세스하고, 사용자가 사진들 등을 프로세싱하게 하고, 사용자들은 여러 개의 그러한 디바이스들을 가지려는 경향이 있다. 따라서, 디바이스들 사이에서 데이터를 공유하고 다수의 디바이스들 상의 데이터로의 액세스를 갖기는 원하는 사용자도 또한 점점 더 보편화되고 있다. 사용자들은, 통상적으로, 플래시 메모리 스틱들, 이메일 등과 같이, 디바이스들 사이에서 데이터를 전송하기 위한 모든 종류들의 상이한 기법들을 사용할 수 있다. 사용자의 디바이스들 사이에서 데이터를 자동으로 공유하기 위한 더 효율적인 기법들이 요망된다.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/133-918-507-026-19X,Patent Application,no,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L29/08;;H04L9/32,,0,0,,,,ACTIVE
617,US,A1,US 2022/0009656 A1,169-718-686-348-126,2022-01-13,2022,US 202117483608 A,2021-09-23,US 202117483608 A;;US 202016833575 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/169-718-686-348-126,Patent Application,yes,0,0,2,95,0,A61B46/00;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B2050/3015;;A61M25/00;;A61M25/002;;A61B42/40;;A61M5/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,PENDING
618,KR,A,KR 20190097313 A,198-099-882-181-046,2019-08-20,2019,KR 20197023625 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872022 A;;US 2016/0025440 W,2015-05-31,DYNAMIC GROUP MEMBERSHIP FOR DEVICES,"일부 실시예들은 디바이스들의 상이한 그룹들의 정의들을 식별하는 제 1 디바이스에 대한 방법을 제공하고, 디바이스들 각각은 디바이스가 멤버일 것을 필요로 하는 속성들의 세트에 의해 정의된다. 방법은 그룹 내에서의 멤버십에 대해 디바이스가 적격할 때를 판정하기 위해 제1 디바이스의 속성들을 모니터링한다. 디바이스가 멤버가 아닌 제1 그룹 내에서의 멤버십에 대해 제1 디바이스가 적격할 때, 방법은, 제1 그룹의 멤버인 적어도 하나의 다른 디바이스로, 적어도 디바이스의 개인 키로 서명되는 제1 그룹 내에서의 멤버십을 위한 신청서를 전송한다. 제1 디바이스가 멤버인 제2 그룹 내에서의 멤버십에 대해 제1 디바이스가 부적격하게 될 때, 방법은 제2 그룹으로부터 디바이스를 제거하고 제2 그룹의 멤버들인 다른 디바이스들에게 통지한다.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/198-099-882-181-046,Patent Application,no,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L9/32;;H04L29/08;;H04W12/06,,0,0,,,,ACTIVE
619,CN,A,CN 107736001 A,119-496-087-945-91X,2018-02-23,2018,CN 201680031639 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872022 A;;US 2016/0025440 W,2015-05-31,DYNAMIC GROUP MEMBERSHIP FOR DEVICES,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/119-496-087-945-91X,Patent Application,no,4,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L29/08;;H04L9/32;;H04W4/08,,0,0,,,,PENDING
620,US,B2,US 10059751 B2,131-216-139-696-720,2018-08-28,2018,US 201415021775 A,2014-12-23,US 201415021775 A;;US 201361919925 P;;US 201462012690 P;;US 2014/0072228 W,2013-12-23,Peptide combinations and uses thereof in treating dust mite allergy,"The invention relates to combinations of peptides or variants thereof derived from a portion of an amino sequence of a house dust mite allergen, e.g. the allergens Der p 1, Der f 1, Der p 2 and/or Der f 2. Such peptides comprise at least one T cell epitope and a significant high number of patients in a worldwide population will have HLA alleles with the potential to bind the peptides of the peptide combinations. The invention also relates to the use of such peptide combinations in relieving an immune response caused by a dust mite.",ALK ABELLO AS;;LA JOLLA INST ALLERGY & IMMUNOLOGY;;ALK ABELLO AS;;LA JOLLA INST FOR ALLERGY AND IMMUNOGY,LUNDEGAARD CLAUS;;CHRISTENSEN LARS HARDER;;WURTZEN PETER ADLER;;SETTE ALESSANDRO;;SIDNEY JOHN;;LUND GITTE;;ANDERSEN PETER SEJER,LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY (2016-05-12);;ALK-ABELLÓ A/S (2016-05-13),https://lens.org/131-216-139-696-720,Granted Patent,yes,16,1,15,15,354,A61K39/35;;A61K39/35;;A61K39/35;;A61K39/35;;A61K2039/555;;A61P37/08;;C07K14/43531;;C07K14/43531;;C07K14/43531,A61K39/00;;A61K39/35;;C07K14/00;;C07K14/435,,33,30,063-640-832-834-034;;073-212-088-312-095;;016-203-996-044-020;;024-410-221-639-40X;;064-530-633-815-972;;005-748-129-761-516;;132-088-915-552-897;;056-201-471-905-934;;010-681-116-468-270;;000-084-161-082-58X;;009-293-561-193-754;;023-434-722-052-076;;015-054-897-877-526;;033-259-909-782-017;;058-567-300-315-349;;084-843-739-748-133;;048-901-477-921-123;;015-824-239-192-144;;032-728-154-591-070;;012-761-230-276-400;;018-208-239-340-186;;025-502-903-207-115;;085-764-009-624-439;;015-390-005-997-251;;038-617-189-853-751;;042-712-328-153-588;;066-622-073-370-530;;017-216-732-209-839;;028-373-705-126-470;;023-434-722-052-076,10631780;;10.1016/s0167-7799(99)01398-0;;10.1101/gr.10.4.398;;10779480;;10.1016/s0168-9525(98)01486-3;;9635409;;9359093;;10.1038/nbt1197-1222;;8909140;;10.1016/0168-9525(96)60040-7;;10.1038/nbt1001-974;;11581666;;10.4049/jimmunol.1200850;;pmc3411923;;22786768;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1016/s0006-291x(03)00585-0;;12711317;;10.1007/s00251-011-0513-0;;pmc3626422;;21305276;;pmc2527365;;18647321;;10.1111/j.1365-2249.2008.03710.x;;10.1186/1471-2105-7-153;;pmc1513259;;16545123;;pmc3809066;;10.1007/s00251-013-0720-y;;23900783;;pmc3573279;;10.1111/imm.12032;;23113712;;10.1007/s00251-013-0684-y;;23392739;;pmc3633633;;10.1034/j.1399-0039.2003.00062.x;;12753660;;21507007;;10.1111/j.1398-9995.2011.02610.x;;pmc1325229;;16351712;;10.1186/1745-7580-1-6;;10.1016/0022-2836(70)90057-4;;5420325;;19765293;;pmc2753847;;10.1186/1471-2105-10-296;;21073747;;pmc2994798;;10.1186/1745-7580-6-9;;10.1385/1-59259-192-2:185;;10547837;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;21093025;;10.1016/j.jaci.2010.09.027;;10.1186/1745-7580-4-2;;pmc2248166;;18221540;;10.4049/jimmunol.1001006;;20810981;;pmc3307390;;10.4049/jimmunol.0903655;;pmc2935290;;20139279;;10.1016/0196-8858(81)90046-4;;10.1016/0022-2836(81)90087-5;;7265238;;10.1186/1471-2105-7-153;;pmc1513259;;16545123,"Skolnick et al. (2000, Trends in Biotech. 18:34-39).;;Bork (2000, Genome Research 10:398-400).;;Doerks et al. (1998, Trends in Genetics 14:248-250).;;Smith et al. (1997, Nature Biotechnology 15:1222-1223).;;Bork et al. (1996, Trends in Genetics 12:425-427).;;Cottingham et al., (Nature Biotechnology. 2001. 19:974-977).;;Oseroff et al., (J Immunol. ePub Jul. 11, 2012;189:1800-1811).;;Altschul, S., et al., “Basic Local Alignment Search Tool,” J. Mol Biol., 1990,vol. 215,pp. 403-410.;;Bostick, D., et al., “A new topological method to measure protein structure similarity,” Biochemical and Biophysical Research Communications, 2003, vol. 304, pp. 320-325.;;Greenbaum, J., et al., “Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes,” Immunogenetics, 2011, vol. 63, pp. 325-335.;;Henmar, H., et al., “Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy,” Clinical and Experimental Immunology, 2008, vol. 153, pp. 316-323.;;Huynh-Hoa, B., et al., “Predicting population coverage of T-cell epitope-based diagnostics and vaccines,” BMC Bioinformatics, 2006,vol. 7(153), pp. 1-5.;;Karosiene, E., et al., “NetMHCIIpan-3.0, a common pan-specifi MNC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ,” Immunogenetics, 2013, vol. 65(10), pp. 1-25.;;Mackenzie, K., et al., Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation, Immunology, 2013, vol. 138, pp. 258-268.;;McKinney, D., et al., “A strategy to determine HLA class II restriction broadly covering the DR, DP and DQ allelic variants most commonly expressed in the general population,” Immunogenetics, 2014, vol. 65(5), doi: 10.1007/s00251-013-0684-y, pp. 1-23.;;Meyer, D., et al., “Chapter 4: Single locus polymorphism of classical HLA genes,” 13th IHWS Anthropology/Human Genetic Diversity Report; Immunobiology of the Human MHC; Proceedings of the 13th International Histocompatibility Workshop and Conference, 2006, pp. 653-704.;;Middleton, D., et al., “New allele frequency database: www.allelefrequencies.net,” Tissue Antigens, 2003, vol. 61, pp. 403-407.;;Moldaver, D., et al, “Immunotherapy with peptides,” Allergy, 2011, vol. 66, pp. 784-791.;;Murugan, N., et al, “Prediction of MHC class II binding peptides based on an iterative learning model,” Immunome Research, 2005, vol. 1(6), pp. 1-10.;;Needleman, S., et al., “A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins,” J. Mol. Biol., 1970, vol. 48, pp. 443-453.;;Nielsen, M., et al, “NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction,” BMC Bioinformatics, 2009, vol. 10(296), pp. 1-10.;;Nielsen, M., et al., NetMHCIIpan-2.0—Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure, Immunome Research, 2010, vol. 6(9), pp. 1-10.;;Pearson, William R., Flexible Sequence Similarity Searching with the FASTA3 Program Package, Methods in Molecular Biology, 2000, vol. 132: Bioinformatics Methods and Protocols, pp. 185-219.;;Pearson, W., et al., “Improved tools for biological sequence comparison,” Proc. Natl. Acad. Sci. USA, 1988, vol. 85, pp. 2444-2448.;;Prickett, S., et al., “Ara h 2 peptides containing dominant CD4+ T-cell epitodes: Candidates for a peanut allergy therapeutic,” J. Allergy Clin Immunol, 2011, vol. 127(3), pp. 608-615e5.;;Sidney, J., et al., “Measurement of MHC/Peptide Interactions by Gel Filtration,” Current Protocols in Immunology, 1998, Supplement 31, pp. 18.3.1-18.3.19.;;Sidney, J., et al., “Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries,” Immunome Research, 2008, vol. 4(2), pp. 1-14.;;Sidney, J., et al., “Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population,” The Journal of Immunology, 2010, vol. 185, pp. 4189-4198.;;Sidney, J., et al., “Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Biding Specificity,” The Journal of Immunology, 2010, doi:10.4049/jimmunol.0903655, pp. 2492-2503, http://www.jimmunol.org/content/early/2010/02/05/jimmunol.0903655.full.pdf.;;Smith, Temple F., “Comparison of Biosequences,” Advanced in Applied Mathematics, 1981, vol. 2, pp. 482-489.;;Smith, T., et al, “Identification of Common Molecular Subsequences,” J. Mol. Biol., 1981,vol. 147, pp. 195-197.;;Bui H., et al., “Predicting population coverage of T-cell epitope-based diagnostics and vaccines,” BMC Bioinformatics, 2006, vol. 7(153), pp. 1-5. (corrected citation).;;Sidney, J., et al., “Measurement of MHC/Peptide Interactions by Gel Filtration of Monoclonal Antibody Capture,” Curr Protoc Immunol. Published online 2013, Unit 18.3, pp. 1-47.",ACTIVE
621,AU,B2,AU 2021/200403 B2,153-971-825-066-072,2022-05-19,2022,AU 2021/200403 A,2021-01-21,AU 2021/200403 A;;AU 2020/203360 A;;AU 2019/201374 A;;AU 2016/271071 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/153-971-825-066-072,Granted Patent,no,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08,,0,0,,,,ACTIVE
622,US,A1,US 2021/0237915 A1,013-941-249-224-517,2021-08-05,2021,US 202117180680 A,2021-02-19,US 202117180680 A;;US 201715803383 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P,2009-06-30,"CATHETER TRAY, PACKAGING SYSTEM, INSTRUCTION INSERT, AND ASSOCIATED METHODS","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,MEDLINE INDUSTRIES LP (2021-09-07),https://lens.org/013-941-249-224-517,Patent Application,yes,0,0,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,DISCONTINUED
623,KR,A,KR 20220040506 A,007-919-062-213-246,2022-03-30,2022,KR 20227008901 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872013 A;;KR 20217005075 A;;US 2016/0025431 W,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,"중첩되는 기능을 가진 다수의 디바이스들을 소유한 사용자가 점점 더 보편화되고 있다. 스마트폰들, 태블릿, 및 컴퓨터들은 모두 웹에 액세스하고, 사용자가 사진들 등을 프로세싱하게 하고, 사용자들은 여러 개의 그러한 디바이스들을 가지려는 경향이 있다. 따라서, 디바이스들 사이에서 데이터를 공유하고 다수의 디바이스들 상의 데이터로의 액세스를 갖기는 원하는 사용자도 또한 점점 더 보편화되고 있다. 사용자들은, 통상적으로, 플래시 메모리 스틱들, 이메일 등과 같이, 디바이스들 사이에서 데이터를 전송하기 위한 모든 종류들의 상이한 기법들을 사용할 수 있다. 사용자의 디바이스들 사이에서 데이터를 자동으로 공유하기 위한 더 효율적인 기법들이 요망된다.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/007-919-062-213-246,Patent Application,no,1,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L67/1095;;H04L9/32;;H04L67/30,,1,0,,,"Mario Di Raimondo 외 2명, “Secure Off-the-Record Messaging”, WPES’05 (2005.11.07.)*",ACTIVE
624,US,A1,US 2018/0057196 A1,061-049-492-930-730,2018-03-01,2018,US 201715803383 A,2017-11-03,US 201715803383 A;;US 201715684787 A;;US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P,2009-06-30,"Catheter Tray, Packaging System, Instruction Insert, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,MEDLINE INDUSTRIES LP (2021-09-07),https://lens.org/061-049-492-930-730,Patent Application,yes,24,17,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,B65B11/00;;A61M5/00;;A61M25/00,,0,0,,,,ACTIVE
625,AU,A1,AU 2019/201374 A1,081-453-410-246-258,2019-03-21,2019,AU 2019/201374 A,2019-02-27,AU 2019/201374 A;;AU 2016/271071 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P;;US 2016/0025431 W,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/081-453-410-246-258,Patent Application,no,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,0,0,,,,ACTIVE
626,JP,A,JP 2009093650 A,147-434-540-826-428,2009-04-30,2009,JP 2008259630 A,2008-10-06,US 97787707 P;;US 24298408 A,2007-10-05,SELECTION OF TAG FOR DOCUMENT BY PARAGRAPH ANALYSIS OF DOCUMENT,"<P>PROBLEM TO BE SOLVED: To solve the problem that a conventional document tag assignment method may not be effective for finding of information, and a conventional search method may not be effective for finding of relevant information. <P>SOLUTION: In one embodiment, assigning tags to a document includes accessing the document, where the document comprises text units that include words. The following is performed for each text unit: a subset of words of a text unit is selected as candidate tags, relatedness is established among the candidate tags, and candidate tags are selected according to the established relatedness to yield a candidate tag set for the text unit. Relatedness between the candidate tags of each candidate tag set and the candidate tags of other candidate tag sets is determined. At least one candidate tag is assigned to the document according to the determined relatedness. <P>COPYRIGHT: (C)2009,JPO&INPIT",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,,https://lens.org/147-434-540-826-428,Patent Application,no,4,1,8,8,0,G06F16/313;;G06F40/117;;G06F40/242;;G06F40/284;;G06F16/313;;G06F40/284;;G06F40/117;;G06F40/242,G06F17/30;;G06F17/21,,5,0,,,"JPN6013010712; 砂山渡、外１名: 'サブストーリーモデルに基づく文章の流れの抽出' 電子情報通信学会技術研究報告 第１０４巻、第４１８号, 20041030, ｐｐ．１〜６, 社団法人電子情報通信学会;;CSNG200501167001; 砂山渡、外１名: 'サブストーリーモデルに基づく文章の流れの抽出' 電子情報通信学会技術研究報告 第１０４巻、第４１８号, 20041030, ｐｐ．１〜６, 社団法人電子情報通信学会;;JPN6013029292; 鈴木斎、外２名: '語の意味分類の出現傾向を考慮したキーワード抽出の試み' 情報処理学会研究報告 Ｖｏｌ．９３， Ｎｏ．１０１（９３-ＮＬ-９８）, 19931119, ｐｐ．７３〜８０, 社団法人情報処理学会;;CSNG200200705001; 鈴木斎、外２名: '語の意味分類の出現傾向を考慮したキーワード抽出の試み' 情報処理学会研究報告 Ｖｏｌ．９３， Ｎｏ．１０１（９３-ＮＬ-９８）, 19931119, ｐｐ．７３〜８０, 社団法人情報処理学会;;JPN6013010712; 砂山渡、外１名: 'サブストーリーモデルに基づく文章の流れの抽出' 電子情報通信学会技術研究報告 第１０４巻、第４１８号, 20041030, ｐｐ．１〜６, 社団法人電子情報通信学会",ACTIVE
627,US,A1,US 2009/0094231 A1,152-658-616-909-195,2009-04-09,2009,US 24298408 A,2008-10-01,US 24298408 A;;US 97787707 P,2007-10-05,Selecting Tags For A Document By Analyzing Paragraphs Of The Document,"In one embodiment, assigning tags to a document includes accessing the document, where the document comprises text units that include words. The following is performed for each text unit: a subset of words of a text unit is selected as candidate tags, relatedness is established among the candidate tags, and certain candidate tags are selected according to the established relatedness to yield a candidate tag set for the text unit. Relatedness between the candidate tags of each candidate tag set and the candidate tags of other candidate tag sets is determined. At least one candidate tag is assigned to the document according to the determined relatedness.",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,FUJITSU LIMITED (2008-09-18),https://lens.org/152-658-616-909-195,Patent Application,yes,10,64,8,8,0,G06F16/313;;G06F40/117;;G06F40/242;;G06F40/284;;G06F16/313;;G06F40/284;;G06F40/117;;G06F40/242,G06F17/27;;G06F17/30,707/5;;704/9;;X707E17001,1,1,082-723-405-116-073,10.1145/1135777.1135869,"Christopher H. Brooks & Nancy Montanez, ""Improved Annotation of the Blogosphere via Autotagging and Hierarchical Clustering"", ACM WWW 2006, pages 625-631.",ACTIVE
628,US,B2,US 9745088 B2,189-386-486-609-00X,2017-08-29,2017,US 201514793455 A,2015-07-07,US 201514793455 A;;US 201313860902 A;;US 201113155026 A;;US 49514809 A;;US 64751509 A;;US 201113153265 A;;US 201113153300 A;;US 35214010 P;;US 35215510 P;;US 201061428944 P;;US 201161437796 P;;US 479607 A,2007-12-21,"Catheter tray, packaging system, instruction insert, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. Printed instructions ( 1001 ) can be included with the tray ( 100 ). One or more layers of wrap material ( 2200 ) can be folded about the tray ( 100 ) to enclose the tray ( 100 ) and other items, such as an additional layer of wrap material ( 2701 ), packaged liquid hand sanitizer ( 2401 ), and packaged gloves ( 2402 ). When a health care services provider ( 3101 ) unfolds the wrap material, the same can be used to create a sterile field beneath a patient ( 3201 ).",MEDLINE IND INC,TOMES JENNIFER E;;DICKINSON SARAH;;ADLER DEBORAH;;MAZE JACK;;SAVAGE ALBERTO;;CHUA KENNETH;;WILSON EARL;;KUTSCH JOHN,,https://lens.org/189-386-486-609-00X,Granted Patent,yes,200,27,15,95,0,A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;A61M2209/06;;A61M5/002;;A61L2202/18;;A61L2202/182;;A61J2205/50;;A61J2205/40;;A61M25/00;;A61M25/0017;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/002;;B65B11/00,A61M25/00;;A61B42/00;;A61B46/00;;A61B50/30;;A61B50/33;;A61M5/00;;B65B11/00,,165,0,,,"Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; Memorandum in Support of C.R. Bard's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Sep. 25, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Defendant C.R. Bards, Inc's Second Amended Answer to Second Amended Complaint; Filed Sep. 25, 2015.;;Poon, Robert “Non-Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; dated Aug. 4, 2010.;;Yuan, Minqiang “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Sep. 9, 2010.;;European Patent Office, “Extended EPO Search Report”, EPO Application No. 10251025.2, In the Name of Medline Industries, dated Sep. 29, 2010.;;Medline, “Medline Aritcle/Brochure”, Published 2008.;;Yuan, Minquiang “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Jun. 4, 2010.;;European Patent Office, “Extended EPO Search Report”, Application No. 10251024.5, In the Name of Medline Industries, dated Oct. 18, 2010.;;Examiner, Chinese Patent Office “First Office Action”, CN Application No. 201020219785.9; dated Nov. 18, 2010; dated Jun. 3, 2010.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, dated Mar. 3, 2011.;;Prange, Sharon M., “Response to First Office Action”, U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; dated Oct. 28, 2009.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/362,279, filed May 21, 2010, dated Sep. 19, 2011.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 22, 2011.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; dated Oct. 1, 2009.;;Cavanna, Mark “NonFinal Office Action”, U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; dated Mar. 27, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Jun. 28, 2012.;;Cavanna, Mark “Ex Parte Quayle Action”, U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; dated Aug. 14, 2012.;;Poon, Robert “Restriction Requirement”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 23, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2011/068193, filed Dec. 30, 2011; dated Aug. 22, 2012.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 26, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 2, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 1, 2012.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Oct. 4, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2012/039311; Filed May 24, 2011; dated Oct. 25, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Nov. 30, 2012.;;Byun, Sung Cheal “PCT Search Report and Written Opinion”, PCT/US2012/037524; Filed May 11, 2012; dated Nov. 16, 2012.;;“EPO Intent to Grant”, EPO Application No. 10251024.5; Filed Jun. 2, 2010; dated Nov. 2, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Feb. 1, 2013.;;Pass, Natalie “NonFinal OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Mar. 5, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Feb. 1, 2013.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; dated May 9, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 13, 2013.;;Hand, Melanie J., “Final OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Jun. 5, 2013.;;Pass, Natalie “Final OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jul. 12, 2013.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Jul. 31, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Aug. 6, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Aug. 6, 2013.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 10, 2013.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; dated Oct. 17, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; dated Oct. 28, 2013.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Nov. 20, 2013.;;“Instructions”, Naming a character website. URL:.<https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>, 2008.Retreived from Internet Dec. 10, 2013.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown—bear—brown—bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://ww.merriann-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Lion King Sticker website. URL:<http://kobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;“Examiner's Answer”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Dec. 17, 2013.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Dec. 18, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 18, 2013.;;“Extended EPO Exam Report”, EPO App No. 10251025.2; Filed Jun. 2, 2010; dated Dec. 17, 2013.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Apr. 30, 2014.;;Gimenez Burgos, R “Extended European Search Report”, 11854003.8; Filed Dec. 30, 2011; dated Jun. 3, 2014.;;“Bardex I.C. Infection Control Foley Tray”, Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006.;;“Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System”, Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006.;;“Bardex I.C. Infection Control 350ml Urine Meter Foley Tray”, Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006.;;“Bard Medical Division Care & Catheterization Script”, Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Catheterization Techniques; Copyright 2006; AV0512-06 R12/052 XXX.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 2.3 Contentions—Inital Non-Infringement; Exhibits 1 and A-H; dated Sep. 5, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Inital Invalidity Contentions; Exhibits A-H; dated Sep. 19, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatories; dated Sep. 26, 2014.;;“Publication”, European Commission: Pharmaceutical Committee “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Dated Sep. 29, 1998.;;“Bard Publication”, “A few important words about Catheter Care”; C.R. Bard, Inc; Copyright 2001 C.R. Bard, Inc.;;“NonFinal Office Action”, U.S. Appl. No. 13/680,902, filed Apr. 11, 2014; dated Dec. 2, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,448,786”, U.S. Pat. No. 8,448,786; Filed Dec. 30, 2014; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration U.S. Pat. No. 8,448,786 Patent; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Kimmel CV—Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Susan Carrow Declaration U.S. Pat. No. 8,448,786 patent; mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Carrow CV—Susan Carrow CV; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; EC Guideline 2009; “Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use”; Revision 1 Published Jan. 12, 2009 (Jan. 12, 2009); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—EC Guideline 1998; “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Published Sep. 29, 1998 (Sep. 29, 1998); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Nursing Standard; Article in Learning Zone—Continue Professional Development; “Reducing the risks associated with urinary catheters”; Published Mar. 25, 2009.;;“Inter Partes Review Petition”, Exhibit—Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014.;;“Inter Partes Review Petition”, Exhibit—Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,678,190”, Inter Partes Review Petition for U.S. Pat. No. 8,678,190; Filed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Declaration of Susan Carrow for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Response to Office Action in U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Response Filed Nov. 19, 2010.;;“Inter Partes Review Petition”, Exhibit—RCE Filed Nov. May 31, 2011 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010.;;“Inter Partes Review Petition”, Exhibit—Morning Start Article; “Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent”; Published Jan. 2011.;;“Inter Partes Review Petition”, Exhibit—Medical News Today Article; ‘Getting to Zero:’Medlines 'Erase Cauti Program Helps Hospitals Reduce Catheter Use by 20 Percent; Article Date Apr. 13, 2011.;;“Inter Partes Review Petition”, Exhibit—The Journal of Healthcare Contracting, Oct. 2012; “Catheter-associated urinary tract infections”.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; Mailed Dec. 30, 2014.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Dec. 31, 2014.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Dec. 30, 2014.;;Gimenez Burgos, R “European Examination Report”, European Application No. 11 854 003.8-1659; dated Jan. 22, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EPO App No. 12 79 3939; dated Jan. 27, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EU App No. 12792423.1-1659/2713933; PCT/US2012039311; dated Jan. 27, 2015.;;“Bard IPR Exhibit”, “Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935; Susan Carrow Declaration; dated Dec. 30, 2014.;;“Article 94(3) EPC Examination”, European Application No. 10 251 025.2-1501; dated Mar. 13, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Apr. 7, 2015.;;“Office Action”, Chinese Application No. 201180066491.4; dated Mar. 24, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,448,786; IPR2015-00509; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00511; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00513; Filed Apr. 21, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,678,190; Inter Partes Review No. IPR2015-00514; Filed Apr. 21, 2015.;;“IPR2015-00514 Decision Institution of Inter Partes Review”, IPR2015-00514; U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015; Decision Institution of Inter Partes Review.;;“IPR2015-00509 Institution Decision”, IPR2015-00509; U.S. Pat. No. 8,448,786; Mailed Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR 2015-00514 Petitioner's Request for Rehearing”, IPR 2015-00514 Petitioner's Request for Rehearing; U.S. Pat. No. 8,678,190; Dated Jul. 10, 2015.;;“IPR2015-00511 Institution Decision”, IPR2015-00511; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR2015-00513 Institution Decision”, IPR2015-00513 Institution Decision; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Institution of Inter Partes Review.;;Hand, Melanie JO “Final OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated May 22, 2015.;;“IPR 2015-00514—Request for Rehearing Denied”, IPR2015-00514; U.S. Pat. No. 8,678,190; Decision on Request for Rehearing—Denied; Mailed Jul. 16, 2015.;;“IPR 2015-00514—Patent Owner's Objection to Evidence”, IPR 2015-00514—Patent Owner's Objection to Evidence Submitted During a Preliminary Proceeding; U.S. Pat. No. 8,678,190; Mailed Jul. 13, 2015.;;“IPR2015-00513—Patent Owner's Request for Adverse Judgement”, U.S. Pat. No. 8,631,935; Mailed Jul. 23, 2015.;;“IPR0215-00513 Scheduling Order”, U.S. Pat. No. 8,631,935; Mailed Jul. 15, 2015.;;“IPR 2015-00514—Patent Owner's Request for Adverse Judgement”, U.S. Pat. No. 8,678,190; Mailed Jul. 23, 2015.;;“IPR2015-00514—Scheduling Order”, U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015.;;“IPR2015-00514 Judgement—Termination of Proceeding”, U.S. Pat. No. 8,678,190; Mailed Jul. 24, 2015.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Aug. 4, 2015.;;“IPR2015-00513—Request for Adverse Judgement”, IPR2015-00513—Request for Adverse Judgement; Granted—Proceedings Terminated; U.S. Pat. No. 8,631,935; dated Aug. 11, 2015.;;“Australian First Exam Report”, AU Patent Application No. 2011351971; Patent Examination Report No. 1; Mailed 25JL2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Oct. 2, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2015; dated Oct. 5, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Notice of Medline Industries Inc's Motion to Dismiss C.R. Bard Inc's Inequitable Conduct Counterclaim and to strike affirmative defense for the '786 Patent; Filed Oct. 20, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries Inc's Opposition to C.R.Bard Inc's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Oct. 20, 2015.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; Mailed Aug. 18, 2015.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Oct. 26, 2015.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Nov. 19, 2015.;;Medline Industries vs. CR Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 3.1 Contentions; Filed Nov. 24, 2015.;;“Office Action Received”, Chinese App No. 201280035246.1; NonFinal OA; dated Sep. 16, 2015.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 14/718,912, filed May 21, 2015; dated Jan. 5, 2016.;;“Office Action”, Chinese Application No. 201180066491.4; dated Nov. 11, 2015.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Feb. 2, 2016.;;“Office Action”, Australian Application No. 2011351971; Reference No. 35204298/GP; dated Feb. 18, 2016.;;Notice of Allowance; EP Application No. 10251025.2-1501; Reference P112645EP00; dated Feb. 18, 2016.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,670; Ref No. 15468-8; dated Apr. 25, 2016.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,647; Ref No. 15468-P37235CA00; dated Apr. 21, 2016.;;Hand, Melanie JO “Appeal Decision”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated May 18, 2016.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; dated Jun. 30, 2016.;;“Second Office Action”, Chinese Application No. 201280035240.4; dated Jun. 23, 2016.;;“Intent to Grant”, Chinese Application No. 201280035246.1; Filed Dec. 30, 2011; dated Jul. 6, 2016.;;“Notice of Acceptance”, Australian Application No. 2011351971; Filed Dec. 30, 2011; dated May 13, 2016.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Jul. 15, 2016.;;Marcetich, Adam M., “Final OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Aug. 11, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc; C.R. Bard's LPR 3.1 Contentions; Civil Action No. 1:16-cs-3529; Judge Sharon Johnson Coleman; Filed Aug. 26, 2016.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Sep. 14, 2016.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Sep. 12, 2016.;;Vasat, Peter “Notice of Allowance”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Sep. 12, 2016,.;;Cavanna, Mark “Non-Final Office Action”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Sep. 26, 2016.;;Poon, Robert “Appeal Decision”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 24, 2016.;;Long, Fonya M “Appeal Decision”, U.S. Appl. No. 13/154,265, filed Jun. 3, 2011; dated Oct. 6, 2016.;;Poon, Robert “Appeal Decision”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 12, 2016.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Nov. 8, 2016.;;Schultz, Ottmar “Extended European Search Report”, EP Application No. 16177903-8-1501; Filed Jun. 30, 2009; dated Oct. 27, 2016.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Apr. 1, 2016.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Nov. 28, 2016.;;Poon, Robert “Final OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; dated Jan. 13, 2017.;;Poon, Robert “Final OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Jan. 10, 2017.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Feb. 28, 2017.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,670; dated Feb. 10, 2017.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,647; Ref No. 15486-P37235CA00 10055U CA; dated Feb. 10, 2017.;;Pothier, Andrew “Office Action”, Canadian Application No. 2,822,905; Reference No. 15468-P44352CA00; dated May 1, 2017.;;“Third Office Action”, Chinese Application No. 201280035240.4; dated Apr. 1, 2017.;;Gilligan, C. Luke “Notice of Allowance”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jun. 15, 2017.;;Cavanna, Mark “Final OA”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Jun. 1, 2017.;;“DVD”, Entitiled “Preventing UTI: Care and Catheterization Techniques”; Publication Date unknown but believed to be prior to 2007.",ACTIVE
629,US,S,US D0412415 S,184-391-187-473-266,1999-08-03,1999,US 9026098 F,1998-07-02,US 9026098 F,1998-07-02,Table,,AMF BOWLING PRODUCTS INC,ADLER ARI T;;ARNEY MICHAEL D;;CHASTAIN DAVID P;;COSTELLO JOHN C;;MALINA DAVID;;WOOD RONALD G,QUBICAAMF WORLDWIDE LLC (2005-09-15);;AMF BOWLING INC (1998-06-23),https://lens.org/184-391-187-473-266,Design Right,yes,2,6,1,1,0,,,D 6480;;0603,0,0,,,,EXPIRED
630,US,A1,US 2018/0053091 A1,005-588-566-813-070,2018-02-22,2018,US 201715679926 A,2017-08-17,US 201715679926 A;;US 201662376259 P,2016-08-17,SYSTEM AND METHOD FOR MODEL COMPRESSION OF NEURAL NETWORKS FOR USE IN EMBEDDED PLATFORMS,"Embodiments of the present disclosure include a non-transitory computer-readable medium with computer-executable instructions stored thereon executed by one or more processors to perform a method to select and implement a neural network for an embedded system. The method includes selecting a neural network from a library of neural networks based on one or more parameters of the embedded system, the one or more parameters constraining the selection of the neural network. The method also includes training the neural network using a dataset. The method further includes compressing the neural network for implementation on the embedded system, wherein compressing the neural network comprises adjusting at least one float of the neural network.",HAWXEYE INC,SAVVIDES MARIOS;;LIN AN PANG;;VENUGOPALAN SHREYAS;;THANIKKAL AJMAL;;SINGH KARANHAAR;;MATTY JOHN;;ADLER GAVRIEL;;NEBLETT KYLE,HAWXEYE INC (2018-03-13);;BOSSA NOVA ROBOTICS IP INC (2018-07-26);;BOSSA NOVA ROBOTICS INC (2018-05-25),https://lens.org/005-588-566-813-070,Patent Application,yes,0,65,1,1,0,G06N3/045;;G06N3/08;;G06N3/04;;G06N3/045,G06N3/08;;G06N3/04,,0,0,,,,DISCONTINUED
631,US,A1,US 2016/0352526 A1,021-976-258-442-073,2016-12-01,2016,US 201514872022 A,2015-09-30,US 201514872022 A;;US 201562168893 P;;US 201562172127 P,2015-05-31,Dynamic Group Membership For Devices,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,APPLE INC (1997-06-20),https://lens.org/021-976-258-442-073,Patent Application,yes,2,63,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L9/32,,0,0,,,,ACTIVE
632,US,B2,US 10198182 B2,090-019-694-451-484,2019-02-05,2019,US 201514872013 A,2015-09-30,US 201514872013 A;;US 201562168893 P;;US 201562172127 P,2015-05-31,Synchronization and verification groups among related devices,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,APPLE INC (1997-06-20),https://lens.org/090-019-694-451-484,Granted Patent,yes,20,31,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06;;H04L9/32;;H04L29/08;;H04W4/08,,4,0,,,"International Patent Application No. PCT/US2016/025440—International Search Report and Written Opinion dated Jul. 1, 2016.;;International Search Report and Written Opinion of PCT/US2016/025431, dated Jul. 4, 2016, Apple Inc.;;Author Unknown, “iOS Security,” Oct. 1, 2014, pp. 1-50, Apple Inc., US, available at https://www.apple.com/br/privacy/docs/iOS_Security_Guide_Oct_2014.pdf.;;Taskin, Halil Kemal, “End-to-end Encrypted Communication Between Multi-devise Users,” 7th International Conference on Information Security and Cryptology, Oct. 14, 2014, pp. 173-177, Istanbul, Turkey, available at http://iscturkey.org/wp-content/uploads/2016/03/isc2014-51.pdf.",ACTIVE
633,US,B2,US 8280892 B2,097-750-723-124-608,2012-10-02,2012,US 24298408 A,2008-10-01,US 24298408 A;;US 97787707 P,2007-10-05,Selecting tags for a document by analyzing paragraphs of the document,"In one embodiment, assigning tags to a document includes accessing the document, where the document comprises text units that include words. The following is performed for each text unit: a subset of words of a text unit is selected as candidate tags, relatedness is established among the candidate tags, and certain candidate tags are selected according to the established relatedness to yield a candidate tag set for the text unit. Relatedness between the candidate tags of each candidate tag set and the candidate tags of other candidate tag sets is determined. At least one candidate tag is assigned to the document according to the determined relatedness.",MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS;;FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,FUJITSU LIMITED (2008-09-18),https://lens.org/097-750-723-124-608,Granted Patent,yes,45,23,8,8,0,G06F16/313;;G06F40/117;;G06F40/242;;G06F40/284;;G06F16/313;;G06F40/284;;G06F40/117;;G06F40/242,G06F17/30,707/749;;704/9,23,7,082-723-405-116-073;;190-861-557-775-052;;052-040-394-327-789;;075-953-898-583-170;;029-978-456-947-486;;055-761-967-435-592;;035-190-043-902-101,10.1145/1135777.1135869;;10.1007/11765448_5;;10.1007/11495772_21;;10.1145/1135777.1135839;;10.1007/978-3-540-72667-8_44;;10.1145/860722.860744;;10.1007/11765448_6,"Christopher H. Brooks & Nancy Montanez, ""Improved Annotation of the Blogosphere via Autotagging and Hierarchical Clustering"", ACM WWW 2006, pp. 625-631.;;Communication from the European Patent Office, European Search Report dated Jan. 19, 2009 for European Patent Application No. 08165841.1-1527, 6 pages.;;U.S. Appl. No. 12/243,050, by inventors David L. Marvit et al., entitled ""Recommending Terms to Specify Ontology Space,"", 51 pages including drawings, Oct. 1, 2008.;;U.S. Appl. No. 12/368,689, by inventors Yannis Labrou et al., entitled ""Determining Words Related to a Given Set of Words,"" filed Feb. 10, 2009, 70 pages including drawings.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166182.4, Chinese Office Action and English Translation, 15 pages, Jul. 14, 2010.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166181.X, Chinese Office Action and English Translation, 8 pages, Sep. 2, 2010.;;Communication from European Patent Office, European Search Report dated Dec. 27, 2010 for European Patent Application No. 09152741.6-1527/2090992.;;Communication from Chinese Patent Office, Text of the First Office Action for Chinese Patent Application No. 200910007161.2, 6 pages, transmitted Feb. 21, 2011.;;Chinese Office Action with English Translation; Application No. 200810166181.X; pp. 6, Mar. 16, 2012.;;Chinese Office Action, Application No. 200810166182.4, with English Translation, 14 pages, Sep. 20, 2011.;;Tomassen et al.; ""Document Space Adapted Ontology: Application in Query Enrichment""; C. Kop et al. (Eds.): NLDB 2006, LNCS 3999; pp. 46-57, 2006.;;Hassan-Montero et al.; ""Improving Tag-Clouds as Visual Information Retrieval Interfaces""; International Conference on Multidisciplinary Information Sciences and Technologies; p. 6, 2006.;;Dey et al.; ""Ontology Aided Query Expansion for Retrieving Relevant Texts""; AWIC 2005; LNAI 3528; pp. 126-132, 2005.;;Wu et al.; ""Exploring Social Annotations for the Semantic Web""; (IW3C2); pp. 417-426, 2006.;;Specia wt al.; ""Integrating Folksonomies with the Semantic Web""; (Eds.): ESWC 2007, LNCS 4519; pp. 624-639, 2007.;;Ceccaroni et al.; ""A Graphic Environment for Ontology Development""; AAMAS' 03, Jul. 14-18, 2003; pp. 958-959, 2003.;;Sood et al.; ""TagAssist: Automatic Tag Suggestion for Blog Posts""; ICWSM; pp. 7, 2007.;;Marlow et al.; ""Position Paper, Tagging, Taxonomy, Flickr, Article, ToReda""; pp. 9, 2006.;;Herzog et al.; ""Combining Social and Semantic Metadata for Search in a Document Repository""; pp. 14-21, 2007.;;Santos-Neto et al.; ""Tracking Usage in Collaborative Tagging Communities""; pp. 8, 2007.;;Csaba Veres; ""The Language of Folksonomies: What Tags Reveal About User Classification""; NLDB 2006; LNCS 3999; pp. 58-69, 2006.;;United States Office Action; U.S. Appl. No. 12/243,050; pp. 52, Oct. 19, 2011.;;United States Final Office Action; U.S. Appl. No. 12/243,050; pp. 39, Mar. 29, 2012.",ACTIVE
634,EP,A2,EP 2045739 A2,130-984-236-648-785,2009-04-08,2009,EP 08165836 A,2008-10-03,US 97785507 P;;US 24326708 A,2007-10-05,Modeling topics using statistical distributions,"In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. Words of a document are selected as keywords of the document. The documents are clustered according to the keywords to yield clusters, where each cluster corresponds to a topic. A statistical distribution is generated for a cluster from words of the documents of the cluster. A topic is modeled using the statistical distribution generated for the cluster corresponding to the topic.
",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,,https://lens.org/130-984-236-648-785,Patent Application,yes,2,6,7,7,0,G06F16/355;;G06F16/313;;G06F16/355;;G06F16/313,G06F17/30,,0,0,,,,DISCONTINUED
635,US,A1,US 2023/0259276 A1,092-651-413-246-292,2023-08-17,2023,US 202318304309 A,2023-04-20,US 202318304309 A;;US 201916427235 A;;US 201514872022 A;;US 201562172127 P;;US 201562168893 P,2015-05-31,DYNAMIC GROUP MEMBERSHIP FOR DEVICES,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/092-651-413-246-292,Patent Application,yes,4,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06;;G06Q10/06;;G06Q10/10;;G06Q90/00;;H04L9/32;;H04L67/1095;;H04W4/08,,0,0,,,,PENDING
636,EP,B1,EP 0612599 B1,089-741-685-902-776,1997-07-30,1997,EP 94102402 A,1994-02-17,US 2125593 A,1993-02-23,Rotary die for extruding honeycombs,,CORNING INC,ADLER MERYLE DANIEL WALTER;;FROST RODNEY IRVING;;BAGLEY RODNEY DELANO;;LANNING JOHN GUSTIN;;SHAFER HAROLD GORDON JR,,https://lens.org/089-741-685-902-776,Granted Patent,yes,4,0,9,9,0,B28B3/269;;B28B3/269;;B28B3/269,B28B3/26;;B28B3/20,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 14, no. 231 (M-974)16 May 1990 & JP-A-02 060 714 (BABCOCK HITACHI KK) 1 March 1990;;SOVIET INVENTIONS ILLUSTRATED Week 8418, 13 June 1984 Derwent Publications Ltd., London, GB; AN 84-112418/18 & SU-A-1 031 731 (KHARK ENG CONS INST) 30 July 1983",EXPIRED
637,KR,A,KR 20210022157 A,097-168-572-309-539,2021-03-02,2021,KR 20217005075 A,2016-03-31,US 201562168893 P;;US 201562172127 P;;US 201514872013 A;;KR 20207003179 A;;US 2016/0025431 W,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,"중첩되는 기능을 가진 다수의 디바이스들을 소유한 사용자가 점점 더 보편화되고 있다. 스마트폰들, 태블릿, 및 컴퓨터들은 모두 웹에 액세스하고, 사용자가 사진들 등을 프로세싱하게 하고, 사용자들은 여러 개의 그러한 디바이스들을 가지려는 경향이 있다. 따라서, 디바이스들 사이에서 데이터를 공유하고 다수의 디바이스들 상의 데이터로의 액세스를 갖기는 원하는 사용자도 또한 점점 더 보편화되고 있다. 사용자들은, 통상적으로, 플래시 메모리 스틱들, 이메일 등과 같이, 디바이스들 사이에서 데이터를 전송하기 위한 모든 종류들의 상이한 기법들을 사용할 수 있다. 사용자의 디바이스들 사이에서 데이터를 자동으로 공유하기 위한 더 효율적인 기법들이 요망된다.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/097-168-572-309-539,Patent Application,no,2,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04L29/08;;H04L9/32,,0,0,,,,ACTIVE
638,US,B1,US 6433372 B1,114-851-849-232-206,2002-08-13,2002,US 52786300 A,2000-03-17,US 52786300 A,2000-03-17,Dense multi-gated device design,"
    A multigated FET having reduced diffusion capacitance, self-compensating effective channel length, improved short channel effects control, and enhanced density. Forming the FET by providing a plurality of separated insulated gates on a substrate, including forming insulating material on at least four surfaces of each of the gates, forming a dielectric layer on the substrate between the insulated gates, depositing and planarizing a layer of conductive material on and between the insulated gates down to the insulating material on the top surface of the insulated gates, and implanting diffusion regions into the substrate, adjacent to and beneath a portion of two distal ones of the plurality of insulated gates. 
",IBM,ADLER ERIC;;BERNSTEIN KERRY;;ELLIS-MONAGHAN JOHN J;;LARY JENIFER E;;NOWAK EDWARD J;;ROHRER NORMAN J,INTERNATIONAL BUSINESS MACHINES CORPORATION (2000-03-16),https://lens.org/114-851-849-232-206,Granted Patent,yes,17,8,1,1,0,H01L29/66484;;H01L29/66484,H01L21/336,257/288;;257/506;;257/513;;257/752;;438/620;;438/624;;438/637,0,0,,,,EXPIRED
639,US,A1,US 2019/0272101 A1,164-675-086-879-493,2019-09-05,2019,US 201916250890 A,2019-01-17,US 201916250890 A;;US 201514872013 A;;US 201562172127 P;;US 201562168893 P,2015-05-31,SYNCHRONIZATION AND VERIFICATION GROUPS AMONG RELATED DEVICES,Some embodiments provide a method for a first device to synchronize a set of data items with a second device. The method receives a request to synchronize the set of data items stored on the first device with the second device. The method determines a subset of the synchronization data items stored on the first device that belong to at least one synchronization sub-group in which the second device participates. Participation in at least one of the synchronization sub-groups is defined based on membership in at least one verification sub-group. The first and second devices are part of a set of related devices with several different verification sub-groups. The method sends only the subset of the synchronization data items that belong to at least one synchronization sub-group in which the second device participates to the second device using a secure channel.,APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/164-675-086-879-493,Patent Application,yes,0,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06;;G06Q10/06;;G06Q10/10;;G06Q90/00;;H04L9/32;;H04L29/08;;H04W4/08,,0,0,,,,ACTIVE
640,JP,A,JP 2009093651 A,003-644-667-803-593,2009-04-30,2009,JP 2008259631 A,2008-10-06,US 97785507 P;;US 24326708 A,2007-10-05,MODELING TOPICS USING STATISTICAL DISTRIBUTION,"<P>PROBLEM TO BE SOLVED: To solve the problem that the corpus of data holding large amounts of information makes it difficult to find out relevant information, and that while assigning tags to documents makes it easy to search relevant information, a conventional document tag assignment method may not be effective for finding of information in some cases. <P>SOLUTION: In one embodiment, modeling topics includes accessing a corpus comprising documents that include words. Words of a document are selected as keywords of the document. The documents are clustered according to the keywords, where each cluster corresponds to a topic. A statistical distribution is generated for a cluster from words of the documents of the cluster. A topic is modeled by using the statistical distribution generated for the cluster corresponding to the topic. <P>COPYRIGHT: (C)2009,JPO&INPIT",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS,,https://lens.org/003-644-667-803-593,Patent Application,no,0,1,7,7,0,G06F16/355;;G06F16/355;;G06F16/313;;G06F16/313,G06F17/30,,0,0,,,,DISCONTINUED
641,WO,A1,WO 2016/195799 A1,101-624-429-721-394,2016-12-08,2016,US 2016/0025440 W,2016-03-31,US 201514872022 A;;US 201562168893 P;;US 201562172127 P,2015-05-31,DYNAMIC GROUP MEMBERSHIP FOR DEVICES,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/101-624-429-721-394,Patent Application,yes,7,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,H04W4/08;;H04L29/08,,2,0,,,"""iOS Security Contents"", 1 October 2014 (2014-10-01) - 1 October 2014 (2014-10-01), pages 1 - 50, XP055145007, Retrieved from the Internet <URL:http://images.apple.com/privacy/docs/iOS_Security_Guide_Oct_2014.pdf>;;HALIL KEMAL TAKIN ET AL: ""END-TO-END ENCRYPTED COMMUNICATION BETWEEN MULTI-DEVICE USERS End-to-end Encrypted Communication Between Multi-device Users"", 14 October 2014 (2014-10-14), pages 173 - 177, XP055282698, Retrieved from the Internet <URL:http://iscturkey2016.org/wp-content/uploads/2016/03/isc2014-51.pdf> [retrieved on 20160622]",PENDING
642,US,S,US D0427802 S,001-884-291-073-122,2000-07-11,2000,US 090259,1998-07-02,,,Bowling ball rack and table,,,Adler; Ari T.;;Arney; Michael D.;;Chastain; David P.;;Costello; John C.;;Malina; David;;Wood; Ronald G.,QUBICAAMF WORLDWIDE LLC (2005-09-15);;AMF BOWLING INC (1998-06-23),https://lens.org/001-884-291-073-122,Design Right,yes,4,7,1,1,0,,,D 6397;;D6552,0,0,,,,UNKNOWN
643,CN,B,CN 101408885 B,104-498-459-680-081,2012-12-19,2012,CN 200810166172 A,2008-10-06,US 97785507 P;;US 24326708 A,2007-10-05,Modeling topics using statistical distributions,,FUJITSU LTD,LABROU YANNIS;;STERGIOU STERGIOS;;MARVIT DAVID L;;ADLER B THOMAS;;JAIN JAWAHAR;;GILMAN ALEX;;SIDOROWICH JOHN J,,https://lens.org/104-498-459-680-081,Granted Patent,no,0,0,7,7,0,G06F16/355;;G06F16/355;;G06F16/313;;G06F16/313,G06F17/30;;G06F17/27,,0,0,,,,ACTIVE
644,US,B2,US 11669244 B2,157-042-639-418-467,2023-06-06,2023,US 201916427235 A,2019-05-30,US 201916427235 A;;US 201514872022 A;;US 201562172127 P;;US 201562168893 P,2015-05-31,Dynamic group membership for devices,"Some embodiments provide a method for a first device that identifies definitions of different groups of devices, each of which is defined by a set of properties required for a device to be a member. The method monitors properties of the first device to determine when the device is eligible for membership in a group. When the first device is eligible for membership in a first group of which the device is not a member, the method sends an application for membership in the first group signed with at least a private key of the device to at least one other device that is a member of the first group. When the first device becomes ineligible for membership in a second group of which the first device is a member, the method removes the device from the second group and notifies other devices that are members of the second group.",APPLE INC,ADLER MITCHELL D;;BROUWER MICHAEL;;WHALLEY ANDREW R;;HURLEY JOHN C;;MURPHY RICHARD F;;FINKELSTEIN DAVID P,,https://lens.org/157-042-639-418-467,Granted Patent,yes,37,0,37,37,0,H04L9/3268;;H04L67/1095;;H04W4/08;;H04L67/1044;;G06Q10/06;;G06Q90/00;;H04L67/30;;H04L9/3255;;G06F3/0604;;G06Q10/10;;G06F3/0683;;H04W12/06;;G06F3/065;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q10/06;;G06Q10/10;;H04L9/3255;;H04L67/1095;;H04L67/30;;H04L67/1095;;H04W4/08;;H04L67/1044;;H04L9/3268;;G06Q90/00;;G06Q10/06;;G06Q10/10;;G06F3/0604;;G06F3/065;;G06F3/0683,G06F3/06;;G06Q10/06;;G06Q10/10;;G06Q90/00;;H04L9/32;;H04L67/104;;H04L67/1095;;H04W4/08,,10,1,140-369-067-808-554,10.1145/1102199.1102216,"Chinese Patent Application No. 201680031832.7—Notification to Grant Patent Right dated Apr. 14, 2021.;;Korean Patent Application No. 10-2019-7023625—Notice of Preliminary Rejection dated Aug. 19, 2019.;;European Patent Application No. 16718754.1—Examination Report dated Sep. 23, 2019.;;International Patent Application No. PCT/US2016/025431—International Search Report and Written Opinion dated Jul. 1, 2016.;;Author Unknown, “iOS Security,” Oct. 1, 2014, pp. 1-50, Apple Inc., US, available at https://www.apple.com/br/privacy/docs/iOS_Security_Guide_Oct_2014.pdf.;;Taşkin, Halil Kemal, “End-to-end Encrypted Communication Between Multi-devise Users,” 7th International Conference on Information Security and Cryptology, Oct. 14, 2014, pp. 173-177, Istanbul, Turkey, available at http://iscturkey.org/wpcontent/uploads/2016/03/isc2014-51.pdf.;;International Patent Application No. PCT/US2016/025440—International Search Report and Written Opinion dated Jul. 1, 2016.;;Korean Patent Application No. 10-2021-7005075—Notice of Preliminary Rejection dated May 30, 2021.;;Korean Patent Application No. 10-2022-7008901—Notice of Allolwance dated Jul. 27, 2022.;;Mario Di Raimondo et al., “Secure Off-the-Record Messaging,” WPES'05 (Nov. 7, 2005).",ACTIVE
645,CN,B,CN 101408886 B,182-607-032-474-683,2012-12-19,2012,CN 200810166181 A,2008-10-06,US 97787707 P;;US 24298408 A,2007-10-05,Selecting tags for a document by analyzing paragraphs of the document,,FUJITSU LTD,MARVIT DAVID L;;SIDOROWICH JOHN J;;ADLER B THOMAS;;LABROU YANNIS;;JAIN JAWAHAR;;GILMAN ALEX;;STERGIOU STERGIOS,,https://lens.org/182-607-032-474-683,Granted Patent,no,0,0,8,8,0,G06F16/313;;G06F40/117;;G06F40/242;;G06F40/284;;G06F16/313;;G06F40/284;;G06F40/117;;G06F40/242,G06F17/30,,0,0,,,,ACTIVE
646,WO,A1,WO 2023/018535 A1,184-815-934-491-617,2023-02-16,2023,US 2022/0037977 W,2022-07-22,US 202117399199 A,2021-08-11,SYSTEM AND COMPUTER-IMPLEMENTED METHOD FOR DETERMINING WEAR LEVELS OF A GROUND ENGAGING TOOL OF A WORK MACHINE INDICATIVE OF A TOOL REPLACEMENT CONDITION,An example wear detection system (110) receives first image data related to at least one ground engaging tool (GET) of a work machine (100) from one or more sensors at a first time instance in a dig-dump cycle of the work machine. The wear detection system processes the first image data to determine a first wear measurement and first wear level for the at least one GET. The wear detection system determines whether the first wear level is indicative of a GET replacement condition. The wear detection system generates an alert when the first wear level is indicative of the GET replacement condition. The wear detection system receives second image data related to the at least one GET a second time instance different from the first time instance when the first wear level is not indicative of the GET replacement condition and determines a second wear measurement and second wear level for the at least one GET. The wear detection system generates an alert indicative of the first wear level and the second wear level based on determining that the first wear level and the second wear level are indicative of the GET replacement condition.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;MATHEW SHAWN NAINAN;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;ADLER DANIEL PAUL,,https://lens.org/184-815-934-491-617,Patent Application,yes,5,0,6,6,0,E02F9/267;;E02F9/2808;;G06Q10/20;;G06T7/593;;H04N13/239;;G06V2201/06;;G06T7/001;;G06T2207/20081;;G06T2207/20228;;G06T2207/30164;;G08B21/182;;G08B31/00,E02F9/26;;E02F9/28;;G06Q10/00,,0,0,,,,PENDING
647,WO,A9,WO 2023/018535 A9,151-229-234-991-03X,2023-11-30,2023,US 2022/0037977 W,2022-07-22,US 202117399199 A,2021-08-11,SYSTEM AND COMPUTER-IMPLEMENTED METHOD FOR DETERMINING WEAR LEVELS OF A GROUND ENGAGING TOOL OF A WORK MACHINE INDICATIVE OF A TOOL REPLACEMENT CONDITION,An example wear detection system (110) receives first image data related to at least one ground engaging tool (GET) of a work machine (100) from one or more sensors at a first time instance in a dig-dump cycle of the work machine. The wear detection system processes the first image data to determine a first wear measurement and first wear level for the at least one GET. The wear detection system determines whether the first wear level is indicative of a GET replacement condition. The wear detection system generates an alert when the first wear level is indicative of the GET replacement condition. The wear detection system receives second image data related to the at least one GET a second time instance different from the first time instance when the first wear level is not indicative of the GET replacement condition and determines a second wear measurement and second wear level for the at least one GET. The wear detection system generates an alert indicative of the first wear level and the second wear level based on determining that the first wear level and the second wear level are indicative of the GET replacement condition.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;MATHEW SHAWN NAINAN;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;ADLER DANIEL PAUL,,https://lens.org/151-229-234-991-03X,Search Report,yes,0,0,6,6,0,E02F9/267;;E02F9/2808;;G06Q10/20;;G06T7/593;;H04N13/239;;G06V2201/06;;G06T7/001;;G06T2207/20081;;G06T2207/20228;;G06T2207/30164;;G08B21/182;;G08B31/00,E02F9/26;;E02F9/28;;G06Q10/00,,0,0,,,,PENDING
648,US,A1,US 2010/0235518 A1,186-652-388-243-403,2010-09-16,2010,US 72042310 A,2010-03-09,US 72042310 A;;US 16060109 P;;US 16064409 P,2009-03-16,CONNECTION TO MULTIPLE ACCESSORIES WITH MULTIPLE ACCESSORY-SPECIFIC PROTOCOLS,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHEL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM;;ANANNY JOHN,APPLE INC (2010-02-23),https://lens.org/186-652-388-243-403,Patent Application,yes,67,33,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F15/16;;H04M1/72409;;H04M1/72412,709/227;;709/230,0,0,,,,ACTIVE
649,US,A,US 5829900 A,134-586-560-367-32X,1998-11-03,1998,US 85171197 A,1997-05-06,US 85171197 A,1997-05-06,Container for cosmetic stick,"A dispenser for a cosmetic stick comprising (a) a removable cap in the form of a sleeve having an open upper end, for containing the cosmetic stick, (b) a base in the form of a sleeve having an open upper end, (c) fitted inside the base sleeve, an internal sleeve open at both ends for containing the cosmetic stick, (d) a product advancing mechanism comprising a platform which forms the bottom closure of the internal tubular sleeve, the platform having an upper surface having two protrusions affixed thereto, and a lower surface, and (e) a porous material affixed to the upper surface of the platform and securing the cosmetic stick to the platform.",REVLON CONSUMER PROD CORP,BROWN ROBERT NATHAN;;PODER BARBARA BONE;;STISO ALBERT JOSEPH;;THALHEIMER JAMES J;;WILCZYNSKI ROBERT JOHN;;COCHRAN MONROE ADLER,REVLON CONSUMER PRODUCTS CORPORATION (2004-07-09),https://lens.org/134-586-560-367-32X,Granted Patent,yes,20,7,1,1,0,A45D40/04;;A45D40/16;;A45D40/04;;A45D40/16,A45D40/04;;A45D40/16,401/87;;401/68;;401/75;;401/86;;401/88,0,0,,,,EXPIRED
650,US,A1,US 2023/0053154 A1,164-931-907-877-605,2023-02-16,2023,US 202117399433 A,2021-08-11,US 202117399433 A,2021-08-11,GROUND ENGAGING TOOL WEAR AND LOSS DETECTION SYSTEM AND METHOD,An example wear detection system receives a plurality of images from a plurality of sensors associated with a work machine. Individual sensors of the plurality of sensors have respective fields-of-view different from other sensors of the plurality of sensors. The wear detection system identifies a first region of interest and second region of interest associated with the at least one GET. The wear detection system determines a first set of image points and a second set of images points for the at least one GET based on geometric parameters associated with the GET. The wear detection system determines a wear level or loss for the at least one GET based on the GET measurement.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;MATHEW SHAWN NAINAN;;ADLER DANIEL PAUL,CATERPILLAR INC (2021-08-05),https://lens.org/164-931-907-877-605,Patent Application,yes,5,4,4,4,0,E02F9/2883;;G01S17/89;;G01S17/86;;G06T7/12;;G06T7/174;;G06T7/593;;G06V10/25;;G06T7/001;;G06T7/60;;G06T2207/10012;;G06T2207/10028;;G06T2207/20081;;G06T2207/30164,G06T7/00;;G06T7/12;;G06T7/174;;G06T7/593;;G06T7/60,,0,0,,,,PENDING
651,CA,A1,CA 3228401 A1,087-845-335-062-459,2023-02-16,2023,CA 3228401 A,2022-07-22,US 202117399199 A;;US 2022/0037977 W,2021-08-11,SYSTEM AND COMPUTER-IMPLEMENTED METHOD FOR DETERMINING WEAR LEVELS OF A GROUND ENGAGING TOOL OF A WORK MACHINE INDICATIVE OF A TOOL REPLACEMENT CONDITION,An example wear detection system (110) receives first image data related to at least one ground engaging tool (GET) of a work machine (100) from one or more sensors at a first time instance in a dig-dump cycle of the work machine. The wear detection system processes the first image data to determine a first wear measurement and first wear level for the at least one GET. The wear detection system determines whether the first wear level is indicative of a GET replacement condition. The wear detection system generates an alert when the first wear level is indicative of the GET replacement condition. The wear detection system receives second image data related to the at least one GET a second time instance different from the first time instance when the first wear level is not indicative of the GET replacement condition and determines a second wear measurement and second wear level for the at least one GET. The wear detection system generates an alert indicative of the first wear level and the second wear level based on determining that the first wear level and the second wear level are indicative of the GET replacement condition.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;MATHEW SHAWN NAINAN;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;ADLER DANIEL PAUL,,https://lens.org/087-845-335-062-459,Patent Application,no,0,0,6,6,0,E02F9/267;;E02F9/2808;;G06Q10/20;;G06T7/593;;H04N13/239;;G06V2201/06;;G06T7/001;;G06T2207/20081;;G06T2207/20228;;G06T2207/30164;;G08B21/182;;G08B31/00,,,0,0,,,,PENDING
652,US,B2,US 8554924 B2,035-650-938-427-596,2013-10-08,2013,US 72042310 A,2010-03-09,US 72042310 A;;US 16060109 P;;US 16064409 P,2009-03-16,Connection to multiple accessories with multiple accessory-specific protocols,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM;;ANANNY JOHN;;APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM;;ANANNY JOHN,APPLE INC (2010-02-23),https://lens.org/035-650-938-427-596,Granted Patent,yes,73,16,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F15/16;;H04M1/72409;;H04M1/72412,709/227;;709/230;;710/2,17,0,,,"""A Specification of the Bluetooth System"" ""Bluetooth"" Jul. 26, 2007, Copyright 1999; Agere Systems Inc et al., 1420 pages.;;""Bluetooth"" Wikipedia, the free Encyclopedia, downloaded on Jan. 11, 2010, Retrieved from the Internet: URL:http://en.wikipedia.org/w/index.php?ti tle=Bluetooth&oldid=273620532; 16 pages.;;""Reverse-DNS"" Wikipedia, the free Encyclopedia, downloaded on Jan. 11, 2010 Retrieved from the Internet: URL:http://en.wikipedia.org/w/index.php?ti tle=Reverse-DNS&oldid=270747273; 2 pages.;;International Application No. PCT/US2010/027058, International Search Report and Written Opinion, 13 pages, Apr. 26, 2010.;;Tanenbaum, Andrew S.; Structured Computer Organization; 1984; Prentice-Hall, Inc.; Second Edition; pp. 10-11, 4 pages.;;International Search Report and Written Opinion in PCT/US2011/052827, mailed Nov. 28, 2011, 9 pages.;;Wikipedia, ""Reverse DNS lookup"", Accessed Mar. 11, 2012, http://en.wikipedia.org/wiki/Reverse-DNS-lookup; 3 pages.;;Carey, D., ""Turning a mobile phone into wallet"", Electronic Engineering Times, n 1443, p. 24-25, Oct. 2, 2006.;;U.S. Appl. No. 13/250,681, filed Sep. 30, 2011, Holden et al.;;U.S. Appl. No. 13/250,900, filed Sep. 30, 2011, Holden et al.;;Google Releases Car Home App Into the Android Market [Car Home App for Android Now Available in the Android Market, for Those Running Android 2.2], web-pages downloaded from nexus404.com/.../google-releases-car-h . . . , Aug. 1, 2011, 7 pages.;;Non-Final Office Action mailed Apr. 3, 2013 in U.S. Appl. No. 12/720,375, 26 pages.;;Non-Final Office Action mailed May 8, 2013 in U.S. Appl. No. 13/085,952, 34 pages.;;Notice of Allowance mailed Nov. 15, 2012, U.S. Appl. No. 13/250,681, 6 pages.;;Notice of Allowance mailed Nov. 15, 2012, U.S. Appl. No. 13/250,681.;;Notice of Allowance mailed Nov. 14, 2012, U.S. Appl. No. 12/720,446.;;Non-Final Office Action mailed Jan. 3, 2013, U.S. Appl. No. 12/720,400.",ACTIVE
653,AU,A1,AU 2022/328115 A1,049-857-657-680-057,2024-02-22,2024,AU 2022/328115 A,2022-07-22,US 202117399199 A;;US 2022/0037977 W,2021-08-11,SYSTEM AND COMPUTER-IMPLEMENTED METHOD FOR DETERMINING WEAR LEVELS OF A GROUND ENGAGING TOOL OF A WORK MACHINE INDICATIVE OF A TOOL REPLACEMENT CONDITION,An example wear detection system (110) receives first image data related to at least one ground engaging tool (GET) of a work machine (100) from one or more sensors at a first time instance in a dig-dump cycle of the work machine. The wear detection system processes the first image data to determine a first wear measurement and first wear level for the at least one GET. The wear detection system determines whether the first wear level is indicative of a GET replacement condition. The wear detection system generates an alert when the first wear level is indicative of the GET replacement condition. The wear detection system receives second image data related to the at least one GET a second time instance different from the first time instance when the first wear level is not indicative of the GET replacement condition and determines a second wear measurement and second wear level for the at least one GET. The wear detection system generates an alert indicative of the first wear level and the second wear level based on determining that the first wear level and the second wear level are indicative of the GET replacement condition.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;MATHEW SHAWN NAINAN;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;ADLER DANIEL PAUL,,https://lens.org/049-857-657-680-057,Patent Application,no,0,0,6,6,0,E02F9/267;;E02F9/2808;;G06Q10/20;;G06T7/593;;H04N13/239;;G06V2201/06;;G06T7/001;;G06T2207/20081;;G06T2207/20228;;G06T2207/30164;;G08B21/182;;G08B31/00,E02F9/26;;E02F9/28;;G06Q10/00,,0,0,,,,PENDING
654,WO,A1,WO 2023/018540 A1,109-780-354-472-99X,2023-02-16,2023,US 2022/0038292 W,2022-07-26,US 202117399433 A,2021-08-11,WORK MACHINE GROUND ENGAGING TOOL WEAR AND LOSS DETECTION SYSTEM AND METHOD,"An example wear detection system (110) receives a plurality of images from a plurality of sensors (126, 128) associated with a work machine (100). Individual sensors of the plurality of sensors have respective fields-of-view (127, 129) different from other sensors of the plurality of sensors. The wear detection system identifies a first region of interest(550) and second region of interest (550) associated with the at least one GET. The wear detection system determines a first set of image points (920) and a second set of images points (920) for the at least one GET based on geometric parameters (535) associated with the GET. The wear detection system determines a wear level or loss for the at least one GET based on the GET measurement.",CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;PLOUZEK JOHN M;;WISE RAYMOND A;;MATHEW SHAWN N;;ADLER DANIEL P,,https://lens.org/109-780-354-472-99X,Patent Application,yes,9,0,4,4,0,E02F9/2883;;G01S17/89;;G01S17/86;;G06T7/12;;G06T7/174;;G06T7/593;;G06V10/25;;G06T7/001;;G06T7/60;;G06T2207/10012;;G06T2207/10028;;G06T2207/20081;;G06T2207/30164,E02F9/28;;G01S17/894;;G06T15/00,,1,1,099-330-654-221-624,10.1117/12.2002129,"LUIS E. GURRIERI ET AL: ""Stereoscopic cameras for the real-time acquisition of panoramic 3D images and videos"", PROCEEDINGS OF SPIE, vol. 8648, 12 March 2013 (2013-03-12), US, pages 1 - 17, XP055479312, ISBN: 978-1-5106-1533-5, DOI: 10.1117/12.2002129",PENDING
655,US,A1,US 2023/0051843 A1,055-372-348-217-108,2023-02-16,2023,US 202117399199 A,2021-08-11,US 202117399199 A,2021-08-11,GROUND ENGAGING TOOL WEAR AND LOSS DETECTION SYSTEM AND METHOD,An example wear detection system receives first image data related to at least one ground engaging tool (GET) of a work machine from one or more sensors at a first time instance in a dig-dump cycle of the work machine. The wear detection system processes the first image data to determine a first wear measurement and first wear level for the at least one GET. The wear detection system determines whether the first wear level is indicative of a GET replacement condition. The wear detection system generates an alert when the first wear level is indicative of the GET replacement condition. The wear detection system receives second image data related to the at least one GET a second time instance different from the first time instance when the first wear level is not indicative of the GET replacement condition and determines a second wear measurement and second wear level for the at least one GET. The wear detection system generates an alert indicative of the first wear level and the second wear level based on determining that the first wear level and the second wear level are indicative of the GET replacement condition.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;MATHEW SHAWN NAINAN;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;ADLER DANIEL PAUL,CATERPILLAR INC (2021-08-05),https://lens.org/055-372-348-217-108,Patent Application,yes,6,1,6,6,0,E02F9/267;;E02F9/2808;;G06Q10/20;;G06T7/593;;H04N13/239;;G06V2201/06;;G06T7/001;;G06T2207/20081;;G06T2207/20228;;G06T2207/30164;;G08B21/182;;G08B31/00,G08B21/18;;G06T7/00;;G06T7/593;;G08B31/00;;H04N13/239,,0,0,,,,ACTIVE
656,US,B2,US 11869331 B2,049-813-870-414-976,2024-01-09,2024,US 202117399199 A,2021-08-11,US 202117399199 A,2021-08-11,Ground engaging tool wear and loss detection system and method,An example wear detection system receives first image data related to at least one ground engaging tool (GET) of a work machine from one or more sensors at a first time instance in a dig-dump cycle of the work machine. The wear detection system processes the first image data to determine a first wear measurement and first wear level for the at least one GET. The wear detection system determines whether the first wear level is indicative of a GET replacement condition. The wear detection system generates an alert when the first wear level is indicative of the GET replacement condition. The wear detection system receives second image data related to the at least one GET a second time instance different from the first time instance when the first wear level is not indicative of the GET replacement condition and determines a second wear measurement and second wear level for the at least one GET. The wear detection system generates an alert indicative of the first wear level and the second wear level based on determining that the first wear level and the second wear level are indicative of the GET replacement condition.,CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;MATHEW SHAWN NAINAN;;PLOUZEK JOHN M;;WISE RAYMOND ALAN;;ADLER DANIEL PAUL,CATERPILLAR INC (2021-08-05),https://lens.org/049-813-870-414-976,Granted Patent,yes,28,0,6,6,0,E02F9/267;;E02F9/2808;;G06Q10/20;;G06T7/593;;H04N13/239;;G06V2201/06;;G06T7/001;;G06T2207/20081;;G06T2207/20228;;G06T2207/30164;;G08B21/182;;G08B31/00,G08B21/18;;G06T7/00;;G06T7/593;;G08B31/00;;H04N13/239,,0,0,,,,ACTIVE
657,CA,A1,CA 3228396 A1,100-199-074-099-637,2023-02-16,2023,CA 3228396 A,2022-07-26,US 202117399433 A;;US 2022/0038292 W,2021-08-11,WORK MACHINE GROUND ENGAGING TOOL WEAR AND LOSS DETECTION SYSTEM AND METHOD,"An example wear detection system (110) receives a plurality of images from a plurality of sensors (126, 128) associated with a work machine (100). Individual sensors of the plurality of sensors have respective fields-of-view (127, 129) different from other sensors of the plurality of sensors. The wear detection system identifies a first region of interest(550) and second region of interest (550) associated with the at least one GET. The wear detection system determines a first set of image points (920) and a second set of images points (920) for the at least one GET based on geometric parameters (535) associated with the GET. The wear detection system determines a wear level or loss for the at least one GET based on the GET measurement.",CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;PLOUZEK JOHN M;;WISE RAYMOND A;;MATHEW SHAWN N;;ADLER DANIEL P,,https://lens.org/100-199-074-099-637,Patent Application,no,0,0,4,4,0,E02F9/2883;;G01S17/89;;G01S17/86;;G06T7/12;;G06T7/174;;G06T7/593;;G06V10/25;;G06T7/001;;G06T7/60;;G06T2207/10012;;G06T2207/10028;;G06T2207/20081;;G06T2207/30164,G01S17/894,,0,0,,,,PENDING
658,AU,A1,AU 2022/328116 A1,072-552-573-400-106,2024-02-22,2024,AU 2022/328116 A,2022-07-26,US 202117399433 A;;US 2022/0038292 W,2021-08-11,WORK MACHINE GROUND ENGAGING TOOL WEAR AND LOSS DETECTION SYSTEM AND METHOD,"An example wear detection system (110) receives a plurality of images from a plurality of sensors (126, 128) associated with a work machine (100). Individual sensors of the plurality of sensors have respective fields-of-view (127, 129) different from other sensors of the plurality of sensors. The wear detection system identifies a first region of interest(550) and second region of interest (550) associated with the at least one GET. The wear detection system determines a first set of image points (920) and a second set of images points (920) for the at least one GET based on geometric parameters (535) associated with the GET. The wear detection system determines a wear level or loss for the at least one GET based on the GET measurement.",CATERPILLAR INC,MIANZO LAWRENCE A;;OBLAK TOD A;;PLOUZEK JOHN M;;WISE RAYMOND A;;MATHEW SHAWN N;;ADLER DANIEL P,,https://lens.org/072-552-573-400-106,Patent Application,no,0,0,4,4,0,E02F9/2883;;G01S17/89;;G01S17/86;;G06T7/12;;G06T7/174;;G06T7/593;;G06V10/25;;G06T7/001;;G06T7/60;;G06T2207/10012;;G06T2207/10028;;G06T2207/20081;;G06T2207/30164,E02F9/28;;G01S17/894;;G06T15/00,,0,0,,,,PENDING
659,US,B2,US 10680997 B2,097-782-037-146-440,2020-06-09,2020,US 201816108576 A,2018-08-22,US 201816108576 A;;US 201514872134 A;;US 201562171917 P;;US 201562171952 P;;US 201562171978 P,2015-06-05,Network messaging for paired devices,"Messaging between a companion device and an accessory device is controlled such that different modes of communication may be utilized. The different modes can implement different messaging strategies, each of which is intended for efficient power management, in view of the limited electrical power that is typically available at the accessory device. A received request message for sending from the companion device to the accessory device is sent if predetermined conditions apply, and similarly for messages from the accessory device to the companion device.",APPLE INC,LEDWITH ALEXANDER;;JENSEN CHRISTOPHER C;;IAROCCI JOHN J;;KROCHMAL MARC J;;WOLKOWICKI ZIV;;POLLACK DANIEL B;;ADLER DARIN B,,https://lens.org/097-782-037-146-440,Granted Patent,yes,33,1,6,29,0,H04L67/06;;H04L51/58;;H04L67/55;;H04L67/06;;H04L51/56;;H04L67/55;;H04L51/58,H04L12/58;;H04L29/08,,5,0,,,"Watchapp Communication product data sheet, Pebble Technology Corporation, [online], [retrieved May 20, 2015], retrieved from the internet, URL: https://developer.getpebble.com/guides/pebble-apps/communications/, 3 pages.;;U.S. Appl. No. 14/872,134, “Corrected Notice of Allowance,” dated May 11, 2018, 6 pages.;;U.S. Appl. No. 14/872,134, “Notice of Allowance,” dated Apr. 26, 2018, 9 pages.;;U.S. Appl. No. 14/872,134, “Final Office Action,” dated Oct. 18, 2017, 14 pages.;;U.S. Appl. No. 14/872,134, “Non-Final Office Action,” dated Jun. 16, 2017, 9 pages.",ACTIVE
660,JP,A,JP 2009093649 A,042-556-921-692-003,2009-04-30,2009,JP 2008259629 A,2008-10-06,US 97793407 P;;US 24305008 A,2007-10-05,RECOMMENDATION FOR TERM SPECIFYING ONTOLOGY SPACE,"<P>PROBLEM TO BE SOLVED: To solve the problem that a conventional document assignment method may not be effective for finding of information, and that a conventional search method may not be effective for finding of relevant information in the same way. <P>SOLUTION: In one embodiment, a set of target search terms for a search is received. Candidate terms are selected, where a candidate term is selected to reduce an ontology space of the search. The candidate terms are sent to a computer to recommend the candidate terms as search terms. In another embodiment, a document stored in tangible media is accessed. A set of target tags for the document is received. Terms are selected, where a term is selected to reduce an ontology space of the document. The terms are sent to a computer to recommend the terms as tags. <P>COPYRIGHT: (C)2009,JPO&INPIT",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS;;REINHARDT ALBERT,,https://lens.org/042-556-921-692-003,Patent Application,no,1,5,7,7,0,G06F16/3338;;G06F16/3338;;G06F16/313;;G06F16/313;;G06F16/3325;;G06F16/3325;;G06F16/951;;G06F16/951,G06F17/30,,0,0,,,,ACTIVE
661,US,A1,US 2016/0359666 A1,141-114-678-773-241,2016-12-08,2016,US 201514872134 A,2015-09-30,US 201514872134 A;;US 201562171917 P;;US 201562171952 P;;US 201562171978 P,2015-06-05,NETWORK MESSAGING FOR PAIRED DEVICES,"Messaging between a companion device and an accessory device is controlled such that different modes of communication may be utilized. The different modes can implement different messaging strategies, each of which is intended for efficient power management, in view of the limited electrical power that is typically available at the accessory device. A received request message for sending from the companion device to the accessory device is sent if predetermined conditions apply, and similarly for messages from the accessory device to the companion device.",APPLE INC,LEDWITH ALEXANDER;;JENSEN CHRISTOPHER C;;IAROCCI JOHN J;;KROCHMAL MARC J;;WOLKOWICKI ZIV;;POLLACK DANIEL B;;ADLER DARIN B,APPLE INC (2015-06-22),https://lens.org/141-114-678-773-241,Patent Application,yes,5,15,6,29,0,H04L67/06;;H04L51/58;;H04L67/55;;H04L67/06;;H04L51/56;;H04L67/55;;H04L51/58,H04L12/24;;H04L12/58;;H04L29/08,,0,0,,,,ACTIVE
662,US,B2,US 11451508 B2,188-640-852-765-139,2022-09-20,2022,US 202016884520 A,2020-05-27,US 202016884520 A;;US 201816108576 A;;US 201514872134 A;;US 201562171917 P;;US 201562171952 P;;US 201562171978 P,2015-06-05,Network messaging for paired devices,"Messaging between a companion device and an accessory device is controlled such that different modes of communication may be utilized. The different modes can implement different messaging strategies, each of which is intended for efficient power management, in view of the limited electrical power that is typically available at the accessory device. A received request message for sending from the companion device to the accessory device is sent if predetermined conditions apply, and similarly for messages from the accessory device to the companion device.",APPLE INC,LEDWITH ALEXANDER;;JENSEN CHRISTOPHER C;;IAROCCI JOHN J;;KROCHMAL MARC J;;WOLKOWICKI ZIV;;POLLACK DANIEL B;;ADLER DARIN B,,https://lens.org/188-640-852-765-139,Granted Patent,yes,68,0,6,29,0,H04L67/06;;H04L51/58;;H04L67/55;;H04L67/06;;H04L51/56;;H04L67/55;;H04L51/58,H04L51/56;;H04L51/58;;H04L67/06;;H04L67/55,,9,0,,,"Watchapp Communication product data sheet, Pebble Technology Corporation, [online], [retrieved May 20, 2015], retrieved from the internet, URL: https://deve!oper,getpebble.com!guides/pebb˜e-apps/communications/, 3 pages (of-record in parent application).;;U.S. Appl. No. 14/872,134, “Corrected Notice of Allowance”, dated May 11, 2018, 6 pages (of-record in parent application).;;U.S. Appl. No. 14/872,134, “Final Office Action”, dated Oct. 18, 2017, 14 pages (of-record in parent application).;;U.S. Appl. No. 14/872,134, “Non-Final Office Action”, dated Jun. 16, 2017, 9 pages (of-record in parent application).;;U.S. Appl. No. 14/872,134, “Notice of Allowance”, dated Apr. 26, 2018, 9 pages (of-record in parent application).;;U.S. Appl. No. 16/108,576, “Final Office Action”, dated Aug. 21, 2019, 11 pages (of-record in parent application).;;U.S. Appl. No. 16/108,576, “First Action Interview Office Action Summary”, dated Jun. 10, 2019, 4 pages (of-record in parent application).;;U.S. Appl. No. 16/108,576, “First Action Interview Pilot Program Pre-Interview Commu”, dated Apr. 4, 2019, 4 pages (of-record in parent application).;;U.S. Appl. No. 16/108,576, “Notice of Allowance”, dated Feb. 5, 2020, 20 pages (of-record in parent application).",ACTIVE
663,US,B2,US 10272226 B2,073-139-648-763-129,2019-04-30,2019,US 201414278398 A,2014-05-15,US 201414278398 A;;US 201313860926 A;;US 201261623855 P;;US 201361775430 P;;US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P,2012-04-13,Auto-feedback valve for a sleep apnea device,A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD CHRISTIAN;;ADLER MARK ALAN;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN EUGENE;;ANDERSON STEPHEN WILLIAM;;CHEN KEVIN NAI HONG,FRESCA MEDICAL INC (2014-01-23),https://lens.org/073-139-648-763-129,Granted Patent,yes,66,1,2,63,0,A61M16/208;;A61M16/208;;A61B5/11;;A61B5/4809;;A61B5/4836;;A61B5/4836;;A61M16/0057;;A61M16/0057;;A61M16/0069;;A61M16/0069;;A61M16/06;;A61M16/06;;A61M16/0683;;A61M16/0683;;A61M16/0688;;A61M16/0688;;A61M16/0833;;A61M16/0833;;A61M16/0866;;A61M16/0866;;A61M16/0875;;A61M16/0875;;A61M16/107;;A61M16/107;;A61M16/201;;A61M16/201;;A61M16/202;;A61M16/202;;A61M16/206;;A61M16/206;;A61M16/209;;A61M16/209;;A61M2016/0027;;A61M2016/0027;;A61M2016/0039;;A61M2016/0039;;A61M2016/0661;;A61M2016/0661;;A61M2205/18;;A61M2205/18;;A61M2205/3375;;A61M2205/3375;;A61M2205/3553;;A61M2205/3553;;A61M2205/3561;;A61M2205/3561;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/42;;A61M2205/42;;A61M2205/505;;A61M2205/505;;A61M2205/52;;A61M2205/52;;A61M2205/8206;;A61M2205/8206;;A61M2205/8237;;A61M2205/8237;;A61M2205/8281;;A61M2205/8281;;A61M2209/06;;A61M2209/06;;A61M2209/088;;A61M2209/088;;A61M2230/04;;A61M2230/04;;A61M2230/18;;A61M2230/18;;A61M2230/205;;A61M2230/205;;A61M2230/63;;A61M2230/63;;Y10T29/49826;;Y10T29/49826,A61M16/20;;A61B5/00;;A61B5/11;;A61M16/00;;A61M16/06;;A61M16/08;;A61M16/10,,1,0,,,"International Search Report dated Nov. 18, 2014 in PCT/US2014/038215 (6 pages).",INACTIVE
664,US,B2,US 11514533 B2,183-688-157-032-364,2022-11-29,2022,US 201916718737 A,2019-12-18,US 201916718737 A,2019-12-18,Systems and methods for identifying a MCC-misclassified merchant,"A computer system for identifying merchant category code misclassifications includes at least one processor in communication with a transaction database and a high-risk merchant database. The transaction database stores transaction records by a plurality of account holders. The high-risk merchant database stores high-risk merchant records each associated with high-risk merchants. The processor queries the transaction database for transaction records and calculates a high-risk cardholder metric for each of the account numbers. The at least one processor further queries the transaction database for transaction records including (i) the account number of high-risk cardholders, and (ii) a merchant identifier associated with other than the plurality of high-risk merchants, to retrieve a second set of transaction records. The at least one processor further calculates a high-risk merchant metric for each of the merchant identifiers, identifying a MCC misclassified merchant.",MASTERCARD INTERNATIONAL INC,ROLFS MELINDA L;;TRIVELAS JONATHAN;;KATZMAN NICOLE MARIE;;PAOLUCCI PAUL JOHN;;ADLER GARY;;RODRIGUEZ-LEMUS LUIS F;;ZHOU XIANZHE,MASTERCARD INTERNATIONAL INCORPORATED (2019-12-09),https://lens.org/183-688-157-032-364,Granted Patent,yes,18,0,3,3,0,G06Q40/12;;G06Q20/4016;;G06Q20/4014;;G06Q20/12;;G06Q40/12;;G06F16/953;;G06F16/2379;;G06Q20/4016,G06Q40/00;;G06F16/23;;G06F16/953;;G06Q20/40,,0,0,,,,ACTIVE
665,US,B2,US 10307562 B2,004-306-131-127-819,2019-06-04,2019,US 201414278587 A,2014-05-15,US 201414278587 A;;US 201313860926 A;;US 201261623855 P;;US 201361775430 P;;US 201361823553 P;;US 201361838191 P;;US 201361962501 P;;US 201361909956 P;;US 201461927355 P,2012-04-13,Auto-feedback valve for a sleep apnea device,A device for treating a patient suffering from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing chamber can be configured to receive air from the air flow generator through the feedback port.,FRESCA MEDICAL INC,CRAGG ANDREW H;;LOGAN JOHN;;NISSIMOV HAIM;;EWERS RICHARD CHRISTIAN;;ADLER MARK ALAN;;CHEN EUGENE G;;TRUSHEIM JOHN EDWIN;;NOLTING JOHN EUGENE;;ANDERSON STEPHEN WILLIAM;;CHEN KEVIN NAI HONG,FRESCA MEDICAL INC (2014-01-23),https://lens.org/004-306-131-127-819,Granted Patent,yes,83,1,4,63,0,A61M16/208;;A61M16/208;;A61B5/11;;A61B5/4809;;A61B5/4818;;A61B5/4836;;A61B5/4836;;A61M16/0057;;A61M16/0057;;A61M16/0069;;A61M16/0069;;A61M16/06;;A61M16/06;;A61M16/0683;;A61M16/0683;;A61M16/0688;;A61M16/0688;;A61M16/0833;;A61M16/0833;;A61M16/0866;;A61M16/0866;;A61M16/0875;;A61M16/0875;;A61M16/107;;A61M16/107;;A61M16/201;;A61M16/201;;A61M16/202;;A61M16/202;;A61M16/206;;A61M16/206;;A61M16/209;;A61M16/209;;A61M2016/0027;;A61M2016/0027;;A61M2016/0039;;A61M2016/0039;;A61M2016/0661;;A61M2016/0661;;A61M2205/18;;A61M2205/18;;A61M2205/3375;;A61M2205/3375;;A61M2205/3553;;A61M2205/3553;;A61M2205/3561;;A61M2205/3561;;A61M2205/3584;;A61M2205/3584;;A61M2205/3592;;A61M2205/3592;;A61M2205/42;;A61M2205/42;;A61M2205/505;;A61M2205/505;;A61M2205/52;;A61M2205/52;;A61M2205/8206;;A61M2205/8206;;A61M2205/8237;;A61M2205/8237;;A61M2205/8281;;A61M2205/8281;;A61M2209/06;;A61M2209/06;;A61M2209/088;;A61M2209/088;;A61M2230/04;;A61M2230/04;;A61M2230/18;;A61M2230/18;;A61M2230/205;;A61M2230/205;;A61M2230/63;;A61M2230/63;;Y10T29/49412;;Y10T29/49412,A61M16/20;;A61B5/00;;A61B5/11;;A61M16/00;;A61M16/06;;A61M16/08;;A61M16/10,,1,0,,,"International Search Report dated Nov. 18, 2014 in PCT/US2014/038215 (6 pages).",INACTIVE
666,US,A1,US 2019/0028423 A1,189-688-037-337-073,2019-01-24,2019,US 201816108576 A,2018-08-22,US 201816108576 A;;US 201514872134 A;;US 201562171917 P;;US 201562171952 P;;US 201562171978 P,2015-06-05,NETWORK MESSAGING FOR PAIRED DEVICES,"Messaging between a companion device and an accessory device is controlled such that different modes of communication may be utilized. The different modes can implement different messaging strategies, each of which is intended for efficient power management, in view of the limited electrical power that is typically available at the accessory device. A received request message for sending from the companion device to the accessory device is sent if predetermined conditions apply, and similarly for messages from the accessory device to the companion device.",APPLE INC,LEDWITH ALEXANDER;;JENSEN CHRISTOPHER C;;IAROCCI JOHN J;;KROCHMAL MARC J;;WOLKOWICKI ZIV;;POLLACK DANIEL B;;ADLER DARIN B,,https://lens.org/189-688-037-337-073,Patent Application,yes,17,1,6,29,0,H04L67/06;;H04L51/58;;H04L67/55;;H04L67/06;;H04L51/56;;H04L67/55;;H04L51/58,H04L12/58;;H04L29/08,,0,0,,,,ACTIVE
667,US,A1,US 2009/0094020 A1,029-151-847-267-474,2009-04-09,2009,US 24305008 A,2008-10-01,US 24305008 A;;US 97793407 P,2007-10-05,Recommending Terms To Specify Ontology Space,"In one embodiment, a set of target search terms for a search is received. Candidate terms are selected, where a candidate term is selected to reduce an ontology space of the search. The candidate terms are to a computer to recommend the candidate terms as search terms. In another embodiment, a document stored in one or more tangible media is accessed. A set of target tags for the document is received. Terms are selected, where a term is selected to reduce an ontology space of the document. The terms are sent to a computer to recommend the terms as tags.",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;REINHARDT ALBERT;;LABROU YANNIS,FUJITSU LIMITED (2008-09-18),https://lens.org/029-151-847-267-474,Patent Application,yes,66,32,7,7,0,G06F16/3338;;G06F16/3338;;G06F16/313;;G06F16/313;;G06F16/3325;;G06F16/3325;;G06F16/951;;G06F16/951,G06F17/27;;G06F17/30,704/9;;707/5;;X704E15018;;X707E17015,4,2,035-190-043-902-101;;003-543-027-674-540,10.1007/11765448_6;;10.1145/1242572.1242602,"Santos-Neto et al. ""Tracking Usage in Collaborative Tagging Communities"" 2007.;;Veres. ""The Language of Folksonomies: What Tags Reveal About User Classification"" 2006.;;Xu et al. ""Towards the Semantic Web: Collaborative Tag Suggestions"" 2006.;;Halpin et al. ""The Complex Dynamics of Collaborative Tagging"" May 2007.",ACTIVE
668,EP,A1,EP 2045740 A1,009-833-317-392-318,2009-04-08,2009,EP 08165841 A,2008-10-03,US 97793407 P;;US 24305008 A,2007-10-05,Recommending terms to specify ontology space,"In one embodiment, a set of target search terms for a search is received. Candidate terms are selected, where a candidate term is selected to reduce an ontology space of the search. The candidate terms arc to a computer to recommend the candidate terms as search terms. In another embodiment, a document stored in one or more tangible media is accessed. A set of target tags for the document is received. Terms are selected, where a term is selected to reduce an ontology space of the document. The terms are sent to a computer to recommend the terms as tags.
",FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS;;REINHARDT ALBERT,,https://lens.org/009-833-317-392-318,Patent Application,yes,4,2,7,7,0,G06F16/3338;;G06F16/3338;;G06F16/313;;G06F16/313;;G06F16/3325;;G06F16/3325;;G06F16/951;;G06F16/951,G06F17/30,,0,0,,,,DISCONTINUED
669,US,A1,US 2020/0287862 A1,189-041-699-849-855,2020-09-10,2020,US 202016884520 A,2020-05-27,US 202016884520 A;;US 201816108576 A;;US 201514872134 A;;US 201562171917 P;;US 201562171952 P;;US 201562171978 P,2015-06-05,NETWORK MESSAGING FOR PAIRED DEVICES,"Messaging between a companion device and an accessory device is controlled such that different modes of communication may be utilized. The different modes can implement different messaging strategies, each of which is intended for efficient power management, in view of the limited electrical power that is typically available at the accessory device. A received request message for sending from the companion device to the accessory device is sent if predetermined conditions apply, and similarly for messages from the accessory device to the companion device.",APPLE INC,LEDWITH ALEXANDER;;JENSEN CHRISTOPHER C;;IAROCCI JOHN J;;KROCHMAL MARC J;;WOLKOWICKI ZIV;;POLLACK DANIEL B;;ADLER DARIN B,,https://lens.org/189-041-699-849-855,Patent Application,yes,0,0,6,29,0,H04L67/06;;H04L51/58;;H04L67/55;;H04L67/06;;H04L51/56;;H04L67/55;;H04L51/58,H04L12/58;;H04L29/08,,0,0,,,,ACTIVE
670,US,A1,US 2021/0192640 A1,028-111-635-445-619,2021-06-24,2021,US 201916718737 A,2019-12-18,US 201916718737 A,2019-12-18,SYSTEMS AND METHODS FOR IDENTIFYING A MCC-MISCLASSIFIED MERCHANT,"A computer system for identifying merchant category code misclassifications includes at least one processor in communication with a transaction database and a high-risk merchant database. The transaction database stores transaction records by a plurality of account holders. The high-risk merchant database stores high-risk merchant records each associated with high-risk merchants. The processor queries the transaction database for transaction records and calculates a high-risk cardholder metric for each of the account numbers. The at least one processor further queries the transaction database for transaction records including (i) the account number of high-risk cardholders, and (ii) a merchant identifier associated with other than the plurality of high-risk merchants, to retrieve a second set of transaction records. The at least one processor further calculates a high-risk merchant metric for each of the merchant identifiers, identifying a MCC misclassified merchant.",MASTERCARD INTERNATIONAL INC,ROLFS MELINDA L;;TRIVELAS JONATHAN;;KATZMAN NICOLE MARIE;;PAOLUCCI PAUL JOHN;;ADLER GARY;;RODRIGUEZ-LEMUS LUIS F;;ZHOU XIANZHE,MASTERCARD INTERNATIONAL INCORPORATED (2019-12-09),https://lens.org/028-111-635-445-619,Patent Application,yes,0,5,3,3,0,G06Q40/12;;G06Q20/4016;;G06Q20/4014;;G06Q20/12;;G06Q40/12;;G06F16/953;;G06F16/2379;;G06Q20/4016,G06Q40/00;;G06F16/23;;G06F16/953;;G06Q20/40,,0,0,,,,ACTIVE
671,US,B2,US 8639733 B2,104-164-251-542-202,2014-01-28,2014,US 72040010 A,2010-03-09,US 72040010 A;;US 16060109 P;;US 16064409 P,2009-03-16,Automatic identification of compatible applications and accessories,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;TOPRANI SHYAM;;ANANNY JOHN;;LANGENFELD PETER;;KRUEGER SCOTT;;APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;TOPRANI SHYAM;;ANANNY JOHN;;LANGENFELD PETER;;KRUEGER SCOTT,APPLE INC (2010-02-23),https://lens.org/104-164-251-542-202,Granted Patent,yes,82,25,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F17/30;;H04M1/72409;;H04M1/72412,707/827;;717/178,25,0,,,"Carey, D., ""Turning a mobile phone into wallet"", Electronic Engineering Times, n 1441, p. 64, Sep. 18, 2006, 2 pages.;;Google Releases Car Home App Into the Android Market [Car Home App for Android Now Available in the Android Market, for Those Running Android 2.2], web-pages downloaded from nexus404.com/.../google-releases-car-h . . . , 7 pages, Oct. 2010.;;International Application No. PCT/US2010/027058, International Search Report and Written Opinion, 13 pages, Apr. 26, 2010.;;""A Specification of the Bluetooth System"" ""Bluetooth"" Jul. 26, 2007, Copyright 1999; Agere Systems Inc et al., 1420 pages.;;""Bluetooth"" Wikipedia, the free Encyclopedia, downloaded on Jan. 11, 2010, Retrieved from the Internet: URL:http://en.wikipedia.org/w/index.php?ti tle=Bluetooth&oldid=273620532; 16 pages.;;""Reverse-DNS"" Wikipedia, the free Encyclopedia, downloaded on Jan. 11, 2010 Retrieved from the Internet: URL:http://en.wikipedia.org/w/index.php?ti tle=Reverse-DNS&oldid=270747273; 2 pages.;;U.S. Appl. No. 13/250,681, filed Sep. 30, 2011, Holden et al.;;U.S. Appl. No. 13/250,900, filed Sep. 30, 2011, Holden et al.;;Tanenbaum, Andrew S.; Structured Computer Organization; 1984; Prentice-Hall, Inc.; Second Edition; pp. 10-11, 4 pages.;;International Search Report and Written Opinion in PCT/US2011/052827, mailed Nov. 28, 2011, 9 pages.;;Wikipedia, ""Reverse DNS lookup"", Accessed Mar. 11, 2012, http://en.wikipedia.org/wiki/Reverse-DNS-lookup; 3 pages.;;Notice of Allowance mailed Jul. 26, 2013, U.S. Appl. No. 12/720,423, 33 pages.;;Notice of Allowance mailed Nov. 14, 2012, U.S. Appl. No. 12/720,446, 5 pages.;;Non-Final Office Action mailed Jan. 3, 2013, U.S. Appl. No. 12/720,400, 22 pages.;;Non-Final Office Action mailed Jan. 4, 2013, U.S. Appl. No. 12/720,423, 8 pages.;;Notice of Allowance mailed Nov. 15, 2012, U.S. Appl. No. 13/250,681, 6 pages.;;Non-Final Office Action mailed Apr. 3, 2013, U.S. Appl. No. 12/720,375, 26 pages.;;Non-Final Office Action mailed May 8, 2013, U.S. Appl. No. 13/085,952, 34 pages.;;Office Action mailed Oct. 9, 2013 in U.S. Appl. No. 12/720,349, 7 pages.;;European Search Report mailed Sep. 26, 2013 in EP 13166559.8, 8 pages.;;Japanese Office Action mailed Sep. 30, 2013 in JP 2011-220451, 2 pages, English Translation.;;European Search Report mailed Oct. 7, 2013 in EP 13166560.6, 5 pages.;;USB Implementers Forum, ""Universal Serial Bus Specification Revision 2.0,"" Chapters 1-5 and 9, internet citation, Apr. 27, 2000, Retrieved from the internet, [retrieved on Dec. 19, 2006], title page and table of contents only.;;Hulvey, Robert, ""Device Identification Profile Specification,"" Bluetooth Specification, Jul. 26, 2007, Retrieved from the internet: http://www.bluetooth.org/DeviceID-Spec-V13.pdf [retrieved on Sep. 23, 2013], 22 pages.;;Office Action mailed Nov. 29, 2013 in U.S. Appl. No. 12/720,375, 20 pages.",ACTIVE
672,CN,B,CN 101408887 B,098-644-179-656-279,2015-06-17,2015,CN 200810166182 A,2008-10-06,US 97793407 P;;US 24305008 A,2007-10-05,Recommending terms to specify body space,,FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;LABROU YANNIS;;REINHARDT ALBERT,,https://lens.org/098-644-179-656-279,Granted Patent,no,0,0,7,7,0,G06F16/3338;;G06F16/3338;;G06F16/313;;G06F16/313;;G06F16/3325;;G06F16/3325;;G06F16/951;;G06F16/951,G06F17/30,,0,0,,,,ACTIVE
673,US,B2,US 10069785 B2,152-695-740-244-349,2018-09-04,2018,US 201514872134 A,2015-09-30,US 201514872134 A;;US 201562171917 P;;US 201562171952 P;;US 201562171978 P,2015-06-05,Network messaging for paired devices,"Messaging between a companion device and an accessory device is controlled such that different modes of communication may be utilized. The different modes can implement different messaging strategies, each of which is intended for efficient power management, in view of the limited electrical power that is typically available at the accessory device. A received request message for sending from the companion device to the accessory device is sent if predetermined conditions apply, and similarly for messages from the accessory device to the companion device.",APPLE INC,LEDWITH ALEXANDER;;JENSEN CHRISTOPHER C;;IAROCCI JOHN J;;KROCHMAL MARC J;;WOLKOWICKI ZIV;;POLLACK DANIEL B;;ADLER DARIN B,APPLE INC (2015-06-22),https://lens.org/152-695-740-244-349,Granted Patent,yes,12,2,6,29,0,H04L67/06;;H04L51/58;;H04L67/55;;H04L67/06;;H04L51/56;;H04L67/55;;H04L51/58,H04L12/58;;H04L29/08,,1,0,,,"Watchapp Communication product data sheet, Pebble Technology Corporation, [online], [retrieved May 20, 2015], retrieved from the internet, URL: https://developer.getpebble.com/guides/pebble-apps/communications/, 3 pages.",ACTIVE
674,US,A1,US 2023/0079865 A1,121-712-642-387-298,2023-03-16,2023,US 202218056152 A,2022-11-16,US 202218056152 A;;US 201916718737 A,2019-12-18,SYSTEMS AND METHODS FOR IDENTIFYING A MCC-MISCLASSIFIED MERCHANT,A computer system for identifying merchant category code misclassifications includes at least one processor in communication with a transaction database and a merchant database. The transaction database stores transaction records by a plurality of account holders. The processor generates a first MCC profile including at least one transaction characteristic representative of merchants properly classified as the first MCC and comparing the first MCC profile to a second set of transaction records. If the comparison satisfies a comparison threshold for the first MCC the processor identifies the corresponding selected merchant as being MCC misclassified.,MASTERCARD INTERNATIONAL INC,ROLFS MELINDA L;;TRIVELAS JONATHAN;;KATZMAN NICOLE MARIE;;PAOLUCCI PAUL JOHN;;ADLER GARY;;RODRIGUEZ-LEMUS LUIS F;;ZHOU XIANZHE,MASTERCARD INTERNATIONAL INCORPORATED (2019-12-09),https://lens.org/121-712-642-387-298,Patent Application,yes,4,0,3,3,0,G06Q40/12;;G06Q20/4016;;G06Q20/4014;;G06Q20/12;;G06Q40/12;;G06F16/953;;G06F16/2379;;G06Q20/4016,G06Q40/00;;G06F16/23;;G06F16/953;;G06Q20/40,,0,0,,,,PENDING
675,US,B2,US 9081852 B2,142-286-165-206-96X,2015-07-14,2015,US 24305008 A,2008-10-01,US 24305008 A;;US 97793407 P,2007-10-05,Recommending terms to specify ontology space,"In one embodiment, a set of target search terms for a search is received. Candidate terms are selected, where a candidate term is selected to reduce an ontology space of the search. The candidate terms are sent to a computer to recommend the candidate terms as search terms. In another embodiment, a document stored in one or more tangible media is accessed. A set of target tags for the document is received. Terms are selected, where a term is selected to reduce an ontology space of the document. The terms are sent to a computer to recommend the terms as tags.",MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;REINHARDT ALBERT;;LABROU YANNIS;;FUJITSU LTD,MARVIT DAVID L;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;ADLER B THOMAS;;SIDOROWICH JOHN J;;REINHARDT ALBERT;;LABROU YANNIS,FUJITSU LIMITED (2008-09-18),https://lens.org/142-286-165-206-96X,Granted Patent,yes,71,9,7,7,0,G06F16/3338;;G06F16/3338;;G06F16/313;;G06F16/313;;G06F16/3325;;G06F16/3325;;G06F16/951;;G06F16/951,G06F17/27;;G06F17/30,,29,8,190-861-557-775-052;;052-040-394-327-789;;075-953-898-583-170;;029-978-456-947-486;;055-761-967-435-592;;035-190-043-902-101;;003-543-027-674-540;;082-723-405-116-073,10.1007/11765448_5;;10.1007/11495772_21;;10.1145/1135777.1135839;;10.1007/978-3-540-72667-8_44;;10.1145/860722.860744;;10.1007/11765448_6;;10.1145/1242572.1242602;;10.1145/1135777.1135869,"Tomassen et al. ""Document Space Adapted Ontology: Application in Query Enrichment"" 2006.;;Hassan-Montero et al. ""Improving Tag-Clouds as Visual Information Retrieval Interfaces"" Oct. 2006.;;Dey et al. ""Ontology Aided Query Expansion for Retrieving Relevant Texts"" 2005.;;Wu et al. ""Exploring Social Annotations for the Semantic Web"" May 2006.;;Specia et al. ""Integrating Folksonomies with the Semantic Web"" Jun. 2007.;;Ceccaroni et al. ""A Graphical Environment for Ontology Development"" 2003.;;Sood et al. ""TagAssist: Automatic Tag Suggestion for Blog Posts"" Mar. 2007.;;Marlow et al. ""Position Paper, Tagging, Taxonomy, Flickr, Article, ToRead"" 2006.;;Herzog et al. ""Combining Social and Semantic Metadata for Search in a Document Repository"" Jun. 2007.;;Santos-Neto et al. ""Tracking Usage in Collaborative Tagging Communities"" 2007.;;Veres. ""The Language of Folksonomies: What Tags Reveal About User Classification"" 2006.;;Xu et al. ""Towards the Semantic Web: Collaborative Tag Suggestions"" 2006.;;Halpin et al. ""The Complex Dynamics of Collaborative Tagging"" May 2007.;;Communication from European Patent Office, European Search Report dated Dec. 27, 2010 for European Patent Application No. 09152741.6-1527/2090992.;;Communication from the European Patent Office, European Search Report dated Jan. 19, 2009 for European Patent Application No. 08165841.1-1527, 6 pages, Jan. 19, 2009.;;U.S. Appl. No. 12/368,689, by inventors Yann is Labrou et al., entitled ""Determining Words Related to a Given Set of Words,"" filed Feb. 10, 2009, 70 pages including drawings, Feb. 10, 2009.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166181.X, Chinese Office Action and English Translation, 8 pages, Sep. 2, 2010.;;The State Intellectual Property Office of China, First Notification of Office Action, Patent Application No. 200810166182.4, Chinese Office Action and English Translation, 15 pages, Jul. 14, 2010.;;Communication from Chinese Patent Office, Text of the First Office Action for Chinese Patent Application No. 200910007161.2, 6 pages, Transmitted Feb. 21, 2011.;;U.S. Appl. No. 12/242,984, by inventors David L. Marvit et al., entitled ""Selecting Tags for a Document by Analyzing Paragraphs of the Document,"" 48 pages including drawings, Oct. 1, 2008.;;Brooks et al.; ""Improved Annotation of the Blogospere via Autotagging and Hierarchical Clustering""; ACM WWW 2006; pp. 625-631, 2006.;;United States Office Action; U.S. Appl. No. 12/242,984; pp. 28 , Jul. 20, 2011.;;United States Office Action; U.S. Appl. No. 12/242,984; pp. 20, Jan. 5, 2012.;;Chinese Office Action with English Translation; Application No. 200810166181.X; pp. 6, Mar. 16, 2012.;;Chinese Office Action, Application No. 200810166182.4, with English Translation, 14 pages, Sep. 20, 2011.;;Chinese Office Action, Application No. 200810166182.4, with English Translation, 9 pages, Nov. 15, 2014.;;Chinese Office Action, Application No. 200810166182.4, with English Translation, 17 pages, May 5, 2014.;;Japanese Office Action with English Translation; Application No. 2008-25629; pp. 13, Mar. 5, 2013.;;European Office Action, Application No. 08 165 841.1-1507; pp. 7, Apr. 2, 2013.",ACTIVE
676,WO,A9,WO 2020/214833 A9,101-807-145-435-435,2020-12-24,2020,US 2020/0028549 W,2020-04-16,US 201916388831 A,2019-04-18,REMOTE INTERACTION WITH A DEVICE USING SECURE RANGE DETECTION,"In some embodiments, a first device performs ranging operations to allow a user to perform one or more operations on the first device without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account that is authorized to perform operations on the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the operations to be performed on the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the operation is authorized on the first device.",APPLE INC,LEDWITH ALEXANDER;;BENSON WADE;;KROCHMAL MARC;;IAROCCI JOHN;;HAUCK JERROLD;;BROUWER MICHAEL;;ADLER MITCHELL;;SIERRA YANNICK;;SYKORA LIBOR;;MARGARITOV JIRI,,https://lens.org/101-807-145-435-435,Search Report,yes,0,0,4,33,0,G06F21/57;;G06F21/44;;G06F21/316;;G06F21/606;;H04L63/107;;H04L63/0853;;H04W12/33;;H04W12/64;;H04W12/64;;H04W12/33,H04L29/06;;H04W12/00,,0,0,,,,PENDING
677,US,A1,US 2010/0235373 A1,072-550-200-726-278,2010-09-16,2010,US 72040010 A,2010-03-09,US 72040010 A;;US 16060109 P;;US 16064409 P,2009-03-16,AUTOMATIC IDENTIFICATION OF COMPATIBLE APPLICATIONS AND ACCESSORIES,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;TOPRANI SHYAM;;ANANNY JOHN;;LANGENFELD PETER T;;KRUEGER SCOTT,APPLE INC (2010-02-23),https://lens.org/072-550-200-726-278,Patent Application,yes,69,52,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F15/16;;G06F17/30;;H04M1/72409;;H04M1/72412,707/758;;709/227;;709/217;;X707E17014,0,0,,,,ACTIVE
678,US,B2,US 11438322 B2,085-253-365-762-833,2022-09-06,2022,US 201916264478 A,2019-01-31,US 201916264478 A;;US 201615275203 A;;US 201662349029 P,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,APPLE INC (2016-09-22),https://lens.org/085-253-365-762-833,Granted Patent,yes,88,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,G06F7/04;;G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04L9/40;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/086,,21,0,,,"International Search Report and Written Opinion from PCT/US2020/028549, dated Aug. 31, 2020, 18 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 27, 2020, 26 pages including English language translation.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Sep. 25, 2020, 5 pages including English language translation.;;Notice of Acceptance from Australian Patent Application No. 2017286140, dated Oct. 12, 2020, 3 pages.;;Korean Office Action from Korean Patent Application No. 2018-7034644, dated Nov. 26, 2020, 9 pages including English language translation.;;European Office Action dated Mar. 2, 2020, from European Patent Application No. 17731348.3, 6 pages.;;SRP Documentation, retrieved from http://srp.stanford.edu/doc.html#standards, visited Apr. 3, 2018, 3 pages.;;Wu, “The Secure Remote Password Protocol,” retrieved from http://srp.stanford.edu/ndss.html, 1998, 24 pages.;;International Search Report and Written Opinion of International Patent Application PCT/US2017/035601, dated Oct. 18, 2017, 20 pages.;;Written Opinion of the International Preliminary Examining Authority from PCT/US2017/035601, dated May 8, 2018, 8 pages.;;Invitation to Pay Additional Fees from PCT/US2020/028549, dated Jul. 10, 2020, 13 pages.;;European Office Action from European Patent Application No. 17731348.3, dated Sep. 12, 2019, 7 pages.;;Australian Examination Report from Australian Patent Application No. 2017286140, dated Nov. 26, 2019, 4 pages.;;Japanese Office Action from Japanese Patent Application No. 2018-5 62555, dated Jan. 6, 2020, 14 pages including English language translation.;;Korean Office Action from Korean Patent Application No. 10-2018-7034644, dated Jan. 14, 2020, 10 pages including English language translation.;;Japanese Notice of Allowance from Japanese Patent Application No. 2018-562555, dated May 31, 2021, 5 pages including English language translation.;;Korean Notice of Allowance from Korean Patent Application No. 10-2018-7034644, dated May 31, 2021, 5 pages including English language translation.;;European Office Action from European Patent Application No. 17731348.3, dated Jul. 2, 2021, 5 pages.;;Australian Examination Report from Australian Patent Application No. 2021200451, dated Sep. 28, 2021, 3 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 25, 2021, 19 pages including English language translation.;;Chinese Office Action from Chinese Patent Application No. 202080028656.8, dated Jun. 9, 2022, 21 pages including machine-generated English language translation.",ACTIVE
679,US,A1,US 2014/0231288 A1,169-282-707-408-630,2014-08-21,2014,US 201414265920 A,2014-04-30,US 201414265920 A;;US 84667510 A;;US 18362909 P;;US 49514809 A,2009-06-03,"Catheter Tray, Packaging System, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/169-282-707-408-630,Patent Application,yes,8,18,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B46/23,206/364;;53/471,0,0,,,,ACTIVE
680,WO,A1,WO 2019/050551 A1,096-449-727-116-139,2019-03-14,2019,US 2017/0054880 W,2017-10-03,US 201762554876 P,2017-09-06,"SELF-SHIELDED, INTEGRATED-CONTROL RADIOSURGERY SYSTEM","A self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery and precision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table is provided. The radiation shield can include an axial shield rotatable about an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiation beams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,,https://lens.org/096-449-727-116-139,Patent Application,yes,12,7,6,15,0,A61B6/10;;G21F7/06;;A61N5/1048;;A61N2005/1061;;A61N2005/1094;;A61N5/107;;A61N5/1049,A61N5/00;;A61B6/10;;G21F7/06,,2,1,097-194-108-082-165,10.7759/cureus.2146;;29632755;;pmc5880589,"WEIDLICH ET AL.: ""Characterization of a Novel Revolving Radiation Collimator"", CUREUS, vol. 10, no. 2, 2 February 2018 (2018-02-02), pages e2146, XP055580788, ISSN: 2168-8184, DOI: 10.7759/cureus.2146;;See also references of EP 3678736A4",PENDING
681,US,B2,US 11779516 B2,109-065-815-656-693,2023-10-10,2023,US 202217835747 A,2022-06-08,US 202217835747 A;;US 201916258231 A;;US 201414265920 A;;US 84667510 A;;US 49514809 A;;US 18362909 P,2009-06-03,"Catheter tray, packaging system, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND LP,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/109-065-815-656-693,Granted Patent,yes,287,0,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61M25/00;;A61B42/00;;A61B46/00;;A61B46/23;;A61B50/30;;A61B50/33;;A61J1/00,,509,4,044-145-043-807-87X;;098-777-794-605-077;;008-481-422-937-006;;055-945-454-377-987,10.4135/9781412963855.n765;;10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610;;10.1097/00000542-200701000-00013;;17197846,"“Ex Parte Reexamination Request”, Reexamination Control No. 90/015,051 for U.S. Pat. No. 9,522,753; Mailed Jun. 28, 2022; Request and Exhibits 1-28.;;“Request for Ex Parte Reexamination”, Reexam Control No. 90/014,964 for U.S. Pat. No. 8,448,786; Mailed Mar. 8, 2022; Request and Exhibits 1-35.;;Marcetich, Adam , “NonFinal Office Action”, U.S. Appl. No. 16/833,575, filed Mar. 28, 2020; dated Sep. 13, 2022.;;Poon, Robert , “Final Office Action”, U.S. Appl. No. 16/986,803, filed Aug. 6, 2020; dated Jul. 5, 2022.;;Poon, Robert , “Final Office Action”, U.S. Appl. No. 17/180,680, filed Feb. 19, 2021; dated Sep. 16, 2022.;;Reip, David Owen , “Ex Parte Reexamination Order—Request Granted”, Reexam Control No. 90/014,964 for U.S. Pat. No. 8,448,786; Mailed Apr. 19, 2022.;;Reip, David Owen , “Ex Parte Reexamination Order—Request Granted”, Reexmination Control No. 90/015,051 for U.S. Pat. No. 9,522,753; Mailed Jul. 7, 2022.;;Reip, David Owen , “Reexam NonFinal Office Action”, U.S. Appl. No. 90/014,964, filed Feb. 24, 2022; dated Sep. 29, 2022.;;JP2000281144-A Machine translation Oct. 17, 2022; Cited in U.S. Appl. No. 16/721,718 on Oct. 26, 2022.;;JP2002068309-A Machine translation Oct. 17, 2022; Cited in U.S. Appl. No. 16/721,718 on Oct. 26, 2022.;;Marcetich, Adam M. , “Notice of Allowance”, U.S. Appl. No. 16/721,718, filed Dec. 19, 2019; dated Oct. 26, 2022.;;Marcetich, Adam M. , “Non-Final Office Action”, U.S. Appl. No. 16/944,667, filed Jul. 31, 2020; dated Oct. 7, 2022.;;Marcetich, Adam M. , “Notice of Allowance”, U.S. Appl. No. 16/721,718, filed Dec. 19, 2019; dated Feb. 9, 2023.;;Reip, David O. , “Re-Exam Non-Final Office Action”, U.S. Appl. No. 90/015,051, filed Jun. 8, 2022; dated Dec. 14, 2022.;;[Medline Industries Inc vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;C. R. Bard, Inc. v. Medline Industries, Inc., 2020-1900, 2020-1905, 2020-1908, 2020-1910 Slip Opinion (Fed. Cir. 2021). Dated Aug. 13, 2021.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; Mailed Aug. 18, 2015.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Dover Intermittent Catheter Tray—14 fr, Red Rubber; Website http://tinyurl.com/o4esrwh; Unknown Publication Date.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,795,761; Inter Partes Review No. IPR2019-00109; Filed Feb. 22, 2019.;;Inter Partes Review—Patent Owner's Prelim. Response; U.S. Pat. No. 9,808,400; Inter Partes Review No. IPR2019-00208; Filed Mar. 7, 2019.;;IPR Petition 2001, Declaration of Meyst dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036.;;IPR Petition 2002, Declaration of Weintraub dated Jan. 11, 2019; IPR 2019-00035, IPR-2019-00036.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Feb. 22, 2019; IPR2019-00109.;;IPR Petition Exhibit 2001, Declaration of Meyst dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2001; Declaration of Meyst dated Mar. 7, 2019; IPR2019-00223.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00208.;;IPR Petition Exhibit 2002, Declaration of Weintraub dated Mar. 7, 2019; IPR2019-00223.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL Khttp://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit A to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15. 2016.;;Medline Industries Inc vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit 4 to Declaration ol Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard. Inc. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-CV-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc; Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R Bard, Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc, vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee: Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Declaration oi Nicole M Smith n Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counter Claims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z, Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit A—C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:17-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline industries Inc vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 1 to Declaration ol Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 2 to Declaration ol Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-33618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 3, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit F to Declaration of Dyian J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 3, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Bard Opening Claim Construction Brief; Civil Action No. 1 16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-33518; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-33618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surreply: Civil Action No. 1:14-cv-33618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Exhibit i to Declaration of Nicoie M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 I6-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1.14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc.; Declaration of Karl L. Leinsing n Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, P016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-33618; Judge John Z. Lee, Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit 4 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-33618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit A to Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-33529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1;16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit B to Declaration ot Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15. 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv 03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit D to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit D to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1.14-cv-03618; Judge John Z. Lee. Filed Aug. 15. 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit E to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit F to Declaration of Kevin A Lake: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support ol Bard's Reply Claim Construction Brief; Civil Action No. 1. I4-CV-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit G to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit H to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit H to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action Mo. 1:16-cv-Q3529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit I to Declaration of Kevin A. Lake; Civil Action No. 1.14-sv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit N to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Medline Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1;14-cv-33618; Judge John Z. Lee. Filed Jan. 25, 2017.;;Medline industries Inc vs C.R Bard, Inc.; Medline Surreply to Claim Construction Brief; Civil Action No. 1.14-CV-Q3618: Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Transcript of Deposition ot Richard Meyst; Civil Action No. 1:16-W-03529. Jan. 20, 2017.;;Medline Industries Inc vs C.R Bard, Inc: Exhibit G to C.R Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L Ellis; Filed Jan. 16, 2013.;;Medline Industries Inc vs C.R Bard, Inc; Exhibit 3 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-CV-7216; Judge Sara L Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R Bard, Inc; Exhibit C to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R Bard, Inc; Exhibit D to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Etlis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R Bard, Inc; Exhibit E to C R. Bard's LPR 2.3 Contentions; Civil Action No. 1;17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R Bard, Inc, Exhibit H to C.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-CV-7216; Judge Sara L. Ellis: Filed Jan. 16, 2018.;;Medline industries Inc vs C.R Bard, Inc., Declaration of Brian Eutermoser in Support of Medline Surreply. Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit 8 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-33618: Judge John Z. Lee: Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit A to Declaration of Barbara Weintraub Regarding Claim Construction: Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit A to Declaration of Nicole Smith in Support of Bard Repiy to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit B to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit E to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R Bard. Inc. Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard. Inc. Exhibit 11 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard. Inc. Exhibit A to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1;14-cv-33618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard. Inc. Medline Motion to Supplement Record on Claim Construction with Leinsing Testimony; Civil Action No. 1:14-w-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Bard Reply Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard. Inc.; Bard Response to Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Feb. 8, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Declaration of Karl R. leinsing in Support of Bard Reply io Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit 3 to Declaration ol Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618: Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit 8 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit C to Declaration of Kevin A. Lake; Civil Action No. 1 14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit G to Declaration ol Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline industries Inc vs C.R Bard. Inc.; Exhibit H to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 2016.;;Medline Industries Inc vs C.R Bard. Inc.; Transcript of Deposition of Barbara A Weintraub; Civil Action Mo. 1:16-cv-03529; Jan. 20, 2017.;;Medline Industries Inc vs C.R Bard. Inc.; Transcript ol Deposition of Karl Leinsing; Civil Action No. 1:16-cv-03529; Feb. 17, 2017.;;Medline industries Inc vs C.R Sard. Inc.; Exhibit 9 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc., Bard Response to Medline Surreply re Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 13, 2016.;;Medline Industries Inc vs C.R. Bard, Inc., Exhibit 2 to Declaration of Karl L. Lansing in Support of Bard's Rebuttal on Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc vs C.R. Bard, Inc., Exhibit B to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard, Inc., Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R. Bard, Inc., Exhibit J to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc., Exhibit K to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc. Exhibit 1 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc vs C.R. Bard, Inc. Exhibit 9 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-33618; Judge John Z. Lee; Filed July 8. 2016.;;Medline Industries Inc vs C.R. Bard, Inc. Exhibit L to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc. Medline Response to Bard Claim Construction Brief. Civil Action No. 1:14˜cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.: Exhibit 2 to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 117-CV-7216; Judge Sara L Eiiis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R. Bard, Inc.; Declaration of Barbara Weintraub re Claim Construction: Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. I:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12. 2 018.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit 10 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit 2 to Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Mar. 23, 2017.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit 5 to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman, Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit 6 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit 7 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit C to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit E to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit M to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R. Bard. Inc., Exhibit 2 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-33618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard. Inc.; Exhibit 5 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-33618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard. Inc.; Exhibit 6 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-33618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline industries Inc vs C.R. Bard. Inc.; Medline Response to Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc vs OR. Bard, Inc.; Exhibit E to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc, Exhibit I to C.R. Bard's LPR 2.3 Contentions. Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11,2 016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 11 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-33618; Judge John Z Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc. Declaration of Kevin A. Lake in Support of Medline Response to Bard Claim Construction Brief: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Declaration of Barbara Weintraub Regarding Claim Construction; Civil Action No. 1:14-cv-03618 Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R Bard, Inc.; Exhibit D to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard. Inc.; Exhibit 1 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard, Inc, Exhibit 4 to C.R. Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc vs C.R. Bard, Inc., Declaration of Peter Sauer in Support of Medline's Motion to Supplement Record; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Mar. 23, 2017.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit D to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc vs C.R. Bard. Inc., Exhibit 1 to Declaration of Brian Eutermoser in Support of Medline Surreply; Civil Action No. 1:14-cv-33618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc vs C R. Bard, Inc.; Exhibit B to Declaration ol Nicole M. Smith; Civil Action No. 1:14˜cv43618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc vs C R. Bard, Inc.; Exhibit D to Declaration of Nicole M Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit E to Declaration oi Nicole M. Smith; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit F to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C R. Bard's Opening Claim Construction Bnel; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc; C.R Bard's Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Declaration of Dylan Raife in Support of Motion for Leave to Add CounterClaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc; Exhibit C to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline industries Inc. vs C R. Bard. Inc; Exhibit 1 to C R. Bard's LPR 2.3 Contentions, Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis. Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Richard Meyst re Claim Construction: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; C R. Bard's Final LPR 2.3 Contentions; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Jul. 24, 2018. et al.",ACTIVE
682,AU,A1,AU 2021/200451 A1,002-929-956-707-816,2021-02-25,2021,AU 2021/200451 A,2021-01-22,AU 2021/200451 A;;AU 2017/286140 A;;US 201715497203 A;;US 201662349029 P;;US 201615275203 A;;US 2017/0035601 W,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/002-929-956-707-816,Patent Application,no,0,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06,,0,0,,,,ACTIVE
683,US,S,US D0650912 S,012-314-533-886-703,2011-12-20,2011,US 36227910 F,2010-05-21,US 36227910 F;;US 35278309 F;;US 33802209 F,2009-06-03,Medical tray,,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H;;MEDLINE IND INV,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/012-314-533-886-703,Design Right,no,0,38,4,4,0,,,2401;;D24/227,0,0,,,,ACTIVE
684,CN,A,CN 114466361 A,091-154-327-655-061,2022-05-10,2022,CN 202210119565 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;CN 201780033185 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE BY,"The invention relates to modifying a security state through security range detection. Some embodiments of the present invention provide for a trusted (or initiator) device a method of modifying the secure state of a target device (e.g., unlocking the device) based on secure ranging operations (e.g., determining distance, proximity, etc. The methods of some embodiments exchange messages as part of ranging operations to determine whether the trusted device and the target device are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the message is derived by two devices based on a shared secret and is used to validate the ranging signal source for the ranging operation. In some embodiments, the method is performed using a plurality of different frequency bands.",APPLE COMPANY,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/091-154-327-655-061,Patent Application,no,5,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04W12/084;;G06F21/44;;H04W12/63,,0,0,,,,PENDING
685,US,S,US D0704856 S,109-052-235-977-260,2014-05-13,2014,US 201329444526 F,2013-01-31,US 201329444526 F;;US 38047410 F,2010-12-06,Medical tray,,MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/109-052-235-977-260,Design Right,no,0,27,2,2,0,,,2402;;D24/227,0,0,,,,ACTIVE
686,EP,A3,EP 4284046 A3,083-417-798-842-068,2024-01-17,2024,EP 23202648 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;EP 17731348 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"There is provided a method comprising announcing, by a proxy device (830), an availability of a trusted device (520); in response to the announced availability, receiving, by the proxy device (830), a first request (850) from a target device (510); and upon receiving the first request from the target device (510), sending, by the proxy device (830), a second request to the trusted device (520), wherein the second request (855) comprises a request for the trusted device (520) to announce its availability directly to the target device (510) from which the first request was received, and the trusted device (520) establishes a communication connection with the target device (510) based on the second request.
",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/083-417-798-842-068,Search Report,yes,3,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04W8/00;;H04L9/40;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/086,,0,0,,,,PENDING
687,US,S,US D0623765 S,082-183-527-892-13X,2010-09-14,2010,US 35278309 F,2009-12-27,US 35278309 F;;US 33802209 F,2009-06-03,Medical tray,,MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/082-183-527-892-13X,Design Right,no,0,24,4,4,0,,,2401;;D24/227,0,0,,,,ACTIVE
688,AU,B2,AU 2021/200451 B2,086-172-215-470-52X,2022-09-29,2022,AU 2021/200451 A,2021-01-22,AU 2021/200451 A;;AU 2017/286140 A;;US 201715497203 A;;US 201662349029 P;;US 201615275203 A;;US 2017/0035601 W,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/086-172-215-470-52X,Granted Patent,no,2,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L9/40;;H04L9/28;;H04L9/32,,0,0,,,,ACTIVE
689,US,A1,US 2019/0151195 A1,184-492-502-527-475,2019-05-23,2019,US 201916258231 A,2019-01-25,US 201916258231 A;;US 201414265920 A;;US 84667510 A;;US 49514809 A;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, and Associated Mehtods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/184-492-502-527-475,Patent Application,yes,0,8,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B46/23;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,DISCONTINUED
690,EP,B1,EP 3449611 B1,025-419-084-857-423,2023-10-11,2023,EP 17731348 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,,APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/025-419-084-857-423,Granted Patent,yes,1,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L9/40;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/086,,0,0,,,,ACTIVE
691,US,A1,US 2020/0146640 A1,117-795-063-714-428,2020-05-14,2020,US 201916681305 A,2019-11-12,US 201916681305 A;;US 2017/0054880 W;;US 201816123834 A;;US 201762554876 P,2017-09-06,"Self-Shielded, Integrated-Control Radiosurgery System","A self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery and precision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table is provided. The radiation shield can include an axial shield rotatable about an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiation beams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,ZAP SURGICAL SYSTEMS INC (2018-09-07),https://lens.org/117-795-063-714-428,Patent Application,yes,1,1,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61B6/10;;A61B6/00;;A61B6/02;;A61B6/04;;A61B6/12;;A61N5/10,,0,0,,,,ACTIVE
692,US,A1,US 2019/0171465 A1,014-122-018-038-212,2019-06-06,2019,US 201916264478 A,2019-01-31,US 201916264478 A;;US 201615275203 A;;US 201662349029 P,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,APPLE INC (2016-09-22),https://lens.org/014-122-018-038-212,Patent Application,yes,0,5,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04L29/06;;H04W12/04;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
693,US,B2,US 11178127 B2,183-925-019-279-373,2021-11-16,2021,US 201715497203 A,2017-04-26,US 201715497203 A;;US 201662349029 P,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,APPLE INC (1997-06-20),https://lens.org/183-925-019-279-373,Granted Patent,yes,82,2,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04W12/08;;G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04L29/06;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/086,,20,0,,,"Invitation to Pay Additional Fees, and Where Applicable, Protest Fee for commonly owned International Patent Application PCT/US2017/035601, dated Aug. 23, 2017, 14 pages, International Searching Authority.;;Non-Published commonly owned International Patent Applciation No. PCT/US2017/035601, filed Jun. 2, 2017, 62 pages, Apple Inc.;;Non-Published commonly owned U.S. Appl. No. 15/275,203, filed Sep. 23, 2016, 61 pages, Apple Inc.;;SRP Documentation, retrieved from http://srp.stanford.edu/doc.html#standards, visited Apr. 3, 2018, 3 pages.;;Wu, “The Secure Remote Password Protocol,” retrieved from http://srp.stanford.edu/ndss.html, 1998, 24 pages.;;Written Opinion of the International Preliminary Examining Authority from PCT/US2017/035601, dated May 8, 2018, 8 pages.;;Australian Examination Report from Australian Patent Application No. 2017286140, dated Nov. 26, 2019, 4 pages.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Jan. 6, 2020, 14 pages including English language translation.;;Korean Office Action from Korean Patent Application No. 10-2018-7034644, dated Jan. 14, 2020, 10 pages including English language translation.;;European Office Action from European Patent Application No. 17721348.3, dated Sep. 12, 2019, 7 pages.;;European Office Action dated Mar. 2, 2020, from European Patent Application No. 17731348.3, 6 pages.;;International Search Report and Written Opinion from PCT/US2020/028549, dated Aug. 31, 2020, 18 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 27, 2020, 26 pages including English language translation.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Sep. 25, 2020, 5 pages including English language translation.;;Notice of Acceptance from Australian Patent Application No. 2017286140, dated Oct. 12, 2020, 3 pages.;;Invitation to Pay Additional Fees from PCT/US2020/028549, dated Jul. 10, 2020, 13 pages.;;Korean Office Action from Korean Patent Application No. 2018-7034644, dated Nov. 26, 2020, 9 pages including English language translation.;;Japanese Notice of Allowance from Japanese Patent Application No. 2018-562555, dated May 31, 2021, 5 pages including English language translation.;;Korean Notice of Allowance from Korean Patent Application No. 10-2018-7034644, dated May 31, 2021, 5 pages including English language translation.;;European Office Action from European Patent Application No. 17731348.3, dated Jul. 2, 2021, 5 pages.",ACTIVE
694,CA,C,CA 2705647 C,014-693-332-981-443,2018-05-01,2018,CA 2705647 A,2010-05-27,US 18362909 P;;US 49514809 A,2009-06-03,"CATHETER TRAY, PACKAGING SYSTEM, AND ASSOCIATED METHODS","A tray (100) for accommodating a coiled medical device, such as a catheter assembly (700), includes a first compartment (101), a second compartment (102), and a third compartment (103). The catheter assembly (700) and devices associated with a catheterization procedure, such as syringes (701,702) containing sterile water and lubricating jelly and a specimen container (703) can be disposed within the tray. A first barrier (105) and second barrier (106) separate the compartments. The barriers can have openings (121,122) therein to accommodate large syringes or to enable the first compartment (101) to be used as a lubricant applicator for the catheter. The first compartment (101) can include a stair-stepped contour (115) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray (100) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/014-693-332-981-443,Granted Patent,no,0,0,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B50/33;;A61B46/23;;A61B50/30;;B65D85/30,,0,0,,,,ACTIVE
695,US,A1,US 2017/0359169 A1,021-452-549-245-70X,2017-12-14,2017,US 201715497203 A,2017-04-26,US 201715497203 A;;US 201662349029 P,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,APPLE INC (1997-06-20),https://lens.org/021-452-549-245-70X,Patent Application,yes,12,14,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L9/08;;H04L9/14;;H04L9/32;;H04L29/06;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
696,EP,A1,EP 3449611 A1,037-930-082-586-387,2019-03-06,2019,EP 17731348 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,,APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/037-930-082-586-387,Patent Application,yes,0,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06,,0,0,,,,ACTIVE
697,US,B2,US 8631935 B2,069-257-469-979-71X,2014-01-21,2014,US 49514809 A,2009-06-30,US 49514809 A;;US 18362909 P,2009-06-03,"Catheter tray, packaging system, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H;;MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,MEDLINE INDUSTRIES INC (2009-06-04),https://lens.org/069-257-469-979-71X,Granted Patent,yes,103,52,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B19/02;;A61B46/23,206/370;;206/570;;206/364;;53/474,34,0,,,"Yuan, Minqiang ""Non-Final Office Action"", Chinese Application No. 200920267201.2, Mailed Sep. 9, 2010.;;Extended EPO Search Report, EPO Application No. 10251025.2, In the Name of Medline Industries, Mailed Sep. 29, 2010.;;Medline, ""Medline Aritcle/Brochure"", Published 2008.;;Yuan, Minqiang ""Non-Final Office Action"", Chinese Application No. 200920267201.2, Mailed Jun. 4, 2010.;;Extended EPO Search Report, EPO Application No. 10251024.5, In the Name of Medline Industries, Mailed Oct. 18, 2010.;;Poon, Robert ""Restriction Requirement"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 23, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 12/647,515, filed Dec. 2009; Mailed Jun. 28, 2012.;;Cavanna, Mark ""Ex Parte Quayle Action"", U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/362,279; May 21, 2010, Mailed Sep. 19, 2011.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Dec. 22, 2011.;;Cavanna, Mark ""NonFinal Office Action"", U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; Mailed Mar. 27, 2012.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; Mailed Oct. 1, 2009.;;Examiner, Chinese Patent Office ""First Office Action"", mailed: Nov. 18, 2010 application 201020219785.9 10055U CIP.CN Filed: Jun. 3, 2010.;;Prange, Sharon M., ""Response to First Office Action"", Dated: Aug. 6, 2009 U.S. Appl. No. 12/004,796 Inventor: Jonathan S. Primer et al. filed: Dec. 21, 2007.;;Hand, Melanie J., ""Notice of Allowance"", U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Feb. 1, 2013.;;Pass, Natalie ""NonFinal OA"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Mar. 5, 2013.;;Hand, Melanie J., ""NonFinal OA"", U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Feb. 1, 2013.;;""EPO Intent to Grant"", EPO Application No. 10251024.5; Filed Jun. 2, 2010; Mailed Nov. 2, 2012.;;Byun, Sung Cheal ""PCT Search Report and Written Opinion"", PCT/US2012/037524; Filed May 11, 2012; Mailed Nov. 16, 2012.;;Hand, Melanie J., ""NonFinal OA"", U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Nov. 30, 2012.;;Byun, Sung C., ""PCT Search Report"", PCT/US2012/039311; Filed May 24, 2011; Mailed Oct. 25, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Oct. 1, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Oct. 2, 2012.;;Poon, Robert ""Final Office Action"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Sep. 26, 2012.;;Byun, Sung C., ""PCT Search Report"", PCT/US2011/068193; Filed Dec. 30, 2011; Mailed Aug. 22, 2012.;;Poon, Robert ""Final OA"", U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Aug. 6, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Aug. 6, 2013.;;Poon, Robert ""NonFinal OA"", U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; Mailed Sep. 10, 2013.;;Hand, Melanie J., ""NonFinal OA"", U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; Mailed May 9, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 13, 2013.;;Hand, Melanie J., ""Final OA"", U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Jun. 5, 2013.;;Pass, Natalie ""Final OA"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Jul. 12, 2013.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; Mailed Oct. 17, 2013.;;Hand, Melanie J., ""Notice of Allowance"", U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; Mailed Oct. 28, 2013.",ACTIVE
698,US,B2,US 8746452 B2,089-001-831-189-662,2014-06-10,2014,US 84667510 A,2010-07-29,US 84667510 A;;US 49514809 A;;US 18362909 P,2009-06-03,"Catheter tray, packaging system, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY;;MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/089-001-831-189-662,Granted Patent,yes,101,28,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B46/23,206/366;;206/571;;206/561,45,0,,,"Poon, Robert ""Non-Final Office Action"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; mailed: Aug. 4, 2010.;;Yuan, Minqiang ""Non-Final Office Action"", Chinese Application No. 200920267201.2, Mailed Sep. 9, 2010.;;European Patent Office, ""Extended EPO Search Report"", EPO Application No. 10251025.2, In the Name of Medline Industries, Mailed Sep. 29, 2010.;;Medline, ""Medline Aritcle/Brochure"", Published 2008.;;Yuan, Minquiang ""Non-Final Office Action"", Chinese Application No. 200920267201.2, Mailed Jun. 4, 2010.;;European Patent Office, ""Extended EPO Search Report"", Application No. 10251024.5, In the Name of Medline Industries, Mailed Oct. 18, 2010.;;Examiner, Chinese Patent Office ""First Office Action"", CN Application No. 201020219785.9; Mailed Nov. 18, 2010; Filed Jun. 3, 2010.;;Poon, Robert ""Final Office Action"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, Mailed Mar. 3, 2011.;;Prange, Sharon M., ""Response to First Office Action"", U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; Mailed Oct. 28, 2009.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/362,279, filed May 21, 2010, Mailed Sep. 19, 2011.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; Mailed Oct. 1, 2009.;;Cavanna, Mark ""NonFinal Office Action"", U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; Mailed Mar. 27, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Jun. 28, 2012.;;Cavanna, Mark ""Ex Parte Quayle Action"", U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012.;;Poon, Robert ""Restriction Requirement"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 23, 2012.;;Byun, Sung C., ""PCT Search Report"", PCT/US2011/068193; Filed Dec. 30, 2011; Mailed Aug. 22, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Oct. 2, 2012.;;Poon, Robert ""NonFinal Office Action"", U.S. Appl. No. 13/153,300, filed Jun. 3, 2011, Mailed Oct. 1, 2012.;;Poon, Robert ""NonFinal OA"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Oct. 4, 2012.;;Byun, Sung C., ""PCT Search Report"", PCT/US2012/039311; Filed May 24, 2011; Mailed Oct. 25, 2012.;;Hand, Melanie J., ""NonFinal OA"", U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Nov. 30, 2012.;;Byun, Sung Cheal ""PCT Search Report and Written Opinion"", PCT/US2012/037524; Filed May 11, 2012; Mailed Nov. 16, 2012.;;""EPO Intent to Grant"", EPO Application No. 10251024.5; Filed Jun. 2, 2010; Mailed Nov. 2, 2012.;;Hand, Melanie J., ""NonFinal OA"", U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Feb. 1, 2013.;;Pass, Natalie ""NonFinal OA"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Mar. 5, 2013.;;Hand, Melanie J., ""Notice of Allowance"", U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; Mailed Feb. 1, 2013.;;Hand, Melanie J., ""NonFinal OA"", U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; Mailed May 9, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed May 13, 2013.;;Hand, Melanie J., ""Final OA"", U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed Jun. 5, 2013.;;Pass, Natalie ""Final OA"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Jul. 12, 2013.;;Poon, Robert ""Final Office Action"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Jul. 31, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Aug. 6, 2013.;;Poon, Robert ""Final OA"", U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; Mailed Aug. 6, 2013.;;Cavanna, Mark ""Notice of Allowance"", U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; Mailed Oct. 17, 2013.;;Hand, Melanie J., ""Notice of Allowance"", U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; Mailed Oct. 28, 2013.;;Poon, Robert ""Notice of Allowance"", U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Mailed Nov. 20, 2013.;;""Instructions"", Naming a character website. URL:<https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>. 2008.Retreived from Internet Dec. 10, 2013.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown-bear-brown-bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013.;;Dictionary definition m-w. URL:. Retrieved fro Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:. Retrieved from Internet Dec. 10, 2013.;;Lion King Sticker website. URL:. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: . 1998 Retrieved from Internet Dec. 10, 2013.;;""Examiner's Answer"", U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; Mailed Dec. 17, 2013.;;Poon, Robert ""NonFinal OA"", U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; Mailed Dec. 18, 2013.;;""EPO Exam Report"" EPO App No. 10251025.2; Filed Jun. 2, 2010; Mailed Dec. 17, 2013.",ACTIVE
699,US,B2,US 10251812 B2,134-039-133-031-319,2019-04-09,2019,US 201414265920 A,2014-04-30,US 201414265920 A;;US 84667510 A;;US 18362909 P;;US 49514809 A,2009-06-03,"Catheter tray, packaging system, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/134-039-133-031-319,Granted Patent,yes,237,21,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B42/00;;A61B46/00;;A61B46/23;;A61B50/30;;A61B50/33;;A61M25/00,,396,2,098-777-794-605-077;;008-481-422-937-006,10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610,"“IPR2015-00514 Decision Institution of Inter Partes Review”, IPR2015-00514; U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015; Decision Institution of Inter Partes Review.;;“IPR2015-00509 Institution Decision”, IPR2015-00509; U.S. Pat. No. 8,448,786; Mailed Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR 2015-00514 Petitioners Request for Rehearing”, IPR 2015-00514 Petitioner's Request for Rehearing; U.S. Pat. No. 8,678,190; Dated Jul. 10, 2015.;;“IPR2015-00511 Institution Decision”, IPR2015-00511; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR2015-00513 Institution Decision”, IPR2015-00513 Institution Decision; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Institution of Inter Partes Review.;;“Non-Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; dated Aug. 4, 2010.;;Yuan, Minqiang “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Sep. 9, 2010.;;European Patent Office, “Extended EPO Search Report”, EPO Application No. 10251025.2, In the Name of Medline Industries, dated Sep. 29, 2010.;;Medline, “Medline Aritcle/Brochure”, Published 2008.;;Yuan, Minquiang “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Jun. 4, 2010.;;European Patent Office, “Extended EPO Search Report”, Application No. 10251024.5, In the Name of Medline Industries, dated Oct. 18, 2010.;;Chinese Patent Office “First Office Action”, CN Application No. 201020219785.9; dated Nov. 18, 2010; Filed Jun. 3, 2010.;;“Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, dated Mar. 3, 2011.;;Prange, Sharon M., “Response to First Office Action”, U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; dated Oct. 28, 2009.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/362,279, filed May 21, 2010, dated Sep. 19, 2011.;;“NonFinal Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 22, 2011.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; dated Oct. 1, 2009.;;Cavanna, Mark “NonFinal Office Action”, U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; dated Mar. 27, 2012.;;“NonFinal Office Action”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Jun. 28, 2012.;;Cavanna, Mark “Ex Parte Quayle Action”, U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012.;;“Restriction Requirement”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 23, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2011/068193, filed Dec. 30, 2011; dated Aug. 22, 2012.;;“Final Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 26, 2012.;;“NonFinal Office Action”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 2, 2012.;;“NonFinal Office Action”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 1, 2012.;;“NonFinal OA”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Oct. 4, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2012/039311, filed May 24, 2011; dated Oct. 25, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Nov. 30, 2012.;;Byun, Sung Cheal “PCT Search Report and Written Opinion”, PCT/US2012/037524; filed May 11, 2012; dated Nov. 16, 2012.;;“EPO Intent to Grant”, EPO Application No. 10251024.5; Filed Jun. 2, 2012; dated Nov. 2, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Feb. 1, 2013.;;Pass, Natalie “NonFinal OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Mar. 5, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Feb. 1, 2013.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/155,053, filed Jun. 7, 2011; dated May 9, 2013.;;“Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 13, 2013.;;Hand, Melanie J., “Final OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Jun. 5, 2013.;;Pass, Natalie “Final OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jul. 12, 2013.;;“Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Jul. 31, 2013.;;“Final OA”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Aug. 6, 2013.;;“Final OA”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Aug. 6, 2013.;;“NonFinal OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 10, 2013.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; dated Oct. 17, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; dated Oct. 28, 2013.;;“Notice of Allowance”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Nov. 20, 2013.;;“Instructions”, Naming a character website, URL: <https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>, 2008.Retrieved from Internet Dec. 10, 2013.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown_bear_brown_bear.html>. (2006) . . . Retrived from Internet Dec. 11, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: >http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;“Examiner's Answer”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Dec. 17, 2013.;;“NonFinal OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Dec. 18, 2013.;;“Final OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010, dated Dec. 18, 2013.;;“Extended EPO Exam Report”, EPO App No. 10251025.2; Filed Jun. 2, 2010; dated Dec. 17, 2013.;;“Notice of Allowance”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Apr. 30, 2014.;;Gimenez Burgos, R “Extended European Search Report”, 11854003.8; Filed Dec. 30, 2011; dated Jun. 3, 2014.;;“Bardex I.C. Infection Control Foley Tray”, Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006.;;“Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System”, Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006.;;“Bardex I.C. Infection Control 350ml Urine Meter Foley Tray”, Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006.;;“Bard Medical Division Care & Catherterization Script”, Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Cathererization Techniques; Copyright 2006; AV0512-06 R12/05 XXX.;;Medline Industries, Inc. vs. C.R. Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 2.3 Contentions—Intitial Non-Infringement; Exhibits 1 and A-H; Dated Sep. 5, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Initial Invalidity Contentions; Exhibits A-H; Dated Sep. 19, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; Dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatroies; Dated Sep. 26, 2014.;;“Publication”, European Commission: Pharmaceutical Committee “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Dated Sep. 29, 1998.;;“Bard Publication”, “A few important words about Catheter Care”; C.R. Bard, Inc; Copyright 2001 C.R. Bard, Inc.;;Dover Intermittent Catheter Tray—14 fr, Red Rubber; Website http://tinyurl.com/o4esrwh; Unknown Publication Date.;;“YouTube Training Video”, https://www.youtube.com/watch?v=ISBya_5cIM.;;“YouTube Training Video”, https://www.youtube.com/watch?v=YwqcRUP35nl&list_=UUG7a6rFPh1wvF0QDM_Z3DarQ.;;“NonFinal Office Action”, U.S. Appl. No. 13/680,902, filed Apr. 11, 2014; dated Dec. 2, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,448,786”, U.S. Pat. No. 8,448,786; Filed Dec. 30, 2014; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration U.S. Pat. No. 8,448,786 Patent; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Kimmel CV—Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Susan Carrow Declaration U.S. Pat. No. 8,448,786; mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Carrow CV—Susan Carrow CV; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; EC Guideline 2009; “Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use”; Revision 1 Published Jan. 12, 2009 (Dec. 1, 2009); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—EC Guideline 1998; “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Published Sep. 29, 1998 (Sep. 29, 1998); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Soroka Glossary_wrap; Illustrated Glossary of Packaging Terminology; second edition; publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Soroka Glossary ‘Bag’; Illustrated Glossary of Packaging Terminology, second edition; Walter Soroka; publication.;;“Inter Partes Review Petition”, Exhibit—Encyclopedia Dictionary of Medicine, Nursing and Allied Health; Miller Keane, Seventh Edition.;;“Inter Partes Review Petition”, Exhibit—Dorland's Definition of Bag; Dorland's Illustrated Medical Dictionary; 31st Edition; Publication Date Unknown.;;“Inter Partes Review Petition”, Exhibit—Nursing Standard; Article in Learning Zone—Continue Professional Development; “Reducing the risks associated with urinary catheters”; Published Mar. 25, 2009.;;“Inter Partes Review Petition”, Exhibit—Websters Dictionary Definition of Dispose; Webster's Third New International Dictionary; Copyright 2003; publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Bard DFU; Bardex Infection Control Foley Tray; Copyright 2006, publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014.;;“Inter Partes Review Petition”, Exhibit—FDA Article; Guidance for the Content of Premarkt Notifications fro Conventional and Antimicrobial Foley Catheters; http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm080884.htm; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Bardex DFU; Directions for Use/Patient Education Information—Urology; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Mosby's Pocket Guide Excerpt; Mosby's Pocket Guide to Basic Skills and Procedures; Sixth Edition; Perry & Potter; “Urinary Catheter: Indwelling, Straight, Care and Removal”; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008.;;“Inter Partes Review Petition”, Exhibit—FAQs “Catheter-Associated Urinary Tract Infection”; Unknown Publisher; Unknown Publication Date.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,678,190”, Inter Partes Review Petition for U.S. Pat. No. 8,678,190; Filed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Declaration of Susan Carrow for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Response to Office Action in U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; Response Filed Nov. 19, 2010.;;“Inter Partes Review Petition”, Exhibit—RCE Filed November May 31, 2011 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148, filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010.;;“Inter Partes Review Petition”, Exhibit—Morning Start Article; “Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent”; Published Jan. 2011.;;“Inter Partes Review Petition”, Exhibit—Medical News Today Article; ‘Getting to Zero:’ Medlines' Erase Cauti Program Helps Hospitals Reduce Catheter Use By 20 Percent; Article Date Apr. 13, 2011.;;“Inter Partes Review Petition”, Exhibit—The Journal of Healthcare Contracting, Oct. 2012; “Catheter-associated urinary tract infections”.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; Mailed Dec. 30, 2014.;;“NonFinal OA”, U.S. Appl. No. 14/265,909, filed Apr. 30, 2014; dated Dec. 31, 2014.;;Gimenez Burgos, R “European Examination Report”, European Application No. 11 854 003.8-1659; Ref SJG/P128064EP00; dated Jan. 22, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EPO App No. 12 79 3939; Reference No. SJG/P130269EP00; dated Jan. 27, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EU App No. 12792423.1-1659/2713933; PCT/US2012039311; REference No. SJG/P130270EP00; dated Jan. 27, 2015.;;“Bard IPR Exhibit”, “Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Article 94(3) EPC Examination”, European Application No. 10 251 025.2-1501; Reference P112645EP00; dated Mar. 13, 2015.;;“Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Apr. 7, 2015.;;“Office Action”, Chinese Application No. 201180066491.4; dated Mar. 24, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,448,786; IPR2015-00509; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00511; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00513; Filed Apr. 21, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,678,190; Inter Partes Review No. IPR2015-00514; Filed Apr. 21, 2015.;;Ortega, Rafael et al., “Female Urethral Catheterization”, N. Engl. J. Med vol. 358:e15; published 2008.;;Thomsen, Todd , “Male Urethral Catheterization”, N. Engl. J. Med vol. 354:e22; Published 2006.;;“Inter Partes Review No. IPR2019-00109”, Petition for Review; U.S. Pat. No. 9,795,761; Filed Oct. 24, 2018.;;“Inter Partes Review Petition for U.S. Pat. No. 9,745,088”, IPR-0036; Filed Oct. 4, 2018.;;“Inter Partes Review Petition for U.S. Pat. No. 9,745,088”, IPR2019-0035, filed Oct. 4, 2018.;;“IPR 2019-00109”, U.S. Pat. No. 9,795,761; Filed Oct. 24, 2018; Declaration of Dr. Edward Yun.;;“IPR 2019-010109”, Exhibit 1031—Declaration of Jennifer Tomes filed in U.S. Appl. No. 12/647,515 dated Dec. 7, 2012.;;“IPR Exhibit 1002”, Declaration of Plishka; IPR2019-0035, Filed Oct. 4, 2018.;;“IPR Exhibit 1003”, Declaration of Yun; IPR2019-0035; Filed Oct. 4, 2018.;;“IPR Exhibit 1022”, Email from Medline counsel re claims constructions; IPR2019-0035; Filed Oct. 4, 2018.;;“IPR Petition Exhibit 1016”, Excerpt from “The Design of Everyday Things”; IPR2019-0035; Filed Oct. 4, 2018.;;“IPR Petition Exhibit 1024”, Email from Bard counsel re claims constructions; IPR2019-0035; Filed Oct. 4, 2018.;;“IPR2019-00109”, Exhibit 1026—Bard's Opening Claim Construction Brief; Civil Action No. 1:17-cv-07216; Filed Oct. 10, 2018.;;“IPR2019-00109”, Exhibit 1030—Medline Industries, Inc.'s Final Infringement Contentions; Filed Jul. 24, 2018 in Civil Action No. 1:17-cv-07216.;;“IPR2019-00109”, U.S. Pat. No. 9,795,761; Filed Oct. 24, 2018; Exhibit 1002 Declaration of Michael Plishka.;;Mian, Ali , “Non-Final Office Action”, Canadian Application No. 2,837,324; dated Oct. 3, 2018.;;“Non-Final Office Action”, U.S. Appl. No. 15/803,393, filed Nov. 3, 2017; dated Oct. 15, 2018.;;“Non-Final Office Action”, U.S. Appl. No. 15/804,520, filed Nov. 6, 2017; dated Nov. 2, 2018.;;Pothier, Andrew , “NonFinal Office Action”, Canadian Patent Application No. 2,822,905; Reference No. 15468-P44352CA00 (10055U CIP4 CA); dated Aug. 31, 2018.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; Mailed Aug. 18, 2015.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A lo Declaration of Bnan Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 4 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee: Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; C.R. Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C R. Bard, Inc.; Declaration of Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z, Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C R. Bard, Inc.; Exhibit A—C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!7-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 1 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 2 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. I:14-cv-03518; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R. Bard, Inc.; Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surreply: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit I to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit I to Declaration of Nicole M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Bard Reply to Medline Claim Construction Brief; Civil Action No. 1 I6-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; C. R. Bard's Reply in Support of Claim Construction Brief; Civil Action No. 1.14-cv-03618, Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-CV-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618. Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Declaration of Richard Meyst re Claim Construction; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 1 to Declaration of Karl L Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1.14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 1 to Declaration of Karl R Leinsing in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 3 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee, Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit 4 to Declaration of Richard Meyst Regarding Claim Construction; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit A to Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit B to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1;16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit B to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit C to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1:14-cv 03618; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1.14-cv-03618; Judge John Z. Lee. Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit D to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618, Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F lo Declaration of Kevin A Lake: Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit F to Declaration of Dylan J. Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. 1. 14-cv-03618; Judge John Z. Lee, Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit G to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618. Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit G to Declaration of Nicole Smith in Support ofBard Reply to Medline Claim Construction Brief: Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit H to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit H to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief. Civil Action Mo. 1:16-cv-Q3529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit I to Declaration of Kevin A. Lake; Civil Action No. 1.14-sv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit N to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Medline Memo of Law re Expert Testimony in Claim Construction Proceedings; Civil Action No. 1:14-cv-03618; Judge John Z. Lee. Filed Jan. 25, 2017.;;Medline Industries Inc. vs C.R. Bard, Inc.; Medline Surreply to Claim Construction Brief; Civil Action No. 1:14-CV-Q3618: Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Transcript of Deposition of Richard Meyst; Civil Action No. 1:16-W-03529. Jan. 20, 2017. et al.",ACTIVE
700,CA,A1,CA 2705647 A1,112-527-118-049-064,2010-12-03,2010,CA 2705647 A,2010-05-27,US 18362909 P;;US 49514809 A,2009-06-03,"CATHETER TRAY, PACKAGING SYSTEM, AND ASSOCIATED METHODS","A tray (100) for accommodating a coiled medical device, such as a catheter assembly (700), includes a first compartment (101), a second compartment (102), and a third compartment (103). The catheter assembly (700) and devices associated with a catheterization procedure, such as syringes (701,702) containing sterile water and lubricating jelly and a specimen container (703) can be disposed within the tray. A first barrier (105) and second barrier (106) separate the compartments. The barriers can have openings (121,122) therein to accommodate large syringes or to enable the first compartment (101) to be used as a lubricant applicator for the catheter. The first compartment (101) can include a stair-stepped contour (115) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray (100) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/112-527-118-049-064,Patent Application,no,0,1,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B19/02;;A61B46/23;;B65D85/30,,0,0,,,,ACTIVE
701,US,A1,US 2017/0357523 A1,172-948-025-021-152,2017-12-14,2017,US 201615275203 A,2016-09-23,US 201615275203 A;;US 201662349029 P,2016-06-12,Modifying Security State With Secured Range Detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,APPLE INC (1997-06-20),https://lens.org/172-948-025-021-152,Patent Application,yes,5,7,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,G06F9/445;;H04L29/06;;H04W12/04;;H04W12/06,,0,0,,,,ACTIVE
702,US,A1,US 2022/0296467 A1,078-094-838-552-90X,2022-09-22,2022,US 202217835747 A,2022-06-08,US 202217835747 A;;US 201916258231 A;;US 201414265920 A;;US 84667510 A;;US 49514809 A;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, and Associated Mehtods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND LP,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/078-094-838-552-90X,Patent Application,yes,5,0,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B46/23;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,ACTIVE
703,WO,A1,WO 2017/218208 A1,134-189-178-473-712,2017-12-21,2017,US 2017/0035601 W,2017-06-02,US 201615275203 A;;US 201715497203 A;;US 201662349029 P,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/134-189-178-473-712,Patent Application,yes,7,3,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06,,0,0,,,,PENDING
704,EP,A1,EP 3678736 A1,043-344-105-295-183,2020-07-15,2020,EP 17924466 A,2017-10-03,US 201762554876 P;;US 2017/0054880 W,2017-09-06,"SELF-SHIELDED, INTEGRATED-CONTROL RADIOSURGERY SYSTEM",,ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,,https://lens.org/043-344-105-295-183,Patent Application,yes,0,0,6,15,0,A61B6/10;;G21F7/06;;A61N5/1048;;A61N2005/1061;;A61N2005/1094;;A61N5/107;;A61N5/1049,A61N5/00;;A61B6/10;;G21F7/06,,0,0,,,,PENDING
705,US,B2,US 9808400 B2,059-413-434-925-067,2017-11-07,2017,US 201414265909 A,2014-04-30,US 201414265909 A;;US 84667510 A;;US 18362909 P;;US 49514809 A,2009-06-03,"Catheter tray, packaging system, and associated methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,MEDLINE INDUSTRIES LP (2009-06-04),https://lens.org/059-413-434-925-067,Granted Patent,yes,208,28,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B42/00;;A61B46/00;;A61B46/23;;A61B50/30;;A61B50/33;;A61M25/00,,186,0,,,"“IPR 2015-00514—Request for Rehearing Denied”, IPR2015-00514; U.S. Pat. No. 8,678,190; Decision on Request for Rehearing—Denied; Mailed Jul. 16, 2015.;;“IPR 2015-00514—Patent Owner's Objection to Evidence”, IPR 2015-00514—Patent Owner's Objection to Evidence Submitted During a Preliminary Proceeding; U.S. Pat. No. 8,678,190; Mailed Jul. 13, 2015.;;“IPR 2015-00514—Patent Owner's Request for Adverse Judgement”, U.S. Pat. No. 8,678,190; Mailed Jun. 23, 2015.;;“IPR2015-00514—Scheduling Order”, U.S. Pat. No. 8,678,190; Mailed Jun. 26, 2015.;;“IPR2015-00514 Judgement—Termination of Proceeding”, U.S. Pat. No. 8,678,190; Mailed Jul. 24, 2015.;;“Australian First Exam Report”, AU Patent Application No. 2011351971; Patent Examination Report No. 1; dated Jul. 25, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Oct. 2, 2015.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014; dated Oct. 26, 2015.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Nov. 19, 2015.;;Vasat, Peter “Notice of Allowance”, U.S. Appl. No. 12/785,064, filed May 21, 2010, dated Sep. 12, 2016.;;Medline Industries vs. CR Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 3.1 Contentions; Filed Nov. 24, 2015.;;“Office Action Received”, Chinese App No. 201280035246.1: NonFinal OA; dated Sep. 16, 2015.;;“Office Action”, Australian Application No. 2011351971; Reference No. 35204298/GP; dated Feb. 18, 2016.;;Notice of Allowance; EP Application No. 10251025.2-1501; Reference P112645EP00; dated Feb. 18, 2016.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,670; Ref No. 15468-8; dated Apr. 25, 2016.;;Hand, Melanie Jo “Appeal Decision”, U.S. Appl. No. 12/785,064, filed May 21, 2010; Mailed May 18, 2016.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 15/067,903; filed Mar. 11, 2016, dated Jun. 30, 2016.;;“Notice of Acceptance”, Australian Application No. 2011351971; Filed Dec. 30, 2011; dated May 13, 2016.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; dated Jul. 15, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc; C.R. Bard's LPR 3.1 Contentions; Civil Action No. 1:16-cs-3529; Judge Sharon Johnson Coleman; Filed Aug. 26, 2016.;;“Medline Catalog”, Turkel Safety Thoracentesis Procedure Trays by Covidien; http://www.medline.com/jump/sku/x/MDPKDL566059; Unknown Publication date but believed to be prior to present application filing date.;;“Medline Catalog”, Turkel Safety Thoracentesis Procedure Trays by Covidien; 5″; http://www.medline.com/sku/item/MDPKDL566075; Unknown Publication date but believed to be prior to present application filing date.;;“Medline Catalog”, Paracentesis Trays by Covidien; http://www.medline.com/sku/item/MDPSWD568006; Unknown Publication Date but believed to be prior to filing of present application.;;“Medline Catalog”, Argyle Turkel Safety Thoracentesis System by Covidien; http://www.medline.com/sku/item/MDPKDL5014; Unknown Publication Date but believe to be prior to filing of present application.;;“Medline Catalog”, Argyle Trocar Catheter Kits by Covidien; http://www.medline.com/sku/item/MDPSWD565028; Unknown Publication Date but believed to be prior to filing of present application.;;“Medline Catalog”, Paracentesis Trays by Halyard Health; http://www.medline.com/sku/item/MDPBAA61450. Unknown Publication Date but believed to be prior to filing of present application.;;“Medline Catalog”, Safe-T Thoracentesis/Paracentesis Tray by Carefusion; http://www.medline.com/sku/item/MDPBXTTPT1000SP; Unknown publication date but believed to be prior to filing of present application.;;“Medline Catalog”, Thoracentesis Trays by Carefusion; http://www.medline.com/sku/item/MDPBXTPIG1280K; Unknown publication date but believed to be prior to filing of present application.;;“Medline Catalog”, Argyle Turkel Safety Thoracentesis System by Covidien; 6″; http://www.medline.com/sku/item/MDPKDL5016; Unknown Publication Date but believed to be prior to filing of present application.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013, dated Sep. 14, 2016.;;Cavanna, Mark “Non-Final Office Action”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Sep. 26, 2016.;;Poon, Robert “Final OA”, U.S. Appl. No. 15/067,903, filed Mar. 11, 2016; dated Jan. 13, 2017.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014, dated Feb. 28, 2017.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,670, dated Feb. 10, 2017.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,647; dated Feb. 10, 2017.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Aug. 4, 2015.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; Reference No. 10055U CIP5 CN; dated Nov. 28, 2016.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013, dated Apr. 1, 2016.;;Poon, Robert “Appeal Decision”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 12, 2016.;;Long, Fonya M “Appeal Decision”, U.S. Appl. No. 13/154,265, filed Jun. 3, 2011; dated Oct. 6, 2016.;;Poon, Robert “Appeal Decision”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; Mailed Oct. 24, 2016.;;“Second Office Action”, Chinese Application No. 201280035240.4; dated Jun. 23, 2016.;;Mackenzie, Kristian “Office Action”, Canadian Application No. 2,705,647; Ref No. 15468-P37235CA00; dated Apr. 21, 2016.;;Chinese Application No. 201280035240.4; Filed May 24, 2012; dated Aug. 18, 2015.;;Hand, Melanie Jo “Final OA”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated May 22, 2015.;;Schultz, Ottmar “Extended European Search Report”, EP Application No. 16177903.8-1501; Filed Jun. 30, 2009; dated Oct. 27, 2016.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 13/860,902, filed Apr. 11, 2013; dated Nov. 8, 2016.;;Marcetich, Adam M., “Final OA”, U.S. Appl. No. 14/165,044, filed Jan. 27, 2014, dated Aug. 11, 2016.;;“Intent to Grant”, Chinese Application No. 201180066491.4: Flled Dec. 30, 2011; dated Jul. 6, 2016.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Feb. 2, 2016.;;“Office Action”, Chinese Application No. 201180066491.4; dated Nov. 11, 2015.;;“IPR2015-00513—Patent Owner's Request for Adverse Judgement”, U.S. Pat. No. 8,631,935, dated Jul. 23, 2015.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Jan. 5, 2016.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries Inc's Opposition to C.R.Bard Inc's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Oct. 20, 2015.;;Medline Industries, Inc. vs C.R. Bard. Inc; No. 1:14-cv-03618; Notice of Medline Industries Inc's Motion to Dismiss C.R. Bard Inc's Inequitable Conduct Counterclaim and to strike affirmative defense for the '786 Patent; Filed Oct. 20, 2015.;;“IPR2015-00513—Request for Adverse Judgement”, IPR2015-00513—Request for Adverse Judgement; Granted—Proceedings Terminated; U.S. Pat. No. 8,631,935; Entered Aug. 11, 2015.;;“IPR0215-00513 Scheduling Order”, U.S. Pat. No. 8,631,935; Mailed Jul. 15, 2015.;;Cavanna, Mark “Final OA”, U.S. Appl. No. 29/479,600, filed Jan. 17, 2014; dated Jun. 1, 2017.;;Marcetich, Adam “Notice of Allowance”; U.S. Appl. No. 14/793,455, filed Jul. 7, 2015; dated Jul. 20, 2017.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Defendant C.R. Bards, Inc's Second Amended Answer to Second Amended Complaint; Filed Sep. 25, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; Memorandum in Support of C.R. Bard's Motion for Leave to File Second Amended Answer to Add Counterclaim. Filed Sep. 25, 2015.;;“IPR2015-00514 Decision Institution of Inter Partes Review”, IPR2015-00514; U.S. Pat. No. 8,678,190, mailed Jun. 26, 2015; Decision Institution of Inter Partes Review.;;“IPR2015-00509 Institution Decision”, IPR2015-00509; U.S. Pat. No. 8,448,786; Mailed Jul. 15, 2015; Decision Denying Institution of Inter Partes.;;“IPR 2015-00514 Petitioner's Request for Rehearing”, IPR 2015-00514 Petitioner's Request for Rehearing; U.S. Pat. No. 8,678,190; Dated Jul. 10, 2015.;;“IPR2015-00511 Institution Decision”, IPR2015-00511; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR2015-00513 Institution Decision”, IPR2015-00513 Institution Decision; U.S. Pat. No. 8,631,935; Entered Jul. 15, 2015; Decision Institution of Inter Partes Review.;;Marcetich, Adam. Non-Final Office Action, U.S. Appl. No. 14/793,455, filed Jul. 7, 2015; dated May 3, 2017.;;Office Action, Chinese Application No. 201280035240.4; dated Apr. 1, 2017.;;Poon, Robert. Final Office Action, U.S. Appl. No. 14/718,792, filed May 21, 2015; dated Jan. 5, 2016.;;Poon, Robert. Notice of Allowance, U.S. Appl. No. 15/067,903; dated Aug. 23, 2017.;;Pothier, Andrew. Office Action, Canadian Application No. 2,822,905; Reference No. 15468-P44352CA00; dated May 1, 2017.;;“DVD”, Entitled “Preventing UTI: Care and Catheterization Techniques”; Publication Date unknown but believed to be prior to 2007.;;Poon, Robert “Non-Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; first inventor: Jennifer E. Tomes; dated Aug. 4, 2010.;;Yuan, Minqiang “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Sep. 9, 2010.;;European Patent Office, “Extended EPO Search Report”, EPO Application No. 10251025.2, In the Name of Medline Industries, dated Sep. 29, 2010.;;Medline, “Medline Aritcle/Brochure”, Published 2008.;;Yuan, Minquiang “Non-Final Office Action”, Chinese Application No. 200920267201.2; dated Jun. 4, 2010.;;European Patent Office, “Extended EPO Search Report”, Application No. 10251024.5, In the Name of Medline Industries, dated Oct. 18, 2010.;;Chinese Patent Office “First Office Action”, CN Application No. 201020219785.9; dated Nov. 18, 2010; Filed Jun. 3, 2010.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/495,148, flled Jun. 30, 2009, dated Mar. 3, 2011.;;Prange, Sharon M., “Response to First Office Action”, U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; dated Oct. 28, 2009.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/362,279, filed May 21, 2010, dated Sep. 19, 2011.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 22, 2011.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/338,022, filed Jun. 3, 2009; dated Oct. 1, 2009.;;Cavanna, Mark “NonFinal Office Action”, U.S. Appl. No. 29/380,474, filed Dec. 26, 2012; dated Mar. 27, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Jun. 28, 2012.;;Cavanna, Mark “Ex Parte Quayle Action”, U.S. Appl. No. 29/380,474, filed Dec. 6, 2010; Mailed Aug. 14, 2012.;;Poon, Robert “Restriction Requirement”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 23, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2011/068193; Filed Dec. 30, 2011; dated Aug. 22, 2012.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 26, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Oct. 2, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Oct. 1, 2012.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Oct. 4, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2012/039311; Filed May 24, 2011; dated Oct. 25, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Nov. 30, 2012.;;Byun, Sung Cheal “PCT Search Report and Written Opinion”, PCT/US2012/037524; Filed May 11, 2012; dated Nov. 16, 2012.;;“EPO Intent to Grant”, EPO Application No. 10251024.5; Filed Jun. 2, 2010; dated Nov. 2, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Feb. 1, 2013.;;Pass, Natalie “NonFinal OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Mar. 5, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,026, filed Jun. 7, 2011; dated Feb. 1, 2013.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/115,053, filed Jun. 7, 2011; dated May 9, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated May 13, 2013.;;Hand, Melanie J., “Final OA”, U.S. Appl. No. 12/785,064, filed May 21, 2010; dated Jun. 5, 2013.;;Pass, Natalie “Final OA”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Jul. 12, 2013.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Jul. 31, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 13/374,509, filed Dec. 30, 2011; dated Aug. 6, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 13/153,300, filed Jun. 3, 2011; dated Aug. 6, 2013.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Sep. 10, 2013.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/444,526, filed Jan. 31, 2013; dated Oct. 17, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,054, filed Jun. 7, 2011; dated Oct. 28, 2013.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009; dated Nov. 20, 2013.;;“Instructions”, Naming a character website. URL: <https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>. 2008.Retreived from Internet Dec. 10, 2013.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboard.org/brown—bear—brown—bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet. Dec. 10, 2013.;;“Examiner's Answer”, U.S. Appl. No. 13/153,265, filed Jun. 3, 2011; dated Dec. 17, 2013.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Dec. 18, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Dec. 18, 2013.;;“Extended EPO Exam Report”, EPO App No. 10251025.2; Filed Jun. 2, 2010; dated Dec. 17, 2013.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 12/846,675, filed Jul. 29, 2010; dated Apr. 30, 2014.;;Gimenez Burgos, R “Extended European Search Report”, 11854003.8; Filed Dec. 30, 2011; dated Jun. 3, 2014.;;“Bardex I.C. Infection Control Foley Tray”, Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006.;;“Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System”, Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006.;;“Bardex I.C. Infection Control 350ml Urine Meter Foley Tray”, Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006.;;“Bard Medical Division Care & Catheterization Script”, Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Catheterization Techniques; Copyright 2006; AV0512-06 R12/05 XXX.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 2.3 Contentions—Initial Non-Infringement; Exhibits 1 and A-H; Dated Sep. 5, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Initial Invalidity Contentions; Exhibits A-H; Dated Sep. 19, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; Dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatories; dated Sep. 26, 2014.;;“Publication”, European Commission: Pharmaceutical Committee “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Dated Sep. 29, 1998.;;“Bard Publication”, “A few important words about Catheter Care”; C.R. Bard, Inc; Copyright 2001 C.R. Bard, Inc.;;Dover Intermittent Catheter Tray—14 fr, Red Rubber; Website http://tinyurl.com/o4esrwh; Unknown Publication Date.;;“YouTube Training Video”, https://www.youtube.com/watch?v=ISBya—5cIM.;;“YouTube Training Video”, https://www.youtube.com/watch?v=YwqcRUP35nl&list=UUG7a6tFPh1wvF0QDM Z3DarQ.;;“NonFinal Office Action”, U.S. Appl. No. 13/680,902, filed Apr. 11, 2014; dated Dec. 2, 2014.;;“Inter Partes Review Petition for 8,448,786”, U.S. Pat. No. 8,448,786; Filed Dec. 30, 2014; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration U.S. Pat. No. 8,448,786; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Kimmel CV—Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Susan Carrow Declaration 8,448,786 patent; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Carrow CV—Susan Carrow CV; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; EC Guideline 2009; “Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use”; Revision 1 Published Jan. 12, 2009 (Dec. 1, 2009); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—EC Guideline 1998; “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Published Sep. 29, 1998 (Sep. 29, 1998); Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Soroka Glossary wrap; Illustrated Glossary of Packaging Terminology; second edition; publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Soroka Glossary ‘Bag’; Illustrated Glossary of Packaging Terminology, second edition; Walter Soroka; publication unknown.;;“Inter Partes Review Petition”, Exhibit—Encyclopedia Dictionary of Medicine, Nursing and Allied Health; Miller Keane, Seventh Edition.;;“Inter Partes Review Petition”, Exhibit—Dorland's Definition of Bag; Dorland's Illustrated Medical Dictionary; 31st Edition; Publication Date Unknown.;;“Inter Partes Review Petition”, Exhibit—Nursing Standard; Article in Learning Zone—Continue Professional Development; “Reducing the risks associated with urinary catheters”; Published Mar. 25, 2009.;;“Inter Partes Review Petition”, Exhibit—Websters Dictionary Definition of Dispose; Webster's Third New International Dictionary; Copyright 2003; publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Bard DFU; Bardex Infection Control Foley Tray; Copyright 2006, publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014.;;“Inter Partes Review Petition”, Exhibit—FDA Article; Guidance for the Content of Premarkt Notifications fro Conventional and Antimicrobial Foley Catheters; http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm080884.htm; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Bardex DFU; Directions for Use/Patient Education Information—Urology; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Mosby's Pocket Guide Excerpt; Mosby's Pocket Guide to Basic Skills and Procedures; Sixth Edition; Perry & Potter; “Urinary Catheter: Indwelling, Straight, Care and Removal”; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008.;;“Inter Partes Review Petition”, Exhibit—FAQs “Catheter-Associated Urinary Tract Infection”; Unknown Publisher; Unknown Publication Date.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,631,935”, Inter Partes Review Petition for U.S. Pat. No. 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for U.S. Pat. No. 8,678,190”, Inter Partes Review Petition for U.S. Pat. No. 8,678,190; Filed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Declaration of Susan Carrow for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Response to Office Action in U.S. Appl. No. 12/495,148; Application Filed Jun. 30, 2009; Response Filed Nov. 19, 2010.;;“Inter Partes Review Petition”, Exhibit—RCE Filed November May 31, 2011 for U.S. Appl. No. 12/495,148; Application Filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148; Application Filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010.;;“Inter Partes Review Petition”, Exhibit—Morning Start Article; “Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent”; Published Jan. 2011.;;“Inter Partes Review Petition”, Exhibit—Medical News Today Article; ‘Getting To Zero:’ Medlines' Erase Cauti Program Helps Hospitals Reduce Catheter Use by 20 Percent; Article Date Apr. 13, 2011.;;“Inter Partes Review Petition”, Exhibit—The Journal of Healthcare Contracting, Oct. 2012; “Catheter-associated urinary tract infections”.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; Mailed Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; Mailed Dec. 30, 2014.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,920, filed Apr. 30, 2014; dated Dec. 30, 2014.;;Gimenez Burgos, R “European Examination Report”, European Application No. 11 854 003.8-1659; Ref SJG/P128064EP00; dated Jan. 22, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EPO App No. 12 79 3939; Reference No. SJG/P130269EP00; dated Jan. 27, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EU App No. 12792423.1-1659/2713933; PCT/US2012039311; REference No. SJG/P130270EP00; dated Jan. 27, 2015.;;“Bard IPR Exhibit”, “Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935; Susan Carrow Declaration; Mailed Dec. 30, 2014.;;“Article 94(3) EPC Examination”, European Application No. 10 251 025.2-1501; Reference P112645EP00; dated Mar. 13, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/647,515, filed Dec. 27, 2009; dated Apr. 7, 2015.;;“Office Action”, Chinese Application No. 201180066491.4; dated Mar. 24, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,448,786; IPR2015-00509; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00511; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00513; Filed Apr. 21, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,678,190; Inter Partes Review No. IPR2015-00514; Filed Apr. 21, 2015.",ACTIVE
706,AU,A1,AU 2017/286140 A1,178-656-939-849-937,2018-12-20,2018,AU 2017/286140 A,2017-06-02,US 201715497203 A;;US 201662349029 P;;US 201615275203 A;;US 2017/0035601 W,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/178-656-939-849-937,Patent Application,no,0,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06,,0,0,,,,ACTIVE
707,US,B2,US 11844637 B2,180-466-055-861-345,2023-12-19,2023,US 201916681305 A,2019-11-12,US 201916681305 A;;US 2017/0054880 W;;US 201816123834 A;;US 201762554876 P,2017-09-06,Therapeutic radiation beam detector for radiation treatment systems,"A self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery and precision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table is provided. The radiation shield can include an axial shield rotatable about an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiation beams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,JENKINS CESARE;;ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH,ZAP SURGICAL SYSTEMS INC (2018-09-07),https://lens.org/180-466-055-861-345,Granted Patent,yes,182,1,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61B6/00;;A61B6/02;;A61B6/04;;A61B6/10;;A61B6/12;;A61N5/10,,12,0,,,"Bodduluri et al., “X-ray guided robotic radiosurgery for solid tumors”, Industrial Robot: An International Journal, vol. 29, No. 3, 2002, pp. 221-227.;;Dong et al., “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, 1995, pp. 1053-1060.;;Hissoiny et al., “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, physics.med-ph, Jan. 2011, 28 pp.;;Jung et al., “Flexible Gd2O2S:Tb scintillators pixelated with polyethylene microstructures for digital x-ray image sensors”, J. Micromech. Microeng. 19, 2009, 10pp.;;Lo et al., “Hardware acceleration of a Monte Carlo simulation for photodynamic treatment planning”, Journal of Biomedical Optics, vol. 14(1), Jan./Feb. 2009, pp. 014019-1 thru 014019-11.;;Mackie et al., “Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.”, Medical Physics 20, 1709 (1993); doi: 10.1118/1.596958, Jun. 4, 1998, 1709-1719.;;Osher et al., “Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising”, 2008, pp. 1-19.;;PCTUS2017/038256 International Search Report and Written Opinion dated Apr. 27, 2018, 20 pages.;;Ruchala et al., “Megavoltage CT image reconstruction during tomotherapy treatments”, Phys. Med. Biol. vol. 45, 2000, pp. 3545-3562.;;Schonberg, “The History of the Portable Linear Accelerator”, American Association for Physicists in Medicine, downloaded from the internet: https://www.aapm.org/meetings/2001AM/pdf/7221-68900.pdf, 2001, pp. 1-14.;;Weidlich et al., “Characterization of a Novel Revolving Radiation Collimator”, Cureus, vol. 10, No. 2, Feb. 2, 2018, pp. 1-9.;;Zaman et al., “Scintillating Balloon-Enabled Fiber-Optic System for Radionuclide Imaging of Atherosclerotic Plaques”, J Nucl Med 56(5), 2015, 771-777.",ACTIVE
708,JP,A,JP 2021168166 A,195-487-451-756-43X,2021-10-21,2021,JP 2021109365 A,2021-06-30,JP 2018562555 A;;US 201615275203 A;;US 201715497203 A;;US 201662349029 P,2016-06-12,CORRECTION OF SECURITY STATE USING PROTECTION RANGE DETECTION,"To provide a method for correcting a security state of a target device (for example, unlocking a device) by using a reliable device.SOLUTION: A method supports to establish connection between a target device 510 and a reliable device 520. A request 850 is transmitted to a proxy device 830 (801). The proxy device 830 transmits another request 855 to the device (802). The target device 510 and the reliable device 520 exchanges range data 860 as part of a range process (803). The target device 510 determines it to have been unlocked if the reliable device 520 is within an allowable range (804).SELECTED DRAWING: Figure 8",APPLE INC,WADE BENSON;;MARC J KROCHMAL;;ALEXANDER R LEDWITH;;JOHN IAROCCI;;JERROLD V HAUCK;;BROUWER MICHAEL;;MITCHELL D ADLER;;YANNICK L SIERRA,,https://lens.org/195-487-451-756-43X,Patent Application,no,4,1,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,G06F21/35;;G06F21/44,,0,0,,,,ACTIVE
709,KR,A,KR 20190003977 A,012-253-961-374-548,2019-01-10,2019,KR 20187034644 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;US 2017/0035601 W,2016-06-12,보안 범위 검출에 의한 보안 상태 수정,"본 발명의 일부 실시예들은 보안 레인징 동작(예를 들어, 거리, 근접도 등을 결정하는 것)에 기초하여 신뢰된(또는 발신자) 디바이스가 타겟 디바이스의 보안 상태를 수정(예컨대, 디바이스를 잠금해제)하기 위한 방법을 제공한다. 일부 실시예들의 방법은 신뢰된 디바이스가 타겟 디바이스의 보안 상태를 수정하도록 허용하기 전에 신뢰된 및 타겟 디바이스들이 서로의 특정 범위 내에 있는지 여부를 결정하기 위해, 레인징 동작의 일부로서 메시지들을 교환한다. 일부 실시예들에서, 메시지들은 공유 비밀에 기초하여 디바이스들 둘 모두에 의해 유도되고, 레인징 동작에 사용되는 레인징 신호들의 소스를 검증하는 데 사용된다. 일부 실시예들에서, 방법은 다수의 상이한 주파수 대역들을 사용하여 수행된다.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/012-253-961-374-548,Patent Application,no,4,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06;;G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04W12/04;;H04W12/06;;H04W12/08,,0,0,,,,ACTIVE
710,US,A1,US 2023/0300122 A1,055-898-695-883-857,2023-09-21,2023,US 202318107982 A,2023-02-09,US 202318107982 A;;US 201615275203 A;;US 201662349029 P,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/055-898-695-883-857,Patent Application,yes,0,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L9/40;;G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/086,,0,0,,,,PENDING
711,US,A1,US 2010/0307941 A1,126-657-239-957-708,2010-12-09,2010,US 84667510 A,2010-07-29,US 84667510 A;;US 49514809 A;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/126-657-239-957-708,Patent Application,yes,79,30,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B46/23,206/366;;206/364;;206/370,0,0,,,,ACTIVE
712,US,S,US D0609819 S,106-997-346-348-786,2010-02-09,2010,US 33802209 F,2009-06-03,US 33802209 F,2009-06-03,Medical tray,,MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,MEDLINE INDUSTRIES INC (2009-06-04),https://lens.org/106-997-346-348-786,Design Right,no,0,53,4,4,0,,,2401;;D24/227,0,0,,,,EXPIRED
713,US,S,US D0932649 S,056-899-570-126-773,2021-10-05,2021,US 201429479600 F,2014-01-17,US 201429479600 F;;US 201329444526 F;;US 38047410 F,2010-12-06,Medical tray,,MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,,https://lens.org/056-899-570-126-773,Design Right,no,264,5,2,2,0,,,2402;;D24/227,477,3,098-777-794-605-077;;008-481-422-937-006;;055-945-454-377-987,10.1056/nejmvcm0706671;;18385493;;10.1056/nejmvcm054648;;16723610;;10.1097/00000542-200701000-00013;;17197846,"Poon, Robert “Non-Final Office Action”, U.S. Appl. No. 12/495,148; filed Jun. 30, 2009: first inventor: Jennifer E. Tomes; dated: Aug. 4, 2010.;;Yuan, Minqiang “Non-Final Office Action”, Chinese Application No. 200920267201.2, dated Sep. 9, 2010.;;European Patent Office, “Extended EPO Search Report”, EPO Application No. 10251025.2, In the Name of Medline Industries, dated Sep. 29, 2010.;;Medline, “Medline Aritcle/Brochure”, Published 2008.;;Yuan, Minquiang “Non-Final Office Action”, Chinese Application No. 200920267201.2; dated Jun. 4, 2010.;;European Patent Office, “Extended EPO Search Report”, Application No. 10251024.5, In the Name of Medline Industries, dated Oct. 18, 2010.;;Examiner, Chinese Patent Office “First Office Action”, CN Application No. 201020219785.9; dated Nov. 18, 2010; Filed Jun. 3, 2010.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/495,148, filed Jun. 30, 2009, dated Mar. 3, 2011.;;Prange, Sharon M., “Response to First Office Action”, U.S. Appl. No. 12/004,796, filed Dec. 21, 2007; dated Oct. 28, 2009.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/362,279; filed May 21, 2010, dated Sep. 19, 2011.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 12/846,675; filed Jul. 29, 2010; dated Dec. 22, 2011.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/338,022; filed Jun. 3, 2009; dated Oct. 1, 2009.;;Cavanna, Mark “NonFinal Office Action”, U.S. Appl. No. 29/380,474; filed Dec. 26, 2012; dated Mar. 27, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 12/647,515; filed Dec. 2009; dated Jun. 28, 2012.;;Cavanna, Mark “Ex Parte Quayle Action”, U.S. Appl. No. 29/380,474; filed Dec. 6, 2010; dated Aug. 14, 2012.;;Poon, Robert “Restriction Requirement”, U.S. Appl. No. 12/647,515; filed Dec. 27, 2009; dated May 23, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2011/068193; filed Dec. 30, 2011; dated Aug. 22, 2012.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/846,675; filed Jul. 29, 2010; dated Sep. 26, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 13/374,509; filed Dec. 30, 2011; dated Oct. 2, 2012.;;Poon, Robert “NonFinal Office Action”, U.S. Appl. No. 13/153,300; filed Jun. 3, 2011; dated Oct. 1, 2012.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/495,148; filed Jun. 30, 2009; dated Oct. 4, 2012.;;Byun, Sung C., “PCT Search Report”, PCT/US2012/039311; Filed May 24, 2011; dated Oct. 25, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/155,026; filed Jun. 7, 2011; dated Nov. 30, 2012.;;Byun, Sung Cheal “PCT Search Report and Written Opinion”, PCT/US2012/037524; Filed May 11, 2012; dated Nov. 16, 2012.;;“EPO Intent to Grant”, EPO Application No. 10251024.5; Filed Jun. 2, 2010; dated Nov. 2, 2012.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 12/785,064; filed May 21, 2010; dated Feb. 1, 2013.;;Pass, Natalie “NonFinal OA”, U.S. Appl. No. 13/153,265; filed Jun. 3, 2011; dated Mar. 5, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,026; filed Jun. 7, 2011; dated Feb. 1, 2013.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 13/115,053; filed Jun. 7, 2011; dated May 9, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/647,515; filed Dec. 27, 2009; dated May 13, 2013.;;Hand, Melanie J., “Final OA”, U.S. Appl. No. 12/785,064; filed May 21, 2010; dated Jun. 5, 2013.;;Pass, Natalie “Final OA”, U.S. Appl. No. 13/153,265; filed Jun. 3, 2011; dated Jul. 12, 2013.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 12/495,148; filed Jun. 30, 2009; dated Jul. 31, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 13/374,509; filed Dec. 30, 2011; dated Aug. 6, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 13/153,300; filed Jun. 3, 2011; dated Aug. 6, 2013.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/846,675; filed Jul. 29, 2010; dated Sep. 10, 2013.;;Cavanna, Mark “Notice of Allowance”, U.S. Appl. No. 29/444,526; filed Jan. 31, 2013; dated Oct. 17, 2013.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/155,054; filed Jun. 7, 2011; dated Oct. 28, 2013.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 12/495,148; filed Jun. 30, 2009; dated Nov. 20, 2013.;;“Instructions”, Naming a character website. URL: <https://web.archive.org/web/20080410122058/http://www.wilihow.com/Make-Your-Own-Anime-or-Mange-Character>. 2008.Retreived from Internet Dec. 10, 2013.;;Naming Characters on Cards website. URL:<https://web.archive.org/web/20060219171403/http://www.hubbardscupboa.rd.org/brown_bear_brown_bear.html>. (2006) . . . Retrieved form Internet Dec. 11, 2013.;;Dictionary definition m-w. URL:<http://www.merriam-webster.com/dictionary/brave>. Retrieved fro Internet Dec. 10, 2013.;;Dictionary definition m-w. URL:<http://ww.merriam-webster.com/dictionary/reassure>. Retrieved from Internet Dec. 10, 2013.;;Lion King Sticker website. URL: <http://tlkobession.wuffpaws.org/OldSite/games/games2.html>. 1996 Retrieved from Internet Dec. 10, 2013.;;Lion Sticker Activity Book website. URL: <http://www.amazon.com/Disneys-Simbas-Pride-Sticker-Activity/dp/B0018DOJZA>. 1998 Retrieved from Internet Dec. 10, 2013.;;“Examiners Answer”, U.S. Appl. No. 13/153,265; filed Jun. 3, 2011; dated Dec. 17, 2013.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 12/647,515; filed Dec. 27, 2009; dated Dec. 18, 2013.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/846,675; filed Jul. 29, 2010; dated Dec. 18, 2013.;;“Extended EPO Exam Report”, EPO App No. 10251025.2; filed Jun. 2, 2010; dated Dec. 17, 2013.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 12/846,675; filed Jul. 29, 2010; dated Apr. 30, 2014.;;Gimenez Burgos, R “Extended European Search Report”, 11854003.8; Filed Dec. 30, 2011; dated Jun. 3, 2014.;;“Bardex I.C. Infection Control Foley Tray”, Bard Infection Control System; Bardex I.C. Directions for Use Infection Control Foley Tray; Copyright Dated 2006.;;“Bardex I.C. Complete Care StateLock Device 350 ml Urine Meter Foley Tray with Bacteriostatic Collection System”, Bard Infection Control System; Bardex I.C. Complete Care Directions for Use; Copyright Dated Sep. 2006.;;“Bardex I.C. Infection Control 350ml Urine Meter Foley Tray”, Bard Infection Control System; Bardex I.C. Urine Meter Foley Tray Directions for Use; Copyright Dated 2006.;;“Bard Medical Division Care & Catheterization Script”, Care & Catheterization/Preventing UTI Script for education video; Preventing UTI: Care and Catheterization Techniques; Copyright 2006; AV0512-06 R12/05 XXX.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR.2.3 Contentions—Initial Non—Infringement; Exhibits 1 and A-H; Dated Sep. 5, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries, Inc.'s Response to C.R. Bard's Initial Invalidity Contentions; Exhibits A-H; Dated Sep. 19, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-3618; Responses to Medline Industries, Inc.'s First set of Requests for the Production of Documents; Dated Sep. 26, 2014.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Response to Medline Industries, Inc.'s First Set of Interrogatories; Dated Sep. 26, 2014.;;“Publication”, European Commission: Pharmaceutical Committee “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Dated Sep. 29, 1998.;;“Bard Publication”, “A few important words about Catheter Care”; C.R. Bard, Inc; Copyright 2001 C.R. Bard, Inc.;;Dover Intermittent Catheter Tray—14 fr, Red Rubber; Website http://tinyurl.com/o4esrwh; Unknown Publication Date.;;“YouTube Training Video”, https://www.youtube.com/watch?v=ISBya_5cIM, “YouTube Training Video”, https://www.youtube.com/watch?v=YwqcRUP35nl&list=UUG7a6tFPh1wvF0QDMZ3DarQ.;;“NonFinal Office Action”, U.S. Appl. No. 13/680,902; filed Apr. 11, 2014; dated Dec. 2, 2014.;;“Inter Partes Review Petition for 8,448,786”, U.S. Pat. No. 8,448,786; Filed Dec. 30, 2014; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration 8,448,786 Patent; Dr. Robert M. Kimmel Declaration; Received Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Kimmel CV—Dr. Robert M. Kimmel; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Susan Carrow Declaration 8,448,786 patent; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; Carrow CV—Susan Carrow CV; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit; EC Guideline 2009; “Guideline on the Readability of the Labelling and Package Leaflet of Medicinal Products for Human Use”; Revision 1 Published Jan. 12, 2009 (Dec. 1, 2009); dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—EC Guideline 1998; “A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use”; Published Sep. 29, 1998 (Sep. 29, 1998); dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Soroka Glossary wrap; Illustrated Glossary of Packaging Terminology; second edition; publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Soroka Glossary ‘Bag’; Illustrated Glossary of Packaging Terminology, second edition; Walter Soroka; publication unknown.;;“Inter Partes Review Petition”, Exhibit—Encyclopedia Dictionary of Medicine, Nursing and Allied Health; Miller Keane, Seventh Edition.;;“Inter Partes Review Petition”, Exhibit—Dorland's Definition of Bag; Dorland's Illustrated Medical Dictionary; 31st Edition; Publication Date Unknown.;;“Inter Partes Review Petition”, Exhibit—Nursing Standard; Article in Learning Zone—Continue Professional Development; “Reducing the risks associated with urinary catheters”; Published Mar. 25, 2009.;;“Inter Partes Review Petition”, Exhibit—Websters Dictionary Definition of Dispose; Webster's Third New International Dictionary; Copyright 2003; publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Bard DFU; Bardex Infection Control Foley Tray; Copyright 2006, publication date unknown.;;“Inter Partes Review Petition”, Exhibit—Medline Initial Infringement Contentions; Medline Industries vs. C.R. Bard; Dated Aug. 22, 2014.;;“Inter Partes Review Petition”, Exhibit—FDA Article; Guidance for the Content of Premarkt Notifications fro Conventional and Antimicrobial Foley Catheters; http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm080884.htm; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Bardex DFU; Directions for Use/Patient Education Information—Urology; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Mosby's Pocket Guide Excerpt; Mosby's Pocket Guide to Basic Skills and Procedures; Sixth Edition; Perry & Potter; “Urinary Catheter: Indwelling, Straight, Care and Removal”; Unknown Publication Date.;;“Inter Partes Review Petition”, Exhibit—Health Protection Scotland; CAUTI Maintenance Bundel; Version 2, Feb. 2008.;;“Inter Partes Review Petition”, Exhibit—FAQs “Catheter-Associated Urinary Tract Infection”; Unknown Publisher; Unknown Publication Date.;;“Inter Partes Review Petition for 8,631,935”, Inter Partes Review Petition for 8,631,935 for claims 1-4 and 11-20; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for 8,631,935”, Inter Partes Review Petition for 8,631,935 for Claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Filed Dec. 30, 2014.;;“Inter Partes Review Petition for 8,678,190”, Inter Partes Review Petition for 8,678,190; Filed Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Declaration of Susan Carrow for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, Exhibit—Response to Office Action in U.S. Appl. No. 12/495,148; Application filed Jun. 30, 2009; Response Filed Nov. 19, 2010.;;“Inter Partes Review Petition”, Exhibit—RCE Filed November May 31, 2011 for U.S. Appl. No. 12/495,148; Application Filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Amendment filed on Apr. 3, 2013 for U.S. Appl. No. 12/495,148; Application filed Jun. 30, 2009.;;“Inter Partes Review Petition”, Exhibit—Infection Control Today Article; Medical Center Cuts Catheterizations by 21 Percent with Foley Catheter Management System; Published 2010.;;“Inter Partes Review Petition”, Exhibit—Morning Start Article; “Floyd Medical Center Reduces Catheter-Associated Urinary Tract Infections 83 Percent and Catheter Use by 23 Percent”; Published Jan. 2011.;;“Inter Partes Review Petition”, Exhibit—Medical News Today Article; ‘Getting to Zero:’ ‘Medlines’ Erase Cauti Program Helps Hospitals Reduce Catheter Use by 20 Percent; Article Date Apr. 13, 2011.;;“Inter Partes Review Petition”, Exhibit—The Journal of Healthcare Contracting, Oct. 2012; “Catheter-associated urinary tract infections”.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Declaration of Dr. Robert M. Kimmel; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935 claims 1-4 and 11-20; Susan Carrow Declaration; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,631,935 claims 7-8, 10, 21-23, 25, 27-28, and 30-34; Declaration of Dr. Robert M. Kimmel; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Kimmel Declaration for U.S. Pat. No. 8,768,190; Declaration of Dr. Robert M. Kimmel; dated Dec. 30, 2014.;;“Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,768,190; Declaration of Susan Carrow; dated Dec. 30, 2014.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,909; filed Apr. 30, 2014; dated Dec. 31, 2014.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,920; filed Apr. 30, 2014; dated Dec. 30, 2014.;;Gimenez Burgos, R “European Examination Report”, European Application No. 11 854 003.8-1659; Ref SJG/P128064EP00; dated Jan. 22, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EPO App No. 12 79 3939; Reference No. SJG/P130269EP00; dated Jan. 27, 2015.;;Gimenez Burgos, R “Extended European Search Report”, EU App No. 12792423.1-1659/2713933; PCT/US2012039311; REference No. SJG/P130270EP00; dated Jan. 27, 2015.;;“Bard IPR Exhibit”, “Inter Partes Review Petition”, IPR Exhibit—Carrow Declaration for U.S. Pat. No. 8,631,935; Susan Carrow Declaration; dated Dec. 30, 2014.;;“Article 94(3) EPC Examination”, European Application No. 10 251 025.2-1501; Reference P112645EP00; dated Mar. 13, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 12/647,515; filed Dec. 27, 2009; dated Apr. 7, 2015.;;“Office Action”, Chinese Application No. 201180066491.4; dated Mar. 24, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,448,786; IPR2015-00509; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,631,935; Inter Partes Review No. IPR2015-00511; Filed Apr. 22, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; Patent 8,631,935; Inter Partes Review No. IPR2015-00513; Filed Apr. 21, 2015.;;“Inter Partes Review—Patent Owner Response”, Inter Partes Review—Patent Owner Response; U.S. Pat. No. 8,678,190; Inter Partes Review No. IPR2015-00514; Filed Apr. 21, 2015.;;“IPR2015-00514 Decision Institution of Inter Partes Review”, IPR2015-00514; Patent 8,678,190; dated Jun. 26, 2015; Decision Institution of Inter Partes Review.;;“IPR2015-00509 Institution Decision”, IPR2015-00509; Patent No. 8,448,786; dated Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR 2015-00514 Petitioner's Request for Rehearing”, IPR 2015-00514 Petitioner's Request for Rehearing; Patent 8678,190; Dated Jul. 10, 2015.;;“IPR2015-00511 Institution Decision”, IPR2015-00511; Patent 8,631,935; Entered Jul. 15, 2015; Decision Denying Institution of Inter Partes Review.;;“IPR2015-00513 Institution Decision”, IPR2015-00513 Institution Decision; Patent 8,631,935; Entered Jul. 15, 2015; Decision Institution of Inter Partes Review.;;Hand, Melanie Jo “Final OA”, U.S. Appl. No. 13/860,902; filed Apr. 11, 2013; dated May 22, 2015.;;“IPR 2015-00514—Request for Rehearing Denied”, IPR2015-00514; Patent No. 8,678,190; Decision on Request for Rehearing—Denied; dated Jul. 16, 2015.;;“IPR 2015-00514—Patent Owner's Objection to Evidence”, IPR 2015-00514; Patent Owners Objection to Evidence Submitted During a Preliminary Proceeding; U.S. Pat. No. 8,678,190; dated Jul. 13, 2015.;;“IPR2015-00513—Patent Owner's Request for Adverse Judgement”, Patent No. 8,631,935; dated Jul. 23, 2015.;;“IPR0215-00513 Scheduling Order”, U.S. Pat. No. 8,631,935; dated Jul. 15, 2015.;;“IPR 2015-00514—Patent Owner's Request for Adverse Judgement”, Patent No. 8,678,190; dated Jul. 23, 2015.;;“IPR2015-00514—Scheduling Order”, U.S. Pat. No. 8,678,190; dated Jun. 26, 2015.;;“IPR2015-00514 Judgement—Termination of Proceeding”, Patent No. 8,678,190; dated Jul. 24, 2015.;;Hand, Melanie J., “Notice of Allowance”, U.S. Appl. No. 13/860,902; filed Apr. 11, 2013; dated Aug. 4, 2015.;;“IPR2015-00513—Request for Adverse Judgement”, IPR2015-00513—Request for Adverse Judgement; Granted—Proceedings Terminated; Patent No. 8,631,935; Entered Aug. 11, 2015.;;“Australian First Exam Report”, AU Patent Application No. 2011351971; Patent Examination Report No. 1; dated Jul. 25, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 14/265,920; filed Apr. 30, 2014; dated Oct. 2, 2015.;;Poon, Robert “Final OA”, U.S. Appl. No. 14/265,909; filed Apr. 30, 2015; dated Oct. 5, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Notice of Medline Industries Inc's Motion to Dismiss C.R. Bard Inc's Inequitable Conduct Counterclaim and to strike affirmative defense for the '786 Patent; Filed Oct. 20, 2015.;;Medline Industries, Inc. vs C.R. Bard, Inc; No. 1:14-cv-03618; Medline Industries Inc's Opposition to C.R.Bard Inc's Motion for Leave to File Second Amended Answer to Add Counterclaim; Filed Oct. 20, 2015.;;Chinese Application No: 201280035240.4; Filed May 24, 2012; dated Aug. 18, 2015.;;Hand, Melanie J., “NonFinal OA”, U.S. Appl. No. 14/165,044; filed Jan. 27, 2014; dated Oct. 26, 2015.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/718,792; filed May 21, 2015; dated Nov. 19, 2015.;;Medline Industries vs. CR Bard, Inc; No. 14-cv-3618; C.R. Bard's LPR 3.1 Contentions; Filed Nov. 24, 2015.;;“Office Action Received”, Chinese App No. 201280035246.1; NonFinal OA; dated Sep. 16, 2015.;;Poon, Robert “Final Office Action”, U.S. Appl. No. 14/718,912; filed May 21, 2015; dated Jan. 5, 2016.;;“Office Action”, Chinese Application No. 201180066491.4; dated Nov. 11, 2015.;;Poon, Robert “Notice of Allowance”, U.S. Appl. No. 14/718,792; filed May 21, 2015; dated Feb. 2, 2016.;;“Office Action”, Australian Application No. 2011351971; Reference No. 35204298/GP; dated Feb. 18, 2016.;;EP Application No. 10251025.2-1501; Reference P112645EP00; dated Feb. 18, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc; C.R. Bard's LPR 3.1 Contentions; Civil Action No. 1:16-cs-3529; Judge Sharon Johnson Coleman; Filed Aug. 26, 2016.;;“Medline Catalog”, Turkel Safety Thoracentesis Procedure Trays by Covidien; http://www.medline.com/jump/sku/x/MDPKDL566059; Unknown Publication date but believed to be prior to present application filing date.;;“Medline Catalog”, Turkel Safety Thoracentesis Procedure Trays by Covidien; 5″; http://www.medline.com/sku/item/MDPKDL566075; Unknown Publication date but believed to be prior to present application filing date.;;“Medline Catalog”, Paracentesis Trays by Covidien; http://www.medline.com/sku/item/MDPSWD568006; Unknown Publication Date but believed to be prior to filing of present application.;;“Medline Catalog”, Argyle Turkel Safety Thoracentesis System by Covidien; http://www.medline.com/sku/item/MDPKDL5014; Unknown Publication Date but believe to be prior to filing of present application.;;“Medline Catalog”, Argyle Trocar Catheter Kits by Covidien; http://www.medline.com/sku/item/MDPSWD565028; Unknown Publication Date but believed to be prior to filing of present application.;;“Medline Catalog”, Paracentesis Trays by Halyard Health; http://www.medline.com/sku/item/MDPBAA61450; Unknown Publication Date but believed to be prior to filing of present application.;;“Medline Catalog”, Safe-T Thoracentesis/Paracentesis Tray by Carefusion; http://www.medline.com/sku/item/MDPBXTTPT10005P; Unknown publication date but believed to be prior to filing of present application.;;“Medline Catalog”, Thoracentesis Trays by Carefusion; http://www.medline.com/sku/item/MDPBXTPIG1280K; Unknown publication date but believed to be prior to filing of present application.;;“Medline Catalog”, Argyle Turkel Safety Thoracentesis System by Covidien; 6″; http://www.medline.com/sku/item/MDPKDL5016; Unknown Publication Date but believed to be prior to filing of present application.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 13/860,902; filed Apr. 11, 2013; dated Sep. 14, 2016.;;Poon, Robert “NonFinal OA”, U.S. Appl. No. 14/265,909; filed Apr. 30, 2014; dated Sep. 12, 2016.;;Vasat, Peter “Notice of Allowance”, U.S. Appl. No. 12/785,064; filed May 21, 2010; dated Sep. 12, 2016.;;Poon, Robert “Appeal Decision”, U.S. Appl. No. 13/374,509; filed Dec. 30, 2011; dated Oct. 24, 2016.;;Long, Fonya M “Appeal Decision”, U.S. Appl. No. 13/154,265; filed Jun. 3, 2011; dated Oct. 6, 2016.;;Poon, Robert “Appeal Decision”, U.S. Appl. No. 13/153,300; filed Jun. 3, 2011; dated Oct. 12, 2016.;;Marcetich, Adam “Notice of Allowance”, U.S. Appl. No. 13/860,902; filed Apr. 11, 2013; dated Nov. 8, 2016.;;Schultz, Ottmar “Extended European Search Report”, EP Application No. 161779038-1501; Filed Jun. 30, 2009; dated Oct. 27, 2016.;;Hand, Melanie J., “NonFinal 0A”, U.S. Appl. No. 13/860,902; filed Apr. 11, 2013; dated Apr. 1, 2016.;;“Office Action”, Chinese Application No. 201280035246.1; Filed May 11, 2012; Reference No. 10055U CIP5 CN; dated Nov. 28, 2016.;;“Third Office Action”, Chinese Application No. 201280035240.4; dated Apr. 1, 2017.;;Gilligan, C. Luke , “Notice of Allowance”, U.S. Appl. No. 13/153,265; filed Jun. 3, 2011; dated Jun. 15, 2017.;;MacKenzie, Kristian , “Office Action”, Canadian Application No. 2,705,647; Ref No. 15486-P37235CA00 10055U CA; dated Feb. 10, 2017.;;MacKenzie, Kristian , “Office Action”, Canadian Application No. 2,705,670; dated Feb. 10, 2017.;;Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 14/165,044; filed Jan. 27, 2014; dated Feb. 28, 2017.;;Marcetich, Adam , “Notice of Allowance”, U.S. Appl. No. 14/793,455; filed Jul. 7, 2015; dated Jul. 20, 2017.;;Marcitech, Adam , “NonFinal OA”, U.S. Appl. No. 14/793,455; filed Jul. 7, 2015; dated May 3, 2017.;;Poon, Robert , “Final OA”, U.S. Appl. No. 14/265,909; filed Apr. 30, 2014; dated Jan. 10, 2017.;;Poon, Robert , “Final OA”, U.S. Appl. No. 15/067,903; filed Mar. 11, 2016; dated Jan. 13, 2017.;;Poon, Robert , “Non-Final OA”, U.S. Appl. No. 14/265,909; filed Apr. 30, 2014; dated Aug. 24, 2017.;;Poon, Robert ,“Notice of allowance”, U.S. Appl. No. 15/067,903; filed Mar. 11, 2016; dated Aug. 23, 2017.;;Pothier, Andrew , “Office Action”, Canadian Application No. 2,822,905; Reference No. 15468-P44352CA00; dated May 1, 2017.;;Medline Industries Inc vs C.R Bard. Inc., Exhibit G to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit 1 to Declaration of Karl L. Leinsing in Support of Bard's Rebuttal on Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 12, 2018.;;Medline Industries Inc vs C.R Bard, Inc.. Exhibit A lo Declaration of Bnan Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief; Civil Action No. t:14-cv-03618: Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc: Exhibit F to C.R. Bard's LPR 2.3 Contentions; Civil Action No. 1.17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit 4 to Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc., Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Claim Construction Brief; Civil Action No. 1.16-cv-03529; Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R Bard. Inc.. Exhibit 3 to Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman. Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit C to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 116-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard. Inc.; Exhibit F to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R. Bard, Inc.; Exhibit E to Declaration of Nicole Smith in Support of Bard Reply lo Claim Construction Brief; Civil Action No. 1.16-cv-03529. Judge Sharon Johnson Coleman. Filed Jan. 12, 2018.;;Medline Industries Inc. vs C.R. Bard, Inc., Exhibit A (List of Invalidating Prior Art) to C R. Bard's LPR 2 3 Contentions; Civil Action No. t:17-cv-7216; Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc., vs C R. Bard, Inc; Exhibit E to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc., vs C.R Bard, Inc.; Exhibit A to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee: Filed Jun. 4, 2016.;;Medline Industries Inc., vs C R. Bard, Inc; C.R Bard's LPR 2 3 Contentions; Civil Action No. 1:17-cv-7216, Judge Sara L. Ellis; Filed Jan. 16, 2018.;;Medline Industries Inc., vs C R. Bard, Inc; Declaration of Nicole M Smith in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc., vs C R. Bard, Inc; Exhibit B to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv7216; Judge Sara L. Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc., vs C R. Bard, Inc; Exhibit D to Declaration of Dylan Raife in Support of Motion for Leave to Add Counterclaims; Civil Action No. 1:17-cv-7216; Judge Sara L. Ellis: Filed Feb. 27, 2018.;;Medline Industries Inc., vs C.R Bard, Inc.; Exhibit G to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z, Lee; Filed Jun. 4, 2016.;;Medline Industries Inc., vs C.R Bard, Inc.; Exhibit H to Declaration of Nicole M. Smith; Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jun. 4, 2016.;;Medline Industries Inc., vs C R. Bard, inc; Exhibit A- C R. Bards Second Amended Answer to Second Amended Complaint: Civil Action No. 1:!7-cv-7216; Judge Sara L Ellis; Filed Feb. 27, 2018.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Barbara Weintraub re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 22, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 17, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 1 to Declaration ofRichard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 2 lo Declaration of Richard Meyst re Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit 7 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1;16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit A to Declaration of Kevin A. Lake. Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit B to Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529: Judge Sharon Johnson Coleman: Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief, Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit F to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc., Exhibit H to Declaration of Kevin A. Lake; Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Bard Opening Claim Construction Brief; Civil Action No. 1″ 16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Declaration of Dylan J Raife in Support of Bard's Reply Claim Construction Brief: Civil Action No. 1:14-cv-03518; Judge John Z. Lee; Filed Aug. 15, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 1 to Declaration of Dylan J. Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Nov. 11, 2016.;;Medline Industries Inc vs C.R Bard, Inc.. Exhibit 10 to Declaration of Richard Meyst Regarding Claim Construction: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Jul. 8, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit 2 to Declaration of Brian Eutermoser in Support of Medline Surrepiy: Civil Action No. 1:14-cv-03618; Judge John Z. Lee; Filed Sep. 7, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit C to Declaration of Dylan J Raife in Support of Bard Opening Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman: Filed Nov. 11, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit E to Declaration of Nicole Smith in Support of Bard Reply to Medline Claim Construction Brief; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Jan. 27, 2017.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit Ito Declaration of Brian Eutermoser in Support of Medline Response to Bard Opening Claim Construction; Civil Action No. 1:16-cv-03529; Judge Sharon Johnson Coleman; Filed Dec. 9, 2016.;;Medline Industries Inc. vs C.R Bard, Inc.. Exhibit i to Declaration of Nicole M. Smith, Civil Action No. 1:14-cv-03618: Judge John Z. Lee; Filed Jun. 4, 2016. et al.",ACTIVE
714,CN,A,CN 115738106 A,089-471-374-916-014,2023-03-07,2023,CN 202211503859 A,2017-10-03,US 201762554876 P;;CN 201780001150 A;;US 2017/0054880 W,2017-09-06,Self-shielding integrated control radiosurgical system,"A self-shielding and computer-controlled system for performing non-invasive stereotactic radiosurgery and precise radiotherapy using a linear accelerator mounted within a two degree of freedom radiation shield coupled to a three degree of freedom patient table is provided. The radiation shield may include an axial shield rotatable about an axial axis and a tilt shield independently rotatable about a tilt axis, thereby providing an improved range of trajectories for therapeutic and diagnostic radiation beams. Such shields may be balanced about their corresponding axes of rotation and about a common support structure in order to facilitate easy movement. Such a system may further include an imaging system for accurately delivering radiation to a therapeutic target and automatically making corrections required to maintain the anatomical target at a system isodepth point. Various subsystems are also provided for automating the controlled and coordinated movement of the movable shield member and the operation of the treatment-related subsystems in order to optimize performance and ensure safety.",ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RICHARD;;ADLER JOHN;;BIRANG MOHIT;;BODDULURI RADHIKA MOHAN;;ZHANG HONG;;T MCDERMOTT;;LI CHONG;;SONAVALLI KRISHNA;;C JENKINS,,https://lens.org/089-471-374-916-014,Patent Application,no,0,0,6,15,0,A61B6/10;;G21F7/06;;A61N5/1048;;A61N2005/1061;;A61N2005/1094;;A61N5/107;;A61N5/1049,A61N5/10,,0,0,,,,PENDING
715,EP,A1,EP 2258302 A1,157-389-776-363-928,2010-12-08,2010,EP 10251025 A,2010-06-02,US 18362909 P;;US 49514809 A,2009-06-03,"Catheter tray, packing system, and associated methods","A tray (100) for accommodating a coiled medical device, such as a catheter assembly (700), includes a first compartment (101), a second compartment (102), and a third compartment (103). The catheter assembly (700) and devices associated with a catheterization procedure, such as syringes (701,702) containing sterile water and lubricating jelly and a specimen container (703) can be disposed within the tray. A first barrier (105) and second barrier (106) separate the compartments. The barriers can have openings (121,122) therein to accommodate large syringes or to enable the first compartment (101) to be used as a lubricant applicator for the catheter. The first compartment (101) can include a stair-stepped contour (115) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray (100) in accordance with their order of use in the catheterization procedure.
",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,"MEDLINE INDUSTRIES, LP, NORTHFIELD, US (2023-07-18);;MEDLINE INDUSTRIES, LP; US (2023-06-16)",https://lens.org/157-389-776-363-928,Patent Application,yes,4,5,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61M25/00;;A61B46/23,,0,0,,,,ACTIVE
716,US,A1,US 2023/0404849 A1,136-991-580-674-767,2023-12-21,2023,US 202318242829 A,2023-09-06,US 202318242829 A;;US 202217835747 A;;US 201916258231 A;;US 201414265920 A;;US 84667510 A;;US 49514809 A;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, and Associated Mehtods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND LP,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/136-991-580-674-767,Patent Application,yes,0,0,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B46/23;;A61B50/30;;A61B50/33;;A61M25/00,,0,0,,,,PENDING
717,US,A1,US 2014/0231287 A1,171-754-757-066-119,2014-08-21,2014,US 201414265909 A,2014-04-30,US 201414265909 A;;US 84667510 A;;US 18362909 P;;US 49514809 A,2009-06-03,"Catheter Tray, Packaging System, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,MEDLINE INDUSTRIES LP (2009-06-04),https://lens.org/171-754-757-066-119,Patent Application,yes,9,20,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61J1/00;;A61B46/23,206/364,0,0,,,,ACTIVE
718,US,A1,US 2010/0307942 A1,006-279-436-545-36X,2010-12-09,2010,US 49514809 A,2009-06-30,US 49514809 A;;US 18362909 P,2009-06-03,"Catheter Tray, Packaging System, and Associated Methods","A tray ( 100 ) for accommodating a coiled medical device, such as a catheter assembly ( 700 ), includes a first compartment ( 101 ), a second compartment ( 102 ), and a third compartment ( 103 ). The catheter assembly ( 700 ) and devices associated with a catheterization procedure, such as syringes ( 701,702 ) containing sterile water and lubricating jelly and a specimen container ( 703 ) can be disposed within the tray. A first barrier ( 105 ) and second barrier ( 106 ) separate the compartments. The barriers can have openings ( 121,122 ) therein to accommodate large syringes or to enable the first compartment ( 101 ) to be used as a lubricant applicator for the catheter. The first compartment ( 101 ) can include a stair-stepped contour ( 115 ) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray ( 100 ) in accordance with their order of use in the catheterization procedure.",TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,MEDLINE INDUSTRIES INC (2009-06-04),https://lens.org/006-279-436-545-36X,Patent Application,yes,99,48,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B19/02;;A61B46/23;;B65B7/28;;B65D6/04,206/370;;206/561;;53/467,0,0,,,,ACTIVE
719,US,A1,US 2021/0369217 A1,109-129-911-214-502,2021-12-02,2021,US 202117398798 A,2021-08-10,US 202117398798 A;;US 2017/0054880 W;;US 201916681305 A;;US 201816123834 A;;US 201762554876 P,2017-09-06,Imaging Systems and Methods for Image-Guided Radiosurgery,"A self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery and precision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table is provided. The radiation shield can include an axial shield rotatable about an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiation beams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,ZAP SURGICAL SYSTEMS INC (2018-09-07),https://lens.org/109-129-911-214-502,Patent Application,yes,1,0,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61B6/10;;A61B6/00;;A61B6/02;;A61B6/04;;A61B6/12;;A61N5/10,,0,0,,,,PENDING
720,US,S,US D0636894 S,104-852-072-168-488,2011-04-26,2011,US 36680810 F,2010-07-29,US 36680810 F;;US 36227910 F;;US 35278309 F;;US 33802209 F,2009-06-03,Medical tray,,MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN HENRY,,https://lens.org/104-852-072-168-488,Design Right,no,0,33,4,4,0,,,2401;;D24/227,0,0,,,,ACTIVE
721,AU,B2,AU 2017/286140 B2,155-727-953-751-339,2020-10-22,2020,AU 2017/286140 A,2017-06-02,US 201715497203 A;;US 201662349029 P;;US 201615275203 A;;US 2017/0035601 W,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/155-727-953-751-339,Granted Patent,no,2,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06,,0,0,,,,ACTIVE
722,CN,A,CN 109196840 A,192-989-819-680-359,2019-01-11,2019,CN 201780033185 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to determine whether the trusted and target devices arewithin a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/192-989-819-680-359,Patent Application,no,6,6,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L29/06,,0,0,,,,DISCONTINUED
723,EP,A4,EP 3678736 A4,009-829-427-803-710,2021-06-09,2021,EP 17924466 A,2017-10-03,US 201762554876 P;;US 2017/0054880 W,2017-09-06,"SELF-SHIELDED, INTEGRATED-CONTROL RADIOSURGERY SYSTEM",,ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,,https://lens.org/009-829-427-803-710,Search Report,no,0,0,6,15,0,A61B6/10;;G21F7/06;;A61N5/1048;;A61N2005/1061;;A61N2005/1094;;A61N5/107;;A61N5/1049,G21F7/06;;A61B6/10;;A61N5/10,,1,0,,,No further relevant documents disclosed,PENDING
724,CN,A,CN 108325093 A,008-859-893-261-761,2018-07-27,2018,CN 201810186309 A,2018-03-07,US 201762554876 P;;US 2017/0054880 W,2017-09-06,Self-shielded integrated-control radiosurgery system,"The disclosure relates to a self-shielded integrated-control radiosurgery system. Disclosed is a self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery andprecision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table. The radiation shield can include an axialshield rotatable abount an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiationbeams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,RADHIKA MOHAN BODDULURI;;RAYMOND WILBUR;;JOHN ADLER;;CHRIS LEE;;YOUNES ACHKIRE;;TOM MCDERMOTT;;MANOOCHER BIRANG;;CESARE JENKINS;;HUI ZHANG;;KAUSTUBH SONAWALE,,https://lens.org/008-859-893-261-761,Patent Application,no,10,3,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61N5/10,,0,0,,,,ACTIVE
725,EP,A2,EP 4284046 A2,059-798-346-427-084,2023-11-29,2023,EP 23202648 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;EP 17731348 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"There is provided a method comprising announcing, by a proxy device (830), an availability of a trusted device (520); in response to the announced availability, receiving, by the proxy device (830), a first request (850) from a target device (510); and upon receiving the first request from the target device (510), sending, by the proxy device (830), a second request to the trusted device (520), wherein the second request (855) comprises a request for the trusted device (520) to announce its availability directly to the target device (510) from which the first request was received, and the trusted device (520) establishes a communication connection with the target device (510) based on the second request.
",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/059-798-346-427-084,Patent Application,yes,2,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04W12/086,,0,0,,,,PENDING
726,MX,A,MX 2010006100 A,079-051-398-977-766,2011-06-02,2011,MX 2010006100 A,2010-06-03,US 18362909 P;;US 49514809 A,2009-06-03,"CATHETER TRAY, PACKAGING SYSTEM, AND ASSOCIATED METHODS.","A tray (100) for accommodating a coiled medical device, such as a catheter assembly (700), includes a first compartment (101), a second compartment (102), and a third compartment (103). The catheter assembly (700) and devices associated with a catheterization procedure, such as syringes (701,702) containing sterile water and lubricating jelly and a specimen container (703) can be disposed within the tray. A first barrier (105) and second barrier (106) separate the compartments. The barriers can have openings (121,122) therein to accommodate large syringes or to enable the first compartment (101) to be used as a lubricant applicator for the catheter. The first compartment (101) can include a stair-stepped contour (115) such that the syringes are held at different depths to facilitate ease of use. The various devices can be disposed within the tray (100) in accordance with their order of use in the catheterization procedure.",MEDLINE IND INC,ADLER DEBORAH B;;SAVAGE ALBERTO C;;TOMES JENNIFER E;;WILSON EARL D;;MAZE JACK E;;CHUA KENNETH S;;KUTSCH JOHN H,,https://lens.org/079-051-398-977-766,Patent Application,no,0,0,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61B19/02;;A61B46/23,,0,0,,,,ACTIVE
727,EP,B1,EP 2258302 B1,118-069-654-183-526,2016-08-10,2016,EP 10251025 A,2010-06-02,US 18362909 P;;US 49514809 A,2009-06-03,"Catheter tray, packing system, and associated methods",,MEDLINE IND INC,TOMES JENNIFER E;;ADLER DEBORAH B;;MAZE JACK E;;SAVAGE ALBERTO C;;CHUA KENNETH S;;WILSON EARL D;;KUTSCH JOHN H,"MEDLINE INDUSTRIES, LP, NORTHFIELD, US (2023-07-18);;MEDLINE INDUSTRIES, LP; US (2023-06-16)",https://lens.org/118-069-654-183-526,Granted Patent,yes,3,0,20,95,0,A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61M25/00;;A61M25/002;;A61B2050/3015;;A61B50/30;;A61B50/33;;A61B2050/3008;;A61B42/00;;A61B46/00;;A61J1/00,A61M25/00;;A61B46/23,,0,0,,,,ACTIVE
728,US,A1,US 2019/0069856 A1,003-535-346-578-281,2019-03-07,2019,US 201816123834 A,2018-09-06,US 201816123834 A;;US 2017/0054880 W;;US 201762554876 P,2017-09-06,"SELF-SHIELDED, INTEGRATED-CONTROL RADIOSURGERY SYSTEM","A self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery and precision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table is provided. The radiation shield can include an axial shield rotatable about an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiation beams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,ZAP SURGICAL SYSTEMS INC (2018-09-07),https://lens.org/003-535-346-578-281,Patent Application,yes,0,12,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61B6/10;;A61B6/00;;A61B6/04;;A61N5/10,,0,0,,,,ACTIVE
729,JP,A,JP 2009193584 A,017-574-990-085-787,2009-08-27,2009,JP 2009031981 A,2009-02-13,US 2823308 P;;US 36868909 A,2008-02-13,DETERMINING WORDS RELATED TO WORD SET,"<P>PROBLEM TO BE SOLVED: To solve the problem that it is difficult for data corpus to hold a large amount of information and find related information. <P>SOLUTION: In one embodiment, a user entry window of a graphical user interface is displayed. Search terms input into the user entry window is received to initiate a first search. One or more first search results from a corpus of documents are determined based on the search terms. Search terms are displayed at a current search term window of the graphical user interface. The first search result is displayed at the search result window of the graphical user interface. The first search suggestions is displayed at a search suggestion window of the graphical user interface. <P>COPYRIGHT: (C)2009,JPO&INPIT",FUJITSU LTD,MARVIT DAVID L;;LABROU YANNIS;;JAIN JAWAHAR;;STERGIOU STERGIOS;;GILMAN ALEX;;BALAKRISHNAN RAJALAKSHMI;;ADLER B THOMAS;;SIDOROWICH JOHN J;;REINHARDT ALBERT,,https://lens.org/017-574-990-085-787,Patent Application,no,10,8,6,8,0,G06F16/3322;;G06F16/3322,G06F17/30,,2,0,,,"JPN6013008026; 梶 博行 他: 'コーパス対応の関連シソーラスナビゲーション' 情報処理学会研究報告 ９９-ＤＢＳ-１１８ ９９-ＦＩ-５４ 第９９巻 第３９号, 19990517, ｐｐ．９７-１０４, 社団法人情報処理学会;;CSNG200001287013; 梶 博行 他: 'コーパス対応の関連シソーラスナビゲーション' 情報処理学会研究報告 ９９-ＤＢＳ-１１８ ９９-ＦＩ-５４ 第９９巻 第３９号, 19990517, ｐｐ．９７-１０４, 社団法人情報処理学会",ACTIVE
730,CN,A,CN 116094831 A,139-370-941-476-254,2023-05-09,2023,CN 202310126438 A,2017-06-02,US 201662349029 P;;US 201615275203 A;;US 201715497203 A;;CN 201780033185 A;;US 2017/0035601 W,2016-06-12,MODIFYING SECURITY STATE BY,"The invention relates to modifying a security state through security range detection. Some embodiments of the present invention provide for a trusted (or initiator) device a method of modifying the secure state of a target device (e.g., unlocking the device) based on secure ranging operations (e.g., determining distance, proximity, etc. The methods of some embodiments exchange messages as part of ranging operations to determine whether the trusted device and the target device are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the message is derived by two devices based on a shared secret and is used to validate the ranging signal source for the ranging operation. In some embodiments, the method is performed using a plurality of different frequency bands.",APPLE INC,BENSON WILLY;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,,https://lens.org/139-370-941-476-254,Patent Application,no,0,0,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,H04L9/40;;G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086,,0,0,,,,PENDING
731,US,B2,US 11582215 B2,160-682-040-806-969,2023-02-14,2023,US 201615275203 A,2016-09-23,US 201615275203 A;;US 201662349029 P,2016-06-12,Modifying security state with secured range detection,"Some embodiments of the invention provide a method for a trusted (or originator) device to modify the security state of a target device (e.g., unlocking the device) based on a securing ranging operation (e.g., determining a distance, proximity, etc.). The method of some embodiments exchanges messages as a part of a ranging operation in order to determine whether the trusted and target devices are within a specified range of each other before allowing the trusted device to modify the security state of the target device. In some embodiments, the messages are derived by both devices based on a shared secret and are used to verify the source of ranging signals used for the ranging operation. In some embodiments, the method is performed using multiple different frequency bands.",APPLE INC,BENSON WADE;;KROCHMAL MARC J;;LEDWITH ALEXANDER R;;IAROCCI JOHN;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L,APPLE INC (1997-06-20),https://lens.org/160-682-040-806-969,Granted Patent,yes,91,1,25,33,0,H04L63/0428;;H04L63/06;;H04L63/08;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04W12/04;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/08;;H04W12/086;;G06F9/44505;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/06;;H04W12/0431;;H04W12/041;;H04W12/086;;H04W8/005;;G06F9/44505;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/06;;H04L63/083;;H04L63/107;;H04L63/108;;H04L63/1466;;H04W12/06;;H04W12/08;;H04L2209/80;;H04L63/08;;H04L63/107;;H04L63/1466;;H04W12/041;;H04W12/086;;H04W12/0431;;G06F9/44505;;H04L63/06;;H04L63/083;;H04W12/06;;H04L9/0822;;H04L9/085;;H04L9/0894;;H04L9/14;;H04L9/3226;;H04L63/0428;;H04L63/108;;H04L2209/80,G06F7/04;;G06F9/445;;H04L9/08;;H04L9/14;;H04L9/32;;H04L9/40;;H04W12/041;;H04W12/0431;;H04W12/06;;H04W12/086,,28,0,,,"International Search Report and Written Opinion of commonly owned International Patent Application PCT/US2017/035601, dated Oct. 18, 2017, 20 pages, International Searching Authority.;;Non-published commonly owned U.S. Appl. No. 15/497,203, filed Apr. 26, 2017, 62 pages, Apple Inc.;;Non-published commonly owned International Patent Application PCT/US2017/035601, filed Jun. 2, 2017, 62 pages, Apple Inc.;;Written Opinion of the International Preliminary Examining Authority from PCT/US2017/035601, dated May 8, 2018, 8 pages.;;SRP Documentation, retrieved from http://srp.stanford.edu/doc.html#standards, visited Apr. 3, 2018, 3 pages.;;Wu, “The Secure Remote Password Protocol,” retrieved from http://srp.stanford.edu/ndss.html, 1998, 24 pages.;;European Office Action from European Patent Application No. 17731348.3, dated Sep. 12, 2019, 7 pages.;;Australian Examination Report from Australian Patent Application No. 2017286140, dated Nov. 26, 2019, 4 pages.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Jan. 6, 2020, 14 pages including English language translation.;;Korean Office Action from Korean Patent Application No. 10-2018-7034644, dated Jan. 14, 2020, 10 pages including English language translation.;;Australian Notice of Acceptance from Australian Patent Application No. 2017286140, dated Oct. 12, 2020, 3 pages.;;Australian Examination Report from Australian Patent Application No. 2021200451, dated Sep. 28, 2021, 3 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Jul. 11, 2022, 23 pages including English language translation.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 25, 2021, 19 pages including English language translation.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Jun. 3, 2021, 23 pages including machine-generated English language translation.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 27, 2020, 26 pages including English language translation.;;Chinese Office Action from Chinese Patent Application No. 202080028656.8, dated Jun. 9, 2022, 21 pages including machine-generated English language translation.;;European Office Action from European Patent Application No. 17731348.3, dated Mar. 2, 2020, 6 pages.;;European Office Action from European Patent Application No. 17731348.3, dated Jul. 2, 2021, 5 pages.;;Invitation to Pay Additional Fees from PCT/US2020/028549, dated Jul. 10, 2020, 13 pages.;;International Search Report and Written Opinion from PCT/US2020/028549, dated Aug. 31, 2020, 18 pages.;;International Search Report and Written Opinion from PCT/US2020/028549, dated Oct. 20, 2020, 19 pages.;;Japanese Notice of Allowance from Japanese Patent Application No. 2018-562555, dated May 31, 2021, 5 pages including English language translation.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Sep. 25, 2020, 5 pages including English language translation.;;Korean Office Action from Korean Patent Application No. 2018-7034644, dated Nov. 26, 2020, 9 pages including English language translation.;;Korean Notice of Allowance from Korean Patent Application No. 10-2018-7034644, dated May 31, 2021, 5 pages including English language translation.;;Japanese Office Action from Japanese Patent Application No. 2021-109365, dated Sep. 2, 2022, 4 pages including English language translation.;;Chinese Board Decision from 201780033185.8, dated Nov. 7, 2022, 16 pages with partial English language translation.",ACTIVE
732,US,B2,US 10499861 B2,179-507-598-145-727,2019-12-10,2019,US 201816123834 A,2018-09-06,US 201816123834 A;;US 2017/0054880 W;;US 201762554876 P,2017-09-06,"Self-shielded, integrated-control radiosurgery system","A self-shielded and computer controlled system for performing non-invasive stereotactic radiosurgery and precision radiotherapy using a linear accelerator mounted within a two degree-of-freedom radiation shield coupled to a three-degree of freedom patient table is provided. The radiation shield can include an axial shield rotatable about an axial axis and an oblique shield independently rotatable about an oblique axis, thereby providing improved range of trajectories of the therapeutic and diagnostic radiation beams. Such shields can be balanced about their respective axes of rotation and about a common support structure to facilitate ease of movement. Such systems can further include an imaging system to accurately deliver radiation to the treatment target and automatically make corrections needed to maintain the anatomical target at the system isocenter. Various subsystems to automate controlled and coordinated movement of the movable shield components and operation of the treatment related subsystems to optimize performance and ensure safety are also provided.",ZAP SURGICAL SYSTEMS INC,ACHKIRE YOUNES;;WILBUR RAYMOND;;ADLER JOHN;;BIRANG MANOOCHER;;BODDULURI RADHIKA MOHAN;;ZHANG HUI;;MCDERMOTT TOM;;LEE CHRIS;;SONAWALE KAUSTUBH;;JENKINS CESARE,ZAP SURGICAL SYSTEMS INC (2018-09-07),https://lens.org/179-507-598-145-727,Granted Patent,yes,127,2,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61B6/10;;A61B6/00;;A61B6/04;;A61N5/10,,12,9,062-298-666-510-335;;012-667-555-559-504;;034-891-604-485-05X;;014-120-520-883-13X;;001-579-699-735-942;;097-194-108-082-165;;023-034-676-931-826;;055-694-801-470-702;;036-671-788-803-785,10.1016/0360-3016(95)02082-9;;7493831;;21452713;;10.1118/1.3539725;;10.1117/1.3080134;;19256707;;10.21236/ada497867;;pmc4638225;;10.2967/jnumed.114.153239;;25858046;;10.7759/cureus.2146;;29632755;;pmc5880589;;8309444;;10.1118/1.596958;;10.1088/0031-9155/45/12/303;;11131183;;10.1108/01439910210425504,"International Search Report dated Apr. 27, 2018.;;Dong et al., “An Image Correlation Procedure for Digitally Reconstructed Radiographs and Electronic Portal Images”, Int. J. Radiation Oncology Biol. Phys., vol. 33, No. 5, 1995, pp. 1053-1060.;;Hissoiny et al., “GPUMCD: a new GPU-Oriented Monte Carlo dose calculation platform”, physics.med-ph, Jan. 2011, 28 pp.;;Jung et al., “Flexible Gd2O2S:Tb scintillators pixelated with polyethylene microstructures for digital x-ray image sensors”, J. Micromech. Microeng. 19, 2009, 10pp.;;Lo et al., “Hardware acceleration of a Monte Carlo simulation for photodynamic treatment planning”, Journal of Biomedical Optics, vol. 14(1), Jan./Feb. 2009, pp. 014019-1 thru 014019-11.;;Osher et al., “Fast Linearized Bregman Iteration for Compressive Sensing and Sparse Denoising”, 2008, pp. 1-19.;;Zaman et al., “Scintillating Balloon-Enabled Fiber-Optic System for Radionuclide Imaging of Atherosclerotic Plaques”, J Nucl Med 56(5), 2015, pp. 771-777.;;Weidlich et al., “Characterization of a Novel Revolving Radiation Collimator”, Cureus, vol. 10, No. 2, Feb. 2, 2018, pp. 1-9.;;Mackie et al., “Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.”, Medical Physics 20, 1709 (1993); doi: 10.1118/1.596958, Jun. 4, 1998, pp. 1709-1719.;;Schonberg, “The History of the Portable Linear Accelerator”, American Association for Physicists in Medicine, downloaded from the internet: https://www.aapm.org/meetings/2001AM/pdf/7221-68900.pdf, 2001, pp. 1-14.;;Ruchala et al., “Megavoltage CT image reconstruction during tomotherapy treatments”, Phys. Med. Biol. vol. 45, 2000, pp. 3545-3562.;;Bodduluri et al., “X-ray guided robotic radiosurgery for solid tumors”, Industrial Robot: An International Journal, vol. 29, No. 3, 2002, pp. 221-227.",ACTIVE
733,CN,A,CN 113692584 A,187-111-419-720-159,2021-11-23,2021,CN 202080028656 A,2020-04-16,US 201916388831 A;;US 2020/0028549 W,2019-04-18,REMOTE INTERACTION WITH A DEVICE USING SECURE RANGE DETECTION,"In some embodiments, a first device performs ranging operations to allow a user to perform one or more operations on the first device without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account that is authorized to perform operations on the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the operations to be performed on the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the operation is authorized on the first device.",APPLE INC,LEDWITH ALEXANDER;;BENSON WADE;;KROCHMAL MARC J;;IAROCCI JOHN;;HAUCK JERROLD;;BROUWER MICHAEL;;ADLER MITCHELL;;SIERRA YANNICK;;L SIKOLA;;MARGARITOV JIRI,,https://lens.org/187-111-419-720-159,Patent Application,no,7,0,4,33,0,G06F21/57;;G06F21/44;;G06F21/316;;G06F21/606;;H04L63/107;;H04L63/0853;;H04W12/33;;H04W12/64;;H04W12/64;;H04W12/33,G06F21/57;;G06F21/31;;G06F21/44;;G06F21/60,,0,0,,,,DISCONTINUED
734,US,B2,US 10303329 B2,102-327-777-524-595,2019-05-28,2019,US 201615161645 A,2016-05-23,US 201615161645 A,2016-05-23,Display system for smart products,A display system and method of displaying media content on a display screen includes a processor that receives from an input device an indication that one of a plurality of vignettes has been selected. The selected vignette is accessed from a data store. Each vignette includes digital media content. The digital media content is instructed by the processor to be played on a display screen located behind a plurality of smart products that are on display. Each smart product is positioned relative to the display screen at a set location. The digital media content includes a sequence of frames of digital images including frames that produce a halo of light behind a smart product being described in the frames.,TARGET BRANDS INC,LASKOWITZ ADAM M;;ADLER PATRICIA S;;BARTON JACOB A;;ADKISSON NATHAN G;;HOPPE PAUL A;;ROCKEL PHILIPP;;RYAN JOHN D;;GUILLIN NICO,TARGET BRANDS INC (2016-05-16);;LOCAL PROJECTS LLC (2016-05-20),https://lens.org/102-327-777-524-595,Granted Patent,yes,14,0,4,4,0,G06F3/0482;;G06Q30/0643;;G06F3/0482;;G06F3/0487;;G06F3/0487;;G06F9/451;;G06F9/451;;G06Q30/0641;;H04L12/282;;H04L12/282,G06F3/0482;;G06F3/0487;;G06F9/451;;H04L12/28,,1,0,,,"Retail Merchandising Blog, “How to Create Customer Dreams in Your Store”, http://merchandisingblog.inspire.ca/how-to-create-customer-dreams-in-your-store/, at least as early as Feb. 18, 2016, 6 pages.",ACTIVE
735,CN,A,CN 108401421 A,076-755-615-449-836,2018-08-14,2018,CN 201780001150 A,2017-10-03,US 201762554876 P;;US 2017/0054880 W,2017-09-06,Self-Shielded integrated control radiosurgery system,"The invention provides a self-shielded and computer-controlled system for performing a non-invasive stereo directional radiosurgery and precise radiotherapy by using a linear accelerator. The linear accelerator is arranged in a dual-degree-of-freedom radiation shield piece coupled to a three-degree-of-freedom patient table. The radiation shield piece can include an axial shield piece rotatable about an axial axis and a tilt shield piece that is independently rotatable about a tilt axis, thereby providing an improved range of trajectories for treating and diagnosing a radiation beam. The shieldpieces can be balanced about its corresponding axis of rotation and a common support structure to facilitate easy movement. The self-shielded and computer-controlled system can further include an imaging system. The imaging system is used for authentically delivering radiation to a therapeutic target and automatically performing corrections required to maintain an anatomical target at a deep point, such as a system. Various subsystems are also provided for enabling the movable shield components to move in a controlled and coordinated manner and for operation automation of the subsystems related with treatment to optimize performance and ensure safety.",ZAP SURGICAL SYSTEMS INC,YOUNES ACHKIRE;;RAYMOND WILBUR;;JOHN R ADLER;;MANUSH BIRANG;;RADHIKA MOHAN BODDULURI;;HUI ZHANG;;T MCDERMOTT;;C LEE;;K SONAVALLI;;CESARE JENKINS,,https://lens.org/076-755-615-449-836,Patent Application,no,10,3,9,15,0,A61N5/103;;A61N5/1048;;A61N5/1081;;A61N5/1045;;A61N5/1077;;A61N2005/1095;;A61N2005/1094;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094;;A61B6/107;;A61B6/0421;;A61B6/4258;;A61B6/12;;A61B6/022;;A61B6/5235;;A61N2005/1061;;A61B6/0487;;A61B6/4258;;A61B6/022;;A61B6/12;;A61B6/0421;;A61B6/0487;;A61B6/0407;;A61B6/107;;A61B6/4241;;A61B6/5235;;A61B6/547;;A61N5/1042;;A61N5/1082;;A61N2005/1054;;A61N2005/1059;;A61N2005/1074;;A61N2005/1094,A61N5/10,,0,0,,,,ACTIVE
736,US,A1,US 2019/0250774 A1,009-137-567-813-542,2019-08-15,2019,US 201916378854 A,2019-04-09,US 201916378854 A;;US 201615161645 A,2016-05-23,DISPLAY SYSTEM FOR SMART PRODUCTS,"A display system includes a plurality of smart products arranged in a physical display setting in a retail store and being available for purchased by a customer, a display screen located behind the plurality of smart products, an input device and a controller coupled to the input device and to the display screen. The controller is configured to receive an indication from the input device to instruct digital media content to be displayed on the display screen. The digital media content includes a sequence of frames of digital images that describe information related to functional features of at least a first smart product and a second smart product on physical display in front of the display screen including the functional features of how the first smart product is interconnected to the second smart product so that the first smart product prompts the second smart product to perform a function.",TARGET BRANDS INC,LASKOWITZ ADAM M;;ADLER PATRICIA S;;BARTON JACOB A;;ADKISSON NATHAN G;;HOPPE PAUL A;;ROCKEL PHILIPP;;RYAN JOHN D;;GUILLIN NICO,,https://lens.org/009-137-567-813-542,Patent Application,yes,0,0,4,4,0,G06F3/0482;;G06Q30/0643;;G06F3/0482;;G06F3/0487;;G06F3/0487;;G06F9/451;;G06F9/451;;G06Q30/0641;;H04L12/282;;H04L12/282,G06F3/0482;;G06F3/0487;;G06F9/451;;H04L12/28,,0,0,,,,ACTIVE
737,US,B2,US 10937085 B2,178-761-247-698-255,2021-03-02,2021,US 201916378854 A,2019-04-09,US 201916378854 A;;US 201615161645 A,2016-05-23,Display system for smart products,"A display system includes a plurality of smart products arranged in a physical display setting in a retail store and being available for purchased by a customer, a display screen located behind the plurality of smart products, an input device and a controller coupled to the input device and to the display screen. The controller is configured to receive an indication from the input device to instruct digital media content to be displayed on the display screen. The digital media content includes a sequence of frames of digital images that describe information related to functional features of at least a first smart product and a second smart product on physical display in front of the display screen including the functional features of how the first smart product is interconnected to the second smart product so that the first smart product prompts the second smart product to perform a function.",TARGET BRANDS INC,LASKOWITZ ADAM M;;ADLER PATRICIA S;;BARTON JACOB A;;ADKISSON NATHAN G;;HOPPE PAUL A;;ROCKEL PHILIPP;;RYAN JOHN D;;GUILLIN NICO,,https://lens.org/178-761-247-698-255,Granted Patent,yes,15,0,4,4,0,G06F3/0482;;G06Q30/0643;;G06F3/0482;;G06F3/0487;;G06F3/0487;;G06F9/451;;G06F9/451;;G06Q30/0641;;H04L12/282;;H04L12/282,G06Q30/06;;G06F3/0482;;G06F3/0487;;G06F9/451;;H04L12/28,,4,0,,,"Michael Wittwer, Travel Map Animation [Free After Effects Template], Sep. 6, 2014, captured image from https://www.youtube.com/watch?v=rs8Djcf8NAU, 1 page (Year: 2014).;;PieterExplainsTech, How Network Address Translation Works, a YouTube video captured at https://www.youtube.com/watch?v=QBqPzHEDzvo, Dec. 4, 2012, 11 pages (Year: 2012).;;Heather Kelly, Helping ‘smart’ devices talk to each other, Mar. 28, 2014, CNN, 5 pages (Year: 2014).;;Retail Merchandising Blog, “How to Create Customer Dreams in Your Store”, http://merchandisingblog.inspire.ca/how-to-create-customer-dreams-in-your-store/, at least as early as Feb. 18, 2016, 6 pages.",ACTIVE
738,WO,A1,WO 2021/223038 A1,122-742-695-975-249,2021-11-11,2021,CA 2021050649 W,2021-05-10,US 202063022196 P;;US 202063092177 P,2020-05-08,METHOD AND SYSTEM FOR ELECTRICAL IMPEDANCE TOMOGRAPHY,"A system for electrical impedance tomography (EIT) includes an EIT backend.The EIT backend includes a processor configured to execute instructions for obtaining a frame of EIT impedance measurements, and reconstructing an EIT image from the frame of EIT impedance measurements.",TOMA JONATHAN EMANUEL;;PALLOPSON CHAD MICHAEL JOHN;;SAWYER AUSTIN;;PELLETIER STEPHANIE ALISHA;;DOURTHE BENJAMIN LOUIS;;SUNG ARTHUR WAI;;ARDESHIRI RAMTIN;;ADLER ANDREW,TOMA JONATHAN EMANUEL;;PALLOPSON CHAD MICHAEL JOHN;;SAWYER AUSTIN;;PELLETIER STEPHANIE ALISHA;;DOURTHE BENJAMIN LOUIS;;SUNG ARTHUR WAI;;ARDESHIRI RAMTIN;;ADLER ANDREW,,https://lens.org/122-742-695-975-249,Patent Application,yes,4,4,1,1,0,G16H30/40;;A61B5/0536;;G06N3/08;;G16H40/63;;G16H40/67;;G16H15/00;;G16H20/40;;G16H40/40;;G16H50/50;;G06N3/047;;G06N3/045,A61B5/0536;;G06N3/02;;G06N3/08;;G16H30/40,,2,1,081-665-665-904-923,10.1007/s11831-019-09388-y,"ZACH EATON-ROSEN, FELIX BRAGMAN, SEBASTIEN OURSELIN, M. JORGE CARDOSO: ""Improving Data Augmentation for Medical Image Segmentation"", 6 July 2018 (2018-07-06), XP055709256, Retrieved from the Internet <URL:https://openreview.net/pdf?id=rkBBChjiG> [retrieved on 20200626];;ALQAHTANI HAMED; KAVAKLI-THORNE MANOLYA; KUMAR GULSHAN: ""Applications of Generative Adversarial Networks (GANs): An Updated Review"", ARCHIVES OF COMPUTATIONAL METHODS IN ENGINEERING, SPRINGER NETHERLANDS, DORDRECHT, vol. 28, no. 2, 1 January 1900 (1900-01-01), Dordrecht , pages 525 - 552, XP037360202, ISSN: 1134-3060, DOI: 10.1007/s11831-019-09388-y",PENDING
739,US,A1,US 2017/0336945 A1,137-849-425-371-079,2017-11-23,2017,US 201615161645 A,2016-05-23,US 201615161645 A,2016-05-23,DISPLAY SYSTEM FOR SMART PRODUCTS,A display system and method of displaying media content on a display screen includes a processor that receives from an input device an indication that one of a plurality of vignettes has been selected. The selected vignette is accessed from a data store. Each vignette includes digital media content. The digital media content is instructed by the processor to be played on a display screen located behind a plurality of smart products that are on display. Each smart product is positioned relative to the display screen at a set location. The digital media content includes a sequence of frames of digital images including frames that produce a halo of light behind a smart product being described in the frames.,TARGET BRANDS INC,LASKOWITZ ADAM M;;ADLER PATRICIA S;;BARTON JACOB A;;ADKISSON NATHAN G;;HOPPE PAUL A;;ROCKEL PHILIPP;;RYAN JOHN D;;GUILLIN NICO,TARGET BRANDS INC (2016-05-16);;LOCAL PROJECTS LLC (2016-05-20),https://lens.org/137-849-425-371-079,Patent Application,yes,10,3,4,4,0,G06F3/0482;;G06Q30/0643;;G06F3/0482;;G06F3/0487;;G06F3/0487;;G06F9/451;;G06F9/451;;G06Q30/0641;;H04L12/282;;H04L12/282,G06F3/0484;;G06F3/0482,,0,0,,,,ACTIVE
740,US,A1,US 2016/0371698 A1,003-304-672-631-22X,2016-12-22,2016,US 201615184660 A,2016-06-16,US 201615184660 A;;US 201562180251 P,2015-06-16,"Systems and Methods for Authenticating Business Partners, in Connection With Requests by the Partners for Products and/or Services","Systems and methods for use in authenticating business partners, in connection with requests by the partners for various products and/or services, are disclosed. An exemplary method generally includes receiving a request from a business partner for a product and/or a service where the product and/or service relates, for example, at least partly, to transaction data, or other data. The method also generally includes assigning a risk score to the business partner, comparing the risk score assigned to the business partner to a sensitivity threshold associated with the requested product and/or service, and distributing the product and/or service to the business partner, when the risk score satisfies the sensitivity threshold.",MASTERCARD INTERNATIONAL INC,ADLER GARY;;CIMATU MICHAEL MIRALLES;;BAKER JOHN;;D'ERIZANS RICHARD D;;DONOVAN JENNIFER L;;WEI YANSHENG;;FIEBIGER SARA E;;PANUS SHEILA R;;MAUS JAMES,MASTERCARD INTERNATIONAL INCORPORATED (2016-07-06),https://lens.org/003-304-672-631-22X,Patent Application,yes,20,12,1,1,0,G06Q20/4016;;G06Q20/4016;;G06Q20/4014;;G06Q20/4014,G06Q20/40,,0,0,,,,DISCONTINUED
741,KR,A,KR 20140039334 A,021-013-820-118-085,2014-04-01,2014,KR 20147004760 A,2012-07-31,US 201113204171 A;;US 2012/0048944 W,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,,APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/021-013-820-118-085,Patent Application,no,3,0,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/08;;G06F11/14,,0,0,,,,ACTIVE
742,AU,A1,AU 2018/202051 A1,124-253-801-612-771,2018-04-12,2018,AU 2018/202051 A,2018-03-22,AU 2018/202051 A;;AU 2016/200941 A;;AU 2012/294770 A;;US 201113204171 A;;US 2012/0048944 W,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/124-253-801-612-771,Patent Application,no,0,0,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,G06F11/14;;H04L9/08,,0,0,,,,DISCONTINUED
743,WO,A2,WO 2013/022647 A2,199-330-153-155-636,2013-02-14,2013,US 2012/0048944 W,2012-07-31,US 201113204171 A,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC;;SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/199-330-153-155-636,Patent Application,yes,0,1,22,22,0,H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04L2463/062;;H04L63/0428;;H04W12/08;;H04W12/041;;H04L2463/062;;H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04W12/041;;H04W12/08;;G06F11/1458;;H04L9/0637;;H04L63/0428;;H04L63/0435;;H04L63/061,G06F11/14;;H04L9/08,,0,0,,,,PENDING
744,AU,B2,AU 2012/294770 B2,182-595-685-638-555,2015-11-26,2015,AU 2012/294770 A,2012-07-31,US 201113204171 A;;US 2012/0048944 W,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/182-595-685-638-555,Granted Patent,no,5,0,22,22,0,H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04L2463/062;;H04L63/0428;;H04W12/08;;H04W12/041;;H04L2463/062;;H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04W12/041;;H04W12/08;;G06F11/1458;;H04L9/0637;;H04L63/0428;;H04L63/0435;;H04L63/061,G06F11/14;;H04L9/08,,0,0,,,,ACTIVE
745,EP,A1,EP 2320011 A1,195-957-431-572-274,2011-05-11,2011,EP 10184066 A,2000-01-21,EP 00906988 A;;US 23533899 A,1999-01-22,Padlock,"A padlock (1) is provided with 
(a) a lock body (2); 
(b) a shackle (9) releasably lockable to the body in a closed position defining a closed space (10) between the shackle and the body for securing to an object, and movable to an open position for receiving and releasing the object between the shackle and the body; and 
(c) a key-operable lock (18) having a rotatable lock cylinder (21) housed in the lock body and operatively connected to the shackle by a drive linkage, the drive linkage comprising: 
(i) cam gear teeth (26) rotatable with the lock-cylinder; 
(ii) a gear rack operatively engaged with the cam gear teeth and releasably attachable to the shackle for rotation therewith; 
wherein upon rotation of the lock cylinder, the cam gear teeth move the gear rack which moves the shackle from the closed to the open position.
",MASTER LOCK CO,CHASTAIN DAVID P;;FEIGENER JOHN D;;THOMPSON ROY A;;GERINGER JOSEPH R;;WEST HARRY;;ADLER ARI T;;FINIW MARYANN;;KAJUCH PETE;;MARCELLE JESSE A,,https://lens.org/195-957-431-572-274,Patent Application,yes,21,0,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B67/30;;E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28,,0,0,,,,DISCONTINUED
746,EP,B1,EP 2730049 B1,142-100-651-652-377,2020-04-22,2020,EP 12775334 A,2012-07-31,US 201113204171 A;;US 2012/0048944 W,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,,APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,APPLE INC. (2018-08-01),https://lens.org/142-100-651-652-377,Granted Patent,yes,5,0,22,22,0,H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04L2463/062;;H04L63/0428;;H04W12/08;;H04W12/041;;H04L2463/062;;H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04W12/041;;H04W12/08;;G06F11/1458;;H04L9/0637;;H04L63/0428;;H04L63/0435;;H04L63/061,H04L9/08;;G06F11/14;;H04L29/06;;H04W12/04;;H04W12/08,,0,0,,,,ACTIVE
747,US,A1,US 2016/0036791 A1,046-727-473-795-277,2016-02-04,2016,US 201514874360 A,2015-10-02,US 201514874360 A;;US 201113204171 A,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/046-727-473-795-277,Patent Application,yes,0,27,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L29/06;;H04W12/04;;H04W12/08,,0,0,,,,ACTIVE
748,EP,A4,EP 1149221 A4,082-394-879-721-676,2002-10-23,2002,EP 00906988 A,2000-01-21,US 0001572 W;;US 23533899 A,1999-01-22,PADLOCK,,MASTER LOCK CO,CHASTAIN DAVID P;;FIEGENER JOHN D;;THOMPSON ROY A;;GERINGER JOSEPH R;;WEST HARRY;;ADLER ARI T;;FINIW MARYANN;;KAJUCH PETE;;MARCELLE JESSE A,,https://lens.org/082-394-879-721-676,Search Report,no,9,0,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,,1,0,,,See also references of WO 0043623A1,DISCONTINUED
749,AU,B2,AU 2016/200941 B2,097-983-905-955-733,2018-01-04,2018,AU 2016/200941 A,2016-02-12,AU 2016/200941 A;;AU 2012/294770 A;;US 201113204171 A;;US 2012/0048944 W,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/097-983-905-955-733,Granted Patent,no,5,0,22,22,0,H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04L2463/062;;H04L63/0428;;H04W12/08;;H04W12/041;;H04L2463/062;;H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04W12/041;;H04W12/08;;G06F11/1458;;H04L9/0637;;H04L63/0428;;H04L63/0435;;H04L63/061,G06F11/14;;H04L9/08,,0,0,,,,ACTIVE
750,AU,A1,AU 2016/200941 A1,152-319-453-395-049,2016-03-03,2016,AU 2016/200941 A,2016-02-12,AU 2016/200941 A;;AU 2012/294770 A;;US 201113204171 A;;US 2012/0048944 W,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/152-319-453-395-049,Patent Application,no,0,0,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,G06F11/14;;H04L9/08,,0,0,,,,ACTIVE
751,CA,A1,CA 2358818 A1,042-842-739-425-985,2000-07-27,2000,CA 2358818 A,2000-01-21,US 23533899 A;;US 0001572 W,1999-01-22,PADLOCK,"A padlock (1) is provided with a multi-layer (4, 6) protective metal shell having non-aligned, alternating seams (5, 7) among the various layers (4, 6) , primary (18) and secondary (31) key-operable locks attached to the shackle ( 9) of the padlock (1) by a drive linkage (23) that will fail before the primary (18) and secondary (31) locks to maintain the integrity of the lock, an ergonomic shape, an offset shackle (9) for facilitating use of the lock in close-quarter applications, and a modular cushioned bumper (38) for attachme nt to the outside of the lock body that is color-coded to correspond to a key a nd includes a protective cover (44, 45) over the keyway accessing the lock cylinder (21) which is moveable to facilitate insertion of the key into the padlock (1).",MASTER LOCK CO,FINIW MARYANN;;FIEGENER JOHN D;;KAJUCH PETE;;WEST HARRY;;ADLER ARI T;;GERINGER JOSEPH R;;THOMPSON ROY A;;CHASTAIN DAVID P;;MARCELLE JESSE A,,https://lens.org/042-842-739-425-985,Patent Application,no,0,0,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,,0,0,,,,EXPIRED
752,AU,A1,AU 2012/294770 A1,147-428-709-819-610,2014-02-20,2014,AU 2012/294770 A,2012-07-31,US 201113204171 A;;US 2012/0048944 W,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/147-428-709-819-610,Patent Application,no,0,0,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,G06F11/14;;H04L9/08,,0,0,,,,ACTIVE
753,CN,A,CN 103748827 A,044-636-553-549-459,2014-04-23,2014,CN 201280038007 A,2012-07-31,US 2012/0048944 W;;US 201113204171 A,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/044-636-553-549-459,Patent Application,no,6,12,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/08;;G06F11/14,,3,0,,,"王灿，秦志光，冯朝胜，彭静: ""面向重复数据消除的备份数据加密方法"", 《计算机应用》;;王冕，周玉洁: ""基于硬件的密钥安全备份和恢复机制"", 《微计算机信息》;;张德刚，戴冠中，刘航，石峰，张贞: ""一种改进的高安全性密钥恢复机制"", 《计算机测量与控制》",ACTIVE
754,EP,A1,EP 1149221 A1,006-096-078-502-367,2001-10-31,2001,EP 00906988 A,2000-01-21,US 0001572 W;;US 23533899 A,1999-01-22,PADLOCK,,MASTER LOCK CO,CHASTAIN DAVID P;;FIEGENER JOHN D;;THOMPSON ROY A;;GERINGER JOSEPH R;;WEST HARRY;;ADLER ARI T;;FINIW MARYANN;;KAJUCH PETE;;MARCELLE JESSE A,,https://lens.org/006-096-078-502-367,Patent Application,yes,0,0,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,,0,0,,,,DISCONTINUED
755,AU,A,AU 2000/028559 A,014-152-954-283-322,2000-08-07,2000,AU 2000/028559 A,2000-01-21,US 23533899 A;;US 0001572 W,1999-01-22,Padlock,,MASTER LOCK CO,CHASTAIN DAVID P;;FIEGENER JOHN D;;THOMPSON ROY A;;GERINGER JOSEPH R;;WEST HARRY;;ADLER ARI T;;FINIW MARYANN;;KAJUCH PETE;;MARCELLE JESSE A,,https://lens.org/014-152-954-283-322,Patent Application,no,0,0,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,,0,0,,,,DISCONTINUED
756,WO,A3,WO 2013/022647 A3,018-542-577-302-143,2013-05-23,2013,US 2012/0048944 W,2012-07-31,US 201113204171 A,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC;;SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/018-542-577-302-143,Search Report,yes,5,0,22,22,0,H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04L2463/062;;H04L63/0428;;H04W12/08;;H04W12/041;;H04L2463/062;;H04L9/0822;;H04L9/0894;;H04L9/0825;;H04L9/0863;;G06F11/1464;;H04W12/041;;H04W12/08;;G06F11/1458;;H04L9/0637;;H04L63/0428;;H04L63/0435;;H04L63/061,H04L9/08;;G06F11/14,,0,0,,,,PENDING
757,CA,C,CA 2358818 C,057-572-584-200-673,2004-10-19,2004,CA 2358818 A,2000-01-21,US 23533899 A;;US 0001572 W,1999-01-22,PADLOCK,"A padlock (1) is provided with a multi-layer (4,6) protective metal shell having non-aligned, alternating seams (5, 7) among the various layers (4,6), primary (18) and secondary (31) key-operable locks attached to the shackle (9) of the padlock (1) by a drive linkage (23) that will fail before the primary (18) and secondary (31) locks to maintain the integrity of the lock, an ergonomic shape, an offset shackle (9) for facilitating use of the lock in close-quarter applications, and a modular cushioned bumper (38) for attachment to the outside of the lock body that is color-coded to correspond to a key and includes a protective cover (44, 45) over the keyway accessing the lock cylinder (21) which is moveable to facilitate insertion of the key into the padlock (1).",MASTER LOCK CO,MARCELLE JESSE A;;KAJUCH PETE;;GERINGER JOSEPH R;;FIEGENER JOHN D;;THOMPSON ROY A;;WEST HARRY;;FINIW MARYANN;;CHASTAIN DAVID P;;ADLER ARI T,,https://lens.org/057-572-584-200-673,Granted Patent,no,0,0,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,,0,0,,,,EXPIRED
758,US,B2,US 9401898 B2,037-497-020-156-846,2016-07-26,2016,US 201514874360 A,2015-10-02,US 201514874360 A;;US 201113204171 A,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/037-497-020-156-846,Granted Patent,yes,26,2,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/00;;G06F11/14;;H04L9/08;;H04L29/06;;H04W12/04;;H04W12/08,,0,0,,,,ACTIVE
759,US,B2,US 11176237 B2,142-886-458-530-957,2021-11-16,2021,US 201815996413 A,2018-06-01,US 201815996413 A;;US 201715497203 A;;US 201762514897 P;;US 201662349029 P,2016-06-12,Modifying security state with secured range detection,"In some embodiments, a first device performs ranging operations to allow a user to access the first device under one of several user accounts without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account under which a user can access (e.g., can log into) the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the user is allowed to access the first device under the first user account. In some embodiments, the substitute interaction occurs while the first device is logged into under a second user account.",APPLE INC,BENSON WADE;;LEDWITH ALEXANDER R;;KROCHMAL MARC J;;IAROCCI JOHN J;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L;;SYKORA LIBOR,APPLE INC (1997-06-20),https://lens.org/142-886-458-530-957,Granted Patent,yes,85,0,2,33,0,G06F21/34;;H04W4/02;;H04W12/068;;H04W12/082;;H04W12/33;;H04W12/64;;G06F21/36;;G06F21/34;;H04W4/80;;H04W4/02;;H04W12/068;;H04W12/082;;H04W12/33;;H04W12/64,G06F21/34;;G06F21/36;;H04W4/02;;H04W4/80;;H04W12/06;;H04W12/082;;H04W12/63,,18,0,,,"Written Opinion of the International Preliminary Examining Authority from PCT/US2017/035601, dated May 8, 2018, 8 pages.;;European Office Action from European Patent Application No. 17731348.3, dated Sep. 12, 2019, 7 pages.;;Australian Examination Report from Australian Patent Application No. 2017286140, dated Nov. 26, 2019, 4 pages.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Jan. 6, 2020, 14 pages including English language translation.;;Korean Office Action from Korean Patent Application No. 10-2018-7034644, dated Jan. 14, 2020, 10 pages including English language translation.;;SRP Documentation, retrieved from http://srp.stanford.edu/doc.html#standards, visited Apr. 3, 2018, 3 pages.;;Wu, “The Secure Remote Password Protocol,” retrieved from http://srp.stanford.edu/ndss.html, 1998, 24 pages.;;International Search Report and Written Opinion from PCT/US2017/035601, dated Oct. 18, 2017, 20 pages.;;European Office Action dated Mar. 2, 2020, from European Patent Application No. 17731348.3, 6 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 27, 2020, 26 pages including English language translation.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Sep. 25, 2020, 5 pages including English language translation.;;Notice of Acceptance from Australian Patent Application No. 2017286140, dated Oct. 12, 2020, 3 pages.;;Korean Office Action from Korean Patent Application No. 2018-7034644, dated Nov. 26, 2020, 9 pages including English language translation.;;Invitation to Pay Additional Fees from PCT/US2020/028549, dated Jul. 10, 2020, 13 pages.;;International Search Report and Written Opinion from PCT/US2020/028549, dated Aug. 31, 2020, 18 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Jun. 3, 2021, 17 pages including English language translation.;;Japanese Notice of Allowance from Japanese Patent Application No. 2018-562555, dated May 27, 2021, 5 pages including English language translation.;;Korean Notice of Allowance from 10-2018-7034644, dated May 31, 2021, 5 pages including English language translation.",ACTIVE
760,US,A1,US 2018/0276367 A1,164-986-376-807-656,2018-09-27,2018,US 201815996413 A,2018-06-01,US 201815996413 A;;US 201715497203 A;;US 201762514897 P;;US 201662349029 P,2016-06-12,MODIFYING SECURITY STATE WITH SECURED RANGE DETECTION,"In some embodiments, a first device performs ranging operations to allow a user to access the first device under one of several user accounts without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account under which a user can access (e.g., can log into) the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the user is allowed to access the first device under the first user account. In some embodiments, the substitute interaction occurs while the first device is logged into under a second user account.",APPLE INC,BENSON WADE;;LEDWITH ALEXANDER R;;KROCHMAL MARC J;;IAROCCI JOHN J;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L;;SYKORA LIBOR,APPLE INC (1997-06-20),https://lens.org/164-986-376-807-656,Patent Application,yes,10,19,2,33,0,G06F21/34;;H04W4/02;;H04W12/068;;H04W12/082;;H04W12/33;;H04W12/64;;G06F21/36;;G06F21/34;;H04W4/80;;H04W4/02;;H04W12/068;;H04W12/082;;H04W12/33;;H04W12/64,G06F21/34;;G06F21/36;;H04W4/02;;H04W4/80;;H04W12/06,,0,0,,,,ACTIVE
761,US,B1,US 6305198 B1,021-259-430-828-786,2001-10-23,2001,US 23533899 A,1999-01-22,US 23533899 A,1999-01-22,Padlock,"A padlock is provided with a multi-layer protective metal shell having non-aligned, alternating seams among the various layers, primary and secondary key-operable locks attached to the shackle of the padlock by a drive linkage that will fail before the primary and secondary locks to maintain the integrity of the lock, an ergonomic shape, an offset shackle for facilitating use of the lock in close-quarters applications, and a modular cushioned bumper for attachment to the outside of the lock body that is color-coded to correspond to a key and includes a protective cover over the keyway accessing the lock cylinder which is moveable to facilitate insertion of the key into the padlock.",MASTER LOCK CO,CHASTAIN DAVID PAUL;;FIEGENER JOHN DARRIN;;THOMPSON ROY ALDEN;;GERINGER JOSEPH ROBERT;;WEST HARRY;;ADLER ARI TAO;;FINIW MARYANN;;KAJUCH PETE;;MARCELLE JESSE ALAN,MASTER LOCK COMPANY LLC (1999-03-23),https://lens.org/021-259-430-828-786,Granted Patent,yes,74,32,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,70/40;;70/52;;70/56;;70/417,0,0,,,,EXPIRED
762,US,A1,US 2017/0019383 A1,123-345-900-687-172,2017-01-19,2017,US 201615217674 A,2016-07-22,US 201615217674 A;;US 201514874360 A;;US 201113204171 A,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted tile key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUDERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MICHAEL JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/123-345-900-687-172,Patent Application,yes,0,4,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L29/06;;G06F11/14;;H04L9/06;;H04L9/08;;H04W12/04,,0,0,,,,ACTIVE
763,PE,A1,PE 20081140 A1,152-772-349-816-291,2008-09-22,2008,PE 2007001455 A,2007-10-25,US 85467406 P;;US 99537007 P,2006-10-25,AGENTES TERAPEUTICOS A BASE DE PEPTIDOS DERIVADOS DE TOXINAS,"SE REFIERE A UNA COMPOSICION DE MATERIA DE FORMULA I, DONDE: F1 Y F2 SON FRACCIONES QUE PROLONGAN LA SEMIVIDA, COMO POLIETILENGLICOL DE 5kDa Y 20 kDa, PROPILENGLICOL, CARBOXIMETILCELULOSA, ACIDO GRASO, UN DOMINIO Fc DE LA Ig G HUMANA O UNA PARTE DE ESTE Y COMPRENDE UNA SECUENCIA SEQ ID NOS: 2,470,71,72,74,75,76,1340,1341,1342 Y 1359 A 1363; d Y e SON CADA UNO 0-1; X1, X2 Y X3 SON CADA UNO -(L)f-P-(L)g-; f Y g SON CADA UNO 0-1; P ES UN PEPTIDO DERIVADO DE TOXINAS, DE PREFERENCIA ANALOGO DEL PEPTIDO DE LA TOXINA OSK1; L ES UN LIGADOR; a, b Y c SON CADA UNO 0-1, DONDE AL MENOS 1 DE a , b O c SEA 1. TAMBIEN SE REFIERE A UNA SECUENCIA DE ADN UN VECTOR DE EXPRESION Y CELULAS HOSPEDANTES. DICHA COMPOSICION FARMACEUTICA ES UTIL PARA EL TRATAMIENTO DE TRANSTORNOS AUTOINMUNES COMO LA ESCLEROSIS MULTIPLE, DIABETES TIPO I, ESCLERODERMIA, ENTRE OTROS",AMGEN INC,SULLIVAN JOHN K;;MCGIVERN JOSEPH;;MIRANDA LESLIE PHILLIP;;NGUYEN HUNG Q;;WALKER KENNETH WILLIAM;;HU SHAW-FEN SYLVIA;;GEGG COLIN VICTOR;;ADLER BEVERLY S,,https://lens.org/152-772-349-816-291,Patent Application,no,0,0,20,20,0,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K38/00,,0,0,,,,DISCONTINUED
764,WO,A1,WO 2000/043623 A1,051-535-963-218-338,2000-07-27,2000,US 0001572 W,2000-01-21,US 23533899 A,1999-01-22,PADLOCK,"A padlock (1) is provided with a multi-layer (4, 6) protective metal shell having non-aligned, alternating seams (5, 7) among the various layers (4, 6), primary (18) and secondary (31) key-operable locks attached to the shackle (9) of the padlock (1) by a drive linkage (23) that will fail before the primary (18) and secondary (31) locks to maintain the integrity of the lock, an ergonomic shape, an offset shackle (9) for facilitating use of the lock in close-quarter applications, and a modular cushioned bumper (38) for attachment to the outside of the lock body that is color-coded to correspond to a key and includes a protective cover (44, 45) over the keyway accessing the lock cylinder (21) which is moveable to facilitate insertion of the key into the padlock (1).",MASTER LOCK CO,CHASTAIN DAVID P;;FIEGENER JOHN D;;THOMPSON ROY A;;GERINGER JOSEPH R;;WEST HARRY;;ADLER ARI T;;FINIW MARYANN;;KAJUCH PETE;;MARCELLE JESSE A,,https://lens.org/051-535-963-218-338,Patent Application,yes,29,2,13,13,0,E05B17/0054;;E05B17/185;;E05B17/186;;E05B67/04;;E05B67/28;;E05B2067/025;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/28;;Y10T70/498;;Y10T70/457;;Y10T70/489;;Y10T70/7921;;E05B67/04;;E05B17/186;;E05B17/0054;;E05B67/28;;E05B17/185;;E05B2067/025,E05B17/00;;E05B17/18;;E05B67/02;;E05B67/04;;E05B67/28;;E05B67/30,,1,0,,,See also references of EP 1149221A4,PENDING
765,EP,A2,EP 2730049 A2,012-631-310-593-320,2014-05-14,2014,EP 12775334 A,2012-07-31,US 201113204171 A;;US 2012/0048944 W,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,,APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,APPLE INC. (2018-08-01),https://lens.org/012-631-310-593-320,Patent Application,yes,0,0,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/08;;G06F11/14,,1,0,,,See references of WO 2013022647A2,ACTIVE
766,US,A1,US 2002/0078358 A1,022-562-464-049-324,2002-06-20,2002,US 98998901 A,2001-11-21,US 98998901 A;;US 14962199 P;;US 53483600 A;;US 53592700 A;;US 25276200 P,1999-08-16,Electronic voting system,"
   A facility for conducting an election is described. The facility establishes a public key infrastructure for use in the election. The facility then employs the established key infrastructure in the operation of a voting site. 
",NEFF C. ANDREW;;ADLER JAMES M.;;BENTSON RANDOLPH A.;;BERG ANDREW C.;;HORNBAKER JOHN H.;;JANKE LEONARD C.;;MCCANN JAMES R.;;PETERSON ERIC A.,NEFF C ANDREW;;ADLER JAMES M;;BENTSON RANDOLPH A;;BERG ANDREW C;;HORNBAKER JOHN H;;JANKE LEONARD C;;MCCANN JAMES R;;PETERSON ERIC A,VOTEHERE INC (2002-01-28);;DATEGRITY CORPORATION (2005-05-10),https://lens.org/022-562-464-049-324,Patent Application,yes,19,59,1,98,0,G06F21/33;;G06F21/645;;G06F2211/008;;G06F2221/2119;;G07C13/00;;H04L9/006;;H04L9/3218;;H04L2209/463;;H04L9/3218;;G06F2211/008;;H04L2209/463;;G06F21/645;;G06F2221/2119;;G07C13/00;;H04L9/006;;G06F21/33,G06F1/00;;G06F21/00;;G07C13/00;;H04L9/32,713/176,0,0,,,,DISCONTINUED
767,JP,A,JP 2016189626 A,181-712-646-714-088,2016-11-04,2016,JP 2016145458 A,2016-07-25,US 201113204171 A,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,"PROBLEM TO BE SOLVED: To provide systems, methods and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device.SOLUTION: A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations on the basis of a file key.SELECTED DRAWING: Figure 6",APPLE INC,CONRAD SAUERWALD;;VRAJESH RAJESH BHAVSAR;;KENNETH BUFFALO MCNEIL;;THOMAS BROGAN DUFFY;;MICHAEL LAMBERTUS HUBERTUS BROUWER;;MATTHEW JOHN BYOM;;MITHELL DAVID ADLER;;ERIC BRANDON TAMURA,,https://lens.org/181-712-646-714-088,Patent Application,no,6,0,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/08;;G06F11/14;;G06F12/00;;G06F21/60,,0,0,,,,ACTIVE
768,US,A1,US 2013/0034229 A1,152-267-594-479-295,2013-02-07,2013,US 201113204171 A,2011-08-05,US 201113204171 A,2011-08-05,SYSTEM AND METHOD FOR WIRELESS DATA PROTECTION,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC;;SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY JR THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY JR THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,APPLE INC (2011-08-03),https://lens.org/152-267-594-479-295,Patent Application,yes,13,71,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/00,380/46;;380/277;;380/47,0,0,,,,DISCONTINUED
769,US,B2,US 9813389 B2,008-256-042-107-464,2017-11-07,2017,US 201615217674 A,2016-07-22,US 201615217674 A;;US 201514874360 A;;US 201113204171 A,2011-08-05,System and method for wireless data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for wireless data protection utilizing cryptographic key management on a primary device and a backup device. A system encrypts a file with a file key and encrypts the file key twice, resulting in two encrypted file keys. The system encrypts each file key differently and stores a first file key on the primary device and transmits one of the encrypted file keys in addition to the encrypted file to a backup device for storage. On the backup device, the system associates the encrypted file key with a set of backup keys protected by a user password. In one embodiment, the system generates an initialization vector for use in cryptographic operations based on a file key. In another embodiment, the system manages cryptographic keys on a backup device during a user password change.",APPLE INC,SAUERWALD CONRAD;;BHAVSAR VRAJESH RAJESH;;MCNEIL KENNETH BUFFALO;;DUFFY JR THOMAS BROGAN;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;BYOM MATTHEW JOHN;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON,,https://lens.org/008-256-042-107-464,Granted Patent,yes,27,3,22,22,0,G06F11/1458;;G06F11/1464;;G06F11/1464;;H04L63/0428;;H04L63/0428;;H04L9/0637;;H04L9/0822;;H04L9/0822;;H04L9/0825;;H04L9/0825;;H04L9/0863;;H04L9/0863;;H04L9/0894;;H04L9/0894;;H04L63/0435;;H04L63/061;;H04L2463/062;;H04L2463/062;;H04W12/041;;H04W12/041;;H04W12/08;;H04W12/08,H04L9/00;;G06F11/14;;H04L9/06;;H04L9/08;;H04L29/06;;H04W12/04;;H04W12/08,,0,0,,,,ACTIVE
770,GB,B,GB 2481349 B,134-215-568-797-866,2014-01-29,2014,GB 201117660 A,2010-03-11,US 2010/0027058 W;;US 16060109 P;;US 72040010 A;;US 72034910 A;;US 72044610 A;;US 16064409 P;;US 72042310 A;;US 72037510 A;;US 72048910 A,2009-03-16,Accessory and mobile computing device communication using an application communication protocol,,APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;SCHUBERT EMILY CLARK;;TOPRANI SHYAM S;;LANGENFELD PETER T;;KRUEGER SCOTT;;ANANNY JOHN M;;ADLER MITCHELL;;DOROGUSKER JESSE,,https://lens.org/134-215-568-797-866,Granted Patent,no,4,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F13/38;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
771,CN,A,CN 105162955 A,161-054-033-627-291,2015-12-16,2015,CN 201510462782 A,2010-03-11,US 16060109 P;;US 16064409 P;;US 72040010 A;;US 72044610 A;;US 72048910 A;;US 72037510 A;;US 72034910 A;;US 72042310 A;;CN 201080021428 A,2009-03-16,Accessory and mobile computing device communication using an application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE;;GANATRA NITIN;;ADLER MITCHELL;;CLARK SCHUBERT EMILY;;DOROGUSKER JESSE LEE;;SHYAM TOPRANI S;;LANGENFELD PETER T;;KRUEGER SCOTT;;ANANNY JOHN M,,https://lens.org/161-054-033-627-291,Patent Application,no,4,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F13/38;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
772,AR,A1,AR 063384 A1,086-477-999-820-846,2009-01-28,2009,AR P070104718 A,2007-10-25,US 99537007 P;;US 85467406 P,2006-10-25,AGENTES TERAPEUTICOS A BASE DE PEPTIDOS DERIVADOS DE TOXINAS,"Se revela una composicion de materia que tiene la siguiente formula (1): (X1)a-(F1)d-(X2)b-(F2)e-(X3)c y sus multímeros, donde F1 y F2 son fracciones que prolongan la semivida, y d y e son, cada uno en forma independiente, 0 o 1, siempre que al menos uno de d y e sea 1; X1, X2 y X3 son, cada uno en forma independiente, -(L)f-P-(L)g-, y f y g son, cada uno en forma independiente, 0 o 1; P es un péptido derivado de toxinas de no más de 80 residuos de aminoácidos, aproximadamente, que comprende al menos dos enlaces di-sulfuro intrapeptídicos, y al menos un P es un análogo del péptido OSK1; L es un enlazador optativo; y a, b y c son, cada uno en forma independiente, 0 o 1, siempre que al menos uno de a, b y c sea 1. La ligadura con la o las fracciones que prolongan la semivida aumenta la semivida in vivo del péptido derivado de toxinas, que de otra manera se degradaría rápidamente. Una composicion farmacéutica comprende la composicion y un portador farmacéuticamente aceptable. También se revelan ADN que codifican la composicion de materia novedosa, un vector de expresion que comprende el ADN y células hospedantes que comprenden el vector de expresion. También se revelan los métodos para tratar un trastorno autoinmune, tal como esclerosis multiple, diabetes tipo 1, psoriasis, enfermedad inflamatoria intestinal, dermatitis por contacto, artritis reumatoidea, artritis psoriásica, asma, alergia, restenosis, esclerosis sistémica, fibrosis, esclerodermia, glomerulonefritis, síndrome de Sjogren, resorcion osea inflamatoria, rechazo en transplante, enfermedad de injerto frente a anfitrion y lupus, pero sin limitarse exclusivamente a estos; como así también para prevenir o mitigar la recurrencia de un síntoma de esclerosis multiple.",AMGEN INC,GEGG COLIN VICTOR JR;;MIRANDA LESLIE PHILLIP;;ADLER BEVERLY S;;WALKER KENNETH WILLIAM;;HU SHAW-FEN SYLVIA;;SULLIVAN JOHN K;;MCGIVERN JOSEPH;;NGUYEN HUNG Q,,https://lens.org/086-477-999-820-846,Patent Application,no,0,0,20,20,0,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,,,0,0,,,,DISCONTINUED
773,TW,A,TW 200833840 A,145-201-213-881-470,2008-08-16,2008,TW 96139989 A,2007-10-25,US 85467406 P;;US 99537007 P,2006-10-25,Toxin peptide therapeutic agents,"Disclosed is a composition of matter of the formula (I) (X1)a-(F1)d-(X2)b-(F2)e-(X3)c and multimers thereof, in which F1 and F2 are half-life extending moieties, and d and e are each independently 0 or 1, provided that at least one of d and e is 1; X1, X2, and X3 are each independently -(L)f-P-(L)g-, and f and g are each independently 0 or 1; P is a toxin peptide of no more than about 80 amino acid residues in length, comprising at least two intrapeptide disulfide bonds, and at least one P is an OSK1 peptide analog; L is an optional linker; and a, b, and c are each independently 0 or 1, provided that at least one of a, b and c is 1. Linkage to the half-life extending moiety or moieties increases the in vivo half-life of the toxin peptide, which otherwise would be quickly degraded. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder, such as, but not limited to, multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, contact-mediated dermatitis, rheumatoid arthritis, psoriatic arthritis, asthma, allergy, restinosis, systemic sclerosis, fibrosis, scleroderma, glomerulonephritis, Sjogren syndrome, inflammatory bone resorption, transplant rejection, graft-versus-host disease, and lupus and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",AMGEN INC,SULLIVAN JOHN K;;MCGIVERN JOSEPH;;MIRANDA LESLIE PHILLIP;;NGUYEN HUNG Q;;WALKER KENNETH WILLIAM;;HU SHAW-FEN SYLVIA;;GEGG COLIN VICTOR JR;;ADLER BEVERLY S,,https://lens.org/145-201-213-881-470,Patent of Addition,no,0,0,20,20,0,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,C12N15/09;;A61K39/395;;A61P37/02;;C07K16/28,,0,0,,,,PENDING
774,US,A1,US 2019/0318074 A1,059-861-655-851-945,2019-10-17,2019,US 201916388831 A,2019-04-18,US 201916388831 A;;US 201815996413 A;;US 201715497203 A;;US 201662349029 P;;US 201762514897 P,2016-06-12,REMOTE INTERACTION WITH A DEVICE USING SECURE RANGE DETECTION,"In some embodiments, a first device performs ranging operations to allow a user to perform one or more operations on the first device without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account that is authorized to perform operations on the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the operations to be performed on the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the operation is authorized on the first device.",APPLE INC,LEDWITH ALEXANDER R;;BENSON WADE;;KROCHMAL MARC J;;IAROCCI JOHN J;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L;;SYKORA LIBOR;;MARGARITOV JIRI,APPLE INC (1997-06-20),https://lens.org/059-861-655-851-945,Patent Application,yes,0,13,2,33,0,G06F21/34;;G06F1/163;;H04W12/08;;H04W12/63;;H04W12/084;;H04W12/33;;G06F21/34;;G06F1/163;;H04W12/63;;H04W12/33,G06F21/34;;G06F1/16;;H04W12/00,,0,0,,,,ACTIVE
775,US,A1,US 2020/0128957 A1,081-598-839-795-038,2020-04-30,2020,US 201916667827 A,2019-10-29,US 201916667827 A;;US 201862753765 P,2018-10-31,MODULAR ENCLOSURE SYSTEM,A modular enclosure system includes a plurality of anchor rails configured to be mounted to a surface such as a wall to which the modular enclosure system is to be attached. The modular enclosure system includes a first partition having a plurality of partition segments and a second partition having a plurality of partition segments. The first partition and the second partition are each coupled to a first rail and a second rail of the plurality of anchor rails.,AMERICAN WOODMARK CORP,ADLER DEREK CREIGHTON;;CRAIG CHRISTOPHER DOUGLAS;;DUNSTON STEVEN CARY;;KHAN TABISH SHAMIM;;KRAEMER MICHAEL JOSEPH;;SMITH JEREMIAH GENE;;FERRY JOSHUA DAVID;;SCHROER JOHN MICHAEL;;MORRISON KEVIN,AMERICAN WOODMARK CORPORATION (2019-11-18),https://lens.org/081-598-839-795-038,Patent Application,yes,0,1,3,3,0,F16B5/0032;;F16B5/0614;;A47B47/042;;A47B95/008;;A47B47/0075;;A47B96/205;;A47B96/04;;A47B95/008;;A47B47/042;;A47B96/066;;A47B96/02;;A47B77/02;;A47B57/585;;A47B96/20;;A47B96/201;;A47B2230/0025;;A47B2230/0022;;A47B2230/07;;A47B2230/13;;A47B47/047;;A47B2230/0081,A47B47/00;;A47B77/08;;A47B96/04;;A47B96/20;;F16B5/00,,0,0,,,,ACTIVE
776,AU,B2,AU 2013/205264 B2,167-807-894-627-957,2015-04-02,2015,AU 2013/205264 A,2013-04-10,AU 2010/226111 A;;AU 2013/205264 A,2010-03-11,Accessory and mobile computing device communication using an application communication protocol,"1000149438_I.DOCX Abstract Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/167-807-894-627-957,Granted Patent,no,1,0,4,4,0,,H04J3/16,,0,0,,,,ACTIVE
777,DE,B4,DE 112010001170 B4,191-056-094-003-068,2019-02-28,2019,DE 112010001170 T,2010-03-11,US 16064409 P;;US 16060109 P;;US 72048910 A;;US 72040010 A;;US 72034910 A;;US 72037510 A;;US 72042310 A;;US 72044610 A;;US 2010/0027058 W,2009-03-16,Zubehörvorrichtung und mobile Rechenvorrichtungskommunikation mit Hilfe eines Anwendungskommunikationsprotokolls,"Verfahren umfassend:Kommunizieren, durch eine Zubehörvorrichtung, mit einem Betriebssystem, das auf einer mobilen Rechenvorrichtung ausgeführt wird, mit Hilfe eines Zubehörvorrichtungskommunikationsprotokolls;Kommunizieren, durch die Zubehörvorrichtung, an die mobile Rechenvorrichtung, von Information, die durch die mobile Rechenvorrichtung verwendbar ist, um ein Anwendungskommunikationsprotokoll zu identifizieren, das durch die Zubehörvorrichtung unterstützt wird, um mit einer Anwendung, die auf der mobilen Rechenvorrichtung ausgeführt wird, zu kommunizieren, wobei die Information mit Hilfe des Zubehörvorrichtungskommunikationsprotokolls kommuniziert wird, und wobei sich das Anwendungskommunikationsprotokoll von dem Zubehörvorrichtungskommunikationsprotokoll unterscheidet; undKommunizieren, durch die Zubehörvorrichtung, mit der Anwendung, die auf der mobilen Rechenvorrichtung ausgeführt wird mit Hilfe des Anwendungs-kommunikationsprotokollswobei das Kommunizieren mit dem Betriebssystem, das auf der mobilen Rechenvorrichtung ausgeführt wird, ein Senden an das Betriebssystem der mobilen Rechenvorrichtung einer ersten Mitteilung, welche dem Zubehörvorrichtungskommunikationsprotokoll entspricht über einen Anschluss der mobile Rechenvorrichtung, der einen bestimmten Kommunikationskanal unterstützt, umfasst; undwobei das Kommunizieren mit der Anwendung, die auf der mobilen Rechenvorrichtung ausgeführt wird, umfasst:Erzeugen einer zweiten Mitteilung, welche dem Zubehörvorrichtungskommunikationsprotokoll entspricht, wobei die zweite Mitteilung eine dritte Mitteilung durch Einkapseln, Umschlagen oder Einpacken enthält, die dem Anwendungskommunikationsprotokoll entspricht; undSenden der zweiten Mitteilung an das Betriebssystem der mobilen Rechenvorrichtung über den Anschluss der mobile Rechenvorrichtung, der den bestimmten Kommunikationskanal unterstützt, wobei das Betriebssystem der mobilen Rechenvorrichtung die dritte Mitteilung an die Anwendung weiterleitet und die dritte Mitteilung durch die Anwendung interpretiert wird.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/191-056-094-003-068,Granted Patent,no,4,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;G06F13/12;;G06F13/14;;G06F13/38;;H04L29/06;;H04L29/08;;H04M1/21;;H04M1/72409;;H04M1/72412;;H04W88/02,,0,0,,,,ACTIVE
778,WO,A2,WO 2002/056230 A2,185-124-713-905-47X,2002-07-18,2002,US 0143962 W,2001-11-21,US 25276200 P,2000-11-22,ELECTRONIC VOTING SYSTEM,A facility for conducting an election is described. The facility establishes a public key infrastructure for use in the election. The facility then employs the established key infrastructure in the operation of a voting site.,VOTEHERE INC;;NEFF C ANDREW;;ADLER JAMES M;;BERG ANDREW C;;HORNBAKER JOHN H III;;JANKE LEONARD C;;BENTSON RANDOLPH A;;MCCANN JAMES R III;;PETERSON ERIC A,NEFF C ANDREW;;ADLER JAMES M;;BERG ANDREW C;;HORNBAKER JOHN H III;;JANKE LEONARD C;;BENTSON RANDOLPH A;;MCCANN JAMES R III;;PETERSON ERIC A,,https://lens.org/185-124-713-905-47X,Patent Application,no,0,0,3,98,0,G07C13/00,G07C13/00,,0,0,,,,PENDING
779,AU,A1,AU 2010/226111 A1,170-565-573-395-875,2011-10-13,2011,AU 2010/226111 A,2010-03-11,US 72048910 A;;US 72037510 A;;US 72034910 A;;US 16064409 P;;US 72040010 A;;US 16060109 P;;US 72044610 A;;US 72042310 A;;US 2010/0027058 W,2009-03-16,Accessory and mobile computing device communication using an application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,PAUL HOLDEN;;BOLTON LAWRENCE G;;NITIN GANATRA;;MITCHELL ADLER;;CLARK SCHUBERT EMILY;;LEE DOROGUSKER JESSE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;SCOTT KRUEGER,,https://lens.org/170-565-573-395-875,Patent Application,no,3,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
780,CN,B,CN 102428665 B,026-104-084-808-197,2015-06-17,2015,CN 201080021428 A,2010-03-11,US 2010/0027058 W;;US 16060109 P;;US 16064409 P;;US 72037510 A;;US 72048910 A;;US 72044610 A;;US 72042310 A;;US 72040010 A;;US 72034910 A,2009-03-16,Accessory and mobile computing device communication using application communication protocol,,APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/026-104-084-808-197,Granted Patent,no,0,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
781,HK,A1,HK 1164584 A1,163-250-109-304-87X,2012-09-21,2012,HK 12104661 A,2012-05-11,US 2010/0027058 W;;US 16060109 P;;US 72040010 A;;US 72034910 A;;US 72044610 A;;US 16064409 P;;US 72042310 A;;US 72037510 A;;US 72048910 A,2009-03-16,ACCESSORY AND MOBILE COMPUTING DEVICE COMMUNICATION USING AN APPLICATION COMMUNICATION PROTOCOL,,APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE L;;TOPRANI SHYAM S;;LANGENFELD PETER T;;KRUEGER SCOTT;;ANANNY JOHN M;;ADLER MITCHELL,,https://lens.org/163-250-109-304-87X,Patent Application,no,0,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04M1/72409;;H04M1/72412,,0,0,,,,PENDING
782,WO,A1,WO 2010/107660 A1,001-098-672-947-884,2010-09-23,2010,US 2010/0027058 W,2010-03-11,US 16060109 P;;US 16064409 P;;US 72034910 A;;US 72037510 A;;US 72040010 A;;US 72042310 A;;US 72044610 A;;US 72048910 A,2009-03-16,ACCESSORY AND MOBILE COMPUTING DEVICE COMMUNICATION USING AN APPLICATION COMMUNICATION PROTOCOL,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC;;HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/001-098-672-947-884,Patent Application,yes,3,15,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,PENDING
783,WO,A1,WO 2020/092539 A1,034-608-411-585-218,2020-05-07,2020,US 2019/0058832 W,2019-10-30,US 201862753765 P;;US 201916667827 A,2018-10-31,MODULAR ENCLOSURE SYSTEM,A modular enclosure system includes a plurality of anchor rails configured to be mounted to a surface such as a wall to which the modular enclosure system is to be attached. The modular enclosure system includes a first partition having a plurality of partition segments and a second partition having a plurality of partition segments. The first partition and the second partition are each coupled to a first rail and a second rail of the plurality of anchor rails.,AMERICAN WOODMARK CORP,ADLER DEREK CREIGHTON;;CRAIG CHRISTOPHER DOUGLAS;;DUNSTON STEVEN CARY;;KHAN TABISH SHAMIM;;KRAEMER MICHAEL JOSEPH;;SMITH JEREMIAH GENE;;FERRY JOSHUA DAVID;;SCHROER JOHN MICHAEL;;MORRISON KEVIN,,https://lens.org/034-608-411-585-218,Patent Application,yes,4,0,3,3,0,F16B5/0032;;F16B5/0614;;A47B47/042;;A47B95/008;;A47B47/0075;;A47B96/205;;A47B96/04;;A47B95/008;;A47B47/042;;A47B96/066;;A47B96/02;;A47B77/02;;A47B57/585;;A47B96/20;;A47B96/201;;A47B2230/0025;;A47B2230/0022;;A47B2230/07;;A47B2230/13;;A47B47/047;;A47B2230/0081,A47B47/03;;A47B47/05;;A47B57/58,,0,0,,,,PENDING
784,AU,B2,AU 2013/205261 B2,059-031-617-066-53X,2015-04-02,2015,AU 2013/205261 A,2013-04-10,AU 2010/226111 A;;AU 2013/205261 A,2010-03-11,Accessory and mobile computing device communication using an application communication protocol,"1000149427_1.DOCX Abstract Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/059-031-617-066-53X,Granted Patent,no,2,0,4,4,0,,H04J3/16,,1,0,,,"SPECIFICATION OF THE BLUETOOTH SYSTEM, ""Wireless Connection Made Easy"", Covered Core Package Version: 2.1 + EDR",ACTIVE
785,AU,A1,AU 2013/205261 A1,038-573-823-178-553,2013-05-02,2013,AU 2013/205261 A,2013-04-10,AU 2010/226111 A;;AU 2013/205261 A,2010-03-11,Accessory and mobile computing device communication using an application communication protocol,"1000149427_1.DOCX Abstract Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/038-573-823-178-553,Patent Application,no,0,0,4,4,0,,H04J3/16,,0,0,,,,ACTIVE
786,BR,A2,BR PI1009309 A2,161-855-324-801-747,2016-03-08,2016,BR PI1009309 A,2010-03-11,US 2010/0027058 W;;US 16064409 P;;US 16060109 P;;US 72042310 A;;US 72044610 A;;US 72037510 A;;US 72048910 A;;US 72034910 A;;US 72040010 A,2009-03-16,comunicação de acessório e dispositivo de computação móvel usando um protocolo de comunicação de aplicativo,,APPLE INC,SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;ANANNY JOHN M;;BOLTON LAWRENCE G;;ADLER MITCHELL;;GANATRA NITIN;;HOLDEN PAUL;;LANGENFELD PETER T;;KRUEGER SCOTT;;TOPRANI SHYAM S,,https://lens.org/161-855-324-801-747,Patent Application,no,0,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
787,CN,A,CN 102428665 A,095-126-336-490-075,2012-04-25,2012,CN 201080021428 A,2010-03-11,US 2010/0027058 W;;US 16060109 P;;US 16064409 P;;US 72037510 A;;US 72048910 A;;US 72044610 A;;US 72042310 A;;US 72040010 A;;US 72034910 A,2009-03-16,Accessory and mobile computing device communication using application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,PAUL HOLDEN;;BOLTON LAWRENCE G;;NITIN GANATRA;;MITCHELL ADLER;;CLARK SCHUBERT EMILY;;LEE DOROGUSKER JESSE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;SCOTT KRUEGER,,https://lens.org/095-126-336-490-075,Patent Application,no,4,10,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
788,MX,A,MX 2011009737 A,148-677-129-107-215,2011-12-16,2011,MX 2011009737 A,2010-03-11,US 16060109 P;;US 16064409 P;;US 72040010 A;;US 72044610 A;;US 72048910 A;;US 72037510 A;;US 72034910 A;;US 72042310 A;;US 2010/0027058 W,2009-03-16,ACCESSORY AND MOBILE COMPUTING DEVICE COMMUNICATION USING AN APPLICATION COMMUNICATION PROTOCOL.,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/148-677-129-107-215,Patent Application,no,0,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
789,GB,A,GB 2481349 A,144-898-011-193-094,2011-12-21,2011,GB 201117660 A,2010-03-11,US 2010/0027058 W;;US 16060109 P;;US 72040010 A;;US 72034910 A;;US 72044610 A;;US 16064409 P;;US 72042310 A;;US 72037510 A;;US 72048910 A,2009-03-16,Accessory and mobile computing device communication using an application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE L;;TOPRANI SHYAM S;;LANGENFELD PETER T;;KRUEGER SCOTT;;ANANNY JOHN M;;ADLER MITCHELL,,https://lens.org/144-898-011-193-094,Patent Application,no,3,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,G06F13/38;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
790,US,B2,US 11253060 B2,076-367-775-824-08X,2022-02-22,2022,US 201916667827 A,2019-10-29,US 201916667827 A;;US 201862753765 P,2018-10-31,Modular enclosure system,A modular enclosure system includes a plurality of anchor rails configured to be mounted to a surface such as a wall to which the modular enclosure system is to be attached. The modular enclosure system includes a first partition having a plurality of partition segments and a second partition having a plurality of partition segments. The first partition and the second partition are each coupled to a first rail and a second rail of the plurality of anchor rails.,AMERICAN WOODMARK CORP,ADLER DEREK CREIGHTON;;CRAIG CHRISTOPHER DOUGLAS;;DUNSTON STEVEN CARY;;KHAN TABISH SHAMIM;;KRAEMER MICHAEL JOSEPH;;SMITH JEREMIAH GENE;;FERRY JOSHUA DAVID;;SCHROER JOHN MICHAEL;;MORRISON KEVIN,AMERICAN WOODMARK CORPORATION (2019-11-18),https://lens.org/076-367-775-824-08X,Granted Patent,yes,77,0,3,3,0,F16B5/0032;;F16B5/0614;;A47B47/042;;A47B95/008;;A47B47/0075;;A47B96/205;;A47B96/04;;A47B95/008;;A47B47/042;;A47B96/066;;A47B96/02;;A47B77/02;;A47B57/585;;A47B96/20;;A47B96/201;;A47B2230/0025;;A47B2230/0022;;A47B2230/07;;A47B2230/13;;A47B47/047;;A47B2230/0081,A47B47/00;;A47B47/04;;A47B57/58;;A47B77/02;;A47B95/00;;A47B96/02;;A47B96/04;;A47B96/06;;A47B96/20,,1,0,,,"International Search Report and Written Opinion issued in corresponding International Application No. PCT/US19/58832, dated Mar. 11, 2020.",ACTIVE
791,DE,T5,DE 112010001170 T5,138-405-420-871-401,2012-05-31,2012,DE 112010001170 T,2010-03-11,US 16064409 P;;US 16060109 P;;US 72048910 A;;US 72040010 A;;US 72034910 A;;US 72037510 A;;US 72042310 A;;US 72044610 A;;US 2010/0027058 W,2009-03-16,Zubehörvorrichtung und mobile Rechenvorrichtungskommunikation mit Hilfe eines Anwendungskommunikationsprotokolls,"Ausführungsformen der vorliegenden Erfindung stellen verschiedene Kommunikationstechniken zur Kommunikation zwischen einer mobilen Rechenvorrichtung und einer Zubehörvorrichtung bereit. Ein Zubehörvorrichtungsprotokoll, das ursprünglich in der mobilen Rechenvorrichtung enthalten ist, kann für einige Kommunikation verwendet werden. Eine Anwendung, die auf der mobilen Rechenvorrichtung ausgeführt wird, kann mit der Zubehörvorrichtung kommunizieren mit Hilfe eines Anwendungskommunikationsprotokolls. In einigen Ausführungsformen kann das Anwendungskommunikationsprotokoll sich von dem Zubehörvorrichtungskommunikationsprotokoll unterscheiden. In anderen Ausführungsformen kann das Anwendungsprotokoll nur von der Anwendung und der Zubehörvorrichtung erkannt werden. In einigen Ausführungsformen können Mitteilungen, die dem Anwendungsprotokoll entsprechen, zwischen der Anwendung und der Zubehörvorrichtung kommuniziert werden durch das Packen der Mitteilungen in eine Mitteilung, die dem Zubehörvorrichtungskommunikationsprotokoll entspricht.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/138-405-420-871-401,Patent Application,no,0,1,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,2,0,,,IEEE 1394-Standard;;IEEE 8o2.11-Familie-Normen,ACTIVE
792,WO,A1,WO 2020/214833 A1,161-926-548-595-749,2020-10-22,2020,US 2020/0028549 W,2020-04-16,US 201916388831 A,2019-04-18,REMOTE INTERACTION WITH A DEVICE USING SECURE RANGE DETECTION,"In some embodiments, a first device performs ranging operations to allow a user to perform one or more operations on the first device without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account that is authorized to perform operations on the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the operations to be performed on the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the operation is authorized on the first device.",APPLE INC,LEDWITH ALEXANDER R;;BENSON WADE;;KROCHMAL MARC J;;IAROCCI JOHN J;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L;;SYKORA LIBOR;;MARGARITOV JIRI,,https://lens.org/161-926-548-595-749,Patent Application,yes,8,0,4,33,0,G06F21/57;;G06F21/44;;G06F21/316;;G06F21/606;;H04L63/107;;H04L63/0853;;H04W12/33;;H04W12/64;;H04W12/64;;H04W12/33,H04W12/00;;H04L29/06,,0,0,,,,PENDING
793,AU,A4,AU 2011/101205 A4,180-972-080-278-014,2012-02-02,2012,AU 2011/101205 A,2011-09-19,US 2010/0027058 W,2010-03-11,Accessory and mobile computing device communication using an application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/180-972-080-278-014,Limited Patent,no,0,1,2,2,0,,H04J3/16,,0,0,,,,INACTIVE
794,AU,A1,AU 2013/205264 A1,184-984-314-840-713,2013-05-02,2013,AU 2013/205264 A,2013-04-10,AU 2010/226111 A;;AU 2013/205264 A,2010-03-11,Accessory and mobile computing device communication using an application communication protocol,"1000149438_I.DOCX Abstract Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/184-984-314-840-713,Patent Application,no,0,0,4,4,0,,H04J3/16,,0,0,,,,ACTIVE
795,KR,A,KR 20110129473 A,195-154-114-406-185,2011-12-01,2011,KR 20117024283 A,2010-03-11,US 72034910 A;;US 72037510 A;;US 72040010 A;;US 72042310 A;;US 72044610 A;;US 72048910 A;;US 16060109 P;;US 16064409 P;;US 2010/0027058 W,2009-03-16,ACCESSORY AND MOBILE COMPUTING DEVICE COMMUNICATION USING AN APPLICATION COMMUNICATION PROTOCOL,,APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/195-154-114-406-185,Patent Application,no,0,4,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04L29/06;;G06F13/14;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
796,WO,A3,WO 2002/056230 A3,005-241-607-272-934,2003-05-01,2003,US 0143962 W,2001-11-21,US 25276200 P,2000-11-22,ELECTRONIC VOTING SYSTEM,A facility for conducting an election is described. The facility establishes a public key infrastructure for use in the election. The facility then employs the established key infrastructure in the operation of a voting site.,VOTEHERE INC;;NEFF C ANDREW;;ADLER JAMES M;;BERG ANDREW C;;HORNBAKER JOHN H III;;JANKE LEONARD C;;BENTSON RANDOLPH A;;MCCANN JAMES R III;;PETERSON ERIC A,NEFF C ANDREW;;ADLER JAMES M;;BERG ANDREW C;;HORNBAKER JOHN H III;;JANKE LEONARD C;;BENTSON RANDOLPH A;;MCCANN JAMES R III;;PETERSON ERIC A,,https://lens.org/005-241-607-272-934,Search Report,yes,3,0,3,98,0,G07C13/00,G07C13/00,,4,2,121-985-603-598-918;;076-191-696-865-389,10.1109/hicss.1997.661700;;10.1016/0167-4048(96)00002-8,"CRANOR AND CYTRON: ""Sensus: A security-conscious Electronic Polling System for the Internet"", IEEE, 31 January 1997 (1997-01-31), pages 1 - 9, XP002215651, Retrieved from the Internet <URL:http://lorrie.cranor.org/pubs/hicss/hicss.html> [retrieved on 20020930];;HERSCHBERG: ""Secure Electronic Voting Over the World Wide Web"", MASSACHUSETTS INSTITUTE OF TECHNOLOGY, 27 May 1997 (1997-05-27), Massachusetts, USA, pages 1 - 82, XP002215652;;BORRELL J ET AL: ""An implementable secure voting scheme"", COMPUTERS & SECURITY. INTERNATIONAL JOURNAL DEVOTED TO THE STUDY OF TECHNICAL AND FINANCIAL ASPECTS OF COMPUTER SECURITY, ELSEVIER SCIENCE PUBLISHERS. AMSTERDAM, NL, vol. 15, no. 4, 1996, pages 327 - 338, XP004025182, ISSN: 0167-4048;;CRANOR: ""Electronic Voting"", ACM, 6 May 1999 (1999-05-06), XP002215653, Retrieved from the Internet <URL:http://web.archive.org/web/19990506040153/http://www1.acm.org/crossroads/xrds2-4/voting.html> [retrieved on 20020930]",PENDING
797,AU,B4,AU 2011/101205 B4,073-003-543-795-068,2012-08-23,2012,AU 2011/101205 A,2011-09-19,US 2010/0027058 W,2010-03-11,Accessory and mobile computing device communication using an application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/073-003-543-795-068,Limited Patent,no,3,0,2,2,0,,H04J3/16,,0,0,,,,INACTIVE
798,US,B2,US 11250118 B2,015-561-452-735-580,2022-02-15,2022,US 201916388831 A,2019-04-18,US 201916388831 A;;US 201815996413 A;;US 201715497203 A;;US 201662349029 P;;US 201762514897 P,2016-06-12,Remote interaction with a device using secure range detection,"In some embodiments, a first device performs ranging operations to allow a user to perform one or more operations on the first device without providing device-access credentials. For example, when a second device is within a first distance of the first device, the first device determines that the second device is associated with a first user account that is authorized to perform operations on the first device. In response to the determination, the first device enables at least one substitute interaction (e.g., a password-less UI interaction) to allow the operations to be performed on the first device to be accessed without receiving access credentials through a user interface. In response to detecting an occurrence of the substitute interaction, the operation is authorized on the first device.",APPLE INC,LEDWITH ALEXANDER R;;BENSON WADE;;KROCHMAL MARC J;;IAROCCI JOHN J;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L;;SYKORA LIBOR;;MARGARITOV JIRI,APPLE INC (1997-06-20),https://lens.org/015-561-452-735-580,Granted Patent,yes,87,0,2,33,0,G06F21/34;;G06F1/163;;H04W12/08;;H04W12/63;;H04W12/084;;H04W12/33;;G06F21/34;;G06F1/163;;H04W12/63;;H04W12/33,G06F21/34;;G06F1/16;;H04W12/63,,21,0,,,"Australian Examination Report from Australian Patent Application No. 2017286140, dated Nov. 26, 2019, 4 pages.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Jan. 6, 2020, 14 pages including English language translation.;;Korean Office Action from Korean Patent Application No. 10-2018-7034644, dated Jan. 14, 2020, 10 pages including English language translation.;;European Office Action dated Mar. 2, 2020, from European Patent Application No. 17731348.3, 6 pages.;;European Office Action from European Patent Application No. 17731348.3, dated Sep. 12, 2019, 7 pages.;;International Search Report and Written Opinion of International Patent Application from PCT/US2017/035601, dated Oct. 18, 2017, 20 pages.;;Written Opinion of the International Preliminary Examining Authority from PCT/US2017/035601, dated May 8, 2018, 8 pages.;;SRP Documentation, retrieved from http://srp.stanford.edu/doc.html#standards, visited Apr. 3, 2018, 3 pages.;;Wu, “The Secure Remote Password Protocol,” retrieved from http://srp.stanford.edu/ndss.html, 1998, 24 pages.;;Invitation to Pay Additional Fees from PCT/US2020/028549, dated Jul. 10, 2020, 13 pages.;;International Search Report and Written Opinion from PCT/US2020/028549, dated Aug. 31, 2020, 18 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 27, 2020, 26 pages including English language translation.;;Japanese Office Action from Japanese Patent Application No. 2018-562555, dated Sep. 25, 2020, 5 pages including English language translation.;;Notice of Acceptance from Australian Patent Application No. 2017286140, dated Oct. 12, 2020, 3 pages.;;Korean Office Action from Korean Patent Application No. 2018-7034644, dated Nov. 26, 2020, 9 pages including English language translation.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Jun. 3, 2021, 17 pages including English language translation.;;Japanese Notice of Allowance from Japanese Patent Application No. 2018-562555, dated May 31, 2021, 5 pages including English language translation.;;Korean Notice of Allowance from 10-2018-7034644, dated May 31, 2021, 5 pages including English language translation.;;European Office Action from European Patent Application No. 17731348.3, dated Jul. 2, 2021, 5 pages.;;Australian Examination Report from Australian Patent Application No. 2021200451, dated Sep. 28, 2021, 3 pages.;;Chinese Office Action from Chinese Patent Application No. 201780033185.8, dated Oct. 25, 2021, 19 pages including English language translation.",ACTIVE
799,EP,A1,EP 3925254 A1,180-418-248-300-396,2021-12-22,2021,EP 20724335 A,2020-04-16,US 201916388831 A;;US 2020/0028549 W,2019-04-18,REMOTE INTERACTION WITH A DEVICE USING SECURE RANGE DETECTION,,APPLE INC,LEDWITH ALEXANDER R;;BENSON WADE;;KROCHMAL MARC J;;IAROCCI JOHN J;;HAUCK JERROLD V;;BROUWER MICHAEL;;ADLER MITCHELL D;;SIERRA YANNICK L;;SYKORA LIBOR;;MARGARITOV JIRI,,https://lens.org/180-418-248-300-396,Patent Application,yes,0,0,4,33,0,G06F21/57;;G06F21/44;;G06F21/316;;G06F21/606;;H04L63/107;;H04L63/0853;;H04W12/33;;H04W12/64;;H04W12/64;;H04W12/33,H04W12/00;;H04L29/06,,0,0,,,,DISCONTINUED
800,AU,B2,AU 2010/226111 B2,158-669-057-999-80X,2013-01-24,2013,AU 2010/226111 A,2010-03-11,US 72048910 A;;US 72037510 A;;US 72034910 A;;US 16064409 P;;US 72040010 A;;US 16060109 P;;US 72044610 A;;US 72042310 A;;US 2010/0027058 W,2009-03-16,Accessory and mobile computing device communication using an application communication protocol,"Embodiments of the present invention provide various communication techniques for communication between a mobile computing device and an accessory. An accessory protocol that is generic to the mobile computing device can be used for some communication. An application executing at the mobile computing device can communicate with the accessory using an application communication protocol. In some embodiments, the application communication protocol can be different from the accessory communication protocol. In other embodiments the application protocol may only be recognized by the application and the accessory. In some embodiments, messages conforming to an application protocol can be communicated between the application and the accessory by packaging the messages inside a message conforming to the accessory communication protocol.",APPLE INC,HOLDEN PAUL;;BOLTON LAWRENCE G;;GANATRA NITIN;;ADLER MITCHELL;;SCHUBERT EMILY CLARK;;DOROGUSKER JESSE LEE;;TOPRANI SHYAM S;;ANANNY JOHN M;;LANGENFELD PETER T;;KRUEGER SCOTT,,https://lens.org/158-669-057-999-80X,Granted Patent,no,3,0,48,78,0,G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/385;;H04M1/72412;;H04M1/72409;;G06F13/14;;H04L9/40;;H04M1/72409;;H04M1/72412;;G06F13/385;;H04M1/0254,H04J3/16;;H04M1/72409;;H04M1/72412,,0,0,,,,ACTIVE
801,US,B1,US 6571235 B1,142-835-607-896-312,2003-05-27,2003,US 44942199 A,1999-11-23,US 44942199 A,1999-11-23,System for providing an interface for accessing data in a discussion database,"
    A method for facilitating effective access to application specific data in a discussion database. In use, the data is received from multiple users in a plurality of categories. To disseminate the data, access is provided to the data via an interface which not only lists, but also describes the categories. By describing the categories, a user may effectively select the categories on the interface which are most relevant. Such selection in turn subscribes the user to the data in the selected categories. 
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;DANGEL COLIN K;;YAMMINE PASCAL R,ACCENTURE GLOBAL SERVICES LIMITED (2010-09-01);;ACCENTURE LLP (2001-01-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-08-31),https://lens.org/142-835-607-896-312,Granted Patent,yes,12,98,1,12,0,G06F16/954;;G06F16/954;;Y10S707/99933,G06F17/30,707/3;;707/10,4,1,081-373-730-511-209,10.1109/enabl.1996.555183,"Cleetus, K. J. et al., ""PACT-a software package to manage proects and coordinate people"", Proceedings of the 5th Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises (Wet Ice '96) (96TB100058), Proceedings of Wet Ice '96, IEEE 5th Workshop on Enabling Technologies; Infrastructure for Collaborative Enterprises, St, pp. 162-169, 1996, Los Alamitos, CA, USA, IEEE Compt. Soc.;;Mason, K., ""Bulletin Board and Notepad For Reminders (ICONS)"" Research Disclosure, Kenneth Mason Publ., Hampshire, GB, No. 312, (Apr. 1, 1990), p. 322.;;Microsoft Team Manager 97 Brochure, 'Online! 1997, XP002165311 Retriev. From Internet: <URL:http://www.microsoft.com/office/teammanager/tmm97brch/>.;;""Project Management Environment"", IBM Tech. Disclosure Bulletin, US, IBM Corp. New York, vol. 32, No. 9A, (Feb. 1, 1990), pp. 250-254.",EXPIRED
802,US,S,US D0928820 S,042-495-500-204-765,2021-08-24,2021,US 201929711248 F,2019-10-29,US 201929711248 F;;US 201829637055 F,2018-02-13,Display screen or portion thereof with graphical user interface for a radiation treatment,,ZAP SURGICAL SYSTEMS INC,BODDULURI RADHIKA MOHAN;;SEIJO BERNADETTE;;ADLER JR JOHN R;;CHEN BEN;;WANG HONGWU;;WANG JIN-WU;;LIU DEZHI;;TSAI CHENG-CHIEH;;TING YUN-YI;;LIN YA-SHAN;;LIU YAN-LING,ZAP SURGICAL SYSTEMS INC (2018-10-23),https://lens.org/042-495-500-204-765,Design Right,no,42,22,2,2,0,,,1404;;D14/486;;D14/488,4,0,,,"“LG Urbane Watch LTE” Mar. 1, 2015, YouTube, site visited Dec. 1, 2020: https://youtu.be/2-AFM3RFXyA (Year: 2015).;;“Discover OsiriX MD The World Famous Medical Imaging Viewer”, OsiriX, Available Online at https://web.archive.org/web/20170421193753/https://www.osirix-viewer.com/osirix/osirix-md/, Apr. 21, 2017, 12 pages.;;“High-Resolution Cardiac Imaging”, Biomedial Physics Research Group, Available Online at, https://web.archive.org/web/20170313072011/https://www.bmp.ds.mpg.de/high-resolution-cardiac-imaging.html, Mar. 13, 2017, 1 page.;;Heiberg, “Figure 2”, Researchgate, Available online at, https://www.researchgate.net/figure/ Annotated-screen-shot-of-the-main-user-interface-of-Segment-The-circles-indicate_fig1_4090686, Jan. 2010.",ACTIVE
803,US,S,US D0900838 S,090-302-912-972-661,2020-11-03,2020,US 201829637055 F,2018-02-13,US 201829637055 F,2018-02-13,Display screen or portion thereof with graphical user interface for a radiation treatment,,ZAP SURGICAL SYSTEMS INC,BODDULURI RADHIKA MOHAN;;SEIJO BERNADETTE;;ADLER JR JOHN R;;CHEN BEN;;WANG HONGWU;;WANG JIN-WU;;LIU DEZHI;;TSAI CHENG-CHIEH;;TING YUN-YI;;LIU YAN-LING;;LIN YA-SHAN,ZAP SURGICAL SYSTEMS (2018-10-23),https://lens.org/090-302-912-972-661,Design Right,no,26,2,2,2,0,,,1404;;D14/486;;D14/487,3,0,,,"Heiberg, Einar. “Figure 2.” Researchgate, published Jan. 2010 (Retrieved from the Internet May 16, 2019). Internet URL: <https://www.researchgate.net/figure/Annotated-screen-shot-of-the-main-user-interface-of-Segment-The-circles-indicate_fig1_4090686> (Year: 2010).;;“OsiriX MD.” OsiriX, published Apr. 21, 2017 (Retrieved from the Internet May 16, 2019). Internet URL: < https://web.archive.org/web/20170421193753/https://www.osirix-viewer.com/osirix/osirix-md/> (Year: 2017).;;“High Resolution Cardiac Imaging.” Biomedial Physics Research Group, published Mar. 13, 2017 (Retrieved from the Internet Nov. 6, 2019). Internet URL: <https://web.archive.org/web/20170313072011/https://www.bmp.ds.mpg.de/high-resolution-cardiac-imaging.html> (Year: 2017).",ACTIVE
804,US,A1,US 2002/0184191 A1,103-006-992-736-717,2002-12-05,2002,US 44793499 A,1999-11-23,US 44793499 A,1999-11-23,REPORT SEARCHING IN A MERGER AND ACQUISITION ENVIRONMENT,"
   A system, method and article of manufacture are provided for querying a database including a plurality of items generated by multiple users. Users are allowed to create an item with a plurality of fields. The item is stored in a database with an identifier corresponding to the user. Upon receipt of a search query, the database is searched using the search query. The identifiers of a plurality of items found during the search are displayed. Upon selection of the associated identifier of one of the items, the fields of that item are depicted. 
",MARPE JAMES S.;;COYLE DAVID W.;;KIENE BRUCE P.;;CHESTNUT GREGORY P.;;DUROCHER JOHN F.;;ADLER SCOTT R.;;FARNER LAURA L.;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R.;;DANGEL COLIN K,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,ACCENTURE GLOBAL SERVICES LIMITED (2010-09-01);;ACCENTURE LLP (2001-01-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-08-31),https://lens.org/103-006-992-736-717,Patent Application,yes,0,54,2,2,0,G06Q10/10;;G06Q30/0201;;G06Q10/10;;G06Q30/0201;;Y10S707/99945;;Y10S707/99933,G06F17/30;;G06Q10/10;;G06Q30/02,707/3,0,0,,,,EXPIRED
805,WO,A2,WO 2001/039027 A2,140-872-701-151-798,2001-05-31,2001,US 0032278 W,2000-11-22,US 44861899 A,1999-11-23,DECISION MANAGEMENT IN A MERGER AND ACQUISITION ENVIRONMENT AND METHOD THEREOF,"A system, method and article of manufacture are provided for decision management during the execution of a process. A plurality of users are allowed to input decisions as they are made with respect to a process. The decisions are stored in a database via a network. The decisions are listed in an interface in real-time via the network. The users are allowed to create a plurality of items relating to the process which are also stored in the database via the network. The users are allowed to retrieve the items from the database via the network. Information relating to the process is communicated among the users via a bulletin board accessible via the network. As an option, requests for increasing a scope of the process may also be received and stored.",ANDERSEN CONSULTING LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/140-872-701-151-798,Patent Application,yes,0,3,5,5,0,G06Q30/02,G06Q30/00,,0,0,,,,PENDING
806,US,B2,US 6581039 B2,060-908-156-639-385,2003-06-17,2003,US 44793499 A,1999-11-23,US 44793499 A,1999-11-23,Report searching in a merger and acquisition environment,"
    A method of searching for a report in a database including a plurality of items generated by multiple users. Users are allowed to create an item with a plurality of fields. The item is stored in a database with an identifier corresponding to the user. Upon receipt of a search query, the database is searched using the search query. The identifiers of a plurality of items found during the search are displayed. Upon selection of the associated identifier of one of the items, the fields of that item are depicted. 
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,ACCENTURE GLOBAL SERVICES LIMITED (2010-09-01);;ACCENTURE LLP (2001-01-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-08-31),https://lens.org/060-908-156-639-385,Granted Patent,yes,24,85,2,2,0,G06Q10/10;;G06Q30/0201;;G06Q10/10;;G06Q30/0201;;Y10S707/99945;;Y10S707/99933,G06F17/30;;G06Q10/10;;G06Q30/02,705/7;;345/650;;345/594;;345/733;;345/751;;345/810;;345/834;;709/200;;709/253;;706/61;;705/1;;705/7;;705/11;;707/3;;707/104.1,0,0,,,,EXPIRED
807,EP,A1,EP 1234267 A1,047-060-715-832-717,2002-08-28,2002,EP 00986232 A,2000-11-22,US 0032245 W;;US 44862199 A,1999-11-23,REPORTING AND TRACKING IN A MERGER AND ACQUISITION ENVIRONMENT,,ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,ACCENTURE GLOBAL SERVICES LIMITED (2011-04-20);;ACCENTURE GLOBAL SERVICES GMBH (2010-11-17),https://lens.org/047-060-715-832-717,Patent Application,yes,0,0,3,3,0,G06Q10/06,G06Q10/00,,2,0,,,"ANONYMOUS: ""Database for Navigational Links for a Text Part in a Compound Document"", IBM TECHNICAL DISCLOSURE BULLETIN, vol. 38, no. 1, 1 January 1995 (1995-01-01), New York, US, pages 371 - 372;;See also references of WO 0139083A1",DISCONTINUED
808,WO,A9,WO 2001/039027 A9,154-688-904-370-462,2002-05-30,2002,US 0032278 W,2000-11-22,US 44861899 A,1999-11-23,DECISION MANAGEMENT IN A MERGER AND ACQUISITION ENVIRONMENT,"A system, method and article of manufacture are provided for decision management during the execution of a process. A plurality of users are allowed to input decisions as they are made with respect to a process. The decisions are stored in a database via a network. The decisions are listed in an interface in real-time via the network. The users are allowed to create a plurality of items relating to the process which are also stored in the database via the network. The users are allowed to retrieve the items from the database via the network. Information relating to the process is communicated among the users via a bulletin board accessible via the network. As an option, requests for increasing a scope of the process may also be received and stored.",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/154-688-904-370-462,Patent Application,no,0,0,5,5,0,G06Q30/02,G06Q30/00,,0,0,,,,PENDING
809,US,B1,US 8606588 B1,088-429-073-953-158,2013-12-10,2013,US 44768099 A,1999-11-23,US 44768099 A,1999-11-23,Merger and acquisition knowledgebase,"A system, method and article of manufacture are provided for managing a merger or an acquisition. A plurality of statistics are tracked relating to a merger or an acquisition for reporting purposes. Further, a plurality of decisions are stored relating to the merger or acquisition. Such decisions may be accessed by a plurality of users involved in the merger or acquisition. In addition, a plurality of items associated with the merger or acquisition are inputted into a database. Each item is associated with at least one of the users. The users may be search for the items in the database.",MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K;;ACCENTURE GLOBAL SERVICES LTD,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,ACCENTURE GLOBAL SERVICES LIMITED (2010-09-01);;ACCENTURE LLP (2001-01-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-08-31),https://lens.org/088-429-073-953-158,Granted Patent,yes,69,7,3,3,0,G06Q10/0637;;G06Q10/0637,G06Q10/00,705/1.1;;705/311;;705/301,10,2,081-373-730-511-209;;066-009-416-680-35X,10.1109/enabl.1996.555183;;10.21236/ada177198,"Booz Allen and Hamilton, ""Making Acquisitions work: Capturing Value after the deal"", 1999, 24 pages.;;Dayco Statement Regarding Related Applications.;;""User's Guide for Microsoft Project for Windows 95 and Windows 3.1,"" copyright 1995.;;Cleetus, K. J. et al., ""PACT-A software package to manage projects and coordinate people"", Proceedings of the 5th Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises (WET ICE '96) (96TB100058), Proceedings of Wet Ice '96, IEEE 5th Workshop on Enabling Technologies; Infrastructure for Collaborative Enterprises, St, pp. 162-169, 1996, Los Alamitos, CA, USA, IEEE Compt. Soc.;;Mason, K., ""Bulletin Board and Notepad for Reminders (ICONS)"" Research Disclosure, Kenneth Mason Publ., Hampshire, GB, No. 312, (Apr. 1, 1990), p. 322.;;Microsoft Team Manager 97 Brochure, 'Online! 1997, XP002165311 Retriev. From Internet: .;;""Project Management Environment"", IBM Tech. Disclosure Bulletin, US, IBM Corp. New York, vol. 32, No. 9A, (Feb. 1, 1990), pp. 250-254.;;Planning Big with Mac Project, James Halcomb. 1986.;;S.L. Smith, J.N. Mosier: ""Guidelines for Designing User Interface Software"" [Online] Aug. 1986, MITRE Corp., Bedford, MA; USA, XP002430677 Retrieved from the Internet: URL: http://www.userlab. com/Downloads/Smith-Mosier-guideline-.pdf> [retrieved on Apr. 23, 2007] paragraph [003.] paragraphs [03.0]- [0007]-paragraphs [03.0]- [0011] paragraph [3.1.3] paragraphs [3.1.3]- [0021]-paragraphs [3.1.3]- [0024].;;Search report completed by the EPO on May 8, 2008 on Application No. 08153773.0-2201.",EXPIRED
810,US,B1,US 6671693 B1,062-104-392-822-287,2003-12-30,2003,US 44862499 A,1999-11-23,US 44862499 A,1999-11-23,System for effectively collecting and disseminating data,"
    A method for effectively collecting and disseminating information. In use, data is retrieved from multiple users in a plurality of categories. To disseminate the information, access is provided to the data via an interface which lists the data categories. By selecting a category in the interface, the user can subscribe to a data category and access the data therein. 
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,ACCENTURE GLOBAL SERVICES LIMITED (2010-09-01);;ACCENTURE LLP (2001-01-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-08-31),https://lens.org/062-104-392-822-287,Granted Patent,yes,44,129,1,12,0,G06F16/954;;G06F16/954;;Y10S707/99943,G06F17/30,707/102;;715/514;;709/229;;345/761;;345/762,6,1,081-373-730-511-209,10.1109/enabl.1996.555183,"""User's Guide for Microsoft Project for Windows 95 and Windows 3.1,"" copyright 1995.;;Cleetus, K. J. et al., ""PACT-a software package to manage projects and coordinate people"", Proceedings of the 5th Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises (WET ICE '96) (96TB100058), Proceedings of Wet Ice '96, IEEE 5th Workshop on Enabling Technologies; Infrastructure for Collaborative Enterprises, St, pp. 162-169, 1996, Los Alamitos, CA, USA, IEEE Compt. Soc.;;Mason, K., ""Bulletin Board and Notepad For Reminders (ICONS)"" Research Disclosure, Kenneth Mason Publ., Hampshire, GB, No. 312, (Apr. 1, 1990), p. 322.;;Microsoft Team Manager 97 Brochure, 'Online! 1997, XP002165311 Retriev. From Internet: <URL:http://www.microsoft.com/office/teammanager/tmm97brch/>.;;""Project Management Environment"", IBM Tech. Disclosure Bulletin, US, IBM Corp. New York, vol. 32, No. 9A, (Feb. 1, 1990), pp. 250-254.;;Planning Big with Mac Project, James Halcomb. 1986.",EXPIRED
811,AU,A,AU 2001/017993 A,199-650-312-021-225,2001-06-04,2001,AU 2001/017993 A,2000-11-22,US 44861899 A;;US 0032278 W,1999-11-23,Decision management in a merger and acquisition environment and method thereof,,ANDERSEN CONSULTING LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/199-650-312-021-225,Patent Application,no,0,0,5,5,0,G06Q30/02,G06Q30/00,,0,0,,,,DISCONTINUED
812,US,B2,US 9123011 B2,057-823-967-083-068,2015-09-01,2015,US 201314031174 A,2013-09-19,US 201314031174 A;;US 44768099 A,1999-11-23,"System, method, and article of manufacture for a merger and acquisition knowledgebase","A system, method and article of manufacture are provided for managing a merger or an acquisition. A plurality of statistics are tracked relating to a merger or an acquisition for reporting purposes. Further, a plurality of decisions are stored relating to the merger or acquisition. Such decisions may be accessed by a plurality of users involved in the merger or acquisition. In addition, a plurality of items associated with the merger or acquisition are inputted into a database. Each item is associated with at least one of the users. The users may be search for the items in the database.",ACCENTURE GLOBAL SERVICES LTD,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/057-823-967-083-068,Granted Patent,yes,68,0,3,3,0,G06Q10/0637;;G06Q10/0637,G06Q10/06,,9,2,066-009-416-680-35X;;081-373-730-511-209,10.21236/ada177198;;10.1109/enabl.1996.555183,"Booz Allen and Hamilton, ""Making Acquisitions work: Capturing Value after the deal"", 1999, 24 pages.;;Billow Butler & Company, L.L.C. ""Merges & Acquisitions"", 1997, 30 pages.;;S.L. Smith, J.N. Mosier: ""Guidelines for Designing User Interface Software"" [Online) Aug. 1986, Mitre Corp., Bedford, MA; USA, XP002430677 Retrieved from the Internet: URL: http://www.userlab. com/Downloads/Smith-Mosier-guideline-.pdf>[retrieved on Apr. 23, 2007] paragraph [003.) paragraphs [03.0]. [0007]-paragraphs [03.0) -[0011) paragraph [3.1.3) paragraphs [3.1.3]-[0021)-paragraphs [3.1.3]-[00241.;;Planning Big with Mac Project. James Holcomb: 1986.;;Project Management Environment, IBM Tech. Disclosure Bulletin. US, IBM Corp. New York, vol. 32, No. 9A, (211190), pp. 250-254 ..;;Microsoft Team Manager 97 Brochure, 'Onl1net 1997, XP002165311 Retrieved. From Internet .;;Mason. K., ""Bulletin Board and Notepad for Reminders (ICONS)"" Research Disclosure, Kenneth Mason Publ. Hampshire. GB, No. 312, (411190), p. 322.;;Cleetus, K. J. et al., ""PACT-a software package to manage projects and coordinate people"", Proceedings of the 5th Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises (WET ICE '96) (96TB100058), Proceedings of Wet Ice '96 , IEEE 5th Workshop on Enabling Technologies: Infrastructure for Collaborative Enterprises, St. pp. 162-169, 1996, Los Alamitos, CA, USA, IEEE Compt. Soc.;;User's Guide for Microsoft Project for Windows 95 and Windows 3.1, copyright 1995.",EXPIRED
813,WO,A3,WO 2001/039027 A3,198-530-733-827-689,2001-12-06,2001,US 0032278 W,2000-11-22,US 44861899 A,1999-11-23,DECISION MANAGEMENT IN A MERGER AND ACQUISITION ENVIRONMENT,"A system, method and article of manufacture are provided for decision management during the execution of a process. A plurality of users are allowed to input decisions as they are made with respect to a process. The decisions are stored in a database via a network. The decisions are listed in an interface in real-time via the network. The users are allowed to create a plurality of items relating to the process which are also stored in the database via the network. The users are allowed to retrieve the items from the database via the network. Information relating to the process is communicated among the users via a bulletin board accessible via the network. As an option, requests for increasing a scope of the process may also be received and stored.",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/198-530-733-827-689,Search Report,yes,3,0,5,5,0,G06Q30/02,G06Q30/00,,2,1,081-373-730-511-209,10.1109/enabl.1996.555183,"CLEETUS K J ET AL: ""PACT-a software package to manage projects and coordinate people"", PROCEEDINGS OF THE 5TH WORKSHOPS ON ENABLING TECHNOLOGIES: INFRASTRUCTURE FOR COLLABORATIVE ENTERPRISES (WET ICE '96) (96TB100058), PROCEEDINGS OF WET ICE '96. IEEE 5TH WORKSHOP ON ENABLING TECHNOLOGIES;INFRASTUCTURE FOR COLLABORATIVE ENTERPRISES, ST, 1996, Los Alamitos, CA, USA, IEEE Comput. Soc. Press, USA, pages 162 - 169, XP002165312, ISBN: 0-8186-7446-6;;""BULLETIN BOARD AND NOTEPAD FOR REMINDERS (ICONS)"", RESEARCH DISCLOSURE,KENNETH MASON PUBLICATIONS, HAMPSHIRE,GB, no. 312, 1 April 1990 (1990-04-01), pages 322, XP000104639, ISSN: 0374-4353",PENDING
814,US,A1,US 2014/0019213 A1,143-119-804-020-597,2014-01-16,2014,US 201314031174 A,2013-09-19,US 201314031174 A;;US 44768099 A,1999-11-23,"SYSTEM, METHOD, AND ARTICLE OF MANUFACTURE FOR A MERGER AND ACQUISITION KNOWLEDGEBASE","A system, method and article of manufacture are provided for managing a merger or an acquisition. A plurality of statistics are tracked relating to a merger or an acquisition for reporting purposes. Further, a plurality of decisions are stored relating to the merger or acquisition. Such decisions may be accessed by a plurality of users involved in the merger or acquisition. In addition, a plurality of items associated with the merger or acquisition are inputted into a database. Each item is associated with at least one of the users. The users may be search for the items in the database.",MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/143-119-804-020-597,Patent Application,yes,0,2,3,3,0,G06Q10/0637;;G06Q10/0637,G06Q10/06,705/7.36,2,0,,,"Booz Allen and Hamilton, ""Making Acquisitions work: Capturing Value after the deal"", 1999, 24 pages;;Billow Butler & Company, L.L.C. ""Merges & Acquisitions"", 1997, 30 pages",EXPIRED
815,EP,A2,EP 1236152 A2,190-596-606-856-605,2002-09-04,2002,EP 00980773 A,2000-11-22,US 0032278 W;;US 44861899 A,1999-11-23,DECISION MANAGEMENT IN A MERGER AND ACQUISITION ENVIRONMENT,,ANDERSEN CONSULTING LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,ACCENTURE GLOBAL SERVICES LIMITED (2011-04-20);;ACCENTURE LLP (2002-10-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-11-17),https://lens.org/190-596-606-856-605,Patent Application,yes,0,0,5,5,0,G06Q30/02,G06Q30/00,,1,0,,,See references of WO 0139027A3,DISCONTINUED
816,AU,A,AU 2001/022510 A,034-449-978-533-659,2001-06-04,2001,AU 2001/022510 A,2000-11-22,US 44862199 A;;US 0032245 W,1999-11-23,Reporting and tracking in a merger and acquisition environment,,ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/034-449-978-533-659,Patent Application,no,0,0,3,3,0,G06Q10/06,G06Q10/00,,0,0,,,,DISCONTINUED
817,WO,A1,WO 2001/039083 A1,054-830-119-293-034,2001-05-31,2001,US 0032245 W,2000-11-22,US 44862199 A,1999-11-23,REPORTING AND TRACKING IN A MERGER AND ACQUISITION ENVIRONMENT,"A system, method and article of manufacture are provided for reporting and tracking on the progress of a process. A plurality of users are allowed to create a plurality of status reports and workplans each including a plurality of fields. The status reports and workplans are stored in a database. The status reports and workplans are subsequently retrieved from the database by searching for information in the fields thereof. The status reports are compared with predetermined milestones to determine whether the milestones have been accomplished. A summary of the status reports, workplans, and accomplished milestones are outputted on a single interface. As an option, a preview of the item may also be displayed after the creation thereof and prior to the storing thereof.",ANDERSEN CONSULTING LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;PEPPER ROBIN;;KIM ROBERT;;YAMMINE PASCAL R;;DANGEL COLIN K,,https://lens.org/054-830-119-293-034,Patent Application,yes,3,4,3,3,0,G06Q10/06,G06Q10/00,,4,1,081-373-730-511-209,10.1109/enabl.1996.555183,"MICROSOFT TEAM MANAGER 97 BROCHURE, 1997, XP002165311, Retrieved from the Internet <URL:http://www.microsoft.com/office/teammanager/tmm97brch/> [retrieved on 20010412];;CLEETUS, CASCAVAL, MATSUZAKI: ""PACT - A Software Package to Manage Projects and Coordinate People"", PROCEEDINGS OF WET ICE'96, 19 June 1999 (1999-06-19) - 21 June 1999 (1999-06-21), Los Alamitos, CA, USA, pages 162 - 169, XP002165312;;""PROJECT MANAGEMENT ENVIRONMENT"", IBM TECHNICAL DISCLOSURE BULLETIN,US,IBM CORP. NEW YORK, vol. 32, no. 9A, 1 February 1990 (1990-02-01), pages 250 - 254, XP000083059, ISSN: 0018-8689;;See also references of EP 1234267A1",PENDING
818,US,A1,US 2009/0299044 A1,112-437-933-436-010,2009-12-03,2009,US 97810407 A,2007-10-25,US 97810407 A;;US 85467406 P;;US 99537007 P,2006-10-25,DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;KHARE TARUNA ARORA;;ADLER BEVERLY S;;MARTIN FRANCIS H,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;KHARE TARUNA ARORA;;ADLER BEVERLY S;;MARTIN FRANCIS H,AMGEN INC (2007-10-25),https://lens.org/112-437-933-436-010,Patent Application,yes,99,4,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,C07H21/04,536/23.53;;536/23.5,0,0,,,,INACTIVE
819,US,B2,US 8043829 B2,142-448-285-373-585,2011-10-25,2011,US 97810407 A,2007-10-25,US 97810407 A;;US 85467406 P;;US 99537007 P,2006-10-25,DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression,"Disclosed is a composition of matter comprising a ShK toxin peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",AMGEN INC,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,AMGEN INC (2007-10-25),https://lens.org/142-448-285-373-585,Granted Patent,yes,107,5,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,C12P21/00;;C07H21/04;;C12N5/10;;C12N15/62;;C12N15/63,435/69.1;;435/320.1;;435/328;;435/358;;435/369;;536/23.4;;536/23.53;;424/192.1;;424/134.1,102,78,027-477-313-726-928;;055-904-468-981-551;;044-070-839-595-346;;055-363-625-771-074;;022-461-717-344-928;;007-466-983-196-613;;143-773-891-771-490;;048-188-266-680-461;;103-932-348-507-545;;055-904-468-981-551;;027-477-313-726-928;;010-441-795-897-073;;110-710-672-061-901;;030-105-861-988-436;;080-485-419-434-773;;020-847-810-326-627;;028-862-168-091-90X;;066-736-071-983-312;;092-889-643-086-28X;;034-856-489-716-364;;032-385-840-854-377;;176-591-317-558-425;;058-183-868-529-742;;020-712-343-829-840;;021-667-798-811-176;;133-853-829-691-438;;037-542-804-662-982;;118-807-355-046-240;;067-544-774-098-213;;127-814-250-198-848;;083-370-213-067-671;;029-249-045-644-253;;078-629-783-492-046;;033-046-720-941-564;;055-568-690-253-037;;014-832-192-068-675;;041-941-499-241-497;;000-477-007-733-855;;028-705-790-086-503;;117-885-585-799-106;;070-647-682-022-246;;033-550-947-665-499;;051-390-199-356-641;;077-235-621-978-627;;097-269-181-564-404;;015-490-622-301-027;;100-286-864-518-416;;041-794-952-758-72X;;049-502-232-253-508;;071-963-545-666-249;;091-265-259-202-774;;035-835-686-803-161;;175-917-863-021-036;;033-201-121-977-677;;056-213-953-481-44X;;052-973-112-238-935;;056-856-449-462-409;;081-811-345-236-834;;039-341-337-181-478;;026-537-055-008-936;;063-897-019-013-181;;063-564-304-865-804;;038-196-087-232-29X;;064-218-742-617-581;;001-901-704-056-999;;064-503-673-552-122;;066-146-798-965-262;;066-836-885-760-853;;008-529-975-759-043;;023-748-289-544-142;;051-699-130-581-846;;021-129-642-629-96X;;015-222-816-005-540;;145-592-871-838-416;;050-974-807-206-157;;045-056-000-866-222;;028-446-000-626-373;;060-590-803-883-353,10.1073/pnas.79.6.1979;;pmc346105;;6804947;;10.1002/jmr.679;;15227640;;8297371;;10.1006/bbrc.1994.1090;;10.1016/j.pharmthera.2005.10.006;;16472864;;9395089;;10.1016/s0014-5793(97)01177-0;;10542442;;10.1016/s0165-6147(99)01398-x;;10.1038/nrd939;;12415245;;2315699;;10.1126/science.2315699;;10.1007/978-1-4684-6831-1_14;;10.1002/jmr.679;;15227640;;10.1073/pnas.79.6.1979;;pmc346105;;6804947;;12926074;;10.1002/(sici)1098-2299(199903/04)46:3/4<219::aid-ddr7>3.0.co;2-s;;2114618;;10.1023/a:1015853824722;;10.1016/0378-5173(90)90052-6;;10.1007/978-94-011-0683-2_118;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;17273162;;10.1038/sj.jid.5700717;;pmc1929164;;10.1111/j.1572-0241.2006.00524.x;;16573777;;10.1073/pnas.0605136103;;pmc1859943;;17088564;;10.1124/mol.104.008193;;15665253;;pmc4275123;;10.1073/pnas.241497298;;11717451;;pmc61146;;11145670;;10.4049/jimmunol.166.2.936;;15347667;;10.1074/jbc.m409627200;;10.1038/nrm1155;;12838342;;12838335;;10.1021/jm960099d;;8809169;;10.1016/j.jaad.2005.10.061;;16488299;;9143706;;10.1146/annurev.immunol.15.1.749;;10.1021/ol016169e;;11483047;;10.1038/sj.emboj.7600515;;pmc545807;;15616581;;10.1085/jgp.110.5.601;;pmc2229388;;9348331;;2473290;;10.1097/00005344-198900135-00036;;10.1016/s0169-409x(03)00108-x;;14499706;;10.1124/mol.63.2.409;;12527813;;10.1124/pr.55.4.5;;14657413;;10.1124/pr.55.4.7;;14657414;;10.1124/pr.55.4.8;;10.1016/j.tips.2004.03.010;;pmc2749963;;15120495;;10.1038/352026b0;;2062374;;12520055;;10.1093/nar/gkg086;;pmc165533;;14657417;;10.1124/pr.55.4.6;;10.1073/pnas.82.24.8737;;3909153;;pmc391512;;4015665;;10.4049/jimmunol.140.10.3482;;3283235;;10.1016/s0021-9258(19)49420-9;;8226817;;15182366;;10.1111/j.1432-1033.2004.04181.x;;1458545;;10.1021/jo048910c.s001;;15527271;;10.1021/jo048910c;;29711173;;10.1002/(sici)1521-3773(19980302)37:4<476::aid-anie476>3.0.co;2-2;;10.1016/s0304-3959(03)00177-5;;14499432;;10.1016/j.jaci.2004.04.005;;15241346;;10872455;;10.1146/annurev.biochem.68.1.383;;pmc320779;;6287432;;10.1093/nar/10.13.4071;;12100994;;10.1016/s0005-2736(02)00398-x;;10.1016/b978-0-12-516302-6.50008-6;;10774722;;10.1016/s0896-6273(00)81057-0;;10.1111/j.1399-3011.1995.tb00597.x;;8537179;;10.1021/bk-1997-0680.ch016;;pmc2212870;;16147976;;10.1084/jem.20050687;;10.1016/b978-0-12-516302-6.50007-4;;15082137;;10.1016/j.pain.2004.01.029;;12838421;;10.1007/s00424-003-1077-0;;10.1016/j.cyto.2004.06.010;;15473953;;pmc2290329;;10.1113/jphysiol.2001.018333;;12042352;;10.1016/s0896-6273(00)00116-1;;11144347;;10.1016/j.transproceed.2005.03.128;;15919441;;1366535;;10.1038/nbt0490-343;;10820646;;10.1615/critrevtherdrugcarriersyst.v17.i2.20;;10.1161/01.atv.0000156399.12787.5c;;15662023;;14657415;;10.1124/pr.55.4.9;;10.1093/protein/12.7.563;;10436082;;10.1016/s0014-5793(01)03254-9;;11943138;;15189139;;10.1146/annurev.biochem.73.012803.092429;;10.1177/088391159501000205;;9292776;;10.3109/10799899709044284;;14657416;;10.1124/pr.55.4.10;;10.7326/0003-4819-111-3-206;;2787611;;10.1124/mol.65.3.630;;14978241,"Rudikoff et al, Proc Natl Acad Sci USA 79:1979-1983, 1982.;;Barrios et al, J Molecular Recognition 17: 332-338, 2004.;;Ngo et al., In the Protein Folding Problem and Tertiary Structure Prediction,1994, Merz et al., (ed.), Birkhauser, Boston, MA, pp. 492-495.;;Bednarek et al., ""Chemical synthesis and structure-function studies of margatoxin, a poten inhibitor of voltage-dependent potassium channel in human T lymphocytes"", Biochemical and Biophysical Research Communications, 198(2): 619-625, (1994).;;Judge et al., ""Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment"", Pharmacology and Therapeutics, Elsevier, GB, 111(1): 224-259, (2006) .;;Legros, et al., ""Influence of a NH2-terminal extension on the activity of KTX2, a K channel blocker purified from Androctonus australis scorpion venom"", FEBS Letters, Elsevier, Amsterdam, NL, 417(1): 123-129, (1997) .;;Tytgat, J. et al., ""A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies"", Trends in Pharmacological Sciences, Elsevier, Haywarth, GB, 20(11): 444-447, (1999).;;Hruby, Victor J., ""Designing Peptide Receptor Agonists and Antagonists"", Nature Reviews, 1: 847-858 (2002).;;U.S. Appl. No. 11/978,076 Office Communication dated Jul. 6, 2009.;;U.S. Appl. No. 11/978,076 Office Communication dated Oct. 27, 2009.;;U.S. Appl. No. 11/978,076 Office Communication dated Feb. 19, 2010.;;U.S. Appl. No. 11/978,110 Office Communication dated Jul. 15, 2009.;;U.S. Appl. No. 11/978,110 Office Communication dated Oct. 27, 2009.;;U.S. Appl. No. 11/978,110 Notice of Allowance dated Mar. 12, 2010.;;U.S. Appl. No. 11/978,111 Office Communication dated Sep. 29, 2009.;;U.S. Appl. No. 11/978,111 Office Communication dated Jan. 19, 2010.;;U.S. Appl. No. 11/978,119 Office Communication dated Jul. 22, 2009.;;U.S. Appl. No. 11/978,119 Office Communication dated Dec. 10, 2009.;;U.S. Appl. No. 11/978,105 Office Communication dated Aug. 27, 2009.;;U.S. Appl. No. 11/978,105 Office Communication dated Dec. 23, 2009.;;Bowie et al., ""Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions"", Science, 247: 1306-1310 (1990).;;Ngo et al., ""Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox"", The Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds), Springer Verlag, pp. 433 and 492-495 (Aug. 1994).;;Barrios et al., Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor, J. Mol. Recognit., 17:332-338, 2004.;;Rudikoff et al., Single amino acid substitution altering antigen-binding specificity, Proc. Natl. Acad. Sci. USA, 79:1979-1983, 1982.;;Abdul, et al., ""Activity of Potassium Channel-blockers in Breast Cancer"", Anticancer Research, 23: 3347-3352 (2003).;;Abuchowski, et al., ""Soluble Polymer-Enzyme Adducts"", Enzymes as Drugs, pp. 362-383 (1981).;;Adams, et al., ""Conotoxins and their Potential Pharmaceutical Applications"", Drug Devel. Research, 46: 219-234 (1999).;;Adjei, et al., Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers, Pharma. Res., 7: 565-569 (1990).;;Adjei, et al., ""Bioavailability of Leuprolide Following Intratracheal Administration to Beagle Dogs"", Internatl. J Pharmaceutics, 61: 135-144 (1990).;;""Advanced Chemtech Handbook of Combinatorial and Solid Phase Organic Chemistry"", Bennett, W.D. (ed.), Advanced Chem Tech, Inc., Louisville, Kentucky, (1998) (Provided Table of Contents only).;;Alberts, et al., ""Synthesis of a Novel Hematopoietic Peptide SK&F 107647"", Thirteenth Am. Pep. Symp, pp. 367-369 (1993).;;Altschul, et al, ""Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs"", Nuc. Acids Res., 25: 3389-3402 (1997).;;Azam, et al., ""Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis"", J Invest. Derm., 127: 1419-1429 (2007).;;Barrett, A., et al., (ed.), ""Handbook of Proteolytic Enzymes"", Academic Press, (1998) (Provided Table of Contents only).;;Baumgart, et al., ""Tacrolimus is Safe and Effective in Patients with Severe Steroid-Refractory or Steroid-Dependent Inflammatory Bowel Disease-A Long-Term Follow-Up"", Amer. J of Gastroenterology, 101: 1048-1056 (2006).;;Beeton, et al., ""Kv1.3 Channels are a Therapeutic Target for T Cell-Mediated Autoimmune Diseases"", PNAS, 103(46): 17414-17419 (2006).;;Beeton, et al., ""Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases"", Mol. Pharmacol., 67(4): 1369-1381 (2005).;;Beeton, et al., ""Selective Blockade of T Lymphocyte K+ Channels Ameliorates Experimental Autoimmune Encephalomyelitis, a Model for Multiple Sclerosis"", PNAS, 98(24): 13942-13947 (2001).;;Beeton, et al., ""Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation1"", J of Immunology, 166: 936-944 (2001).;;Begenisich, et al., ""Physiological Roles of the Intermediate Conductance, Ca2+-activated Potassium Channel Kcnn4"", J of Biological Chem., 279(46): 47681-47687 (2004).;;Berridge, et al., ""Calcium Signalling: Dynamics, Homeostasis and Remodelling"", Nature Reviews Mol. Cell Biol., 4: 517-529 (2003).;;Bhatnagar, et al., ""Structure-Activity Relationships of Novel Hematoregulatory Pepticides"", J Med. Chem., 39: 3814-3819 (1996).;;Bissonnette, et al., ""A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 2 Trial of ISA247 in Patients with Chronic Plaque Psoriasis"", J Am. Acad. Dermatol., 54: 472-478 (2006).;;Bodanszky, et al., ""The Practice of Peptide Synthesis"", 2nd Revised Ed., Springer-Verlag (1994) (Provided Table of Contents only).;;Bodanszky, ""Principles of Peptide Synthesis"", 2nd Ed., Springer Laboratory (1993) (Provided Table of Contents only).;;Boehm, et al., ""Cellular Response to Interferon-gamma"", Annu. Rev. Immunul., 15: 749-795 (1997).;;Bong, et al., ""Chemoselective Pd(0)-Catalyzed Peptide Coupling in Water"", Org. Lett., 3(16): 2509-2511 (2001).;;Bourinet, et al., ""Silencing of the Cav3.2 T-type Calcium Channel Gene in Sensory Neurons Demonstrates its Major Role in Nociception"", EMBO J, 24(2): 315-324 (2005).;;Bowlby, et al., ""Modulation of the Kv1.3 Potassium Channel by Receptor Tyrosine Kinases"", J Gen. Physiol, 110: 601-610 (1997).;;Braquet, et al., ""Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig"", J of Cardiovascular Pharmacol., 13(Suppl. 5): S143-S146 (1989).;;Caliceti, et al., ""Pharmacokinetic and Biodistribution Properties of Poly(ethylene glycol)-Protein Conjugates"", Advanced Drug Delivery Reviews, 55: 1261-1277 (2003).;;Castle, et al., ""Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels"", Mol. Pharmacol., 63(2): 409-418 (2003).;;Catterall, et al., ""International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels"", Pharmacol. Rev., 55(4): 573-574 (2003).;;Catterall, et al., ""International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels"", Pharmacol. Rev., 55(4): 575-578 (2003).;;Catterall, et al., ""International Union of Pharmacology, XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels"", Pharmacol. Rev., 55(4): 579-581 (2003).;;Chan, W. C. and White, P. D., Eds., ""Fmos Solid Phase Peptide Synthesis: A Practical Approach"", Oxford University Press, (2000) (Provided Table of Contents only).;;Chandy, et al., ""K+ Channels as Targets for Specific Immunomodulation"", Trends in Pharmacol. Sciences, 25(5): 280-289 (2004).;;Chandy, ""Simplified Gene Nomenclature"", Nature, 352: pp. 26 (1991).;;Chen, et al., ""MMDB: Entrez's 3D-Structure Database"", Nucleic Acids Res., 31(1), 474-477 (2003).;;Clapham, et al., ""International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels"", Pharmacol. Rev., 55(4): 591-596 (2003).;;Connelly et al., ""Neutral Endopeptidase 24.11 in Human Neutrophils: Cleavage of Chemotactic Peptide"", Proc. Natl. Acad. Sci. USA, 82: 8737-8741 (1985).;;Creighton, ""Proteins: Structures and Molecular Principles"", W. H. Freeman & Co., San Francisco, pp. 70-86 (1983).;;Davis, et al., ""Preparation and Characterization of Antibodies with Specificity for the Amino-Terminal Tetrapeptide Sequence of the Platelet-Derived Connective Tissue"", Biochem Intl., 10(3): 395-404 (1985).;;Debs, et al., ""Lung-Specific Delivery of Cytokines Induces Sustained Pulmonary and Systemic Immunomodulation in Rats"", J Immunol., 140: 3482-3488 (1988).;;Dedman, et al., Selection of Targeted Biological Modifiers from a Bacteriophage Library of Random Peptides, J Biol. Chem., 268(31): 23025-23030 (1993).;;del Rio-Portilla, et al., ""NMR Solution Structure of Cn12, a Novel Peptide from the Mexican Scorpion Centruroides noxius with a Typical beta-Toxin Sequence but with alpha-Like Physiological Activity"", Eur. J Biochem., 271: 2504-2516 (2004).;;Delgado, et al., ""The Uses and Properties of PEG-Linked Proteins"", Critical Ref in Thera. Drug Carrier Sys., 9(3,4): 249-304 (1992).;;DeVasher, et al., ""Aqueous-Phase, Palladium-Catalyzed Cross-Coupling of Aryl Bromides Under Mild Conditions, Using Water-Soluble, Sterically Demanding Alkylphosphines"", J Org. Chem., 69: 7919-7927 (2004).;;Dibowski, et al., ""Bioconjunction of Peptides by Palladium Catalyzed C-C Cross-Coupling in Water"", Angew. Chem. Int. Ed., 37(4): 476-478 (1998).;;Dogrul, et al., ""Reversal of Experimental Neuropathic Pain by T-Type Calcium Channel Blockers"", Pain, 105: 159-168 (2003).;;Duffy, et al., The K+ Channel iKcAl Potentiates Ca2+ Influx and Degranulation in Human Lung Mast Cells; J Allergy Clin. Immunol., 114(1): 66-72 (2004).;;Earnshaw; et al., ""Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis"", Annu. Rev. Biochem., 68: 383-424 (1999).;;Ellison, et al., ""The Nucleotide Sequence of a Human Immunoglobulin Cgamma1Gene"", Nucleic Acids Res., 10(13): 4071-4079 (1982).;;Engel, et al., ""Insertion of Carrier Proteins into Hydrophilic Loops of the Escherichia coli Lactose Permease"", Biochimica et Biophysica Acta, 1564: 38-46 (2002).;;Erickson, et al., ""Solid-Phase Peptide Synthesis"", The Proteins, (3rd ed.), Chapter 3: 257-517 (1976).;;Ertel, et al., ""Nomenclature of Voltage-Gated Calcium Channels"", Neuron 25: 533-535 (2000).;;Felix, A.M., ""Pegylated Peptides IV: Enhanced Biological Activity of Site-Directed Pegylated GRF Analogs"", Int. J Peptide Protein Res. 46: 253-264 (1995).;;Felix, a.M., ""Site-Specific Poly(ethylene glycol)ylation of Peptides"", American Chem. Soc., Chapter 16, pp. 218-238 (1997).;;Feske, et al., ""A Severe Defect in CRAC Ca2+ Channel Activation and altered K+ Channel Gating in T Cells from Immunodeficient Patients"", J Exp. Med. 202(5): 651-662 (2005).;;Fields, et al., ""Principles and Practice of Solid-Phase Peptide Synthesis"", Synthetic Peptides: A User's Guide, Chapter 3, pp. 77-129, [G. Grant, ed., Oxford University PresS] (1992).;;Fields, et al., ""Synthetic Peptides: A User's Guide"", Oxford University Press, Grant, G.A. (ed.), (2nd ed.), Chapter 3, pp. 93-218 (2002).;;Finn, et al., The Proteins, ""The Synthesis of Peptides by Solution Methods with Emphasis on Peptide Hormones"", (3rd ed.), vol. II, pp. 105-253 (1976).;;Flatters, et al., ""Ethosuximide Reverses Paclitaxel- and Vincristine-Induced Painful Peripheral Neuropathy"", Pain, 109: 150-161 (2004).;;Fraser, et al., ""Predominant Expression of Kv1.3 Voltage-Gated K+ Channel Subunit in Rat Prostate Cancer Cell Lines: Electrophysiological, Pharmacological and Molecular Characterisation"", Eur. J Physiol., 446: 559-571 (2003).;;Gaffen, et al., ""Overview of Interleukin-2 Function, Production and Clinical Applications"", Cytokine, 28; 109-123 (2004).;;Gennaro, A. R., Remington's Pharmaceutical Sciences, 18th Ed., Mack Publishing Co., Easton, PA, (1990) (Provided Table of Contents only).;;Glazebrook, et al., ""Potassium Channels Kv1.1, Kv1.2 and Kv1.6 Influence Excitablity of Rat Visceral Sensory Neurons"", J Physiology 541.2: 467-482 (2002).;;Goldin, et al, ""Nomenclature of Voltage-Gated Sodium Channels"", Neuron, 28: 365-368 (2000).;;Gonzalez-Pinto, et al., ""Five-Year Follow-Up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplanation"", Transplan. Proc., 37: 1713-1715 (2005).;;Goodson, ""Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site"", Biotechnology, 8: 343-346 (1990).;;Greene, et al., Protective Groups in Organic Synthesis, 3rd. Ed., John Wiley & Sons, Inc., (1999) (Provided Table of Contents only).;;Greenwald, et al., ""Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive Review"", Crit. Rev. in Therap. Drug Carrier Systems, 17(2): 101-161 (2000).;;Grgic, et al., ""Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo"", Arterioscler Thromb. Vasc. Biol., 25: 704-709 (2005).;;Gutman, et al., ""International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels"", Pharmacol. Rev., 55(4): 583-586 (2003).;;Halaby, et al., ""The Immunoglobin Fold Family: Sequence Analysis and 3D Structure Comparisons"", Prot. Engin., 12(7): 563-571 (1999).;;Harte, et al., ""Genome-Wide Detection and Family Clustering of Ion Channels"", FEBS Letters, 514 129-134 (2002).;;Hendrickson, et al., ""Incorporation of Nonnatural Amino Acids into Proteins"", Annu. Rev. Biochem., 73: 147-176 (2004).;;Herman, et al., Poly(Ethylene Glycol) with Reactive Endgroups: I. Modification of Proteins, J. Bioactive and Comp. Polymers, 10(2): 145-187 (1995).;;Herz, et al., ""Molecular Aproaches to Receptors as Targets for Drug Discovery"", J of Receptor & Signal Transduction Research, 17(5): 671-776 (1997).;;Hofmann, et al., ""International Union of Pharmacology. XLII. Compendium of Voltage-Gated Ion Channels: Cyclic Nucleotide-Modulated Channels"", Pharmacol. Rev., 55(4): 587-589 (2003).;;Hubbard, et al., ""Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in alpha1-Antitrypsin Deficiency Directly Augmented with an Aerosol of alpha1-Antitrypsin"", Annals of Internal Med., 111(3): 206-212 (1989).;;Jäger, et al., ""Blockage of Intermediate-Conductance Ca2+-Activated K+ Channels Inhibit Human Pancreatic Cancer Cell Growth In Vitro"", Mol. Pharmacol., 65(3): 630-638 (2004).",INACTIVE
820,WO,A2,WO 2008/088422 A2,112-889-168-770-413,2008-07-24,2008,US 2007/0022831 W,2007-10-25,US 85467406 P;;US 99537007 P,2006-10-25,TOXIN PEPTIDE THERAPEUTIC AGENTS,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",AMGEN INC;;SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG COLIN V JR;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG COLIN V JR;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,,https://lens.org/112-889-168-770-413,Patent Application,yes,0,83,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K38/00,,0,0,,,,PENDING
821,EP,A2,EP 2081602 A2,141-673-808-794-86X,2009-07-29,2009,EP 07872190 A,2007-10-25,US 2007/0022831 W;;US 85467406 P;;US 99537007 P,2006-10-25,TOXIN PEPTIDE THERAPEUTIC AGENTS,,AMGEN INC,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG COLIN V JR;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,,https://lens.org/141-673-808-794-86X,Patent Application,yes,0,0,20,20,0,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K47/48,,0,0,,,,DISCONTINUED
822,AU,A1,AU 2007/343796 A1,009-782-183-774-929,2008-07-24,2008,AU 2007/343796 A,2007-10-25,US 99537007 P;;US 85467406 P;;US 2007/0022831 W,2006-10-25,Toxin peptide therapeutic agents,,AMGEN INC,NGUYEN HUNG Q;;HU SHAW-FEN SYLVIA;;KHARE TARUNA ARORA;;MIRANDA LESLIE P;;SULLIVAN JOHN K;;GEGG COLIN V JR;;ADLER BEVERLY S;;WALKER KENNETH W;;MARTIN FRANCIS H;;MCGIVERN JOSEPH G,,https://lens.org/009-782-183-774-929,Patent Application,no,0,1,20,20,0,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K47/48;;A61K38/16;;A61P37/06;;C07K14/435;;C12N15/62,,0,0,,,,DISCONTINUED
823,EP,A1,EP 1986111 A1,083-822-235-090-551,2008-10-29,2008,EP 08162531 A,2000-11-22,EP 08153773 A;;EP 00986233 A;;US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,Method for effectively collecting and disseminating information,"A method for effectively collecting and disseminating information comprises receiving data from multiple users in a plurality of categories, providing access to the data via an interface that lists the categories and subscribing and accessing the categories of data in response to one user action.
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/083-822-235-090-551,Patent Application,yes,3,0,9,12,0,G06F16/954,G06F17/30,,3,1,020-739-405-271-230,10.17487/rfc1866,"No Search;;T. BERNERS-LEE; D. CONNOLY, RFC 1866: HYPERTEXT MARKUP LANGUAGE - 2.0"", November 1995 (1995-11-01);;R. FIELDING ET AL., HYPERTEXT TRANSFER PROTOCOL -- HTTP/1.1: HTTP WORKING GROUP INTERNET DRAFT, 2 May 1996 (1996-05-02)",DISCONTINUED
824,US,A1,US 2009/0297520 A1,089-582-211-838-674,2009-12-03,2009,US 97811107 A,2007-10-25,US 97811107 A;;US 85467406 P;;US 99537007 P,2006-10-25,Methods of using conjugated toxin peptide therapeutic agents,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,AMGEN INC (2007-10-25),https://lens.org/089-582-211-838-674,Patent Application,yes,6,4,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K39/395;;A61K38/16,424/134.1;;514/12,0,0,,,,INACTIVE
825,WO,A3,WO 2008/088422 A3,006-107-134-945-420,2009-02-19,2009,US 2007/0022831 W,2007-10-25,US 85467406 P;;US 99537007 P,2006-10-25,TOXIN PEPTIDE THERAPEUTIC AGENTS,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",AMGEN INC;;SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG COLIN V JR;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG COLIN V JR;;ARORA KHARE TARUNA;;ADLER BEVERLY S;;MARTIN FRANCIS H,,https://lens.org/006-107-134-945-420,Search Report,yes,10,1,20,20,0,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K38/16;;A61K47/48;;A61P37/06;;C07K14/435;;C12N15/62,,5,5,007-466-983-196-613;;055-363-625-771-074;;022-780-978-787-581;;044-070-839-595-346;;022-461-717-344-928,10542442;;10.1016/s0165-6147(99)01398-x;;10.1016/j.pharmthera.2005.10.006;;16472864;;10.1042/bj20041379;;15588251;;pmc1134677;;8297371;;10.1006/bbrc.1994.1090;;9395089;;10.1016/s0014-5793(97)01177-0,"TYTGAT J ET AL: ""A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies"", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER, HAYWARTH, GB, vol. 20, no. 11, 1 November 1999 (1999-11-01), pages 444 - 447, XP004182937, ISSN: 0165-6147;;JUDGE ET AL: ""Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment"", PHARMACOLOGY AND THERAPEUTICS, ELSEVIER, GB, vol. 111, no. 1, 1 July 2006 (2006-07-01), pages 224 - 259, XP005451102, ISSN: 0163-7258;;MOUHAT S ET AL: ""K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom"", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, vol. 385, no. Part 1, 1 January 2005 (2005-01-01), pages 95 - 104, XP002352829, ISSN: 0264-6021;;BEDNAREK MARIA A ET AL: ""Chemical synthesis and structure-function studies of margatoxin, a potent inhibitor of voltage-dependent potassium channel in human T lymphocytes"", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 198, no. 2, 1994, pages 619 - 625, XP002492920, ISSN: 0006-291X;;LEGROS C ET AL: ""Influence of a NH2-terminal extension on the activity of KTX2, a K<+> channel blocker purified from Androctonus australis scorpion venom"", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 417, no. 1, 3 November 1997 (1997-11-03), pages 123 - 129, XP004261406, ISSN: 0014-5793",PENDING
826,US,B2,US 7910102 B2,119-570-562-283-496,2011-03-22,2011,US 97811107 A,2007-10-25,US 97811107 A;;US 85467406 P;;US 99537007 P,2006-10-25,Methods of using conjugated toxin peptide therapeutic agents,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",AMGEN INC,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;KHARE TARUNA ARORA;;ADLER BEVERLY S;;MARTIN FRANCIS H,AMGEN INC (2007-10-25),https://lens.org/119-570-562-283-496,Granted Patent,yes,101,3,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K38/16;;A61K39/00,424/134.1;;514/21.3,100,77,143-773-891-771-490;;044-070-839-595-346;;055-363-625-771-074;;022-461-717-344-928;;007-466-983-196-613;;010-441-795-897-073;;110-710-672-061-901;;030-105-861-988-436;;080-485-419-434-773;;020-847-810-326-627;;028-862-168-091-90X;;066-736-071-983-312;;092-889-643-086-28X;;034-856-489-716-364;;032-385-840-854-377;;176-591-317-558-425;;058-183-868-529-742;;020-712-343-829-840;;021-667-798-811-176;;133-853-829-691-438;;037-542-804-662-982;;118-807-355-046-240;;067-544-774-098-213;;127-814-250-198-848;;083-370-213-067-671;;029-249-045-644-253;;078-629-783-492-046;;033-046-720-941-564;;055-568-690-253-037;;014-832-192-068-675;;041-941-499-241-497;;000-477-007-733-855;;028-705-790-086-503;;117-885-585-799-106;;070-647-682-022-246;;033-550-947-665-499;;051-390-199-356-641;;077-235-621-978-627;;097-269-181-564-404;;015-490-622-301-027;;100-286-864-518-416;;041-794-952-758-72X;;049-502-232-253-508;;071-963-545-666-249;;091-265-259-202-774;;035-835-686-803-161;;175-917-863-021-036;;033-201-121-977-677;;056-213-953-481-44X;;052-973-112-238-935;;056-856-449-462-409;;081-811-345-236-834;;039-341-337-181-478;;026-537-055-008-936;;063-897-019-013-181;;063-564-304-865-804;;038-196-087-232-29X;;064-218-742-617-581;;001-901-704-056-999;;064-503-673-552-122;;066-146-798-965-262;;066-836-885-760-853;;008-529-975-759-043;;023-748-289-544-142;;051-699-130-581-846;;021-129-642-629-96X;;015-222-816-005-540;;145-592-871-838-416;;050-974-807-206-157;;045-056-000-866-222;;028-446-000-626-373;;060-590-803-883-353;;023-371-073-708-948;;003-570-543-269-131;;087-772-943-309-334;;015-228-210-033-464;;054-364-879-761-587,10.1038/nrd939;;12415245;;8297371;;10.1006/bbrc.1994.1090;;10.1016/j.pharmthera.2005.10.006;;16472864;;9395089;;10.1016/s0014-5793(97)01177-0;;10542442;;10.1016/s0165-6147(99)01398-x;;12926074;;10.1002/(sici)1098-2299(199903/04)46:3/4<219::aid-ddr7>3.0.co;2-s;;2114618;;10.1023/a:1015853824722;;10.1016/0378-5173(90)90052-6;;10.1007/978-94-011-0683-2_118;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;17273162;;10.1038/sj.jid.5700717;;pmc1929164;;10.1111/j.1572-0241.2006.00524.x;;16573777;;10.1073/pnas.0605136103;;pmc1859943;;17088564;;10.1124/mol.104.008193;;15665253;;pmc4275123;;10.1073/pnas.241497298;;11717451;;pmc61146;;11145670;;10.4049/jimmunol.166.2.936;;15347667;;10.1074/jbc.m409627200;;10.1038/nrm1155;;12838342;;12838335;;10.1021/jm960099d;;8809169;;10.1016/j.jaad.2005.10.061;;16488299;;9143706;;10.1146/annurev.immunol.15.1.749;;10.1021/ol016169e;;11483047;;10.1038/sj.emboj.7600515;;pmc545807;;15616581;;10.1085/jgp.110.5.601;;pmc2229388;;9348331;;2473290;;10.1097/00005344-198900135-00036;;10.1016/s0169-409x(03)00108-x;;14499706;;10.1124/mol.63.2.409;;12527813;;10.1124/pr.55.4.5;;14657413;;10.1124/pr.55.4.7;;14657414;;10.1124/pr.55.4.8;;10.1016/j.tips.2004.03.010;;pmc2749963;;15120495;;10.1038/352026b0;;2062374;;12520055;;10.1093/nar/gkg086;;pmc165533;;14657417;;10.1124/pr.55.4.6;;10.1073/pnas.82.24.8737;;3909153;;pmc391512;;4015665;;10.4049/jimmunol.140.10.3482;;3283235;;10.1016/s0021-9258(19)49420-9;;8226817;;15182366;;10.1111/j.1432-1033.2004.04181.x;;1458545;;10.1021/jo048910c.s001;;15527271;;10.1021/jo048910c;;29711173;;10.1002/(sici)1521-3773(19980302)37:4<476::aid-anie476>3.0.co;2-2;;10.1016/s0304-3959(03)00177-5;;14499432;;10.1016/j.jaci.2004.04.005;;15241346;;10872455;;10.1146/annurev.biochem.68.1.383;;pmc320779;;6287432;;10.1093/nar/10.13.4071;;12100994;;10.1016/s0005-2736(02)00398-x;;10.1016/b978-0-12-516302-6.50008-6;;10774722;;10.1016/s0896-6273(00)81057-0;;10.1111/j.1399-3011.1995.tb00597.x;;8537179;;10.1021/bk-1997-0680.ch016;;pmc2212870;;16147976;;10.1084/jem.20050687;;10.1016/b978-0-12-516302-6.50007-4;;15082137;;10.1016/j.pain.2004.01.029;;12838421;;10.1007/s00424-003-1077-0;;10.1016/j.cyto.2004.06.010;;15473953;;pmc2290329;;10.1113/jphysiol.2001.018333;;12042352;;10.1016/s0896-6273(00)00116-1;;11144347;;10.1016/j.transproceed.2005.03.128;;15919441;;1366535;;10.1038/nbt0490-343;;10820646;;10.1615/critrevtherdrugcarriersyst.v17.i2.20;;10.1161/01.atv.0000156399.12787.5c;;15662023;;14657415;;10.1124/pr.55.4.9;;10.1093/protein/12.7.563;;10436082;;10.1016/s0014-5793(01)03254-9;;11943138;;15189139;;10.1146/annurev.biochem.73.012803.092429;;10.1177/088391159501000205;;9292776;;10.3109/10799899709044284;;14657416;;10.1124/pr.55.4.10;;10.7326/0003-4819-111-3-206;;2787611;;10.1124/mol.65.3.630;;14978241;;10.1021/bi9614390;;9063870;;11732639;;10.2174/1389450013348173;;10.1074/jbc.273.49.32697;;9830012;;10.1016/s1359-6446(98)01220-3;;15308774;;10.1073/pnas.0403413101;;pmc515085,"Hruby. Designing peptide receptor agonists and antagonists. Nature Reviews. Drug Discovery, 2002. vol. 1, pp. 847-858.;;Bednarek et al., ""Chemical synthesis and structure-function studies of margatoxin, a poten inhibitor of voltage-dependent potassium channel in human T lymphocytes"", Biochemical and Biophysical Research Communications, 198(2): 619-625, (1994).;;Judge et al., ""Potassium channel blockers in multiple sclerosis: Neuronal Kv channels and effects of symptomatic treatment"", Pharmacology and Therapeutics, Elsevier, GB, 111(1): 224-259, (2006).;;Legros, et al., ""Influence of a NH2-terminal extension on the activity of KTX2, a K channel blocker purified from Androctonus australis scorpion venom"", FEBS Letters, Elsevier, Amsterdam, NL, 417(1): 123-129, (1997).;;Tytgat, J. et al., ""A unified nomenclature for short-chain peptides isolated from scorpion venoms: alpha-KTx molecular subfamilies"", Trends in Pharmacological Sciences, Elsevier, Haywarth, GB, 20(11): 444-447, (1999).;;USPTO Office Communication mailed Jul. 6, 2009 for U.S. Appl. No. 11/978,076.;;USPTO Office Communication mail Jul. 15, 2009 for U.S. Appl. No. 11/978,110 .;;USPTO Office Communication mail Jul. 22, 2009 for U.S. Appl. No. 11/978,119.;;USPTO Office Communication mail Aug. 27, 2009 for U.S. Appl. No. 11/978,105.;;Applicants' Restriction Requirement Response filed Aug. 5, 2009 for U.S. Appl. No. 11/978,110.;;Applicants' Restriction Requirement Response filed Aug. 5, 2009 for U.S. Appl. No. 11/978,076.;;Applicants' Restriction Requirement Response filed Aug. 5, 2009 for U.S. Appl. No. 11/978,119.;;Applicants' Amendment and Supporting Documents filed Sep. 11, 2009 for U.S. Appl. No. 11/978,110.;;Applicants' Restriction Requirement Response filed filed Sep. 11, 2009 for U.S. Appl. No. 11/978,105.;;Applicants' Amendment and Supporting Documents filed Sep. 11, 2009 for U.S. Appl. No. 11/978,105.;;Applicants' Amendment and Supporting Documents filed Sep. 11, 2009 for U.S. Appl. No. 11/978,119.;;Abdul, et al., ""Activity of Potassium Channel-blockers in Breast Cancer"", Anticancer Research, 23: 3347-3352 (2003).;;Abuchowski, et al., ""Soluble Polymer-Enzyme Adducts"", Enzymes as Drugs, pp. 362-383 (1981).;;Adams, et al., ""Conotoxins and their Potential Pharmaceutical Applications"", Drug Devel. Research, 46: 219-234 (1999).;;Adjei, et al., Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers, Pharma. Res., 7: 565-569 (1990).;;Adjei, et al., ""Bioavailability of Leuprolide Following Intratracheal Administration to Beagle Dogs"", Internatl. J Pharmaceutics, 61: 135-144 (1990).;;""Advanced Chemtech Handbook of Combinatorial and Solid Phase Organic Chemistry"", Bennett, W.D. (ed.), Advanced Chem Tech, Inc., Louisville, Kentucky, (1998) (Provided Table of Contents only).;;Alberts, et al., ""Synthesis of a Novel Hematopoietic Peptide SK&F 107647"", Thirteenth Am. Pep. Symp., pp. 367-369 (1993).;;Altschul, et al, ""Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs"", Nuc. Acids Res., 25: 3389-3402 (1997).;;Azam, et al., ""Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis"", J Invest. Derm., 127: 1419-1429 (2007).;;Barrett, A., et al., (ed.), ""Handbook of Proteolytic Enzymes"", Academic Press, (1998) (Provided Table of Contents only).;;Baumgart, et al., ""Tacrolimus is Safe and Effective in Patients with Severe Steroid-Refractory or Steroid-Dependent Inflammatory Bowel Disease-A Long-Term Follow-Up"", Amer. J of Gastroenterology, 101: 1048-1056 (2006).;;Beeton, et al., ""Kv1.3 Channels are a Therapeutic Target for T Cell-Mediated Autoimmune Diseases"", PNAS, 103(46): 17414-17419 (2006).;;Beeton, et al., ""Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases"", Mol. Pharmacol., 67(4): 1369-1381 (2005).;;Beeton, et al., ""Selective Blockade of T Lymphocyte K+ Channels Ameliorates Experimental Autoimmune Encephalomyelitis, a Model for Multiple Sclerosis"", PNAS, 98(24): 13942-13947 (2001).;;Beeton, et al., ""Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activations"", J of Immunology, 166: 936-944 (2001).;;Begenisich, et al., ""Physiological Roles of the Intermediate Conductance, Ca2+ -activated Potassium Channel Kcnn4"", J of Biological Chem., 279(46): 47681-47687 (2004).;;Berridge, et al., ""Calcium Signalling: Dynamics, Homeostasis and Remodelling"", Nature Reviews Mol. Cell Biol., 4: 517-529 (2003).;;Bhatnagar, et al., ""Structure-Activity Relationships of Novel Hematoregulatory Pepticides"", J Med. Chem., 39: 3814-3819 (1996).;;Bissonnette, et al., ""A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 2 Trial of ISA247 in Patients with Chronic Plaque Psoriasis"", J Am. Acad. Dermatol., 54: 472-478 (2006).;;Bodanszky, et al., ""The Practice of Peptide Synthesis"", 2nd Revised Ed., Springer-Verlag (1994) (Provided Table of Contents only).;;Bodanszky, ""Principles of Peptide Synthesis"", 2nd Ed., Springer Laboratory (1993) (Provided Table of Contents only).;;Boehm, et al., ""Cellular Response to Interferon-gamma"", Annu. Rev. Immunul., 15: 749-795 (1997).;;Bong, et al., ""Chemoselective Pd(0)-Catalyzed Peptide Coupling in Water"", Org. Lett., 3(16): 2509-2511 (2001).;;Bourinet, et al., ""Silencing of the Cav3.2 T-type Calcium Channel Gene in Sensory Neurons Demonstrates its Major Role in Nociception"", EMBO J, 24(2): 315-324 (2005).;;Bowlby, et al., ""Modulation of the Kv1.3 Potassium Channel by Receptor Tyrosine Kinases"", J Gen. Physiol., 110: 601-610 (1997).;;Braquet, et al., ""Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig"", J of Cardiovascular Pharmacol., 13(Suppl. 5): S143-S146 (1989).;;Caliceti, et al., ""Pharmacokinetic and Biodistribution Properties of Poly(ethylene glycol)-Protein Conjugates"", Advanced Drug Delivery Reviews, 55: 1261-1277 (2003).;;Castle, et al., ""Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels"", Mol. Pharmacol., 63(2): 409-418 (2003).;;Catterall, et al., ""International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels"", Pharmacol. Rev., 55(4): 573-574 (2003).;;Catterall, et al., ""International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels"", Pharmacol. Rev., 55(4): 575-578 (2003).;;Catterall, et al., ""International Union of Pharmacology, XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels"", Pharmacol. Rev., 55(4): 579-581 (2003).;;Chan, W. C. and White, P. D., Eds., ""Fmoc Solid Phase Peptide Synthesis: A Practical Approach"", Oxford University Press, (2000) (Provided Table of Contents only).;;Chandy, et al., ""K+ Channels as Targets for Specific Immunomodulation"", Trends in Pharmacol. Sciences, 25(5): 280-289 (2004).;;Chandy, ""Simplified Gene Nomenclature"", Nature, 352: pp. 26 (1991).;;Chen, et al., ""MMDB: Entrez's 3D-Structure Database"", Nucleic Acids Res., 31(1), 474-477 (2003).;;Clapham, et al., ""International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels"", Pharmacol. Rev., 55(4): 591-596 (2003).;;Connelly et al., ""Neutral Endopeptidase 24.11 in Human Neutrophils: Cleavage of Chemotactic Peptide"", Proc. Natl. Acad. Sci. USA, 82: 8737-8741 (1985).;;Creighton, ""Proteins: Structures and Molecular Principles"", W. H. Freeman & Co., San Francisco, pp.70-86 (1983).;;Davis, et al., ""Preparation and Characterization of Antibodies with Specificity for the Amino-Terminal Tetrapeptide Sequence of the Platelet-Derived Connective Tissue"", Biochem Intl., 10(3): 395-404 (1985).;;Debs, et al., ""Lung-Specific Delivery of Cytokines Induces Sustained Pulmonary and Systemic Immunomodulation in Rats"", J Immunol., 140: 3482-3488 (1988).;;Dedman, et al., ""Selection of Targeted Biological Modifiers from a Bacteriophage Library of Random Peptides"", J Biol. Chem., 268(31): 23025-23030 (1993).;;del Rio-Portilla, et al., ""NMR Solution Structure of Cn12, a Novel Peptide from the Mexican Scorpion Centruroides Noxius with a Typical beta-Toxin Sequence but with alpha-Like Physiological Activity"", Eur. J Biochem., 271: 2504-2516 (2004).;;Delgado, et al., ""The Uses and Properties of PEG-Linked Proteins"", Critical Ref. in Thera. Drug Carrier Sys., 9(3,4): 249-304 (1992).;;DeVasher, et al., ""Aqueous-Phase, Palladium-Catalyzed Cross-Coupling of Aryl Bromides Under Mild Conditions, Using Water-Soluble, Sterically Demanding Alkylphosphines"", J Org. Chem., 69: 7919-7927 (2004).;;Dibowski, et al., ""Bioconjunction of Peptides by Palladium Catalyzed C-C Cross-Coupling in Water"", Angew. Chem. Int. Ed., 37(4): 476-478 (1998).;;Dogrul, et al., ""Reversal of Experimental Neuropathic Pain by T-Type Calcium Channel Blockers"", Pain, 105: 159-168 (2003).;;Duffy, et al., The K+ Channel iKCA1 Potentiates Ca2+ Influx and Degranulation in Human Lung Mast Cells; J Allergy Clin. Immunol., 114(1): 66-72 (2004).;;Earnshaw; et al., ""Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis"", Annu. Rev. Biochem., 68: 383-424 (1999).;;Ellison, et al., ""The Nucleotide Sequence of a Human Immunoglobulin Cgamma1 Gene"", Nucleic Acids Res., 10(13): 4071-4079 (1982).;;Engel, et al., ""Insertion of Carrier Proteins into Hydrophilic Loops of the Escherichia Coli Lactose Permease"", Biochimica et Biophysica Acta, 1564: 38-46 (2002).;;Erickson, et al., ""Solid-Phase Peptide Synthesis"", The Proteins, (3rd ed.), Chapter 3: 257-517 (1976).;;Ertel, et al., ""Nomenclature of Voltage-Gated Calcium Channels"", Neuron 25: 533-535 (2000).;;Felix, A.M., ""Pegylated Peptides IV: Enhanced Biological Activity of Site-Directed Pegylated GRF Analogs"", Int. J Peptide Protein Res. 46: 253-264 (1995).;;Felix, A.M., ""Site-Specific Poly(ethylene glycol)ylation of Peptides"", American Chem. Soc., Chapter 16, pp. 218-238 (1997).;;Feske, et al., ""A Severe Defect in CRAC Ca2+ Channel Activation and altered K+Channel Gating in T Cells from Immunodeficient Patients"", J Exp. Med. 202(5): 651-662 (2005).;;Fields, et al., ""Principles and Practice of Solid-Phase Peptide Synthesis"", Synthetic Peptides: A User's Guide, Chapter 3, pp. 77-129, [G. Grant, ed., Oxford University Press] (1992).;;Fields, et al., ""Synthetic Peptides: A User's Guide"", Oxford University Press, Grant, G.A. (ed.), (2nd ed.), Chapter 3, pp. 93-218 (2002).;;Finn, et al., The Proteins, ""The Synthesis of Peptides by Solution Methods with Emphasis on Peptide Hormones"", (3rd ed.), vol. II, pp. 105-253 (1976).;;Flatters, et al., ""Ethosuximide Reverses Paclitaxel- and Vincristine-Induced Painful Peripheral Neuropathy"", Pain, 109: 150-161 (2004).;;Fraser, et al., ""Predominant Expression of Kv1.3 Voltage-Gated K+ Channel Subunit in Rat Prostate Cancer Cell Lines: Electrophysiological, Pharmacological and Molecular Characterisation"", Eur. J Physiol., 446: 559-571 (2003).;;Gaffen, et al., ""Overview of Interleukin-2 Function, Production and Clinical Applications"", Cytokine, 28; 109-123 (2004).;;Gennaro, A. R., Remington's Pharmaceutical Sciences, 18th Ed., Mack Publishing Co., Easton, PA, (1990) (Provided Table of Contents only).;;Glazebrook, et al., ""Potassium Channels Kv1.1, Kv1.2 and Kv1.6 Influence Excitablity of Rat Visceral Sensory Neurons"", J Physiology 541.2: 467-482 (2002).;;Goldin, et al, ""Nomenclature of Voltage-Gated Sodium Channels"", Neuron, 28: 365-368 (2000).;;González-Pinto, et al., ""Five-Year Follow-Up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplanation"", Transplan. Proc., 37: 1713-1715 (2005).;;Goodson, ""Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site"", Biotechnology, 8: 343-346 (1990).;;Greene, et al., Protective Groups in Organic Synthesis, 3rd. Ed., John Wiley & Sons, Inc., (1999).(Provided Table of Contents only).;;Greenwald, et al., ""Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive Review"", Crit. Rev. in Therap. Drug Carrier Systems, 17(2): 101-161 (2000).;;Grgic, et al., ""Selective Blockade of the Intermediate-Conductance Ca2+ -Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis in Vivo"", Arterioscler Thromb. Vasc. Biol., 25: 704-709 (2005).;;Gutman, et al., ""International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels"", Pharmacol. Rev., 55(4): 583-586 (2003).;;Halaby, et al., ""The Immunoglobin Fold Family: Sequence Analysis and 3D Structure Comparisons"", Prot. Engin., 12(7): 563-571 (1999).;;Harte, et al., ""Genome-Wide Detection and Family Clustering of Ion Channels"", FEBS Letters, 514 129-134 (2002).;;Hendrickson, et al., ""Incorporation of Nonnatural Amino Acids into Proteins"", Annu. Rev. Biochem., 73: 147-176 (2004).;;Herman, et al., Poly(Ethylene Glycol) with Reactive Endgroups: I. Modification of Proteins, J. Bioactive and Comp. Polymers, 10(2): 145-187 (1995).;;Herz, et al., ""Molecular Aproaches to Receptors as Targets for Drug Discovery"", J of Receptor & Signal Transduction Research, 17(5): 671-776 (1997).;;Hofmann, et al., ""International Union of Pharmacology. XLII. Compendium of Voltage-Gated Ion Channels: Cyclic Nucleotide-Modulated Channels"", Pharmacol. Rev., 55(4): 587-589 (2003).;;Hubbard, et al., ""Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in alpha1-Antitrypsin Deficiency Directly Augmented with an Aerosol of alpha1-Antitrypsin"", Annals of Internal Med., 111(3): 206-212 (1989).;;Jäger, et al., ""Blockage of Intermediate-Conductance Ca2+ -Activated K+Channels Inhibit Human Pancreatic Cancer Cell Growth in Vitro"", Mol. Pharmacol., 65(3): 630-638 (2004).;;Jaravine, et al., ""Three-Dimensional Structure of Toxin OSK1 from Orthochirus scrobiculosus Scorpion Venom"", Biochemistry, 36: 1223-1232 (1997).;;Jensen, et al., ""The Ca2+ -Activated K+ Channel of Intermediate Conductance: A Molecular Target for Novel Treatments?"" Current Drug Targets, 2: 401-422 (2001).;;Kalman, et al., ""ShK-Dap22, a Potent Kv1.3-Specific Immunosuppressive Polypeptide"", J Biol. Chem., 273(49): 32697-32707 (1998).;;Kay, et al., ""From Peptides to Drugs Via Phage Display"", Drug Disc. Today, 3(8): 370-378 (1998).;;Keil, B., Specificity of Proteolysis, Springer-Verlag, (Berlin/Heidelberg/New York) (1992) (Provided Table of Contents only).;;Kho, et al., ""A Tagging-Via-Substrate Technology for Detection and Proteomics of Farnesylated Proteins"", PNAS, 101(34): 12479-12484 (2004).",INACTIVE
827,EP,A1,EP 1986112 A1,027-335-524-588-170,2008-10-29,2008,EP 08162533 A,2000-11-22,EP 08153773 A;;EP 00986233 A;;US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,Method for providing a summary of data,"A method for providing a summary of data relating to a merger or acquisition via an interface to a database comprises identifying a plurality of issues relating to a merger or acquisition, determining a plurality of milestones associated with the merger or acquisition, identifying a plurality of projects corresponding to the merger or acquisition, gauging a progress of the projects in terms of a plurality of criterion and outputting the issues, the milestones, and the gauged progress of the projects.
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/027-335-524-588-170,Patent Application,yes,3,0,9,12,0,G06F16/954,G06F17/30,,3,1,020-739-405-271-230,10.17487/rfc1866,"The technical aspects identified in the present application (Art. 92 EPC) are considered part of common general knowledge. Due to their notoriety no documentary evidence is found to be required. For further details see the accompanying Opinion and the reference below.;;T. BERNERS-LEE; D. CONNOLY, RFC 1866: HYPERTEXT MARKUP LANGUAGE - 2.0, November 1995 (1995-11-01);;R. FIELDING ET AL., HYPERTEXT TRANSFER PROTOCOL -- HTTP/1.1: HTTP WORKING GROUP INTEMET DRAFT, 2 May 1996 (1996-05-02)",DISCONTINUED
828,US,S,US D0843582 S,081-280-677-024-31X,2019-03-19,2019,US 201729616477 F,2017-09-06,US 201729616477 F,2017-09-06,Radiosurgery system,,ZAP SURGICAL SYSTEMS INC,ADLER JOHN;;ACHKIRE YOUNES;;TING YUN-YI;;CHEN YING-JHANG;;TSAI CHENG-CHIEH;;YU TZU-CHENG;;BRINKERHOFF MARK;;HOPMANS THOMAS;;BODDULURI RADHIKA MOHAN;;BOEDER RON;;MCDERMOTT THOMAS;;WANG JIN-WU;;SONAWALE KAUSTUBH,ZAP SURGICAL SYSTEMS INC (2017-10-10),https://lens.org/081-280-677-024-31X,Design Right,no,9,0,1,1,0,,,2401;;D24/158,0,0,,,,ACTIVE
829,CA,A1,CA 2667678 A1,085-925-916-477-49X,2008-07-24,2008,CA 2667678 A,2007-10-25,US 85467406 P;;US 99537007 P;;US 2007/0022831 W,2006-10-25,TOXIN PEPTIDE THERAPEUTIC AGENTS,"Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising t he expression vector. Methods of treating an autoimmune disorder and of prev enting or mitigating a relapse of a symptom of multiple sclerosis are also d isclosed.",AMGEN INC,ADLER BEVERLY S;;MARTIN FRANCIS H;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;ARORA KHARE TARUNA;;SULLIVAN JOHN K;;GEGG COLIN V JR;;HU SHAW-FEN SYLVIA;;WALKER KENNETH W,,https://lens.org/085-925-916-477-49X,Patent Application,no,0,1,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K47/48;;A61K38/16;;A61P37/06;;C07K14/435;;C12N15/62,,0,0,,,,DISCONTINUED
830,US,A1,US 2009/0291885 A1,089-796-376-141-457,2009-11-26,2009,US 97807607 A,2007-10-25,US 97807607 A;;US 85467406 P;;US 99537007 P,2006-10-25,Conjugated toxin peptide therapeutic agents,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;SYLVIA HU SHAW-FEN;;GEGG JR COLIN V;;KHARE TARUNA ARORA;;ADLER BEVERLY S;;MARTIN FRANCIS H,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;SYLVIA HU SHAW-FEN;;GEGG JR COLIN V;;KHARE TARUNA ARORA;;ADLER BEVERLY S;;MARTIN FRANCIS H,AMGEN INC (2007-10-22),https://lens.org/089-796-376-141-457,Patent Application,yes,6,11,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K38/16;;A61K38/10;;A61P43/00,514/12;;514/13,0,0,,,,INACTIVE
831,US,A1,US 2013/0331376 A1,182-245-101-329-338,2013-12-12,2013,US 201313966434 A,2013-08-14,US 201313966434 A;;US 97462210 A;;US 28998009 P;;US 40479710 P,2009-12-23,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E 1 , E 2 , R 1 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN CORP INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/182-245-101-329-338,Patent Application,yes,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/00,514/214.02;;544/258;;544/257;;544/251;;544/118;;544/238;;540/578;;544/247;;514/249;;514/250;;514/234.2;;514/230.2,0,0,,,,DISCONTINUED
832,US,B2,US 7820623 B2,043-646-177-765-061,2010-10-26,2010,US 97807607 A,2007-10-25,US 97807607 A;;US 85467406 P;;US 99537007 P,2006-10-25,Conjugated toxin peptide therapeutic agents,"Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.",AMGEN INC,SULLIVAN JOHN K;;MCGIVERN JOSEPH G;;MIRANDA LESLIE P;;NGUYEN HUNG Q;;WALKER KENNETH W;;HU SHAW-FEN SYLVIA;;GEGG JR COLIN V;;KHARE TARUNA ARORA;;ADLER BEVERLY S;;MARTIN FRANCIS H,AMGEN INC (2007-10-22),https://lens.org/043-646-177-765-061,Granted Patent,yes,101,7,20,20,5014,A61K38/00;;C07K14/43522;;C07K2319/30;;C07K2319/31;;A61K47/60;;A61P29/00;;A61P37/00;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/43522;;C07K2319/30;;A61K38/00;;C07K2319/31;;A61K47/60,A61K38/00,514/12;;514/13,100,87,143-773-891-771-490;;010-441-795-897-073;;110-710-672-061-901;;030-105-861-988-436;;080-485-419-434-773;;020-847-810-326-627;;028-862-168-091-90X;;066-736-071-983-312;;092-889-643-086-28X;;034-856-489-716-364;;032-385-840-854-377;;176-591-317-558-425;;058-183-868-529-742;;020-712-343-829-840;;021-667-798-811-176;;133-853-829-691-438;;037-542-804-662-982;;118-807-355-046-240;;067-544-774-098-213;;127-814-250-198-848;;083-370-213-067-671;;029-249-045-644-253;;078-629-783-492-046;;033-046-720-941-564;;055-568-690-253-037;;014-832-192-068-675;;041-941-499-241-497;;000-477-007-733-855;;028-705-790-086-503;;117-885-585-799-106;;070-647-682-022-246;;033-550-947-665-499;;051-390-199-356-641;;077-235-621-978-627;;097-269-181-564-404;;015-490-622-301-027;;100-286-864-518-416;;041-794-952-758-72X;;049-502-232-253-508;;071-963-545-666-249;;091-265-259-202-774;;035-835-686-803-161;;175-917-863-021-036;;033-201-121-977-677;;056-213-953-481-44X;;052-973-112-238-935;;056-856-449-462-409;;081-811-345-236-834;;039-341-337-181-478;;026-537-055-008-936;;063-897-019-013-181;;063-564-304-865-804;;038-196-087-232-29X;;064-218-742-617-581;;001-901-704-056-999;;064-503-673-552-122;;066-146-798-965-262;;066-836-885-760-853;;008-529-975-759-043;;023-748-289-544-142;;051-699-130-581-846;;021-129-642-629-96X;;015-222-816-005-540;;145-592-871-838-416;;050-974-807-206-157;;045-056-000-866-222;;028-446-000-626-373;;060-590-803-883-353;;023-371-073-708-948;;003-570-543-269-131;;087-772-943-309-334;;015-228-210-033-464;;054-364-879-761-587;;098-567-867-555-440;;037-656-230-524-665;;037-980-303-543-336;;035-533-191-186-41X;;017-335-327-412-456;;064-221-524-689-680;;003-762-234-479-609;;062-791-288-912-765;;067-569-294-141-48X;;011-428-853-962-022;;165-307-994-673-332;;006-495-124-376-110;;054-349-693-915-247;;066-407-564-136-114,10.1038/nrd939;;12415245;;12926074;;10.1002/(sici)1098-2299(199903/04)46:3/4<219::aid-ddr7>3.0.co;2-s;;2114618;;10.1023/a:1015853824722;;10.1016/0378-5173(90)90052-6;;10.1007/978-94-011-0683-2_118;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;17273162;;10.1038/sj.jid.5700717;;pmc1929164;;10.1111/j.1572-0241.2006.00524.x;;16573777;;10.1073/pnas.0605136103;;pmc1859943;;17088564;;10.1124/mol.104.008193;;15665253;;pmc4275123;;10.1073/pnas.241497298;;11717451;;pmc61146;;11145670;;10.4049/jimmunol.166.2.936;;15347667;;10.1074/jbc.m409627200;;10.1038/nrm1155;;12838342;;12838335;;10.1021/jm960099d;;8809169;;10.1016/j.jaad.2005.10.061;;16488299;;9143706;;10.1146/annurev.immunol.15.1.749;;10.1021/ol016169e;;11483047;;10.1038/sj.emboj.7600515;;pmc545807;;15616581;;10.1085/jgp.110.5.601;;pmc2229388;;9348331;;2473290;;10.1097/00005344-198900135-00036;;10.1016/s0169-409x(03)00108-x;;14499706;;10.1124/mol.63.2.409;;12527813;;10.1124/pr.55.4.5;;14657413;;10.1124/pr.55.4.7;;14657414;;10.1124/pr.55.4.8;;10.1016/j.tips.2004.03.010;;pmc2749963;;15120495;;10.1038/352026b0;;2062374;;12520055;;10.1093/nar/gkg086;;pmc165533;;14657417;;10.1124/pr.55.4.6;;10.1073/pnas.82.24.8737;;3909153;;pmc391512;;4015665;;10.4049/jimmunol.140.10.3482;;3283235;;10.1016/s0021-9258(19)49420-9;;8226817;;15182366;;10.1111/j.1432-1033.2004.04181.x;;1458545;;10.1021/jo048910c.s001;;15527271;;10.1021/jo048910c;;29711173;;10.1002/(sici)1521-3773(19980302)37:4<476::aid-anie476>3.0.co;2-2;;10.1016/s0304-3959(03)00177-5;;14499432;;10.1016/j.jaci.2004.04.005;;15241346;;10872455;;10.1146/annurev.biochem.68.1.383;;pmc320779;;6287432;;10.1093/nar/10.13.4071;;12100994;;10.1016/s0005-2736(02)00398-x;;10.1016/b978-0-12-516302-6.50008-6;;10774722;;10.1016/s0896-6273(00)81057-0;;10.1111/j.1399-3011.1995.tb00597.x;;8537179;;10.1021/bk-1997-0680.ch016;;pmc2212870;;16147976;;10.1084/jem.20050687;;10.1016/b978-0-12-516302-6.50007-4;;15082137;;10.1016/j.pain.2004.01.029;;12838421;;10.1007/s00424-003-1077-0;;10.1016/j.cyto.2004.06.010;;15473953;;pmc2290329;;10.1113/jphysiol.2001.018333;;12042352;;10.1016/s0896-6273(00)00116-1;;11144347;;10.1016/j.transproceed.2005.03.128;;15919441;;1366535;;10.1038/nbt0490-343;;10820646;;10.1615/critrevtherdrugcarriersyst.v17.i2.20;;10.1161/01.atv.0000156399.12787.5c;;15662023;;14657415;;10.1124/pr.55.4.9;;10.1093/protein/12.7.563;;10436082;;10.1016/s0014-5793(01)03254-9;;11943138;;15189139;;10.1146/annurev.biochem.73.012803.092429;;10.1177/088391159501000205;;9292776;;10.3109/10799899709044284;;14657416;;10.1124/pr.55.4.10;;10.7326/0003-4819-111-3-206;;2787611;;10.1124/mol.65.3.630;;14978241;;10.1021/bi9614390;;9063870;;11732639;;10.2174/1389450013348173;;10.1074/jbc.273.49.32697;;9830012;;10.1016/s1359-6446(98)01220-3;;15308774;;10.1073/pnas.0403413101;;pmc515085;;10.1161/01.cir.0000086464.04719.dd;;12939222;;9164927;;10.1046/j.1365-2133.1998.02319.x;;9764154;;10.1074/jbc.274.33.23229;;10438496;;10961539;;10.1034/j.1399-3011.2000.00716.x;;15691265;;10.1111/j.1432-2277.2004.00041.x;;7108955;;10.1016/0022-2836(82)90515-0;;10.1152/physrev.1999.79.4.1317;;10508236;;14526382;;10.1038/nrd1197;;14662389;;10.1016/j.copbio.2003.10.011;;10.1016/0923-1137(94)90120-1;;9789547;;10.1038/nri1632;;15928679;;10.1126/science.3296191;;3296191,"Hruby. Designing Peptide Receptor Agonists and Antagonists. Nature Reviews. Drug Discovery. Nov. 2002. vol. 1, pp. 847-858.;;Abdul, et al., ""Activity of Potassium Channel-blockers in Breast Cancer"", Anticancer Research, 23: 3347-3352 (2003).;;Abuchowski, et al., ""Soluble Polymer-Enzyme Adducts"", Enzymes as Drugs, pp. 362-383 (1981).;;Adams, et al., ""Conotoxins and their Potential Pharmaceutical Applications"", Drug Devel. Research, 46: 219-234 (1999).;;Adjei, et al., Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers, Pharma. Res., 7: 565-569 (1990).;;Adjei, et al., ""Bioavailability of Leuprolide Following Intratracheal Administration to Beagle Dogs"", Internatl. J Pharmaceutics, 61: 135-144 (1990).;;""Advanced Chemtech Handbook of Combinatorial and Solid Phase Organic Chemistry"", Bennett, W.D. (ed.), Advanced Chem Tech, Inc., Louisville, Kentucky, (1998) (Provided Table of Contents only).;;Alberts, et al., ""Synthesis of a Novel Hematopoietic Peptide SK&F 107647"", Thirteenth Am. Pep. Symp., pp. 367-369 (1993).;;Altschul, et al, ""Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs"", Nuc. Acids Res., 25: 3389-3402 (1997).;;Azam, et al., ""Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis"", J Invest. Derm., 127: 1419-1429 (2007).;;Barrett, A., et al., (ed.), ""Handbook of Proteolytic Enzymes"", Academic Press, (1998) (Provided Table of Contents only).;;Baumgart, et al., ""Tacrolimus is Safe and Effective in Patients with Severe Steroid-Refractory or Steroid-Dependent Inflammatory Bowel Disease-A Long-Term Follow-Up"", Amer. J of Gastroenterology, 101: 1048-1056 (2006).;;Beeton, et al., ""Kv1.3 Channels are a Therapeutic Target for T Cell-Mediated Autoimmune Diseases"", PNAS, 103(46): 17414-17419 (2006).;;Beeton, et al., ""Targeting Effector Memory T Cells with a Selective Peptide Inhibitor of Kv1.3 Channels for Therapy of Autoimmune Diseases"", Mol. Pharmacol., 67(4): 1369-1381 (2005).;;Beeton, et al., ""Selective Blockade of T Lymphocyte K+ Channels Ameliorates Experimental Autoimmune Encephalomyelitis, a Model for Multiple Sclerosis"", PNAS, 98(24): 13942-13947 (2001).;;Beeton, et al., ""Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation1"", J of Immunology, 166: 936-944 (2001).;;Begenisich, et al., ""Physiological Roles of the Intermediate Conductance, Ca2+-activated Potassium Channel Kcnn4"", J of Biological Chem., 279(46): 47681-47687 (2004).;;Berridge, et al., ""Calcium Signalling: Dynamics, Homeostasis and Remodelling"", Nature Reviews Mol. Cell Biol., 4: 517-529 (2003).;;Bhatnagar, et al., ""Structure-Activity Relationships of Novel Hematoregulatory Pepticides"", J Med. Chem., 39: 3814-3819 (1996).;;Bissonnette, et al., ""A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 2 Trial of ISA247 in Patients with Chronic Plaque Psoriasis"", J Am. Acad. Dermatol., 54: 472-478 (2006).;;Bodanszky, et al., ""The Practice of Peptide Synthesis"", 2nd Revised Ed., Springer-Verlag (1994) (Provided Table of Contents only).;;Bodanszky, ""Principles of Peptide Synthesis"", 2nd Ed., Springer Laboratory (1993) (Provided Table of Contents only).;;Boehm, et al., ""Cellular Response to Interferon-gamma"", Annu. Rev. Immunul., 15: 749-795 (1997).;;Bong, et al., ""Chemoselective Pd(0)-Catalyzed Peptide Coupling in Water"", Org. Lett., 3(16): 2509-2511 (2001).;;Bourinet, et al., ""Silencing of the Cav3.2 T-type Calcium Channel Gene in Sensory Neurons Demonstrates its Major Role in Nociception"", EMBO J, 24(2): 315-324 (2005).;;Bowlby, et al., ""Modulation of the Kv1.3 Potassium Channel by Receptor Tyrosine Kinases"", J Gen. Physiol., 110: 601-610 (1997).;;Braquet, et al., ""Effect of Endothelin-1 on Blood Pressure and Bronchopulmonary System of the Guinea Pig"", J of Cardiovascular Pharmacol., 13(Suppl. 5): S143-S146 (1989).;;Caliceti, et al., ""Pharmacokinetic and Biodistribution Properties of Poly(ethylene glycol)-Protein Conjugates"", Advanced Drug Delivery Reviews, 55: 1261-1277 (2003).;;Castle, et al., ""Maurotoxin: A Potent Inhibitor of Intermediate Conductance Ca2+-Activated Potassium Channels"", Mol. Pharmacol., 63(2): 409-418 (2003).;;Catterall, et al., ""International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels"", Pharmacol. Rev., 55(4): 573-574 (2003).;;Catterall, et al., ""International Union of Pharmacology. XXXIX. Compendium of Voltage-Gated Ion Channels: Sodium Channels"", Pharmacol. Rev. 55(4): 575-578 (2003).;;Catterall, et al., ""International Union of Pharmacology, XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels"", Pharmacol. Rev., 55(4): 579-581 (2003).;;Chan, W. C. and White, P. D., Eds., ""Fmoc Solid Phase Peptide Synthesis: A Practical Approach"", Oxford University Press, (2000) (Provided Table of Contents only).;;Chandy, et al., ""K+ Channels as Targets for Specific Immunomodulation"", Trends in Pharmacol. Sciences, 25(5): 280-289 (2004).;;Chandy, ""Simplified Gene Nomenclature"", Nature, 352: pp. 26 (1991).;;Chen, et al., ""MMDB: Entrez's 3D-Structure Database"", Nucleic Acids Res., 31(1), 474-477 (2003).;;Clapham, et al., ""International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels"", Pharmacol. Rev., 55(4): 591-596 (2003).;;Connelly et al., ""Neutral Endopeptidase 24.11 in Human Neutrophils: Cleavage of Chemotactic Peptide"", Proc. Natl. Acad. Sci. USA, 82: 8737-8741 (1985).;;Creighton, ""Proteins: Structures and Molecular Principles"", W. H. Freeman & Co., San Francisco, pp. 70-86 (1983).;;Davis, et al., ""Preparation and Characterization of Antibodies with Specificity for the Amino-Terminal Tetrapeptide Sequence of the Platelet-Derived Connective Tissue"", Biochem Intl., 10(3): 395-404 (1985).;;Debs, et al., ""Lung-Specific Delivery of Cytokines Induces Sustained Pulmonary and Systemic Immunomodulation in Rats"", J Immunol., 140: 3482-3488 (1988).;;Dedman, et al., Selection of Targeted Biological Modifiers from a Bacteriophage Library of Random Peptides, J Biol. Chem., 268(31): 23025-23030 (1993).;;del Rio-Portilla, et al., ""NMR Solution Structure of Cn12, a Novel Peptide from the Mexican Scorpion Centruroides noxius with a Typical beta-Toxin Sequence but with alpha-Like Physiological Activity"", Eur. J Biochem., 271: 2504-2516 (2004).;;Delgado, et al., ""The Uses and Properties of PEG-Linked Proteins"", Critical Ref. in Thera. Drug Carrier Sys., 9(3,4): 249-304 (1992).;;DeVasher, et al., ""Aqueous-Phase, Palladium-Catalyzed Cross-Coupling of Aryl Bromides Under Mild Conditions, Using Water-Soluble, Sterically Demanding Alkylphosphines"", J Org. Chem., 69: 7919-7927 (2004).;;Dibowski, et al., ""Bioconjunction of Peptides by Palladium Catalyzed C-C Cross-Coupling in Water"", Angew. Chem. Int. Ed., 37(4): 476-478 (1998).;;Dogrul, et al., ""Reversal of Experimental Neuropathic Pain by T-Type Calcium Channel Blockers"", Pain, 105: 159-168 (2003).;;Duffy, et al., The K+ Channel iKCA1 Potentiates Ca2+ Influx and Degranulation in Human Lung Mast Cells; J Allergy Clin. Immunol., 114(1): 66-72 (2004).;;Earnshaw; et al., ""Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis"", Annu. Rev. Biochem., 68: 383-424 (1999).;;Ellison, et al., ""The Nucleotide Sequence of a Human Immunoglobulin Cgamma1Gene"", Nucleic Acids Res., 10(13): 4071-4079 (1982).;;Engel, et al., ""Insertion of Carrier Proteins into Hydrophilic Loops of the Escherichia coli Lactose Permease"", Biochimica et Biophysica Acta, 1564: 38-46 (2002).;;Erickson, et al., ""Solid-Phase Peptide Synthesis"", The Proteins, (3rd ed.), Chapter 3: 257-517 (1976).;;Ertel, et al., ""Nomenclature of Voltage-Gated Calcium Channels"", Neuron 25: 533-535 (2000).;;Felix, A.M., ""Pegylated Peptides IV: Enhanced Biological Activity of Site-Directed Pegylated GRF Analogs"", Int. J Peptide Protein Res. 46: 253-264 (1995).;;Felix, A.M., ""Site-Specific Poly(ethylene glycol)ylation of Peptides"", American Chem. Soc., Chapter 16, pp. 218-238 (1997).;;Feske, et al., ""A Severe Defect in CRAC Ca2+ Channel Activation and altered K+ Channel Gating in T Cells from Immunodeficient Patients"", J Exp. Med. 202(5): 651-662 (2005).;;Fields, et al., ""Principles and Practice of Solid-Phase Peptide Synthesis"", Synthetic Peptides: A User's Guide, Chapter 3, pp. 77-129, [G. Grant, ed., Oxford University Press] (1992).;;Fields, et al., ""Synthetic Peptides: A User's Guide"", Oxford University Press, Grant, G.A. (ed.), (2nd ed.), Chapter 3, pp. 93-218 (2002).;;Finn, et al., The Proteins, ""The Synthesis of Peptides by Solution Methods with Emphasis on Peptide Hormones"", (3rd ed.), vol. II, pp. 105-253 (1976).;;Flatters, et al., ""Ethosuximide Reverses Paclitaxel- and Vincristine-Induced Painful Peripheral Neuropathy"", Pain, 109: 150-161 (2004).;;Fraser, et al., ""Predominant Expression of Kv1.3 Voltage-Gated K+ Channel Subunit in Rat Prostate Cancer Cell Lines: Electrophysiological, Pharmacological and Molecular Characterisation"", Eur. J Physiol., 446: 559-571 (2003).;;Gaffen, et al., ""Overview of Interleukin-2 Function, Production and Clinical Applications"", Cytokine, 28; 109-123 (2004).;;Gennaro, A. R., Remington's Pharmaceutical Sciences, 18th Ed., Mack Publishing Co., Easton, PA, (1990) (Provided Table of Contents only).;;Glazebrook, et al., ""Potassium Channels Kv1.1, Kv1.2 and Kv1.6 Influence Excitablity of Rat Visceral Sensory Neurons"", J Physiology 541.2: 467-482 (2002).;;Goldin, et al, ""Nomenclature of Voltage-Gated Sodium Channels"", Neuron, 28: 365-368 (2000).;;González-Pinto, et al., ""Five-Year Follow-Up of a Trial Comparing Tacrolimus and Cyclosporine Microemulsion in Liver Transplanation"", Transplan. Proc., 37: 1713-1715 (2005).;;Goodson, ""Site-Directed Pegylation of Recombinant Interleukin-2 at its Glycosylation Site"", Biotechnology, 8: 343-346 (1990).;;Greene, et al., Protective Groups in Organic Synthesis, 3rd. Ed., John Wiley & Sons, Inc., (1999) (Provided Table of Contents only).;;Greenwald, et al., ""Poly(ethylene glycol) Conjugated Drugs and Prodrugs: A Comprehensive Review"", Crit. Rev. in Therap. Drug Carrier Systems, 17(2): 101-161 (2000).;;Grgic, et al., ""Selective Blockade of the Intermediate-Conductance Ca2+ -Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo"", Arterioscler Thromb. Vasc. Biol., 25: 704-709 (2005).;;Gutman, et al., ""International Union of Pharmacology. XLI. Compendium of Voltage-Gated Ion Channels: Potassium Channels"", Pharmacol. Rev., 55(4): 583-586 (2003).;;Halaby, et al., ""The Immunoglobin Fold Family: Sequence Analysis and 3D Structure Comparisons"", Prot. Engin., 12(7): 563-571 (1999).;;Harte, et al., ""Genome-Wide Detection and Family Clustering of Ion Channels"", FEBS Letters, 514 129-134 (2002).;;Hendrickson, et al., ""Incorporation of Nonnatural Amino Acids into Proteins"", Annu. Rev. Biochem., 73: 147-176 (2004).;;Herman, et al., Poly(Ethylene Glycol) with Reactive Endgroups: I. Modification of Proteins, J. Bioactive and Comp. Polymers, 10(2): 145-187 (1995).;;Herz, et al., ""Molecular Aproaches to Receptors as Targets for Drug Discovery"", J of Receptor & Signal Transduction Research, 17(5): 671-776 (1997).;;Hofmann, et al., ""International Union of Pharmacology. XLII. Compendium of Voltage-Gated Ion Channels: Cyclic Nucleotide-Modulated Channels"", Pharmacol. Rev., 55(4): 587-589 (2003).;;Hubbard, et al., ""Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in alpha1-Antitrypsin Deficiency Directly Augmented with an Aerosol of alpha1-Antitrypsin"", Annals of Internal Med., 111(3): 206-212 (1989).;;Jäger, et al., ""Blockage of Intermediate-Conductance Ca2+-Activated K+ Channels Inhibit Human Pancreatic Cancer Cell Growth in Vitro"", Mol. Pharmacol., 65(3): 630-638 (2004).;;Jaravine, et al., ""Three-Dimensional Structure of Toxin OSK1 from Orthochirus scrobiculosus Scorpion Venom"", Biochemistry, 36: 1223-1232 (1997).;;Jensen, et al., ""The Ca2+-Activated K+ Channel of Intermediate Conductance: A Molecular Target for Novel Treatments?"" Current Drug Targets, 2: 401-422 (2001).;;Kalman, et al., ""ShK-Dap22, a Potent Kv1.3-Specific Immunosuppressive Polypeptide"", J Biol. Chem., 273(49): 32697-32707 (1998).;;Kay, et al., ""From Peptides to Drugs Via Phage Display"", Drug Disc. Today, 3(8): 370-378 (1998).;;Keil, B., Specificity of Proteolysis, Springer-Verlag, (Berlin/Heidelberg/New York) (1992) (Provided Table of Contents only).;;Kho, et al., ""A Tagging-Via-Substrate Technology for Detection and Proteomics of Farnesylated Proteins"", PNAS, 101(34): 12479-12484 (2004).;;Kocienski, P.J., ""Protecting Groups"", Georg Thieme Verlag, (Stuttgart/New York) (1994) (Provided Table of Contents only).;;Köhler, et al., ""Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis"", Circulation, 108: 1119-1125 (2003).;;Koo, et al., ""Blockade of the Voltage-Gated Potassium Channel Kv1.3 Inhibits Immune Responses in Vivo"", J Immunol., 158: 5120-5128 (1997).;;Koo, J., ""A Randomized, Double-Blind Study Comparing the Efficacy, Safety and Optional Dose of Two Formulations of Cyclosporin, Neoral and Sandimmun, in Patients with Severe Psoriasis"", British J Derm., 139: 88-95 (1998).;;Krysan, et al., ""Quantitative Characterization of Furin Specificity"", J of Biol. Chem., 274(33): 23229-23234 (1999).;;Kuai, et al., ""Plasminogen Activator Inhibitor-1 Fused with Erythropoietin (EPO) Mimetic Peptide (EMP) Enhances the EPO Activity of EMP"", J Peptide Res., 56: 59-62 (2000).;;Kuypers, D.R. J., ""Immunosuppressive Drug Monitoring-What to Use in Clinical Practice Today to Improve Renal Graft Outcome"", Transplant Internat., 18: 140-150 (2005).;;Kyte, et al., ""A Simple Method for Displaying the Hydropathic Character of a Protein"", J Mol. Biol., 157: 105-132 (1982).;;Lehmann-Horn, et al., ""Voltage-Gated Ion Channels and Hereditary Disease"", Physiol. Reviews, 79(4): 1317-1372 (1999).;;Lewis, et al., ""Therapeutic Potential of Venom Peptides"", Nature Reviews/Drug Dis., 2: 790-802 (2003).;;Link, et al., ""Non-Canonical Amino Acids in Protein Engineering"", Curr. Opn. in Biotech., 14: 603-609 (2003).;;Lu, et al., ""Pegylated Peptides, III. Solid-Phase Synthesis with Pegylating Reagents of Varying Molecular Weight: Synthesis of Multiply Peglylated Peptides"", Reactive Polymers, 22: 221-229 (1994).;;MacLennan, et al., ""Structure-Function Relationships in the Ca2+-Binding and Translocation Domain of SERCA1: Physiological Correlates in Brody Disease"", Acta. Physiol. Scand., 163(Suppl 643) 55-67 (1998).;;Macian, F., ""NFAT Proteins: Key Regulators of T-Cell Development and Function"", Nature/Reviews/Immunol., 5: 472-484 (2005).;;Maniatis, et al., ""Regulation of Inducible and Tissue-Specific Gene Expression"", Science, 236: 1237-1245 (1987).",INACTIVE
833,EP,A2,EP 1939769 A2,089-108-412-569-572,2008-07-02,2008,EP 08153773 A,2000-11-22,EP 00986233 A;;US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,"Method for navigation, interface, collection and dissemination of data","A system, method, and article of manufacture are provided for facilitating the navigation of application specific data on a data page, i.e. web page, during use of a data browser, i.e. Netscape, MS Explorer, etc. Included on the data page are a plurality of links each corresponding to data. In use, the data may be retrieved upon selection of the corresponding link. To facilitate the navigation of the data, the links are displayed each as a component of an indicia such as a pointer or chevron to imply a relationship between the data. 
In one embodiment of the present invention, the aforementioned relationship is a progressional relationship and the indicia implies a direction of progressional movement through the data. In order to imply direction, the indicia may take the form of a chevron or any other type of pointer that implies direction. As an option, each of the components of indicia may also be shaped as a chevron. 
In yet another embodiment of the present invention, a currently selected link is visually differentiated with respect to the remaining links. This may be accomplished by highlighting a currently selected link. Further, the links may be continuously displayed with the data in order to continuously imply the progressional relationship and a current location among the data.
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/089-108-412-569-572,Patent Application,yes,0,2,9,12,0,G06F16/954,G06F17/30,,0,0,,,,DISCONTINUED
834,WO,A3,WO 2001/039047 A3,068-836-071-534-729,2008-01-17,2008,US 0032248 W,2000-11-22,US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,"METHOD FOR NAVIGATION, INTERFACE, COLLECTION AND DISSEMINATION OF DATA","A system, method, and article of manufacture are provided for facilitating the navigation of application specific data on a data page, i.e. web page, during use of a data browser, i.e. Netscape, MS Explorer, etc. Included on the data page are a plurality of links each corresponding to data. In use, the data may be retrieved upon selection of the corresponding link. To facilitate the navigation of the data, the links are displayed each as a component of an indicia such as a pointer or chevron to imply a relationship between the data.",ACCENTURE LLP,MARPE JAMES M;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/068-836-071-534-729,Search Report,yes,0,0,9,12,0,G06F16/954,G06F17/30,,1,1,066-009-416-680-35X,10.21236/ada177198,"S.L SMITH, J.N. MOSIER: ""Guidelines For Designing User Interface Software"", August 1986, MITRE CORP., BEDFORD, MA; USA, XP002430677",PENDING
835,US,A1,US 2015/0126502 A1,143-504-382-733-052,2015-05-07,2015,US 201514596824 A,2015-01-14,US 201514596824 A;;US 201313864332 A;;US 97440110 A;;US 28998009 P;;US 40479710 P,2009-12-23,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 , are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/143-504-382-733-052,Patent Application,yes,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,514/230.2;;544/258;;514/249;;544/257;;544/118;;514/234.2;;544/251;;514/250;;544/238;;544/259;;544/101;;544/231;;544/247,0,0,,,,DISCONTINUED
836,US,A1,US 2011/0207716 A1,180-846-864-311-292,2011-08-25,2011,US 97462210 A,2010-12-21,US 97462210 A;;US 28998009 P;;US 40479710 P,2009-12-23,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E 1 , E 2 , R 1 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,ELAN PHARMACEUTICAL INC (2011-04-05),https://lens.org/180-846-864-311-292,Patent Application,yes,4,1,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A61K31/519;;A61K31/5377;;A61K31/5383;;A61K31/55;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D475/00;;C07D475/12,514/214.02;;544/258;;544/257;;544/251;;544/118;;544/238;;540/578;;544/231;;514/249;;514/250;;514/234.2;;514/230.2,1,1,001-516-175-552-397,10.1016/s0169-409x(01)00097-7;;11325474,Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.,INACTIVE
837,US,B2,US 8541418 B2,101-243-012-569-340,2013-09-24,2013,US 97462210 A,2010-12-21,US 97462210 A;;US 28998009 P;;US 40479710 P,2009-12-23,Inhibitors of polo-like kinase,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E 1 , E 2 , R 1 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P;;ELAN PHARMACEUTICAL INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,ELAN PHARMACEUTICAL INC (2011-04-05),https://lens.org/101-243-012-569-340,Granted Patent,yes,21,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A61K31/4965;;C07D475/00,514/255.05;;544/258,4,1,001-516-175-552-397,10.1016/s0169-409x(01)00097-7;;11325474,"Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.;;International Search Report for related International Application No. PCT/US2010/061551 mailed Feb. 15, 2011.;;U.S. Appl. No. 12/974,401, filed Dec. 21, 2012.;;Office Action dated Apr. 11, 2012, in U.S. Appl. No. 12/974,401.",INACTIVE
838,US,A1,US 2013/0231335 A1,135-686-080-799-670,2013-09-05,2013,US 201313864332 A,2013-04-17,US 201313864332 A;;US 97440110 A;;US 28998009 P;;US 40479710 P,2009-12-23,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 , are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/135-686-080-799-670,Patent Application,yes,0,2,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A61K31/519;;A61K31/5377;;A61K31/5383,514/230.2;;514/249;;514/234.2;;514/250,0,0,,,,DISCONTINUED
839,US,A1,US 2011/0212942 A1,190-858-423-657-600,2011-09-01,2011,US 97440110 A,2010-12-21,US 97440110 A;;US 28998009 P;;US 40479710 P,2009-12-23,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,ELAN PHARMACEUTICALS INC (2011-04-05),https://lens.org/190-858-423-657-600,Patent Application,yes,4,1,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A61K31/55;;A61K31/4985;;A61K31/5383;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D471/14;;C07D475/00;;C07D487/14;;C07D498/14,514/214.02;;544/257;;544/251;;540/578;;544/101;;514/249;;514/250;;514/230.2,1,1,001-516-175-552-397,10.1016/s0169-409x(01)00097-7;;11325474,Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.,INACTIVE
840,WO,A2,WO 2001/039047 A2,168-183-580-397-865,2001-05-31,2001,US 0032248 W,2000-11-22,US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,"METHOD FOR NAVIGATION, INTERFACE, COLLECTION AND DISSEMINATION OF DATA","A system, method, and article of manufacture are provided for facilitating the navigation of application specific data on a data page, i.e. web page, during use of a data browser, i.e. Netscape, MS Explorer, etc. Included on the data page are a plurality of links each corresponding to data. In use, the data may be retrieved upon selection of the corresponding link. To facilitate the navigation of the data, the links are displayed each as a component of an indicia such as a pointer or chevron to imply a relationship between the data.",ANDERSEN CONSULTING LLP,MARPE JAMES M;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/168-183-580-397-865,Patent Application,yes,0,2,9,12,0,G06F16/954,G06F17/30,,0,0,,,,PENDING
841,WO,A9,WO 2001/039047 A9,015-911-555-280-539,2002-05-30,2002,US 0032248 W,2000-11-22,US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,"METHOD FOR NAVIGATION, INTERFACE, COLLECTION AND DISSEMINATION OF DATA","A system, method, and article of manufacture are provided for facilitating the navigation of application specific data on a data page, i.e. web page, during use of a data browser, i.e. Netscape, MS Explorer, etc. Included on the data page are a plurality of links each corresponding to data. In use, the data may be retrieved upon selection of the corresponding link. To facilitate the navigation of the data, the links are displayed each as a component of an indicia such as a pointer or chevron to imply a relationship between the data.",ACCENTURE LLP,MARPE JAMES M;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/015-911-555-280-539,Patent Application,no,0,0,9,12,0,G06F16/954,G06F17/30,,0,0,,,,PENDING
842,EP,A3,EP 1939769 A3,016-952-636-491-36X,2008-09-24,2008,EP 08153773 A,2000-11-22,EP 00986233 A;;US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,"Method for navigation, interface, collection and dissemination of data","A system, method, and article of manufacture are provided for facilitating the navigation of application specific data on a data page, i.e. web page, during use of a data browser, i.e. Netscape, MS Explorer, etc. Included on the data page are a plurality of links each corresponding to data. In use, the data may be retrieved upon selection of the corresponding link. To facilitate the navigation of the data, the links are displayed each as a component of an indicia such as a pointer or chevron to imply a relationship between the data. 
In one embodiment of the present invention, the aforementioned relationship is a progressional relationship and the indicia implies a direction of progressional movement through the data. In order to imply direction, the indicia may take the form of a chevron or any other type of pointer that implies direction. As an option, each of the components of indicia may also be shaped as a chevron. 
In yet another embodiment of the present invention, a currently selected link is visually differentiated with respect to the remaining links. This may be accomplished by highlighting a currently selected link. Further, the links may be continuously displayed with the data in order to continuously imply the progressional relationship and a current location among the data.
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/016-952-636-491-36X,Search Report,yes,0,0,9,12,0,G06F16/954,G06F17/30,,1,1,066-009-416-680-35X,10.21236/ada177198,"S.L SMITH, J.N. MOSIER: ""Guidelines For Designing User Interface Software"", August 1986, MITRE CORP., BEDFORD, MA; USA, XP002430677",DISCONTINUED
843,AU,A,AU 2001/022511 A,166-488-168-376-581,2001-06-04,2001,AU 2001/022511 A,2000-11-22,US 44794199 A;;US 44862499 A;;US 44942199 A;;US 0032248 W,1999-11-23,"Method for navigation, interface, collection and dissemination of data",,ANDERSEN CONSULTING LLP,MARPE JAMES M;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,,https://lens.org/166-488-168-376-581,Patent Application,no,0,0,9,12,0,G06F16/954,G06F17/30,,0,0,,,,DISCONTINUED
844,EP,A2,EP 1275060 A2,066-839-950-559-042,2003-01-15,2003,EP 00986233 A,2000-11-22,US 0032248 W;;US 44794199 A;;US 44862499 A;;US 44942199 A,1999-11-23,"METHOD FOR NAVIGATION, INTERFACE, COLLECTION AND DISSEMINATION OF DATA",,ANDERSEN CONSULTING LLP,MARPE JAMES M;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,ACCENTURE LLP (2008-05-21),https://lens.org/066-839-950-559-042,Patent Application,yes,0,2,9,12,0,G06F16/954,G06F17/30,,1,0,,,See references of WO 0139047A3,DISCONTINUED
845,US,B2,US 8445503 B2,008-945-228-726-814,2013-05-21,2013,US 97440110 A,2010-12-21,US 97440110 A;;US 28998009 P;;US 40479710 P,2009-12-23,Inhibitors of polo-like kinase,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P;;ELAN PHARM INC,GALEMMO ROBERT A;;ARTIS DEAN R;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE;;TRUONG ANH;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,ELAN PHARMACEUTICALS INC (2011-04-05),https://lens.org/008-945-228-726-814,Granted Patent,yes,21,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A01N43/54;;A61K31/505;;C07D491/00,514/267;;544/251,4,1,001-516-175-552-397,10.1016/s0169-409x(01)00097-7;;11325474,"Vippagunta et. al. Advanced Drug Delivery Reviews 48 (2001) 3-26.;;International Search Report for related International Application No. PCT/US2010/061535 mailed Feb. 15, 2011.;;U.S. Appl. No. 12/974,622, filed Dec. 21, 2012.;;Office Action dated Apr. 11, 2012, in U.S. Appl. No. 12/974,622.",INACTIVE
846,SG,A,SG 10201607721Y A,049-669-858-278-04X,2017-04-27,2017,SG 10201607721Y A,2016-09-15,US 201514858235 A,2015-09-18,Controller For An Aircraft Tracker,,BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,,https://lens.org/049-669-858-278-04X,Unknown,no,0,0,4,4,0,G08G5/0008;;G08G5/0013;;G08G5/0021;;G08G5/0082;;G07C5/008;;B64D2045/0065;;B64D45/00;;B64D45/00;;G07C5/008;;G08G5/0008;;G08G5/0013;;G08G5/0021;;G08G5/0082,,,0,0,,,,PENDING
847,CA,C,CA 2937854 C,040-610-144-837-184,2021-03-30,2021,CA 2937854 A,2016-08-02,US 201514858235 A;;US 201514832879 A;;US 201514832851 A,2015-08-21,CONTROLLER FOR AN AIRCRAFT TRACKER,"A method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and a policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,,https://lens.org/040-610-144-837-184,Granted Patent,no,0,0,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,G08G5/00;;G01C21/00;;H04W4/90,,0,0,,,,ACTIVE
848,JP,A,JP 2017095083 A,080-361-167-001-220,2017-06-01,2017,JP 2016179206 A,2016-09-14,US 201514858235 A;;US 201514832851 A;;US 201514832879 A,2015-08-21,CONTROLLER FOR AIRCRAFT TRACKER,"PROBLEM TO BE SOLVED: To provide a method, a device, and an aircraft tracker system for reporting status information on an aircraft.SOLUTION: The state 212 of an aircraft 202 is specified by using the sensor data 210 which has been received from an aircraft sensor system 206 in the aircraft. The state information is transmitted in the report frequency which is set by using: the state of the aircraft, which has been specified on the basis of the sensor data; at least one of a crew command 214 or a ground command 218, in the case where the crew command has been received from a crew interface 216 or where the ground command has been received from a ground source 220; and a policy, which regulates the priority for the report based on at least one of the states of the aircraft specified on the basis of the crew command, the ground command, or the sensor data.SELECTED DRAWING: Figure 2",BOEING CO,CHARLES OTIS ADLER;;TED EIGLE;;WILLIAM RAYMOND RICHARDS;;TIMOTHY ALLEN MURPHY;;JOHN HARVEY ROBERSON;;THOMAS JOSE THALAKOTTUR;;RICARDO MESSIAS FRICKS;;FADL IBRAHIM KHALIL;;STEVEN MARK WALSTROM;;DANIEL BRUCE HOLTON;;JESSIE TURNER;;TIMOTHY EDWARD JACKSON,,https://lens.org/080-361-167-001-220,Patent Application,no,0,0,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,B64D47/00;;B64D45/00;;G08C15/00;;H04W4/90,,0,0,,,,ACTIVE
849,BR,A2,BR 102016021336 A2,119-239-367-216-829,2017-03-28,2017,BR 102016021336 A,2016-09-15,US 201514858235 A;;US 201514832851 A;;US 201514832879 A,2015-08-21,"aparelho, e, método para relatar informação de estado para uma aeronave","um método, aparelho e sistema de rastreamento de aeronave para relatar informação de estado para uma aeronave. um estado da aeronave é identificado usando dados de sensor recebidos de um sistema de sensor de aeronave na aeronave. a informação de estado é transmitida a uma taxa de relato configurada usando o estado da aeronave identificado a partir dos dados de sensor, pelo menos um dentre um comando da tripulação ou um comando do solo quando pelo menos um dentre o comando da tripulação é recebido de uma interface da tripulação ou o comando do solo é recebido de uma fonte do solo, e uma política definindo prioridades para relato, que são baseadas em pelo menos um dentre o comando da tripulação, o comando do solo ou o estado da aeronave identificado a partir dos dados do sensor.",BOEING CO,CHARLES OTIS ADLER;;DANIEL BRUCE HOLTON;;FADL IBRAHIM KHALIL;;JESSIE TURNER;;JOHN HARVEY ROBERSON;;RICARDO MESSIAS FRICKS;;STEVEN MARK WALSTROM;;TED EIGLE;;THOMAS JOSE THALAKOTTUR;;TIMOTHY ALLEN MURPHY;;TIMOTHY EDWARD JACKSON;;WILLIAM RAYMOND RICHARDS,,https://lens.org/119-239-367-216-829,Patent Application,no,0,0,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,B64D45/00;;H04W4/90,,0,0,,,,ACTIVE
850,EP,A1,EP 3144921 A1,024-621-954-262-910,2017-03-22,2017,EP 16188916 A,2016-09-15,US 201514858235 A,2015-09-18,CONTROLLER FOR AN AIRCRAFT TRACKER,"A method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and a policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.
",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,,https://lens.org/024-621-954-262-910,Patent Application,yes,5,2,4,4,0,G08G5/0008;;G08G5/0013;;G08G5/0021;;G08G5/0082;;G07C5/008;;B64D2045/0065;;B64D45/00;;B64D45/00;;G07C5/008;;G08G5/0008;;G08G5/0013;;G08G5/0021;;G08G5/0082,G08G5/00;;B64D45/00;;G01S5/02;;G07C5/00,,0,0,,,,DISCONTINUED
851,CA,A1,CA 2937854 A1,099-687-677-813-296,2017-03-18,2017,CA 2937854 A,2016-08-02,US 201514858235 A;;US 201514832879 A;;US 201514832851 A,2015-08-21,CONTROLLER FOR AN AIRCRAFT TRACKER,"A method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and a policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,,https://lens.org/099-687-677-813-296,Patent Application,no,0,0,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,G08G5/00;;G01C21/00;;H04W4/90,,0,0,,,,ACTIVE
852,US,A1,US 2017/0082455 A1,126-579-004-776-493,2017-03-23,2017,US 201514858235 A,2015-09-18,US 201514832879 A;;US 201514832851 A;;US 201514858235 A,2015-08-21,Controller for an Aircraft Tracker,"A method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and a policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,THE BOEING COMPANY (2015-09-17),https://lens.org/126-579-004-776-493,Patent Application,yes,0,13,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,G01C23/00;;B64D45/00;;G07C5/08;;G08G5/00;;H04W4/90,,0,0,,,,ACTIVE
853,AU,A1,AU 2016/208451 A1,010-021-877-097-861,2017-04-06,2017,AU 2016/208451 A,2016-08-01,US 201514858235 A;;US 201514832851 A;;US 201514832879 A,2015-08-21,Controller for an aircraft tracker,"CONTROLLER FOR AN AIRCRAFT TRACKER A method, apparatus, and aircraft tracker system for reporting state information for an aircraft (202). A state (212) of the aircraft (202) is identified using sensor data (210) received from an aircraft sensor system (206) in the aircraft (202). The state information (222) is transmitted at a reporting rate (224) set using the state (212) of the aircraft (202) identified from the sensor data (210), at least one of a crew command (214) or a ground command (218) when at least one of the crew command (214) is received from a crew interface or the ground command (218) is received from a ground source (220), and a policy (518) defining priorities for reporting that are based on at least one of the crew command (214), the ground command (218), or the state (212) of the aircraft (202) identified from the sensor data (210). 202 AIRCRAFT 209 AIRCRAFT TRACKING SYSTEM 212N\ STATE REPORTING J 224 204 AIRCRAFT TRACKER -4 ESTATEE 210 fl SENSORDATA INFORMATION 222 AIRCRAFT COMMUNICATIONS 206 SENSOR SYSTEM SYSTEM 208 CREW GROUND 214-L COMMAND COMMAND K 2 18 CREW GROUND 216 INTERFACE SOURCE 220",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,,https://lens.org/010-021-877-097-861,Patent Application,no,0,0,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,G08G5/02;;G05D1/00;;H04W4/90,,0,0,,,,DISCONTINUED
854,CN,A,CN 106548534 A,063-356-544-341-149,2017-03-29,2017,CN 201610704063 A,2016-08-22,US 201514858235 A;;US 201514832851 A;;US 201514832879 A,2015-08-21,Method and apparatus for reporting state information for an aircraft,"A method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and a policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.",BOEING CO,RICARDO MESSIAS FRICKS;;TED EIGLE;;TIMOTHY ALLEN MURPHY;;DANIEL BRUCE HOLTON;;CHARLES OTIS ADLER;;THOMAS JOSE THALAKOTTUR;;FADL IBRAHIM KHALIL;;STEVEN MARK WALSTROM;;JESSIE TURNER;;JOHN HARVEY ROBERSON;;WILLIAM RAYMOND RICHARDS;;TIMOTHY EDWARD JACKSON,,https://lens.org/063-356-544-341-149,Patent Application,no,6,10,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,G07C5/08;;B64C19/00;;G01D21/02;;H04N7/18;;H04W4/90,,0,0,,,,ACTIVE
855,BR,B1,BR 102016021336 B1,159-424-078-545-015,2022-11-16,2022,BR 102016021336 A,2016-09-15,US 201514858235 A;;US 201514832851 A;;US 201514832879 A,2015-08-21,APARELHO PARA RELATAR INFORMAÇÃO DE ESTADO PARA UMA AERONAVE,"APARELHO, E, MÉTODO PARA RELATAR INFORMAÇÃO DE ESTADO PARA UMA AERONAVE. Um método, aparelho e sistema de rastreamento de aeronave para relatar informação de estado para uma aeronave. Um estado da aeronave é identificado usando dados de sensor recebidos de um sistema de sensor de aeronave na aeronave. A informação de estado é transmitida a uma taxa de relato configurada usando o estado da aeronave identificado a partir dos dados de sensor, pelo menos um dentre um comando da tripulação ou um comando do solo quando pelo menos um dentre o comando da tripulação é recebido de uma interface da tripulação ou o comando do solo é recebido de uma fonte do solo, e uma política definindo prioridades para relato, que são baseadas em pelo menos um dentre o comando da tripulação, o comando do solo ou o estado da aeronave identificado a partir dos dados do sensor.",BOEING CO,CHARLES OTIS ADLER;;TED EIGLE;;WILLIAM RAYMOND RICHARDS;;TIMOTHY ALLEN MURPHY;;JOHN HARVEY ROBERSON;;THOMAS JOSE THALAKOTTUR;;RICARDO MESSIAS FRICKS;;FADL IBRAHIM KHALIL;;STEVEN MARK WALSTROM;;DANIEL BRUCE HOLTON;;JESSIE TURNER;;TIMOTHY EDWARD JACKSON,,https://lens.org/159-424-078-545-015,Granted Patent,no,0,0,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,B64D45/00;;H04W4/90,,0,0,,,,ACTIVE
856,KR,A,KR 20170035801 A,162-394-584-120-961,2017-03-31,2017,KR 20160117391 A,2016-09-12,US 201514858235 A,2015-09-18,CONTROLLER FOR AN AIRCRAFT TRACKER,"The present invention discloses a method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,,https://lens.org/162-394-584-120-961,Patent Application,no,4,0,4,4,0,G08G5/0008;;G08G5/0013;;G08G5/0021;;G08G5/0082;;G07C5/008;;B64D2045/0065;;B64D45/00;;B64D45/00;;G07C5/008;;G08G5/0008;;G08G5/0013;;G08G5/0021;;G08G5/0082,B64F1/00;;G08G5/00,,0,0,,,,ACTIVE
857,US,B2,US 10030995 B2,190-164-721-208-241,2018-07-24,2018,US 201514858235 A,2015-09-18,US 201514832879 A;;US 201514832851 A;;US 201514858235 A,2015-08-21,Controller for an aircraft tracker,"A method, apparatus, and aircraft tracker system for reporting state information for an aircraft. A state of the aircraft is identified using sensor data received from an aircraft sensor system in the aircraft. The state information is transmitted at a reporting rate set using the state of the aircraft identified from the sensor data, at least one of a crew command or a ground command when at least one of the crew command is received from a crew interface or the ground command is received from a ground source, and a policy defining priorities for reporting that are based on at least one of the crew command, the ground command, or the state of the aircraft identified from the sensor data.",BOEING CO,ADLER CHARLES OTIS;;EIGLE TED;;RICHARDS WILLIAM RAYMOND;;MURPHY TIMOTHY ALLEN;;ROBERSON JOHN HARVEY;;THALAKOTTUR THOMAS JOSE;;FRICKS RICARDO MESSIAS;;KHALIL FADL IBRAHIM;;WALSTROM STEVEN MARK;;HOLTON DANIEL BRUCE;;TURNER JESSIE;;JACKSON TIMOTHY EDWARD,THE BOEING COMPANY (2015-09-17),https://lens.org/190-164-721-208-241,Granted Patent,yes,43,2,15,38,0,B64D45/0031;;B64D45/0059;;B64D45/0015;;B64C19/00;;G01D21/02;;G07C5/08;;H04N7/18;;G07C5/008;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/0059;;B64D45/00;;B64D2045/0065;;G07C5/085;;G08G5/0013;;G08G5/0021;;B64D45/0059;;G07C5/008;;G01S19/17;;G01S13/91;;G08G5/0056;;G01S2205/002;;B64D45/00;;B64D2045/0065;;G01C23/00;;G07C5/085;;G08G5/0013;;G08G5/0021,G01C23/00;;B64D45/00;;G01S13/91;;G01S19/17;;G07C5/00;;G07C5/08;;G08G5/00;;H04W4/90,,7,0,,,"Extended European Search Report, dated Nov. 22, 2016, regarding Application No. EP16184621, 7 pages.;;Extended European Search Report, dated Feb. 7, 2017, regarding Application No. EP16188916.7, 10 pages.;;Extended European Search Report, dated Sep. 27, 2017, regarding Application No. EP16184621.7, 6 pages.;;Office Action dated Jul. 12, 2017, U.S. Appl. No. 14/832,879, 28 pages.;;Office Action, dated Jul. 12, 2017, regarding U.S. Appl. No. 14/832,879, 28 pages.;;Murphy, “Aircraft Tracking Method and Device and Method of Installation,” U.S. Appl. No. 14/832,879, filed Aug. 21, 2015, 53 pages.;;Murphy, “Aircraft Distress Tracking and Interface to Search and Rescue System,” U.S. Appl. No. 14/832,851, filed Aug. 21, 2015, 59 pages.",ACTIVE
858,US,B1,US 6671692 B1,149-836-625-821-380,2003-12-30,2003,US 44794199 A,1999-11-23,US 44794199 A,1999-11-23,System for facilitating the navigation of data,"
    A method for facilitating the navigation of application specific data on a data page, i.e. web page, during use of a data browser, i.e. Netscape, MS Explorer, etc. Included on the data page are a plurality of links each corresponding to data. In use, the data may be retrieved upon selection of the corresponding link. To facilitate the navigation of the data, the links are displayed each as a component of an indicia such as a pointer or chevron to imply a relationship between the data. 
",ACCENTURE LLP,MARPE JAMES S;;COYLE DAVID W;;KIENE BRUCE P;;CHESTNUT GREGORY P;;DUROCHER JOHN F;;ADLER SCOTT R;;FARNER LAURA L;;BACKES KAREN L;;PEPPER ROBIN;;GOUZIE SUZANNE M;;CHRISTENSEN ALAN R;;RININGER CHRISTOPHER A,ACCENTURE GLOBAL SERVICES LIMITED (2010-09-01);;ACCENTURE LLP (2001-01-02);;ACCENTURE GLOBAL SERVICES GMBH (2010-08-31),https://lens.org/149-836-625-821-380,Granted Patent,yes,44,121,1,12,0,G06F16/954;;G06F16/954;;Y10S707/99943,G06F17/30,707/102;;715/514;;709/229;;345/761;;345/762,6,1,081-373-730-511-209,10.1109/enabl.1996.555183,"""User's Guide for Microsoft Project for Windows 95 and Windows 3.1,"" copyright 1995.;;Cleetus, K. J. et al., ""PACT-a software package to manage projects and coordinate people"", Proceedings of the 5th Workshops on Enabling Technologies: Infrastructure for Collaborative Enterprises (WET ICE '96) (96TB100058), Proceedings Wet Ice '96, IEEE 5th Workshop on Enabling Technologies; Infrastructure for Collaborative Enterprises, St, pp. 162-169, 1996, Los Alamitos, CA, USA, IEEE Compt. Soc.;;Mason, K., ""Bulletin Board and Notepad For Reminders (ICONS)"" Research Disclosure, Kenneth Mason Publ., Hampshire, GB, No. 312, (Apr. 1, 1990), pp. 322.;;Microsoft Team Manager 97 Brochure, Online! 1997, XP002165311 Retriev. From Internet: <URL:http://www/microsoft.com/office/teammanager/tmm97brch/>.;;""Project Management Environment"", IBM Tech. Disclosure Bulletin, US, IBM Corp. New York, vol. 32, No. 9A, (Feb. 1, 1990), pp. 250-254.;;Planning Big with Mac Project, James Halcomb. 1986.",EXPIRED
859,US,A1,US 2011/0252234 A1,145-980-277-759-955,2011-10-13,2011,US 75615310 A,2010-04-07,US 75615310 A,2010-04-07,SYSTEM AND METHOD FOR FILE-LEVEL DATA PROTECTION,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for encryption and key management. The method includes encrypting each file on a computing device with a unique file encryption key, encrypting each unique file encryption key with a corresponding class encryption key, and encrypting each class encryption key with an additional encryption key. Further disclosed are systems, methods, and non-transitory computer-readable storage media for encrypting a credential key chain. The method includes encrypting each credential on a computing device with a unique credential encryption key, encrypting each unique credential encryption key with a corresponding credential class encryption key, and encrypting each class encryption key with an additional encryption key. Also disclosed is a method of verifying a password by decrypting a key bag, retrieving data from an encrypted file using an encryption key from the decrypted key bag, and verifying the password by comparing retrieved data with expected data.",APPLE INC,DE ATLEY DALLAS BLAKE;;FREEDMAN GORDON;;DUFFY JR THOMAS BROGAN;;WRIGHT JOHN ANDREW;;BHAVSAR VRAJESH RAJESH;;BALLARD LUCIA ELENA;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;SAUERWALD CONRAD;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON;;RAHARDJA DAVID;;GUENTHER CARSTEN,APPLE INC (2010-04-07),https://lens.org/145-980-277-759-955,Patent Application,yes,28,73,10,18,0,H04L9/0891;;H04L9/0894;;H04L9/12;;H04L9/3226;;H04L2209/80;;H04W12/02;;H04W12/04;;H04W12/06;;H04W12/082;;G06F9/4406;;H04L9/0816;;H04W12/02;;H04W12/04;;H04W12/06;;H04L9/0891;;H04L9/0894;;H04L9/12;;H04L9/3226;;H04L2209/80;;H04W12/082;;G06F21/602;;G06F9/4401;;H04L9/30,H04L9/00;;G06F21/24,713/165;;380/277,0,0,,,,ACTIVE
860,BR,A2,BR 112013008526 A2,199-060-485-416-946,2016-07-12,2016,BR 112013008526 A,2011-10-06,US 2011/0055134 W;;US 40475810 P;;US 201061425560 P,2010-10-08,inibidores de quinase do tipo polo,,ELAN PHARM INC,TROUNG ANH P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;NEITZ JEFREY R;;SEALY JENNIFER;;ANDERSON JOHN P;;ADLER MARC;;BEROZA PAUL;;GALEMMO ROBERT A;;HOM ROY K;;BOWERS SIMEON;;YE XIAOCONG MICHAEL;;ZHU YONG-LIANG,,https://lens.org/199-060-485-416-946,Patent Application,no,0,0,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,C07D487/14;;A61K31/519;;A61K31/5377;;A61K31/5383;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;C07D487/22;;C07D498/22,,0,0,,,,DISCONTINUED
861,WO,A2,WO 2012/048129 A2,146-578-170-431-635,2012-04-12,2012,US 2011/0055134 W,2011-10-06,US 40475810 P;;US 201061425560 P,2010-10-08,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I):or a salt or solvate thereof, wherein ring A, U 1 , U 2 , U 3 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC;;NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,,https://lens.org/146-578-170-431-635,Patent Application,yes,8,16,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,A61K31/519;;A61K31/55;;A61K31/5377;;A61K31/5383;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D471/22;;C07D487/14;;C07D487/22;;C07D498/22,,46,36,003-409-263-368-003;;035-230-918-361-883;;030-225-587-843-686;;041-534-448-493-098;;002-972-920-890-077;;070-801-253-703-695;;026-289-049-481-540;;057-671-213-911-031;;063-835-022-264-930;;054-025-416-907-950;;041-271-159-372-749;;076-845-131-264-017;;080-695-392-237-504;;084-150-602-860-325;;014-696-377-683-427;;012-020-821-983-096;;093-557-965-213-363;;007-364-858-655-289;;077-295-491-167-117;;090-749-638-658-16X;;167-688-150-427-62X;;104-783-266-464-860;;104-783-266-464-860;;048-592-719-447-422;;120-430-536-528-542;;022-092-066-305-51X;;001-563-249-626-750;;057-429-263-597-25X;;041-977-751-080-440;;049-112-389-383-948;;110-660-094-595-326;;047-328-226-758-004;;094-514-970-124-484;;019-333-780-541-25X;;076-858-276-625-162;;052-483-331-367-591,8909416;;10.1212/wnl.47.5.1113;;10.1001/archneur.1994.00540210060013;;8080388;;9278044;;10.1038/42166;;10.1038/42172;;pmc1857971;;9466562;;9547168;;10.1016/s0304-3940(97)00891-4;;10.1038/ng0298-106;;9462735;;9197268;;10.1126/science.276.5321.2045;;10678833;;10.1126/science.287.5456.1265;;10746727;;10.1038/35006074;;10.1002/ana.20834;;16566021;;10.1007/bf01660129;;3037441;;10.1212/wnl.37.7.1253;;10.1212/wnl.45.4.709;;7723959;;10214756;;10.1212/wnl.52.6.1269;;6088351;;10.1016/0016-5085(84)90079-9;;11576395;;10.1046/j.1365-2982.2001.00275.x;;10.1007/s004010050693;;9255396;;10.1002/jps.2600660104;;833720;;10.1002/0471220574;;11667239;;10.1021/jo960057x;;10.1002/0471264180.or059.01;;10.1021/ja00092a058;;10.1021/ja00092a058;;10.1351/pac199163030419;;10.1002/anie.198605081;;10.3748/wjg.15.4177;;pmc2738815;;19725153;;pmc2410182;;14970859;;10.1038/sj.bjc.6601610;;10.1111/j.1349-7006.2003.tb01411.x;;12708489;;pmc2409566;;10.1038/sj.bjc.6601540;;14735186;;10.1016/s0344-0338(00)80107-7;;11186170;;10383133;;9053852;;10.1038/sj.onc.1200862;;10.1016/j.tetlet.2005.02.025;;10.1016/j.tetlet.2005.10.134;;15099102;;10.1021/ja0400382;;10.1021/ja0400382.s001;;10.1055/s-2005-923604,"MCKEITH ET AL., NEUROLOGY, vol. 47, 1996, pages 1113 - 1124;;GALASKO ET AL., ARCH. NEUROL., vol. 51, 1994, pages 888 - 895;;SPILLANTINI ET AL., NATURE, vol. 388, 1997, pages 839 - 840;;TAKEDA ET AL., J. PATHOL., vol. 152, 1998, pages 367 - 372;;WAKABAYASHI ET AL., NEUROSCI. LETT., vol. 239, 1997, pages 45 - 48;;KRUGER ET AL., NATURE GEN., vol. 18, 1998, pages 106 - 8;;POLYMCROPOULOS, SCIENCE, vol. 276, 1997, pages 2045 - 2047;;MASLIAH ET AL., SCIENCE, vol. 287, 2000, pages 1265 - 1269;;FEANY ET AL., NATURE, vol. 404, 2000, pages 394 - 398;;LANGSTON: ""Annals of Neurology"", vol. 59, 2006, pages: 591 - 596;;HERZOG E.; DTCH Z, NERVENHEILK, vol. 107, 1928, pages 75 - 80;;KUPSKY ET AL., NEUROLOGY, vol. 37, 1987, pages 1253 - 1255;;UCHIYAMA ET AL., NEUROLOGY, vol. 45, 1995, pages 709 - 712;;IWANAGA ET AL., NEUROLOGY, vol. 52, 1999, pages 1269 - 1271;;QUALMAN ET AL., GASTROENTEROLOGY, vol. 87, 1984, pages 848 - 856;;CASTELL ET AL., NCUROGASDTROCNTCROL MOTIL, vol. 13, 2001, pages 361 - 364;;HAGUE, ACTA NCUROPATHOL (BCRL, vol. 94, 1997, pages 192 - 196;;BERGE ET AL., JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19;;""Harrison's Principles of Tnternal Medicine"", 1991, pages: 93 - 98;;WILLIAMS ET AL., J. OFMED CHEM., vol. 42, 1999, pages 1481 - 1485;;T. W. GREENE; P.G. M. WUTS: ""Protecting Groups in Organic Svnthesis"", 1999, WILCY;;A. F. ABDEL-MAGID; K. G. CARSON; B. D. HARRIS; C. A. MARYANOFF; R. D. SHAH, J. ORG. CHEM., vol. 61, 1996, pages 3849 - 3862;;ELLEN W. BAXTER; ALLEN B. REITZ: ""Reducing Agents in Organic Reactions"", 2002, JOHN WILEY AND SONS, article ""Reductive Aminations of Carbonyl Compounds with Borohydride and Borane"";;JOHN P. WOLFE; STEPHEN L. BUCHWALD: ""Palladium-Catalyzed Amination Of Aryl Halides And Aryl Triflates"", ORG. SYNTH., vol. 10, 2004, pages 423;;FREDERIC PAUL; JOE PATT; JOHN F. HARTWIG: ""Palladium-catalyzed formation of carbon-nitrogen bonds. Reaction intermediates and catalyst improvements in the hetero cross-coupling of aryl halides and tin amides"", J. AM. CHEM. SOC., vol. 116, 1994, pages 5969 - 5970;;FREDERIC PAUL; JOE PATT; JOHN F. HARTWIG: ""Palladium-catalyzed formation of carbon-nitrogen bonds"", J. AM. CHEM. SOC., vol. 116, 1994, pages 5969 - 5970;;SUZUKI, A, PURE APPL. CHEM., vol. 63, 1991, pages 419 - 422;;STILLE, J. K., ANGEW. CHEM. INT. ED. ENGL., vol. 25, 1986, pages 508 - 524;;NIAZI, SARFARAZ K.: ""Handbook of Phannaceutical Manufacturing Fonnulations"", vol. 1-6, 2005, TAYLOR & FRANCIS GROUP;;ANDO, KIYOHIRO ET AL., NICHIDAI IGAKU ZASSHI, vol. 62, no. 9, 2003, pages 496 - 501;;DUAN ET AL., XIANDAI ZHONGLIU YIXUE, vol. 15, no. 7, 2007, pages 912 - 913;;FAN, YU ET AL., ZHONGHUA SHENJINGYIXUE ZAZHI, vol. 8, no. 1, 2009, pages 5 - 9;;PELLEGRINO ET AL., HEPATOLOGY (HOBOKEN, NJ, UNITED STATES, vol. 51, no. 3, 2010, pages 857 - 868;;HE, ZI-LI ET AL., WORLD JOURNAL OF GASTROENTEROLOGY, vol. 15, no. 33, 2009, pages 4177 - 4182;;ZHU, YI ET AL., YIXIANBINGXUE, vol. 7, no. 1, 2007, pages 9 - 12;;WEICHERT, W. ET AL., BRITISH JOURNAL OF CANCER, vol. 90, no. 4, 2004, pages 815 - 821;;TAKAHASHI, TAKAO ET AL., CANCER SCIENCE, vol. 94, no. 2, 2003, pages 148 - 152;;ITO,Y, BRITISH JOURNAL OF CANCER, vol. 90, no. 2, 2004, pages 414 - 418;;WOLF, GEORG ET AL., PATHOLOGY, RESEARCH AND PRACTICE, vol. 196, no. 11, 2000, pages 753 - 759;;KNECHT, RAINALD ET AL., CANCER RESEARCH, vol. 59, no. 12, 1999, pages 2794 - 2797;;WOLF, GEORG ET AL., ONCOGENE, vol. 14, no. 5, 1997, pages 543 - 549;;FUJIOKA ET AL., TETRAHEDRON LETTERS, vol. 46, 2005, pages 2197 - 2199;;GOGOI, KONWAR, TETRAHEDRON LETTERS, vol. 47, 2006, pages 79 - 82;;NICOLAOU ET AL., J. AM. CHEM. SOC., vol. 126, 2004, pages 5192 - 5201;;ISHIHARA, TOGO, SYNLETT, 2006, pages 227 - 230;;VOSS ET AL., TETRAHEDRON, vol. 64, 2008, pages 645 - 51",PENDING
862,AU,A1,AU 2011/311960 A1,022-865-398-896-477,2014-04-10,2014,AU 2011/311960 A,2011-10-06,US 40475810 P;;US 201061425560 P;;US 2011/0055134 W,2010-10-08,Inhibitors of polo-like kinase,"The present invention provides compounds having a structure according to Formula (I):or a salt or solvate thereof, wherein ring A, U",ELAN PHARM INC,NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,,https://lens.org/022-865-398-896-477,Patent Application,no,0,0,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,C07D471/22;;A61K31/519;;A61K31/5377;;A61K31/5383;;A61K31/55;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,,0,0,,,,DISCONTINUED
863,EP,A2,EP 2661268 A2,020-762-584-629-183,2013-11-13,2013,EP 11831612 A,2011-10-06,US 40475810 P;;US 201061425560 P;;US 2011/0055134 W,2010-10-08,INHIBITORS OF POLO-LIKE KINASE,,ELAN PHARM INC,NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,"ELAN PHARMACEUTICALS, LLC (2014-07-23)",https://lens.org/020-762-584-629-183,Patent Application,yes,0,0,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,A61K31/55;;A61K31/519;;A61K31/5377;;A61K31/5383;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D471/22;;C07D487/14;;C07D487/22;;C07D498/22,,0,0,,,,DISCONTINUED
864,WO,A3,WO 2012/048129 A3,038-112-382-790-816,2012-07-26,2012,US 2011/0055134 W,2011-10-06,US 40475810 P;;US 201061425560 P,2010-10-08,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I):or a salt or solvate thereof, wherein ring A, U 1 , U 2 , U 3 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC;;NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,,https://lens.org/038-112-382-790-816,Search Report,yes,4,0,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,A61K31/519;;A61K31/5377;;A61K31/5383;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;C07D487/14;;C07D487/22;;C07D498/22,,0,0,,,,PENDING
865,US,B2,US 8510552 B2,137-874-690-112-929,2013-08-13,2013,US 75615310 A,2010-04-07,US 75615310 A,2010-04-07,System and method for file-level data protection,"Disclosed herein are systems, methods, and non-transitory computer-readable storage media for encryption and key management. The method includes encrypting each file on a computing device with a unique file encryption key, encrypting each unique file encryption key with a corresponding class encryption key, and encrypting each class encryption key with an additional encryption key. Further disclosed are systems, methods, and non-transitory computer-readable storage media for encrypting a credential key chain. The method includes encrypting each credential on a computing device with a unique credential encryption key, encrypting each unique credential encryption key with a corresponding credential class encryption key, and encrypting each class encryption key with an additional encryption key. Also disclosed is a method of verifying a password by decrypting a key bag, retrieving data from an encrypted file using an encryption key from the decrypted key bag, and verifying the password by comparing retrieved data with expected data.",DE ATLEY DALLAS BLAKE;;FREEDMAN GORDON;;DUFFY JR THOMAS BROGAN;;WRIGHT JOHN ANDREW;;BHAVSAR VRAJESH RAJESH;;BALLARD LUCIA ELENA;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;SAUERWALD CONRAD;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON;;RAHARDJA DAVID;;GUENTHER CARSTEN;;APPLE INC,DE ATLEY DALLAS BLAKE;;FREEDMAN GORDON;;DUFFY JR THOMAS BROGAN;;WRIGHT JOHN ANDREW;;BHAVSAR VRAJESH RAJESH;;BALLARD LUCIA ELENA;;BROUWER MICHAEL LAMBERTUS HUBERTUS;;SAUERWALD CONRAD;;ADLER MITCHELL DAVID;;TAMURA ERIC BRANDON;;RAHARDJA DAVID;;GUENTHER CARSTEN,APPLE INC (2010-04-07),https://lens.org/137-874-690-112-929,Granted Patent,yes,30,51,10,18,0,H04L9/0891;;H04L9/0894;;H04L9/12;;H04L9/3226;;H04L2209/80;;H04W12/02;;H04W12/04;;H04W12/06;;H04W12/082;;G06F9/4406;;H04L9/0816;;H04W12/02;;H04W12/04;;H04W12/06;;H04L9/0891;;H04L9/0894;;H04L9/12;;H04L9/3226;;H04L2209/80;;H04W12/082;;G06F21/602;;G06F9/4401;;H04L9/30,H04L9/00;;H04L29/06;;H04L9/08,713/165;;380/277;;380/280,0,0,,,,ACTIVE
866,CA,A1,CA 2814084 A1,005-992-206-697-891,2012-04-12,2012,CA 2814084 A,2011-10-06,US 40475810 P;;US 201061425560 P;;US 2011/0055134 W,2010-10-08,INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I):or a salt or solvate thereof, wherein ring A, U1, U2, U3, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,,https://lens.org/005-992-206-697-891,Patent Application,no,0,0,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,A61K31/519;;C07D487/14;;A61K31/5383;;A61P25/00;;A61P35/00,,0,0,,,,DISCONTINUED
867,CN,A,CN 103403010 A,078-677-477-186-055,2013-11-20,2013,CN 201180056853 A,2011-10-06,US 2011/0055134 W;;US 40475810 P;;US 201061425560 P,2010-10-08,Inhibitors of polo-like kinase,"The present invention provides compounds having a structure according to Formula (I):or a salt or solvate thereof, wherein ring A, U1, U2, U3, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,NEITZ R JEFFREY;;TROUNG ANH P;;GALEMMO ROBERT A;;YE XIAOCONG MICHAEL;;SEALY JENNIFER;;ADLER MARC;;BOWERS SIMEON;;BEROZA PAUL;;ANDERSON JOHN P;;AUBELE DANIELLE L;;ARTIS DEAN RICHARD;;HOM ROY K;;ZHU YONG-LIANG,,https://lens.org/078-677-477-186-055,Patent Application,no,3,4,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,C07D487/14;;A61K31/52;;A61K31/5377;;A61K31/5383;;A61K31/55;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D471/22;;C07D487/22;;C07D498/22;;C07D519/00,,0,0,,,,DISCONTINUED
868,WO,A1,WO 2011/079118 A1,185-703-866-592-466,2011-06-30,2011,US 2010/0061551 W,2010-12-21,US 28998009 P;;US 40479710 P,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E 1 , E 2 , R 1 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC;;GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/185-703-866-592-466,Patent Application,yes,11,7,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,43,33,003-409-263-368-003;;035-230-918-361-883;;030-225-587-843-686;;041-534-448-493-098;;002-972-920-890-077;;070-801-253-703-695;;026-289-049-481-540;;057-671-213-911-031;;063-835-022-264-930;;054-025-416-907-950;;041-271-159-372-749;;076-845-131-264-017;;080-695-392-237-504;;084-150-602-860-325;;014-696-377-683-427;;012-020-821-983-096;;093-557-965-213-363;;007-364-858-655-289;;077-295-491-167-117;;090-749-638-658-16X;;167-688-150-427-62X;;104-783-266-464-860;;022-092-066-305-51X;;001-563-249-626-750;;057-429-263-597-25X;;041-977-751-080-440;;049-112-389-383-948;;110-660-094-595-326;;047-328-226-758-004;;094-514-970-124-484;;019-333-780-541-25X;;076-858-276-625-162;;052-483-331-367-591,8909416;;10.1212/wnl.47.5.1113;;10.1001/archneur.1994.00540210060013;;8080388;;9278044;;10.1038/42166;;10.1038/42172;;pmc1857971;;9466562;;9547168;;10.1016/s0304-3940(97)00891-4;;10.1038/ng0298-106;;9462735;;9197268;;10.1126/science.276.5321.2045;;10678833;;10.1126/science.287.5456.1265;;10746727;;10.1038/35006074;;10.1002/ana.20834;;16566021;;10.1007/bf01660129;;3037441;;10.1212/wnl.37.7.1253;;10.1212/wnl.45.4.709;;7723959;;10214756;;10.1212/wnl.52.6.1269;;6088351;;10.1016/0016-5085(84)90079-9;;11576395;;10.1046/j.1365-2982.2001.00275.x;;10.1007/s004010050693;;9255396;;10.1002/jps.2600660104;;833720;;10.1002/0471220574;;11667239;;10.1021/jo960057x;;10.1002/0471264180.or059.01;;10.1021/ja00092a058;;10.3748/wjg.15.4177;;pmc2738815;;19725153;;pmc2410182;;14970859;;10.1038/sj.bjc.6601610;;10.1111/j.1349-7006.2003.tb01411.x;;12708489;;pmc2409566;;10.1038/sj.bjc.6601540;;14735186;;10.1016/s0344-0338(00)80107-7;;11186170;;10383133;;9053852;;10.1038/sj.onc.1200862;;10.1016/j.tetlet.2005.02.025;;10.1016/j.tetlet.2005.10.134;;15099102;;10.1021/ja0400382;;10.1021/ja0400382.s001;;10.1055/s-2005-923604,"MCKEITH ET AL., NEUROLOGY, vol. 47, 1996, pages 1113 - 1124;;GALASKO ET AL., ARCH. NEUROL., vol. 51, 1994, pages 888 - 895;;SPILLANTINI ET AL., NATURE, vol. 388, 1997, pages 839 - 840;;TAKEDA ET AL., J. PATHOL., vol. 152, 1998, pages 367 - 372;;WAKABAYASHI ET AL., NEUROSCI. LETT., vol. 239, 1997, pages 45 - 48;;KRUGER ET AL., NATURE GEN., vol. 18, 1998, pages 106 - 8;;POLYMEROPOULOS ET AL., SCIENCE, vol. 276, 1997, pages 2045 - 2047;;MASLIAH ET AL., SCIENCE, vol. 287, 2000, pages 1265 - 1269;;FEANY ET AL., NATURE, vol. 404, 2000, pages 394 - 398;;LANGSTON, ANNALS OF NEUROLOGY, vol. 59, 2006, pages 591 - 596;;HERZOG E.; DTCH Z, NERVENHEILK, vol. 107, 1928, pages 75 - 80;;KUPSKY ET AL., NEUROLOGY, vol. 37, 1987, pages 1253 - 1255;;UCHIYAMA ET AL., NEUROLOGY, vol. 45, 1995, pages 709 - 712;;IWANAGA ET AL., NEUROLOGY, vol. 52, 1999, pages 1269 - 1271;;QUALMAN ET AL., GASTROENTEROLOGY, vol. 87, 1984, pages 848 - 856;;CASTELL ET AL., NEUROGASDTROENTEROL MOTIL, vol. 13, 2001, pages 361 - 364;;HAGUE ET AL., ACTA NEUROPATHOL (BERL), vol. 94, 1997, pages 192 - 196;;BERGE ET AL., JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19;;""Harrison's Principles of Internal Medicine"", 1991, pages: 93 - 98;;WILLIAMS ET AL., J. OF MED. CHEM., vol. 42, 1999, pages 1481 - 1485;;T. W. GREENE; P.G. M. WUTS: ""Protecting Groups in Organic Synthesis"", 1999, WILEY;;A. F. ABDEL-MAGID; K. G. CARSON; B. D. HARRIS; C. A. MARYANOFF; R. D. SHAH, J. ORG. CHEM., vol. 61, 1996, pages 3849 - 3862;;ELLEN W. BAXTER; ALLEN B. REITZ: ""Reductive Aminations of Carbonyl Compounds with Borohydride and Borane Reducing Agents in Organic Reactions"", 2002, JOHN WILEY AND SONS;;JOHN P. WOLFE; STEPHEN L. BUCHWALD: ""Palladium-Catalyzed Amination Of Aryl Halides And Aryl Triflates"", ORG. SYNTH., COLL., vol. 10, 2004, pages 423;;FREDERIC PAUL; JOE PATT; JOHN F. HARTWIG: ""Palladium-catalyzed formation of carbon-nitrogen bonds. Reaction intermediates and catalyst improvements in the hetero cross-coupling of aryl halides and tin amides"", J. AM. CHEM. SOC., vol. 116, 1994, pages 5969 - 5970;;NIAZI, SARFARAZ K.: ""Handbook ofPharmaceutical Manufacturing Formulations"", vol. 1-6, 2005, TAYLOR & FRANCIS GROUP;;ANDO; KIYOHIRO ET AL., NICHIDAI IGAKU ZASSHI, vol. 62, no. 9, 2003, pages 496 - 501;;DUAN ET AL., XIANDAI ZHONGLIU YIXUE, vol. 15, no. 7, 2007, pages 912 - 913;;FAN; YU ET AL., ZHONGHUA SHENJINGYIXUE ZAZHI, vol. 8, no. 1, 2009, pages 5 - 9;;PELLEGRINO ET AL., HEPATOLOGY, vol. 51, no. 3, 2010, pages 857 - 868;;HE, ZI-LI ET AL., WORLD JOURNAL OF GASTROENTEROLOGY, vol. 15, no. 33, 2009, pages 4177 - 4182;;ZHU, YI ET AL., YIXIANBINGXUE, vol. 7, no. 1, 2007, pages 9 - 12;;WEICHERT, W. ET AL., BRITISH JOURNAL OF CANCER, vol. 90, no. 4, 2004, pages 815 - 821;;TAKAHASHI; TAKAO ET AL., CANCER SCIENCE, vol. 94, no. 2, 2003, pages 148 - 152;;ITO,Y, BRITISH JOURNAL OF CANCER, vol. 90, no. 2, 2004, pages 414 - 418;;WOLF, GEORG ET AL., PATHOLOGY, RESEARCH AND PRACTICE, vol. 196, no. 11, 2000, pages 753 - 759;;KNECHT, RAINALD ET AL., CANCER RESEARCH, vol. 59, no. 12, 1999, pages 2794 - 2797;;WOLF, GEORG ET AL., ONCOGENE, vol. 14, no. 5, 1997, pages 543 - 549;;FUJIOKA ET AL., TETRAHEDRON LETTERS, vol. 46, 2005, pages 2197 - 2199;;GOGOI, KONWAR, TETRAHEDRON LETTERS, vol. 47, 2006, pages 79 - 82;;NICOLAOU ET AL., J. AM. CHEM. SOC., vol. 126, 2004, pages 5192 - 5201;;ISHIHARA, TOGO, SYNLETT., 2006, pages 227 - 230;;VOSS ET AL., TETRAHEDRON, vol. 64, 2008, pages 645 - 51",PENDING
869,SG,A1,SG 181908 A1,176-210-311-288-071,2012-08-30,2012,SG 2012046769 A,2010-12-21,US 28998009 P;;US 40479710 P;;US 2010/0061551 W,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E1, E2, R1, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/176-210-311-288-071,Patent Application,no,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,,,0,0,,,,PENDING
870,CA,A1,CA 2783258 A1,002-328-274-243-213,2011-06-30,2011,CA 2783258 A,2010-12-21,US 28998009 P;;US 40479710 P;;US 2010/0061551 W,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E1, E2, R1, R2, R3 and R4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/002-328-274-243-213,Patent Application,no,0,2,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,0,0,,,,DISCONTINUED
871,AU,A1,AU 2010/336509 A1,152-093-595-724-814,2012-07-19,2012,AU 2010/336509 A,2010-12-21,US 28998009 P;;US 40479710 P;;US 2010/0061551 W,2009-12-23,Pteridinones as inhibitors of polo-like kinase,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, E, E, R, R, R and R are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO JR ROBERT A;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/152-093-595-724-814,Patent Application,no,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,0,0,,,,DISCONTINUED
872,WO,A1,WO 2011/079114 A1,134-933-279-364-657,2011-06-30,2011,US 2010/0061535 W,2010-12-21,US 28998009 P;;US 40479710 P,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO - LIKE KINASE,"The present invention provides compounds having a structure according to Formula (I) or a salt or solvate thereof, wherein ring A, X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 , are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC;;GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/134-933-279-364-657,Patent Application,yes,13,20,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,42,34,003-409-263-368-003;;035-230-918-361-883;;030-225-587-843-686;;041-534-448-493-098;;002-972-920-890-077;;070-801-253-703-695;;026-289-049-481-540;;057-671-213-911-031;;063-835-022-264-930;;054-025-416-907-950;;041-271-159-372-749;;076-845-131-264-017;;080-695-392-237-504;;084-150-602-860-325;;014-696-377-683-427;;012-020-821-983-096;;093-557-965-213-363;;007-364-858-655-289;;090-749-638-658-16X;;167-688-150-427-62X;;104-783-266-464-860;;022-092-066-305-51X;;001-563-249-626-750;;057-429-263-597-25X;;041-977-751-080-440;;049-112-389-383-948;;110-660-094-595-326;;047-328-226-758-004;;094-514-970-124-484;;019-333-780-541-25X;;076-858-276-625-162;;052-483-331-367-591;;024-843-876-473-942;;055-060-815-141-905,8909416;;10.1212/wnl.47.5.1113;;10.1001/archneur.1994.00540210060013;;8080388;;9278044;;10.1038/42166;;10.1038/42172;;pmc1857971;;9466562;;9547168;;10.1016/s0304-3940(97)00891-4;;10.1038/ng0298-106;;9462735;;9197268;;10.1126/science.276.5321.2045;;10678833;;10.1126/science.287.5456.1265;;10746727;;10.1038/35006074;;10.1002/ana.20834;;16566021;;10.1007/bf01660129;;3037441;;10.1212/wnl.37.7.1253;;10.1212/wnl.45.4.709;;7723959;;10214756;;10.1212/wnl.52.6.1269;;6088351;;10.1016/0016-5085(84)90079-9;;11576395;;10.1046/j.1365-2982.2001.00275.x;;10.1007/s004010050693;;9255396;;10.1002/jps.2600660104;;833720;;11667239;;10.1021/jo960057x;;10.1002/0471264180.or059.01;;10.1021/ja00092a058;;10.3748/wjg.15.4177;;pmc2738815;;19725153;;pmc2410182;;14970859;;10.1038/sj.bjc.6601610;;10.1111/j.1349-7006.2003.tb01411.x;;12708489;;pmc2409566;;10.1038/sj.bjc.6601540;;14735186;;10.1016/s0344-0338(00)80107-7;;11186170;;10383133;;9053852;;10.1038/sj.onc.1200862;;10.1016/j.tetlet.2005.02.025;;10.1016/j.tetlet.2005.10.134;;15099102;;10.1021/ja0400382;;10.1021/ja0400382.s001;;10.1055/s-2005-923604;;10.1074/jbc.m600933200;;16847063;;10.1074/jbc.c800206200;;pmc2631975;;19004816,"MCKEITH ET AL., NEUROLOGY, vol. 47, 1996, pages 1113 - 1124;;GALASKO ET AL., ARCH. NEUROL., vol. 51, 1994, pages 888 - 895;;SPILLANTINI ET AL., NATURE, vol. 388, 1997, pages 839 - 840;;TAKEDA ET AL., J. PATHOL., vol. 152, 1998, pages 367 - 372;;WAKABAYASHI ET AL., NEUROSCI. LETT., vol. 239, 1997, pages 45 - 48;;KRUGER ET AL., NATURE GEN., vol. 18, 1998, pages 106 - 8;;POLYMEROPOULOS ET AL., SCIENCE, vol. 276, 1997, pages 2045 - 2047;;MASLIAH ET AL., SCIENCE, vol. 287, 2000, pages 1265 - 1269;;FEANY ET AL., NATURE, vol. 404, 2000, pages 394 - 398;;LANGSTON, ANNALS OF NEUROLOGY, vol. 59, 2006, pages 591 - 596;;HERZOG E., DTCH Z NERVENHEILK, vol. 107, 1928, pages 75 - 80;;KUPSKY ET AL., NEUROLOGY, vol. 37, 1987, pages 1253 - 1255;;UCHIYAMA ET AL., NEUROLOGY, vol. 45, 1995, pages 709 - 712;;IWANAGA ET AL., NEUROLOGY, vol. 52, 1999, pages 1269 - 1271;;QUALMAN ET AL., GASTROENTEROLOGY, vol. 87, 1984, pages 848 - 856;;CASTELL ET AL., NEUROGASDTROENTEROL MOTIL, vol. 13, 2001, pages 361 - 364;;HAGUE ET AL., ACTA NEUROPATHOL (BERL), vol. 94, 1997, pages 192 - 196;;BERGE ET AL., JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19;;A. F. ABDEL-MAGID; K. G. CARSON; B. D. HARRIS; C. A. MARYANOFF; R. D. SHAH, J. ORG. CHEM., vol. 61, 1996, pages 3849 - 3862;;ELLEN W. BAXTER; ALLEN B. REITZ: ""Reductive Aminations of Carbonyl Compounds with Borohydride and Borane Reducing Agents in Organic Reactions"", 2002, JOHN WILEY AND SONS;;JOHN P. WOLFE; STEPHEN L. BUCHWALD: ""Palladium-Catalyzed Amination Of Aryl Halides And Aryl Triflates"", ORG. SYNTH., COLL., vol. 10, 2004, pages 423;;FREDERIC PAUL; JOE PATT; JOHN F. HARTWIG: ""Palladium-catalyzed formation of carbon-nitrogen bonds. Reaction intermediates and catalyst improvements in the hetero cross-coupling of aryl halides and tin amides"", J. AM. CHEM. SOC., vol. 116, 1994, pages 5969 - 5970;;NIAZI, SARFARAZ K.: ""Handbook of Pharmaceutical Manufacturing Formulations"", vol. 1-6, 2005, TAYLOR & FRANCIS GROUP;;ANDO; KIYOHIRO ET AL., NICHIDAI IGAKU ZASSHI, vol. 62, no. 9, 2003, pages 496 - 501;;DUAN ET AL., XIANDAI ZHONGLIU YIXUE, vol. 15, no. 7, 2007, pages 912 - 913;;FAN, YU ET AL., ZHONGHUA SHENJINGYIXUE ZAZHI, vol. 8, no. 1, 2009, pages 5 - 9;;PELLEGRINO ET AL., HEPATOLOGY, vol. 51, no. 3, 2010, pages 857 - 868;;HE, ZI-LI ET AL., WORLD JOURNAL OF GASTROENTEROLOGY, vol. 15, no. 33, 2009, pages 4177 - 4182;;ZHU, YI ET AL., YIXIANBINGXUE, vol. 7, no. 1, 2007, pages 9 - 12;;WEICHERT, W. ET AL., BRITISH JOURNAL OF CANCER, vol. 90, no. 4, 2004, pages 815 - 82 1;;TAKAHASHI, TAKAO ET AL., CANCER SCIENCE, vol. 94, no. 2, 2003, pages 148 - 152;;ITO,Y, BRITISH JOURNAL OF CANCER, vol. 90, no. 2, 2004, pages 414 - 418;;WOLF, GEORG ET AL., PATHOLOGY, RESEARCH AND PRACTICE, vol. 196, no. 11, 2000, pages 753 - 759;;KNECHT, RAINALD ET AL., CANCER RESEARCH, vol. 59, no. 12, 1999, pages 2794 - 2797;;WOLF, GEORG ET AL., ONCOGENE, vol. 14, no. 5, 1997, pages 543 - 549;;FUJIOKA ET AL., TETRAHEDRON LETTERS, vol. 46, 2005, pages 2197 - 2199;;GOGOI, KONWAR, TETRAHEDRON LETTERS, vol. 47, 2006, pages 79 - 82;;NICOLAOU ET AL., J. AM. CHEM. SOC., vol. 126, 2004, pages 5192 - 5201;;ISHIHARA; TOGO, SYNLETT, 2006, pages 227 - 230;;VOSS ET AL., TETRAHEDRON, vol. 64, 2008, pages 645 - 51;;J. BIOL. CHEM., vol. 281, 2006, pages 29739 - 29752;;J. BIOL. CHEM., vol. 284, no. 5, 2009, pages 2598 - 2602",PENDING
873,CN,A,CN 102762568 A,131-024-208-623-327,2012-10-31,2012,CN 201080064541 A,2010-12-21,US 2010/0061535 W;;US 28998009 P;;US 40479710 P,2009-12-23,Pteridinones as inhibitors of polo - like kinase,"The present invention provides compounds having a structure according to Formula (I) or a salt or solvate thereof, wherein ring A, X, R1, R2, R3, R4, R5 and R6, are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,GALEMMO ROBERT A JR;;RICHARD ARTIS DEAN;;MICHAEL YE XIAOCONG;;AUBELE DANIELLE L;;TRUONG ANH P;;SIMEON BOWERS;;HOM ROY K;;YONG-LIANG ZHU;;JEFFREY NEITZ R;;JENNIFER SEALY;;MARC ADLER;;PAUL BEROZA;;ANDERSON JOHN P,,https://lens.org/131-024-208-623-327,Patent Application,no,11,6,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,2,0,,,"MICHAEL KOTHE 等: ""Structure of the Catalytic Domain of Human Polo-like Kinase 1"", 《BIOCHEMISTRY》;;段崇刚 等: ""N8-芳基取代4-氨基-6-氯-7(8H)-蝶啶酮的合成"", 《有机化学》",PENDING
874,BR,A2,BR 112012015714 A2,135-366-482-023-629,2017-04-25,2017,BR 112012015714 A,2010-12-21,US 2010/0061535 W;;US 28998009 P;;US 40479710 P,2009-12-23,"composto, composição farmacêutica, método para o tratamento de uma doença neurodegenerativa, método para reduzir a concentração de p-ser-alfa-sinucleina em tecido cerebral, e, método para o tratamento de um câncer","pteridinonas como inibidores de polo-like quinase. a presente invenção fornece compostos tendo uma estrutura de acordo com a fórmula (i) ou um sal ou solvato dos mesmos, em que o anel a, x,r^ 1^, r^ 2^, r^ 3^, r^ 4^, r^ 5^ e r^ 6^ são definidos aqui. a invenção ainda fornece composições farmacêuticas incluindo os compostos da invenção e métodos de fazer usar os compostos e as composições da invenção, por exemplo, no tratamento e na prevenção de vários distúrbios, tal como doença de parkinson.",ELAN PHARM INC,ANH P TRUONG;;DANIELLE L AUBELE;;DEAN RICHARD ARTIS;;JENNIFER SEALY;;JOHN P ANDERSON;;MARC ADLER;;PAUL BEROZA;;R JEFFREY NEITZ;;ROBERT A JR GALEMMO;;ROY K HOM;;SIMEON BOWERS;;XIAOCONG MICHAEL YE;;YONG-LIANG ZHU,,https://lens.org/135-366-482-023-629,Patent Application,no,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A61K31/4985;;C07D475/04;;A61P25/00;;C07D475/12,,0,0,,,,DISCONTINUED
875,EP,A1,EP 2516441 A1,083-705-934-878-935,2012-10-31,2012,EP 10798439 A,2010-12-21,US 28998009 P;;US 40479710 P;;US 2010/0061551 W,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE,,ELAN PHARM INC,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/083-705-934-878-935,Patent Application,yes,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,0,0,,,,ACTIVE
876,EP,B1,EP 2516441 B1,047-713-798-165-950,2015-01-21,2015,EP 10798439 A,2010-12-21,US 28998009 P;;US 40479710 P;;US 2010/0061551 W,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE,,ELAN PHARM INC,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,,https://lens.org/047-713-798-165-950,Granted Patent,yes,6,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,0,0,,,,ACTIVE
877,MX,A,MX 2012007273 A,125-525-685-002-871,2012-12-17,2012,MX 2012007273 A,2010-12-21,US 28998009 P;;US 40479710 P;;US 2010/0061535 W,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO - LIKE KINASE.,"The present invention provides compounds having a structure according to Formula (I) or a salt or solvate thereof, wherein ring A, X, R1, R2, R3, R4, R5 and R6, are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",ELAN PHARM INC,BOWERS SIMEON;;HOM ROY K;;TRUONG ANH P;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;SEALY JENNIFER;;ZHU YONG-LIANG;;GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;NEITZ R J EFFREY;;ADLER MARC;;ANDERSON JOHN P;;BEROZA PAUL,,https://lens.org/125-525-685-002-871,Patent Application,no,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,C07D475/04;;A61K31/4985;;A61P25/00;;C07D475/12,,0,0,,,,ACTIVE
878,US,A1,US 2012/0115848 A1,097-706-036-480-047,2012-05-10,2012,US 201113267834 A,2011-10-06,US 201113267834 A;;US 40475810 P;;US 201061425560 P,2010-10-08,Inhibitors of Polo-Like Kinase,"The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, U 1 , U 2 , U 3 , R 2 , R 3 and R 4 are defined herein. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinson's disease.",GALEMMO JR ROBERT A;;ARTIS I DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P;;ELAN PHARM INC,GALEMMO JR ROBERT A;;ARTIS I DEAN RICHARD;;YE XIAOCONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL;;ANDERSON JOHN P,ELAN PHARMACEUTICALS INC (2011-11-08),https://lens.org/097-706-036-480-047,Patent Application,yes,0,1,11,11,0,C07D487/14;;C07D487/22;;C07D498/22;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D487/14;;C07D487/22;;C07D498/22,A61K31/55;;A61K31/519;;A61K31/5377;;A61K31/5383;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;C07D471/22;;C07D487/14;;C07D487/22;;C07D498/22,514/214.02;;544/251;;544/247;;544/99;;540/578;;544/115;;544/238;;514/250;;514/229.5;;514/233.2,1,0,,,American Chemical Society. STN. Chemical Abstract Service. RN CAS (Registry database).,DISCONTINUED
879,ZA,B,ZA 201204136 B,011-019-512-451-972,2013-08-28,2013,ZA 201204136 A,2012-06-06,US 28998009 P;;US 40479710 P;;US 2010/0061551 W,2009-12-23,PTERIDINONES AS INHIBITORS OF POLO-LIKE KINASE,,ELAN PHARM INC,GALEMMO ROBERT A JR;;ARTIS DEAN RICHARD;;YE XIACONG MICHAEL;;AUBELE DANIELLE L;;TRUONG ANH P;;BOWERS SIMEON;;HOM ROY K;;ZHU YONG-LIANG;;NEITZ R JEFFREY;;SEALY JENNIFER;;ADLER MARC;;BEROZA PAUL P;;ANDERSON JOHN P,,https://lens.org/011-019-512-451-972,Granted Patent,no,0,0,22,22,0,C07D475/04;;C07D475/12;;C07D487/14;;C07D498/14;;C07D519/00;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;A61P25/00;;A61P25/16;;A61P25/28;;A61P35/00;;A61P35/02;;A61P35/04;;A61P43/00;;C07D475/04;;C07D475/12;;A61K31/4985;;C07D475/04;;C07D475/12;;A61K31/519;;A61K31/5377;;A61K31/5383;;C07D475/00;;C07D487/14;;C07D498/14;;C07D519/00,A61K/;;A61P/;;C07D/,,0,0,,,,ACTIVE
880,EP,B1,EP 1151374 B1,130-640-087-346-281,2017-08-02,2017,EP 00905812 A,2000-01-28,US 0002239 W;;US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,EXECUTING PROGRAMS FOR A FIRST COMPUTER ARCHITECTURE ON A COMPUTER OF A SECOND ARCHITECTURE,,ADVANCED SILICON TECH LLC,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,"ATI TECHNOLOGIES ULC (2010-02-17);;ADVANCED SILICON TECHNOLOGIES, LLC (2016-06-29)",https://lens.org/130-640-087-346-281,Granted Patent,yes,2,4,12,44,0,G06F9/30174;;G06F9/30189;;G06F9/3808;;G06F9/455,G06F9/455;;G06F12/08;;G06F9/30;;G06F9/38;;G06F9/46;;G06F12/10,,0,0,,,,EXPIRED
881,JP,A,JP 2011040087 A,155-993-919-483-184,2011-02-24,2011,JP 2010211102 A,2010-09-21,US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,METHOD FOR REFERRING TO MEMORY OF COMPUTER AND COMPUTER PROGRAM,"<P>PROBLEM TO BE SOLVED: To provide a computer configured to execute instructions of first and second instruction sets. <P>SOLUTION: The program is coded by instructions of the first and second instruction sets, and uses first and second data storage conventions. A switch controls an instruction processor 100 to interpret each instruction under, alternately, the first or second instruction set as directed by the first flag value of the table entry corresponding to a memory page for the instruction in response to a first flag value stored in each table entry. A transition handler recognizes a time when program execution has transferred from a page of instructions using first data storage convention to a page of instructions using second data storage convention as indicated by a second flag value stored in the table entry corresponding to each page, and then adjusts a data storage structure of the computer from the first storage convention to the second data storage convention. A history record provides a record of the classification of a recently-executed instruction. <P>COPYRIGHT: (C)2011,JPO&INPIT",ATI TECHNOLOGIES ULC,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,,https://lens.org/155-993-919-483-184,Patent Application,no,2,2,12,44,0,G06F9/30189;;G06F9/30174;;G06F9/3808;;G06F9/455,G06F9/455;;G06F12/08;;G06F9/30;;G06F9/45;;G06F9/46;;G06F11/30;;G06F12/10,,0,0,,,,INACTIVE
882,EP,A2,EP 1151374 A2,153-378-389-693-565,2001-11-07,2001,EP 00905812 A,2000-01-28,US 0002239 W;;US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,EXECUTING PROGRAMS FOR A FIRST COMPUTER ARCHITECTURE ON A COMPUTER OF A SECOND ARCHITECTURE,,ATI INT SRL,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,"ATI TECHNOLOGIES ULC (2010-02-17);;ADVANCED SILICON TECHNOLOGIES, LLC (2016-06-29)",https://lens.org/153-378-389-693-565,Patent Application,yes,0,0,12,44,0,G06F9/30189;;G06F9/30174;;G06F9/3808;;G06F9/455,G06F9/455;;G06F12/08;;G06F9/30;;G06F9/38;;G06F9/46;;G06F12/10,,1,0,,,See references of WO 0045257A3,EXPIRED
883,CN,A,CN 103272637 A,051-076-628-668-315,2013-09-04,2013,CN 201310116965 A,2007-04-10,CN 201310116965 A,2007-04-10,"Method used for preparing compounds or high-purity compounds having general formula of R(4-m-n)AClmHn, especially silane, and apparatus thereof","The invention relates to a method used for preparing compounds or high-purity compounds having a general formula of R(4-m-n)AClmHn, and an apparatus suitable for implementing the method, and especially relates to an apparatus for preparing silane having a general formula of HnSiCl4-n through disproportionating highly-chlorinated silane in the presence of a catalyst, and a method thereof, wherein A is Si, Ge, Ti or Sn; n is 1, 2, 3 or 4; and the apparatus used for the method is an assembly composed of at least one distillation tower and at least one bypass reactor which is an external reactor. The invention also relates to a catalyst comprising alkylaminotrialkoxy silane having a general formula of (CxH2x+1O)3Si(CH2)zN(CyH2y+1)2, and a method for preparing trichlorosilane (HSiCl3) through catalytic hydrogenation dehalogenation of tetrachlorosilicane (SiCl4) in the presence of hydrogen. The invention further relates to a method for preparing alkylhydrochlorosilane having a general formula of Ia(R(4-m-n)SiClmHn), wherein m is 1 or 2, n is 1 or 2, the m+n value is not equal to 3, and R represents a C1-5 alkyl group. The invention discloses a method for processing silicon tetrachloride, germanium tetrachloride, titanium tetrachloride or tin tetrachloride containing at least one hydrogen-containing compound which cannot be separated through distillation, and an apparatus thereof. The invention also discloses a continuous method for preparing high-purity silicon tetrachloride, germanium tetrachloride, titanium tetrachloride or tin tetrachloride, and an apparatus and a reactor thereof.",EVONIK DEGUSSA GMBH,PETER ADLER;;K BOEMHAMMER;;HANS JUERGEN HOENE;;JOHN KAHSNITZ;;S KORSER;;JURGEN ERWIN LANG;;R MATTHESS;;JAROSLAW MONKIEWICA;;RAINER NICOLAI;;TIM POPKEN;;HANNS-PETER POPP;;HARTWIG RAULEDER;;I ROFFER;;G ROVER;;REINHOLD SCHORK;;JOACHIM SCHULER;;RAYMUND SONNENSCHEIN;;HANS-JOACHIM VAHLENSIECK,,https://lens.org/051-076-628-668-315,Patent Application,no,2,3,1,1,0,,B01J31/02;;C07F7/12,,0,0,,,,DISCONTINUED
884,WO,B1,WO 2000/045257 B1,110-509-479-914-031,2001-06-14,2001,US 0002239 W,2000-01-28,US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,EXECUTING PROGRAMS FOR A FIRST COMPUTER ARCHITECTURE ON A COMPUTER OF A SECOND ARCHITECTURE,"A computer able to execute programs coded in either of two binary instruction sets. Memory is divided into regions, and each region is marked to indicate which of the two instruction sets are to be used to execute instructions fetched from that region. The native operating system manages contexts so that the operating system for the guest instruction set architecture can context switch, even if the process being context-switched out is a process in the native instruction set. Code in the guest instruction set is profiled to determine which portions are most profitably translated into the native instruction set. Circuitry recognizes when execution of a binary in the guest instruction set has reached a flow point for which a translated native equivalent exists. Concurrency controls protect the translated native code against modification by self-modifying code or DMA writes.",ATI INT SRL;;YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;DYKE KORBIN S VAN;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,,https://lens.org/110-509-479-914-031,Patent Application,no,0,0,12,44,0,G06F9/30189;;G06F9/30174;;G06F9/3808;;G06F9/455,G06F12/08;;G06F9/30;;G06F9/455;;G06F9/46;;G06F12/10,,0,0,,,,PENDING
885,JP,A,JP 2012108938 A,092-791-767-521-76X,2012-06-07,2012,JP 2012021896 A,2012-02-03,US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,"METHOD OF REFERRING TO MEMORY OF COMPUTER, AND COMPUTER","PROBLEM TO BE SOLVED: To provide a computer with new architecture which shares the same address space with a new binary and executes an old binary without any correction.SOLUTION: The computer profiles a first computer instruction stream, analyzes the profile of the first computer instruction stream, converts only a frequency execution section of the first computer instruction stream into a second computer instruction stream, saves bit vectors including bits corresponding to respective instructions of the first computer instruction stream, monitors execution of the first computer instruction stream, moves the execution from the first computer instruction stream to the second computer instruction stream, and returns to the execution of the first computer instruction stream when the execution of the frequency execution section is completed.",ATI TECHNOLOGIES ULC,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,,https://lens.org/092-791-767-521-76X,Patent Application,no,6,1,2,44,0,,G06F9/30;;G06F9/38;;G06F9/45;;G06F9/455,,2,0,,,"JPN6012028203; 瀬古弘和: '高速エミュレーション技術-ＦＸ！３２-' 情報処理 第３８巻，第１１号（通巻３９３号）, 19971115, ｐｐ．１０２７〜１０２８, 社団法人情報処理学会;;CSNG199800179010; 瀬古弘和: '高速エミュレーション技術-ＦＸ！３２-' 情報処理 第３８巻，第１１号（通巻３９３号）, 19971115, ｐｐ．１０２７〜１０２８, 社団法人情報処理学会",INACTIVE
886,WO,A2,WO 2000/045257 A2,090-634-946-921-310,2000-08-03,2000,US 0002239 W,2000-01-28,US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,EXECUTING PROGRAMS FOR A FIRST COMPUTER ARCHITECTURE ON A COMPUTER OF A SECOND ARCHITECTURE,"A computer able to execute programs coded in either of two binary instruction sets. Memory is divided into regions, and each region is marked to indicate which of the two instruction sets are to be used to execute instructions fetched from that region. The native operating system manages contexts so that the operating system for the guest instruction set architecture can context switch, even if the process being context-switched out is a process in the native instruction set. Code in the guest instruction set is profiled to determine which portions are most profitably translated into the native instruction set. Circuitry recognizes when execution of a binary in the guest instruction set has reached a flow point for which a translated native equivalent exists. Concurrency controls protect the translated native code against modification by self-modifying code or DMA writes.",ATI INT SRL;;YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;DYKE KORBIN S VAN;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,,https://lens.org/090-634-946-921-310,Patent Application,yes,0,18,12,44,0,G06F9/30189;;G06F9/30174;;G06F9/3808;;G06F9/455,G06F12/08;;G06F9/30;;G06F9/455;;G06F9/46;;G06F12/10,,0,0,,,,PENDING
887,WO,A3,WO 2000/045257 A3,033-077-768-744-49X,2001-03-08,2001,US 0002239 W,2000-01-28,US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,EXECUTING PROGRAMS FOR A FIRST COMPUTER ARCHITECTURE ON A COMPUTER OF A SECOND ARCHITECTURE,"A computer able to execute programs coded in either of two binary instruction sets. Memory is divided into regions, and each region is marked to indicate which of the two instruction sets are to be used to execute instructions fetched from that region. The native operating system manages contexts so that the operating system for the guest instruction set architecture can context switch, even if the process being context-switched out is a process in the native instruction set. Code in the guest instruction set is profiled to determine which portions are most profitably translated into the native instruction set. Circuitry recognizes when execution of a binary in the guest instruction set has reached a flow point for which a translated native equivalent exists. Concurrency controls protect the translated native code against modification by self-modifying code or DMA writes.",ATI INT SRL;;YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;DYKE KORBIN S VAN;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,,https://lens.org/033-077-768-744-49X,Search Report,yes,2,0,12,44,0,G06F9/30174;;G06F9/30189;;G06F9/3808;;G06F9/455,G06F12/08;;G06F9/30;;G06F9/455;;G06F9/46;;G06F12/10,,0,0,,,,PENDING
888,AU,A,AU 2000/027436 A,141-148-246-096-633,2000-08-18,2000,AU 2000/027436 A,2000-01-28,US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A;;US 0002239 W,1999-01-28,Executing programs for a first computer architecture on a computer of a second architecture,,ATI INT SRL,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;DYKE KORBIN S VAN;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,,https://lens.org/141-148-246-096-633,Patent Application,no,0,0,12,44,0,G06F9/30189;;G06F9/30174;;G06F9/3808;;G06F9/455,G06F12/08;;G06F9/30;;G06F9/455;;G06F9/46;;G06F12/10,,0,0,,,,DISCONTINUED
889,EP,A1,EP 2320318 A1,162-063-762-048-75X,2011-05-11,2011,EP 10075684 A,2000-01-28,EP 00905812 A;;US 23919499 A;;US 32244399 A;;US 33226399 A;;US 33453099 A;;US 38539499 A,1999-01-28,Executing programs for a first computer architecture on a computer of a second architecture,"A method for transferring execution from a first computer instruction stream to a second computer instruction stream, comprising: 
profiling the first computer instruction stream, wherein the profiling includes recording details of the execution flow of the first computer instruction stream to create a profile of the first computer instruction stream; 
analyzing the profile of the first computer instruction stream to identify a frequently executed section; 
translating the frequently executed section of the first computer instruction stream into the second computer instruction stream; 
monitoring execution of the first computer instruction stream to determine when execution has reached the frequently executed section; 
transferring execution from the first computer instruction stream to the second computer instruction stream to execute the frequently executed section; and 
returning execution to the first computer instruction stream when execution of the frequently executed section is complete.
",ATI TECHNOLOGIES ULC,YATES JOHN S JR;;REESE DAVID L;;HOHENSEE PAUL H;;ADLER MICHAEL C;;VAN DYKE KORBIN S;;RAMESH T R;;THUSOO SHALESH;;SAUND GURJEET SINGH;;PURCELL STEPHEN C;;PATKAR NITEEN ARAVIND;;NIJHAWAN SANDEEP;;STORCH MATTHEW F;;JURICH DALE R;;CAMPBELL PAUL,"ADVANCED SILICON TECHNOLOGIES, LLC (2016-07-13)",https://lens.org/162-063-762-048-75X,Patent Application,yes,2,4,12,44,0,G06F9/30174;;G06F9/30189;;G06F9/3808;;G06F9/455,G06F9/455;;G06F12/08;;G06F9/30;;G06F9/318;;G06F9/38;;G06F9/46;;G06F12/10,,15,1,020-573-614-436-735,10.1145/265924.265930,"GRISWOLD D: ""THE JAVA(TM) HOTSPOT(TM) VIRTUAL MACHINE ARCHITECTURE"", WHITE PAPER ABOUT SUN'S SECOND GENERATION JAVA VIRTUAL MACHINE, XX, XX, 1 March 1998 (1998-03-01), pages 1 - 14, XP000962784;;VENNERS B: ""CHAPTER 1 INTRODUCTION TO JAVA'S ARCHITECTURE"", INSIDE THE JAVA 2.0 VIRTUAL MACHINE, XX, XX, 1 August 1999 (1999-08-01), pages 1 - 10, XP000962224;;""Intel Corp."", vol. 1-3, 1997, article ""INTEL ARCHITECTURE SOFTWARE DEVELOPER'S MANUAL"";;LAWRENCE KENAH; SIMON BATE: ""VAX/VMS INTERNALS AND DATA STRUCTURES"", 1984, DIGITAL PRESS;;""INTEL ARCHITECTURE SOFTWARE DEVELOPER'S MANUAL"", vol. 2, pages: 3 - 388;;""INTEL ARCHITECTURE SOFTWARE DEVELOPER'S MANUAL"", vol. 3, 1997, INTEL CORP.;;""INTEL ARCHITECTURE SOFTWARE DEVELOPER' MANUAL"", vol. 2, pages: 3 - 41;;""INTEL ARCHITECTURE SOFTWARE DEVELOPER'S MANUAL"", vol. 1-3, 1997, INTEL CORP.;;GERRY KANE: ""PA-Rl8C 2.0 ARCHITECTURE"", 1996, HEWLETT-PACKARD PROFESSIONAL BOOKS;;RICHARD L. SITES; RICHARD T. WITEK: ""THE ALPHA AXP ARCHITECTURE REFERENCE MANUAL"", 1995, DIGITAL PRESS;;DAVID A.; PATTERSON; JOHN L. HENNESSEY: ""COMPUTER ARCHITECTURE: A QUANTITATIVE APPROACH"", 1990, MORGAN KAUFMAN PUBL.;;""VAX ARCHITECTURE REFERENCE MANUAL"", 1987, DIGITAL EQUIPMENT CORP.;;PETER M. KOGGE: ""THE ARCHITECTURE OF PIPELINED COMPUTERS"", 1981, HEMISPHERE PUBL., MCGRAW HILL;;JOHN MICK; JAMES BRICK: ""BIT-SLICE MICROPROCESSOR DESIGN"", 1980, MCGRAW-HILL;;BUGNION E ET AL: ""DISCO: RUNNING COMMODITY OPERATING SYSTEMS ON SCALABLE MULTIPROCESSORS"", ACM TRANSACTIONS ON COMPUTER SYSTEMS (TOCS), ASSOCIATION FOR COMPUTING MACHINERY, INC, US, vol. 15, no. 4, 1 November 1997 (1997-11-01), pages 412 - 447, XP000765709, ISSN: 0734-2071, DOI: 10.1145/265924.265930",DISCONTINUED
890,EP,A3,EP 3295915 A3,093-369-985-128-029,2018-06-20,2018,EP 17187129 A,2017-08-21,US 201662377984 P;;US 201662435919 P;;US 201762478864 P,2016-08-22,PERCUSSION THERAPY APPARATUS AND METHODS THEREOF,"Devices, systems, and methods for percussion therapy of a patient's torso area provide percussive force to release and/or dislodge mucous from respiratory airways of a human patient. Such devices, systems, and methods may include a torso covering for securing to a patient's torso, percussive devices coupled to the torso covering, and an attachment assembly for supporting the torso covering. The percussive devices may include a percussion frame, an electromechanically actuated percussor for controlled movement between end positions, and resilient members attached to opposite ends of the percussion frame for assisting controlled movement of the percussor. The devices, systems, and methods disclosed herein provide efficient and comfortable high-frequency percussive force to a patient's torso, reducing stress on the patient and improving patient experience.
",HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENKATARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY JANE;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA SYTZE A;;RUTGERS PETRUS;;VAN DEN OEVER PETRUS J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX,,https://lens.org/093-369-985-128-029,Search Report,yes,2,0,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H23/02;;A61H23/00,,0,0,,,,ACTIVE
891,EP,B1,EP 3295915 B1,006-003-877-445-009,2020-07-15,2020,EP 17187129 A,2017-08-21,US 201662377984 P;;US 201662435919 P;;US 201762478864 P,2016-08-22,PERCUSSION THERAPY APPARATUS AND METHODS THEREOF,,HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENKATARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY JANE;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA SYTZE A;;RUTGERS PETRUS;;VAN DEN OEVER PETRUS J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX,,https://lens.org/006-003-877-445-009,Granted Patent,yes,2,0,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H23/02;;A61H23/00,,0,0,,,,ACTIVE
892,EP,A1,EP 3744304 A1,056-248-217-009-403,2020-12-02,2020,EP 20185497 A,2017-08-21,US 201662377984 P;;US 201662435919 P;;US 201762478864 P;;EP 17187129 A,2016-08-22,PERCUSSION THERAPY APPARATUS AND METHODS THEREOF,"Devices, systems, and methods for percussion therapy of a patient's torso area provide percussive force to release and/or dislodge mucous from respiratory airways of a human patient. Such devices, systems, and methods may include a torso covering for securing to a patient's torso, percussive devices coupled to the torso covering, and an attachment assembly for supporting the torso covering. The percussive devices may include a percussion frame, an electromechanically actuated percussor for controlled movement between end positions, and resilient members attached to opposite ends of the percussion frame for assisting controlled movement of the percussor. The devices, systems, and methods disclosed herein provide efficient and comfortable high-frequency percussive force to a patient's torso, reducing stress on the patient and improving patient experience.
",HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENKATARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY JANE;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA SYTZE A;;RUTGERS PETRUS;;VAN DEN OEVER PETRUS J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX,,https://lens.org/056-248-217-009-403,Patent Application,yes,4,1,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H23/02;;A61H23/00,,0,0,,,,PENDING
893,EP,A2,EP 3295915 A2,138-051-168-871-833,2018-03-21,2018,EP 17187129 A,2017-08-21,US 201662377984 P;;US 201662435919 P;;US 201762478864 P,2016-08-22,PERCUSSION THERAPY APPARATUS AND METHODS THEREOF,"Devices, systems, and methods for percussion therapy of a patient's torso area provide percussive force to release and/or dislodge mucous from respiratory airways of a human patient. Such devices, systems, and methods may include a torso covering for securing to a patient's torso, percussive devices coupled to the torso covering, and an attachment assembly for supporting the torso covering. The percussive devices may include a percussion frame, an electromechanically actuated percussor for controlled movement between end positions, and resilient members attached to opposite ends of the percussion frame for assisting controlled movement of the percussor. The devices, systems, and methods disclosed herein provide efficient and comfortable high-frequency percussive force to a patient's torso, reducing stress on the patient and improving patient experience.
",HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENKATARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY JANE;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA SYTZE A;;RUTGERS PETRUS;;VAN DEN OEVER PETRUS J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX,,https://lens.org/138-051-168-871-833,Patent Application,yes,0,0,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H23/02;;A61H23/00,,0,0,,,,ACTIVE
894,US,A1,US 2022/0241138 A1,073-301-066-397-133,2022-08-04,2022,US 202217724709 A,2022-04-20,US 202217724709 A;;US 201715672346 A;;US 201662377984 P;;US 201662435919 P;;US 201762478864 P,2016-08-22,VEST APPARATUS FOR PROVIDING VIBRATIONAL STIMULUS,"Devices, systems, and methods for percussion therapy of a patient's torso area provide percussive force to release and/or dislodge mucous from respiratory airways of a human patient. Such devices, systems, and methods may include a torso covering for securing to a patient's torso, percussive devices coupled to the torso covering, and an attachment assembly for supporting the torso covering. The percussive devices may include a percussion frame, an electromechanically actuated percussor for controlled movement between end positions, and resilient members attached to opposite ends of the percussion frame for assisting controlled movement of the percussor. The devices, systems, and methods disclosed herein provide efficient and comfortable high-frequency percussive force to a patient's torso, reducing stress on the patient and improving patient experience.",HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENKATARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY J;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA STYZE;;RUTGERS PETRUS T;;VAN DEN OEVER PETER J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX,,https://lens.org/073-301-066-397-133,Patent Application,yes,10,1,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H9/00;;A61H7/00;;A61H23/00;;A61H23/02,,0,0,,,,PENDING
895,US,B2,US 11471366 B2,018-744-785-442-146,2022-10-18,2022,US 201715672346 A,2017-08-09,US 201715672346 A;;US 201662377984 P;;US 201662435919 P;;US 201762478864 P,2016-08-22,Percussion therapy apparatus and methods thereof,"Devices, systems, and methods for percussion therapy of a patient's torso area provide percussive force to release and/or dislodge mucous from respiratory airways of a human patient. Such devices, systems, and methods may include a torso covering for securing to a patient's torso, percussive devices coupled to the torso covering, and an attachment assembly for supporting the torso covering. The percussive devices may include a percussion frame, an electromechanically actuated percussor for controlled movement between end positions, and resilient members attached to opposite ends of the percussion frame for assisting controlled movement of the percussor. The devices, systems, and methods disclosed herein provide efficient and comfortable high-frequency percussive force to a patient's torso, reducing stress on the patient and improving patient experience.",HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENTAKARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY J;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA SYTZE A;;VAN DEN OEVER PETRUS J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX;;RUTGERS PETRUS T,,https://lens.org/018-744-785-442-146,Granted Patent,yes,158,1,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H9/00;;A61H7/00;;A61H23/00;;A61H23/02,,9,1,009-055-028-191-685,10.1378/chest.115.4.1120;;10208218,"International Biophysics Corporation; AffloVest Instructions for Use and Owner's Manual; Jun. 13, 2013; AffloVest.com (Year: 2013 ).;;Extended European Search Report for European Patent Application No. 17187129.6 dated May 18, 2018; 10 pages.;;The “VibraVest” by OxyCare GmbH, VibraVest_engl_web.pdf, Nov. 23, 2011 (3 pages).;;International Biophysics Corporation—“AffloVest Answering Needs: The Role of the AffloVest in the Respiratory Market,” AffloVest White Paper; 12 pages.;;Rubin, Bruce K.; “Emerging Therapies for Cystic Fibrosis Lung Disease;” Chest 1999; 115:1120-1126 (7 pages).;;AffloVest Instructions for Use and Owner's Manual, AffloVest.com; document created Jun. 24, 2013 (18 pages).;;Clinical Study of the AffloVest, Mar. 2013 (6 pages).;;Extended European Search Report for European Patent Application No. 20185497.3 dated Nov. 2, 2020 (8 pages).;;Partial European Search Report for European Patent Application No. 1718729.6, dated Feb. 12, 2018; 13 pages.",ACTIVE
896,US,A1,US 2018/0049939 A1,154-607-173-716-337,2018-02-22,2018,US 201715672346 A,2017-08-09,US 201715672346 A;;US 201662377984 P;;US 201662435919 P;;US 201762478864 P,2016-08-22,PERCUSSION THERAPY APPARATUS AND METHODS THEREOF,"Devices, systems, and methods for percussion therapy of a patient's torso area provide percussive force to release and/or dislodge mucous from respiratory airways of a human patient. Such devices, systems, and methods may include a torso covering for securing to a patient's torso, percussive devices coupled to the torso covering, and an attachment assembly for supporting the torso covering. The percussive devices may include a percussion frame, an electromechanically actuated percussor for controlled movement between end positions, and resilient members attached to opposite ends of the percussion frame for assisting controlled movement of the percussor. The devices, systems, and methods disclosed herein provide efficient and comfortable high-frequency percussive force to a patient's torso, reducing stress on the patient and improving patient experience.",HILL ROM SERVICES PTE LTD,BOBEY JOHN A;;CHNG BRYAN;;ONG KOK BOON R;;CABRAL HAROLD M;;BARILEA DENY D;;VENTAKARAYA SURESHA;;TAN WEI T;;PIRIO CLEMENTINE;;MANN NICHOLAS;;BOERST CHAD M;;ROSSINI MARY J;;SIN DENIS;;JOSHI VINAY;;TJEPKEMA DIRK;;SPIJKSMA SYTZE A;;VAN DEN OEVER PETRUS J;;ADLER ARI T;;STEWART WILLIAM C;;ROBINSON JASON;;PROULX TIMOTHY R;;STAUDT ALEX;;RUTGERS PETRUS T,,https://lens.org/154-607-173-716-337,Patent Application,yes,0,17,7,7,0,A61H23/0218;;A61H2023/002;;A61H2201/123;;A61H2201/165;;A61H2201/1664;;A61H23/006;;A61H2201/123;;A61H2201/165;;A61H2023/002;;A61H2201/1664;;A61H23/0218;;A61H23/006;;A61H7/004;;A61H9/005;;A61H2201/0134,A61H9/00;;A61H7/00,,0,0,,,,ACTIVE
897,CN,A,CN 116027943 A,174-725-016-239-402,2023-04-28,2023,CN 202310042931 A,2021-03-31,DK PA202070633 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;CN 202180040304 A;;US 2021/0025051 W,2020-04-10,User interface for enabling activities,"The present disclosure generally relates to user interfaces for enabling activities. In some embodiments, an exemplary user interface for invoking activities associated with an application is described. In some embodiments, an exemplary user interface is described for customizing display content based on a situation in which the content is invoked. In some embodiments, an exemplary user interface for managing an application for enabling an activity is described. In some embodiments, an exemplary user interface is described for managing settings for an activity-enabled application.",APPLE INC,ZHANG YU;;ABBASIAN REZA;;ADLER DORON;;CHEN ALVIN;;COFFMAN PATRICK L;;DOHERTY NIRANJAN S;;DUBOIS DANIEL J;;ETZEL CHRISTOPHER B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KAREN A A;;FOSS CHRISTOPHER PATRICK;;GARABALLI SAM H;;GOLDBERG BRIAN E;;KHAN NAWAZ A;;KO HEENA;;KOWALCZYKOWSKI KEVIN P;;MEHRA RAJDEEP;;PAUL GRANT;;RAMASWAMY PRASANNA;;RICCI GIOVANNI;;ROBBIN JEFFREY L;;SAVAGE JOHN S;;SIBSON MICHAEL;;SINGH GURPREET;;STACK CAELAN G;;XUE MINGZHE M;;YIN LUMING;;YING CHANGHAN HOBIE;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;A C DAY,,https://lens.org/174-725-016-239-402,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/04817;;G06F3/0482;;G06F3/0488,,0,0,,,,PENDING
898,CN,A,CN 115943359 A,003-912-882-819-30X,2023-04-07,2023,CN 202180040304 A,2021-03-31,DK PA202070633 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;US 2021/0025051 W,2020-04-10,User interface for enabling activities,"The present disclosure generally relates to a user interface for enabling activities using a computer system. In some embodiments, an exemplary user interface for invoking activities associated with an application is described. In some embodiments, an exemplary user interface is described for customizing display content based on a situation in which the content is invoked. In some embodiments, an exemplary user interface for managing an application for enabling an activity is described. In some embodiments, an exemplary user interface is described for managing settings for an activity-enabled application.",APPLE INC,ZHANG YU;;ABBASIAN REZA;;ADLER DORON;;CHEN ALVIN;;COFFMAN PATRICK L;;DOHERTY NIRANJAN S;;DUBOIS DANIEL J;;ETZEL CHRISTOPHER B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KAREN A A;;FOSS CHRISTOPHER PATRICK;;GARABALLI SAM H;;GOLDBERG BRIAN E;;KHAN NAWAZ A;;KO HEENA;;KOWALCZYKOWSKI KEVIN P;;MEHRA RAJDEEP;;PAUL GRANT;;RAMASWAMY PRASANNA;;RICCI GIOVANNI;;ROBBIN JEFFREY L;;SAVAGE JOHN S;;SIBSON MICHAEL;;SINGH GURPREET;;STACK CAELAN G;;XUE MINGZHE M;;YIN LUMING;;YING CHANGHAN HOBIE;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;A C DAY,,https://lens.org/003-912-882-819-30X,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,PENDING
